cprd bibliography

CPRD bibliography

Last updated 6 May 2022

cprd.com/bibliography

http://www.cprd.com/bibliography

2022

Baptiste, P., Wong, A., Schultze, A., Cunnington, M., Mann, J., Clase, C., Leyrat, C., Tomlinson, L.,

& Wing, K. (2022). Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a

UK cohort study using routinely collected electronic health records with validation against the

ONTARGET trial. BMJ Open, 12(3), e051907. https://doi.org/10.1136/bmjopen-2021-051907

Vounzoulaki, E., Khunti, K., Miksza, J., Tan, B., Davies, M., & Gillies, C. (2022). Screening for type

2 diabetes after a diagnosis of gestational diabetes by ethnicity: A retrospective cohort study.

Prim Care Diabetes. https://doi.org/10.1016/j.pcd.2022.03.008

van Veelen, A., Abtahi, S., Souverein, P., Driessen, J. H. M., Klungel, O. H., Dingemans, A. C., van

Geel, R., de Vries, F., & Croes, S. (2022). Characteristics of patients with lung cancer in clinical

practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or

immune checkpoint inhibitors. Cancer Epidemiol, 78, 102149.

https://doi.org/10.1016/j.canep.2022.102149

van Sloten, T. T., Souverein, P. C., Stehouwer, C. D., & Driessen, J. H. (2022). Angiotensin-

converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among

older people with hypertension. J Psychopharmacol, 2698811221082470.

https://doi.org/10.1177/02698811221082470

Suissa, S., Dell’Aniello, S., & Ernst, P. (2022). Discontinuation of Inhaled Corticosteroids from

Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. Copd,

19(1), 133–141. https://doi.org/10.1080/15412555.2022.2045265

Suissa, S., Dell’Aniello, S., & Ernst, P. (2022). Fluticasone-Based versus Budesonide-Based Triple

Therapies in COPD: Real-World Comparative Effectiveness and Safety. Copd, 19(1), 109–117.

https://doi.org/10.1080/15412555.2022.2035705

Strongman, H., Gadd, S., Matthews, A. A., Mansfield, K. E., Stanway, S., Lyon, A. R., Dos-Santos-

Silva, I., Smeeth, L., & Bhaskaran, K. (2022). Does Cardiovascular Mortality Overtake Cancer

Mortality During Cancer Survivorship?: An English Retrospective Cohort Study. JACC

CardioOncol, 4(1), 113–123. https://doi.org/10.1016/j.jaccao.2022.01.102

Stafford, M., Knight, H., Hughes, J., Alarilla, A., Mondor, L., Pefoyo Kone, A., Wodchis, W. P., &

Deeny, S. R. (2022). Associations between multiple long-term conditions and mortality in

diverse ethnic groups. PLoS One, 17(4), e0266418.

https://doi.org/10.1371/journal.pone.0266418

Penner, L. S., Gavan, S. P., Ashcroft, D. M., Peek, N., & Elliott, R. A. (2022). Does co-prescribing

non-steroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major

bleeding, stroke and systemic embolism? Br J Clin Pharmacol.

https://doi.org/10.1111/bcp.15371

Morales, D. R., Moreno-Martos, D., Matin, N., & McGettigan, P. (2022). Health conditions in adults

with HIV compared with the general population: A population-based cross-sectional analysis.

EClinicalMedicine, 47, 101392. https://doi.org/10.1016/j.eclinm.2022.101392

Lu, S., Yin, H., Yu, O. H. Y., & Azoulay, L. (2022). Incretin-Based Drugs and the Incidence of

Prostate Cancer Among Patients with Type 2 Diabetes. Epidemiology.

https://doi.org/10.1097/ede.0000000000001486

CPRD bibliography

2

Launders, N., Hayes, J. F., Price, G., & Osborn, D. P. J. (2022). Clustering of physical health

multimorbidity in people with severe mental illness: An accumulated prevalence analysis of

United Kingdom primary care data. PLoS Med, 19(4), e1003976.

https://doi.org/10.1371/journal.pmed.1003976

Khosrow-Khavar, F., Azoulay, L., Montastruc, J. L., Montastruc, F., & Renoux, C. (2022). Aromatase

inhibitors and the incidence of Parkinson disease: A population-based cohort study. Cancer.

https://doi.org/10.1002/cncr.34208

Hope, H., Pierce, M., Johnstone, E. D., Myers, J., & Abel, K. M. (2022). The sexual and reproductive

health of women with mental illness: a primary care registry study. Arch Womens Ment Health.

https://doi.org/10.1007/s00737-022-01214-y

Haroon, S., Nirantharakumar, K., Hughes, S. E., Subramanian, A., Aiyegbusi, O. L., Davies, E. H.,

Myles, P., Williams, T., Turner, G., Chandan, J. S., McMullan, C., Lord, J., Wraith, D. C.,

McGee, K., Denniston, A. K., Taverner, T., Jackson, L. J., Sapey, E., Gkoutos, G., … Calvert,

M. (2022). Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-

reported outcomes and immunology to targeted therapies (The TLC Study). BMJ Open, 12(4),

e060413. https://doi.org/10.1136/bmjopen-2021-060413

Foley, K. A., Maile, E. J., Bottle, A., Neale, F. K., Viner, R., Kenny, S. E., Majeed, A., Hargreaves,

D. S., & Saxena, S. (2022). Impact of covid-19 on primary care contacts with children and

young people aged 0-24 years in England; longitudinal trends study 2015-2020. British Journal

of General Practice. https://doi.org/10.3399/BJGP.2021.0643

Elwenspoek, M. M. C., O’Donnell, R., Jackson, J., Everitt, H., Gillett, P., Hay, A. D., Jones, H. E.,

Robins, G., Watson, J. C., Mallett, S., & Whiting, P. (2022). Development and external

validation of a clinical prediction model to aid coeliac disease diagnosis in primary care: An

observational study. EClinicalMedicine, 46, 101376.

https://doi.org/10.1016/j.eclinm.2022.101376

Danese, M., Sidelnikov, E., Villa, G., Catterick, D., Iqbal, M., Gleeson, M., Lubeck, D., & Patel, J.

(2022). Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with

cardiovascular disease treated with lipid-lowering therapy in the UK. BMJ Open, 12(4),


Chang, W. H., Katsoulis, M., Tan, Y. Y., Mueller, S. H., Green, K., & Lai, A. G. (2022). Late effects

of cancer in children, teenagers and young adults: Population-based study on the burden of 183

conditions, in-patient and critical care admissions and years of life lost. Lancet Reg Health Eur,

12, 100248. https://doi.org/10.1016/j.lanepe.2021.100248

Bilitou, A., Were, J., Farrer, A., Rabe, A., Ming, S. W. Y., Haq, I., & Dunton, K. (2022). Prevalence

and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK:

Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019. Clinicoecon

Outcomes Res, 14, 189–203. https://doi.org/10.2147/ceor.s347085

Baksh, R. A., Strydom, A., Pape, S. E., Chan, L. F., & Gulliford, M. C. (2022). Susceptibility to

COVID-19 Diagnosis in People with Down Syndrome Compared to the General Population:

Matched-Cohort Study Using Primary Care Electronic Records in the UK. J Gen Intern Med, 1–

7. https://doi.org/10.1007/s11606-022-07420-9

Alkabbani, W., Zongo, A., Minhas-Sandhu, J. K., Eurich, D. T., Shah, B. R., Alsabbagh, M. W., &

Gamble, J. M. (2022). Five comparative cohorts to assess the risk of genital tract infections

CPRD bibliography

3

associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus.

Diabet Med, e14858. https://doi.org/10.1111/dme.14858

Dziopa, K., Asselbergs, F. W., Gratton, J., Chaturvedi, N., & Schmidt, A. F. (2022). Cardiovascular

risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings.

Diabetologia, 65(4), 644–656. https://doi.org/10.1007/s00125-021-05640-y

Joseph, R. M., Jack, R. H., Morriss, R., Knaggs, R. D., Butler, D., Hollis, C., Hippisley-Cox, J., &

Coupland, C. (2022). The risk of all-cause and cause-specific mortality in people prescribed

mirtazapine: an active comparator cohort study using electronic health records. BMC Med,

20(1), 43. https://doi.org/10.1186/s12916-022-02247-x

Tran, C. T., Bøg, M., Collings, S. L., Johnson, M., Qizilbash, N., Lind, S., Baker, R. A., & Jorgensen,

K. T. (2022). Antipsychotic treatment patterns in Alzheimer{\textquoteright}s disease patients

with agitation: a cohort study using the UK clinical practice research datalink. Curr Med Res

Opin, 1–8. https://doi.org/10.1080/03007995.2022.2029381

Pradhan, R., Patorno, E., Tesfaye, H., Schneeweiss, S., Yin, H., Franklin, J., Pawar, A., Santella, C.,

Yu, O. H. Y., Renoux, C., & Azoulay, L. (2022). Glucagon-Like Peptide-1 Receptor Agonists

and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-

Based Cohort Study. Am J Epidemiol. https://doi.org/10.1093/aje/kwac021

Ozen, G., Dell’Aniello, S., Pedro, S., Michaud, K., & Suissa, S. (2022). Reduction of Cardiovascular

Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with

Rheumatoid Arthritis. Arthritis Care Res (Hoboken). https://doi.org/10.1002/acr.24866

Wright, A. K., Carr, M. J., Kontopantelis, E., Leelarathna, L., Thabit, H., Emsley, R., Buchan, I.,

Mamas, M. A., van Staa, T. P., Sattar, N., Ashcroft, D. M., & Rutter, M. K. (2022). Primary

Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor

Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care.

https://doi.org/10.2337/dc21-1113

Zheng, B., Su, B., Udeh-Momoh, C., Price, G., Tzoulaki, I., Vamos, E. P., Majeed, A., Riboli, E.,

Ahmadi-Abhari, S., & Middleton, L. T. (2022). Associations of Cardiovascular and Non-

Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a

Large UK Cohort Study. J Prev Alzheimers Dis, 9(1), 86–91.

https://doi.org/10.14283/jpad.2022.8

Abhishek, A., Tata, L. J., Mamas, M., & Avery, A. J. (2022). Has the gout epidemic peaked in the

UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from

1997 to across the COVID-19 pandemic in 2021. Ann Rheum Dis.

https://doi.org/10.1136/annrheumdis-2021-221989

Wolf, S., Chitnis, A. S., Manoranjith, A., Vanderkarr, M., Plaza, J. Q., Gador, L. V, Holy, C. E.,

Sparks, C., & Lambert, S. M. (2022). Surgical treatment, complications, reoperations, and

healthcare costs among patients with clavicle fracture in England. BMC Musculoskelet Disord,

23(1), 135. https://doi.org/10.1186/s12891-022-05075-5

Campbell, J., Bhaskaran, K., Thomas, S., Williams, R., McDonald, H. I., & Minassian, C. (2022).

Investigating the optimal handling of uncertain pregnancy episodes in the CPRD GOLD

Pregnancy Register: a methodological study using UK primary care data. BMJ Open, 12(2),


CPRD bibliography

4

Bloom, C. I., Montonen, J., Jöns, O., Garry, E. M., & Bhatt, S. P. (2022). Treatment Transitions in

Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare

Databases. Pulm Ther. https://doi.org/10.1007/s41030-021-00180-7

Foch, C., Allignol, A., Hohenberger, T., Boutmy, E., Schaefer, S., & Hostalek, U. (2022).

Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort

study in the Clinical Practice Research Datalink. J Comp Eff Res. https://doi.org/10.2217/cer-

2021-0305

Tazare, J., Wyss, R., Franklin, J. M., Smeeth, L., Evans, S. J. W., Wang, S. V, Schneeweiss, S.,

Douglas, I. J., Gagne, J. J., & Williamson, E. J. (2022). Transparency of high-dimensional

propensity score analyses: guidance for diagnostics and reporting. Pharmacoepidemiol Drug

Saf. https://doi.org/10.1002/pds.5412

Yu, D., Missen, M., Jordan, K. P., Edwards, J. J., Bailey, J., Wilkie, R., Fitzpatrick, J., Ali, N.,

Niblett, P., & Peat, G. (2022). Trends in the Annual Consultation Incidence and Prevalence of

Low Back Pain and Osteoarthritis in England from 2000 to 2019: Comparative Estimates from

Two Clinical Practice Databases. Clin Epidemiol, 14, 179–189.

https://doi.org/10.2147/clep.s337323

Bhavsar, A., Aris, E., Harrington, L., Simeone, J. C., Ramond, A., Lambrelli, D., Papi, A., Boulet, L.

P., Meszaros, K., Jamet, N., Sergerie, Y., & Mukherjee, P. (2022). Burden of Pertussis in

Individuals with a Diagnosis of Asthma: A Retrospective Database Study in England. J Asthma

Allergy, 15, 35–51. https://doi.org/10.2147/jaa.s335960

Abner, S., Gillies, C. L., Shabnam, S., Zaccardi, F., Seidu, S., Davies, M. J., Adeyemi, T., Khunti, K.,

& Webb, D. R. (2022). Consultation rates in people with type 2 diabetes with and without

vascular complications: a retrospective analysis of 141,328 adults in England. Cardiovasc

Diabetol, 21(1), 8. https://doi.org/10.1186/s12933-021-01435-y

Ayodele, O. A., Cabral, H. J., McManus, D. D., & Jick, S. S. (2022). Glucocorticoids and Risk of

Venous Thromboembolism in Asthma Patients Aged 20-59 Years in the United

Kingdom{\textquoteright}s CPRD 1995-2015. Clin Epidemiol, 14, 83–93.


Hageman, S. H. J., McKay, A. J., Ueda, P., Gunn, L. H., Jernberg, T., Hagström, E., Bhatt, D. L.,

Steg, P. G., Läll, K., Mägi, R., Nordbø Gynnild, M., Ellekjær, H., Saltvedt, I., Tuñón, J.,

Mahíllo, I., Aceña, Á., Kaminski, K., Chlabicz, M., Sawicka, E., … Visseren, F. L. J. (2022).

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established

cardiovascular disease: the updated SMART2 algorithm. Eur Heart J.

https://doi.org/10.1093/eurheartj/ehac056

Herrett, E., Strongman, H., Gadd, S., Tomlinson, L., Nitsch, D., Bhaskaran, K., Williamson, E., Van

Staa, T., Sofat, R., Timmis, A., Wells, S., Smeeth, L., & Jackson, R. (2022). The importance of

blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of

cardiovascular disease: a cohort study in English primary care. Lancet Healthy Longev, 3(1),

e22–e30. https://doi.org/10.1016/s2666-7568(21)00281-6

Steeg, S., Carr, M., Trefan, L., Ashcroft, D., Kapur, N., Nielsen, E., McMillan, B., & Webb, R.

(2022). Primary care clinical management following self-harm during the first wave of COVID-

19 in the UK: population-based cohort study. BMJ Open, 12(2), e052613.

https://doi.org/10.1136/bmjopen-2021-052613

CPRD bibliography

5

Strongman, H., Carreira, H., De Stavola, B. L., Bhaskaran, K., & Leon, D. A. (2022). Factors

associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the

UK: A time series analysis using the Clinical Practice Research Datalink. PLoS Med, 19(1),

e1003870. https://doi.org/10.1371/journal.pmed.1003870

Swain, S., Coupland, C., Strauss, V., Mallen, C., Kuo, C. F., Sarmanova, A., Bierma-Zeinstra, S. M.

A., Englund, M., Prieto-Alhambra, D., Doherty, M., & Zhang, W. (2022). Clustering of

comorbidities and associated outcomes in people with osteoarthritis - A UK Clinical Practice

Research Datalink study. Osteoarthritis Cartilage. https://doi.org/10.1016/j.joca.2021.12.013

Weiss, T., Yang, L., Carr, R. D., Pal, S., Sawhney, B., Boggs, R., Rajpathak, S., & Iglay, K. (2022).

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes

initiating glucagon-like peptide-1 receptor agonists in the UK. BMJ Open Diabetes Res Care,

10(1). https://doi.org/10.1136/bmjdrc-2021-002517

SH, R. C., Meier, C., Jick, S. S., Meier, C. R., & Becker, C. (2022). Association between glycemic

control and risk of venous thromboembolism in diabetic patients: a nested case-control study.

Cardiovasc Diabetol, 21(1), 2. https://doi.org/10.1186/s12933-021-01432-1

Delgado, J., Evans, P. H., Gray, D. P., Sidaway-Lee, K., Allan, L., Clare, L., Ballard, C., Masoli, J.,

Valderas, J. M., & Melzer, D. (2022). Continuity of GP care for patients with dementia: impact

on prescribing and the health of patients. Br J Gen Pract, 72(715), e91–e98.

https://doi.org/10.3399/bjgp.2021.0413

Morgan, C. L., Thomas, M., Ständer, S., Jabbar-Lopez, Z. K., Piketty, C., Gabriel, S., Currie, C., &

Puelles, J. (2022). Epidemiology of prurigo nodularis in England: a retrospective database

analysis. Br J Dermatol. https://doi.org/10.1111/bjd.21032

Pradhan, R., Yu, O., Platt, R. W., & Azoulay, L. (2022). Long-Term patterns of cancer incidence

among patients with and without type 2 diabetes in the United Kingdom. Diabetes Res Clin

Pract, 185, 109229. https://doi.org/10.1016/j.diabres.2022.109229

Iyen, B., Vinogradova, Y., Akyea, R. K., Weng, S., Qureshi, N., & Kai, J. (2022). Ethnic disparities in

mortality among overweight or obese adults with newly diagnosed type 2 diabetes: a population-

based cohort study. J Endocrinol Invest. https://doi.org/10.1007/s40618-021-01736-9

Lemp, J. M., Nuthanapati, M. P., Bärnighausen, T. W., Vollmer, S., Geldsetzer, P., & Jani, A. (2022).

Use of lifestyle interventions in primary care for individuals with newly diagnosed hypertension,

hyperlipidaemia or obesity: a retrospective cohort study. J R Soc Med, 1410768221077381.

https://doi.org/10.1177/01410768221077381

Pradhan, R., Yin, H., Yu, O., & Azoulay, L. (2022). Glucagon-Like Peptide 1 Receptor Agonists and

Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease

Among Patients With Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc21-1953

Bornand, D., Reinau, D., Jick, S. S., & Meier, C. R. (2022). β-Blockers and the Risk of Depression: A

Matched Case-Control Study. Drug Saf. https://doi.org/10.1007/s40264-021-01140-5

Nealon, J., Modin, D., Ghosh, R. E., Rudin, D., Gislason, G., Booth, H. P., Jensen, J. U. S., Williams,

R., Shepherd, H., Yelland, E., Bricout, H., Chaves, S. S., & Biering-Sørensen, T. (2022). The

feasibility of pragmatic influenza vaccine randomized controlled real-world trials in Denmark

and England. NPJ Vaccines, 7(1), 25. https://doi.org/10.1038/s41541-022-00444-6

CPRD bibliography

6

Adesanya, E., Cook, S., Crellin, E., Langan, S., Mansfield, K., Smeeth, L., & Herrett, E. (2022).

Alcohol use recording in adults with depression in English primary care: a cross-sectional study.

BMJ Open, 12(1), e055975. https://doi.org/10.1136/bmjopen-2021-055975

Gayle, A. V, Minelli, C., & Quint, J. K. (2022). Respiratory-related death in individuals with incident

asthma and COPD: a competing risk analysis. BMC Pulm Med, 22(1), 28.

https://doi.org/10.1186/s12890-022-01823-4

Clarke, C. S., Williamson, E., Denaxas, S., Carpenter, J. R., Thomas, M., Blackshaw, H., Schilder, A.

G. M., Philpott, C. M., Hopkins, C., & Morris, S. (2022). Observational retrospective study

calculating health service costs of patients receiving surgery for chronic rhinosinusitis in

England, using linked patient-level primary and secondary care electronic data. BMJ Open,

12(2), e055603. https://doi.org/10.1136/bmjopen-2021-055603

Lee, S. I., Azcoaga-Lorenzo, A., Agrawal, U., Kennedy, J. I., Fagbamigbe, A. F., Hope, H.,

Subramanian, A., Anand, A., Taylor, B., Nelson-Piercy, C., Damase-Michel, C., Yau, C.,

Crowe, F., Santorelli, G., Eastwood, K. A., Vowles, Z., Loane, M., Moss, N., Brocklehurst, P.,

… McCowan, C. (2022). Epidemiology of pre-existing multimorbidity in pregnant women in the

UK in 2018: a population-based cross-sectional study. BMC Pregnancy Childbirth, 22(1), 120.

https://doi.org/10.1186/s12884-022-04442-3

Khalid, S., Calderon-Larranaga, S., Sami, A., Hawley, S., Judge, A., Arden, N., Van Staa, T. P.,

Cooper, C., Abrahamsen, B., Javaid, M. K., & Prieto-Alhambra, D. (2022). Comparative risk of

acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of

propensity-matched cohort findings from the UK Clinical Practice Research Database and the

Catalan SIDIAP Database. Osteoporos Int. https://doi.org/10.1007/s00198-021-06262-1

Warren-Gash, C., Williamson, E., Shiekh, S. I., Borjas-Howard, J., Pearce, N., Breuer, J. M., &

Smeeth, L. (2022). No evidence that herpes zoster is associated with increased risk of dementia

diagnosis. Ann Clin Transl Neurol. https://doi.org/10.1002/acn3.51525

Ashdown, H. F., Smith, M., McFadden, E., Pavord, I. D., Butler, C. C., & Bafadhel, M. (2022). Blood

eosinophils to guide inhaled maintenance therapy in a primary care COPD population. ERJ

Open Res, 8(1). https://doi.org/10.1183/23120541.00606-2021

Bloom, C. I., Montonen, J., Jöns, O., Garry, E. M., & Bhatt, S. P. (2022). First Maintenance Therapy

for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare

Databases. Pulm Ther. https://doi.org/10.1007/s41030-021-00179-0

Whittaker, H., Rubino, A., Mullerova, H., Morris, T., Varghese, P., Xu, Y., de Nigris, E., & Quint, J.

(2022). Frequency and Severity of Exacerbations of COPD Associated with Future Risk of

Exacerbations and Mortality: A UK Routine Health Care Data Study. Int J Chron Obstruct

Pulmon Dis, 17, 427–437. https://doi.org/10.2147/copd.s346591

Watt, T., Sullivan, R., & Aggarwal, A. (2022). Primary care and cancer: an analysis of the impact and

inequalities of the COVID-19 pandemic on patient pathways. BMJ Open, 12(3), e059374.


Smith, L., Garriga, C., Kingsbury, S., Pinedo-Villanueva, R., Delmestri, A., Arden, N., Stone, M.,

Conaghan, P., & Judge, A. (2022). UK poSt Arthroplasty Follow-up rEcommendations (UK

SAFE): what does analysis of linked, routinely collected national data sets tell us about mid-late

term revision risk after hip replacement? Retrospective cohort study. BMJ Open, 12(3),


CPRD bibliography

7

Guedes, S., Bricout, H., Langevin, E., Tong, S., & Bertrand-Gerentes, I. (2022). Epidemiology of

invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to

2017 - a secondary database analysis. BMC Public Health, 22(1), 521.

https://doi.org/10.1186/s12889-022-12933-3

Archer, C., MacNeill, S., Mars, B., Turner, K., Kessler, D., & Wiles, N. (2022). Rise in prescribing

for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using

Clinical Practice Research Datalink. Br J Gen Pract. https://doi.org/10.3399/bjgp.2021.0561

James, G., Kim, J., Mellström, C., Ford, K., Jenkins, N., Tsang, C., Evans, M., & McEwan, P. (2022).

Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal

disease or diabetes: a retrospective UK database study. Clin Kidney J, 15(4), 758–770.

https://doi.org/10.1093/ckj/sfab225

Van Staa, T., Li, Y., Gold, N., Chadborn, T., Welfare, W., Palin, V., Ashcroft, D. M., & Bircher, J.

(2022). Comparing antibiotic prescribing between clinicians in UK primary care: an analysis in a

cohort study of eight different measures of antibiotic prescribing. BMJ Qual Saf.

https://doi.org/10.1136/bmjqs-2020-012108

Ayele, H., Douros, A., & Filion, K. (2022). 5-α reductase inhibitors and the risk of anaemia among

men with benign prostatic hyperplasia: A population-based cohort study. Br J Clin Pharmacol.


Jordan, K., Rathod-Mistry, T., Bailey, J., Chen, Y., Clarson, L., Denaxas, S., Hayward, R.,

Hemingway, H., van der Windt, D., & Mamas, M. (2022). Long-Term Cardiovascular Risk and

Management of Patients Recorded in Primary Care With Unattributed Chest Pain: An Electronic

Health Record Study. J Am Heart Assoc, 11(7), e023146.

https://doi.org/10.1161/jaha.121.023146

Yang, Z., Toh, S., Li, X., Edwards, D., Brayne, C., & Mant, J. (2022). Statin use is associated with

lower risk of dementia in stroke patients: a community-based cohort study with inverse

probability weighted marginal structural model analysis. Eur J Epidemiol.

https://doi.org/10.1007/s10654-022-00856-7

Jayasooriya, N., Blackwell, J., Saxena, S., Bottle, A., Petersen, I., Creese, H., Hotopf, M., & Pollok,

R. (2022). Antidepressant medication use in Inflammatory Bowel Disease: a nationally

representative population-based study. Aliment Pharmacol Ther.

https://doi.org/10.1111/apt.16820

Smith, L., Garriga, C., Kingsbury, S., Pinedo-Villanueva, R., Delmestri, A., Arden, N., Stone, M.,

Conaghan, P., & Judge, A. (2022). UK poSt Arthroplasty Follow-up rEcommendations (UK

SAFE): what does analysis of linked, routinely collected national datasets tell us about mid-late

term revision risk after knee replacement? BMJ Open, 12(3), e046900.


Mueller, A., Meier, C., Jick, S., & Schneider, C. (2022). Characterization of the deterioration of

diabetes control in patients with a subsequent diagnosis of pancreatic cancer: A descriptive

study. Pancreatology. https://doi.org/10.1016/j.pan.2022.03.012

Hope, H., Pierce, M., Osam, C., Morgan, C., John, A., & Abel, K. (2022). Self-harm risk in

pregnancy: recurrent-event survival analysis using UK primary care data. Br J Psychiatry, 1–7.

https://doi.org/10.1192/bjp.2022.31

CPRD bibliography

8

Tyrer, F., Bhaskaran, K., & Rutherford, M. (2022). Immortal time bias for life-long conditions in

retrospective observational studies using electronic health records. BMC Med Res Methodol,

22(1), 86. https://doi.org/10.1186/s12874-022-01581-1

Rivero-Ferrer, E., Olesen, M., Plana, E., Aguado, J., Saigi-Morgui, N., Rubino, A., Daoud, S., Lei, A.,

Perez-Gutthann, S., Schink, T., Kristiansen, N., Hallas, J., Pottegard, A., & Rebordosa, C.

(2022). Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other

COPD Medications in the United Kingdom, Denmark, and Germany. Clin Drug Investig.

https://doi.org/10.1007/s40261-022-01120-2

Bottle, A., Newson, R., Faitna, P., Hayhoe, B., & Cowie, M. (2022). Changes in heart failure

management and long-term mortality over 10 years: observational study. Open Heart, 9(1).

https://doi.org/10.1136/openhrt-2021-001888

Roy Chowdhury, K., Michaud, J., Yu, O. H. Y., Yin, H., Azoulay, L., & Renoux, C. (2022).

Effectiveness and safety of apixaban vs. rivaroxaban in patients with atrial fibrillation and type 2

diabetes mellitus. Thromb Haemost. https://doi.org/10.1055/a-1798-2116

Yu, D., Hellberg, C., Appleyard, T., Dell’Isola, A., Thomas, G., Turkiewicz, A., Englund, M., & Peat,

G. (2022). Opioid use prior to total knee replacement: comparative analysis of trends in England

and Sweden. Osteoarthritis Cartilage. https://doi.org/10.1016/j.joca.2022.02.621

Price, S., Gibson, N., Hamilton, W., King, A., & Shephard, E. (2022). Intra-abdominal cancer risk

with abdominal pain: a prospective cohort primary care study. Br J Gen Pract.


Hope, H., Osam, C. S., Kontopantelis, E., Hughes, S., Munford, L., Ashcroft, D. M., Pierce, M., &

Abel, K. M. (2021). The healthcare resource impact of maternal mental illness on children and

adolescents: UK retrospective cohort study. Br J Psychiatry, 219(3), 515–522.


McFadden, E., Lay-Flurrie, S., Koshiaris, C., Richards, G. C., & Heneghan, C. (2021). The Long-

Term Impact of Vaginal Surgical Mesh Devices in UK Primary Care: A Cohort Study in the

Clinical Practice Research Datalink. Clin Epidemiol, 13, 1167–1180.


Musgrove, R., Carr, M. J., Kapur, N., Chew-Graham, C. A., Mughal, F., Ashcroft, D. M., & Webb, R.

T. (2021). Suicide and other causes of death among working-age and older adults in the year

after discharge from in-patient mental healthcare in England: matched cohort study. Br J

Psychiatry, 1–8. https://doi.org/10.1192/bjp.2021.176

Wang, H. I., Han, L., Jacobs, R., Doran, T., Holt, R. I. G., Prady, S. L., Gilbody, S., Shiers, D.,

Alderson, S., Hewitt, C., Taylor, J., Kitchen, C. E. W., Bellass, S., & Siddiqi, N. (2021).

Healthcare resource use and costs for people with type 2 diabetes mellitus with and without

severe mental illness in England: longitudinal matched-cohort study using the Clinical Practice

Research Datalink. Br J Psychiatry, 1–8. https://doi.org/10.1192/bjp.2021.131


Gamble, J. M. (2021). Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections:

A Propensity Score-matched Population-based Cohort Study. Can J Diabetes.

https://doi.org/10.1016/j.jcjd.2021.12.005

CPRD bibliography

9

McKay, A., Gunn, L., Nugawela, M., Sathish, T., Majeed, A., E, V., Molina, G., & Sivaprasad, S.

(2021). Associations between attainment of incentivized primary care indicators and incident

sight-threatening diabetic retinopathy in England: A population-based historical cohort study.

Diabetes Obes Metab, 23(6), 1322–1330. https://doi.org/10.1111/dom.14344

Ferguson, R., Prieto-Alhambra, D., Peat, G., Delmestri, A., Jordan, K., Strauss, V. Y., Valderas, J.,

Walker, C., Yu, D., Glyn-Jones, S., & Silman, A. (2021). Does pre-existing morbidity influences

risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients

from linked national datasets in England. BMJ Open, 11(9), e046712.


CPRD bibliography

10

2021

Abel, K. M., Carr, M. J., Ashcroft, D. M., Chalder, T., Chew-Graham, C. A., Hope, H., Kapur, N.,

McManus, S., Steeg, S., Webb, R. T., & Pierce, M. (2021). Association of SARS-CoV-2

Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems

Among UK Primary Care Patients. JAMA Netw Open, 4(11), e2134803.

https://doi.org/10.1001/jamanetworkopen.2021.34803

Abrahami, D., McDonald, E. G., Schnitzer, M. E., Barkun, A. N., Suissa, S., & Azoulay, L. (2021).

Proton pump inhibitors and risk of colorectal cancer. Gut. https://doi.org/10.1136/gutjnl-2021-

325096

Abrahami, D., McDonald, E. G., Schnitzer, M. E., Barkun, A. N., Suissa, S., & Azoulay, L. (2021).

Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut.

https://doi.org/10.1136/gutjnl-2021-325097

Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., van den Bergh, J. P., van Staa, T. P.,

Boonen, A., & de Vries, F. (2021). Low-dose oral glucocorticoid therapy and risk of

osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical

Practice Research Datalink. Rheumatology (Oxford).

https://doi.org/10.1093/rheumatology/keab548

Adiamah, A., Ban, L., Otete, H., Crooks, C. J., West, J., & Humes, D. J. (2021). Outcomes after non-

operative management of perforated diverticular disease: a population-based cohort study. BJS

Open, 5(2). https://doi.org/10.1093/bjsopen/zraa073

Ahmad, S., Carey, I. M., Harris, T., Cook, D. G., DeWilde, S., & Strachan, D. P. (2021). The rising

tide of dementia deaths: triangulation of data from three routine data sources using the Clinical

Practice Research Datalink. BMC Geriatr, 21(1), 375. https://doi.org/10.1186/s12877-021-

02306-7

Ahmed, H., Whitaker, H., Farewell, D., Hippisley-Cox, J., & Noble, S. (2021). Respiratory tract

infection and risk of bleeding in oral anticoagulant users: self-controlled case series. Bmj, 375,

e068037. https://doi.org/10.1136/bmj-2021-068037

Akyea, R. K., Doehner, W., Iyen, B., Weng, S. F., Qureshi, N., & Ntaios, G. (2021). Obesity and

long-term outcomes after incident stroke: a prospective population-based cohort study. J

Cachexia Sarcopenia Muscle. https://doi.org/10.1002/jcsm.12818

Akyea, R. K., Kontopantelis, E., Kai, J., Weng, S. F., Patel, R. S., Asselbergs, F. W., & Qureshi, N.

(2021). Sex disparity in subsequent outcomes in survivors of coronary heart disease. Heart.

https://doi.org/10.1136/heartjnl-2021-319566

Akyea, R. K., Vinogradova, Y., Qureshi, N., Patel, R. S., Kontopantelis, E., Ntaios, G., Asselbergs, F.

W., Kai, J., & Weng, S. F. (2021). Sex, Age, and Socioeconomic Differences in Nonfatal Stroke

Incidence and Subsequent Major Adverse Outcomes. Stroke, 52(2), 396–405.

https://doi.org/10.1161/strokeaha.120.031659

Akyea, R. K., Vinogradova, Y., Qureshi, N., Patel, R. S., Kontopantelis, E., Ntaios, G., Asselbergs, F.

W., Kai, J., Weng, S. F., Arhi, C. S., Dudley, R., Moussa, O., Ardissino, M., Scholtz, S.,

Purkayastha, S., Banerjee, A., Chen, S., Pasea, L., Lai, A. G., … Lyratzopoulos, G. (2021).

Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016. BMJ

Open, 11(1), 106560. https://doi.org/10.1002/pds.5192

CPRD bibliography

11

Alam, N. N., Wright, A. K., Rutter, M. K., Buchan, I., Ashcroft, D. M., Sperrin, M., & Renehan, A.

G. (2021). Body mass index and cancer mortality in patients with incident type 2 diabetes: A

population-based study of adults in England. Diabetes Obes Metab.

https://doi.org/10.1111/dom.14614

Alexander, N., Alexander, D. C., Barkhof, F., & Denaxas, S. (2021). Identifying and evaluating

clinical subtypes of Alzheimer’s disease in care electronic health records using unsupervised

machine learning. BMC Med Inform Decis Mak, 21(1), 343. https://doi.org/10.1186/s12911-021-

01693-6

Alexandridou, M., Cattaert, T., & Verstraeten, T. (2021). Estimation of Risk of Death Attributable to

Acute Gastroenteritis Not Caused by Clostridioides difficile Infection Among Hospitalized

Adults in England. Clin Epidemiol, 13, 309–315. https://doi.org/10.2147/clep.s296516

Al-Hamed, F. S., Kouniaris, S., Tamimi, I., Lordkipanidzé, M., Madathil, S. A., Kezouh, A., Karp, I.,

Nicolau, B., & Tamimi, F. (2021). Acetylcholinesterase inhibitors and risk of bleeding and acute

ischemic events in non-hypertensive Alzheimer’s patients. Alzheimers Dement (N Y), 7(1),

e12184. https://doi.org/10.1002/trc2.12184

Ali, M., Landeira, M., Covernton, P. J. O., Choudhury, N., Jaggi, A., Fatoye, F., & van Maanen, R.

(2021). The use of mono- and combination drug therapy in men and women with lower urinary

tract symptoms (LUTS) in the UK: a retrospective observational study. BMC Urol, 21(1), 119.

https://doi.org/10.1186/s12894-021-00881-w

Alkabbani, W., Gamble, J. M., Eurich, D. T., Minhas-Sandhu, J. K., Shah, B. R., Alsabbagh, M. W.,

& Zongo, A. (2021). Risk of hospitalization and death associated with Sodium Glucose

Cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. Diabetes

Metab, 101305. https://doi.org/10.1016/j.diabet.2021.101305


Gamble, J. M. (2021). Renal effectiveness and safety of the sodium-glucose cotransporter-2

inhibitors: a population-based cohort study. BMJ Open Diabetes Res Care, 9(2).

https://doi.org/10.1136/bmjdrc-2021-002496

Arana, A., Pottegard, A., Kuiper, J. G., Booth, H., Reutfors, J., Calingaert, B., Lund, L. C., Crellin, E.,

Schmitt-Egenolf, M., Kaye, J. A., Gembert, K., Rothman, K. J., Kieler, H., Dedman, D.,

Houben, E., Gutierrez, L., Hallas, J., & Perez-Gutthann, S. (2021). Long-Term Risk of Skin

Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from

the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin

Cancer Evaluation (JOELLE). Clinical Epidemiology, 13.

https://doi.org/https://doi.org/10.2147/CLEP.S331287

Archer, C., Turner, K., Kessler, D., Mars, B., & Wiles, N. (2021). Trends in the recording of anxiety

in UK primary care: a multi-method approach. Soc Psychiatry Psychiatr Epidemiol, 1–12.

https://doi.org/10.1007/s00127-021-02131-8

Ardissino, M., Vincent, M., Hines, O., Amin, R., Eichhorn, C., Tang, A. R., Collins, P., Moussa, O.,

& Purkayastha, S. (2021). Long-term cardiovascular outcomes after orlistat therapy in patients

with obesity: a nationwide, propensity-score matched cohort study. Eur Heart J Cardiovasc

Pharmacother. https://doi.org/10.1093/ehjcvp/pvaa133

Arhi, C. S., Dudley, R., Moussa, O., Ardissino, M., Scholtz, S., & Purkayastha, S. (2021). The

Complex Association Between Bariatric Surgery and Depression: a National Nested-Control

Study. Obes Surg. https://doi.org/10.1007/s11695-020-05201-z

CPRD bibliography

12

Aris, E., Harrington, L., Bhavsar, A., Simeone, J. C., Ramond, A., Papi, A., Vogelmeier, C. F.,

Meszaros, K., Lambrelli, D., & Mukherjee, P. (2021). Burden of Pertussis in COPD: A

Retrospective Database Study in England. Copd, 1–21.

https://doi.org/10.1080/15412555.2021.1899155

Ayodele, O., Cabral, H. J., McManus, D., & Jick, S. (2021). The Risk of Venous Thromboembolism

(VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors

(5ARIs). Clin Epidemiol, 13, 661–673. https://doi.org/10.2147/clep.s317019

Banerjee, A., Chen, S., Pasea, L., Lai, A. G., Katsoulis, M., Denaxas, S., Nafilyan, V., Williams, B.,

Wong, W. K., Bakhai, A., Khunti, K., Pillay, D., Noursadeghi, M., Wu, H., Pareek, N.,

Bromage, D., McDonagh, T. A., Byrne, J., Teo, J. T. H., … Hemingway, H. (2021). Excess

deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev

Cardiol. https://doi.org/10.1093/eurjpc/zwaa155

Baskaran, V., Pearce, F., Harwood, R. H., McKeever, T. M., & Lim, W. S. (2021). Primary care

consultations after hospitalisation for pneumonia: a large population-based cohort study. Br J

Gen Pract, 71(705), e250–e257. https://doi.org/10.3399/bjgp.2020.0890

Berni, T. R., Morgan, C. L., & Rees, D. A. (2021). Women with Polycystic Ovary Syndrome have an

increased risk of major cardiovascular events: a population study. J Clin Endocrinol Metab.

https://doi.org/10.1210/clinem/dgab392

Bianic, F., Guelfucci, F., Robin, L., Martre, C., Game, D., & Bockenhauer, D. (2021). Epidemiology

of Distal Renal Tubular Acidosis: A Study Using Linked UK Primary Care and Hospital Data.

Nephron, 1–10. https://doi.org/10.1159/000516876

Bidulka, P., O’Neill, S., Basu, A., Wilkinson, S., Silverwood, R. J., Charlton, P., Briggs, A., Adler, A.

I., Khunti, K., Tomlinson, L. A., Smeeth, L., Douglas, I. J., & Grieve, R. (2021). Protocol for an

observational cohort study investigating personalised medicine for intensification of treatment in

people with type 2 diabetes mellitus: the PERMIT study. BMJ Open, 11(9), e046912.


Bidulka, P., Vestergaard, S. V, Hlupeni, A., Kjaersgaard, A., Wong, A. Y. S., Langan, S. M.,

Schmidt, S. A. J., Lyon, S., Christiansen, C. F., & Nitsch, D. (2021). Adverse outcomes after

partner bereavement in people with reduced kidney function: Parallel cohort studies in England

and Denmark. PLoS One, 16(9), e0257255. https://doi.org/10.1371/journal.pone.0257255

Birring, S. S., Currie, C. J., Holden, S. E., Jenkins-Jones, S., Berni, E. R., Jones, B., Berni, T. R., &

Langerman, H. (2021). The financial burden of treating patients presenting with acute and

chronic cough. Curr Med Res Opin, 1–32. https://doi.org/10.1080/03007995.2021.1982685

Blackwell, J., Alexakis, C., Saxena, S., Creese, H., Bottle, A., Petersen, I., Hotopf, M., & Pollok, R.

C. G. (2021). Association between antidepressant medication use and steroid dependency in

patients with ulcerative colitis: a population-based study. BMJ Open Gastroenterol, 8(1).

https://doi.org/10.1136/bmjgast-2020-000588

Brown, J. P., Tazare, J. R., Williamson, E., Mansfield, K. E., Evans, S. J., Tomlinson, L. A.,

Bhaskaran, K., Smeeth, L., Wing, K., & Douglas, I. J. (2021). Proton pump inhibitors and risk of

all-cause and cause-specific mortality: a cohort study. Br J Clin Pharmacol.


CPRD bibliography

13

Brunetti, V. C., Reynier, P., Azoulay, L., Yu, O. H. Y., Ernst, P., Platt, R. W., & Filion, K. B. (2021).

SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A

population-based cohort study. Pharmacoepidemiol Drug Saf. https://doi.org/10.1002/pds.5192

Brunetti, V. C., Yu, O. H. Y., Platt, R. W., & Filion, K. B. (2021). Initiation of four basal insulins and

subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom:

Changes over the period 2003-2018. Diabet Med, e14603. https://doi.org/10.1111/dme.14603

Bullock, L., Bedson, J., Chen, Y., Chew-Graham, C. A., & Campbell, P. (2021). Comparative

differences in musculoskeletal pain consultation and analgesic prescription for people with

dementia: a UK-wide matched cohort study. Pain.

https://doi.org/10.1097/j.pain.0000000000002257

Burkard, T., Rauch, M., Jick, S. S., & Meier, C. R. (2021). Validity of bariatric surgery codes in the

UK Clinical Practice Research Datalink (CPRD) GOLD compared with Hospital Episodes

Statistics. Pharmacoepidemiol Drug Saf. https://doi.org/10.1002/pds.5221

Cabrera, C., Quelen, C., Ouwens, M., Hedman, K., Rigney, U., & Quint, J. K. (2021). Evaluating a

Cox marginal structural model to assess the comparative effectiveness of inhaled corticosteroids

versus no inhaled corticosteroid treatment in chronic obstructive pulmonary disease. Ann

Epidemiol. https://doi.org/10.1016/j.annepidem.2021.11.004

Cadogan, S. L., Powell, E., Wing, K., Wong, A. Y., Smeeth, L., & Warren-Gash, C. (2021).

Anticoagulant prescribing for atrial fibrillation and risk of incident dementia. Heart.


Caleyachetty, R., Barber, T. M., Mohammed, N. I., Cappuccio, F. P., Hardy, R., Mathur, R., Banerjee,

A., & Gill, P. (2021). Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in

England: a population-based cohort study. Lancet Diabetes Endocrinol.

https://doi.org/10.1016/s2213-8587(21)00088-7

Cao, T. X. D., Fraga, L. F. C., Fergusson, E., Michaud, J., Dell’Aniello, S., Yin, H., Rej, S., Azoulay,

L., & Renoux, C. (2021). Prescribing Trends of Antidepressants and Psychotropic

Coprescription for Youths in UK Primary Care, 2000-2018. J Affect Disord, 287, 19–25.

https://doi.org/10.1016/j.jad.2021.03.022

Carey, I. M., Banchoff, E., Nirmalananthan, N., Harris, T., DeWilde, S., Chaudhry, U. A. R., & Cook,

D. G. (2021). Prevalence and incidence of neuromuscular conditions in the UK between 2000

and 2019: A retrospective study using primary care data. PLoS One, 16(12), e0261983.


Carey, I. M., Cook, D. G., Harris, T., DeWilde, S., Chaudhry, U. A. R., & Strachan, D. P. (2021).

Risk factors for excess all-cause mortality during the first wave of the COVID-19 pandemic in

England: A retrospective cohort study of primary care data. PLoS One, 16(12), e0260381.


Carr, M. J., Steeg, S., Webb, R. T., Kapur, N., Chew-Graham, C. A., Abel, K. M., Hope, H., Pierce,

M., & Ashcroft, D. M. (2021). Effects of the COVID-19 pandemic on primary care-recorded

mental illness and self-harm episodes in the UK: a population-based cohort study. Lancet Public

Health, 6(2), e124–e135. https://doi.org/10.1016/s2468-2667(20)30288-7

Carr, M. J., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., &

Rutter, M. K. (2021). Impact of COVID-19 restrictions on diabetes health checks and

CPRD bibliography

14

prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in

primary care. BMJ Qual Saf. https://doi.org/10.1136/bmjqs-2021-013613

Carreira, H., Williams, R., Funston, G., Stanway, S., & Bhaskaran, K. (2021). Associations between

breast cancer survivorship and adverse mental health outcomes: A matched population-based

cohort study in the United Kingdom. PLoS Med, 18(1), e1003504.


Cecil, E., Bottle, A., Majeed, A., & Aylin, P. (2021). Factors associated with potentially missed acute

deterioration in primary care. Br J Gen Pract. https://doi.org/10.3399/bjgp.2020.0986

Chalitsios, C. V, Shaw, D. E., & McKeever, T. M. (2021). Risk of subtrochanteric and femoral shaft

fractures due to bisphosphonate therapy in asthma: a population-based nested case-control study.

Osteoporos Int. https://doi.org/10.1007/s00198-021-06197-7

Chen, T. C., Knaggs, R. D., & Chen, L. C. (2021). Association between opioid-related deaths and

prescribed opioid dose and psychotropic medicines in England: a case-crossover study. Br J

Anaesth. https://doi.org/10.1016/j.bja.2021.06.049

Chen, T. C., Knaggs, R. D., & Chen, L. C. (2021). Association between opioid-related deaths and

persistent opioid prescribing in primary care in England: a nested case-control study. Br J Clin

Pharmacol. https://doi.org/10.1111/bcp.15028

Chin, R. F. M., Pickrell, W. O., Guelfucci, F., Martin, M., & Holland, R. (2021). Prevalence,

healthcare resource utilization and mortality of Lennox-Gastaut syndrome: retrospective linkage

cohort study. Seizure, 91, 159–166. https://doi.org/10.1016/j.seizure.2021.05.025

Chudasama, Y. V, Zaccardi, F., Coles, B., Gillies, C. L., Hvid, C., Seidu, S., Davies, M. J., & Khunti,

K. (2021). Ethnic, social and multimorbidity disparities in therapeutic inertia: a UK primary care

observational study in patients newly diagnosed with type 2 diabetes. Diabetes Obes Metab.


Chung, S. C., Sofat, R., Acosta-Mena, D., Taylor, J. A., Lambiase, P. D., Casas, J. P., & Providencia,

R. (2021). Atrial fibrillation epidemiology, disparity and healthcare contacts: a population-wide

study of 5.6 million individuals. Lancet Reg Health Eur, 7, 100157.

https://doi.org/10.1016/j.lanepe.2021.100157

Coles, B., Zaccardi, F., Hvid, C., Davies, M. J., & Khunti, K. (2021). Cardiovascular events and

mortality in people with type 2 diabetes and multimorbidity: A real-world study of patients

followed for up to 19 years. Diabetes Obes Metab, 23(1), 218–227.


Coles, B., Zaccardi, F., Seidu, S., Gillies, C. L., Davies, M. J., Hvid, C., & Khunti, K. (2021). Rates

and estimated cost of primary care consultations in people diagnosed with type 2 diabetes and

comorbidities: A retrospective analysis of 8.9 million consultations. Diabetes Obes Metab.


Costello, R., McDonagh, J., Hyrich, K., & Humphreys, J. (2021). Incidence and prevalence of

Juvenile Idiopathic Arthritis in the United Kingdom 2000-2018: results from the Clinical

Practice Research Datalink. Rheumatology (Oxford).


CPRD bibliography

15

Coughlan, C. H., Ruzangi, J., Neale, F. K., Nezafat Maldonado, B., Blair, M., Bottle, A., Saxena, S.,

& Hargreaves, D. (2021). Social and ethnic group differences in healthcare use by children aged

0-14 years: a population-based cohort study in England from 2007 to 2017. Arch Dis Child.

https://doi.org/10.1136/archdischild-2020-321045

Crossfield, S. S. R., Buch, M. H., Baxter, P., Kingsbury, S. R., Pujades-Rodriguez, M., & Conaghan,

P. G. (2021). Changes in the pharmacological management of rheumatoid arthritis over two

decades. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keaa892

Crossfield, S. S. R., Marzo-Ortega, H., Kingsbury, S. R., Pujades-Rodriguez, M., & Conaghan, P. G.

(2021). Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two

decades. RMD Open, 7(3). https://doi.org/10.1136/rmdopen-2021-001888

Cybulski, L., Ashcroft, D. M., Carr, M. J., Garg, S., Chew-Graham, C. A., Kapur, N., & Webb, R. T.

(2021). Temporal trends in annual incidence rates for psychiatric disorders and self-harm among

children and adolescents in the UK, 2003-2018. BMC Psychiatry, 21(1), 229.

https://doi.org/10.1186/s12888-021-03235-w

Cybulski, L., Ashcroft, D. M., Carr, M. J., Garg, S., Chew-Graham, C. A., Kapur, N., & Webb, R. T.

(2021). Risk factors for nonfatal self-harm and suicide among adolescents: two nested case-

control studies conducted in the UK Clinical Practice Research Datalink. J Child Psychol

Psychiatry. https://doi.org/10.1111/jcpp.13552

Danese, M. D., Pemberton-Ross, P., Catterick, D., & Villa, G. (2021). Estimation of the increased risk

associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the

United Kingdom. Eur J Prev Cardiol, 28(3), 335–343.

https://doi.org/10.1177/2047487319899212

Davidson, J. A., Banerjee, A., Smeeth, L., McDonald, H. I., Grint, D., Herrett, E., Forbes, H., Pebody,

R., & Warren-Gash, C. (2021). Risk of acute respiratory infection and acute cardiovascular

events following acute respiratory infection among adults with increased cardiovascular risk in

England between 2008 and 2018: a retrospective, population-based cohort study. Lancet Digit

Health, 3(12), e773–e783. https://doi.org/10.1016/s2589-7500(21)00203-x

Davidson, J., Banerjee, A., Mathur, R., Ramsay, M., Smeeth, L., Walker, J., McDonald, H., &

Warren-Gash, C. (2021). Ethnic differences in the incidence of clinically diagnosed influenza:

an England population-based cohort study 2008-2018. Wellcome Open Res, 6, 49.

https://doi.org/10.12688/wellcomeopenres.16620.2

Denee, T., Kerr, C., Ming, T., Wood, R., Tritton, T., Middleton-Dalby, C., Massey, O., & Desai, M.

(2021). Current treatments used in clinical practice for major depressive disorder and treatment

resistant depression in England: A retrospective database study. J Psychiatr Res, 139, 172–178.

https://doi.org/10.1016/j.jpsychires.2021.05.026

Dormuth, C. R., Winquist, B., Fisher, A., Wu, F., Reynier, P., Suissa, S., Dahl, M., Ma, Z., Lu, X.,

Zhang, J., Raymond, C. B., Filion, K. B., Platt, R. W., Moriello, C., & Paterson, J. M. (2021).

Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative

Antiemetic Medications in a Multinational, Population-Based Cohort. JAMA Netw Open, 4(4),

e215329. https://doi.org/10.1001/jamanetworkopen.2021.5329

Douros, A., Cui, Y., Platt, R. W., Filion, K. B., Sebastiani, G., & Renoux, C. (2021). Utilization and

long-term persistence of direct oral anticoagulants among patients with non-valvular atrial

fibrillation and liver disease. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.15046

CPRD bibliography

16

Douros, A., Santella, C., Dell’Aniello, S., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2021).

Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study. J

Alzheimers Dis. https://doi.org/10.3233/jad-201534

Ehlken, B., Nishikawa, C., Kaplan, S., Dresco, I., Granados, D., & Toussi, M. (2021). Effectiveness

of risk minimisation measures for valproate: a drug utilisation study based on implementation of

a Risk Minimisation Programme in Europe, analysis of data from the UK. Curr Med Res Opin,

1–20. https://doi.org/10.1080/03007995.2021.1997286

Erridge, S., Moussa, O., McIntyre, C., Hariri, A., Tolley, N., Kotecha, B., & Purkayastha, S. (2021).

Obstructive Sleep Apnea in Obese Patients: a UK Population Analysis. Obes Surg.

https://doi.org/10.1007/s11695-020-05196-7

Erwin, J., Enki, D. G., & Woolf, A. D. (2021). Younger people with rheumatoid arthritis are at

increased risk of fracture even before age 50 years: a population-based cohort study. Osteoporos

Int. https://doi.org/10.1007/s00198-021-05862-1

Espuny Pujol, F., Hancock, R., & Morciano, M. (2021). Trends in survival of older care home

residents in England: A 10-year multi-cohort study. Soc Sci Med, 113883.

https://doi.org/10.1016/j.socscimed.2021.113883

Faillie, J. L., Yin, H., Yu, O. H. Y., Herrero, A., Altwegg, R., Renoux, C., & Azoulay, L. (2021).

Incretin-Based Drugs and Risk of Intestinal Obstruction Among Patients with Type 2 Diabetes.

Clin Pharmacol Ther. https://doi.org/10.1002/cpt.2430

Farmer, R. E., Beard, I., Raza, S. I., Gollop, N. D., Patel, N., Tebboth, A., McGovern, A. P.,

Kanumilli, N., & Ternouth, A. (2021). Prescribing in Type 2 Diabetes Patients With and

Without Cardiovascular Disease History: a Descriptive Analysis in the UK CPRD. Clin Ther.

https://doi.org/10.1016/j.clinthera.2020.12.015

Ferguson, R., Prieto-Alhambra, D., Peat, G., Delmestri, A., Jordan, K. P., Strauss, V. Y., Valderas, J.

M., Walker, C., Yu, D., Glyn-Jones, S., & Silman, A. (2021). Influence of pre-existing

multimorbidity on receiving a hip arthroplasty: cohort study of 28 025 elderly subjects from UK

primary care. BMJ Open, 11(9), e046713. https://doi.org/10.1136/bmjopen-2020-046713

Ford, E., Sheppard, J., Oliver, S., Rooney, P., Banerjee, S., & Cassell, J. A. (2021). Automated

detection of patients with dementia whose symptoms have been identified in primary care but

have no formal diagnosis: a retrospective case-control study using electronic primary care

records. BMJ Open, 11(1), e039248. https://doi.org/10.1136/bmjopen-2020-039248

Fortuny, J., Plana, E., & Kaye, J. A. (2021). Serum lipid trajectories in the years before a lymphoma

diagnosis. Leuk Lymphoma, 1–13. https://doi.org/10.1080/10428194.2021.1992618

Fraser, L. K., Murtagh, F. E., Aldridge, J., Sheldon, T., Gilbody, S., & Hewitt, C. (2021). Health of

mothers of children with a life-limiting condition: a comparative cohort study. Arch Dis Child.

https://doi.org/10.1136/archdischild-2020-320655

Funston, G., Mounce, L. T., Price, S., Rous, B., Crosbie, E. J., Hamilton, W., & Walter, F. M. (2021).

CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a

retrospective cohort study using electronic health records. Br J Gen Pract.


CPRD bibliography

17

Garfinkle, R., Dell’Aniello, S., Bhatnagar, S., Morin, N., Ghitulescu, G., Faria, J., Vasilevsky, C. A.,

Brassard, P., & Boutros, M. (2021). Assessment of long-term bowel dysfunction after restorative

proctectomy for neoplastic disease: A population-based cohort study. Surgery.

https://doi.org/10.1016/j.surg.2021.10.068

Grandi, S. M., Filion, K. B., Hutcheon, J. A., Rosella, L. C., & Platt, R. W. (2021). Accounting for

Repeat Pregnancies in Risk Prediction Models. Epidemiology.

https://doi.org/10.1097/ede.0000000000001349

Green, A., Tillett, W., McHugh, N., & Smith, T. (2021). Using Bayesian Networks to identify

musculoskeletal symptoms influencing the risk of developing Psoriatic Arthritis in people with

psoriasis. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keab310

Groves, D., Karsanji, U., Evans, R. A., Greening, N., Singh, S. J., Quint, J. K., Whittaker, H.,

Richardson, M., Barrett, J., Sutch, S. P., & Steiner, M. C. (2021). Predicting Future Health Risk

in COPD: Differential Impact of Disease-Specific and Multi-Morbidity-Based Risk

Stratification. Int J Chron Obstruct Pulmon Dis, 16, 1741–1754.

https://doi.org/10.2147/copd.s303202

Gulliford, M. C., Charlton, J., Boiko, O., Winter, J. R., Rezel-Potts, E., Sun, X., Burgess, C.,

McDermott, L., Bunce, C., Shearer, J., Curcin, V., Fox, R., Hay, A. D., Little, P., Moore, M. V,

& Ashworth, M. (2021). Health Services and Delivery Research. In Safety of reducing antibiotic

prescribing in primary care: a mixed-methods study. NIHR Journals Library Copyright ©2021

Gulliford et al. This work was produced by Gulliford et al. under the terms of a commissioning

contract issued by the Secretary of State for Health and Social Care. This is an Open Access

publication distributed und. https://doi.org/10.3310/hsdr09090

Gunn, L. H., McKay, A. J., Molokhia, M., Valabhji, J., Molina, G., Majeed, A., & Vamos, E. P.

(2021). Associations between attainment of incentivised primary care indicators and emergency

hospital admissions among type 2 diabetes patients: a population-based historical cohort study. J

R Soc Med, 1410768211005109. https://doi.org/10.1177/01410768211005109

Haase, C. L., Eriksen, K. T., Lopes, S., Satylganova, A., Schnecke, V., & McEwan, P. (2021). Body

mass index and risk of obesity-related conditions in a cohort of 2.9 million people: Evidence

from a UK primary care database. Obes Sci Pract, 7(2), 137–147.

https://doi.org/10.1002/osp4.474

Haase, C. L., Lopes, S., Olsen, A. H., Satylganova, A., Schnecke, V., & McEwan, P. (2021). Weight

loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK

primary care database. Int J Obes (Lond). https://doi.org/10.1038/s41366-021-00788-4

Hamilton, F., Arnold, D., & Payne, R. (2021). Association of prior lymphopenia with mortality in

pneumonia: a cohort study in UK primary care. Br J Gen Pract, 71(703), e148–e156.

https://doi.org/10.3399/bjgp20X713981

Han, L., Doran, T., Holt, R. I. G., Hewitt, C., Jacobs, R., Prady, S. L., Alderson, S. L., Shiers, D.,

Wang, H. I., Bellass, S., Gilbody, S., Kitchen, C. E. W., Lister, J., Taylor, J., & Siddiqi, N.

(2021). The impact of severe mental illness on healthcare use and health outcomes for people

with type 2 diabetes. Br J Gen Pract. https://doi.org/10.3399/bjgp.2020.0884

Hayes, J. F., Osborn, D. P. J., Francis, E., Ambler, G., Tomlinson, L. A., Boman, M., Wong, I. C. K.,

Geddes, J. R., Dalman, C., & Lewis, G. (2021). Prediction of individuals at high risk of chronic

kidney disease during treatment with lithium for bipolar disorder. BMC Med, 19(1), 99.

https://doi.org/10.1186/s12916-021-01964-z

CPRD bibliography

18

Head, A., Fleming, K., Kypridemos, C., Schofield, P., Pearson-Stuttard, J., & O’Flaherty, M. (2021).

Inequalities in incident and prevalent multimorbidity in England, 2004{\textendash}19: a

population-based, descriptive study. Lancet Healthy Longev, 2(Issue 8), e489–e497.

https://doi.org/10.1016/S2666-7568(21)00146-X

Hoffman, V., Hallas, J., Linder, M., Margulis, A. V, Suehs, B. T., Arana, A., Phiri, K., Enger, C.,

Horter, L., Odsbu, I., Olesen, M., Perez-Gutthann, S., Xu, Y., Kristiansen, N. S., Appenteng, K.,

de Vogel, S., & Seeger, J. D. (2021). Cardiovascular Risk in Users of Mirabegron Compared

with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-

Interventional, Multinational, Cohort Study. Drug Saf, 44(8), 899–915.

https://doi.org/10.1007/s40264-021-01095-7

Hope, H., Osam, C. S., Kontopantelis, E., Hughes, S., Munford, L., Ashcroft, D. M., Pierce, M., &

Abel, K. M. (2021). The healthcare resource impact of maternal mental illness on children and

adolescents: UK retrospective cohort study. Br J Psychiatry, 219(3), 515–522.


Humphrey, T. J. L., James, G., Wittbrodt, E. T., Zarzuela, D., & Hiemstra, T. F. (2021). Adverse

clinical outcomes associated with RAAS inhibitor discontinuation: analysis of over 400 000

patients from the UK Clinical Practice Research Datalink (CPRD). Clin Kidney J, 14(10), 2203–

2212. https://doi.org/10.1093/ckj/sfab029

Husemoen, L. L. N., Mørch, L. S., Christensen, P. K., Hartvig, N. V, & Feher, M. D. (2021). All-

Cause and Cardiovascular Mortality Among Insulin-Na{\"\i}ve People With Type 2 Diabetes

Treated With Insulin Detemir or Glargine: A Cohort Study in the UK. Diabetes Ther.

https://doi.org/10.1007/s13300-021-01048-4

Inns, T., Fleming, K. M., Iturriza-Gomara, M., & Hungerford, D. (2021). Paediatric rotavirus

vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study.

BMC Med, 19(1), 147. https://doi.org/10.1186/s12916-021-02017-1

Iwagami, M., Qizilbash, N., Gregson, J., Douglas, I., Johnson, M., Pearce, N., Evans, S., & Pocock, S.

(2021). Blood cholesterol and risk of dementia in more than 1.8 million people over two

decades: a retrospective cohort study. Lancet Healthy Longev, 2(Issue 8), e498–e506.

https://doi.org/10.1016/S2666-7568(21)00150-1

Iyen, B., Akyea, R. K., Weng, S., Kai, J., & Qureshi, N. (2021). Statin treatment and LDL-cholesterol

treatment goal attainment among individuals with familial hypercholesterolaemia in primary

care. Open Heart, 8(2). https://doi.org/10.1136/openhrt-2021-001817

Jackson, S. S., Pfeiffer, R. M., Gabbi, C., Anderson, L., Gadalla, S. M., & Koshiol, J. (2021).

Menopausal hormone therapy and risk of biliary tract cancers. Hepatology.

https://doi.org/10.1002/hep.32198

Jaggi, A., Nazir, J., Fatoye, F., Quelen, C., Tu, X., Ali, M., Siddiqui, E., Covernton, P. J. O., Landeira,

M., & Choudhury, N. (2021). Anticholinergic Burden and Associated Healthcare Resource

Utilization in Older Adults with Overactive Bladder. Drugs Aging.

https://doi.org/10.1007/s40266-021-00884-0

Jerrim, J. (2021). The mental health of adolescents in England: How does it vary during their time at

school? British Educational Research Journal. https://doi.org/https://doi.org/10.1002/berj.3769

CPRD bibliography

19

Jiao, T., Platt, R. W., Douros, A., & Filion, K. B. (2021). Prescription Patterns for the Use of

Antihypertensive Drugs for Primary Prevention among Patients with Hypertension in the United

Kingdom. Am J Hypertens. https://doi.org/10.1093/ajh/hpab137

Jick, S. S., Oleske, D. M., Persson, R., Zamudio, J., & Facheris, M. F. (2021). Epidemiology of skin

event rates among users of pumps for the subcutaneous administration of drugs for chronic

conditions. Curr Med Res Opin, 1–9. https://doi.org/10.1080/03007995.2021.1953971

Johnston, S. S., Jamous, N., Mistry, S., Jain, S., Gangoli, G., Danker, W., Ammann, E., & Hampton,

K. (2021). Association of In-Hospital Surgical Bleeding Events with Prolonged Hospital Length

of Stay, Days Spent in Critical Care, Complications, and Mortality: A Retrospective Cohort

Study Among Patients Undergoing Neoplasm-Directed Surgeries in English Hospitals.

Clinicoecon Outcomes Res, 13, 19–29. https://doi.org/10.2147/ceor.s287970

Jones, B. I., Freedman, A., Thomas, M. J., Villalba-Mendez, C., Sathia, L., Flanagan, D., Francis, S.,

& Currie, C. J. (2021). Comorbid diseases and conditions in people with HIV in the UK. Curr

Med Res Opin, 1–9. https://doi.org/10.1080/03007995.2021.2003671

Katsoulis, M., Lai, A. G., Diaz-Ordaz, K., Gomes, M., Pasea, L., Banerjee, A., Denaxas, S., Tsilidis,

K., Lagiou, P., Misirli, G., Bhaskaran, K., Wannamethee, G., Dobson, R., Batterham, R. L.,

Kipourou, D. K., Lumbers, R. T., Wen, L., Wareham, N., Langenberg, C., & Hemingway, H.

(2021). Identifying adults at high-risk for change in weight and BMI in England: a longitudinal,

large-scale, population-based cohort study using electronic health records. Lancet Diabetes

Endocrinol, 9(10), 681–694. https://doi.org/10.1016/s2213-8587(21)00207-2

Kerkhof, M., Tran, T. N., Allehebi, R., Canonica, G. W., Heaney, L. G., Hew, M., de Llano, L.,

Wechsler, M. E., Bulathsinhala, L., Carter, V. A., Chaudhry, I., Eleangovan, N., Murray, R. B.,

Price, C. A., & Price, D. B. (2021). Asthma phenotyping in primary care: applying the

International Severe Asthma Registry eosinophil phenotype algorithm across all asthma

severities. J Allergy Clin Immunol Pract. https://doi.org/10.1016/j.jaip.2021.07.056

Khalid, S., Pineda-Moncus\’\i, M., El-Hussein, L., Delmestri, A., Ernst, M., Smith, C., Libanati, C.,

Toth, E., Javaid, M. K., Cooper, C., Abrahamsen, B., & Prieto-Alhambra, D. (2021). Predicting

Imminent Fractures in Patients With a Recent Fracture or Starting Oral Bisphosphonate

Therapy: Development and International Validation of Prognostic Models. J Bone Miner Res.

https://doi.org/10.1002/jbmr.4414

Khalid, S., Reyes, C., Ernst, M., Delmestri, A., Toth, E., Libanati, C., Abrahamsen, B., & Prieto-

Alhambra, D. (2021). One- and 2-year incidence of osteoporotic fracture: a multi-cohort

observational study using routinely collected real-world data. Osteoporos Int.

https://doi.org/10.1007/s00198-021-06077-0

Khan, N. F., Booth, H. P., Myles, P., Mullett, D., Gallagher, A., Evans, C., Thomas, N., & Valentine,

J. (2021). Use of prescribing safety quality improvement reports in UK general practices: a

qualitative assessment. BMC Health Serv Res, 21(1), 394. https://doi.org/10.1186/s12913-021-

06417-0

Khan, T., El-Sockary, Y., Hamilton, W. T., & Shephard, E. A. (2021). Recognizing sinonasal cancer

in primary care: a matched case-control study using electronic records. Fam Pract.

https://doi.org/10.1093/fampra/cmab153

Khawagi, W. Y., Steinke, D., Carr, M. J., Wright, A. K., Ashcroft, D. M., Avery, A., & Keers, R. N.

(2021). Evaluating the safety of mental health-related prescribing in UK primary care: a cross-

CPRD bibliography

20

sectional study using the Clinical Practice Research Datalink (CPRD). BMJ Qual Saf.


Khunti, K., Hertz, C. L., Husemoen, L. L. N., Mocevic, E., Nordsborg, R. B., Piltoft, J. S., & Bain, S.

C. (2021). Cardiovascular risk factors early in the course of treatment in people with type 2

diabetes without established cardiovascular disease: A population-based observational

retrospective cohort study. Diabet Med, e14697. https://doi.org/10.1111/dme.14697

Kontopantelis, E., Panagioti, M., Farragher, T., Munford, L. A., Parisi, R., Planner, C., Spooner, S.,

Tse, A., Ashcroft, D. M., & Esmail, A. (2021). Consultation patterns and frequent attenders in

UK primary care from 2000 to 2019: a retrospective cohort analysis of consultation events

across 845 general practices. BMJ Open, 11(12), e054666. https://doi.org/10.1136/bmjopen-

2021-054666

Koshiaris, C., den Bruel, A., Nicholson, B. D., Lay-Flurrie, S., Hobbs, F. R., & Oke, J. L. (2021).

Clinical prediction tools to identify patients at highest risk of myeloma in primary care: a

retrospective open cohort study. Br J Gen Pract, 71(706), e347–e355.


Kuan, V., Fraser, H. C., Hingorani, M., Denaxas, S., Gonzalez-Izquierdo, A., Direk, K., Nitsch, D.,

Mathur, R., Parisinos, C. A., Lumbers, R. T., Sofat, R., Wong, I. C. K., Casas, J. P., Thornton, J.

M., Hemingway, H., Partridge, L., & Hingorani, A. D. (2021). Data-driven identification of

ageing-related diseases from electronic health records. Sci Rep, 11(1), 2938.

https://doi.org/10.1038/s41598-021-82459-y

Langham, J., Barut, V., Samnaliev, M., Langham, S., Weir, S., Wang, X., Desta, B., & Hammond, E.

(2021). Disease severity, flares and treatment patterns in adults with systemic lupus

erythematosus in the UK: a real-world observational retrospective cohort analysis. Rheumatol

Adv Pract, 5(3), rkab061. https://doi.org/10.1093/rap/rkab061

Lawson, C. A., Seidu, S., Zaccardi, F., McCann, G., Kadam, U. T., Davies, M. J., Lam, C. S. P.,

Heerspink, H. L., & Khunti, K. (2021). Outcome trends in people with heart failure, type 2

diabetes mellitus and chronic kidney disease in the UK over twenty years. EClinicalMedicine.

https://doi.org/10.1016/j.eclinm.2021.100739

Lay-Flurrie, S. L., Sheppard, J. P., Stevens, R. J., Mallen, C., Heneghan, C., Hobbs, F. R., Williams,

B., Mant, J., & McManus, R. J. (2021). Impact of changes to national guidelines on

hypertension-related workload: an interrupted time series analysis in English primary care. Br J

Gen Pract, 71(705), e296–e302. https://doi.org/10.3399/bjgp21X714281

le Roux, C. W., Hartvig, N. V, Haase, C. L., Nordsborg, R. B., Olsen, A. H., & Satylganova, A.

(2021). Obesity, cardiovascular risk and healthcare resource utilization in the UK. Eur J Prev

Cardiol, 28(11), 1235–1241. https://doi.org/10.1177/2047487320925639

Lee, C., Waite, F., Smith, M. C., Gao, M., Bankhead, C., Aveyard, P., & Piernas, C. (2021). Weight

change, cardio-metabolic risk factors and cardiovascular incidence in people with serious mental

illness: protocol of a population-based cohort study in the UK from 1998 to 2020. BMJ Open,


Lefeber, G. J., Knol, W., Souverein, P. C., Bouvy, M. L., de Boer, A., & Koek, H. L. (2021). Statins

After Ischemic Stroke in the Oldest: A Cohort Study Using the Clinical Practice Research

Datalink Database. Stroke, Strokeaha120030755. https://doi.org/10.1161/strokeaha.120.030755

CPRD bibliography

21

Lewer, D., Brothers, T. D., Van Hest, N., Hickman, M., Holland, A., Padmanathan, P., & Zaninotto,

P. (2021). Causes of death among people who used illicit opioids in England, 2001-18: a

matched cohort study. Lancet Public Health. https://doi.org/10.1016/s2468-2667(21)00254-1

Li, X., Ostropolets, A., Makadia, R., Shoaibi, A., Rao, A., Sena, A. G., Martinez-Hernandez, E.,

Verhamme, K., Rijnbeek, P., Ryan, P. B., & Prieto-Alhambra, D. (2021). Characterising the

background incidence rates of adverse events of special interest for covid-19 vaccines in eight

countries: multinational network cohort study. BMJ. https://doi.org/10.1136/bmj.n1435

Li, Y., Kurinczuk, J. J., Gale, C., Siassakos, D., & Carson, C. (2021). Evidence of disparities in the

provision of the maternal postpartum 6-week check in primary care in England, 2015-2018: an

observational study using the Clinical Practice Research Datalink (CPRD). J Epidemiol

Community Health. https://doi.org/10.1136/jech-2021-216640

Li, Y., Sperrin, M., Ashcroft, D. M., & van Staa, T. P. (2021). Consistency of ranking was evaluated

as new measure for prediction model stability: longitudinal cohort study. J Clin Epidemiol, 138,

168–177. https://doi.org/10.1016/j.jclinepi.2021.06.026

Ling, S., Zaccardi, F., Lawson, C., Seidu, S. I., Davies, M. J., & Khunti, K. (2021). Glucose Control,

Sulfonylureas, and Insulin Treatment in Elderly People With Type 2 Diabetes and Risk of

Severe Hypoglycemia and Death: An Observational Study. Diabetes Care.

https://doi.org/10.2337/dc20-0876

Lister, J., Han, L., Bellass, S., Taylor, J., Alderson, S. L., Doran, T., Gilbody, S., Hewitt, C., Holt, R.

I. G., Jacobs, R., Kitchen, C. E. W., Prady, S. L., Radford, J., Ride, J. R., Shiers, D., Wang, H. I.,

& Siddiqi, N. (2021). Health Services and Delivery Research. In Identifying determinants of

diabetes risk and outcomes for people with severe mental illness: a mixed-methods study. NIHR

Journals Library Copyright ©2021 Lister et al. This work was produced by Lister et al. under the

terms of a commissioning contract issued by the Secretary of State for Health and Social Care.

This is an Open Access publication distributed under the. https://doi.org/10.3310/hsdr09100

Livingstone, S., Morales, D. R., Donnan, P. T., Payne, K., Thompson, A. J., Youn, J. H., & Guthrie,

B. (2021). Effect of competing mortality risks on predictive performance of the QRISK3

cardiovascular risk prediction tool in older people and those with comorbidity: external

validation population cohort study. Lancet Healthy Longev, 2(6), e352–e361.

https://doi.org/10.1016/s2666-7568(21)00088-x

Lix, L. M., Sobhan, S., St-Jean, A., Daigle, J. M., Fisher, A., Yu, O. H. Y., Dell’Aniello, S., Hu, N.,

Bugden, S. C., Shah, B. R., Ronksley, P. E., Alessi-Severini, S., Douros, A., Ernst, P., & Filion,

K. B. (2021). Validity of an algorithm to identify cardiovascular deaths from administrative

health records: a multi-database population-based cohort study. BMC Health Serv Res, 21(1),

758. https://doi.org/10.1186/s12913-021-06762-0

Lopes, S., Meincke, H. H., Lamotte, M., Olivieri, A. V, & Lean, M. E. J. (2021). A novel decision

model to predict the impact of weight management interventions: The Core Obesity Model.

Obes Sci Pract, 7(3), 269–280. https://doi.org/10.1002/osp4.495

Mansfield, K. E., Mathur, R., Tazare, J., Henderson, A. D., Mulick, A. R., Carreira, H., Matthews, A.

A., Bidulka, P., Gayle, A., Forbes, H., Cook, S., Wong, A. Y. S., Strongman, H., Wing, K.,

Warren-Gash, C., Cadogan, S. L., Smeeth, L., Hayes, J. F., Quint, J. K., … Langan, S. M.

(2021). Indirect acute effects of the COVID-19 pandemic on physical and mental health in the

UK: a population-based study. Lancet Digit Health. https://doi.org/10.1016/s2589-

7500(21)00017-0

CPRD bibliography

22

Matthewman, J., Mansfield, K. E., Prieto-Alhambra, D., Mulick, A. R., Smeeth, L., Lowe, K. E.,

Silverwood, R. J., & Langan, S. M. (2021). Atopic-eczema-associated fracture risk and oral

corticosteroids: a population-based cohort study. J Allergy Clin Immunol Pract.

https://doi.org/10.1016/j.jaip.2021.09.026

Matthews, A. A., Peacock Hinton, S., Stanway, S., Lyon, A. R., Smeeth, L., Lund, J. L., & Bhaskaran,

K. (2021). Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer

survivors. Heart, 107(16), 1327–1335. https://doi.org/10.1136/heartjnl-2020-317510

McFadden, E., Lay-Flurrie, S., Koshiaris, C., Richards, G. C., & Heneghan, C. (2021). The Long-

Term Impact of Vaginal Surgical Mesh Devices in UK Primary Care: A Cohort Study in the

Clinical Practice Research Datalink. Clin Epidemiol, 13, 1167–1180.


McKay, A. J., Gunn, L. H., Ference, B. A., Dorresteijn, J. A. N., Berkelmans, G. F. N., Visseren, F. L.

J., & Ray, K. K. (2021). Is the SMART risk prediction model ready for real-world

implementation? A validation study in a routine care setting of approximately 380 000

individuals. Eur J Prev Cardiol. https://doi.org/10.1093/eurjpc/zwab093

McKay, A. J., Gunn, L. H., Sathish, T., Vamos, E., Nugawela, M., Majeed, A., Molina, G., &

Sivaprasad, S. (2021). Associations between attainment of incentivised primary care indicators

and incident diabetic retinopathy in England: a population-based historical cohort study. BMC

Med, 19(1), 93. https://doi.org/10.1186/s12916-021-01966-x

McKay, A. J., Gunn, L. H., Vamos, E. P., Valabhji, J., Molina, G., Molokhia, M., & Majeed, A.

(2021). Associations between attainment of incentivised primary care diabetes indicators and

mortality in an English cohort. Diabetes Res Clin Pract, 174, 108746.

https://doi.org/10.1016/j.diabres.2021.108746

Merriel, S. W. D., Ingle, S. M., May, M. T., & Martin, R. M. (2021). Retrospective cohort study

evaluating clinical, biochemical and pharmacological prognostic factors for prostate cancer

progression using primary care data. BMJ Open, 11(2), e044420.


Minjon, L., van den Ban, E., Bazelier, M. T., Lalmohamed, A., Egberts, T. C. G., & Heerdink, E. R.

(2021). Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and

Young Adults Prescribed Antipsychotic Drugs by General Practitioners. J Child Adolesc

Psychopharmacol. https://doi.org/10.1089/cap.2021.0026

Mitchell, A., Snowball, J., Welsh, T. J., Watson, M. C., & McGrogan, A. (2021). Prescribing of direct

oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a

cohort study. BMC Med, 19(1), 189. https://doi.org/10.1186/s12916-021-02067-5

Mohammad, H. R., Gooberman-Hill, R., Delmestri, A., Broomfield, J., Patel, R., Huber, J., Garriga,

C., Eccleston, C., Pinedo-Villanueva, R., Malak, T. T., Arden, N., Price, A., Wylde, V., Peters,

T. J., Blom, A. W., & Judge, A. (2021). Risk factors associated with poor pain outcomes

following primary knee replacement surgery: Analysis of data from the clinical practice research

datalink, hospital episode statistics and patient reported outcomes as part of the STAR research

programme. PLoS One, 16(12), e0261850. https://doi.org/10.1371/journal.pone.0261850

Moore, S. F., Price, S. J., Chowienczyk, S., Bostock, J., & Hamilton, W. (2021). The impact of

changing risk thresholds on the number of people in England eligible for urgent investigation for

possible cancer: an observational cross-sectional study. Br J Cancer, 1–5.

https://doi.org/10.1038/s41416-021-01541-4

CPRD bibliography

23

Morales, D. R., Lipworth, B. J., Donnan, P. T., & Wang, H. (2021). Intolerance to Angiotensin

Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based

Cohort Study. J Allergy Clin Immunol Pract. https://doi.org/10.1016/j.jaip.2021.04.055

Morgan, C. L., Jenkins-Jones, S., Knaggs, R., Currie, C., Conway, P., Poole, C. D., & Berni, E.

(2021). Characterization and Associated Costs of Constipation Relating to Exposure to Strong

Opioids in England: An Observational Study. Clin Ther.


Morriss, R., Tyrer, F., Zaccardi, F., & Khunti, K. (2021). Safety of antidepressants in a primary care

cohort of adults with obesity and depression. PLoS One, 16(1), e0245722.


Moussa, O., Ardissino, M., Muttoni, S., Faraj, A., Tang, A., Khan, O., Collins, P., Jaffer, U., &

Purkayastha, S. (2021). Long-term incidence and outcomes of obesity-related peripheral

vascular disease after bariatric surgery. Langenbecks Arch Surg. https://doi.org/10.1007/s00423-

020-02066-9

Moussa, O., Ardissino, M., Tang, A., Edwards, J., Heaton, T., Khan, O., Tsang, K., Collins, P., &

Purkayastha, S. (2021). Long-term cerebrovascular outcomes after bariatric surgery: A

nationwide cohort study. Clin Neurol Neurosurg, 203, 106560.

https://doi.org/10.1016/j.clineuro.2021.106560

Mueller, A. M., Liakoni, E., Schneider, C., Burkard, T., Jick, S. S., Krahenbuhl, S., Meier, C. R., &

Spoendlin, J. (2021). The Risk of Muscular Events Among New Users of Hydrophilic and

Lipophilic Statins: an Observational Cohort Study. J Gen Intern Med.

https://doi.org/10.1007/s11606-021-06651-6

Musgrove, R., Carr, M. J., Kapur, N., Chew-Graham, C. A., Mughal, F., Ashcroft, D. M., & Webb, R.

T. (2021). Suicide and other causes of death among working-age and older adults in the year

after discharge from in-patient mental healthcare in England: matched cohort study. Br J

Psychiatry, 1–8. https://doi.org/10.1192/bjp.2021.176

Muzambi, R., Bhaskaran, K., Smeeth, L., Brayne, C., Chaturvedi, N., & Warren-Gash, C. (2021).

Assessment of common infections and incident dementia using UK primary and secondary care

data: a historical cohort study. Lancet Healthy Longev, 2(7), e426–e435.

https://doi.org/10.1016/s2666-7568(21)00118-5

Nadarajah, R., Wu, J., Frangi, A. F., Hogg, D., Cowan, C., & Gale, C. (2021). Predicting patient-level

new-onset atrial fibrillation from population-based nationwide electronic health records:

protocol of FIND-AF for developing a precision medicine prediction model using artificial

intelligence. BMJ Open, 11(11), e052887. https://doi.org/10.1136/bmjopen-2021-052887

Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Zhang, W., Doherty, M., Taal, M. W., Aithal,

G. P., & Abhishek, A. (2021). What is the incidence of methotrexate or leflunomide

discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?

Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keab254

Nakafero, G., Grainge, M. J., Card, T., Taal, M. W., Aithal, G. P., Zhang, W., Doherty, M., Fox, C.

P., Mallen, C. D., & Abhishek, A. (2021). Development and validation of a prognostic model for

leflunomide discontinuation with abnormal blood-tests during long-term treatment: cohort study

using data from Clinical Practice Research Datalink Gold and Aurum. Rheumatology (Oxford).


CPRD bibliography

24

Nakafero, G., Grainge, M. J., Valdes, A. M., Townsend, N., Mallen, C., Zhang, W., Doherty, M.,

Mamas, M., & Abhishek, A. (2021). β-blocker prescription is associated with lower cumulative

risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score

matched cohort study. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keab234

Neuen, B. L., Weldegiorgis, M., Herrington, W. G., Ohkuma, T., Smith, M., & Woodward, M.

(2021). Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney

Disease Progression. Am J Kidney Dis. https://doi.org/10.1053/j.ajkd.2021.02.335

Ngaosuwan, K., Johnston, D. G., Godsland, I. F., Cox, J., Majeed, A., Quint, J. K., Oliver, N., &

Robinson, S. (2021). Cardiovascular disease in patients with primary and secondary adrenal

insufficiency and the role of comorbidities. J Clin Endocrinol Metab.



Robinson, S. (2021). Increased mortality risk in patients with primary and secondary adrenal

insufficiency. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgab096


Robinson, S. (2021). Full Mortality risk in patients with adrenal insufficiency using

Prednisolone or Hydrocortisone: A Retrospective Cohort study. J Clin Endocrinol Metab.


Noble, M., Burden, A., Stirling, S., Clark, A., Musgrave, S., Al Sallakh, M., Price, D., Davies, G.,

Pinnock, H., Pond, M., Sheikh, A., Sims, E., Walker, S., & Wilson, A. (2021). Predicting

asthma-related crisis events using routine electronic healthcare data. Br J Gen Pract.


O’Dowd, E. L., Ten Haaf, K., Kaur, J., Duffy, S. W., Hamilton, W., Hubbard, R. B., Field, J. K.,

Callister, M. E., Janes, S. M., de Koning, H. J., Rawlinson, J., & Baldwin, D. R. (2021).

Selection of eligible participants for screening for lung cancer using primary care data. Thorax.

https://doi.org/10.1136/thoraxjnl-2021-217142

Offman, J., Pesola, F., Fitzgerald, R. C., Hamilton, W., & Sasieni, P. (2021). Impact of Barrett

oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort

study. Cancer Med. https://doi.org/10.1002/cam4.4484

Olaiya, O. R., & Huynh, M. N. Q. (2021). Dupuytren{‘}s Disease Predicts Increased All-Cause and

Cancer-Specific Mortality: Analysis of a Large Cohort from the U.K. Clinical Practice Research

Datalink. Plast Reconstr Surg, 147(5), 890e-891e.

https://doi.org/10.1097/prs.0000000000007825

Ou, L. B., Azoulay, L., Reynier, P., Platt, R. W., Yoon, S., Grad, R., & Filion, K. B. (2021). Tramadol

versus Codeine and the Short-term Risk of Cardiovascular Events in Patients with Non-Cancer

Pain: A Population-Based Cohort Study. Br J Clin Pharmacol.


Padmanathan, P., Forbes, H., Redaniel, M. T., Gunnell, D., Lewer, D., Moran, P., Watson, B.,

Degenhardt, L., & Hickman, M. (2021). Self-harm and suicide during and after opioid agonist

treatment among primary care patients in England: a cohort study. Lancet Psychiatry.

https://doi.org/10.1016/s2215-0366(21)00392-8

CPRD bibliography

25

Palin, V., Welfare, W., Ashcroft, D. M., & van Staa, T. P. (2021). Shorter and longer courses of

antibiotics for common infections and the association with reductions of infection-related

complications including hospital admissions. Clin Infect Dis. https://doi.org/10.1093/cid/ciab159

Papez, V., Moinat, M., Payralbe, S., Asselbergs, F. W., Lumbers, R. T., Hemingway, H., Dobson, R.,

& Denaxas, S. (2021). Transforming and evaluating electronic health record disease

phenotyping algorithms using the OMOP common data model: a case study in heart failure.

JAMIA Open, 4(3), ooab001. https://doi.org/10.1093/jamiaopen/ooab001

Pathak, N., Zhang, C. X., Boukari, Y., Burns, R., Mathur, R., Gonzalez-Izquierdo, A., Denaxas, S.,

Sonnenberg, P., Hayward, A., & Aldridge, R. W. (2021). Development and Validation of a

Primary Care Electronic Health Record Phenotype to Study Migration and Health in the UK. Int

J Environ Res Public Health, 18(24). https://doi.org/10.3390/ijerph182413304

Peach, E. J., Pearce, F. A., Gibson, J., Cooper, A. J., Chen, L. C., & Knaggs, R. D. (2021). Opioids

and the Risk of Fracture: a Self-Controlled Case Series Study in the Clinical Practice Research

Datalink. Am J Epidemiol. https://doi.org/10.1093/aje/kwab042

Pearson-Stuttard, J., Bennett, J., Cheng, Y. J., Vamos, E. P., Cross, A. J., Ezzati, M., & Gregg, E. W.

(2021). Trends in predominant causes of death in individuals with and without diabetes in

England from 2001 to 2018: an epidemiological analysis of linked primary care records. Lancet

Diabetes Endocrinol, 9(3), 165–173. https://doi.org/10.1016/s2213-8587(20)30431-9

Pearson-Stuttard, J., Cheng, Y. J., Bennett, J., Vamos, E. P., Zhou, B., Valabhji, J., Cross, A. J.,

Ezzati, M., & Gregg, E. W. (2021). Trends in leading causes of hospitalisation of adults with

diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care

records. Lancet Diabetes Endocrinol. https://doi.org/10.1016/s2213-8587(21)00288-6

Persson, M. S. M., Harman, K. E., Thomas, K. S., Chalmers, J. R., Vinogradova, Y., Langan, S. M.,

Hippisley-Cox, J., & Gran, S. (2021). Using electronic health records to inform trial feasibility

in a rare autoimmune blistering skin disease in England. BMC Med Res Methodol, 21(1), 22.

https://doi.org/10.1186/s12874-021-01212-1

Persson, M. S., Harman, K. E., Thomas, K. S., Chalmers, J. R., Vinogradova, Y., Langan, S. M.,

Hippisley-Cox, J., & Gran, S. (2021). Long-term oral prednisolone exposure in primary care for

bullous pemphigoid: population-based study. Br J Gen Pract.


Persson, R., Sponholtz, T., Vasilakis-Scaramozza, C., Hagberg, K. W., Williams, T., Kotecha, D.,

Myles, P., & Jick, S. S. (2021). Quality and Completeness of Myocardial Infarction Recording

in Clinical Practice Research Datalink Aurum. Clin Epidemiol, 13, 745–753.


Phiri, K., Hallas, J., Linder, M., Margulis, A., Suehs, B., Arana, A., Bahmanyar, S., Hoffman, V.,

Enger, C., Horter, L., Odsbu, I., Olesen, M., Perez-Gutthann, S., Kristiansen, N. S., Appenteng,

K., de Vogel, S., & Seeger, J. (2021). A study of cancer occurrence in users of mirabegron and

antimuscarinic treatments for overactive bladder. Curr Med Res Opin, 1.

https://doi.org/10.1080/03007995.2021.1891035

Povey, M., Aris, E., Cheuvart, B., Hall, G., Cohet, C., & Willame, C. (2021). Effectiveness of

“Priorix” Against Measles and Mumps Diseases in Children Born After 2004 in the United

Kingdom: A Retrospective Case-control Study Using the Clinical Practice Research Datalink

GOLD Database. Pediatr Infect Dis J, 40(6), 590–596.

https://doi.org/10.1097/inf.0000000000003111

CPRD bibliography

26

Powell, E. M., Douglas, I. J., Gungabissoon, U., Smeeth, L., & Wing, K. (2021). Real-world effects of

medications for stroke prevention in atrial fibrillation: protocol for a UK population-based non-

interventional cohort study with validation against randomised trial results. BMJ Open, 11(4),


Pradhan, R., Abrahami, D., Yin, H., Yu, O. H. Y., Sahasrabudhe, V., Baumfeld Andre, E., & Azoulay,

L. (2021). Defining Clinically-Relevant Target Populations Using Real-World Data to Guide the

Design of Representative Antidiabetic Drug Trials. Clin Pharmacol Ther.

https://doi.org/10.1002/cpt.2213

Price, S., Abel, G. A., & Hamilton, W. (2021). Guideline interval: A new time interval in the

diagnostic pathway for symptomatic cancer. Cancer Epidemiol, 73, 101969.

https://doi.org/10.1016/j.canep.2021.101969

Prior, J. A., Crawford-Manning, F., Whittle, R., Abdul-Sultan, A., Chew-Graham, C. A., Muller, S.,

Shepherd, T. A., Sumathipala, A., Mallen, C. D., & Paskins, Z. (2021). Vertebral fracture as a

risk factor for self-harm: a retrospective cohort study. BMC Musculoskelet Disord, 22(1), 757.

https://doi.org/10.1186/s12891-021-04631-9

Prior, J. A., Paskins, Z., Whittle, R., Abdul-Sultan, A., Chew-Graham, C. A., Muller, S., Bajpai, R.,

Shepherd, T. A., Sumathipala, A., & Mallen, C. D. (2021). Rheumatic Conditions as Risk

Factors for Self-Harm: A Retrospective Cohort Study. Arthritis Care Res (Hoboken), 73(1),

130–137. https://doi.org/10.1002/acr.24345

Rahman, A., Kane, J., Montastruc, F., & Renoux, C. (2021). Trends in new prescription of

gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017. Br J

Clin Pharmacol. https://doi.org/10.1111/bcp.14727

Rasmussen, N. H., Sarodnik, C., Bours, S. P. G., Schaper, N. C., Souverein, P. C., Jensen, M. H.,

Driessen, J. H. M., van den Bergh, J. P. W., & Vestergaard, P. (2021). The pattern of incident

fractures according to fracture site in people with T1D. Osteoporos Int.

https://doi.org/10.1007/s00198-021-06175-z

Rebordosa, C., Plana, E., Rubino, A., Aguado, J., Lei, A., Daoud, S., Saigi-Morgui, N., Perez-

Gutthann, S., & Rivero-Ferrer, E. (2021). A Cohort Study to Evaluate the Risk of

Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other

Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research

Datalink. Int J Chron Obstruct Pulmon Dis, 16, 1461–1475.


Requena, G., Dedman, D., Quint, J. K., Ghosh, R. E., Williams, R., & Pimenta, J. M. (2021). The

Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A

Retrospective Cohort Study. Int J Chron Obstruct Pulmon Dis, 16, 629–642.


Requena, G., Logie, J., Gibbons, D. C., Steinfeld, J., & Van Dyke, M. K. (2021). The increasing

incidence and prevalence of hypereosinophilic syndrome in the United Kingdom. Immun

Inflamm Dis. https://doi.org/10.1002/iid3.495

Rezel-Potts, E., Douiri, A., Chowienczyk, P. J., & Gulliford, M. C. (2021). Antihypertensive

Medications and COVID-19 Diagnosis and Mortality: Population-based Case-Control Analysis

in the United Kingdom. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.14873

CPRD bibliography

27

Rezel-Potts, E., L’Esperance, V., & Gullifiord, M. (2021). Antimicrobial stewardship during the

COVID-19 epidemic: population-based cohort study and interrupted time series analysis in the

United Kingdom. Br J Gen Pract. https://doi.org/10.3399/bjgp.2020.1051

Richardson, K., Savva, G. M., Boyd, P. J., Aldus, C., Maidment, I., Pakpahan, E., Loke, Y. K.,

Arthur, A., Steel, N., Ballard, C., Howard, R., & Fox, C. (2021). Non-benzodiazepine hypnotic

use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort

studies. Health Technol Assess, 25(1), 1–202. https://doi.org/10.3310/hta25010

Roalfe, A. K., Lay-Flurrie, S. L., Ordonez-Mena, J. M., Goyder, C. R., Jones, N. R., Hobbs, F. D. R.,

& Taylor, C. J. (2021). Long term trends in natriuretic peptide testing for heart failure in UK

primary care: a cohort study. Eur Heart J. https://doi.org/10.1093/eurheartj/ehab781

Robinson, D. E., Ali, M. S., Strauss, V. Y., Elhussein, L., Abrahamsen, B., Arden, N. K., Ben-

Shlomo, Y., Caskey, F., Cooper, C., Dedman, D., Delmestri, A., Judge, A., Javaid, M. K., &

Prieto-Alhambra, D. (2021). Bisphosphonates to reduce bone fractures in stage 3B+ chronic

kidney disease: a propensity score-matched cohort study. Health Technol Assess, 25(17), 1–106.

https://doi.org/10.3310/hta25170

Robinson, D. E., Douglas, I., Tan, G. D., Delmestri, A., Judge, A., Cooper, C., Javaid, M. K., Strauss,

V. Y., & Prieto-Alhambra, D. (2021). Bariatric surgery increases the rate of major fracture: self

controlled case series study in UK Clinical Practice Research Datalink. J Bone Miner Res.

https://doi.org/10.1002/jbmr.4405

Rodgers, L. R., Streeter, A. J., Lin, N., Hamilton, W., & Henley, W. E. (2021). Impact of influenza

vaccination on amoxicillin prescriptions in older adults: A retrospective cohort study using

primary care data. PLoS One, 16(1), e0246156. https://doi.org/10.1371/journal.pone.0246156

Røikjer, J., Werkman, N. C. C., Ejskjaer, N., van den Bergh, J. P. W., Vestergaard, P., Schaper, N. C.,

Jensen, M. H., Klungel, O., de Vries, F., Nielen, J. T. H., Driessen, J. H. M., Ejskjaer, N., van

den Bergh, J. P. W., Vestergaard, P., Schaper, N. C., Hasselstrøm Jensen, M., Klungel, O., de

Vries, F., Nielen, J. T. H., … de Vries, F. (2021). Incidence, hospitalization and mortality and

their changes over time in people with a first ever diabetic foot ulcer. Diabet Med, e14725.

https://doi.org/10.1111/dme.14725

Rouette, J., Yin, H., McDonald, E. G., Barkun, A., & Azoulay, L. (2021). Renin-Angiotensin-

Aldosterone System Inhibitors and Risk of Acute Pancreatitis: A Population-Based Cohort

Study. Drug Saf. https://doi.org/10.1007/s40264-021-01128-1

Roy, D., Akriche, F., Amlani, B., & Shakir, S. (2021). Utilisation and Safety of Polyethylene Glycol

3350 with Electrolytes in Children Under 2 Years: A Retrospective Cohort. J Pediatr

Gastroenterol Nutr. https://doi.org/10.1097/mpg.0000000000003074

Ruigomez, A., Plana, E., Gilsenan, A., Fortuny, J., Cainzos-Achirica, M., Flynn, R. W. V,

MacDonald, T. M., Garcia-Rodriguez, L., Ziemiecki, R., & Andrews, E. B. (2021).

Identification and Validation of Major Cardiovascular Events in the United Kingdom Data

Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride. Drug Saf.

https://doi.org/10.1007/s40264-021-01044-4

Russell, G., Stapley, S., Newlove-Delgado, T., Salmon, A., White, R., Warren, F., Pearson, A., &

Ford, T. (2021). Time trends in autism diagnosis over 20 years: a UK population-based cohort

study. J Child Psychol Psychiatry. https://doi.org/10.1111/jcpp.13505

CPRD bibliography

28

Sabate, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Grave, B., Huerta, C., Martin-

Merino, E., Montero, D., Leon-Munoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R.,

Aakjaer, M., Andersen, M., De Bruin, M. L., Souverein, P., Klungel, O. H., … Ibanez, L.

(2021). Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial

Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015). Front

Pharmacol, 12, 682890. https://doi.org/10.3389/fphar.2021.682890

Samnaliev, M., Barut, V., Weir, S., Langham, J., Langham, S., Wang, X., Desta, B., & Hammond, E.

(2021). Health-care utilization and costs in adults with systemic lupus erythematosus in the

United Kingdom: a real-world observational retrospective cohort analysis. Rheumatol Adv Pract,

5(3), rkab071. https://doi.org/10.1093/rap/rkab071

Schneider, R., Reinau, D., Stoffel, S., Jick, S. S., Meier, C. R., & Spoendlin, J. (2021). Risk of skin

cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active

comparator group. Br J Dermatol. https://doi.org/10.1111/bjd.19880

Schonmann, Y., Mansfield, K. E., Mulick, A., Roberts, A., Smeeth, L., Langan, S. M., & Nitsch, D.

(2021). Inflammatory Skin Diseases and the Risk of Chronic Kidney Disease - Population-Based

Case-control and Cohort analyses. Br J Dermatol. https://doi.org/10.1111/bjd.20067

Schuemie, M. J., Weinstein, R., Ryan, P. B., & Berlin, J. A. (2021). Quantifying bias in epidemiologic

studies evaluating the association between acetaminophen use and cancer. Regul Toxicol

Pharmacol, 120, 104866. https://doi.org/10.1016/j.yrtph.2021.104866

Scott, L., Redaniel, M. T., Booker, M., Payne, R. A., & Tilling, K. (2021). Regression discontinuity

analysis for pharmacovigilance: statin example reflected trial findings showing little evidence of

harm. J Clin Epidemiol. https://doi.org/10.1016/j.jclinepi.2021.10.003

Seesaghur, A., Petruski-Ivleva, N., Banks, V. L., Wang, J. R., Abbasi, A., Neasham, D., &

Ramasamy, K. (2021). Clinical features and diagnosis of multiple myeloma: a population-based

cohort study in primary care. BMJ Open, 11(10), e052759. https://doi.org/10.1136/bmjopen-

2021-052759

Sekelj, S., Sandler, B., Johnston, E., Pollock, K. G., Hill, N. R., Gordon, J., Tsang, C., Khan, S., Ng,

F. S., & Farooqui, U. (2021). Detecting undiagnosed atrial fibrillation in UK primary care:

Validation of a machine learning prediction algorithm in a retrospective cohort study. Eur J Prev

Cardiol, 28(6), 598–605. https://doi.org/10.1177/2047487320942338

Smith, K. J., Peterson, M. D., Victor, C., & Ryan, J. M. (2021). Risk of dementia in adults with

cerebral palsy: a matched cohort study using general practice data. BMJ Open, 11(1), e042652.


Smith, M. C., Ashdown, H. F., Sheppard, J. P., Butler, C. C., & Bankhead, C. (2021). Statin

prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a

retrospective cohort study in the Clinical Practice Research Datalink. BMJ Open, 11(12),


Subota, A., Jetté, N., Josephson, C. B., McMillan, J., Keezer, M. R., Gonzalez-Izquierdo, A., &

Holroyd-Leduc, J. (2021). Risk factors for dementia development, frailty, and mortality in older

adults with epilepsy - A population-based analysis. Epilepsy Behav, 120, 108006.

https://doi.org/10.1016/j.yebeh.2021.108006

CPRD bibliography

29

Suissa, K., Schneeweiss, S., Douros, A., Filion, K. B., Yin, H., Patorno, E., & Azoulay, L. (2021).

The modifying effects of adiposity on the cardiovascular safety of sulphonylureas. Diabetes

Obes Metab. https://doi.org/10.1111/dom.14494

Suissa, S., Dell’Aniello, S., & Ernst, P. (2021). Triple Inhaler versus Dual Bronchodilator Therapy in

COPD: Real-World Effectiveness on Mortality. Copd, 1–9.

https://doi.org/10.1080/15412555.2021.1977789

Suissa, S., Dell’Aniello, S., & Ernst, P. (2021). Comparative Effectiveness of Initial LAMA versus

LABA in COPD: Real-World Cohort Study. Copd, 18(1), 1–8.

https://doi.org/10.1080/15412555.2021.1877649

Suissa, S., Dell’Aniello, S., & Ernst, P. (2021). Comparing initial LABA-ICS inhalers in COPD:

Real-world effectiveness and safety. Respir Med, 189, 106645.

https://doi.org/10.1016/j.rmed.2021.106645

Sun, L., Pennells, L., Kaptoge, S., Nelson, C. P., Ritchie, S. C., Abraham, G., Arnold, M., Bell, S.,

Bolton, T., Burgess, S., Dudbridge, F., Guo, Q., Sofianopoulou, E., Stevens, D., Thompson, J.

R., Butterworth, A. S., Wood, A., Danesh, J., Samani, N. J., … Di Angelantonio, E. (2021).

Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses.

PLoS Med, 18(1), e1003498. https://doi.org/10.1371/journal.pmed.1003498

Swain, S., Coupland, C., Mallen, C., Kuo, C. F., Sarmanova, A., Bierma-Zeinstra, S. M. A., Englund,

M., Prieto-Alhambra, D., Doherty, M., & Zhang, W. (2021). Temporal relationship between

osteoarthritis and comorbidities: a combined case control and cohort study in the UK primary

care setting. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keab067

Szatkowski, L., Vaz, L. R., Fiaschi, L., Tata, L., & Coleman, T. (2021). Trends in prescribing of

nicotine replacement therapy to pregnant women in primary care in England. Nicotine Tob Res.

https://doi.org/10.1093/ntr/ntab037

Taylor, C. J., Lay-Flurrie, S. L., Ordonez-Mena, J. M., Goyder, C. R., Jones, N. R., Roalfe, A. K., &

Hobbs, F. R. (2021). Natriuretic peptide level at heart failure diagnosis and risk of

hospitalisation and death in England 2004-2018. Heart. https://doi.org/10.1136/heartjnl-2021-

319196

Tervonen, T., Prawitz, T., Chua, G. N., Hyacinthe, J., & Pinto, C. A. (2021). Net clinical benefit of

antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment.

J Clin Epidemiol. https://doi.org/10.1016/j.jclinepi.2021.11.036

Torlinska, B., Hazlehurst, J. M., Nirantharakumar, K., Thomas, G. N., Priestley, J. R., Finnikin, S. J.,

Saunders, P., Abrams, K. R., & Boelaert, K. (2021). wEight chanGes, caRdio-mEtabolic risks

and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD-HES linked

cohort study. BMJ Open, 11(10), e055219. https://doi.org/10.1136/bmjopen-2021-055219

Trafford, A. M., Parisi, R., Rutter, M. K., Kontopantelis, E., Griffiths, C. E. M., & Ashcroft, D. M.

(2021). Concordance and timing in recording cancer events in primary care, hospital and

mortality records for patients with and without psoriasis: A population-based cohort study. PLoS

One, 16(7), e0254661. https://doi.org/10.1371/journal.pone.0254661

Tran, J., Norton, R., Canoy, D., Ayala Solares, J. R., Conrad, N., Nazarzadeh, M., Raimondi, F.,

Salimi-Khorshidi, G., Rodgers, A., & Rahimi, K. (2021). Multi-morbidity and blood pressure

CPRD bibliography

30

trajectories in hypertensive patients: A multiple landmark cohort study. PLoS Med, 18(6),


Tyrer, F., Morriss, R., Kiani, R., Gangadharan, S. K., & Rutherford, M. J. (2021). Mortality

disparities and deprivation among people with intellectual disabilities in England: 2000-2019. J

Epidemiol Community Health. https://doi.org/10.1136/jech-2021-216798

Usman, M., Khunti, K., Davies, M. J., & Gillies, C. L. (2021). Association and relative importance of

multiple risk factor control on cardiovascular disease, end-stage renal disease and mortality in

people with type 2 diabetes: A population-based retrospective cohort study. Prim Care Diabetes,

15(2), 218–226. https://doi.org/10.1016/j.pcd.2020.08.008

van Bodegraven, B., Palin, V., Mistry, C., Sperrin, M., White, A., Welfare, W., Ashcroft, D. M., &

van Staa, T. P. (2021). Infection-related complications after common infection in association

with new antibiotic prescribing in primary care: retrospective cohort study using linked

electronic health records. BMJ Open, 11(1), e041218. https://doi.org/10.1136/bmjopen-2020-

041218

van Dalem, J., Cgj Brouwers, M., Burden, A. M., C, D. A. S., Klungel, O. H., de Vries, F., & Hm

Driessen, J. (2021). “Determinants of treatment modification before and after implementation of

the updated 2015 NICE guideline on type 2 diabetes: a retrospective cohort study.” Diabetes Res

Clin Pract, 108828. https://doi.org/10.1016/j.diabres.2021.108828

van Dalem, J., Driessen, J. H. M., Burden, A. M., Stehouwer, C. D. A., Klungel, O. H., de Vries, F.,

& Brouwers, M. (2021). Thiazolidinediones and Glucagon-like Peptide-1 Receptor Agonists and

the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study. Hepatology.

https://doi.org/10.1002/hep.32012

van der Sande, L., Jöbsis, Q., Bannier, M., van de Garde, E. M. W., Coremans, J. J. M., de Vries, F.,

Dompeling, E., & Driessen, J. H. M. (2021). The risk of community-acquired pneumonia in

children using gastric acid suppressants. Eur Respir J. https://doi.org/10.1183/13993003.03229-

2020

Varma, V. R., Wang, Y., An, Y., Varma, S., Bilgel, M., Doshi, J., Legido-Quigley, C., Delgado, J. C.,

Oommen, A. M., Roberts, J. A., Wong, D. F., Davatzikos, C., Resnick, S. M., Troncoso, J. C.,

Pletnikova, O., O’Brien, R., Hak, E., Baak, B. N., Pfeiffer, R., … Thambisetty, M. (2021). Bile

acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and

pharmacoepidemiologic study. PLoS Med, 18(5), e1003615.


Vinogradova, Y., Dening, T., Hippisley-Cox, J., Taylor, L., Moore, M., & Coupland, C. (2021). Use

of menopausal hormone therapy and risk of dementia: nested case-control studies using

QResearch and CPRD databases. Bmj, 374, n2182. https://doi.org/10.1136/bmj.n2182

Walker, J. L., Grint, D. J., Strongman, H., Eggo, R. M., Peppa, M., Minassian, C., Mansfield, K. E.,

Rentsch, C. T., Douglas, I. J., Mathur, R., Wong, A. Y. S., Quint, J. K., Andrews, N., Bernal, J.

L., Scott, J. A., Ramsay, M., Smeeth, L., & McDonald, H. I. (2021). UK prevalence of

underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence

study using electronic health records. BMC Public Health, 21(1), 484.

https://doi.org/10.1186/s12889-021-10427-2

Walker, J. L., Rentsch, C. T., McDonald, H. I., Bak, J., Minassian, C., Amirthalingam, G., Edelstein,

M., & Thomas, S. (2021). Social determinants of pertussis and influenza vaccine uptake in

CPRD bibliography

31

pregnancy: a national cohort study in England using electronic health records. BMJ Open, 11(6),


Wallenhorst, C., Martinez, C., & Freedman, B. (2021). Risk of ischemic stroke in asymptomatic atrial

fibrillation incidentally-detected in primary care compared with other clinical presentations.

Thromb Haemost. https://doi.org/10.1055/a-1541-3885

Wang, H. I., Han, L., Jacobs, R., Doran, T., Holt, R. I. G., Prady, S. L., Gilbody, S., Shiers, D.,

Alderson, S., Hewitt, C., Taylor, J., Kitchen, C. E. W., Bellass, S., & Siddiqi, N. (2021).

Healthcare resource use and costs for people with type 2 diabetes mellitus with and without

severe mental illness in England: longitudinal matched-cohort study using the Clinical Practice

Research Datalink. Br J Psychiatry, 1–8. https://doi.org/10.1192/bjp.2021.131

Watson, J., Darlington-Pollock, F., Green, M., Giebel, C., & Akpan, A. (2021). The Impact of

Demographic, Socio-Economic and Geographic Factors on Mortality Risk among People Living

with Dementia in England (2002-2016). Int J Environ Res Public Health, 18(24).

https://doi.org/10.3390/ijerph182413405

Webb, J., Mount, J., von Arx, L. B., Rachman, J., Spanopoulos, D., Wood, R., Tritton, T., Massey, O.,

& Idris, I. (2021). Cardiovascular risk profiles: A cross-sectional study evaluating the

generalisability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials

Rewind, Leader and Sustain-6 to the real-world type 2 diabetes population in the UK. Diabetes

Obes Metab. https://doi.org/10.1111/dom.14580

Weng, S. F., Akyea, R. K., Man, K. K., Lau, W. C. Y., Iyen, B., Blais, J. E., Chan, E. W., Siu, C. W.,

Qureshi, N., Wong, I. C. K., & Kai, J. (2021). Determining propensity for sub-optimal low-

density lipoprotein cholesterol response to statins and future risk of cardiovascular disease. PLoS


West, J., Card, T. R., Bishton, M. J., Lanyon, P., Ban, L., Bythell, M., Elliss-Brookes, L., Manson, J.

J., Nanduri, V., Rankin, J., Tattersall, R. S., & Crooks, C. J. (2021). Incidence and survival of

haemophagocytic lymphohistiocytosis: A population-based cohort study from England. J Intern

Med. https://doi.org/10.1111/joim.13432

Whittaker, H. R., Gulea, C., Koteci, A., Kallis, C., Morgan, A. D., Iwundu, C., Weeks, M., Gupta, R.,

& Quint, J. K. (2021). GP consultation rates for sequelae after acute covid-19 in patients

managed in the community or hospital in the UK: population based study. Bmj, 375, e065834.

https://doi.org/10.1136/bmj-2021-065834

Whittaker, H. R., Kiddle, S. J., & Quint, J. K. (2021). Challenges and Pitfalls of Using Repeat

Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD

Population. Pragmat Obs Res, 12, 119–130. https://doi.org/10.2147/por.s319965

Wiering, B., Lyratzopoulos, G., Hamilton, W., Campbell, J., & Abel, G. (2021). Concordance with

urgent referral guidelines in patients presenting with any of six ‘alarm’ features of possible

cancer: a retrospective cohort study using linked primary care records. BMJ Qual Saf.


Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., Quint, J. K., &

Douglas, I. (2021). Medications for chronic obstructive pulmonary disease: a historical non-

interventional cohort study with validation against RCT results. Health Technol Assess, 25(51),

1–70. https://doi.org/10.3310/hta25510

CPRD bibliography

32

Wojewodka, G., Gulliford, M. C., Ashworth, M., Richardson, M. P., & Ridsdale, L. (2021). Epilepsy

and mortality: a retrospective cohort analysis with a nested case-control study identifying causes

and risk factors from primary care and linkage-derived data. BMJ Open, 11(10), e052841.


Woods, L. M., Rachet, B., Morris, M., Bhaskaran, K., & Coleman, M. P. (2021). Are socio-economic

inequalities in breast cancer survival explained by peri-diagnostic factors? BMC Cancer, 21(1),

485. https://doi.org/10.1186/s12885-021-08087-x

Xu, Z., Arnold, M., Stevens, D., Kaptoge, S., Pennells, L., Sweeting, M. J., Barrett, J., Angelantonio,

E. D., & Wood, A. M. (2021). Prediction of Cardiovascular Disease Risk Accounting for Future

Initiation of Statin Treatment. Am J Epidemiol. https://doi.org/10.1093/aje/kwab031

Yang, Z., Edwards, D., Burgess, S., Brayne, C., & Mant, J. (2021). Association of major blood lipids

with post-stroke dementia: a community-based cohort study. Eur J Neurol.

https://doi.org/10.1111/ene.15219

Yu, D., Peat, G., Jordan, K. P., Bailey, J., Prieto-Alhambra, D., Robinson, D. E., Strauss, V. Y.,

Walker-Bone, K., Silman, A., Mamas, M., Blackburn, S., Dent, S., Dunn, K., Judge, A.,

Protheroe, J., & Wilkie, R. (2021). Estimating the population health burden of musculoskeletal

conditions using primary care electronic health records. Rheumatology (Oxford).


Yu, Y. H., Filion, K. B., Reynier, P., Platt, R. W., Yu, O. H. Y., & Grandi, S. M. (2021). Use of

levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom:

A population-based assessment. Pharmacol Res Perspect, 9(5), e00848.

https://doi.org/10.1002/prp2.848

Zghebi, S. S., Mamas, M. A., Ashcroft, D. M., Rutter, M. K., VanMarwijk, H., Salisbury, C., Mallen,

C. D., Chew-Graham, C. A., Qureshi, N., Weng, S. F., Holt, T., Buchan, I., Peek, N., Giles, S.,

Reeves, D., & Kontopantelis, E. (2021). Assessing the severity of cardiovascular disease in 213

088 patients with coronary heart disease: a retrospective cohort study. Open Heart, 8(1).

https://doi.org/10.1136/openhrt-2020-001498

Zheng, B., Su, B., Price, G., Tzoulaki, I., Ahmadi-Abhari, S., & Middleton, L. (2021). Glycemic

Control, Diabetic Complications, and Risk of Dementia in Patients With Diabetes: Results From

a Large U.K. Cohort Study. Diabetes Care. https://doi.org/10.2337/dc20-2850

Zhou, Y., Walter, F. M., Singh, H., Hamilton, W., Abel, G. A., & Lyratzopoulos, G. (2021).

Prolonged Diagnostic Intervals as Marker of Missed Diagnostic Opportunities in Bladder and

Kidney Cancer Patients with Alarm Features: A Longitudinal Linked Data Study. Cancers

(Basel), 13(1). https://doi.org/10.3390/cancers13010156

CPRD bibliography

33

2020

Abrahami, D., McDonald, E. G., Schnitzer, M., & Azoulay, L. (2020). Trends in acid suppressant

drug prescriptions in primary care in the UK: a population-based cross-sectional study. BMJ

Open, 10(12), e041529. https://doi.org/10.1136/bmjopen-2020-041529

Abrahami, D., Renoux, C., Yin, H., Fournier, J. P., & Azoulay, L. (2020). The Association between

Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial

Fibrillation. Thromb Haemost. https://doi.org/10.1055/s-0040-1714213

Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., van den Bergh, J. P., van Staa, T. P.,

Boonen, A., & de Vries, F. (2020). Concomitant use of oral glucocorticoids and proton pump

inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a

population-based cohort study. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-

218758

Akyea, R. K., Qureshi, N., Kai, J., & Weng, S. F. (2020). Performance and clinical utility of

supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary

care. NPJ Digit Med, 3, 142. https://doi.org/10.1038/s41746-020-00349-5

Alarkawi, D., Ali, M. S., Bliuc, D., Pallares, N., Tebe, C., Elhussein, L., Caskey, F. J., Arden, N. K.,

Ben-Shlomo, Y., Abrahamsen, B., Diez-Perez, A., Pascual, J., Perez-Saez, M. J., Center, J. R.,

Judge, A., Cooper, C., Javaid, M. K., & Prieto-Alhambra, D. (2020). Oral bisphosphonate use

and all-cause mortality in patients with moderate-severe (grade 3B-5D) chronic kidney disease:

a population-based cohort study. J Bone Miner Res. https://doi.org/10.1002/jbmr.3961

Althunian, T. A., de Boer, A., Groenwold, R. H. H., Rengerink, K. O., Souverein, P. C., & Klungel,

O. H. (2020). Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A

retrospective noninferiority cohort replication study. Pharmacoepidemiol Drug Saf.

https://doi.org/10.1002/pds.5065

Amegadzie, J. E., Gamble, J. M., Farrell, J., & Gao, Z. (2020). Gender Differences in Inhaled

Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A

Population-Based Study. Int J Chron Obstruct Pulmon Dis, 15, 2355–2366.


Arana, A., Margulis, A. V, Varas-Lorenzo, C., Bui, C. L., Gilsenan, A., McQuay, L. J., Reynolds, M.,

Rebordosa, C., Franks, B., de Vogel, S., Appenteng, K., & Perez-Gutthann, S. (2020).

Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research

Datalink in the United Kingdom. Pharmacoepidemiol Drug Saf.


Ardissino, M., Watson, F., Amin, R., Collins, P., Moussa, O., & Purkayastha, S. (2020).

Atherosclerotic Disease Burden After Bariatric Surgery in Patients with Obesity and Type 2

Diabetes. J Diabetes. https://doi.org/10.1111/1753-0407.13151

Arhi, C. S., Burns, E. M., Bottle, A., Bouras, G., Aylin, P., Ziprin, P., & Darzi, A. (2020). Delays in

referral from primary care worsen survival for patients with colorectal cancer: a retrospective

cohort study. Br J Gen Pract, 70(696), e463–e471. https://doi.org/10.3399/bjgp20X710441

Ascott, A., Mansfield, K. E., Schonmann, Y., Mulick, A., Abuabara, K., Roberts, A., Smeeth, L., &

Langan, S. M. (2020). Atopic eczema and obesity: a population-based study. Br J Dermatol.

https://doi.org/10.1111/bjd.19597

CPRD bibliography

34

Axson, E. L., Sundaram, V., Bloom, C. I., Bottle, A., Cowie, M. R., & Quint, J. K. (2020). Temporal

Trends in the Incidence of Heart Failure among Patients with COPD and Its Association with

Mortality. Ann Am Thorac Soc. https://doi.org/10.1513/AnnalsATS.201911-820OC

Ayala Solares, J. R., Diletta Raimondi, F. E., Zhu, Y., Rahimian, F., Canoy, D., Tran, J., Pinho

Gomes, A. C., Payberah, A. H., Zottoli, M., Nazarzadeh, M., Conrad, N., Rahimi, K., & Salimi-

Khorshidi, G. (2020). Deep learning for electronic health records: A comparative review of

multiple deep neural architectures. J Biomed Inform, 101, 103337.

https://doi.org/10.1016/j.jbi.2019.103337

Ayele, H. T., Reynier, P., Azoulay, L., Platt, R. W., Cabaussel, J., Benayoun, S., & Filion, K. B.

(2020). Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from

1998 to 2016: a population-based cohort study. World J Urol. https://doi.org/10.1007/s00345-

020-03429-z

Bakhai, A., Petri, H., Vahidnia, F., Wolf, C., Ding, Y., Foskett, N., & Sculpher, M. (2020). Real-

world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events

among non-valvular atrial fibrillation patients in England. J Eval Clin Pract.

https://doi.org/10.1111/jep.13400

Banerjee, A., Pasea, L., Harris, S., Gonzalez-Izquierdo, A., Torralbo, A., Shallcross, L., Noursadeghi,

M., Pillay, D., Sebire, N., Holmes, C., Pagel, C., Wong, W. K., Langenberg, C., Williams, B.,

Denaxas, S., & Hemingway, H. (2020). Estimating excess 1-year mortality associated with the

COVID-19 pandemic according to underlying conditions and age: a population-based cohort

study. Lancet, 395(10238), 1715–1725. https://doi.org/10.1016/s0140-6736(20)30854-0

Batchelor, H. (2020). Determination of healthcare resource and cost implications of using alternative

sodium valproate formulations in the treatment of epilepsy in children in England: a

retrospective database review. Eur J Pharm Biopharm.

https://doi.org/10.1016/j.ejpb.2020.12.007

Besford, M., Graham, S., Sammon, C., Mehmud, F., Allan, V., Alikhan, R., & Ramagopalan, S.

(2020). Factors associated with non-prescription of oral anticoagulant treatment in non-valvular

atrial fibrillation patients with dementia: a CPRD-HES study. Age Ageing.

https://doi.org/10.1093/ageing/afaa045

Bidulka, P., Fu, E. L., Leyrat, C., Kalogirou, F., McAllister, K. S. L., Kingdon, E. J., Mansfield, K. E.,

Iwagami, M., Smeeth, L., Clase, C. M., Bhaskaran, K., van Diepen, M., Carrero, J. J., Nitsch,

D., & Tomlinson, L. A. (2020). Stopping renin-angiotensin system blockers after acute kidney

injury and risk of adverse outcomes: parallel population-based cohort studies in English and

Swedish routine care. BMC Med, 18(1), 195. https://doi.org/10.1186/s12916-020-01659-x

Bidulka, P., Iwagami, M., Mansfield, K. E., Kalogirou, F., Wong, A. Y. S., Douglas, I. J., Smeeth, L.,

Summers, C., & Tomlinson, L. A. (2020). Comparisons of Staphylococcus aureus infection and

other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II

receptor blockers: lessons for COVID-19 from a nationwide cohort study. Wellcome Open Res,

5, 77. https://doi.org/10.12688/wellcomeopenres.15873.1

Blackwell, J., Saxena, S., Jayasooriya, N., Bottle, A., Petersen, I., Hotopf, M., Alexakis, C., & Pollok,

R. C. (2020). Prevalence and duration of gastrointestinal symptoms before diagnosis of

Inflammatory Bowel Disease and predictors of timely specialist review: a population-based

study. J Crohns Colitis. https://doi.org/10.1093/ecco-jcc/jjaa146

CPRD bibliography

35

Blackwell, J., Saxena, S., Jayasooriya, N., Petersen, I., Hotopf, M., Creese, H., Bottle, A., & Pollok,

R. C. G. (2020). Stoma formation in Crohn’s Disease and the likelihood of antidepressant use: a

population-based cohort study. Clin Gastroenterol Hepatol.

https://doi.org/10.1016/j.cgh.2020.12.026

Blackwell, J., Saxena, S., Petersen, I., Hotopf, M., Creese, H., Bottle, A., Alexakis, C., & Pollok, R.

C. (2020). Depression in individuals who subsequently develop inflammatory bowel disease: a

population-based nested case-control study. Gut. https://doi.org/10.1136/gutjnl-2020-322308

Bloom, C. I., Cabrera, C., Arnetorp, S., Coulton, K., Nan, C., van der Valk, R. J. P., & Quint, J. K.

(2020). Asthma-Related Health Outcomes Associated with Short-Acting β(2)-Agonist Inhaler

Use: An Observational UK Study as Part of the SABINA Global Program. Adv Ther.

https://doi.org/10.1007/s12325-020-01444-5

Borghs, S., Byram, L., Chan, J., Dedeken, P., Logan, J., Kiri, V., Noack-Rink, M., Patsalos, P. N., &

Thieffry, S. (2020). Comparing healthcare cost associated with the use of enzyme-inducing and

non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term

retrospective, matched cohort study. BMC Neurol, 20(1), 7. https://doi.org/10.1186/s12883-019-

1587-9

Bowman, K., Jones, L., Masoli, J., Mujica-Mota, R., Strain, D., Butchart, J., Valderas, J. M.,

Fortinsky, R. H., Melzer, D., & Delgado, J. (2020). Predicting incident delirium diagnoses using

data from primary-care electronic health records. Age Ageing, 49(3), 374–381.


Brookes, M. J., Waller, J., Cappelleri, J. C., Modesto, I., DiBonaventura, M. D., Bohm, N.,

Mokgokong, R., Massey, O., Wood, R., & Bargo, D. (2020). Living with Ulcerative Colitis

Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and

direct healthcare costs of postoperative care in ulcerative colitis. BMJ Open Gastroenterol, 7(1).

https://doi.org/10.1136/bmjgast-2020-000456

Bultink, I. E. M., de Vries, F., van Vollenhoven, R. F., & Lalmohamed, A. (2020). Mortality, causes

of death and influence of medication use in patients with systemic lupus erythematosus vs

matched controls. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keaa267

Burkard, T., Rauch, M., Spoendlin, J., Prieto-Alhambra, D., Jick, S. S., & Meier, C. R. (2020). Risk of

hand osteoarthritis in new users of hormone replacement therapy: A nested case-control

analysis. Maturitas, 132, 17–23. https://doi.org/10.1016/j.maturitas.2019.11.006

Cabrera, C. S., Lee, A. S., Olsson, M., Schnecke, V., Westman, K., Lind, M., Greasley, P. J., &

Skrtic, S. (2020). Impact of CKD Progression on Cardiovascular Disease Risk in a

Contemporary UK Cohort of Individuals With Diabetes. Kidney Int Rep, 5(10), 1651–1660.

https://doi.org/10.1016/j.ekir.2020.07.029

Card, T. R., Zittan, E., Nguyen, G. C., & Grainge, M. J. (2020). Disease Activity in Inflammatory

Bowel Disease Is Associated With Arterial Vascular Disease. Inflamm Bowel Dis.

https://doi.org/10.1093/ibd/izaa156

Carney, M., Quiroga, M., Mounce, L., Shephard, E., Hamilton, W., & Price, S. (2020). Effect of pre-

existing conditions on bladder cancer stage at diagnosis: a cohort study using electronic primary

care records in the UK. Br J Gen Pract. https://doi.org/10.3399/bjgp20X710921

CPRD bibliography

36

Carreira, H., Williams, R., Dempsey, H., Stanway, S., Smeeth, L., & Bhaskaran, K. (2020). Quality of

life and mental health in breast cancer survivors compared with non-cancer controls: a study of

patient-reported outcomes in the United Kingdom. J Cancer Surviv.

https://doi.org/10.1007/s11764-020-00950-3

Carreira, H., Strongman, H., Peppa, M., McDonald, H. I., dos-Santos-Silva, I., Stanway, S., Smeeth,

L., & Bhaskaran, K. (2020). Prevalence of COVID-19-related risk factors and risk of severe

influenza outcomes in cancer survivors: A matched cohort study using linked English electronic

health records data. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2020.100656

Chalitsios, C. V, McKeever, T. M., & Shaw, D. E. (2020). Incidence of osteoporosis and fragility

fractures in asthma: a UK population-based matched cohort study. Eur Respir J.

https://doi.org/10.1183/13993003.01251-2020

Chalitsios, C. V, Shaw, D. E., & McKeever, T. M. (2020). Risk of osteoporosis and fragility fractures

in asthma due to oral and inhaled corticosteroids: two population-based nested case-control

studies. Thorax. https://doi.org/10.1136/thoraxjnl-2020-215664

Charlier, S., Vavanikunnel, J., Becker, C., Jick, S. S., Meier, C., & Meier, C. R. (2020). Antidiabetic

treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-

control study. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa796

Charlton, R., Green, A., Shaddick, G., Snowball, J., Nightingale, A., Tillett, W., Smith, C., &

McHugh, N. (2020). Risk of osteoarthritis in an incident cohort of people with psoriatic arthritis:

a population-based cohort study. J Rheumatol. https://doi.org/10.3899/jrheum.200564

Chen, Y., Hayward, R., Chew-Graham, C. A., Hubbard, R., Croft, P., Sims, K., & Jordan, K. P.

(2020). Prognostic value of first-recorded breathlessness for future chronic respiratory and heart

disease a cohort study using a UK national primary care database. Br J Gen Pract.


Chowienczyk, S., Price, S., & Hamilton, W. (2020). Changes in the presenting symptoms of lung

cancer from 2000-2017: a serial cross-sectional study of observational records in UK primary

care. Br J Gen Pract. https://doi.org/10.3399/bjgp20X708137

Clarke, C., Hamilton, W., Price, S., & Bailey, S. E. (2020). Association of non-malignant diseases

with thrombocytosis: a prospective cohort study in general practice. Br J Gen Pract, 70(701),

e852–e857. https://doi.org/10.3399/bjgp20X713501

Clarson, L. E., Bajpai, R., Whittle, R., Belcher, J., Abdul Sultan, A., Kwok, C. S., Welsh, V., Mamas,

M., & Mallen, C. D. (2020). Interstitial lung disease is a risk factor for ischaemic heart disease

and myocardial infarction. Heart. https://doi.org/10.1136/heartjnl-2019-315511

Coles, B., Khunti, K., Booth, S., Zaccardi, F., Davies, M. J., & Gray, L. J. (2020). Prediction of type 2

diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using

UK primary care data. BMJ Open, 10(10), e037937. https://doi.org/10.1136/bmjopen-2020-

037937

Coles, B., Zaccardi, F., Ling, S., Davies, M. J., Samani, N. J., & Khunti, K. (2020). Cardiovascular

events and mortality in people with and without type 2 diabetes: An observational study in a

contemporary multi-ethnic population. J Diabetes Investig. https://doi.org/10.1111/jdi.13464

CPRD bibliography

37

Costello, R. E., Yimer, B. B., Roads, P., Jani, M., & Dixon, W. G. (2020). Glucocorticoid use is

associated with an increased risk of hypertension. Rheumatology (Oxford).

https://doi.org/10.1093/rheumatology/keaa209

Coulombe, J., Moodie, E. E. M., Shortreed, S. M., & Renoux, C. (2020). Can the Risk of Severe

Depression-Related Outcomes be Reduced by Tailoring the Antidepressant Therapy to Patient

Characteristics? Am J Epidemiol. https://doi.org/10.1093/aje/kwaa260

Cushen, R., & Francis, N. A. (2020). Antibiotic use and serious complications following acute otitis

media and acute sinusitis: a retrospective cohort study. Br J Gen Pract, 70(693), e255–e263.


Danese, M. D., Pemberton-Ross, P., Catterick, D., & Villa, G. (2020). Estimation of the increased risk

associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the

United Kingdom. Eur J Prev Cardiol, 2047487319899212.

https://doi.org/10.1177/2047487319899212

Davies, N. M., Taylor, A. E., Taylor, G. M., Itani, T., Jones, T., Martin, R. M., Munafo, M. R.,

Windmeijer, F., & Thomas, K. H. (2020). Varenicline versus nicotine replacement therapy for

long-term smoking cessation: an observational study using the Clinical Practice Research

Datalink. Health Technol Assess, 24(9), 1–46. https://doi.org/10.3310/hta24090

de Bruin, I. J. A., Wyers, C. E., Souverein, P. C., van Staa, T. P., Geusens, P., van den Bergh, J. P.

W., de Vries, F., & Driessen, J. H. M. (2020). The risk of new fragility fractures in patients with

chronic kidney disease and hip fracture-a population-based cohort study in the UK. Osteoporos

Int. https://doi.org/10.1007/s00198-020-05351-x

Denholm, R., van der Werf, E. T., & Hay, A. D. (2020). Use of antibiotics and asthma medication for

acute lower respiratory tract infections in people with and without asthma: retrospective cohort

study. Respir Res, 21(1), 4. https://doi.org/10.1186/s12931-019-1233-5

Enoch, D. A., Murray-Thomas, T., Adomakoh, N., Dedman, D., Georgopali, A., Francis, N., & Karas,

A. (2020). Risk of complications and mortality following recurrent and non-recurrent

Clostridioides difficile infection: a retrospective, observational, database study in England. J

Hosp Infect. https://doi.org/10.1016/j.jhin.2020.09.025

Esan, O. B., Perera, R., McCarthy, N., Violato, M., & Fanshawe, T. R. (2020). Incidence, risk factors,

and health service burden of sequelae of campylobacter and non-typhoidal salmonella infections

in England, 2000-2015: A retrospective cohort study using linked electronic health records. J

Infect. https://doi.org/10.1016/j.jinf.2020.05.027

Fan, H., Gilbert, R., O’Callaghan, F., & Li, L. (2020). Associations between macrolide antibiotics

prescribing during pregnancy and adverse child outcomes in the UK: population based cohort

study. Bmj, 368, m331. https://doi.org/10.1136/bmj.m331

Flynn, R., Hedenmalm, K., Murray-Thomas, T., Pacurariu, A., Arlett, P., Shepherd, H., Myles, P., &

Kurz, X. (2020). Ability of primary care health databases to assess medicinal products discussed

by the European Union Pharmacovigilance Risk Assessment Committee. Clin Pharmacol Ther.


Forbes, H. J., Bhaskaran, K., Grint, D., Hu, V. H., Langan, S. M., McDonald, H. I., Morton, C.,

Smeeth, L., Walker, J. L., & Warren-Gash, C. (2020). Incidence of acute complications of

CPRD bibliography

38

herpes zoster among immunocompetent adults in England: a matched cohort study using routine

health data. Br J Dermatol. https://doi.org/10.1111/bjd.19687

Forbes, H., Douglas, I., Finn, A., Breuer, J., Bhaskaran, K., Smeeth, L., Packer, S., Langan, S. M.,

Mansfield, K. E., Marlow, R., Whitaker, H., & Warren-Gash, C. (2020). Risk of herpes zoster

after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case

series study using UK electronic healthcare data. Bmj, 368, l6987.

https://doi.org/10.1136/bmj.l6987

Ford, E., Rooney, P., Hurley, P., Oliver, S., Bremner, S., & Cassell, J. (2020). Can the Use of

Bayesian Analysis Methods Correct for Incompleteness in Electronic Health Records Diagnosis

Data? Development of a Novel Method Using Simulated and Real-Life Clinical Data. Front

Public Health, 8, 54. https://doi.org/10.3389/fpubh.2020.00054

Ford, E., Starlinger, J., Rooney, P., Oliver, S., Banerjee, S., van Marwijk, H., & Cassell, J. (2020).

Could dementia be detected from UK primary care patients’ records by simple automated

methods earlier than by the treating physician? A retrospective case-control study. Wellcome

Open Res, 5, 120. https://doi.org/10.12688/wellcomeopenres.15903.1

Fraser, L. K., Murtagh, F. E. M., Sheldon, T., Gilbody, S., & Hewitt, C. (2020). Health of mothers of

children with a life-limiting condition: a protocol for comparative cohort study using the Clinical

Practice Research Datalink. BMJ Open, 10(7), e034024. https://doi.org/10.1136/bmjopen-2019-

034024

Funston, G., Hamilton, W., Abel, G., Crosbie, E. J., Rous, B., & Walter, F. M. (2020). The diagnostic

performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A

population-based cohort study. PLoS Med, 17(10), e1003295.


Gadoud, A., Kane, E., Oliver, S. E., Johnson, M. J., Macleod, U., & Allgar, V. (2020). Palliative care

for non-cancer conditions in primary care: a time trend analysis in the UK (2009-2014). BMJ

Support Palliat Care. https://doi.org/10.1136/bmjspcare-2019-001833

Galvain, T., Chitnis, A., Paparouni, K., Tong, C., Holy, C. E., & Giannoudis, P. V. (2020). The

economic burden of infections following intramedullary nailing for a tibial shaft fracture in

England. BMJ Open, 10(8), e035404. https://doi.org/10.1136/bmjopen-2019-035404

Gao, W., Gulliford, M., Morgan, M., & Higginson, I. J. (2020). Primary care service use by end-of-

life cancer patients: a nationwide population-based cohort study in the United Kingdom. BMC

Fam Pract, 21(1), 76. https://doi.org/10.1186/s12875-020-01127-8

Gayle, A., Schoof, N., Alves, M., Clarke, D., Raabe, C., Das, P., Del Galdo, F., & Maher, T. M.

(2020). Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-

Associated Interstitial Lung Disease: A Retrospective Database Analysis. Adv Ther.

https://doi.org/10.1007/s12325-020-01330-0

Gibbons, D. C., Aggarwal, B., Fairburn-Beech, J., Hinds, D., Fletcher, M., Bosnic-Anticevich, S., &

Price, D. (2020). Treatment patterns among non-active users of maintenance asthma medication

in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink. J

Asthma, 1–12. https://doi.org/10.1080/02770903.2020.1728767

Giorgianni, F., Ernst, P., Dell’Aniello, S., Suissa, S., & Renoux, C. (2020). Beta 2 agonists and the

incidence of Parkinson’s disease. Am J Epidemiol. https://doi.org/10.1093/aje/kwaa012

CPRD bibliography

39

Giustozzi, M., Curcio, A., Weijs, B., Field, T. S., Sudikas, S., Katholing, A., Wallenhorst, C., Weitz,

J. I., Martinez, C., & Cohen, A. T. (2020). Variation in the Association between Antineoplastic

Therapies and Venous Thromboembolism in Patients with Active Cancer. Thromb Haemost,

120(5), 847–856. https://doi.org/10.1055/s-0040-1709527

Glover, G., Williams, R., & Oyinlola, J. (2020). An observational cohort study of numbers and causes

of preventable general hospital admissions in people with and without intellectual disabilities in

England. J Intellect Disabil Res. https://doi.org/10.1111/jir.12722

Gokhale, M., Hattori, T., Evitt, L., Lenney, W., Nordstrom, B., Collins, J., Schultze, A., & Van Dyke,

M. K. (2020). Burden of asthma exacerbations and health care utilization in pediatric patients

with asthma in the US and England. Immun Inflamm Dis. https://doi.org/10.1002/iid3.299

Gopfert, A., Deeny, S. R., Fisher, R., & Stafford, M. (2020). Primary care consultation length by

deprivation and multimorbidity in England: an observational study using electronic patient

records. Br J Gen Pract. https://doi.org/10.3399/bjgp20X714029

Gorton, H. C., Webb, R. T., Parisi, R., Carr, M. J., DelPozo-Banos, M., Moriarty, K. J., Pickrell, W.

O., John, A., & Ashcroft, D. M. (2020). Alcohol-Specific Mortality in People With Epilepsy:

Cohort Studies in Two Independent Population-Based Datasets. Front Neurol, 11, 623139.

https://doi.org/10.3389/fneur.2020.623139

Gravel, C. A., Filion, K. B., Reynier, P. M., & Platt, R. W. (2020). Postmyocardial Infarction Statin

Exposure and the Risk of Stroke with Weighting for Outcome Misclassification. Epidemiology,

31(6), 880–888. https://doi.org/10.1097/ede.0000000000001253

Greenhall, G. H. B., Mansfield, K. E., Nitsch, D., Iwagami, M., Leyrat, C., Johnston, R., Smeeth, L.,

& Tomlinson, L. A. (2020). The effect of initiation of renin-angiotensin system inhibitors on

haemoglobin: A national cohort study. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.14429

Grint, D. J., McDonald, H. I., Walker, J. L., Amirthalingam, G., Andrews, N., & Thomas, S. (2020).

Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a

UK-based observational cohort analysis. BMJ Open, 10(1), e034886.


Grønbaek, L., Otete, H., Ban, L., Crooks, C., Card, T., Jepsen, P., & West, J. (2020). Incidence,

prevalence, and mortality of autoimmune hepatitis in England 1997-2015. A population-based

cohort study. Liver Int. https://doi.org/10.1111/liv.14480

Gulliford, M. C., Charlton, J., Winter, J. R., Sun, X., Rezel-Potts, E., Bunce, C., Fox, R., Little, P.,

Hay, A. D., Moore, M. V, & Ashworth, M. (2020). Probability of sepsis after infection

consultations in primary care in the United Kingdom in 2002-2017: Population-based cohort

study and decision analytic model. PLoS Med, 17(7), e1003202.


Gulliford, M. C., Sun, X., Anjuman, T., Yelland, E., & Murray-Thomas, T. (2020). Comparison of

antibiotic prescribing records in two UK primary care electronic health record systems: cohort

study using CPRD GOLD and CPRD Aurum databases. BMJ Open, 10(6), e038767.


Gulliford, M. C., Sun, X., Charlton, J., Winter, J. R., Bunce, C., Boiko, O., Fox, R., Little, P., Moore,

M., Hay, A. D., & Ashworth, M. (2020). Serious bacterial infections and antibiotic prescribing

CPRD bibliography

40

in primary care: cohort study using electronic health records in the UK. BMJ Open, 10(2),


Gungabissoon, U., Kirichek, O., El Baou, C., & Galwey, N. (2020). Comparison of long-term use of

prolonged-release ropinirole and immediate-release dopamine agonists in an observational study

in patients with Parkinson’}s disease. Pharmacoepidemiol Drug Saf.


Gurol-Urganci, I., Geary, R. S., Mamza, J. B., Iwagami, M., El-Hamamsy, D., Duckett, J., Wilson, A.,

Tincello, D., & van der Meulen, J. (2020). Determinants of referral of women with urinary

incontinence to specialist services: a national cohort study using primary care data from the UK.

BMC Fam Pract, 21(1), 211. https://doi.org/10.1186/s12875-020-01282-y

Hamilton, F., Arnold, D., Henley, W., & Payne, R. A. (2020). Aspirin reduces cardiovascular events

in patients with pneumonia: a prior event rate ratio analysis in a large primary care database. Eur

Respir J. https://doi.org/10.1183/13993003.02795-2020

Hart, A., Ng, S. C., Watkins, J., Paridaens, K., Edwards, J. O., Fullarton, J. R., Sonderegger, Y. L. Y.,

Ghatnekar, O., & Ghosh, S. (2020). The use of 5-aminosalicylates in Crohn’s disease: a

retrospective study using the UK Clinical Practice Research Datalink. Ann Gastroenterol, 33(5),

500–507. https://doi.org/10.20524/aog.2020.0521

Hawley, S., Shaw, N. J., Delmestri, A., Prieto-Alhambra, D., Cooper, C., Pinedo-Villanueva, R., &

Javaid, M. K. (2020). Higher prevalence of non-skeletal comorbidity related to X-linked

hypophosphataemia: a UK parallel cohort study using CPRD. Rheumatology (Oxford).


Heerspink, H. J. L., Karasik, A., Thuresson, M., Melzer-Cohen, C., Chodick, G., Khunti, K., Wilding,

J. P. H., Garcia Rodriguez, L. A., Cea-Soriano, L., Kohsaka, S., Nicolucci, A., Lucisano, G.,

Lin, F. J., Wang, C. Y., Wittbrodt, E., Fenici, P., & Kosiborod, M. (2020). Kidney outcomes

associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a

multinational observational cohort study. Lancet Diabetes Endocrinol, 8(1), 27–35.

https://doi.org/10.1016/s2213-8587(19)30384-5

Heintjes, E. M., Bezemer, I. D., Prieto-Alhambra, D., Smits, E., Booth, H. P., Dedman, D., He, Y.,

Hoti, F., Vehkala, M., de Vogel, S., Robinson, N. J., Appenteng, K., & Penning-van Beest, F. J.

A. (2020). Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce

the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four

European Countries. Clin Epidemiol, 12, 423–433. https://doi.org/10.2147/clep.s242065

Hicks, B. M., Busby, J., Mills, K., O’Neil, F. A., McIntosh, S. A., Zhang, S. D., Liberante, F. G., &

Cardwell, C. R. (2020). Post-diagnostic antipsychotic use and cancer mortality: a population

based cohort study. BMC Cancer, 20(1), 804. https://doi.org/10.1186/s12885-020-07320-3

Hiramatsu, R., Iwagami, M., & Nitsch, D. (2020). Association between chronic kidney disease and

incident diagnosis of dementia in England: a cohort study in Clinical Practice Research Datalink.


Holden, S. E., Morice, A., Birring, S. S., Jenkins-Jones, S., Langerman, H., Weaver, J., & Currie, C. J.

(2020). Cough presentation in primary care and the identification of chronic cough: a need for

diagnostic clarity? Curr Med Res Opin, 36(1), 139–150.

https://doi.org/10.1080/03007995.2019.1673716

CPRD bibliography

41

Hope, H., Parisi, R., Ashcroft, D. M., Williams, R., Coton, S., Kosidou, K., Pierce, M., & Abel, K. M.

(2020). Fertility trends of women with serious mental illness in the United Kingdom 1992-2017:

A primary care cohort study using the clinical practice research datalink. J Affect Disord, 269,

141–147. https://doi.org/10.1016/j.jad.2020.03.037

Houwen, J. P. A., Egberts, A. C. G., de Boer, A., van Maarseveen, E. M., Houwen, R. H. J., &

Lalmohamed, A. (2020). Influence of allopurinol on thiopurine associated toxicity: A

retrospective population-based cohort study. Br J Clin Pharmacol.


Jacobs, R., Aylott, L., Dare, C., Doran, T., Gilbody, S., Goddard, M., Gravelle, H., Gutacker, N.,

Kasteridis, P., Kendrick, T., Mason, A., Rice, N., Ride, J., Siddiqi, N., & Williams, R. (2020).

The association between primary care quality and health-care use, costs and outcomes for people

with serious mental illness: a retrospective observational study. In Health Services and Delivery

Research. NIHR Journals Library Copyright ©Queen’s Printer and Controller of HMSO 2020.

This work was produced by Jacobs et al. under the terms of a commissioning contract issued by

the Secretary of State for Health and Social Care. This issue may b.

https://doi.org/10.3310/hsdr08250

Jani, M., Birlie Yimer, B., Sheppard, T., Lunt, M., & Dixon, W. G. (2020). Time trends and

prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A

retrospective cohort study. PLoS Med, 17(10), e1003270.


Jarvis, S., Parslow, R. C., Hewitt, C., Mitchell, S., & Fraser, L. K. (2020). GPs’ role in caring for

children and young people with life-limiting conditions: a retrospective cohort study. Br J Gen

Pract. https://doi.org/10.3399/bjgp20X708233

Jick, S. S., Hagberg, K. W., Persson, R., Vasilakis-Scaramozza, C., Williams, T., Crellin, E., &

Myles, P. (2020). Quality and completeness of diagnoses recorded in the new CPRD Aurum

Database: evaluation of pulmonary embolism. Pharmacoepidemiol Drug Saf.


Katsoulis, M., Pasea, L., Lai, A. G., Dobson, R. J. B., Denaxas, S., Hemingway, H., & Banerjee, A.

(2020). Obesity during the COVID-19 pandemic: both cause of high risk and potential effect of

lockdown? A population-based electronic health record study. Public Health, 191, 41–47.

https://doi.org/10.1016/j.puhe.2020.12.003

Kerkhof, M., Chaudhry, I., Pavord, I. D., Miravitlles, M., Kook Rhee, C., Halpin, D. M. G., Usmani,

O. S., Jones, R., Kocks, J., Alacqua, M., Morris, T., Kaplan, A., & Price, D. B. (2020). Blood

eosinophil count predicts treatment failure and hospital readmission for COPD. ERJ Open Res,

6(4). https://doi.org/10.1183/23120541.00188-2020

Kerkhof, M., Voorham, J., Dorinsky, P., Cabrera, C., Darken, P., Kocks, J. W., Sadatsafavi, M., Sin,

D. D., Carter, V., & Price, D. B. (2020). Association between COPD exacerbations and lung

function decline during maintenance therapy. Thorax. https://doi.org/10.1136/thoraxjnl-2019-

214457

Khosrow-Khavar, F., Bouganim, N., Filion, K. B., Suissa, S., & Azoulay, L. (2020). Cardiotoxicity of

Sequential Aromatase Inhibitors Use in Women with Breast Cancer. Am J Epidemiol.

https://doi.org/10.1093/aje/kwaa065

Khosrow-Khavar, F., Filion, K. B., Bouganim, N., Suissa, S., & Azoulay, L. (2020). Aromatase

Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A

CPRD bibliography

42

Population-Based Cohort Study. Circulation, 141(7), 549–559.

https://doi.org/10.1161/circulationaha.119.044750

Kiddle, S. J., Whittaker, H. R., Seaman, S. R., & Quint, J. K. (2020). Prediction of five-year mortality

after COPD diagnosis using primary care records. PLoS One, 15(7), e0236011.


Kither, H., Heazell, A., Bruce, I. N., Tower, C., & Crocker, I. (2020). Adverse pregnancy outcomes

and subsequent development of connective tissue disease in the UK: an epidemiological study.

Bjog. https://doi.org/10.1111/1471-0528.16191

Kostikas, K., Price, D., Gutzwiller, F. S., Jones, B., Loefroth, E., Clemens, A., Fogel, R., Jones, R., &

Cao, H. (2020). Clinical Impact and Healthcare Resource Utilization Associated with Early

versus Late COPD Diagnosis in Patients from UK CPRD Database. Int J Chron Obstruct

Pulmon Dis, 15, 1729–1738. https://doi.org/10.2147/copd.s255414

Kostikas, K., Rhee, C. K., Hurst, J. R., Agostoni, P., Cao, H., Fogel, R., Jones, R., Kocks, J. W. H.,

Mezzi, K., Wan Yau Ming, S., Ryan, R., & Price, D. B. (2020). Adequacy of Therapy for People

with Both COPD and Heart Failure in the UK: Historical Cohort Study. Pragmat Obs Res, 11,

55–66. https://doi.org/10.2147/por.s250451

Lahoz, R., Fagan, A., McSharry, M., Proudfoot, C., Corda, S., & Studer, R. (2020). Recurrent heart

failure hospitalizations are associated with increased cardiovascular mortality in patients with

heart failure in Clinical Practice Research Datalink. ESC Heart Fail.

https://doi.org/10.1002/ehf2.12727

Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., Katsoulis, M., Williams, B.,

Pillay, D., Noursadeghi, M., Linch, D., Hughes, D., Forster, M. D., Turnbull, C., Fitzpatrick, N.

K., Boyd, K., Foster, G. R., Enver, T., Nafilyan, V., … Hemingway, H. (2020). Estimated

impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people

with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a

population-based cohort study. BMJ Open, 10(11), e043828. https://doi.org/10.1136/bmjopen-

2020-043828

Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O.,

Alshammari, T. M., Areia, C., Biedermann, P., Banda, J. M., Burn, E., Casajust, P., Fišter, K.,

Hardin, J., Hester, L., Hripcsak, G., Kaas-Hansen, B. S., Khosla, S., … Prieto-Alhambra, D.

(2020). Risk of depression, suicide and psychosis with hydroxychloroquine treatment for

rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford).


Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O.,

Alshammari, T. M., Biedermann, P., Banda, J. M., Burn, E., Casajust, P., Conover, M. M.,

Culhane, A. C., Davydov, A., DuVall, S. L., Dymshyts, D., Fernandez-Bertolin, S., Fišter, K., …

Prieto-Alhambra, D. (2020). Risk of hydroxychloroquine alone and in combination with

azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.

Lancet Rheumatol, 2(11), e698–e711. https://doi.org/10.1016/s2665-9913(20)30276-9

Lawson, C. A., Zaccardi, F., Squire, I., Okhai, H., Davies, M., Huang, W., Mamas, M., Lam, C. S. P.,

Khunti, K., & Kadam, U. T. (2020). Risk Factors for Heart Failure: 20-Year Population-Based

Trends by Sex, Socioeconomic Status, and Ethnicity. Circ Heart Fail, 13(2), e006472.

https://doi.org/10.1161/circheartfailure.119.006472

CPRD bibliography

43

Lay-Flurrie, S. L., Sheppard, J. P., Stevens, R. J., Mallen, C., Heneghan, C., Hobbs, F. D. R.,

Williams, B., Mant, J., & McManus, R. J. (2020). Impact of Changes to National Hypertension

Guidelines on Hypertension Management and Outcomes in the United Kingdom. Hypertension,

75(2), 356–364. https://doi.org/10.1161/hypertensionaha.119.13926

le Roux, C. W., Hartvig, N. V, Haase, C. L., Nordsborg, R. B., Olsen, A. H., & Satylganova, A.

(2020). Obesity, cardiovascular risk and healthcare resource utilization in the UK. Eur J Prev

Cardiol, 2047487320925639. https://doi.org/10.1177/2047487320925639

Leal, J., Murphy, J., Garriga, C., Delmestri, A., Rangan, A., Price, A., Carr, A., Prieto-Alhambra, D.,

& Judge, A. (2020). Costs of joint replacement in osteoarthritis: a study using the National Joint

Registry and Clinical Practice Research Datalink datasets. Arthritis Care Res (Hoboken).

https://doi.org/10.1002/acr.24470

Lee, J. J., Smith, M., Bankhead, C., Perera Salazar, R., Kousoulis, A. A., Butler, C. C., & Wang, K.

(2020). Oseltamivir and influenza-related complications in children: a retrospective cohort in

primary care. Eur Respir J. https://doi.org/10.1183/13993003.02246-2019

Leuppi-Taegtmeyer, A. B., Reinau, D., Yilmaz, S., Ruegg, S., Krahenbuhl, S., Jick, S. S., Leuppi, J.

D., & Meier, C. R. (2020). Antiseizure drugs and risk of developing smoking-related chronic

obstructive pulmonary disease or lung cancer: A population-based case-control study. Br J Clin


Lewer, D., Padmanathan, P., Qummer Ul Arfeen, M., Denaxas, S., Forbes, H., Gonzalez-Izquierdo,

A., & Hickman, M. (2020). Healthcare use by people who use illicit opioids (HUPIO):

development of a cohort based on electronic primary care records in England. Wellcome Open

Res, 5, 282. https://doi.org/10.12688/wellcomeopenres.16431.1

Li, Y., Rao, S., Solares, J. R. A., Hassaine, A., Ramakrishnan, R., Canoy, D., Zhu, Y., Rahimi, K., &

Salimi-Khorshidi, G. (2020). BEHRT: Transformer for Electronic Health Records. Sci Rep,

10(1), 7155. https://doi.org/10.1038/s41598-020-62922-y

Li, Y., Sperrin, M., Ashcroft, D. M., & van Staa, T. P. (2020). Consistency of variety of machine

learning and statistical models in predicting clinical risks of individual patients: longitudinal

cohort study using cardiovascular disease as exemplar. Bmj, 371, m3919.

https://doi.org/10.1136/bmj.m3919

Li, Y., Sperrin, M., Martin, G. P., Ashcroft, D. M., & van Staa, T. P. (2020). Examining the impact of

data quality and completeness of electronic health records on predictions of patients’ risks of

cardiovascular disease. Int J Med Inform, 133, 104033.

https://doi.org/10.1016/j.ijmedinf.2019.104033

Loiacono, M. M., Mahmud, S. M., Chit, A., van Aalst, R., Kwong, J. C., Mitsakakis, N., Skinner, L.,

Thommes, E., Bricout, H., & Grootendorst, P. (2020). Patient and practice level factors

associated with seasonal influenza vaccine uptake among at-risk adults in England, 2011 to

2016: An age-stratified retrospective cohort study. Vaccine X, 4, 100054.

https://doi.org/10.1016/j.jvacx.2020.100054

Loiacono, M. M., Mitsakakis, N., Kwong, J. C., Gomez, G. B., Chit, A., & Grootendorst, P. (2020).

Development and Validation of a Clinical Prediction Tool for Seasonal Influenza Vaccination in

England. JAMA Netw Open, 3(6), e207743. https://doi.org/10.1001/jamanetworkopen.2020.7743

CPRD bibliography

44

Ma, R., Cecil, E., Bottle, A., French, R., & Saxena, S. (2020). Impact of a pay-for-performance

scheme for long-acting reversible contraceptive (LARC) advice on contraceptive uptake and

abortion in British primary care: An interrupted time series study. PLoS Med, 17(9), e1003333.


Manikam, L., Schilder, A. G. M., Lakhanpaul, M., Littlejohns, P., Alexander, E. C., & Hayward, A.

(2020). Respiratory tract infection-related healthcare utilisation in children with Down’s

syndrome. Infection, 48(3), 403–410. https://doi.org/10.1007/s15010-020-01408-5

Martinez, C., Katholing, A., Wallenhorst, C., & Cohen, A. T. (2020). Prediction of significant

bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients. Br

J Haematol. https://doi.org/10.1111/bjh.16383

Martinez, C., Wallenhorst, C., Rietbrock, S., & Freedman, B. (2020). Ischemic Stroke and Transient

Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial

Fibrillation: A Cohort Study. J Am Heart Assoc, 9(2), e014376.


Masoli, J. A. H., Delgado, J., Pilling, L., Strain, D., & Melzer, D. (2020). Blood pressure in frail older

adults: associations with cardiovascular outcomes and all-cause mortality. Age Ageing.


Mathur, R., Farmer, R. E., Eastwood, S. V, Chaturvedi, N., Douglas, I., & Smeeth, L. (2020). Ethnic

disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in

the UK, 1990-2017: A cohort study. PLoS Med, 17(5), e1003106.


Mathur, R., Palla, L., Farmer, R. E., Chaturvedi, N., & Smeeth, L. (2020). Ethnic differences in the

severity and clinical management of type 2 diabetes at time of diagnosis: A cohort study in the

UK Clinical Practice Research Datalink. Diabetes Res Clin Pract, 160, 108006.

https://doi.org/10.1016/j.diabres.2020.108006

Matthews, I., Duong, M., Parsons, V. L., Nozad, B., Qizilbash, N., Patel, Y., & Guimicheva, B.

(2020). Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in

the UK. PLoS One, 15(2), e0229224. https://doi.org/10.1371/journal.pone.0229224

Matthews, I., Lu, X., Xia, Q., Black, W., & Nozad, B. (2020). Pneumococcal vaccine coverage among

individuals aged 18 to 64 years old with underlying medical conditions in the UK: a

retrospective database analysis. BMC Public Health, 20(1), 1584.

https://doi.org/10.1186/s12889-020-09613-5

McGovern, A. P., Hogg, M., Shields, B. M., Sattar, N. A., Holman, R. R., Pearson, E. R., Hattersley,

A. T., Jones, A. G., & Dennis, J. M. (2020). Risk factors for genital infections in people

initiating SGLT2 inhibitors and their impact on discontinuation. BMJ Open Diabetes Res Care,

8(1). https://doi.org/10.1136/bmjdrc-2020-001238

Meier, G. C., Watkins, J., McEwan, P., & Pockett, R. D. (2020). Resource use and direct medical

costs of acute respiratory illness in the UK based on linked primary and secondary care records

from 2001 to 2009. PLoS One, 15(8), e0236472. https://doi.org/10.1371/journal.pone.0236472

Mendonca, S. C., Saunders, C. L., Lund, J., Mant, J., & Edwards, D. (2020). Temporal trends in

incidence of atrial fibrillation in primary care records: a population-based cohort study. BMJ


CPRD bibliography

45

Minhas, J. S., Coles, B., Mistri, A. K., Eveson, D. J., Hussain, S. T., Potter, J. F., Khunti, K., &

Robinson, T. G. (2020). What is the optimal blood pressure level for patients with atrial

fibrillation treated with direct oral anticoagulants? J Hypertens.

https://doi.org/10.1097/hjh.0000000000002487

Mirza, F. N., Yumeen, S., & Walter, F. M. (2020). The Epidemiology of Malignant Melanoma,

Squamous Cell Carcinoma, and Basal Cell Carcinoma in the United Kingdom from 2004-2014:

A Population-Based Cohort Analysis using the Clinical Practice Research Datalink. Br J

Dermatol. https://doi.org/10.1111/bjd.19542

Mistry, C., Palin, V., Li, Y., Martin, G. P., Jenkins, D., Welfare, W., Ashcroft, D. M., & Van Staa, T.

(2020). Development and validation of a multivariable prediction model for infection-related

complications in patients with common infections in UK primary care and the extent of risk-

based prescribing of antibiotics. BMC Med, 18(1), 118. https://doi.org/10.1186/s12916-020-

01581-2

Morgan, A. D., Sinnott, S. J., Smeeth, L., Minassian, C., & Quint, J. (2020). Concordance in the

recording of stroke across UK primary and secondary care datasets: a population-based cohort

study. BJGP Open. https://doi.org/10.3399/bjgpo.2020.0117

Morgan, C. L., Varga, S., Tsong, W., Jenkins-Jones, S., & Holden, S. (2020). Healthcare utilization

and associated costs following initiation of perampanel in patients with epilepsy. Epilepsy

Behav, 110, 107137. https://doi.org/10.1016/j.yebeh.2020.107137

Morton, C. E., Forbes, H. J., Pearce, N., Smeeth, L., & Warren-Gash, C. (2020). Association Between

Common Infections and Incident Post-Stroke Dementia: A Cohort Study Using the Clinical

Practice Research Datalink. Clin Epidemiol, 12, 907–916. https://doi.org/10.2147/clep.s260243

Mounce, L. T., Hamilton, W., & Bailey, S. E. (2020). Cancer incidence following a high-normal

platelet count: cohort study using electronic healthcare records from English primary care. Br J

Gen Pract. https://doi.org/10.3399/bjgp20X710957

Moussa, O., Ardissino, M., Heaton, T., Tang, A., Khan, O., Ziprin, P., Darzi, A., Collins, P., &

Purkayastha, S. (2020). Effect of bariatric surgery on long-term cardiovascular outcomes: a

nationwide nested cohort study. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa069

Nakafero, G., Grainge, M. J., Myles, P. R., Mallen, C. D., Zhang, W., Doherty, M., Nguyen-Van-

Tam, J. S., & Abhishek, A. (2020). Effectiveness of inactivated influenza vaccine in

autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs.

Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keaa078

Nicholson, B. D., Aveyard, P., Price, S. J., Hobbs, F. R., Koshiaris, C., & Hamilton, W. (2020).

Prioritising primary care patients with unexpected weight loss for cancer investigation:

diagnostic accuracy study. Bmj, 370, m2651. https://doi.org/10.1136/bmj.m2651

Nicholson, B. D., Hamilton, W., Koshiaris, C., Oke, J. L., Hobbs, F. D. R., & Aveyard, P. (2020). The

association between unexpected weight loss and cancer diagnosis in primary care: a matched

cohort analysis of 65,000 presentations. Br J Cancer. https://doi.org/10.1038/s41416-020-0829-

3

Nickinson, A. T. O., Coles, B., Zaccardi, F., Gray, L. J., Payne, T., Bown, M. J., Davies, R. S. M.,

Khunti, K., & Sayers, R. D. (2020). Missed Opportunities for Timely Recognition of Chronic

Limb-Threatening Ischaemia in Patients Undergoing a Major Amputation: A Population Based

CPRD bibliography

46

Cohort Study Using the UK’s Clinical Practice Research Datalink. Eur J Vasc Endovasc Surg.

https://doi.org/10.1016/j.ejvs.2020.05.010

Osam, C. S., Pierce, M., Hope, H., Ashcroft, D. M., & Abel, K. M. (2020). The influence of maternal

mental illness on vaccination uptake in children: a UK population-based cohort study. Eur J

Epidemiol. https://doi.org/10.1007/s10654-020-00632-5

Palladino, R., Marrie, R. A., Majeed, A., & Chataway, J. (2020). Evaluating the Risk of

Macrovascular Events and Mortality Among People With Multiple Sclerosis in England. JAMA

Neurol. https://doi.org/10.1001/jamaneurol.2020.0664

Palladino, R., Tabak, A. G., Khunti, K., Valabhji, J., Majeed, A., Millett, C., & Vamos, E. P. (2020).

Association between pre-diabetes and microvascular and macrovascular disease in newly

diagnosed type 2 diabetes. BMJ Open Diabetes Res Care, 8(1). https://doi.org/10.1136/bmjdrc-

2019-001061

Párraga Prieto, C., Ibrahim, F., Campbell, R., Chinoy, H., Galloway, J., & Gordon, P. (2020). Similar

risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in

the first 5~years after diagnosis. Clin Rheumatol. https://doi.org/10.1007/s10067-020-05237-7

Partington, R., Muller, S., Mallen, C. D., Abdul Sultan, A., & Helliwell, T. (2020). Comorbidities in

patients with polymyalgia rheumatica prior to and following diagnosis: A case control and

cohort study. Semin Arthritis Rheum, 50(4), 663–672.

https://doi.org/10.1016/j.semarthrit.2020.05.003

Partington, R., Muller, S., Mallen, C. D., Abdul Sultan, A., & Helliwell, T. (2020). Mortality among

patients with polymyalgia rheumatica:~A retrospective cohort study. Arthritis Care Res

(Hoboken). https://doi.org/10.1002/acr.24403

Pate, A., Elliott, R. A., Gkountouras, G., Thompson, A., Emsley, R., & Van Staa, T. (2020). The

impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on

the number of cardiovascular events prevented. Pharmacoepidemiol Drug Saf.


Pate, A., Emsley, R., Sperrin, M., Martin, G. P., & Van Staa, T. (2020). Impact of sample size on the

stability of risk scores from clinical prediction models: a case study in cardiovascular disease.

Diagn Progn Res, 4, 14. https://doi.org/10.1186/s41512-020-00082-3

Pate, A., Emsley, R., & Van Staa, T. (2020). Impact of lowering the risk threshold for statin treatment

on statin prescribing: a descriptive study in English primary care. Br J Gen Pract, 70(700),


Pate, A., Van Staa, T., & Emsley, R. (2020). An assessment of the potential miscalibration of

cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in

England. BMC Med Res Methodol, 20(1), 289. https://doi.org/10.1186/s12874-020-01173-x

Pauling, J. D., McGrogan, A., Snowball, J., & McHugh, N. J. (2020). Epidemiology of systemic

sclerosis in the UK: an analysis of the Clinical Practice Research Datalink. Rheumatology

(Oxford). https://doi.org/10.1093/rheumatology/keaa680

Payne, R. A., Mendonca, S. C., Elliott, M. N., Saunders, C. L., Edwards, D. A., Marshall, M., &

Roland, M. (2020). Development and validation of the Cambridge Multimorbidity Score. Cmaj,

192(5), E107-e114. https://doi.org/10.1503/cmaj.190757

CPRD bibliography

47

Peng, X. V, McCrimmon, R. J., Shepherd, L., Boss, A., Lubwama, R., Dex, T., Skolnik, N., Ji, L.,

Avogaro, A., & Blonde, L. (2020). Glycemic Control Following GLP-1 RA or Basal Insulin

Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study.

Diabetes Ther. https://doi.org/10.1007/s13300-020-00905-y

Peppa, M., Thomas, S. L., Minassian, C., Walker, J. L., McDonald, H. I., Andrews, N. J., Kempley, S.

T., & Mangtani, P. (2020). Seasonal influenza vaccination during pregnancy and the risk of

major congenital malformations in live-born infants: A 2010-2016 historical cohort study. Clin

Infect Dis. https://doi.org/10.1093/cid/ciaa845

Persson, M. S. M., Harman, K. E., Vinogradova, Y., Langan, S. M., Hippisley-Cox, J., Thomas, K. S.,

& Gran, S. (2020). Validation study of bullous pemphigoid and pemphigus vulgaris recording in

routinely collected electronic primary healthcare records in England. BMJ Open, 10(7),


Persson, M. S. M., Harman, K. E., Vinogradova, Y., Langan, S. M., Hippisley-Cox, J., Thomas, K. S.,

& Gran, S. (2020). Incidence, prevalence, and mortality of bullous pemphigoid in England 1998-

2017: a population-based cohort study. Br J Dermatol. https://doi.org/10.1111/bjd.19022

Persson, R., Lee, S., Ulcickas Yood, M., Wagner Usn Mc, C. M., Minton, N., Niemcryk, S.,

Lindholm, A., Evans, A. M., & Jick, S. S. (2020). Infections in patients diagnosed with multiple

sclerosis: A multi-database study. Mult Scler Relat Disord, 41, 101982.

https://doi.org/10.1016/j.msard.2020.101982

Persson, R., Lee, S., Yood, M. U., Wagner Capt Usn Mc, M. R., Minton, N., Niemcryk, S., Lindholm,

A., Evans, A. M., & Jick, S. (2020). Incident depression in patients diagnosed with multiple

sclerosis: a multi-database study. Eur J Neurol. https://doi.org/10.1111/ene.14314

Persson, R., Lee, S., Yood, M. U., Wagner, M., Minton, N., Niemcryk, S., Lindholm, A., Evans, A.,

& Jick, S. (2020). Incident cardiovascular disease in patients diagnosed with multiple sclerosis:

A multi-database study. Mult Scler Relat Disord, 37, 101423.

https://doi.org/10.1016/j.msard.2019.101423

Persson, R., Vasilakis-Scaramozza, C., Hagberg, K. W., Sponholtz, T., Williams, T., Myles, P., &

Jick, S. S. (2020). CPRD Aurum database: Assessment of data quality and completeness of three

important comorbidities. Pharmacoepidemiol Drug Saf. https://doi.org/10.1002/pds.5135

Planell-Morell, P., Bajekal, M., Denaxas, S., Raine, R., & Alexander, D. C. (2020). Trajectories of

Disease Accumulation Using Electronic Health Records. Stud Health Technol Inform, 270, 469–

473. https://doi.org/10.3233/shti200204

Price, A., Ford, T., Janssens, A., Williams, A. J., & Newlove-Delgado, T. (2020). Regional analysis of

UK primary care prescribing and adult service referrals for young people with attention-deficit

hyperactivity disorder. BJPsych Open, 6(1), e7. https://doi.org/10.1192/bjo.2019.94

Price, S., Spencer, A., Zhang, X., Ball, S., Lyratzopoulos, G., Mujica-Mota, R., Stapley, S.,

Ukoumunne, O. C., & Hamilton, W. (2020). Trends in time to cancer diagnosis around the

period of changing national guidance on referral of symptomatic patients: A serial cross-

sectional study using UK electronic healthcare records from 2006-17. Cancer Epidemiol, 69,

101805. https://doi.org/10.1016/j.canep.2020.101805

CPRD bibliography

48

Price, S., Zhang, X., & Spencer, A. (2020). Measuring the impact of national guidelines: What

methods can be used to uncover time-varying effects for healthcare evaluations? Soc Sci Med,

258, 113021. https://doi.org/10.1016/j.socscimed.2020.113021

Pujades-Rodriguez, M., Morgan, A. W., Cubbon, R. M., & Wu, J. (2020). Dose-dependent oral

glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A

population-based cohort study. PLoS Med, 17(12), e1003432.


Quint, J. K., O’Leary, C., Venerus, A., Holmgren, U., Varghese, P., & Cabrera, C. (2020).

Development and Validation of a Method to Estimate COPD Severity in Multiple Datasets: A

Retrospective Study. Pulm Ther. https://doi.org/10.1007/s41030-020-00139-0

Quint, J. K., O’Leary, C., Venerus, A., Myland, M., Holmgren, U., Varghese, P., Richter, H.,

Bizouard, G., & Cabrera, C. (2020). Prescribing Pathways to Triple Therapy: A Multi-Country,

Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary

Disease. Pulm Ther, 6(2), 333–350. https://doi.org/10.1007/s41030-020-00132-7

Quint, J. K., Venerus, A., O’Leary, C., Myland, M., Holmgren, U., Varghese, P., & Cabrera, C.

(2020). Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults

with Chronic Obstructive Pulmonary Disease in the UK. Int J Chron Obstruct Pulmon Dis, 15,

3261–3271. https://doi.org/10.2147/copd.s278101

Quiroga, M., Shephard, E. A., Mounce, L. T. A., Carney, M., Hamilton, W. T., & Price, S. J. (2020).

Quantifying the impact of pre-existing conditions on the stage of oesophagogastric cancer at

diagnosis: a primary care cohort study using electronic medical records. Fam Pract.

https://doi.org/10.1093/fampra/cmaa132

Ramagopalan, S., Leahy, T. P., Stamp, E., & Sammon, C. (2020). Approaches for the identification of

chronic kidney disease in CPRD-HES-linked studies. J Comp Eff Res.

https://doi.org/10.2217/cer-2019-0190

Rathod-Mistry, T., Marshall, M., Campbell, P., Bailey, J., Chew-Graham, C. A., Croft, P., Frisher,

M., Hayward, R., Negi, R., Robinson, L., Singh, S., Sumathipala, A., Thein, N., Walters, K.,

Weich, S., & Jordan, K. P. (2020). Indicators of dementia disease progression in primary care:

an electronic health record cohort study. Eur J Neurol. https://doi.org/10.1111/ene.14710

Ravindrarajah, R., Reeves, D., Howarth, E., Meacock, R., Soiland-Reyes, C., Cotterill, S., Whittaker,

W., Heller, S., Sutton, M., Bower, P., & Kontopantelis, E. (2020). Epidemiology and

determinants of non-diabetic hyperglycaemia and its conversion to type 2 diabetes mellitus,

2000-2015: cohort population study using UK electronic health records. BMJ Open, 10(9),


Requena, G., Ma, L., Sturmer, T., Layton, J. B., & DiBello, J. (2020). Association Between an Acute,

Drug-Induced Decrease in High-Density Lipoprotein Cholesterol Levels and Risk of

Cardiovascular Events. Clin Drug Investig. https://doi.org/10.1007/s40261-020-00935-1

Requena, G., Wolf, A., Williams, R., Dedman, D., Quint, J. K., Murray-Thomas, T., & Pimenta, J. M.

(2020). Feasibility of using Clinical Practice Research Datalink data to identify patients with

chronic obstructive pulmonary disease to enrol into real-world trials. Pharmacoepidemiol Drug

Saf. https://doi.org/10.1002/pds.5188

CPRD bibliography

49

Rezel-Potts, E., & Gulliford, M. C. (2020). Sepsis recording in primary care electronic health records,

linked hospital episodes and mortality records: Population-based cohort study in England. PLoS


Richardson, K., Loke, Y. K., Fox, C., Maidment, I., Howard, R., Steel, N., Arthur, A., Boyd, P. J.,

Aldus, C., Ballard, C., & Savva, G. M. (2020). Adverse effects of Z-drugs for sleep disturbance

in people living with dementia: a population-based cohort study. BMC Med, 18(1), 351.

https://doi.org/10.1186/s12916-020-01821-5

Robinson, D. E., Ali, M. S., Pallares, N., Tebe, C., Elhussein, L., Abrahamsen, B., Arden, N. K., Ben-

Shlomo, Y., Caskey, F. J., Cooper, C., Dedman, D., Delmestri, A., Judge, A., Perez-Saez, M. J.,

Pascual, J., Nogues, X., Diez-Perez, A., Strauss, V. Y., Javaid, M. K., & Prieto-Alhambra, D.

(2020). Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a bi-

national cohort analysis. J Bone Miner Res. https://doi.org/10.1002/jbmr.4235

Rockenschaub, P., Nguyen, V., Aldridge, R. W., Acosta, D., Garcia-Gomez, J. M., & Saez, C. (2020).

Data-driven discovery of changes in clinical code usage over time: a case-study on changes in

cardiovascular disease recording in two English electronic health records databases (2001-2015).


Rodgers, L. R., Dennis, J. M., Shields, B. M., Mounce, L., Fisher, I., Hattersley, A. T., & Henley, W.

E. (2020). Prior event rate ratio adjustment produced estimates consistent with randomised trial:

a diabetes case study. J Clin Epidemiol. https://doi.org/10.1016/j.jclinepi.2020.03.007

Rouette, J., Yin, H., Pottegard, A., Nirantharakumar, K., & Azoulay, L. (2020). Use of

Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer. Drug Saf.

https://doi.org/10.1007/s40264-020-01015-1

Rouette, J., Yin, H., Yu, O. H. Y., Bouganim, N., Platt, R. W., & Azoulay, L. (2020). Incretin-based

drugs and risk of lung cancer among individuals with type 2 diabetes. Diabet Med.

https://doi.org/10.1111/dme.14287

Rustem Gulluoglu, F., Souverein, P. C., van den Ham, H. A., de Boer, A., & Komen, J. (2020).

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK

patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study.

Pharmacoepidemiol Drug Saf. https://doi.org/10.1002/pds.5181

Ruzangi, J., Blair, M., Cecil, E., Greenfield, G., Bottle, A., Hargreaves, D. S., & Saxena, S. (2020).

Trends in healthcare use in children aged less than 15 years: a population-based cohort study in

England from 2007 to 2017. BMJ Open, 10(5), e033761. https://doi.org/10.1136/bmjopen-2019-

033761

Ruzangi, J., Iwagami, M., Smeeth, L., Mangtani, P., & Nitsch, D. (2020). The association between

chronic kidney disease and tuberculosis; a comparative cohort study in England. BMC Nephrol,

21(1), 420. https://doi.org/10.1186/s12882-020-02065-4

Ryan, J. M., Cameron, M. H., Liverani, S., Smith, K. J., O’Connell, N., Peterson, M. D., Anokye, N.,

Victor, C., & Boland, F. (2020). Incidence of falls among adults with cerebral palsy: a cohort

study using primary care data. Dev Med Child Neurol, 62(4), 477–482.

https://doi.org/10.1111/dmcn.14444

Salisbury, C., Lay-Flurrie, S., Bankhead, C. R., Fuller, A., Murphy, M., Caddick, B., Ordonez-Mena,

J. M., Holt, T., Nicholson, B. D., Perera, R., & Hobbs, F. R. (2020). Measuring the complexity

CPRD bibliography

50

of general practice consultations: a Delphi and cross-sectional study in English primary care. Br

J Gen Pract. https://doi.org/10.3399/bjgp.2020.0486

Santella, C., Yin, H., Hicks, B. M., Yu, O. H. Y., Bouganim, N., & Azoulay, L. (2020). Weight-

lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer

among obese women with diabetes. Epidemiology.

https://doi.org/10.1097/ede.0000000000001196

Sarmanova, A., Doherty, M., Kuo, C., Wei, J., Abhishek, A., Mallen, C., Zeng, C., Wang, Y., Lei, G.,

& Zhang, W. (2020). Statin use and risk of joint replacement due to osteoarthritis and

rheumatoid arthritis: a propensity-score matched longitudinal cohort study. Rheumatology

(Oxford). https://doi.org/10.1093/rheumatology/keaa044

Schlackow, I., Simons, C., Oke, J., Feakins, B., O’Callaghan, C. A., Hobbs, F. D. R., Lasserson, D.,

Stevens, R. J., Perera, R., & Mihaylova, B. (2020). Long-term health outcomes of people with

reduced kidney function in the UK: A modelling study using population health data. PLoS Med,

17(12), e1003478. https://doi.org/10.1371/journal.pmed.1003478

Seesaghur, A., Petruski-Ivleva, N., Banks, V., Wang, J. R., Mattox, P., Hoeben, E., Maskell, J.,

Neasham, D., Reynolds, S. L., & Kafatos, G. (2020). Real-world reproducibility study

characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research

Datalink, a UK-based electronic health records database. Pharmacoepidemiol Drug Saf.


Shallcross, L., Rockenschaub, P., Blackburn, R., Nazareth, I., Freemantle, N., & Hayward, A. (2020).

Antibiotic prescribing for lower UTI in elderly patients in primary care and risk of bloodstream

infection: A cohort study using electronic health records in England. PLoS Med, 17(9),


Siffel, C., Page, M., Maxwell, T., Thun, B., Kolb, N., Rosenlund, M., von Bredow, D., & Keja, J.

(2020). Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with

Attention-Deficit/Hyperactivity Disorder in Europe. J Child Adolesc Psychopharmacol.

https://doi.org/10.1089/cap.2019.0173

Simoneau, G., Moodie, E. E. M., Azoulay, L., & Platt, R. W. (2020). Adaptive Treatment Strategies

with Survival Outcomes: An Application to the Treatment of Type 2 Diabetes using a Large

Observational Database. Am J Epidemiol. https://doi.org/10.1093/aje/kwz272

Sorial, A. K., Anjum, S. A., Cook, M. J., Board, T. N., & O’Neill, T. W. (2020). Statins, bone biology

and revision arthroplasty: review of clinical and experimental evidence. Ther Adv Musculoskelet

Dis, 12, 1759720x20966229. https://doi.org/10.1177/1759720x20966229

Stafford, M., Deeny, S., Dreyer, K., & Jenny, S. (2020). Multimorbidity within households and use of

health and social care. BJGP Open. https://doi.org/10.3399/bjgpo.2020.0134

Strain, W. D., Tsang, C., Hurst, M., McEwan, P., Unadkat, M., Meadowcroft, S., Shardlow, R., &

Evans, M. (2020). What Next After Metformin in Type 2 Diabetes? Selecting the Right Drug for

the Right Patient. Diabetes Ther, 11(6), 1381–1395. https://doi.org/10.1007/s13300-020-00834-

w

Strongman, H., Williams, R., & Bhaskaran, K. (2020). What are the implications of using individual

and combined sources of routinely collected data to identify and characterise incident site-

CPRD bibliography

51

specific cancers? a concordance and validation study using linked English electronic health

records data. BMJ Open, 10(8), e037719. https://doi.org/10.1136/bmjopen-2020-037719

Swain, S., Sarmanova, A., Mallen, C., Kuo, C. F., Coupland, C., Doherty, M., & Zhang, W. (2020).

Trends in incidence and prevalence of osteoarthritis in the United Kingdom: findings from the

Clinical Practice Research Datalink (CPRD). Osteoarthritis Cartilage.

https://doi.org/10.1016/j.joca.2020.03.004

Tafesse, E., Hurst, M., Hoskin, L., Badora, K., Sugrue, D., Qin, L., James, G., & McEwan, P. (2020).

Risk factors associated with the incidence and recurrence of hyperkalaemia in patients with

cardiorenal conditions. Int J Clin Pract, e13941. https://doi.org/10.1111/ijcp.13941

Tang, Y., Weiss, T., Liu, J., Rajpathak, S., & Khunti, K. (2020). Metformin adherence and

discontinuation among patients with type 2 diabetes: A retrospective cohort study. J Clin Transl

Endocrinol, 20, 100225. https://doi.org/10.1016/j.jcte.2020.100225

Taylor, C. J., Ordonez-Mena, J. M., Jones, N. R., Roalfe, A. K., Lay-Flurrie, S., Marshall, T., &

Hobbs, F. D. R. (2020). National trends in heart failure mortality in men and women, United

Kingdom, 2000-2017. Eur J Heart Fail. https://doi.org/10.1002/ejhf.1996

Tazare, J., Smeeth, L., Evans, S. J. W., Williamson, E., & Douglas, I. J. (2020). Implementing high-

dimensional propensity score principles to improve confounder adjustment in UK electronic

health records. Pharmacoepidemiol Drug Saf. https://doi.org/10.1002/pds.5121

Thomas, K. H., Davies, N. M., Taylor, A. E., Taylor, G. M. J., Gunnell, D., Martin, R. M., &

Douglas, I. (2020). Risk of neuropsychiatric and cardiovascular adverse events following

treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice

Research Datalink: a case-crossover study. Addiction. https://doi.org/10.1111/add.15338

Threapleton, C. J. D., Kimpton, J. E., Carey, I. M., DeWilde, S., Cook, D. G., Harris, T., & Baker, E.

H. (2020). Development of a structured clinical pharmacology review for specialist support for

management of complex polypharmacy in primary care. Br J Clin Pharmacol.


Tran, T., Assayag, D., Ernst, P., & Suissa, S. (2020). Effectiveness of proton pump inhibitors in

idiopathic pulmonary fibrosis: a population-based cohort study. Chest.

https://doi.org/10.1016/j.chest.2020.08.2080

Tran, T., & Suissa, S. (2020). Comparing New-User Cohort Designs: The Example of Proton Pump

Inhibitor Effectiveness in Idiopathic Pulmonary Fibrosis. Am J Epidemiol.

https://doi.org/10.1093/aje/kwaa242

Tucker, A., Wang, Z., Rotalinti, Y., & Myles, P. (2020). Generating high-fidelity synthetic patient

data for assessing machine learning healthcare software. NPJ Digit Med.

https://doi.org/10.1038/s41746-020-00353-9

Tyrer, F., Zaccardi, F., Khunti, K., & Morriss, R. (2020). Incidence of Depression and First-Line

Antidepressant Therapy in People with Obesity and Depression in Primary Care. Obesity (Silver

Spring), 28(5), 977–984. https://doi.org/10.1002/oby.22772

van den Dries, C. J., van Doorn, S., Souverein, P., Pajouheshnia, R., Moons, K. G. M., Hoes, A. W.,

Geersing, G. J., & van den Ham, H. A. (2020). The Number of Concomitant Drugs and the

CPRD bibliography

52

Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation. TH Open,

4(4), e417–e426. https://doi.org/10.1055/s-0040-1721499

van Durme, C., Spaetgens, B., Driessen, J., Nielen, J., Sastry, M., Boonen, A., & de Vries, F. (2020).

Obstructive sleep apnea and the risk of gout: a population-based case-control study. Arthritis Res

Ther, 22(1), 92. https://doi.org/10.1186/s13075-020-02176-1

van Staa, T. P., Palin, V., Li, Y., Welfare, W., Felton, T. W., Dark, P., & Ashcroft, D. M. (2020). The

effectiveness of frequent antibiotic use in reducing the risk of infection-related hospital

admissions: results from two large population-based cohorts. BMC Med, 18(1), 40.

https://doi.org/10.1186/s12916-020-1504-5

Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2020). Use of hormone replacement therapy and

risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.

Bmj, 371, m3873. https://doi.org/10.1136/bmj.m3873

Walker, V. M., Davies, N. M., Martin, R. M., & Kehoe, P. G. (2020). Comparison of antihypertensive

drug classes for dementia prevention. Epidemiology.

https://doi.org/10.1097/ede.0000000000001245

Watson, J., Whiting, P., Salisbury, C., Banks, J., & Hamilton, W. (2020). Raised inflammatory

markers as a predictor of one-year mortality: a cohort study in primary care in the UK using

electronic health record data. BMJ Open, 10(10), e036027. https://doi.org/10.1136/bmjopen-

2019-036027

Weinstein, R. B., Ryan, P. B., Berlin, J. A., Schuemie, M. J., Swerdel, J., & Fife, D. (2020).

Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal

Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen. Drug

Saf. https://doi.org/10.1007/s40264-020-00950-3

Weir, S., Samnaliev, M., Kuo, T. C., Tierney, T. S., Manca, A., Taylor, R. S., Bruce, J., Eldabe, S., &

Cumming, D. (2020). Persistent postoperative pain and healthcare costs associated with

instrumented and non-instrumented spinal surgery: a case-control study. J Orthop Surg Res,

15(1), 127. https://doi.org/10.1186/s13018-020-01633-6

Werkman, N. C. C., Nielen, J. T. H., van den Bergh, J. P. W., Ejskjaer, N., Røikjer, J., Schaper, N. C.,

Rossi, B., Klungel, O., Vestergaard, P., de Vries, F., & Driessen, J. H. M. (2020). Use of

Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb Amputation.

Curr Drug Saf. https://doi.org/10.2174/1574886315666200805103053

Whittaker, H. R., Bloom, C., Morgan, A., Jarvis, D., Kiddle, S. J., & Quint, J. K. (2020). Accelerated

FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of

COPD patients. Eur Respir J. https://doi.org/10.1183/13993003.00918-2020

Whittaker, H. R., Pimenta, J. M., Jarvis, D., Kiddle, S. J., & Quint, J. K. (2020). Characteristics

Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic

Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis, 15, 3079–3091.


Wilkinson, S., Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., Douglas,

I. J., & Tomlinson, L. A. (2020). Comparative effects of sulfonylureas, DPP4is and SGLT2

inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK

primary care. Diabetes Obes Metab. https://doi.org/10.1111/dom.13970

CPRD bibliography

53

Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., Quint, J. K., &

Douglas, I. (2020). Real world effects of COPD medications: a cohort study with validation

against RCT results. Eur Respir J. https://doi.org/10.1183/13993003.01586-2020

Winter, J. R., Charlton, J., Ashworth, M., Bunce, C., & Gulliford, M. C. (2020). Peritonsillar Abscess

and Antibiotic Prescribing for Respiratory Infection in Primary Care: A Population-Based

Cohort Study and Decision-Analytic Model. Ann Fam Med, 18(5), 390–396.

https://doi.org/10.1370/afm.2570

Wong, A. Y. S., Froslev, T., Dearing, L., Forbes, H. J., Mulick, A., Mansfield, K. E., Silverwood, R.

J., Kjaersgaard, A., Sorensen, H. T., Smeeth, L., Lewin, A., Schmidt, S. A. J., & Langan, S. M.

(2020). The association between partner bereavement and melanoma: cohort studies in the U.K.

and Denmark. Br J Dermatol. https://doi.org/10.1111/bjd.18889

Wright, A. K., Suarez-Ortegon, M. F., Read, S. H., Kontopantelis, E., Buchan, I., Emsley, R., Sattar,

N., Ashcroft, D. M., Wild, S. H., & Rutter, M. K. (2020). Risk Factor Control and

Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary

Prevention Settings. Circulation, 142(20), 1925–1936.


Wright, A. K., Welsh, P., Gill, J. M. R., Kontopantelis, E., Emsley, R., Buchan, I., Ashcroft, D. M.,

Rutter, M. K., & Sattar, N. (2020). Age-, sex- and ethnicity-related differences in body weight,

blood pressure, HbA(1c) and lipid levels at the diagnosis of type 2 diabetes relative to people

without diabetes. Diabetologia. https://doi.org/10.1007/s00125-020-05169-6

Wu, J., Mackie, S. L., & Pujades-Rodriguez, M. (2020). Glucocorticoid dose-dependent risk of type 2

diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis.

BMJ Open Diabetes Res Care, 8(1). https://doi.org/10.1136/bmjdrc-2020-001220

Yang, Z., Edwards, D., Burgess, S., Brayne, C., & Mant, J. (2020). Association of Prior

Atherosclerotic Cardiovascular Disease with Dementia After Stroke: A Retrospective Cohort

Study. J Alzheimers Dis. https://doi.org/10.3233/jad-200536

Ye, Y., Jiang, B., Manne, S., Moses, P. L., Almansa, C., Bennett, D., Dolin, P., & Ford, A. C. (2020).

Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the

United Kingdom. Gut. https://doi.org/10.1136/gutjnl-2020-321277

Yiu, Z. Z. N., Parisi, R., Lunt, M., Warren, R. B., Griffiths, C. E. M., Langan, S. M., & Ashcroft, D.

M. (2020). Risk of Hospitalisation and Death due to Infection in People with Psoriasis: a

Population-based Cohort Study using the Clinical Practice Research Datalink. Br J Dermatol.

https://doi.org/10.1111/bjd.19052

Yu, D., Appleyard, T., Cottrell, E., & Peat, G. (2020). Co-prescription of gabapentinoids and opioids

among adults with and without osteoarthritis in the United Kingdom between 1995 and 2017.

Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keaa586

Zaccardi, F., Jacquot, E., Cortese, V., Tyrer, F., Seidu, S., Davies, M. J., & Khunti, K. (2020).

Comparative effectiveness of gliclazide modified release vs sitagliptin as second-line treatment

after metformin monotherapy in patients with uncontrolled type 2 diabetes. Diabetes Obes

Metab. https://doi.org/10.1111/dom.14169

CPRD bibliography

54

Zaccardi, F., Ling, S., Lawson, C., Davies, M. J., & Khunti, K. (2020). Severe hypoglycaemia and

absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care

observational study. Diabetologia. https://doi.org/10.1007/s00125-020-05223-3

Zecca, C., Disanto, G., Sacco, R., MacLachlan, S., Kuhle, J., Ramagopalan, S. V, & Gobbi, C. (2020).

Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study.

J Neurol. https://doi.org/10.1007/s00415-020-10170-5

Zghebi, S. S., Mamas, M. A., Ashcroft, D. M., Salisbury, C., Mallen, C. D., Chew-Graham, C. A.,

Reeves, D., van Marwijk, H., Qureshi, N., Weng, S., Holt, T., Buchan, I., Peek, N., Giles, S.,

Rutter, M. K., & Kontopantelis, E. (2020). Development and validation of the DIabetes Severity

SCOre (DISSCO) in 139 626 individuals with type 2 diabetes: a retrospective cohort study. BMJ

Open Diabetes Res Care, 8(1). https://doi.org/10.1136/bmjdrc-2019-000962

Zghebi, S. S., Steinke, D. T., Rutter, M. K., & Ashcroft, D. M. (2020). Eleven-year multimorbidity

burden among 637 255 people with and without type 2 diabetes: a population-based study using

primary care and linked hospitalisation data. BMJ Open, 10(7), e033866.


Zhang, Y., Souverein, P. C., Gardarsdottir, H., van den Ham, H. A., der Zee, A. H., & de Boer, A.

(2020). Risk of major bleeding among users of direct oral anticoagulants combined with

interacting drugs: A population-based nested case-control study. Br J Clin Pharmacol.


Zhu, J., & Gallego, B. (2020). Targeted estimation of heterogeneous treatment effect in observational

survival analysis. J Biomed Inform, 107, 103474. https://doi.org/10.1016/j.jbi.2020.103474

Zhu, Y., Edwards, D., Mant, J., Payne, R. A., & Kiddle, S. (2020). Characteristics, service use and

mortality of clusters of multimorbid patients in England: a population-based study. BMC Med,

18(1), 78. https://doi.org/10.1186/s12916-020-01543-8

CPRD bibliography

55

2019

Abel, K. M., Hope, H., Swift, E., Parisi, R., Ashcroft, D. M., Kosidou, K., Osam, C. S., Dalman, C.,

& Pierce, M. (2019). Prevalence of maternal mental illness among children and adolescents in

the UK between 2005 and 2017: a national retrospective cohort analysis. Lancet Public Health,

4(6), e291–e300. https://doi.org/10.1016/s2468-2667(19)30059-3

Abrahami, D., Douros, A., Yin, H., Yu, O. H. Y., & Azoulay, L. (2019). Sodium-Glucose

Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes.

Diabetes Care, 42(9), e150–e152. https://doi.org/10.2337/dc19-0849

Abtahi, S., Burden, A. M., Geusens, P., van den Bergh, J. P., Van Staa, T., & de Vries, F. (2019). The

Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic

Fracture in the United Kingdom: Population-Based Cohort Study. J Am Med Dir Assoc.

https://doi.org/10.1016/j.jamda.2019.11.003

Adiamah, A., Ban, L., West, J., & Humes, D. J. (2019). The risk of venous thromboembolism after

surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based

cohort study. Dis Esophagus. https://doi.org/10.1093/dote/doz079

Ahmed, H., Farewell, D., Jones, H. M., Francis, N. A., Paranjothy, S., & Butler, C. C. (2019).

Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract

infection: cohort study. Age Ageing, 48(2), 228–234. https://doi.org/10.1093/ageing/afy146

Ailabouni, N. J., Marcum, Z. A., Schmader, K. E., & Gray, S. L. (2019). Medication Use Quality and

Safety in Older Adults: 2018 Update. J Am Geriatr Soc. https://doi.org/10.1111/jgs.16243

Akyea, R. K., Kai, J., Qureshi, N., Iyen, B., & Weng, S. F. (2019). Sub-optimal cholesterol response

to initiation of statins and future risk of cardiovascular disease. Heart.


Alageel, S., & Gulliford, M. C. (2019). Health checks and cardiovascular risk factor values over six

years{\textquoteright} follow-up: Matched cohort study using electronic health records in

England. PLoS Med, 16(7), e1002863. https://doi.org/10.1371/journal.pmed.1002863

Al-Attar, N., Johnston, S., Jamous, N., Mistry, S., Ghosh, E., Gangoli, G., Danker, W., Etter, K., &

Ammann, E. (2019). Impact of bleeding complications on length of stay and critical care

utilization in cardiac surgery patients in England. J Cardiothorac Surg, 14(1), 64.

https://doi.org/10.1186/s13019-019-0881-3

Alikhan, R., Lefevre, C., Menown, I., Lister, S., Bird, A., You, M., Evans, D., & Sammon, C. (2019).

Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K

Antagonists: A Clinical Practice Research Datalink Study. TH Open, 3(4), e316–e324.

https://doi.org/10.1055/s-0039-1698413

Allan, V., Sammon, C. J., McDonald, L., Mehmud, F., Alikhan, R., & Ramagopalan, S. V. (2019).

Impact of atrial fibrillation awareness campaigns: interrupted time series using the Clinical

Practice Research Datalink. Future Cardiol. https://doi.org/10.2217/fca-2019-0025

Alsaggaf, R., Pfeiffer, R. M., Wang, Y., St George, D. M. M., Zhan, M., Wagner, K. R., Amr, S.,

Greene, M. H., & Gadalla, S. M. (2019). Diabetes, Metformin, and Cancer Risk in Myotonic

Dystrophy Type I. Int J Cancer. https://doi.org/10.1002/ijc.32801

CPRD bibliography

56

Alsaggaf, R., St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., Liu, Z.,

Koshiol, J., Bauer, A. J., Wagner, K. R., Greene, M. H., Amr, S., & Gadalla, S. M. (2019).

Benign tumors in myotonic dystrophy type I target disease-related cancer sites. Ann Clin Transl

Neurol, 6(8), 1510–1518. https://doi.org/10.1002/acn3.50856

Amegadzie, J. E., Badejo, O., Gamble, J. M., Wright, M., Farrell, J., Jackson, B., Sultana, K., Hashmi,

M., & Gao, Z. (2019). Validated methods to identify patients with asthma-COPD overlap in

healthcare databases: a systematic review protocol. BMJ Open, 9(3), e024306.


Andersen, Y. M. F., Egeberg, A., Ban, L., Gran, S., Williams, H. C., Francis, N. A., Knop, F. K.,

Gislason, G. H., Skov, L., & Thyssen, J. P. (2019). Association Between Topical Corticosteroid

Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts. Diabetes Care,

42(6), 1095–1103. https://doi.org/10.2337/dc18-2158

Anssar, T. M., Leitzmann, M. F., Linker, R. A., Meier, C., Becker, C., Jick, S., Sahm, K., Platten, M.,

Hau, P., & Seliger, C. (2019). Autoimmune diseases and immunosuppressive therapy in relation

to the risk of glioma. Cancer Med. https://doi.org/10.1002/cam4.2767

Appleyard, T., Ashworth, J., Bedson, J., Yu, D., & Peat, G. (2019). Trends in gabapentinoid

prescribing in patients with osteoarthritis: a United Kingdom national cohort study in primary

care. Osteoarthritis Cartilage. https://doi.org/10.1016/j.joca.2019.06.008

Arhi, C. S., Markar, S., Burns, E. M., Bouras, G., Bottle, A., Hanna, G., Aylin, P., Ziprin, P., & Darzi,

A. (2019). Delays in referral from primary care are associated with a worse survival in patients

with esophagogastric cancer. Dis Esophagus. https://doi.org/10.1093/dote/doy132

Ayala Solares, J. R., Canoy, D., Raimondi, F. E. D., Zhu, Y., Hassaine, A., Salimi-Khorshidi, G.,

Tran, J., Copland, E., Zottoli, M., Pinho-Gomes, A. C., Nazarzadeh, M., & Rahimi, K. (2019).

Long-Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular

Disease: Evidence From Large-Scale Routine Electronic Health Records. J Am Heart Assoc,

8(12), e012129. https://doi.org/10.1161/jaha.119.012129

Banerjee, A., Allan, V., Denaxas, S., Shah, A., Kotecha, D., Lambiase, P. D., Jacob, J., Lund, L. H.,

& Hemingway, H. (2019). Subtypes of atrial fibrillation with concomitant valvular heart disease

derived from electronic health records: phenotypes, population prevalence, trends and prognosis.

Europace. https://doi.org/10.1093/europace/euz220

Becker, C., Jick, S. S., & Meier, C. R. (2019). ACE inhibitor use and risk of cataract: a case-control

analysis. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2018-312980

Bedson, J., Chen, Y., Ashworth, J., Hayward, R. A., Dunn, K. M., & Jordan, K. P. (2019). Risk of

adverse events in patients prescribed long-term opioids: A cohort study in the UK Clinical

Practice Research Datalink. Eur J Pain. https://doi.org/10.1002/ejp.1357

Bellass, S., Taylor, J., Han, L., Prady, S. L., Shiers, D., Jacobs, R., Holt, R. I. G., Radford, J., Gilbody,

S., Hewitt, C., Doran, T., Alderson, S. L., & Siddiqi, N. (2019). Exploring Severe Mental Illness

and Diabetes: Protocol for a Longitudinal, Observational, and Qualitative Mixed Methods Study.

JMIR Res Protoc, 8(9), 13407. https://doi.org/10.2196/13407

Berni, E. R., Jones, B. I., Berni, T. R., Whitehouse, J., Hudson, M., Orr, J., Conway, P., Amlani, B., &

Currie, C. J. (2019). The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of

CPRD bibliography

57

Long-term Outlook of Mortality in Cirrhosis (LOMiC). PLoS One, 14(10), e0223253.


Blackwell, J., Saxena, S., Alexakis, C., Bottle, A., Cecil, E., Majeed, A., & Pollok, R. C. (2019). The

impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a

nationwide population-based study. Aliment Pharmacol Ther, 50(5), 556–567.

https://doi.org/10.1111/apt.15390

Blakey, J. D., Gayle, A., Slater, M. G., Jones, G. H., & Baldwin, M. (2019). Observational cohort

study to investigate the unmet need and time waiting for referral for specialist opinion in adult

asthma in England (UNTWIST asthma). BMJ Open, 9(11), e031740.


Bloom, C. I., Douglas, I., Olney, J., D\textquoterightAncona, G., Smeeth, L., & Quint, J. K. (2019).

Cost saving of switching to equivalent inhalers and its effect on health outcomes. Thorax.


Bloom, C. I., Ricciardi, F., Smeeth, L., Stone, P., & Quint, J. K. (2019). Predicting COPD 1-year

mortality using prognostic predictors routinely measured in primary care. BMC Med, 17(1), 73.

https://doi.org/10.1186/s12916-019-1310-0

Bloom, C. I., Walker, S., & Quint, J. K. (2019). Inadequate specialist care referrals for high-risk

asthma patients in the UK: an adult population-based cohort 2006-2017. J Asthma, 1–7.

https://doi.org/10.1080/02770903.2019.1672723

Booth, H. P., Gallagher, A. M., Mullett, D., Carty, L., Padmanabhan, S., Myles, P. R., Welburn, S. J.,

Hoghton, M., Rafi, I., & Valentine, J. (2019). Quality improvement of prescribing safety: a pilot

study in primary care using UK electronic health records. Br J Gen Pract.


Bottle, A., Kim, D., Hayhoe, B., Majeed, A., Aylin, P., Clegg, A., & Cowie, M. R. (2019). Frailty and

comorbidity predict first hospitalisation after heart failure diagnosis in primary care: population-

based observational study in England. Age Ageing. https://doi.org/10.1093/ageing/afy194

Brauer, R., Herrero-Zazo, M., Barlow, D. J., Gaughran, F., Taylor, D., & Howard, L. M. (2019).

Minocycline and the risk of acute psychiatric events in adolescence: A self-controlled case

series. J Psychopharmacol, 269881118821852. https://doi.org/10.1177/0269881118821852

Bricout, H., Torcel-Pagnon, L., Lecomte, C., Almas, M. F., Matthews, I., Lu, X., Wheelock, A., &

Sevdalis, N. (2019). Determinants of shingles vaccine acceptance in the United Kingdom. PLoS


Broadhurst, C., Rhodes, A. M. L., Harper, P., Perry, D. C., Clarke, N. M. P., & Aarvold, A. (2019).

What is the incidence of late detection of developmental dysplasia of the hip in England? Bone

Joint J, 101-b(3), 281–287. https://doi.org/10.1302/0301-620x.101b3.bjj-2018-1331.r1

Bromley, S. E., Matthews, A., Smeeth, L., Stanway, S., & Bhaskaran, K. (2019). Risk of dementia

among postmenopausal breast cancer survivors treated with aromatase inhibitors versus

tamoxifen: a cohort study using primary care data from the UK. J Cancer Surviv, 13(4), 632–

640. https://doi.org/10.1007/s11764-019-00782-w

Buhl, R., Heaney, L. G., Loefroth, E., Larbig, M., Kostikas, K., Conti, V., & Cao, H. (2019). One-

year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose

CPRD bibliography

58

inhaled corticosteroid-long-acting beta2-agonist in UK primary care settings. Respir Med, 162,

105859. https://doi.org/10.1016/j.rmed.2019.105859

Burkard, T., Moser, M., Rauch, M., Jick, S. S., & Meier, C. R. (2019). Utilization pattern of hormone

therapy in UK general practice between 1996 and 2015: a descriptive study. Menopause.

https://doi.org/10.1097/gme.0000000000001300

Burn, E., Edwards, C. J., Murray, D. W., Silman, A., Cooper, C., Arden, N. K., Prieto-Alhambra, D.,

& Pinedo-Villanueva, R. (2019). The impact of bmi and smoking on risk of revision following

knee and hip replacement surgery: evidence from routinely collected data. Osteoarthritis

Cartilage. https://doi.org/10.1016/j.joca.2019.05.012

Cairns, V., Wallenhorst, C., Rietbrock, S., & Martinez, C. (2019). Incidence of Lyme disease in the

UK: a population-based cohort study. BMJ Open, 9(8), e025916.


Carr, D. F., Francis, B., Jorgensen, A. L., Zhang, E., Chinoy, H., Heckbert, S. R., Bis, J. C., Brody, J.

A., Floyd, J., Psaty, B. M., Molokhia, M., Lapeyre-Mestre, M., Conforti, A., Alfirevic, A., Van

Staa, T., & Pirmohamed, M. (2019). Genome-wide association study of statin-induced myopathy

in patients recruited using the UK clinical practice research datalink. Clin Pharmacol Ther.


Carr, M. J., Ashcroft, D. M., White, P. D., Kapur, N., & Webb, R. T. (2019). Prevalence of comorbid

mental and physical illnesses and risks for self-harm and premature death among primary care

patients diagnosed with fatigue syndromes. Psychol Med, 1–8.

https://doi.org/10.1017/s0033291719001065

Carreira, H., Williams, R., Strongman, H., & Bhaskaran, K. (2019). Identification of mental health

and quality of life outcomes in primary care databases in the UK: a systematic review. BMJ


Carter, B., Verity Bennett, C., Bethel, J., Jones, H. M., Wang, T., & Kemp, A. (2019). Identifying

cerebral palsy from routinely-collected data in England and Wales. Clin Epidemiol, 11, 457–

468. https://doi.org/10.2147/clep.s200748

Chan, M. S., van den Hout, A., Pujades-Rodriguez, M., Jones, M. M., Matthews, F. E., Jagger, C.,

Raine, R., & Bajekal, M. (2019). Socio-economic inequalities in life expectancy of older adults

with and without multimorbidity: a record linkage study of 1.1 million people in England. Int J

Epidemiol. https://doi.org/10.1093/ije/dyz052

Chen, Y., Farooq, S., Edwards, J., Chew-Graham, C. A., Shiers, D., Frisher, M., Hayward, R.,

Sumathipala, A., & Jordan, K. P. (2019). Patterns of symptoms before a diagnosis of first

episode psychosis: a latent class analysis of UK primary care electronic health records. BMC

Med, 17(1), 227. https://doi.org/10.1186/s12916-019-1462-y

Cherney, D. Z. I., Repetto, E., Wheeler, D. C., Arnold, S. V, MacLachlan, S., Hunt, P. R., Chen, H.,

Vora, J., & Kosiborod, M. (2019). Impact of Cardio-Renal-Metabolic Comorbidities on

Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus. Am J Nephrol, 1–9.

https://doi.org/10.1159/000504558

Chou, I. J., Kuo, C. F., Tanasescu, R., Tench, C. R., Tiley, C. G., Constantinescu, C. S., &

Whitehouse, W. P. (2019). Comorbidity in multiple sclerosis: its temporal relationships with

disease onset and dose effect on mortality. Eur J Neurol. https://doi.org/10.1111/ene.14040

CPRD bibliography

59

Chou, I. J., Kuo, C. F., Tanasescu, R., Tench, C. R., Tiley, C. G., Constantinescu, C. S., &

Whitehouse, W. P. (2019). Epilepsy and associated mortality in patients with multiple sclerosis.

Eur J Neurol, 26(2), 342-e23. https://doi.org/10.1111/ene.13821

Conrad, N., Judge, A., Canoy, D., Tran, J., O\textquoterightDonnell, J., Nazarzadeh, M., Salimi-

Khorshidi, G., Hobbs, F. D. R., Cleland, J. G., McMurray, J. J. V, & Rahimi, K. (2019).

Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort

study of 93,000 UK patients. PLoS Med, 16(5), e1002805.


Conrad, N., Judge, A., Canoy, D., Tran, J., Pinho-Gomes, A. C., Millett, E. R. C., Salimi-Khorshidi,

G., Cleland, J. G., McMurray, J. J. V, & Rahimi, K. (2019). Temporal Trends and Patterns in

Mortality After Incident Heart Failure: A Longitudinal Analysis of 86000 Individuals. JAMA

Cardiol. https://doi.org/10.1001/jamacardio.2019.3593

Cook, M. J., Sorial, A. K., Lunt, M., Board, T. N., & O\textquoterightNeill, T. W. (2019). Effect of

timing and duration of statin exposure on risk of hip or knee revision arthroplasty: a population-

based cohort study. J Rheumatol. https://doi.org/10.3899/jrheum.180574

Critchley, J. A., Carey, I. M., Harris, T., DeWilde, S., & Cook, D. G. (2019). Variability in Glycated

Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large

Primary Care Cohort Study. Diabetes Care, 42(12), 2237–2246. https://doi.org/10.2337/dc19-

0848

Curran, D., Hunjan, M., El Ghachi, A., El-Hahi, Y., Bianco, V., & Ferreira, G. (2019). Herpes zoster

related healthcare burden and costs in immunocompromised (IC) and IC-free populations in

England: an observational retrospective database analysis. BMJ Open, 9(8), e023502.


Czoski Murray, C. J., Kingsbury, S. R., Arden, N. K., Hewison, J., Judge, A., Matu, J.,

O\textquoterightShea, J., Pinedo-Villanueva, R., Smith, L. K., Smith, C., Thomas, C. M., West,

R. M., Wright, J. M., Conaghan, P. G., & Stone, M. H. (2019). Towards UK poSt Arthroplasty

Follow-up rEcommendations (UK SAFE): protocol for an evaluation of the requirements for

arthroplasty follow-up, and the production of consensus-based recommendations. BMJ Open,


Danese, M. D., Halperin, M., Duryea, J., & Duryea, R. (2019). The Generalized Data Model for

clinical research. BMC Med Inform Decis Mak, 19(1), 117. https://doi.org/10.1186/s12911-019-

0837-5

Davies, K., Johnson, E. L., Hollen, L., Jones, H. M., Lyttle, M. D., Maguire, S., & Kemp, A. M.

(2019). Incidence of medically attended paediatric burns across the UK. Inj Prev.

https://doi.org/10.1136/injuryprev-2018-042881

Dedman, D., Coton, S. J., Ghosh, R. E., Meeraus, W., Crim, C., Harvey, C., Amelio, J., & Landis, S.

H. (2019). Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and

COPD in UK Primary Care: Retrospective Cohort Study. Pulmonary Therapy, 5(1), 81–95.

https://doi.org/10.1007/s41030-019-0092-z

den Heijer, C., Hoebe, C., Driessen, J. H., Wolffs, P., van den Broek, I., Hoenderboom, B., Williams,

R., de Vries, F., & Dukers-Muijrers, N. (2019). Chlamydia trachomatis and the Risk of Pelvic

Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study

Among Primary Care Patients. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciz429

CPRD bibliography

60

Denaxas, S., Gonzalez-Izquierdo, A., Direk, K., Fitzpatrick, N. K., Fatemifar, G., Banerjee, A.,

Dobson, R. J. B., Howe, L. J., Kuan, V., Lumbers, R. T., Pasea, L., Patel, R. S., Shah, A. D.,

Hingorani, A. D., Sudlow, C., & Hemingway, H. (2019). UK phenomics platform for

developing and validating electronic health record phenotypes: CALIBER. J Am Med Inform

Assoc. https://doi.org/10.1093/jamia/ocz105

Denholm, R., Morris, R., & Payne, R. (2019). Polypharmacy patterns in the last year of life in patients

with dementia. Eur J Clin Pharmacol. https://doi.org/10.1007/s00228-019-02721-1

Dennis, J. M., Henley, W. E., McGovern, A. P., Farmer, A. J., Sattar, N., Holman, R. R., Pearson, E.

R., Hattersley, A. T., Shields, B. M., & Jones, A. G. (2019). Time trends in prescribing of type 2

diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data,

2010-2017. Diabetes Obes Metab. https://doi.org/10.1111/dom.13687

Dickerman, B. A., Garcia-Albeniz, X., Logan, R. W., Denaxas, S., & Hernan, M. A. (2019).

Avoidable flaws in observational analyses: an application to statins and cancer. Nat Med.

https://doi.org/10.1038/s41591-019-0597-x

Douros, A., Dell\textquoterightAniello, S., Dehghan, G., Boivin, J. F., & Renoux, C. (2019). Degree

of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study. Neurology,

93(10), e1010–e1020. https://doi.org/10.1212/wnl.0000000000008060

Douros, A., Dell\textquoterightAniello, S., Yu, O. H. Y., & Suissa, S. (2019). Comparative

cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based

cohort study. Diabetes Obes Metab. https://doi.org/10.1111/dom.13893

Douros, A., Rouette, J., Yin, H., Yu, O. H. Y., Filion, K. B., & Azoulay, L. (2019). Dipeptidyl

Peptidase-4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2

Diabetes. Diabetes Care. https://doi.org/10.2337/dc19-0409

Dregan, A., Matcham, F., Harber-Aschan, L., Rayner, L., Brailean, A., Davis, K., Hatch, S., Pariante,

C., Armstrong, D., Stewart, R., & Hotopf, M. (2019). Common mental disorders within chronic

inflammatory disorders: a primary care database prospective investigation. Ann Rheum Dis.


Eberg, M., Platt, R. W., Reynier, P., & Filion, K. B. (2019). Estimation of high-dimensional

propensity scores with multiple exposure levels. Pharmacoepidemiol Drug Saf.


Farmer, R. E., Ford, D., Mathur, R., Chaturvedi, N., Kaplan, R., Smeeth, L., & Bhaskaran, K. (2019).

Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care

records using inverse probability weighting of marginal structural models. Int J Epidemiol.

https://doi.org/10.1093/ije/dyz005

Feakins, B., Oke, J., McFadden, E., Aronson, J., Lasserson, D., O\textquoterightCallaghan, C., Taylor,

C., Hill, N., Stevens, R., & Perera, R. (2019). Trends in kidney function testing in UK primary

care since the introduction of the quality and outcomes framework: a retrospective cohort study

using CPRD. BMJ Open, 9(6), e028062. https://doi.org/10.1136/bmjopen-2018-028062

Ferguson, R., Culliford, D., Prieto-Alhambra, D., Pinedo-Villanueva, R., Delmestri, A., Arden, N., &

Bowen, C. (2019). Encounters for foot and ankle pain in UK primary care: a population-based

cohort study of CPRD data. Br J Gen Pract, 69(683), e422–e429.


CPRD bibliography

61

Ferreira, G., Stuurman, A. L., Horsmans, Y., Cattaert, T., Verstraeten, T., Feng, Y., Rosillon, D., &

Guignard, A. (2019). Hepatitis B virus infection and the risk of liver disease progression in type

2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational,

cohort study in the United Kingdom Clinical Practice Research Datalink. Eur J Gastroenterol

Hepatol. https://doi.org/10.1097/meg.0000000000001537

Fiaschi, L., Nelson-Piercy, C., Deb, S., King, R., & Tata, L. J. (2019). Clinical management of nausea

and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a

population based study. Bjog. https://doi.org/10.1111/1471-0528.15662

Field, T. S., Weijs, B., Curcio, A., Giustozzi, M., Sudikas, S., Katholing, A., Wallenhorst, C., Weitz,

J. I., Cohen, A. T., & Martinez, C. (2019). Incident Atrial Fibrillation, Dementia and the Role of

Anticoagulation: A Population-Based Cohort Study. Thromb Haemost. https://doi.org/10.1055/s-

0039-1683429

Filion, K. B., Douros, A., Azoulay, L., Yin, H., Yu, O. H., & Suissa, S. (2019). Sulfonylureas as

initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-

based cohort study. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.14056

Florio, A. A., Graubard, B. I., Yang, B., Thistle, J. E., Bradley, M. C., McGlynn, K. A., & Petrick, J.

L. (2019). Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer

in the Clinical Practice Research Datalink. Eur J Epidemiol. https://doi.org/10.1007/s10654-019-

00526-1

Floyd, J. S., Bloch, K. M., Brody, J. A., Maroteau, C., Siddiqui, M. K., Gregory, R., Carr, D. F.,

Molokhia, M., Liu, X., Bis, J. C., Ahmed, A., Liu, X., Hallberg, P., Yue, Q. Y., Magnusson, P.

K. E., Brisson, D., Wiggins, K. L., Morrison, A. C., Khoury, E., … Alfirevic, A. (2019).

Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-

exome sequencing. PLoS One, 14(6), e0218115. https://doi.org/10.1371/journal.pone.0218115

Forbes, H. J., Wong, A. Y. S., Morton, C., Bhaskaran, K., Smeeth, L., Richards, M., Schmidt, S. A. J.,

Langan, S. M., & Warren-Gash, C. (2019). Partner Bereavement and Detection of Dementia: A

UK-Based Cohort Study Using Routine Health Data. J Alzheimers Dis.

https://doi.org/10.3233/jad-190571

Ford, E., Rooney, P., Oliver, S., Hoile, R., Hurley, P., Banerjee, S., van Marwijk, H., & Cassell, J.

(2019). Identifying undetected dementia in UK primary care patients: a retrospective case-

control study comparing machine-learning and standard epidemiological approaches. BMC Med

Inform Decis Mak, 19(1), 248. https://doi.org/10.1186/s12911-019-0991-9

Fortuny, J., Gilsenan, A., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V, Garcia-Rodriguez,

L., Kollhorst, B., Karlsson, P., Linner, L., MacDonald, T. M., Plana, E., Ruigomez, A., Schink,

T., Ziemiecki, R., & Andrews, E. B. (2019). Study Design and Cohort Comparability in a Study

of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol

3350. Drug Saf. https://doi.org/10.1007/s40264-019-00836-z

Frey, N., Bodmer, M., Bircher, A., Jick, S. S., Meier, C. R., & Spoendlin, J. (2019). Stevens-Johnson

Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in

Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-

Control Study. Drug Saf, 42(1), 55–66. https://doi.org/10.1007/s40264-018-0711-x

Gafoor, R., Charlton, J., Ravindrarajah, R., & Gulliford, M. C. (2019). Importance of Frailty for

Association of Antipsychotic Drug Use with Risk of Fracture: Cohort Study Using Electronic

Health Records. J Am Med Dir Assoc. https://doi.org/10.1016/j.jamda.2019.05.009

CPRD bibliography

62

Gallagher, A. M., Dedman, D., Padmanabhan, S., Leufkens, H. G. M., & de Vries, F. (2019). The

accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database

in England compared with the Office for National Statistics death registrations.


Garcia Rodriguez, L. A., Martin-Perez, M., Vora, P., Roberts, L., Balabanova, Y., Brobert, G.,

Fatoba, S., Suzart-Woischnik, K., Schaefer, B., & Ruigomez, A. (2019). Appropriateness of

initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial

fibrillation in the UK. BMJ Open, 9(9), e031341. https://doi.org/10.1136/bmjopen-2019-031341

Gayle, A. V, Axson, E. L., Bloom, C. I., Navaratnam, V., & Quint, J. K. (2019). Changing causes of

death for patients with chronic respiratory disease in England, 2005-2015. Thorax.


Gayle, A., Dickinson, S., Poole, C., Pang, M., Fauconnot, O., & Quint, J. K. (2019). Incidence of type

II diabetes in chronic obstructive pulmonary disease: a nested case-control study. NPJ Prim

Care Respir Med, 29(1), 28. https://doi.org/10.1038/s41533-019-0138-6

Gayle, A., Tebboth, A., Pang, M., Guelfucci, F., Argoubi, R., Sherman, S., & Mak, V. (2019). Real-

life prescribing of asthmatic treatments in UK general practice over time using 2014 BTS/SIGN

steps. NPJ Prim Care Respir Med, 29(1), 25. https://doi.org/10.1038/s41533-019-0137-7

Gharbi, M., Drysdale, J. H., Lishman, H., Goudie, R., Molokhia, M., Johnson, A. P., Holmes, A. H.,

& Aylin, P. (2019). Antibiotic management of urinary tract infection in elderly patients in

primary care and its association with bloodstream infections and all cause mortality: population

based cohort study. Bmj, 364, l525. https://doi.org/10.1136/bmj.l525

Ghosh, R. E., Crellin, E., Beatty, S., Donegan, K., Myles, P., & Williams, R. (2019). How Clinical

Practice Research Datalink data are used to support pharmacovigilance. Therapeutic Advances

in Drug Safety. https://doi.org/10.1177/2042098619854010

Gieling, E., de Vries, F., Williams, R., van Onzenoort, H. A. W., de Boer, A., Ten Cate, V., Kramers,

C., & Burden, A. (2019). Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and

non-vitamin K antagonists. Int J Clin Pharm. https://doi.org/10.1007/s11096-019-00916-1

Gilbert, C., Allgar, V., & Doran, T. (2019). Workload impact of the Quality and Outcomes

Framework for patients with diabetes: an interrupted time series in general practice. Br J Gen

Pract, 69(685), e570–e577. https://doi.org/10.3399/bjgp19X704645

Gilsenan, A., Fortuny, J., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V, Garcia-Rodriguez,

L., Harding, A., Kollhorst, B., Karlsson, P., Linner, L., MacDonald, T. M., Odsbu, I., Plana, E.,

Ruigomez, A., Schink, T., Ziemiecki, R., & Andrews, E. B. (2019). Cardiovascular Safety of

Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort

Study. Drug Saf. https://doi.org/10.1007/s40264-019-00835-0

Glover, G., Williams, R., Tompkins, G., & Oyinlola, J. (2019). An observational study of the use of

acute hospital care by people with intellectual disabilities in England. J Intellect Disabil Res,

63(2), 85–99. https://doi.org/10.1111/jir.12544

Gompels, M., Michael, S., Davies, C., Jones, T., Macleod, J., & May, M. (2019). Trends in HIV

testing in the UK primary care setting: a 15-year retrospective cohort study from 2000 to 2015.


CPRD bibliography

63

Green, A., Shaddick, G., Charlton, R., Snowball, J., Nightingale, A., Smith, C., Tillett, W., &

McHugh, N. (2019). Modifiable risk factors and the development of psoriatic arthritis in people

with psoriasis. Br J Dermatol. https://doi.org/10.1111/bjd.18227

Gregson, J., Qizilbash, N., Iwagami, M., Douglas, I., Johnson, M., Pearce, N., & Pocock, S. (2019).

Blood pressure and risk of dementia and its subtypes: a historical cohort study with long-term

follow-up in 2.6~million people. Eur J Neurol, 26(12), 1479–1486.

https://doi.org/10.1111/ene.14030

Gulliford, M. C., Juszczyk, D., Prevost, A. T., Soames, J., McDermott, L., Sultana, K., Wright, M.,

Fox, R., Hay, A. D., Little, P., Moore, M., Yardley, L., Ashworth, M., & Charlton, J. (2019).

Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections

in primary care: cluster RCT using electronic health records and cohort study. Health Technol

Assess, 23(11), 1–70. https://doi.org/10.3310/hta23110

Gulliford, M. C., Prevost, A. T., Charlton, J., Juszczyk, D., Soames, J., McDermott, L., Sultana, K.,

Wright, M., Fox, R., Hay, A. D., Little, P., Moore, M. V, Yardley, L., & Ashworth, M. (2019).

Effectiveness and safety of electronically delivered prescribing feedback and decision support

on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial. Bmj,

364, l236. https://doi.org/10.1136/bmj.l236

Han, L., Clegg, A., Doran, T., & Fraser, L. (2019). The impact of frailty on healthcare resource use: a

longitudinal analysis using the Clinical Practice Research Datalink in England. Age Ageing.

https://doi.org/10.1093/ageing/afz088

Harmala, S., O\textquoterightBrien, A., Parisinos, C. A., Direk, K., Shallcross, L., & Hayward, A.

(2019). Development and validation of a prediction model to estimate the risk of liver cirrhosis

in primary care patients with abnormal liver blood test results: protocol for an electronic health

record study in Clinical Practice Research Datalink. Diagn Progn Res, 3, 10.

https://doi.org/10.1186/s41512-019-0056-7

Harris, L., Graham, S., MacLachlan, S., Exuzides, A., & Jacob, S. (2019). Healthcare resource

utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ, 1–7.

https://doi.org/10.1080/13696998.2019.1592180

Hawley, S., Edwards, C. J., Arden, N. K., Delmestri, A., Cooper, C., Judge, A., & Prieto-Alhambra,

D. (2019). Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an

analysis of UK electronic medical records. Semin Arthritis Rheum.

https://doi.org/10.1016/j.semarthrit.2019.08.008

Hazra, N. C., Rudisill, C., Jackson, S. H., & Gulliford, M. C. (2019). Cost-Effectiveness of

Antihypertensive Therapy in Patients Older Than 80 Years: Cohort Study and Markov Model.

Value Health, 22(12), 1362–1369. https://doi.org/10.1016/j.jval.2019.08.001

Hedenmalm, K., Blake, K., Donegan, K., Macia, M. A., Gil, M., Williams, J., Montero, D., Candore,

G., Morales, D., Kurz, X., & Arlett, P. (2019). A European multicentre drug utilisation study of

the impact of regulatory measures on prescribing of codeine for pain in children.


Henderson, A., Iwagami, M., Bottomley, C., Tomlinson, L., Mansfield, K., & Nitsch, D. (2019).

Paediatric acute kidney injury hospital admissions in England 1997{\textendash}2014: burden

and risk factors. Clinical Kidney Journal. https://doi.org/10.1093/ckj/sfz075

CPRD bibliography

64

Henry, M. L., Abdul-Sultan, A., Walker, A. J., West, J., & Humes, D. J. (2019). Duration and

Magnitude of Postoperative Risk of Venous Thromboembolism after Cholecystectomy: A

Population-Based Cohort Study. Dig Surg, 1–7. https://doi.org/10.1159/000496435

Herrett, E., Gadd, S., Jackson, R., Bhaskaran, K., Williamson, E., Van Staa, T., Sofat, R., Timmis, A.,

& Smeeth, L. (2019). Eligibility and subsequent burden of cardiovascular disease of four

strategies for blood pressure-lowering treatment: a retrospective cohort study. Lancet.

https://doi.org/10.1016/s0140-6736(19)31359-5

Hill, N. R., Ayoubkhani, D., McEwan, P., Sugrue, D. M., Farooqui, U., Lister, S., Lumley, M.,

Bakhai, A., Cohen, A. T., O\textquoterightNeill, M., Clifton, D., & Gordon, J. (2019). Predicting

atrial fibrillation in primary care using machine learning. PLoS One, 14(11), e0224582.


Hoile, R., Tabet, N., Smith, H., Bremner, S., Cassell, J., & Ford, E. (2019). Are symptoms of

insomnia in primary care associated with subsequent onset of dementia? A matched

retrospective case-control study. Aging Ment Health, 1–6.

https://doi.org/10.1080/13607863.2019.1695737

Hopkins, C., Williamson, E., Morris, S., Clarke, C. S., Thomas, M., Evans, H., Little, P., Lund, V. J.,

Blackshaw, H., Schilder, A., Philpott, C., Carpenter, J., & Denaxas, S. (2019). Antibiotic usage

in chronic rhinosinusitis: analysis of national primary care electronic health records. Rhinology.

https://doi.org/10.4193/Rhin19.136

Horne, L., Ashfaq, A., MacLachlan, S., Sinsakul, M., Qin, L., LoCasale, R., & Wetmore, J. B. (2019).

Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in

England. BMC Nephrol, 20(1), 85. https://doi.org/10.1186/s12882-019-1250-0

Ibanez, L., Sabate, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C.,

Martin Merino, E., Montero, D., Leon-Munoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle,

R., Aakjaer, M., Andersen, M., De Bruin, M. L., Groenwold, R., … Gardarsdottir, H. (2019).

Incidence of Direct Oral Anticoagulant use in patients with non-valvular atrial fibrillation and

characteristics of users in six European countries (2008-2015): A cross-national drug utilization

study. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.14071

Ismail, N., Jordan, K. P., Kadam, U. T., Edwards, J. J., Kinnaird, T., & Mamas, M. A. (2019).

Bleeding After Hospital Discharge Following Acute Coronary Syndrome: Incidence, Types,

Timing, and Predictors. J Am Heart Assoc, 8(21), e013679.


Itani, T., Martin, R., Rai, D., Jones, T., Taylor, G., Thomas, K., Munafo, M., Davies, N., & Taylor, A.

(2019). Use of varenicline and nicotine replacement therapy in people with and without general

practitioner-recorded dementia: retrospective cohort study of routine electronic medical records.


Itani, T., Rai, D., Jones, T., Taylor, G. M. J., Thomas, K. H., Martin, R. M., Munafo, M. R., Davies,

N. M., & Taylor, A. E. (2019). Long-term effectiveness and safety of varenicline and nicotine

replacement therapy in people with neurodevelopmental disorders: A prospective cohort study.

Sci Rep, 9(1), 19488. https://doi.org/10.1038/s41598-019-54727-5

J, P. H. W., Rigney, U., Blak, B. T., Nolan, S. T., Fenici, P., & Medina, J. (2019). Glycaemic, weight,

and blood pressure changes associated with early versus later treatment intensification with

dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus. Diabetes

Res Clin Pract, 107791. https://doi.org/10.1016/j.diabres.2019.107791

CPRD bibliography

65

Jaggi, A., Nazir, J., Fatoye, F., Siddiqui, E., Choudhury, N., Argoubi, R., Ali, M., de Ridder, D., &

Drake, M. J. (2019). Drug utilization patterns and healthcare resource use and costs in patients

with neurogenic bladder in the United Kingdom: A retrospective primary care database study.

Neurourol Urodyn. https://doi.org/10.1002/nau.23981

Johnson, K. D., Lu, X., & Zhang, D. (2019). Adherence to hepatitis A and hepatitis B multi-dose

vaccination schedules among adults in the United Kingdom: a retrospective cohort study. BMC

Public Health, 19(1), 404. https://doi.org/10.1186/s12889-019-6693-5

Joseph, R. M., van Staa, T. P., Lunt, M., Abrahamowicz, M., & Dixon, W. G. (2019). Exposure

measurement error when assessing current glucocorticoid use using UK primary care electronic

prescription data. Pharmacoepidemiol Drug Saf, 28(2), 179–186.


Kalilani, L., Friesen, D., Boudiaf, N., & Asgharnejad, M. (2019). The characteristics and treatment

patterns of patients with Parkinson{\textquoteright}s disease in the United States and United

Kingdom: A retrospective cohort study. PLoS One, 14(11), e0225723.


Karp, I., Sivaswamy, A., & Booth, C. (2019). Does the use of incretin-based medications increase the

risk of cancer in patients with type-2 diabetes mellitus? Pharmacoepidemiol Drug Saf.


Kasteridis, P., Ride, J., Gutacker, N., Aylott, L., Dare, C., Doran, T., Gilbody, S., Goddard, M.,

Gravelle, H., Kendrick, T., Mason, A., Rice, N., Siddiqi, N., Williams, R., & Jacobs, R. (2019).

Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious

Mental Illness in England. Psychiatr Serv, appips201800504.

https://doi.org/10.1176/appi.ps.201800504

Kimpton, J. E., Carey, I. M., Threapleton, C. J. D., Robinson, A., Harris, T., Cook, D. G., DeWilde,

S., & Baker, E. H. (2019). Longitudinal exposure of English primary care patients to

pharmacogenomic drugs: an analysis to inform design of pre-emptive pharmacogenomic testing.

Br J Clin Pharmacol. https://doi.org/10.1111/bcp.14100

Klil-Drori, A. J., Santella, C., Tascilar, K., Yin, H., Aprikian, A., & Azoulay, L. (2019). Androgen

Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-

Based Cohort Study. Drug Saf. https://doi.org/10.1007/s40264-019-00847-w

Kuan, V., Denaxas, S., Gonzalez- Izquierdo, A., Direk, K., Bhatti, O., Husain, S., Sutaria, S.,

Hingorani, M., Nitsch, D., Parisinos, C. A., Lumbers, T., Mathur, R., Sofat, R., Casas, J. P.,

Wong, I. C. K., Hemingway, H., & Hingorani, A. D. (2019). A chronological map of 308

physical and mental health conditions from 4 million individuals in the English National Health

Service. The Lancet Digital Health. https://doi.org/10.1016/S2589-7500(19)30012-3

Kuo, R. Y. L., Ng, M., Prieto-Alhambra, D., & Furniss, D. (2019). Dupuytren{\textquoteright}s

disease predicts increased all-cause and cancer-specific mortality: analysis of a large cohort from

the UK Clinical Practice Research Datalink. Plast Reconstr Surg.

https://doi.org/10.1097/prs.0000000000006551

Landis S.H., Pimenta J.M., Yang S., Compton C., Barnes N., & Brusselle, G. (2019). Association

between blood eosinophils and acute exacerbation of COPD risk in patients with COPD in

primary care. Respiratory Medicine, 1.

https://doi.org/https://doi.org/10.1016/j.yrmex.2019.100011

CPRD bibliography

66

Lautsch, D., Wang, T., Yang, L., & Rajpathak, S. N. (2019). Prevalence of Established

Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK. Diabetes Ther.

https://doi.org/10.1007/s13300-019-00698-9

Lawson, C. A., Zaccardi, F., Squire, I., Ling, S., Davies, M. J., Lam, C. S. P., Mamas, M. A., Khunti,

K., & Kadam, U. T. (2019). 20-year trends in cause-specific heart failure outcomes by sex,

socioeconomic status, and place of diagnosis: a population-based study. Lancet Public Health,

4(8), e406–e420. https://doi.org/10.1016/s2468-2667(19)30108-2

Lay-Flurrie, S., Mathieu, E., Bankhead, C., Nicholson, B. D., Perera-Salazar, R., Holt, T., Hobbs, F.

D. R., & Salisbury, C. (2019). Patient consultation rate and clinical and NHS outcomes: a cross-

sectional analysis of English primary care data from 2.7 million patients in 238 practices. BMC

Health Serv Res, 19(1), 219. https://doi.org/10.1186/s12913-019-4036-y

Lefeber, G. J., Koek, H. L., Souverein, P. C., Bouvy, M. L., de Boer, A., & Knol, W. (2019). Statins

After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research

Datalink Database. J Am Geriatr Soc. https://doi.org/10.1111/jgs.16227

Lefebvre, C. E., Filion, K. B., Reynier, P., Platt, R. W., & Zappitelli, M. (2019). Primary Care

Prescriptions of Potentially Nephrotoxic Medications in Children with CKD. Clin J Am Soc

Nephrol. https://doi.org/10.2215/cjn.03550319

Leon, L. J., McCarthy, F. P., Direk, K., Gonzalez-Izquierdo, A., Prieto-Merino, D., Casas, J. P., &

Chappell, L. (2019). Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort

of Linked Electronic Health Records: A CALIBER Study. Circulation, 140(13), 1050–1060.


Li, Y., Molter, A., White, A., Welfare, W., Palin, V., Belmonte, M., Ashcroft, D. M., Sperrin, M., &

van Staa, T. P. (2019). Relationship between prescribing of antibiotics and other medicines in

primary care: a cross-sectional study. Br J Gen Pract, 69(678), e42–e51.


Li, Y., Sperrin, M., Belmonte, M., Pate, A., Ashcroft, D. M., & van Staa, T. P. (2019). Do population-

level risk prediction models that use routinely collected health data reliably predict individual

risks? Sci Rep, 9(1), 11222. https://doi.org/10.1038/s41598-019-47712-5

Linde, C., Bakhai, A., Furuland, H., Evans, M., McEwan, P., Ayoubkhani, D., & Qin, L. (2019). Real-

World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia,

and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney

Disease or Heart Failure in the United Kingdom. J Am Heart Assoc, 8(22), e012655.


Linde, C., Qin, L., Bakhai, A., Furuland, H., Evans, M., Ayoubkhani, D., Palaka, E., Bennett, H., &

McEwan, P. (2019). Serum potassium and clinical outcomes in heart failure patients: results of

risk calculations in 21 334 patients in the UK. ESC Heart Fail.

https://doi.org/10.1002/ehf2.12402

Liu, P., McMenamin, U. C., Spence, A. D., Johnston, B. T., Coleman, H. G., & Cardwell, C. R.

(2019). Furosemide use and survival in patients with esophageal or gastric cancer: a population-

based cohort study. BMC Cancer, 19(1), 1017. https://doi.org/10.1186/s12885-019-6242-8

Loo, S. Y., Azoulay, L., Nie, R., Dell\textquoterightAniello, S., Yu, O. H. Y., & Renoux, C. (2019).

Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging

CPRD bibliography

67

men with low testosterone levels: a cohort study. Am J Med.

https://doi.org/10.1016/j.amjmed.2019.03.022

Lowe, K. E., Mansfield, K. E., Delmestri, A., Smeeth, L., Roberts, A., Abuabara, K., Prieto-

Alhambra, D., & Langan, S. M. (2019). Atopic eczema and fracture risk in adults: A population-

based cohort study. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2019.09.015

Macleod, J., Steer, C., Tilling, K., Cornish, R., Marsden, J., Millar, T., Strang, J., & Hickman, M.

(2019). Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in

people receiving opioid agonist treatment: Observational study based on the UK Clinical

Practice Research Datalink and Office for National Statistics death records. PLoS Med, 16(11),


Mansfield, K., Crellin, E., Denholm, R., Quint, J. K., Smeeth, L., Cook, S., & Herrett, E. (2019).

Completeness and validity of alcohol recording in general practice within the UK: a cross-

sectional study. BMJ Open, 9(11), e031537. https://doi.org/10.1136/bmjopen-2019-031537

Marinier, K., Macouillard, P., de Champvallins, M., Deltour, N., Poulter, N., & Mancia, G. (2019).

Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A

propensity score-matched cohort study in the UK Clinical Practice Research Datalink.


Marley, C., El Hahi, Y., Ferreira, G., Woods, L., & Ramirez Villaescusa, A. (2019). Evaluation of a

risk score to predict future Clostridium difficile disease using UK primary care and hospital data

in Clinical Practice Research Datalink. Hum Vaccin Immunother, 1–7.

https://doi.org/10.1080/21645515.2019.1589288

Matharu, G. S., Mouchti, S., Twigg, S., Delmestri, A., Murray, D. W., Judge, A., & Pandit, H. G.

(2019). The effect of smoking on outcomes following primary total hip and knee arthroplasty: a

population-based cohort study of 117,024 patients. Acta Orthop, 1–9.

https://doi.org/10.1080/17453674.2019.1649510

Mattishent, K., Richardson, K., Dhatariya, K., Savva, G. M., Fox, C., & Loke, Y. K. (2019). The

effects of hypoglycemia and dementia on cardiovascular events, falls and fractures and all-cause

mortality in older people - a retrospective cohort study. Diabetes Obes Metab.


McGovern, A. P., Dennis, J. M., Shields, B. M., Hattersley, A. T., Pearson, E. R., & Jones, A. G.

(2019). What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or

continue? A MASTERMIND study. BMC Med, 17(1), 79. https://doi.org/10.1186/s12916-019-

1307-8

Menon, S., Nightingale, P., & Trudgill, N. (2019). Chronic Obstructive Pulmonary Disease and the

Risk of Esophagitis, Barrett Esophagus, and Esophageal Adenocarcinoma: A Primary Care

Case-Control Study. J Clin Gastroenterol. https://doi.org/10.1097/mcg.0000000000001215

Metcalfe, D., Masters, J., Delmestri, A., Judge, A., Perry, D., Zogg, C., Gabbe, B., & Costa, M.

(2019). Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded

databases. BMC Med Res Methodol, 19(1), 115. https://doi.org/10.1186/s12874-019-0753-5

Minassian, C., Williams, R., Meeraus, W. H., Smeeth, L., Campbell, O. M. R., & Thomas, S. L.

(2019). Methods to generate and validate a Pregnancy Register in the UK Clinical Practice

CPRD bibliography

68

Research Datalink primary care database. Pharmacoepidemiol Drug Saf, 28(7), 923–933.


Mitchell, A., Welsh, T. J., Watson, M. C., Snowball, J., & McGrogan, A. (2019). Use of oral

anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a

cohort study using the Clinical Practice Research Datalink (CPRD) database. BMJ Open, 9(12),


Montastruc, F., Nie, R., Loo, S., Rej, S., Dell\textquoterightAniello, S., Micallef, J., Suissa, S., &

Renoux, C. (2019). Association of Aripiprazole With the Risk for Psychiatric Hospitalization,

Self-harm, or Suicide. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2018.4149

Morgan, C. L., Jenkins-Jones, S., Currie, C., & Baxter, G. (2019). Outcomes Associated with

Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK

Primary Care Observational Study. Adv Ther. https://doi.org/10.1007/s12325-019-00932-7

Morley, J., Moayyeri, A., Ali, L., Taylor, A., Feudjo-Tepie, M., Hamilton, L., & Bayly, J. (2019).

Persistence and compliance with osteoporosis therapies among postmenopausal women in the

UK Clinical Practice Research Datalink. Osteoporos Int. https://doi.org/10.1007/s00198-019-

05228-8

Moussa, O. M., Ardissino, M., Kulatilake, P., Faraj, A., Muttoni, E., Darzi, A., Ziprin, P., Scholtz, S.,

& Purkayastha, S. (2019). Effect of body mass index on depression in a UK cohort of 363 037

obese patients: A longitudinal analysis of transition. Clin Obes, e12305.

https://doi.org/10.1111/cob.12305

Moussa, O., Ardissino, M., Tang, A., Lazzari, L., Millar, O., Ziprin, P., Darzi, A., Khan, O., Collins,

P., & Purkayastha, S. (2019). Long-term Impact of Bariatric Surgery on Venous

Thromboembolic Risk: A Matched Cohort Study. Ann Surg.

https://doi.org/10.1097/sla.0000000000003750

Muduma, G., Aluvihare, V., Clancy, M., de Nigris, E., Whitlock, C., Landeira, M., & Nazir, J. (2019).

The Last Year Before Graft Failure Negatively Impacts Economic Outcomes and is Associated

With Greater Healthcare Resource Utilization Compared With Previous Years in the United

Kingdom: Results of a Retrospective Observational Study. Transplant Direct, 5(5), e443.

https://doi.org/10.1097/txd.0000000000000884

Mueller, A. M., Meier, C. R., Jick, S. S., & Schneider, C. (2019). Weight change and blood glucose

concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A

matched case-control study. Pancreatology. https://doi.org/10.1016/j.pan.2019.03.006

Nagra, N. S., Robinson, D. E., Douglas, I., Delmestri, A., Dakin, S. G., Snelling, S. J. B., Carr, A. J.,

& Prieto-Alhambra, D. (2019). Antibiotic treatment and flares of rheumatoid arthritis: a self-

controlled case series study analysis using CPRD GOLD. Sci Rep, 9(1), 8941.

https://doi.org/10.1038/s41598-019-45435-1

Nakafero, G., Grainge, M. J., Myles, P. R., Mallen, C. D., Zhang, W., Doherty, M., Nguyen-Van-

Tam, J. S., & Abhishek, A. (2019). Association between inactivated influenza vaccine and

primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series

study using data from the Clinical Practice Research Datalink. Ann Rheum Dis.


CPRD bibliography

69

Nakafero, G., Grainge, M., Valdes, A., Townsend, N., Mallen, C., Zhang, W., Doherty, M., Mamas,

M. A., & Abhishek, A. (2019). Do beta-adrenoreceptor blocking drugs associate with reduced

risk of symptomatic osteoarthritis and total joint replacement in the general population? A

primary care-based, prospective cohort study using the Clinical Practice Research Datalink. BMJ


Newlove-Delgado, T., Ford, T. J., Hamilton, W., Janssens, A., Stein, K., & Ukoumunne, O. C. (2019).

Resumption of attention-deficit hyperactivity disorder medication in early adulthood: findings

from a UK primary care prescribing study. Eur Child Adolesc Psychiatry.

https://doi.org/10.1007/s00787-019-01325-5

Newlove-Delgado, T., Hamilton, W., Ford, T. J., Stein, K., & Ukoumunne, O. C. (2019). Prescribing

for young people with attention deficit hyperactivity disorder in UK primary care: analysis of

data from the Clinical Practice Research Datalink. Atten Defic Hyperact Disord.

https://doi.org/10.1007/s12402-019-00288-6

Nielen, J. T. H., Dagnelie, P. C., Boonen, A., Klungel, O., van den Bemt, B., & de Vries, F. (2019).

Impact of the definition of osteoarthritis and of the timing of its onset on the association between

type 2 diabetes mellitus and osteoarthritis: Clinical Practice Research Datalink. Diabetes Res

Clin Pract, 148, 240–248. https://doi.org/10.1016/j.diabres.2019.01.021

Nissen, F., Douglas, I. J., Mullerova, H., Pearce, N., Bloom, C. I., Smeeth, L., & Quint, J. K. (2019).

Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients

(Clinical Practice Research Datalink). J Asthma Allergy, 12, 7–19.

https://doi.org/10.2147/jaa.s182013

Nowakowska, M., Van Staa, T., Molter, A., Ashcroft, D. M., Tsang, J. Y., White, A., Welfare, W., &

Palin, V. (2019). Antibiotic choice in UK general practice: rates and drivers of potentially

inappropriate antibiotic prescribing. J Antimicrob Chemother. https://doi.org/10.1093/jac/dkz345

Nowakowska, M., Zghebi, S. S., Ashcroft, D. M., Buchan, I., Chew-Graham, C., Holt, T., Mallen, C.,

van Marwijk, H., Peek, N., Perera-Salazar, R., Reeves, D., Rutter, M. K., Weng, S. F., Qureshi,

N., Mamas, M. A., & Kontopantelis, E. (2019). The comorbidity burden of type 2 diabetes

mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med,

17(1), 145. https://doi.org/10.1186/s12916-019-1373-y

O\textquoterightConnell, N. E., Smith, K. J., Peterson, M. D., Ryan, N., Liverani, S., Anokye, N.,

Victor, C., & Ryan, J. M. (2019). Incidence of osteoarthritis, osteoporosis and inflammatory

musculoskeletal diseases in adults with cerebral palsy: A population-based cohort study. Bone,

125, 30–35. https://doi.org/10.1016/j.bone.2019.05.007

on Hormonal Factors in Breast Cancer, C. G. (2019). Type and timing of menopausal hormone

therapy and breast cancer risk: individual participant meta-analysis of the worldwide

epidemiological evidence. Lancet, 394(10204), 1159–1168. https://doi.org/10.1016/s0140-

6736(19)31709-x

Oshagbemi, O. A., Franssen, F. M. E., van Kraaij, S., Braeken, D. C. W., Wouters, E. F. M., der Zee,

A. H., Driessen, J. H. M., & de Vries, F. (2019). Blood Eosinophil Counts, Withdrawal of

Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice

Research Datalink (CPRD). Copd, 1–8. https://doi.org/10.1080/15412555.2019.1608172

Oshagbemi, O. A., Franssen, F. M. E., Wouters, E. F. M., der Zee, A. H., Driessen, J. H. M., de Boer,

A., & de Vries, F. (2019). C-reactive protein as a biomarker of response to inhaled

CPRD bibliography

70

corticosteroids among patients with COPD. Pulm Pharmacol Ther, 101870.

https://doi.org/10.1016/j.pupt.2019.101870

Ozawa, M., Brennan, P. M., Zienius, K., Kurian, K. M., Hollingworth, W., Weller, D., Grant, R.,

Hamilton, W., & Ben-Shlomo, Y. (2019). The usefulness of symptoms alone or combined for

general practitioners in considering the diagnosis of a brain tumour: a case-control study using

the clinical practice research database (CPRD) (2000-2014). BMJ Open, 9(8), e029686.


Palin, V., Molter, A., Belmonte, M., Ashcroft, D. M., White, A., Welfare, W., & Van Staa, T. (2019).

Antibiotic prescribing for common infections in UK general practice: variability and drivers. J

Antimicrob Chemother. https://doi.org/10.1093/jac/dkz163

Pate, A., Emsley, R., Ashcroft, D. M., Brown, B., & Van Staa, T. (2019). The uncertainty with using

risk prediction models for individual decision making: an exemplar cohort study examining the

prediction of cardiovascular disease in English primary care. BMC Med, 17(1), 134.

https://doi.org/10.1186/s12916-019-1368-8

Patel, H. C., Hayward, C., Patel, K. S., Claggett, B., Vazir, A., & Cowie, M. R. (2019). Impact on

survival of combination inhalers in patients with COPD at high risk of cardiovascular events. Int

J Cardiol. https://doi.org/10.1016/j.ijcard.2019.11.138

Persson, R., & Jick, S. (2019). Clinical implications of the association between fluoroquinolones and

tendon rupture: the magnitude of the effect with and without corticosteroids. Br J Clin


Persson, R., Lee, S., Yood, M. U., Wagner, M., Minton, N., Niemcryk, S., Lindholm, A., Evans, A.,

& Jick, S. (2019). Multi-database study of multiple sclerosis: identification, validation and

description of MS patients in two countries. J Neurol. https://doi.org/10.1007/s00415-019-

09238-8

Pikoula, M., Quint, J. K., Nissen, F., Hemingway, H., Smeeth, L., & Denaxas, S. (2019). Identifying

clinically important COPD sub-types using data-driven approaches in primary care population

based electronic health records. BMC Med Inform Decis Mak, 19(1), 86.

https://doi.org/10.1186/s12911-019-0805-0

Powell, G., Logan, J., Kiri, V., & Borghs, S. (2019). Trends in antiepileptic drug treatment and

effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study

using electronic medical records. BMJ Open, 9(12), e032551. https://doi.org/10.1136/bmjopen-

2019-032551

Pradhan, R., Yin, H., Yu, O. H. Y., & Azoulay, L. (2019). The Use of Long-Acting Insulin Analogs

and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based

Cohort Study. Drug Saf. https://doi.org/10.1007/s40264-019-00892-5

Price, D. B., Carter, V., Martin, J., Gardener, E. A., Skinner, D., Yang, S., Hoffman, M., Willis, J. C.,

& Cooper, A. J. (2019). Comparative Safety Profile of the Fixed-Dose Combination

Corticosteroid and Long-acting beta2-Agonist Fluticasone Propionate/Formoterol Fumarate: A

36-Month Longitudinal Cohort Study in UK Primary Care. Drugs.

https://doi.org/10.1007/s40265-019-01224-8

Pufulete, M., Harris, J., Sterne, J. A. C., Johnson, T. W., Lasserson, D., Mumford, A., Doble, B.,

Wordsworth, S., Benedetto, U., Rogers, C. A., Loke, Y., Pithara, C., Redwood, S., & Reeves, B.

CPRD bibliography

71

C. (2019). Comprehensive ascertainment of bleeding in patients prescribed different

combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study

protocol for three population-based cohort studies emulating {\textquoteright}target

trials{\textquoteright} (the ADAPTT Stu. BMJ Open, 9(6), e029388.


Qian, Y., & Jick, S. (2019). Proton pump inhibitor use and myocardial infarction: a nested study in the

UK Clinical Practice Research Datalink. Epidemiology.

https://doi.org/10.1097/ede.0000000000001152

Rafiq, M., Hayward, A., Warren-Gash, C., Denaxas, S., Gonzalez-Izquierdo, A., Lyratzopoulos, G., &

Thomas, S. (2019). Allergic disease, corticosteroid use and risk of Hodgkin{\textquoteright}s

lymphoma: A UK Nationwide case-control study. J Allergy Clin Immunol.

https://doi.org/10.1016/j.jaci.2019.10.033

Rafiq, M., Hayward, A., Warren-Gash, C., Denaxas, S., Gonzalez-Izquierdo, A., Lyratzopoulos, G., &

Thomas, S. (2019). Socioeconomic deprivation and regional variation in

Hodgkin{\textquoteright}s lymphoma incidence in the UK: a population-based cohort study of

10 million individuals. BMJ Open, 9(9), e029228. https://doi.org/10.1136/bmjopen-2019-

029228

Ramagopalan, S. V, Carroll, R., Ulvestad, M., Mehmud, F., & Alikhan, R. (2019). The changing face

of venous thromboembolism management in England. Future Cardiol.

https://doi.org/10.2217/fca-2019-0003

Ramagopalan, S. V, Graham, S., Carroll, R., Raluy-Callado, M., Nordstrom, B. L., Donaldson, R.,

Colby, C., Mehmud, F., & Alikhan, R. (2019). Discontinuation and primary care visits in

nonvalvular atrial fibrillation patients treated with apixaban or warfarin. J Comp Eff Res.

https://doi.org/10.2217/cer-2019-0005

Ramagopalan, S. V, Samnaliev, M., Weir, S., Sammon, C. J., Carroll, R., & Alikhan, R. (2019). Costs

of gastrointestinal bleeding events in atrial fibrillation: a UK Clinical Practice Research Datalink

study. Future Cardiol. https://doi.org/10.2217/fca-2019-0033

Ramagopalan, S. V, Stamp, E., Sammon, C. J., Besford, M., Carroll, R., Mehmud, F., & Alikhan, R.

(2019). Renal function and oral anticoagulant treatment of incident non-valvular atrial

fibrillation: a retrospective study. Future Cardiol. https://doi.org/10.2217/fca-2019-0012

Ramtoola, S., Nyeland, M. E., Jacobsen, J., Ploug, U. J., Kragh, N., & Zimmermann, E. (2019).

Characteristics of newly diagnosed adults with type 1 diabetes in the UK and evolution of

glycaemic control, body mass index and Charlson comorbidity index over the first 5 years after

diagnosis. Prim Care Diabetes. https://doi.org/10.1016/j.pcd.2019.09.009

Rao, A., Kim, D., Darzi, A., Majeed, A., Aylin, P., & Bottle, A. (2019). Regional variations in

trajectories of long-term readmission rates among patients in England with heart failure. BMC

Cardiovasc Disord, 19(1), 86. https://doi.org/10.1186/s12872-019-1057-8

Rassen, J. A., Bartels, D. B., Schneeweiss, S., Patrick, A. R., & Murk, W. (2019). Measuring

prevalence and incidence of chronic conditions in claims and electronic health record databases.

Clin Epidemiol, 11, 1–15. https://doi.org/10.2147/clep.s181242

Rebordosa, C., Aguado, J., Plana, E., Thomas, S., Frances, A., Lei, A., Garcia-Gil, E., Nuevo, J.,

Perez-Gutthann, S., & Castellsague, J. (2019). Use of aclidinium did not increase the risk of

CPRD bibliography

72

death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD),

United Kingdom. Respir Med, 152, 37–43. https://doi.org/10.1016/j.rmed.2019.04.018

Rees, J. L., Shah, A., Edwards, K., Sanchez-Santos, M. T., Robinson, D. E., Delmestri, A., Carr, A.,

Arden, N., Lamb, S. E., Rangan, A., Judge, A., Pinedo-Villanueva, R., Holt, T., Hopewell, S.,

Prieto-Alhambra, D., & Collins, G. (2019). Treatment of first-time traumatic anterior shoulder

dislocation: the UK TASH-D cohort study. Health Technol Assess, 23(18), 1–104.

https://doi.org/10.3310/hta23180

Renzi, C., Lyratzopoulos, G., Hamilton, W., Maringe, C., & Rachet, B. (2019). Contrasting effects of

comorbidities on emergency colon cancer diagnosis: a longitudinal data-linkage study in

England. BMC Health Serv Res, 19(1), 311. https://doi.org/10.1186/s12913-019-4075-4

Renzi, C., Lyratzopoulos, G., Hamilton, W., & Rachet, B. (2019). Opportunities for reducing

emergency diagnoses of colon cancer in women and men: A data-linkage study on pre-

diagnostic symptomatic presentations and benign diagnoses. Eur J Cancer Care (Engl), 28(2),

e13000. https://doi.org/10.1111/ecc.13000

Richardson, K., Mattishent, K., Loke, Y. K., Steel, N., Fox, C., Grossi, C. M., Bennett, K., Maidment,

I., Boustani, M., Matthews, F. E., Myint, P. K., Campbell, N. L., Brayne, C., Robinson, L., &

Savva, G. M. (2019). History of Benzodiazepine Prescriptions and Risk of Dementia: Possible

Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control

Study. Am J Epidemiol, 188(7), 1228–1236. https://doi.org/10.1093/aje/kwz073

Ride, J., Kasteridis, P., Gutacker, N., Doran, T., Rice, N., Gravelle, H., Kendrick, T., Mason, A.,

Goddard, M., Siddiqi, N., Gilbody, S., Williams, R., Aylott, L., Dare, C., & Jacobs, R. (2019).

Impact of family practice continuity of care on unplanned hospital use for people with serious

mental illness. Health Serv Res. https://doi.org/10.1111/1475-6773.13211

Rockenschaub, P., Hayward, A., & Shallcross, L. (2019). Antibiotic prescribing before and after the

diagnosis of comorbidity: a cohort study using primary care electronic health records. Clin Infect

Dis. https://doi.org/10.1093/cid/ciz1016

Rockenschaub, P., Jhass, A., Freemantle, N., Aryee, A., Rafiq, M., Hayward, A., & Shallcross, L.

(2019). Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a

cohort study using electronic health records from the Clinical Practice Research Datalink

(CPRD). J Antimicrob Chemother. https://doi.org/10.1093/jac/dkz411

Root, A., Brown, J. P., Forbes, H. J., Bhaskaran, K., Hayes, J., Smeeth, L., & Douglas, I. J. (2019).

Association of Relative Age in the School Year With Diagnosis of Intellectual Disability,

Attention-Deficit/Hyperactivity Disorder, and Depression. JAMA Pediatr.

https://doi.org/10.1001/jamapediatrics.2019.3194

Ryan, J. M., Peterson, M. D., Matthews, A., Ryan, N., Smith, K. J., O\textquoterightConnell, N. E.,

Liverani, S., Anokye, N., Victor, C., & Allen, E. (2019). Noncommunicable disease among

adults with cerebral palsy: A matched cohort study. Neurology.

https://doi.org/10.1212/wnl.0000000000008199

Ryan, J. M., Peterson, M. D., Ryan, N., Smith, K. J., O\textquoterightConnell N, E., Liverani, S.,

Anokye, N., Victor, C., & Allen, E. (2019). Mortality due to cardiovascular disease, respiratory

disease, and cancer in adults with cerebral palsy. Dev Med Child Neurol.

https://doi.org/10.1111/dmcn.14176

CPRD bibliography

73

Sabido, M., Thilo, H., & Guido, G. (2019). Long-term effectiveness of bisoprolol in patients with

angina: A real-world evidence study. Pharmacol Res, 139, 106–112.

https://doi.org/10.1016/j.phrs.2018.10.031

Saine, M. E., Carbonari, D. M., Newcomb, C. W., Gallagher, A. M., Blak, B. T., Roy, J. A., Wood, J.,

Cardillo, S., Hennessy, S., Strom, B. L., & Lo Re V., 3rd. (2019). Concordance of

hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode

Statistics among patients treated with oral antidiabetic therapies. Pharmacoepidemiol Drug Saf.


Santella, C., Renoux, C., Yin, H., Yu, O. H. Y., & Azoulay, L. (2019). Testosterone Replacement

Therapy and the Risk of Prostate Cancer in Men with Late-Onset Hypogonadism. Am J

Epidemiol. https://doi.org/10.1093/aje/kwz138

Schonmann, Y., Mansfield, K. E., Hayes, J. F., Abuabara, K., Roberts, A., Smeeth, L., & Langan, S.

M. (2019). Atopic eczema in adulthood and risk of depression and anxiety: a population-based

cohort study. J Allergy Clin Immunol Pract. https://doi.org/10.1016/j.jaip.2019.08.030

Schultze, A., Graham, S., Nordstrom, B. L., Mehmud, F., & Ramagopalan, S. V. (2019). Commonly

used definitions in real-world studies may underestimate the prevalence of renal disease among

nonvalvular atrial fibrillation patients. J Comp Eff Res. https://doi.org/10.2217/cer-2019-0070

Scott, J., Jones, T., Redaniel, M. T., May, M. T., Ben-Shlomo, Y., & Caskey, F. (2019). Estimating

the risk of acute kidney injury associated with use of diuretics and renin angiotensin aldosterone

system inhibitors: A population based cohort study using the clinical practice research datalink.

BMC Nephrol, 20(1), 481. https://doi.org/10.1186/s12882-019-1633-2

Scott, L. A., Berni, T. R., Berni, E. R., De Vries, J., & Currie, C. J. (2019). Evaluation of the

healthcare resource use and the related financial costs of managing peanut allergy in the United

Kingdom. Expert Rev Clin Immunol, 15(8), 889–896.

https://doi.org/10.1080/1744666x.2019.1641406

Scott, L. A., Jones, B. I., Berni, T. R., Berni, E. R., De Vries, J., & Currie, C. J. (2019). Evaluation of

the epidemiology of peanut allergy in the United Kingdom. Expert Rev Clin Immunol, 15(12),

1333–1339. https://doi.org/10.1080/1744666x.2020.1693264

Secrest, M. H., Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., Doyle, C. M.,

Dell\textquoterightAniello, S., & Filion, K. B. (2019). Extreme restriction design as a method

for reducing confounding by indication in pharmacoepidemiologic research.


Secrest, M. H., Platt, R. W., Reynier, P., Dormuth, C. R., Benedetti, A., & Filion, K. B. (2019).

Multiple imputation for systematically missing confounders within a distributed data drug safety

network: A simulation study and real-world example. Pharmacoepidemiol Drug Saf.


Shah, A. D., Bailey, E., Williams, T., Denaxas, S., Dobson, R., & Hemingway, H. (2019). Natural

language processing for disease phenotyping in UK primary care records for research: a pilot

study in myocardial infarction and death. J Biomed Semantics, 10(Suppl 1), 20.

https://doi.org/10.1186/s13326-019-0214-4

CPRD bibliography

74

Shephard, E. A., Parkinson, M. A., & Hamilton, W. T. (2019). Recognising laryngeal cancer in

primary care: a large case-control study using electronic records. Br J Gen Pract, 69(679),


Shiekh, S. I., Forbes, H., Mathur, R., Smeeth, L., Pearce, N., & Warren-Gash, C. (2019). Ethnicity

and risk of diagnosed dementia after stroke: a cohort study using the Clinical Practice Research

Datalink. J Epidemiol Community Health. https://doi.org/10.1136/jech-2019-212825

Shields, B. M., Hattersley, A. T., & Farmer, A. J. (2019). Identifying routine clinical predictors of

non-adherence to second line therapies in Type 2 diabetes: a retrospective cohort analysis in a

large primary care database. Diabetes Obes Metab. https://doi.org/10.1111/dom.13865

Sinnott, S. J., Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., & Douglas, I. J.

(2019). The comparative effectiveness of fourth-line drugs in resistant hypertension: An

application in electronic health record data. Pharmacoepidemiol Drug Saf.


Smith, K. J., Peterson, M. D., O\textquoterightConnell, N. E., Victor, C., Liverani, S., Anokye, N., &

Ryan, J. M. (2019). Risk of Depression and Anxiety in Adults With Cerebral Palsy. JAMA

Neurol, 76(3), 294–300. https://doi.org/10.1001/jamaneurol.2018.4147

Smith, R., Han, L., Ali, S., Prady, S. L., Taylor, J., Hughes, T., Ajjan, R. A., Siddiqi, N., & Doran, T.

(2019). Glucose, cholesterol and blood pressure in type II diabetes: A longitudinal observational

study comparing patients with and without severe mental illness. J Psychiatr Ment Health Nurs.

https://doi.org/10.1111/jpm.12546

Spanopoulos, D., Busse, M., Webb, J., Tebboth, A., Gollop, N. D., & Marcus, M. W. (2019). DPP-4

Inhibitor Dose Selection According to Manufacturer Specifications: A Contemporary

Experience From UK General Practice. Clin Ther, 41(8), 1622–1630.


Spanopoulos, D., Okhai, H., Zaccardi, F., Tebboth, A., Barrett, B., Busse, M., Webb, J., & Khunti, K.

(2019). Temporal variation of renal function in people with type 2 diabetes mellitus: a

retrospective UK Clinical Practice Research Datalink cohort study. Diabetes Obes Metab.


Stack, A. G., Johnson, M. E., Blak, B., Klein, A., Carpenter, L., Morlock, R., Maguire, A. R., &

Parsons, V. L. (2019). Gout and the risk of advanced chronic kidney disease in the UK health

system: a national cohort study. BMJ Open, 9(8), e031550. https://doi.org/10.1136/bmjopen-

2019-031550

Steer, C. D., Macleod, J., Tilling, K., Lim, A. G., Marsden, J., Millar, T., Strang, J., Telfer, M.,

Whitaker, H., Vickerman, P., & Hickman, M. (2019). The impact of opiate substitution

treatment on mortality risk in drug addicts: a natural experiment study. Health Services and

Delivery Research, 7. https://doi.org/10.3310/hsdr07030

Stohler, N. A., Reinau, D., Jick, S. S., Bodmer, D., & Meier, C. R. (2019). A study on the

epidemiology of tinnitus in the United Kingdom. Clin Epidemiol, 11, 855–871.


Stolz, D., Kostikas, K., Loefroth, E., Fogel, R., Gutzwiller, F. S., Conti, V., Cao, H., & Clemens, A.

(2019). Differences in COPD exacerbation risk between women and men: analysis from the UK

Clinical Practice Research Datalink data. Chest. https://doi.org/10.1016/j.chest.2019.04.107

CPRD bibliography

75

Strongman, H., Brown, A., Smeeth, L., & Bhaskaran, K. (2019). Body mass index and

Hodgkin{\textquoteright}s lymphoma: UK population-based cohort study of 5.8 million

individuals. Br J Cancer. https://doi.org/10.1038/s41416-019-0401-1

Strongman, H., Gadd, S., Matthews, A., Mansfield, K. E., Stanway, S., Lyon, A. R., dos-Santos-Silva,

I., Smeeth, L., & Bhaskaran, K. (2019). Medium and long-term risks of specific cardiovascular

diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked

UK electronic health records databases. Lancet. https://doi.org/10.1016/s0140-6736(19)31674-5

Strongman, H., Williams, R., Meeraus, W., Murray-Thomas, T., Campbell, J., Carty, L., Dedman, D.,

Gallagher, A., Oyinlola, J., Kousoulis, A., & Valentine, J. (2019). Limitations for health

research with restricted data collection from UK primary care. Pharmacoepidemiol Drug Saf.


Suissa, S., Dell\textquoterightAniello, S., & Ernst, P. (2019). Comparative effectiveness and safety of

LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice. Chest.


Suissa, S., Dell\textquoterightAniello, S., & Ernst, P. (2019). Comparative effects of LAMA-LABA-

ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-

LABA-ICS versus LAMA-LABA in COPD. Chest. https://doi.org/10.1016/j.chest.2019.11.007

Sultan, A. A., Mallen, C., Muller, S., Hider, S., Scott, I., Helliwell, T., & Hall, L. J. (2019). Antibiotic

use and the risk of rheumatoid arthritis: a population-based case-control study. BMC Med, 17(1),

154. https://doi.org/10.1186/s12916-019-1394-6

Sultan, A. A., Muller, S., Whittle, R., Roddy, E., Mallen, C., & Clarson, L. (2019). Venous

thromboembolism in patients with gout and the impact of hospital admission, disease duration

and urate-lowering therapy. Cmaj, 191(22), E597-e603. https://doi.org/10.1503/cmaj.180717

Sumilo, D., Nirantharakumar, K., Willis, B. H., Rudge, G., Martin, J., Gokhale, K., Thayakaran, R.,

Adderley, N. J., Chandan, J. S., Okoth, K., Hewston, R., Skrybant, M., Deeks, J. J., &

Brocklehurst, P. (2019). Long-term impact of giving antibiotics before skin incision versus after

cord clamping on children born by caesarean section: protocol for a longitudinal study based on

UK electronic health records. BMJ Open, 9(9), e033013. https://doi.org/10.1136/bmjopen-2019-

033013

Sun, X., Douiri, A., & Gulliford, M. (2019). Pneumonia incidence trends in UK primary care from

2002 to 2017: population-based cohort study. Epidemiol Infect, 147, e263.

https://doi.org/10.1017/s0950268819001559

Sun, X., & Gulliford, M. C. (2019). Reducing antibiotic prescribing in primary care in England from

2014 to 2017: population-based cohort study. BMJ Open, 9(7), e023989.


Tammes, P., Payne, R. A., Salisbury, C., Chalder, M., Purdy, S., & Morris, R. W. (2019). The impact

of a named GP scheme on continuity of care and emergency hospital admission: a cohort study

among older patients in England, 2012-2016. BMJ Open, 9(9), e029103.


Tanke, M. A. C., Feyman, Y., Bernal-Delgado, E., Deeny, S. R., Imanaka, Y., Jeurissen, P., Lange,

L., Pimperl, A., Sasaki, N., Schull, M., Wammes, J. J. G., Wodchis, W. P., & Meyer, G. S.

CPRD bibliography

76

(2019). A challenge to all. A primer on inter-country differences of high-need, high-cost

patients. PLoS One, 14(6), e0217353. https://doi.org/10.1371/journal.pone.0217353

Tannen, R. L., Barnhart, K. T., & Rubin, J. C. (2019). Advantages of large medical record database

for outcomes research: Insights into post-menopausal hormone therapy. Learn Health Syst, 3(3),

e10193. https://doi.org/10.1002/lrh2.10193

Tao, Y., & Fu, H. (2019). Doubly robust estimation of the weighted average treatment effect for a

target population. Stat Med, 38(3), 315–325. https://doi.org/10.1002/sim.7980

Taylor, C. J., Ordonez-Mena, J. M., Roalfe, A. K., Lay-Flurrie, S., Jones, N. R., Marshall, T., &

Hobbs, F. D. R. (2019). Trends in survival after a diagnosis of heart failure in the United

Kingdom 2000-2017: population based cohort study. Bmj, 364, l223.

https://doi.org/10.1136/bmj.l223

Tiffin, P. A., Mediavilla, J. L., Close, H., Kasim, A. S., Welsh, P., Paton, L. W., & Mason, J. M.

(2019). What were the impacts of the Committee on Safety of Medicines warning and

publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing

in primary care? A population based study. BMJ Open, 9(8), e028201.


Touya, M., Lamy, F. X., Tanasescu, A., Saragoussi, D., Francois, C., Wade, A. G., Llorca, P. M.,

Lancon, C., & Falissard, B. (2019). Creation and validation of a linear index to measure the

health state of patients with depression in automated healthcare databases. J Mark Access Health

Policy, 7(1), 1674115. https://doi.org/10.1080/20016689.2019.1674115

Tran-Duy, A., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A.,

Hoes, A. W., de Vries, F., & de Boer, A. (2019). Use of proton pump inhibitors and risk of iron

deficiency: a population-based case-control study. J Intern Med, 285(2), 205–214.

https://doi.org/10.1111/joim.12826

Troelsen, F. S., & Jick, S. (2019). Antibiotic Use in Childhood and Adolescence and Risk of

Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research

Datalink. Inflamm Bowel Dis. https://doi.org/10.1093/ibd/izz137

Uijl, A., Koudstaal, S., Direk, K., Denaxas, S., Groenwold, R. H. H., Banerjee, A., Hoes, A. W.,

Hemingway, H., & Asselbergs, F. W. (2019). Risk factors for incident heart failure in age- and

sex-specific strata: a population-based cohort using linked electronic health records. Eur J Heart

Fail. https://doi.org/10.1002/ejhf.1350

van Hecke, O., Fuller, A., Bankhead, C., Jenkins-Jones, S., Francis, N., Moore, M., Butler, C., &

Wang, K. (2019). Antibiotic exposure and {\textquoteright}response failure{\textquoteright} for

subsequent respiratory tract infections: an observational cohort study of UK preschool children

in primary care. Br J Gen Pract, 69(686), e638–e646. https://doi.org/10.3399/bjgp19X705089

Vavanikunnel, J., Charlier, S., Becker, C., Schneider, C., Jick, S. S., Meier, C. R., & Meier, C. (2019).

Association between glycemic control and risk of fracture in diabetic patients: A nested case-

control study. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2018-01879

Venkatesan, S., Jorgensen, M. E., Manning, H. J., Andersson, C., Mozid, A. M., Coburn, M.,

Moonesinghe, S. R., Foex, P., Mythen, M., Grocott, M. P. W., Hardman, J. G., Myles, P. R., &

Sanders, R. D. (2019). Preoperative chronic beta-blocker prescription in elderly patients as a risk

CPRD bibliography

77

factor for postoperative mortality stratified by preoperative blood pressure: a cohort study. Br J

Anaesth. https://doi.org/10.1016/j.bja.2019.03.042

Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and

risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD

databases. Bmj, 364, k4810. https://doi.org/10.1136/bmj.k4810

Vogelmeier, C. F., Kostikas, K., Fang, J., Tian, H., Jones, B., Morgan, C. L., Fogel, R., Gutzwiller, F.

S., & Cao, H. (2019). Evaluation of exacerbations and blood eosinophils in UK and US COPD

populations. Respir Res, 20(1), 178. https://doi.org/10.1186/s12931-019-1130-y

Voorham, J., Xu, X., Price, D. B., Golam, S., Davis, J., Zhi Jie Ling, J., Kerkhof, M., Ow, M., &

Tran, T. N. (2019). Healthcare resource utilization and costs associated with incremental

systemic corticosteroid exposure in asthma. Allergy, 74(2), 273–283.

https://doi.org/10.1111/all.13556

Walker, J. L., Zhao, H., Dabrera, G., Andrews, N., Thomas, S. L., Tsang, C., Ellis, J., Donati, M., &

Pebody, R. G. (2019). Assessment of Effectiveness of Seasonal Influenza Vaccination During

Pregnancy in Preventing Influenza Infection in Infants in England, 2013-2014 and 2014-2015. J

Infect Dis. https://doi.org/10.1093/infdis/jiz310

Watson, J., Jones, H. E., Banks, J., Whiting, P., Salisbury, C., & Hamilton, W. (2019). Use of

multiple inflammatory marker tests in primary care: using Clinical Practice Research Datalink to

evaluate accuracy. Br J Gen Pract, 69(684), e462–e469. https://doi.org/10.3399/bjgp19X704309

Watson, J., Salisbury, C., Banks, J., Whiting, P., & Hamilton, W. (2019). Predictive value of

inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using

electronic health records. Br J Cancer. https://doi.org/10.1038/s41416-019-0458-x

Watson, J., Salisbury, C., Whiting, P., Banks, J., Pyne, Y., & Hamilton, W. (2019). Added value and

cascade effects of inflammatory marker tests in UK primary care: a cohort study from the

Clinical Practice Research Datalink. Br J Gen Pract, 69(684), e470–e478.


Wei, L., Lai, E. C., Kao-Yang, Y. H., Walker, B. R., MacDonald, T. M., & Andrew, R. (2019).

Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors:

population based cohort study. Bmj, 365, l1204. https://doi.org/10.1136/bmj.l1204

Weir, S., Kuo, T. C., Samnaliev, M., Tierney, T. S., Manca, A., Taylor, R. S., Bruce, J., Eldabe, S., &

Cumming, D. (2019). Reoperation following lumbar spinal surgery: costs and outcomes in a UK

population cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital

Episode Statistics (HES). Eur Spine J. https://doi.org/10.1007/s00586-018-05871-5

Weldegiorgis, M., Smith, M., Herrington, W. G., Bankhead, C., & Woodward, M. (2019).

Socioeconomic disadvantage and the risk of advanced chronic kidney disease: results from a

cohort study with 1.4 million participants. Nephrology Dialysis Transplantation.

https://doi.org/10.1093/ndt/gfz059

Wetmore, J. B., Yan, H., Horne, L., Peng, Y., & Gilbertson, D. T. (2019). Risk of hyperkalemia from

renin-angiotensin-aldosterone system inhibitors and factors associated with treatment

discontinuities in a real-world population. Nephrol Dial Transplant.

https://doi.org/10.1093/ndt/gfz263

CPRD bibliography

78

Whittaker, H. R., Mullerova, H., Jarvis, D., Barnes, N. C., Jones, P. W., Compton, C. H., Kiddle, S. J.,

& Quint, J. K. (2019). Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients

with COPD in a large UK primary health care setting. Int J Chron Obstruct Pulmon Dis, 14,

1063–1073. https://doi.org/10.2147/copd.s200919

Whittaker, H., Connell, O., Campbell, J., Elbehairy, A. F., Hopkinson, N. S., & Quint, J. K. (2019).

Eligibility for Lung Volume Reduction Surgery in Chronic Obstructive Pulmonary Disease

patients identified in a UK primary care setting. Chest.


Williams, R., Kothny, W., Serban, C., Lopez-Leon, S., de Vries, F., & Schlienger, R. (2019).

Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic

toxicity, and serious infections in patients with type 2 diabetes mellitus: A European

multidatabase, noninterventional, postauthorization safety study. Endocrinol Diabetes Metab,

2(3), e00084. https://doi.org/10.1002/edm2.84

Williams, R., Kothny, W., Serban, C., Lopez-Leon, S., & Schlienger, R. (2019). Pancreatic safety of

vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional,

postauthorization safety study. Endocrinol Diabetes Metab, 2(2), e00052.

https://doi.org/10.1002/edm2.52

Williamson, E., Denaxas, S., Morris, S., Clarke, C. S., Thomas, M., Evans, H., Direk, K., Gonzalez-

Izquierdo, A., Little, P., Lund, V., Blackshaw, H., Schilder, A., Philpott, C., Hopkins, C., &

Carpenter, J. (2019). Risk of mortality and cardiovascular events following macrolide

prescription in chronic rhinosinusitis patients: a cohort study using linked primary care

electronic health records. Rhinology. https://doi.org/10.4193/Rhin18.237

Wolf, A., Dedman, D., Campbell, J., Booth, H., Lunn, D., Chapman, J., & Myles, P. (2019). Data

resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol.

https://doi.org/10.1093/ije/dyz034

Wong, A. Y. S., Froslev, T., Forbes, H. J., Kjaersgaard, A., Mulick, A., Mansfield, K., Silverwood, R.

J., Sorensen, H. T., Smeeth, L., Schmidt, S. A. J., & Langan, S. M. (2019). Partner bereavement

and risk of psoriasis and atopic eczema: cohort studies in the United Kingdom and Denmark. Br

J Dermatol. https://doi.org/10.1111/bjd.18740

Wood, S., Marchant, A., Allsopp, M., Wilkinson, K., Bethel, J., Jones, H., & John, A. (2019).

Epidemiology of eating disorders in primary care in children and young people: a Clinical

Practice Research Datalink study in England. BMJ Open, 9(8), e026691.


Wright, A. K., Kontopantelis, E., Emsley, R., Buchan, I. E., Mamas, M. A., Sattar, N., Ashcroft, D.

M., & Rutter, M. K. (2019). Cardiovascular Risk and Risk Factor Management in Type 2

Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. Circulation.


Zaccardi, F., Nystrup Husemoen, L. L., Thorsted, B. L., Webb, D. R., Paul, S. K., Davies, M. J., &

Khunti, K. (2019). Selectivity of beta-blockers, cardiovascular and all-cause mortality in people

with hypoglycaemia: An observational study. Nutr Metab Cardiovasc Dis, 29(5), 481–488.

https://doi.org/10.1016/j.numecd.2019.01.006

Zhang, J., Haines, C., Watson, A. J. M., Hart, A. R., Platt, M. J., Pardoll, D. M., Cosgrove, S. E.,

Gebo, K. A., & Sears, C. L. (2019). Oral antibiotic use and risk of colorectal cancer in the

CPRD bibliography

79

United Kingdom, 1989-2012: a matched case-control study. Gut. https://doi.org/10.1136/gutjnl-

2019-318593

Zhong, V. W., Juhaeri, J., Cole, S. R., Shay, C. M., Gordon-Larsen, P., Kontopantelis, E., & Mayer-

Davis, E. J. (2019). Proximal HbA1C Level and First Hypoglycemia Hospitalization in Adults

with Incident Type 2 Diabetes. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2018-01402

CPRD bibliography

80

2018

Abenhaim, H. A. et al. (2018). “Effect of Cesarean Delivery on Long-term Riskof Small Bowel Obstruction”. In: Obstet Gynecol 131.2, pp. 354–359. issn:0029-7844. doi: 10.1097/aog.0000000000002440.

Abhishek, A. et al. (2018). “Rheumatoid arthritis and excess mortality: downbut not out. A primary care cohort study using data from Clinical PracticeResearch Datalink”. In: Rheumatology (Oxford) 57.6, pp. 977–981. issn:1462-0324. doi: 10.1093/rheumatology/key013.

Abrahami, D., A. Douros, H. Yin, O. H. Y. Yu, et al. (2018). “Dipeptidylpeptidase-4 inhibitors and incidence of inflammatory bowel disease amongpatients with type 2 diabetes: population based cohort study”. In: Bmj 360,k872. issn: 0959-8138. doi: 10.1136/bmj.k872.

Abrahami, D., A. Douros, H. Yin, O. H. Yu, et al. (2018). “Incretin baseddrugs and risk of cholangiocarcinoma among patients with type 2 diabetes:population based cohort study”. In: Bmj 363, k4880. issn: 0959-8138. doi:10.1136/bmj.k4880.

Abrahami, D., H. Yin, et al. (2018). “Incretin-based Drugs and the Incidenceof Colorectal Cancer in Patients with Type 2 Diabetes”. In: Epidemiology29.2, pp. 246–253. issn: 1044-3983. doi: 10.1097/ede.0000000000000793.

Achana, F. A. et al. (2018). “Peripartum hysterectomy: an economic analysisof direct healthcare costs using routinely collected data”. In: Bjog 125.7,pp. 874–883. issn: 1470-0328. doi: 10.1111/1471-0528.14950.

Ahmadizar, F. et al. (2018). “Undertreatment of hypertension and hypercholes-terolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factorsand medications use”. In: Br J Clin Pharmacol 84.4, pp. 776–785. issn:0306-5251. doi: 10.1111/bcp.13482.

Ahmed, H. et al. (2018). “Risk of adverse outcomes following urinary tractinfection in older people with renal impairment: Retrospective cohort studyusing linked health record data”. In: PLoS Med 15.9, e1002652. issn: 1549-1277. doi: 10.1371/journal.pmed.1002652.

Alatorre, C. I. et al. (2018). “Factors associated with stroke, myocardial in-farction, ischemic heart disease, unstable angina, or mortality in patientsfrom real world clinical practice with newly-diagnosed type 2 diabetes andearly glycemic control”. In: Curr Med Res Opin 34.2, pp. 337–343. issn:0300-7995. doi: 10.1080/03007995.2017.1396969.

Alsaggaf, R. et al. (2018). “Cancer Risk in Myotonic Dystrophy Type I: Evidenceof a Role for Disease Severity”. In: JNCI Cancer Spectr 2.4, pky052. issn:2515-5091. doi: 10.1093/jncics/pky052.

Ankus, E. et al. (2018). “Cancer incidence in patients with a high normal plateletcount: a cohort study using primary care data”. In: Fam Pract 35.6, pp. 671–675. issn: 0263-2136. doi: 10.1093/fampra/cmy018.

Arana, A. et al. (2018). “Variation in Cardiovascular Risk Related to IndividualAntimuscarinic Drugs Used to Treat Overactive Bladder: A UK CohortStudy”. In: Pharmacotherapy 38.6, pp. 628–637. issn: 0277-0008. doi: 10.1002/phar.2121.

CPRD bibliography

81

Archangelidi, O. et al. (2018). “Clinically recorded heart rate and incidence of 12coronary, cardiac, cerebrovascular and peripheral arterial diseases in 233,970men and women: A linked electronic health record study”. In: Eur J PrevCardiol 25.14, pp. 1485–1495. issn: 2047-4873. doi: 10.1177/2047487318785228.

Ardissino, M. et al. (2018). “Idiopathic intracranial hypertension in the Britishpopulation with obesity”. In: Acta Neurochir (Wien). issn: 0001-6268. doi:10.1007/s00701-018-3772-9.

Arhi, C. S., A. Bottle, et al. (2018). “Comparison of cancer diagnosis record-ing between the Clinical Practice Research Datalink, Cancer Registry andHospital Episodes Statistics”. In: Cancer Epidemiol 57, pp. 148–157. issn:1877-7821. doi: 10.1016/j.canep.2018.08.009.

Arhi, C. S., E. M. Burns, et al. (2018). “Complications after discharge anddelays in adjuvant chemotherapy following colonic resection: a cohort studyof linked primary and secondary care data”. In: Colorectal Dis. issn: 1462-8910. doi: 10.1111/codi.14525.

Atkins, J. L. et al. (2018). “Impact of Low Cardiovascular Risk Profiles onGeriatric Outcomes: Evidence From 421,000 Participants in Two Cohorts”.In: J Gerontol A Biol Sci Med Sci. issn: 1079-5006. doi: 10.1093/gerona/gly083.

Axson, E. L., C. I. Bloom, and J. K. Quint (2018). “Nontuberculous mycobac-terial disease managed within UK primary care, 2006-2016”. In: Eur J ClinMicrobiol Infect Dis 37.9, pp. 1795–1803. issn: 0934-9723. doi: 10.1007/s10096-018-3315-6.

Axson, E. L., N. Bual, et al. (2018). “Risk factors and secondary care utilisationin a primary care population with non-tuberculous mycobacterial disease inthe UK”. In: Eur J Clin Microbiol Infect Dis. issn: 0934-9723. doi: 10.

1007/s10096-018-3402-8.Badrick, E., I. Renehan, and A. G. Renehan (2018). “Linkage of the UK Clinical

Practice Research Datalink with the national cancer registry”. In: Eur JEpidemiol. issn: 0393-2990. doi: 10.1007/s10654-018-0441-5.

Balinskaite, V. et al. (2018). “An assessment of potential unintended conse-quences following a national antimicrobial stewardship programme in Eng-land: an interrupted time series analysis”. In: Clin Infect Dis. issn: 1058-4838. doi: 10.1093/cid/ciy904.

Becker, C. et al. (2018). “Cataract in patients with diabetes mellitus-incidencerates in the UK and risk factors”. In: Eye (Lond) 32.6, pp. 1028–1035. issn:0950-222x. doi: 10.1038/s41433-017-0003-1.

Berni, T. R. et al. (2018). “Polycystic Ovary Syndrome Is Associated WithAdverse Mental Health and Neurodevelopmental Outcomes”. In: J Clin En-docrinol Metab 103.6, pp. 2116–2125. issn: 0021-972x. doi: 10.1210/jc.2017-02667.

Bhaskaran, K. et al. (2018). “Association of BMI with overall and cause-specificmortality: a population-based cohort study of 3.6 million adults in the UK”.In: Lancet Diabetes Endocrinol 6.12, pp. 944–953. issn: 2213-8587. doi: 10.1016/s2213-8587(18)30288-2.

Blagojevic-Bucknall, M. et al. (2018). “The risk of gout among patients withsleep apnea: a matched cohort study”. In: Arthritis Rheumatol. issn: 2326-5191. doi: 10.1002/art.40662.

Bloechliger, M. et al. (2018). “Adverse events profile of oral corticosteroidsamong asthma patients in the UK: cohort study with a nested case-control

CPRD bibliography

82

analysis”. In: Respir Res 19.1, p. 75. issn: 1465-9921. doi: 10.1186/s12931-018-0742-y.

Bloom, C. I. et al. (2018). “Exacerbation risk and characterisation of the UK’sasthma population from infants to old age”. In: Thorax 73.4, pp. 313–320.issn: 0040-6376. doi: 10.1136/thoraxjnl-2017-210650.

Bottle, A., D. Kim, P. P. Aylin, et al. (2018). “Real-world presentation withheart failure in primary care: do patients selected to follow diagnostic andmanagement guidelines have better outcomes?” In: Open Heart 5.2, e000935.issn: 2053-3624 (Print) 2053-3624. doi: 10.1136/openhrt-2018-000935.

Bottle, A., D. Kim, P. Aylin, et al. (2018). “Routes to diagnosis of heart failure:observational study using linked data in England”. In: Heart 104.7, pp. 600–605. issn: 1355-6037. doi: 10.1136/heartjnl-2017-312183.

Bou-Antoun, S. et al. (2018). “Age-related decline in antibiotic prescribing foruncomplicated respiratory tract infections in primary care in England fol-lowing the introduction of a national financial incentive (the Quality Pre-mium) for health commissioners to reduce use of antibiotic”. In: J Antimi-crob Chemother 73.10, pp. 2883–2892. issn: 0305-7453. doi: 10.1093/jac/dky237.

Bryan, P. et al. (2018). “Safety of multicomponent meningococcal group Bvaccine (4CMenB) in routine infant immunisation in the UK: a prospectivesurveillance study”. In: Lancet Child Adolesc Health 2.6, pp. 395–403. issn:2352-4642. doi: 10.1016/s2352-4642(18)30103-2.

Burkard, T. et al. (2018). “Risk of Incident Osteoarthritis of the Hand in StatinInitiators: A Sequential Cohort Study”. In: Arthritis Care Res (Hoboken)70.12, pp. 1795–1805. issn: 2151-464x. doi: 10.1002/acr.23616.

Burn, E. et al. (2018). “Trends and determinants of length of stay and hospitalreimbursement following knee and hip replacement: evidence from linkedprimary care and NHS hospital records from 1997 to 2014”. In: BMJ Open8.1, e019146. issn: 2044-6055. doi: 10.1136/bmjopen-2017-019146.

Burton, C. L., Y. Chen, et al. (2018). “Trends in the prevalence, incidence andsurgical management of carpal tunnel syndrome between 1993 and 2013:an observational analysis of UK primary care records”. In: BMJ Open 8.6,e020166. issn: 2044-6055. doi: 10.1136/bmjopen-2017-020166.

Burton, C. L., L. S. Chesterton, et al. (2018). “Predicting surgical interventionin patients presenting with carpal tunnel syndrome in primary care”. In:Clin Epidemiol 10, pp. 739–748. issn: 1179-1349 (Print) 1179-1349. doi:10.2147/clep.s154409.

Busby, J., U. McMenamin, et al. (2018). “Angiotensin receptor blocker use andgastro-oesophageal cancer survival: a population-based cohort study”. In:Aliment Pharmacol Ther 47.2, pp. 279–288. issn: 0269-2813. doi: 10.1111/apt.14388.

Busby, J., K. Mills, et al. (2018a). “Postdiagnostic Calcium Channel Blocker Useand Breast Cancer Mortality: A Population-based Cohort Study”. In: Epi-demiology 29.3, pp. 407–413. issn: 1044-3983. doi: 10.1097/ede.0000000000000814.

— (2018b). “Selective serotonin reuptake inhibitor use and breast cancer sur-vival: a population-based cohort study”. In: Breast Cancer Res 20.1, p. 4.issn: 1465-5411. doi: 10.1186/s13058-017-0928-0.

Busby, J., L. Murray, et al. (2018). “A combined connectivity mapping andpharmacoepidemiology approach to identify existing medications with breast

CPRD bibliography

83

cancer causing or preventing properties”. In: Pharmacoepidemiol Drug Saf27.1, pp. 78–86. issn: 1053-8569. doi: 10.1002/pds.4345.

Cainzos-Achirica, M. et al. (2018). “Methodological challenges when evaluatingpotential off-label prescribing of drugs using electronic health care databases:A case study of dabigatran etexilate in Europe”. In: PharmacoepidemiolDrug Saf 27.7, pp. 713–723. issn: 1053-8569. doi: 10.1002/pds.4416.

Carey, I. M., H. R. Anderson, et al. (2018). “Are noise and air pollution relatedto the incidence of dementia? A cohort study in London, England”. In: BMJOpen 8.9, e022404. issn: 2044-6055. doi: 10.1136/bmjopen-2018-022404.

Carey, I. M., J. A. Critchley, et al. (2018). “Risk of Infection in Type 1 andType 2 Diabetes Compared With the General Population: A Matched CohortStudy”. In: Diabetes Care 41.3, pp. 513–521. issn: 0149-5992. doi: 10.2337/dc17-2131.

Caspard, H. et al. (2018). “Evaluation of the safety of live attenuated influenzavaccine (LAIV) in children and adolescents with asthma and high-risk con-ditions: a population-based prospective cohort study conducted in Englandwith the Clinical Practice Research Datalink”. In: BMJ Open 8.12, e023118.issn: 2044-6055. doi: 10.1136/bmjopen-2018-023118.

Cassell, A. et al. (2018). “The epidemiology of multimorbidity in primary care:a retrospective cohort study”. In: Br J Gen Pract 68.669, e245–e251. issn:0960-1643. doi: 10.3399/bjgp18X695465.

Castellsague, J. et al. (2018). “A cohort study on the risk of lymphoma and skincancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (JointEuropean Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLEstudy)”. In: Clin Epidemiol 10, pp. 299–310. issn: 1179-1349 (Print) 1179-1349. doi: 10.2147/clep.s146442.

Cavender, M. A. et al. (2018). “SGLT-2 Inhibitors and Cardiovascular Risk: AnAnalysis of CVD-REAL”. In: J Am Coll Cardiol 71.22, pp. 2497–2506. issn:0735-1097. doi: 10.1016/j.jacc.2018.01.085.

Cecil, E. et al. (2018). “Impact of preventive primary care on children’s un-planned hospital admissions: a population-based birth cohort study of UKchildren 2000-2013”. In: BMC Med 16.1, p. 151. issn: 1741-7015. doi: 10.1186/s12916-018-1142-3.

Chalmers, J. D. et al. (2018). “Assessing the healthcare resource use associatedwith inappropriate prescribing of inhaled corticosteroids for people withchronic obstructive pulmonary disease (COPD) in GOLD groups A or B: anobservational study using the Clinical Practice Research Data”. In: RespirRes 19.1, p. 63. issn: 1465-9921. doi: 10.1186/s12931-018-0767-2.

Chang, K. C. et al. (2018). “Impact of the NHS Health Check on inequalitiesin cardiovascular disease risk: a difference-in-differences matching analysis”.In: J Epidemiol Community Health. issn: 0143-005x. doi: 10.1136/jech-2018-210961.

Charlton, J. et al. (2018). “Trajectory of Total Cholesterol in the Last Yearsof Life Over Age 80 Years: Cohort Study of 99,758 Participants”. In: JGerontol A Biol Sci Med Sci 73.8, pp. 1083–1089. issn: 1079-5006. doi:10.1093/gerona/glx184.

Charlton, R., A. Green, G. Shaddick, J. Snowball, A. Nightingale, W. Tillett,C. H. Smith, et al. (2018). “Risk of uveitis and inflammatory bowel diseasein people with psoriatic arthritis: a population-based cohort study”. In: Ann

CPRD bibliography

84

Rheum Dis 77.2, pp. 277–280. issn: 0003-4967. doi: 10.1136/annrheumdis-2017-212328.

Charlton, R., A. Green, G. Shaddick, J. Snowball, A. Nightingale, W. Tillett,C. Smith, et al. (2018). “Risk of type 2 diabetes and cardiovascular diseasein an incident cohort of people with psoriatic arthritis: a population-basedcohort study”. In: Rheumatology (Oxford). issn: 1462-0324. doi: 10.1093/rheumatology/key286.

Chen, T. C., L. C. Chen, and R. D. Knaggs (2018). “A 15-year overview of in-creasing tramadol utilisation and associated mortality and the impact of tra-madol classification in the United Kingdom”. In: Pharmacoepidemiol DrugSaf 27.5, pp. 487–494. issn: 1053-8569. doi: 10.1002/pds.4320.

Cherskov, A. et al. (2018). “Polycystic ovary syndrome and autism: A test ofthe prenatal sex steroid theory”. In: Transl Psychiatry 8.1, p. 136. issn:2158-3188. doi: 10.1038/s41398-018-0186-7.

Chu, T. P. C., M. J. Grainge, and T. R. Card (2018). “The risk of venous throm-boembolism during and after hospitalisation in patients with inflammatorybowel disease activity”. In: Aliment Pharmacol Ther 48.10, pp. 1099–1108.issn: 0269-2813. doi: 10.1111/apt.15010.

Chung, S. C. et al. (2018). “Time spent at blood pressure target and the riskof death and cardiovascular diseases”. In: PLoS One 13.9, e0202359. issn:1932-6203. doi: 10.1371/journal.pone.0202359.

Conrad, N. et al. (2018). “Temporal trends and patterns in heart failure inci-dence: a population-based study of 4 million individuals”. In: Lancet 391.10120,pp. 572–580. issn: 0140-6736. doi: 10.1016/s0140-6736(17)32520-5.

Conradt, C. et al. (2018). “Increased Prevalence of Polyneuropathy in Parkin-son’s Disease Patients: An Observational Study”. In: J Parkinsons Dis 8.1,pp. 141–144. issn: 1877-7171. doi: 10.3233/jpd-161057.

Costello, R. et al. (2018). “Representativeness of a digitally engaged populationand a patient organisation population with rheumatoid arthritis and theirwillingness to participate in research: a cross-sectional study”. In: RMD Open4.1, e000664. issn: 2056-5933 (Print) 2056-5933. doi: 10.1136/rmdopen-2018-000664.

Crellin, E. et al. (2018). “Trimethoprim use for urinary tract infection and riskof adverse outcomes in older patients: cohort study”. In: Bmj 360, k341.issn: 0959-8138. doi: 10.1136/bmj.k341.

Critchley, J. A. et al. (2018). “Glycemic Control and Risk of Infections AmongPeople With Type 1 or Type 2 Diabetes in a Large Primary Care CohortStudy”. In: Diabetes Care 41.10, pp. 2127–2135. issn: 0149-5992. doi: 10.2337/dc18-0287.

Crooks, C. J., J. West, and P. Jepsen (2018). “A validation study of the CirComcomorbidity score in an English cirrhosis population using the Clinical Prac-tice Research Datalink”. In: Clin Epidemiol 10, pp. 107–120. issn: 1179-1349(Print) 1179-1349. doi: 10.2147/clep.s147535.

Currie, C. J. et al. (2018). “Impact of differing glucose-lowering regimens on thepattern of association between glucose control and survival”. In: DiabetesObes Metab 20.4, pp. 821–830. issn: 1462-8902. doi: 10.1111/dom.13155.

Curtis, H. J. et al. (2018). “Time trends and geographical variation in prescribingof drugs for diabetes in England from 1998 to 2017”. In: Diabetes Obes Metab20.9, pp. 2159–2168. issn: 1462-8902. doi: 10.1111/dom.13346.

CPRD bibliography

85

Dalem, J. van et al. (2018). “Risk of a first-ever acute myocardial infarctionand all-cause mortality with sulphonylurea treatment: A population-basedcohort study”. In: Diabetes Obes Metab 20.4, pp. 1056–1060. issn: 1462-8902.doi: 10.1111/dom.13168.

Danese, M. D., E. Sidelnikov, and L. Kutikova (2018). “The prevalence, low-density lipoprotein cholesterol levels, and treatment of patients at very highrisk of cardiovascular events in the United Kingdom: a cross-sectional study”.In: Curr Med Res Opin 34.8, pp. 1441–1447. issn: 0300-7995. doi: 10.1080/03007995.2018.1463211.

Daugherty, J. et al. (2018). “The impact of long-term systemic glucocorticoiduse in severe asthma: A UK retrospective cohort analysis”. In: J Asthma55.6, pp. 651–658. issn: 0277-0903. doi: 10.1080/02770903.2017.1353612.

Davies, N. M. et al. (2018). “The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medicalrecords”. In: Addiction 113.6, pp. 1105–1116. issn: 0965-2140. doi: 10.1111/add.14146.

De Jong, H. J. I. et al. (2018). “Pattern of risks of rheumatoid arthritis amongpatients using statins: A cohort study with the clinical practice researchdatalink”. In: PLoS One 13.2, e0193297. issn: 1932-6203. doi: 10.1371/journal.pone.0193297.

Delgado, J. et al. (2018). “Blood Pressure Trajectories in the 20 Years BeforeDeath”. In: JAMA Intern Med 178.1, pp. 93–99. issn: 2168-6106. doi: 10.1001/jamainternmed.2017.7023.

Dell’Agnello, G. et al. (2018). “Reliability of coded data to identify earliestindications of cognitive decline, cognitive evaluation and Alzheimer’s diseasediagnosis: a pilot study in England”. In: BMJ Open 8.3, e019684. issn: 2044-6055. doi: 10.1136/bmjopen-2017-019684.

Dennis, J. M., W. E. Henley, et al. (2018). “Sex and BMI Alter the Benefitsand Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: AFramework for Evaluating Stratification Using Routine Clinical and Indi-vidual Trial Data”. In: Diabetes Care 41.9, pp. 1844–1853. issn: 0149-5992.doi: 10.2337/dc18-0344.

Dennis, J. M., B. M. Shields, et al. (2018). “Precision Medicine in Type 2 Di-abetes: Clinical Markers of Insulin Resistance Are Associated With AlteredShort- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy”. In:Diabetes Care 41.4, pp. 705–712. issn: 0149-5992. doi: 10.2337/dc17-1827.

Desai, U. et al. (2018). “Time to Treatment Intensification After Monother-apy Failure and Its Association With Subsequent Glycemic Control Among93,515 Patients With Type 2 Diabetes”. In: Diabetes Care 41.10, pp. 2096–2104. issn: 0149-5992. doi: 10.2337/dc17-0662.

Dhiman, P. et al. (2018). “Does bone mineral density improve the predictiveaccuracy of fracture risk assessment? A prospective cohort study in NorthernDenmark”. In: BMJ Open 8.4, e018898. issn: 2044-6055. doi: 10.1136/

bmjopen-2017-018898.Disanto, G. et al. (2018). “Prodromal symptoms of multiple sclerosis in primary

care”. In: Ann Neurol 83.6, pp. 1162–1173. issn: 0364-5134. doi: 10.1002/ana.25247.

Donegan, K. et al. (2018). “Exploring the Potential Routine Use of ElectronicHealthcare Record Data to Strengthen Early Signal Assessment in UK Medicines

CPRD bibliography

86

Regulation: Proof-of-Concept Study”. In: Drug Saf 41.9, pp. 899–910. issn:0114-5916. doi: 10.1007/s40264-018-0675-x.

Douros, A., D. Abrahami, et al. (2018). “Use of Dipeptidyl Peptidase-4 In-hibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Dia-betes”. In: Epidemiology 29.6, pp. 904–912. issn: 1044-3983. doi: 10.1097/ede.0000000000000891.

Douros, A., S. Dell’Aniello, et al. (2018). “Sulfonylureas as second line drugsin type 2 diabetes and the risk of cardiovascular and hypoglycaemic events:population based cohort study”. In: Bmj 362, k2693. issn: 0959-8138. doi:10.1136/bmj.k2693.

Douros, A., K. B. Filion, et al. (2018). “Glucagon-Like Peptide 1 ReceptorAgonists and the Risk of Incident Diabetic Retinopathy”. In: Diabetes Care41.11, pp. 2330–2338. issn: 0149-5992. doi: 10.2337/dc17-2280.

Dregan, A. et al. (2018). “Long-term trends in antithrombotic drug prescriptionsamong adults aged 80 years and over from primary care: a temporal trendsanalysis using electronic health records”. In: Ann Epidemiol 28.7, pp. 440–446. issn: 1047-2797. doi: 10.1016/j.annepidem.2018.03.006.

Erridge, S. et al. (2018). “Risk of GERD-Related Disorders in Obese Patientson PPI Therapy: a Population Analysis”. In: Obes Surg 28.9, pp. 2796–2803.issn: 0960-8923. doi: 10.1007/s11695-018-3246-4.

Ferguson, R. J. et al. (2018). “Validation of hip osteoarthritis diagnosis recordingin the UK Clinical Practice Research Datalink”. In: Pharmacoepidemiol DrugSaf. issn: 1053-8569. doi: 10.1002/pds.4673.

Ferreira, G. L. C. et al. (2018). “Incidence and prevalence of hepatitis B inpatients with diabetes mellitus in the UK: A population-based cohort studyusing the UK Clinical Practice Research Datalink”. In: J Viral Hepat 25.5,pp. 571–580. issn: 1352-0504. doi: 10.1111/jvh.12841.

Ferrey, A. E. et al. (2018). “Relative toxicity of mood stabilisers and antipsy-chotics: case fatality and fatal toxicity associated with self-poisoning”. In:BMC Psychiatry 18.1, p. 399. issn: 1471-244x. doi: 10.1186/s12888-018-1993-3.

Furuland, H. et al. (2018). “Serum potassium as a predictor of adverse clinicaloutcomes in patients with chronic kidney disease: new risk equations usingthe UK clinical practice research datalink”. In: BMC Nephrol 19.1, p. 211.issn: 1471-2369. doi: 10.1186/s12882-018-1007-1.

Gafoor, R., H. P. Booth, and M. C. Gulliford (2018). “Antidepressant utilisationand incidence of weight gain during 10 years’ follow-up: population basedcohort study”. In: Bmj 361, k1951. issn: 0959-8138. doi: 10.1136/bmj.k1951.

Gale, S. et al. (2018). “Risk Associated with Cumulative Oral GlucocorticoidUse in Patients with Giant Cell Arteritis in Real-World Databases from theUSA and UK”. In: Rheumatol Ther. issn: 2198-6576 (Print) 2198-6576. doi:10.1007/s40744-018-0112-8.

Gamble, J. M., E. Chibrikov, et al. (2018). “Examining the risk of depressionor self-harm associated with incretin-based therapies used to manage hyper-glycaemia in patients with type 2 diabetes: a cohort study using the UKClinical Practice Research Datalink”. In: BMJ Open 8.10, e023830. issn:2044-6055. doi: 10.1136/bmjopen-2018-023830.

Gamble, J. M., J. R. Donnan, et al. (2018a). “Comparative Safety of DipeptidylPeptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Ther-

CPRD bibliography

87

apies for Three Acute Outcomes”. In: Sci Rep 8.1, p. 15142. issn: 2045-2322.doi: 10.1038/s41598-018-33483-y.

Gamble, J. M., J. R. Donnan, et al. (2018b). “The risk of fragility fracturesin new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureasand other anti-diabetic drugs: A cohort study”. In: Diabetes Res Clin Pract136, pp. 159–167. issn: 0168-8227. doi: 10.1016/j.diabres.2017.12.008.

Garriga, C. et al. (2018). “Oral bisphosphonate use and age-related maculardegeneration: retrospective cohort and nested case-control study”. In: AnnN Y Acad Sci 1415.1, pp. 34–46. issn: 0077-8923. doi: 10.1111/nyas.13589.

Geulayov, G. et al. (2018). “Relative toxicity of benzodiazepines and hypnoticscommonly used for self-poisoning: An epidemiological study of fatal toxicityand case fatality”. In: J Psychopharmacol 32.6, pp. 654–662. issn: 0269-8811.doi: 10.1177/0269881118754734.

Gho, Jmih et al. (2018). “An electronic health records cohort study on heartfailure following myocardial infarction in England: incidence and predictors”.In: BMJ Open 8.3, e018331. issn: 2044-6055. doi: 10.1136/bmjopen-2017-018331.

Glover, G. et al. (2018). “An observational study of the use of acute hospitalcare by people with intellectual disabilities in England”. In: J Intellect DisabilRes. issn: 0964-2633. doi: 10.1111/jir.12544.

Gordon, J. et al. (2018). “Treatment choice, medication adherence and glycemicefficacy in people with type 2 diabetes: a UK clinical practice databasestudy”. In: BMJ Open Diabetes Res Care 6.1, e000512. issn: 2052-4897(Print) 2052-4897. doi: 10.1136/bmjdrc-2018-000512.

Gorton, H. C., R. T. Webb, M. J. Carr, et al. (2018). “Risk of UnnaturalMortality in People With Epilepsy”. In: JAMA Neurol 75.8, pp. 929–938.issn: 2168-6149. doi: 10.1001/jamaneurol.2018.0333.

Gorton, H. C., R. T. Webb, W. O. Pickrell, et al. (2018). “Risk factors for self-harm in people with epilepsy”. In: J Neurol 265.12, pp. 3009–3016. issn:0340-5354. doi: 10.1007/s00415-018-9094-2.

Grandi, S. M. et al. (2018). “The timing of onset of hypertensive disorders inpregnancy and the risk of incident hypertension and cardiovascular disease”.In: Int J Cardiol 270, pp. 273–275. issn: 0167-5273. doi: 10 . 1016 / j .

ijcard.2018.06.059.Griffiths, R. I. et al. (2018). “Quality of diabetes care in breast, colorectal, and

prostate cancer”. In: J Cancer Surviv 12.6, pp. 803–812. issn: 1932-2259.doi: 10.1007/s11764-018-0717-5.

Gruntz, K. et al. (2018). “Parkinson disease and the risk of epileptic seizures”.In: Ann Neurol 83.2, pp. 363–374. issn: 0364-5134. doi: 10.1002/ana.

25157.Hagberg, K. W., A. L. Robijn, and S. Jick (2018). “Maternal depression and an-

tidepressant use during pregnancy and the risk of autism spectrum disorderin offspring”. In: Clin Epidemiol 10, pp. 1599–1612. issn: 1179-1349 (Print)1179-1349. doi: 10.2147/clep.s180618.

Harshfield, A. et al. (2018). “Do GPs accurately record date of death? A UKobservational analysis”. In: BMJ Support Palliat Care. issn: 2045-435x. doi:10.1136/bmjspcare-2018-001514.

Hawley, S. et al. (2018). “Association between NICE guidance on biologic ther-apies with rates of hip and knee replacement among rheumatoid arthritispatients in England and Wales: An interrupted time-series analysis”. In:

CPRD bibliography

88

Semin Arthritis Rheum 47.5, pp. 605–610. issn: 0049-0172. doi: 10.1016/j.semarthrit.2017.09.006.

Hayhoe, B. et al. (2018). “Adherence to guidelines in management of symptomssuggestive of heart failure in primary care”. In: Heart. issn: 1355-6037. doi:10.1136/heartjnl-2018-313971.

Hazra, N. C., C. Rudisill, and M. C. Gulliford (2018). “Determinants of healthcare costs in the senior elderly: age, comorbidity, impairment, or proximityto death?” In: Eur J Health Econ 19.6, pp. 831–842. issn: 1618-7598. doi:10.1007/s10198-017-0926-2.

Hegade, V. S. et al. (2018). “Pruritus is Common and Under-treated in Pa-tients with Primary Biliary Cholangitis in the United Kingdom”. In: ClinGastroenterol Hepatol. issn: 1542-3565. doi: 10.1016/j.cgh.2018.12.007.

Hickman, M. et al. (2018). “The impact of buprenorphine and methadone onmortality: a primary care cohort study in the United Kingdom”. In: Addic-tion 113.8, pp. 1461–1476. issn: 0965-2140. doi: 10.1111/add.14188.

Hicks, B. M. et al. (2018). “Angiotensin converting enzyme inhibitors and riskof lung cancer: population based cohort study”. In: Bmj 363, k4209. issn:0959-8138. doi: 10.1136/bmj.k4209.

Hire, A. J. et al. (2018). “ADHD in the United Kingdom: Regional and Socioe-conomic Variations in Incidence Rates Amongst Children and Adolescents(2004-2013)”. In: J Atten Disord 22.2, pp. 134–142. issn: 1087-0547. doi:10.1177/1087054715613441.

Hirst, J. A. et al. (2018). “Timings for HbA1c testing in people with diabetes areassociated with incentive payments: an analysis of UK primary care data”.In: Diabet Med. issn: 0742-3071. doi: 10.1111/dme.13810.

Hong, J. L., M. Jonsson Funk, et al. (2018). “Generalizing Randomized ClinicalTrial Results: Implementation and Challenges Related to Missing Data inthe Target Population”. In: Am J Epidemiol 187.4, pp. 817–827. issn: 0002-9262. doi: 10.1093/aje/kwx287.

Hong, J. L., M. Webster-Clark, et al. (2018). “Comparison of Methods to Gen-eralize Randomized Clinical Trial Results without Individual-Level Data forthe Target Population”. In: Am J Epidemiol. issn: 0002-9262. doi: 10.1093/aje/kwy233.

Houghton, R., C. Liu, and F. Bolognani (2018). “Psychiatric Comorbiditiesand Psychotropic Medication Use in Autism: A Matched Cohort Study withADHD and General Population Comparator Groups in the United King-dom”. In: Autism Res. issn: 1939-3806. doi: 10.1002/aur.2040.

Humes, D. J. et al. (2018). “Duration and magnitude of postoperative risk ofvenous thromboembolism after planned inguinal hernia repair in men: apopulation-based cohort study”. In: Hernia 22.3, pp. 447–453. issn: 1248-9204. doi: 10.1007/s10029-017-1716-6.

Idris, I. et al. (2018). “The Trend of High-Dose Insulin Usage Among Patientswith Diabetes in the UK: A Retrospective Study”. In: Diabetes Ther 9.6,pp. 2245–2257. issn: 1869-6953 (Print). doi: 10.1007/s13300-018-0515-0.

Imfeld, P. et al. (2018). “Proton Pump Inhibitor Use and Risk of DevelopingAlzheimer’s Disease or Vascular Dementia: A Case-Control Analysis”. In:Drug Saf 41.12, pp. 1387–1396. issn: 0114-5916. doi: 10.1007/s40264-018-0704-9.

Ingram, J. R. et al. (2018). “Population-based Clinical Practice Research Datalinkstudy using algorithm modelling to identify the true burden of hidradenitis

CPRD bibliography

89

suppurativa”. In: Br J Dermatol 178.4, pp. 917–924. issn: 0007-0963. doi:10.1111/bjd.16101.

Iwagami, M., B. Caplin, et al. (2018). “Chronic kidney disease and cause-specifichospitalisation: a matched cohort study using primary and secondary carepatient data”. In: Br J Gen Pract 68.673, e512–e523. issn: 0960-1643. doi:10.3399/bjgp18X697973.

Iwagami, M., K. E. Mansfield, et al. (2018). “Severe mental illness and chronickidney disease: a cross-sectional study in the United Kingdom”. In: ClinEpidemiol 10, pp. 421–429. issn: 1179-1349 (Print) 1179-1349. doi: 10 .

2147/clep.s154841.Iwagami, M., L. A. Tomlinson, et al. (2018). “Gastrointestinal bleeding risk

of selective serotonin reuptake inhibitors by level of kidney function: Apopulation-based cohort study”. In: Br J Clin Pharmacol 84.9, pp. 2142–2151. issn: 0306-5251. doi: 10.1111/bcp.13660.

Jackson, J. et al. (2018). “Exposure to domestic violence and abuse and con-sultations for emergency contraception: nested case-control study in a UKprimary care dataset”. In: Br J Gen Pract. issn: 0960-1643. doi: 10.3399/bjgp18X700277.

Jain, A., A. J. van Hoek, et al. (2018). “Inequalities in zoster disease burden: apopulation-based cohort study to identify social determinants using linkeddata from the U.K. Clinical Practice Research Datalink”. In: Br J Dermatol178.6, pp. 1324–1330. issn: 0007-0963. doi: 10.1111/bjd.16399.

Jain, A., J. L. Walker, et al. (2018). “Zoster vaccination inequalities: A popu-lation based cohort study using linked data from the UK Clinical PracticeResearch Datalink”. In: PLoS One 13.11, e0207183. issn: 1932-6203. doi:10.1371/journal.pone.0207183.

Jenkins-Jones, S. et al. (2018). “Poor compliance and increased mortality, de-pression and healthcare costs in patients with congenital adrenal hyperpla-sia”. In: Eur J Endocrinol 178.4, pp. 309–320. issn: 0804-4643. doi: 10.1530/eje-17-0895.

Jong, Rgpj de et al. (2018). “Gastrointestinal cancer incidence in type 2 diabetesmellitus; results from a large population-based cohort study in the UK”. In:Cancer Epidemiol 54, pp. 104–111. issn: 1877-7821. doi: 10.1016/j.canep.2018.04.008.

Joseph, R. M., D. W. Ray, et al. (2018). “Low salivary cortisol levels in patientswith rheumatoid arthritis exposed to oral glucocorticoids: a cross-sectionalstudy set within UK electronic health records”. In: RMD Open 4.2, e000700.issn: 2056-5933 (Print) 2056-5933. doi: 10.1136/rmdopen-2018-000700.

Joseph, R. M., J. Soames, et al. (2018). “Supplementing electronic health recordsthrough sample collection and patient diaries: A study set within a primarycare research database”. In: Pharmacoepidemiol Drug Saf 27.2, pp. 239–242.issn: 1053-8569. doi: 10.1002/pds.4323.

Joseph, R. M., T. P. van Staa, et al. (2018). “Exposure measurement errorwhen assessing current glucocorticoid use using UK primary care electronicprescription data”. In: Pharmacoepidemiol Drug Saf. issn: 1053-8569. doi:10.1002/pds.4649.

Julious, S. A. et al. (2018). “Open-label, cluster randomised controlled trialand economic evaluation of a brief letter from a GP on unscheduled medicalcontacts associated with the start of the school year: the PLEASANT trial”.

CPRD bibliography

90

In: BMJ Open 8.4, e017367. issn: 2044-6055. doi: 10.1136/bmjopen-2017-017367.

Karimi, P. et al. (2018). “Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink”. In: Br JHaematol 181.4, pp. 505–514. issn: 0007-1048. doi: 10.1111/bjh.15229.

Kent, S. et al. (2018). “Body mass index and use and costs of primary careservices among women aged 55-79 years in England: a cohort and linkeddata study”. In: Int J Obes (Lond). issn: 0307-0565. doi: 10.1038/s41366-018-0288-6.

Kerkhof, M., T. N. Tran, M. van den Berge, et al. (2018). “Association betweenblood eosinophil count and risk of readmission for patients with asthma:Historical cohort study”. In: PLoS One 13.7, e0201143. issn: 1932-6203.doi: 10.1371/journal.pone.0201143.

Kerkhof, M., T. N. Tran, J. B. Soriano, et al. (2018). “Healthcare resourceuse and costs of severe, uncontrolled eosinophilic asthma in the UK generalpopulation”. In: Thorax 73.2, pp. 116–124. issn: 0040-6376. doi: 10.1136/thoraxjnl-2017-210531.

Keyany, A. et al. (2018). “Use of parenteral glucocorticoids and the risk of newonset type 2 diabetes mellitus: A case-control study”. In: Diabetes Res ClinPract 139, pp. 100–106. issn: 0168-8227. doi: 10.1016/j.diabres.2018.02.010.

Khalid, S. et al. (2018). “Comparative anti-fracture effectiveness of differentoral anti-osteoporosis therapies based on ”real-world” data: a meta-analysisof propensity-matched cohort findings from the UK Clinical Practice Re-search Database and the Catalan SIDIAP Database”. In: Clin Epidemiol10, pp. 1417–1431. issn: 1179-1349 (Print) 1179-1349. doi: 10.2147/clep.s164112.

Khan, T. et al. (2018). “ACL and meniscal injuries increase the risk of primarytotal knee replacement for osteoarthritis: a matched case-control study usingthe Clinical Practice Research Datalink (CPRD)”. In: Br J Sports Med. issn:0306-3674. doi: 10.1136/bjsports-2017-097762.

Khosrow-Khavar, F. et al. (2018). “Aromatase inhibitors and the risk of col-orectal cancer in postmenopausal women with breast cancer”. In: Ann Oncol29.3, pp. 744–748. issn: 0923-7534. doi: 10.1093/annonc/mdx822.

Khunti, K. et al. (2018). “Association of a Combined Measure of Adherenceand Treatment Intensity With Cardiovascular Outcomes in Patients WithAtherosclerosis or Other Cardiovascular Risk Factors Treated With Statinsand/or Ezetimibe”. In: JAMA Netw Open 1.8, e185554. issn: 2574-3805.doi: 10.1001/jamanetworkopen.2018.5554.

Kontopantelis, E. et al. (2018). “Spatial distribution of clinical computer sys-tems in primary care in England in 2016 and implications for primary careelectronic medical record databases: a cross-sectional population study”. In:BMJ Open 8.2, e020738. issn: 2044-6055. doi: 10.1136/bmjopen-2017-020738.

Koppe, U. et al. (2018). “Long-term effects of bariatric surgery on acute kidneyinjury: a propensity-matched cohort in the UK Clinical Practice ResearchDatalink”. In: BMJ Open 8.5, e020371. issn: 2044-6055. doi: 10.1136/

bmjopen-2017-020371.

CPRD bibliography

91

Koshiaris, C. et al. (2018). “Early detection of multiple myeloma in primarycare using blood tests: a case-control study in primary care”. In: Br J GenPract 68.674, e586–e593. issn: 0960-1643. doi: 10.3399/bjgp18X698357.

Kuiper, J. G. et al. (2018). “Use of Topical Tacrolimus and Topical Pimecrolimusin Four European Countries: A Multicentre Database Cohort Study”. In:Drugs Real World Outcomes. issn: 2199-1154 (Print) 2198-9788. doi: 10.1007/s40801-018-0133-1.

Kumar, R. (2018). “Hepatitis B virus infection and diabetes mellitus: An adverserelationship A letter in response to Incidence and prevalence of hepatitis B inpatients with diabetes mellitus in the UK: A population-based cohort studyusing the UK Clinical Practice Researc”. In: J Viral Hepat 25.11, p. 1401.issn: 1352-0504. doi: 10.1111/jvh.12949.

Kuo, C. F. et al. (2018). “Urate-lowering treatment and risk of total joint re-placement in patients with gout”. In: Rheumatology (Oxford) 57.12, pp. 2129–2139. issn: 1462-0324. doi: 10.1093/rheumatology/key212.

Kurdi, A. I. B., R. A. Elliott, and L. C. Chen (2018). “Clinical and economicimplications of therapeutic switching of angiotensin receptor blockers toangiotensin-converting enzyme inhibitors: a population-based study”. In: JHypertens. issn: 0263-6352. doi: 10.1097/hjh.0000000000002009.

Landis, S. et al. (2018). “Demographic and Clinical Characteristics of COPDPatients at Different Blood Eosinophil Levels in the UK Clinical PracticeResearch Datalink”. In: Copd 15.2, pp. 177–184. issn: 1541-2563. doi: 10.1080/15412555.2018.1441275.

Lee, J. J. et al. (2018). “Risk factors for influenza-related complications inchildren during the 2009/10 pandemic: a UK primary care cohort studyusing linked routinely collected data”. In: Epidemiol Infect 146.7, pp. 817–823. issn: 0950-2688. doi: 10.1017/s0950268818000353.

Leite, A., S. L. Thomas, and N. J. Andrews (2018). “Do delays in data avail-ability limit the implementation of near real-time vaccine safety surveillanceusing the Clinical Practice Research Datalink?” In: Pharmacoepidemiol DrugSaf 27.1, pp. 25–29. issn: 1053-8569. doi: 10.1002/pds.4356.

Li, L., T. Neogi, and S. Jick (2018a). “A cohort study of comorbidity in patientswith granulomatosis with polyangiitis”. In: Rheumatology (Oxford) 57.2,pp. 291–299. issn: 1462-0324. doi: 10.1093/rheumatology/kex379.

— (2018b). “Mortality in Patients With Giant Cell Arteritis: A Cohort Studyin UK Primary Care”. In: Arthritis Care Res (Hoboken) 70.8, pp. 1251–1256.issn: 2151-464x. doi: 10.1002/acr.23538.

Liang, M., T. Ye, and H. Fu (2018). “Estimating individualized optimal com-bination therapies through outcome weighted deep learning algorithms”. In:Stat Med 37.27, pp. 3869–3886. issn: 0277-6715. doi: 10.1002/sim.7902.

Littink, K. W. et al. (2018). “Autosomal Recessive NRL Mutations in Patientswith Enhanced S-Cone Syndrome”. In: Genes (Basel) 9.2. issn: 2073-4425(Print) 2073-4425. doi: 10.3390/genes9020068.

Liu, Z. et al. (2018). “Statin use and reduced risk of biliary tract cancers inthe UK Clinical Practice Research Datalink”. In: Gut. issn: 0017-5749. doi:10.1136/gutjnl-2018-317504.

Loo, S. Y. et al. (2018). “Comparative effectiveness of novel oral anticoagulantsin UK patients with non-valvular atrial fibrillation and chronic kidney dis-ease: a matched cohort study”. In: BMJ Open 8.1, e019638. issn: 2044-6055.doi: 10.1136/bmjopen-2017-019638.

CPRD bibliography

92

Mahmoudpour, S. H. et al. (2018). “Prescription patterns of angiotensin-convertingenzyme inhibitors for various indications: A UK population-based study”.In: Br J Clin Pharmacol 84.10, pp. 2365–2372. issn: 0306-5251. doi: 10.1111/bcp.13692.

Mansfield, K. E. et al. (2018). “Acute kidney injury and infections in patientstaking antihypertensive drugs: a self-controlled case series analysis”. In: ClinEpidemiol 10, pp. 187–202. issn: 1179-1349 (Print) 1179-1349. doi: 10 .

2147/clep.s146757.Margulis, A. V., J. Fortuny, et al. (2018a). “Validation of Cancer Cases Using

Primary Care, Cancer Registry, and Hospitalization Data in the UnitedKingdom”. In: Epidemiology 29.2, pp. 308–313. issn: 1044-3983. doi: 10.1097/ede.0000000000000786.

— (2018b). “Value of Free-text Comments for Validating Cancer Cases UsingPrimary-care Data in the United Kingdom”. In: Epidemiology 29.5, e41–e42.issn: 1044-3983. doi: 10.1097/ede.0000000000000856.

Margulis, A. V., M. Linder, et al. (2018). “Patterns of use of antimuscarinicdrugs to treat overactive bladder in Denmark, Sweden, and the UnitedKingdom”. In: PLoS One 13.9, e0204456. issn: 1932-6203. doi: 10.1371/journal.pone.0204456.

Markar, S. R., C. Arhi, A. Leusink, et al. (2018). “The Influence of AntirefluxSurgery on Esophageal Cancer Risk in England: National Population-basedCohort Study”. In: Ann Surg 268.5, pp. 861–867. issn: 0003-4932. doi: 10.1097/sla.0000000000002890.

Markar, S. R., C. Arhi, T. Wiggins, et al. (2018). “Reintervention After An-tireflux Surgery for Gastroesophageal Reflux Disease in England”. In: AnnSurg. issn: 0003-4932. doi: 10.1097/sla.0000000000003131.

Martinez, C. et al. (2018). “Thirteen-year trend in the persistence with vitaminK antagonists for venous thromboembolism in the UK: a cohort study”. In:Curr Med Res Opin 34.11, pp. 1985–1990. issn: 0300-7995. doi: 10.1080/03007995.2018.1481375.

Martin-Merino, E., A. Calderon-Larranaga, et al. (2018). “The impact of differ-ent strategies to handle missing data on both precision and bias in a drugsafety study: a multidatabase multinational population-based cohort study”.In: Clin Epidemiol 10, pp. 643–654. issn: 1179-1349 (Print) 1179-1349. doi:10.2147/clep.s154914.

Martin-Merino, E., I. Petersen, et al. (2018). “Risk of venous thromboembolismamong users of different anti-osteoporosis drugs: a population-based cohortanalysis including over 200,000 participants from Spain and the UK”. In:Osteoporos Int 29.2, pp. 467–478. issn: 0937-941x. doi: 10.1007/s00198-017-4308-5.

Matcho, A. et al. (2018). “Inferring pregnancy episodes and outcomes withina network of observational databases”. In: PLoS One 13.2, e0192033. issn:1932-6203. doi: 10.1371/journal.pone.0192033.

McDonald, L., C. J. Sammon, et al. (2018). “Under-recording of hospital bleed-ing events in UK primary care: a linked Clinical Practice Research Datalinkand Hospital Episode Statistics study”. In: Clin Epidemiol 10, pp. 1155–1168. issn: 1179-1349 (Print) 1179-1349. doi: 10.2147/clep.s170304.

McDonald, L., A. Schultze, et al. (2018). “Performing studies using the UK Clin-ical Practice Research Datalink: to link or not to link?” In: Eur J Epidemiol33.6, pp. 601–605. issn: 0393-2990. doi: 10.1007/s10654-018-0389-5.

CPRD bibliography

93

Mehrabadi, A. et al. (2018). “Domperidone for insufficient lactation in England2002-2015: A drug utilization study with interrupted time series analysis”.In: Pharmacoepidemiol Drug Saf 27.12, pp. 1316–1324. issn: 1053-8569. doi:10.1002/pds.4621.

Merriel, S. W. D., M. T. May, and R. M. Martin (2018). “Predicting prostatecancer progression: protocol for a retrospective cohort study to identify prog-nostic factors for prostate cancer outcomes using routine primary care data”.In: BMJ Open 8.1, e019409. issn: 2044-6055. doi: 10.1136/bmjopen-2017-019409.

Moncrieff, G. et al. (2018). “Cost and effectiveness of prescribing emollienttherapy for atopic eczema in UK primary care in children and adults: a largeretrospective analysis of the Clinical Practice Research Datalink”. In: BMCDermatol 18.1, p. 9. issn: 1471-5945. doi: 10.1186/s12895-018-0076-y.

Morales, D. R. et al. (2018). “External validation of ADO, DOSE, COTE andCODEX at predicting death in primary care patients with COPD usingstandard and machine learning approaches”. In: Respir Med 138, pp. 150–155. issn: 0954-6111. doi: 10.1016/j.rmed.2018.04.003.

Morgan, A. D. et al. (2018). “Chronic obstructive pulmonary disease and the riskof 12 cardiovascular diseases: a population-based study using UK primarycare data”. In: Thorax 73.9, pp. 877–879. issn: 0040-6376. doi: 10.1136/thoraxjnl-2017-210865.

Morgan, C. L., S. E. Inzucchi, et al. (2018). “Impact of treatment with pioglita-zone on stroke outcomes: A real-world database analysis”. In: Diabetes ObesMetab 20.9, pp. 2140–2147. issn: 1462-8902. doi: 10.1111/dom.13344.

Morgan, C. L., Q. Qiao, et al. (2018). “Glucose Control and Weight ChangeAssociated with Treatment with Exenatide Compared with Basal Insulin: ARetrospective Study”. In: Diabetes Ther 9.1, pp. 269–283. issn: 1869-6953(Print). doi: 10.1007/s13300-017-0359-z.

Morgan, C. et al. (2018). “Self-harm in a primary care cohort of older peo-ple: incidence, clinical management, and risk of suicide and other causesof death”. In: Lancet Psychiatry 5.11, pp. 905–912. issn: 2215-0366. doi:10.1016/s2215-0366(18)30348-1.

Mosholder, A. D. et al. (2018). “Long-Term Risk of Acute Myocardial Infarction,Stroke, and Death With Outpatient Use of Clarithromycin: A RetrospectiveCohort Study”. In: Am J Epidemiol 187.4, pp. 786–792. issn: 0002-9262.doi: 10.1093/aje/kwx319.

Moussa, O. M. et al. (2018). “Mortality of the Severely Obese: A PopulationStudy”. In: Ann Surg. issn: 0003-4932. doi: 10.1097/sla.0000000000002730.

Moussa, O. et al. (2018). “Fate of the metabolically healthy obese-is this terma misnomer? A study from the Clinical Practice Research Datalink”. In: IntJ Obes (Lond). issn: 0307-0565. doi: 10.1038/s41366-018-0096-z.

Mueller, A. M. et al. (2018). “The Potential of Glycemic Control and BodyWeight Change as Early Markers for Pancreatic Cancer in Patients WithLong-standing Diabetes Mellitus: A Case-Control Study”. In: PancreasPan-creasPancreas 47.7. 1536-4828¡br/¿Mueller, Alexandra M¡br/¿Meier, ChristophR¡br/¿Jick, Susan S¡br/¿Schneider, Cornelia¡br/¿Journal Article¡br/¿UnitedStates¡br/¿Pancreas. 2018 Aug;47(7):807-815. doi: 10.1097/MPA.0000000000001085.,pp. 807–815.

CPRD bibliography

94

Mukhtar, T. K. et al. (2018). “Factors associated with consultation rates in gen-eral practice in England, 2013-2014: a cross-sectional study”. In: Br J GenPract 68.670, e370–e377. issn: 0960-1643. doi: 10.3399/bjgp18X695981.

Muller, S. et al. (2018). “Searching for a prodrome for rheumatoid arthritis in theprimary care record: A case-control study in the clinical practice researchdatalink”. In: Semin Arthritis Rheum. issn: 0049-0172. doi: 10.1016/j.semarthrit.2018.06.008.

Nakafero, G. et al. (2018). “Predictors and temporal trend of flu vaccination inauto-immune rheumatic diseases in the UK: a nationwide prospective cohortstudy”. In: Rheumatology (Oxford) 57.10, pp. 1726–1734. issn: 1462-0324.doi: 10.1093/rheumatology/key156.

Newlove-Delgado, T. et al. (2018). “Prescribing of medication for attentiondeficit hyperactivity disorder among young people in the Clinical PracticeResearch Datalink 2005-2013: analysis of time to cessation”. In: Eur ChildAdolesc Psychiatry 27.1, pp. 29–35. issn: 1018-8827. doi: 10.1007/s00787-017-1011-1.

Nissen, F. et al. (2018). “Concomitant diagnosis of asthma and COPD: a quan-titative study in UK primary care”. In: Br J Gen Pract 68.676, e775–e782.issn: 0960-1643. doi: 10.3399/bjgp18X699389.

Nortoft, E., B. Chubb, and A. Borglykke (2018). “Obesity and healthcare re-source utilization: comparative results from the UK and the USA”. In: ObesSci Pract 4.1, pp. 41–45. issn: 2055-2238. doi: 10.1002/osp4.148.

Oshagbemi, O. A., F. M. E. Franssen, et al. (2018). “Blood eosinophilia, use ofinhaled corticosteroids, and risk of COPD exacerbations and mortality”. In:Pharmacoepidemiol Drug Saf 27.11, pp. 1191–1199. issn: 1053-8569. doi:10.1002/pds.4655.

Oshagbemi, O. A., S. J. Keene, et al. (2018). “Trends in moderate and severeexacerbations among COPD patients in the UK from 2005 to 2013”. In:Respir Med 144, pp. 1–6. issn: 0954-6111. doi: 10.1016/j.rmed.2018.09.010.

O’Sullivan, J. W., S. Stevens, F. D. R. Hobbs, et al. (2018). “Temporal trends inuse of tests in UK primary care, 2000-15: retrospective analysis of 250 milliontests”. In: Bmj 363, k4666. issn: 0959-8138. doi: 10.1136/bmj.k4666.

O’Sullivan, J. W., S. Stevens, J. Oke, et al. (2018). “Practice variation in theuse of tests in UK primary care: a retrospective analysis of 16 million testsperformed over 3.3 million patient years in 2015/16”. In: BMC Med 16.1,p. 229. issn: 1741-7015. doi: 10.1186/s12916-018-1217-1.

Otete, H. et al. (2018). “Healthcare Utilisation, Morbidities and Alcohol UseMonitoring Prior to Alcoholic Psychosis Diagnosis”. In: Alcohol Alcohol.issn: 0735-0414. doi: 10.1093/alcalc/agy085.

Padmanabhan, S. et al. (2018). “Approach to record linkage of primary caredata from Clinical Practice Research Datalink to other health-related patientdata: overview and implications”. In: Eur J Epidemiol. issn: 0393-2990. doi:10.1007/s10654-018-0442-4.

Parisi, R. et al. (2018). “Psychiatric morbidity and suicidal behaviour in psori-asis: a primary care cohort study”. In: Br J Dermatol. issn: 0007-0963. doi:10.1111/bjd.17004.

Partington, R. J. et al. (2018). “Incidence, prevalence and treatment burdenof polymyalgia rheumatica in the UK over two decades: a population-based

CPRD bibliography

95

study”. In: Ann Rheum Dis 77.12, pp. 1750–1756. issn: 0003-4967. doi:10.1136/annrheumdis-2018-213883.

Paskins, Z., R. Whittle, A. Abdul Sultan, et al. (2018). “Risk of fragility fractureamong patients with late-onset psoriasis: a UK population-based study”. In:Osteoporos Int 29.7, pp. 1659–1664. issn: 0937-941x. doi: 10.1007/s00198-018-4491-z.

Paskins, Z., R. Whittle, A. A. Sultan, et al. (2018). “Risk of fracture amongpatients with polymyalgia rheumatica and giant cell arteritis: a population-based study”. In: BMC Med 16.1, p. 4. issn: 1741-7015. doi: 10.1186/

s12916-017-0987-1.Pate, A. et al. (2018). “Study investigating the generalisability of a COPD trial

based in primary care (Salford Lung Study) and the presence of a Hawthorneeffect”. In: BMJ Open Respir Res 5.1, e000339. issn: 2052-4439 (Print) 2052-4439. doi: 10.1136/bmjresp-2018-000339.

Pearce, F. A., R. B. Hubbard, et al. (2018). “Can granulomatosis with polyangi-itis be diagnosed earlier in primary care? A case-control study”. In: Qjm111.1, pp. 39–45. issn: 1460-2393. doi: 10.1093/qjmed/hcx194.

Pearce, F. A., P. C. Lanyon, et al. (2018). “Novel insights into the aetiologyof granulomatosis with polyangiitis-a case-control study using the ClinicalPractice Research Datalink”. In: Rheumatology (Oxford) 57.6, pp. 1002–1010. issn: 1462-0324. doi: 10.1093/rheumatology/kex512.

Prasad, V., J. West, D. Kendrick, et al. (2018). “Attention-deficit/hyperactivitydisorder: variation by socioeconomic deprivation”. In: Arch Dis Child. issn:0003-9888. doi: 10.1136/archdischild-2017-314470.

Prasad, V., J. West, K. Sayal, et al. (2018). “Injury among children and youngpeople with and without attention-deficit hyperactivity disorder in the com-munity: The risk of fractures, thermal injuries, and poisonings”. In: ChildCare Health Dev 44.6, pp. 871–878. issn: 0305-1862. doi: 10.1111/cch.12591.

Price, D. B. et al. (2018). “Adverse outcomes from initiation of systemic corticos-teroids for asthma: long-term observational study”. In: J Asthma Allergy 11,pp. 193–204. issn: 1178-6965 (Print) 1178-6965. doi: 10.2147/jaa.s176026.

Pujades-Rodriguez, M., V. Assi, et al. (2018). “The diagnosis, burden and prog-nosis of dementia: A record-linkage cohort study in England”. In: PLoS One13.6, e0199026. issn: 1932-6203. doi: 10.1371/journal.pone.0199026.

Pujades-Rodriguez, M., O. P. Guttmann, et al. (2018). “Identifying unmet clin-ical need in hypertrophic cardiomyopathy using national electronic healthrecords”. In: PLoS One 13.1, e0191214. issn: 1932-6203. doi: 10.1371/

journal.pone.0191214.Pye, S. R. et al. (2018). “Assumptions made when preparing drug exposure

data for analysis have an impact on results: An unreported step in phar-macoepidemiology studies”. In: Pharmacoepidemiol Drug Saf 27.7, pp. 781–788. issn: 1053-8569. doi: 10.1002/pds.4440.

Quint, J. K. et al. (2018). “Recruitment of patients with Chronic ObstructivePulmonary Disease (COPD) from the Clinical Practice Research Datalink(CPRD) for research”. In: NPJ Prim Care Respir Med 28.1, p. 21. issn:2055-1010. doi: 10.1038/s41533-018-0089-3.

Rahimian, F. et al. (2018). “Predicting the risk of emergency admission withmachine learning: Development and validation using linked electronic health

CPRD bibliography

96

records”. In: PLoS Med 15.11, e1002695. issn: 1549-1277. doi: 10.1371/journal.pmed.1002695.

Rajaram, S. et al. (2018). “A retrospective observational analysis of post-pandemicinfluenza-related outcomes in the United Kingdom, 2010-2014”. In: HumVaccin Immunother 14.2, pp. 368–377. issn: 2164-5515. doi: 10 . 1080 /

21645515.2017.1403696.Rao, A. et al. (2018). “Long-term trends of use of health service among heart

failure patients”. In: Eur Heart J Qual Care Clin Outcomes 4.3, pp. 220–231.issn: 2058-1742. doi: 10.1093/ehjqcco/qcy013.

Rebordosa, C. et al. (2018). “GOLD assessment of COPD severity in the Clini-cal Practice Research Datalink (CPRD)”. In: Pharmacoepidemiol Drug Saf.issn: 1053-8569. doi: 10.1002/pds.4448.

Rhodes, K. M. et al. (2018). “Computationally efficient methods for fittingmixed models to electronic health records data”. In: Stat Med 37.29, pp. 4557–4570. issn: 0277-6715. doi: 10.1002/sim.7944.

Richardson, E. et al. (2018). “Increased risk of reproductive dysfunction inwomen prescribed long-term opioids for musculoskeletal pain: A matchedcohort study in the Clinical Practice Research Datalink”. In: Eur J Pain22.9, pp. 1701–1708. issn: 1090-3801. doi: 10.1002/ejp.1256.

Richardson, K. et al. (2018). “Anticholinergic drugs and risk of dementia: case-control study”. In: Bmj 361, k1315. issn: 0959-8138. doi: 10.1136/bmj.k1315.

Ride, J. et al. (2018). “Do care plans and annual reviews of physical health in-fluence unplanned hospital utilisation for people with serious mental illness?Analysis of linked longitudinal primary and secondary healthcare records inEngland”. In: BMJ Open 8.11, e023135. issn: 2044-6055. doi: 10.1136/

bmjopen-2018-023135.Roberts, K. J., C. A. Bannister, and H. Schrem (2018). “Enzyme replacement

improves survival among patients with pancreatic cancer: Results of a pop-ulation based study”. In: Pancreatology. issn: 1424-3903. doi: 10.1016/j.pan.2018.10.010.

Robinson, D. E. et al. (2018). “The limitations of using simple definitions ofglucocorticoid exposure to predict fracture risk: A cohort study”. In: Bone117, pp. 83–90. issn: 1873-2763. doi: 10.1016/j.bone.2018.09.004.

Rothnie, K. J., O. Connell, et al. (2018). “Myocardial Infarction and IschemicStroke after Exacerbations of Chronic Obstructive Pulmonary Disease”. In:Ann Am Thorac Soc 15.8, pp. 935–946. issn: 2325-6621. doi: 10.1513/

AnnalsATS.201710-815OC.Rothnie, K. J., H. Mullerova, et al. (2018). “Natural History of Chronic Obstruc-

tive Pulmonary Disease Exacerbations in a General Practice-based Popula-tion with Chronic Obstructive Pulmonary Disease”. In: Am J Respir CritCare Med 198.4, pp. 464–471. issn: 1073-449x. doi: 10.1164/rccm.201710-2029OC.

Roughley, M. et al. (2018). “Risk of chronic kidney disease in patients with goutand the impact of urate lowering therapy: a population-based cohort study”.In: Arthritis Res Ther 20.1, p. 243. issn: 1478-6354. doi: 10.1186/s13075-018-1746-1.

Roux, C. W. le et al. (2018). “Obesity and healthcare resource utilization: resultsfrom Clinical Practice Research Database (CPRD)”. In: Obes Sci Pract 4.5,pp. 409–416. issn: 2055-2238. doi: 10.1002/osp4.291.

CPRD bibliography

97

Royle, J. G. et al. (2018a). “Correction to: The incidence, prevalence, andsurvival of systemic sclerosis in the UK Clinical Practice Research Datalink”.In: Clin Rheumatol 37.9, p. 2601. issn: 0770-3198. doi: 10.1007/s10067-018-4219-7.

— (2018b). “The incidence, prevalence, and survival of systemic sclerosis in theUK Clinical Practice Research Datalink”. In: Clin Rheumatol 37.8, pp. 2103–2111. issn: 0770-3198. doi: 10.1007/s10067-018-4182-3.

Sabido, M., T. Hohenberger, and G. Grassi (2018). “Pharmacological interven-tion in hypertension using beta-blockers: Real-world evidence for long-termeffectiveness”. In: Pharmacol Res 130, pp. 191–197. issn: 1043-6618. doi:10.1016/j.phrs.2018.01.010.

Scheepers, Lejm et al. (2018). “Medication adherence among gout patients ini-tiated allopurinol: a retrospective cohort study in the Clinical Practice Re-search Datalink (CPRD)”. In: Rheumatology (Oxford) 57.9, pp. 1641–1650.issn: 1462-0324. doi: 10.1093/rheumatology/key155.

Schmidt, S. A. J. et al. (2018). “Mood Disorders and Risk of Herpes Zosterin 2 Population-Based Case-Control Studies in Denmark and the UnitedKingdom”. In: Am J Epidemiol 187.5, pp. 1019–1028. issn: 0002-9262. doi:10.1093/aje/kwx338.

Schneider, C. et al. (2018). “Colorectal cancer and markers of anemia”. In:Eur J Cancer Prev 27.6, pp. 530–538. issn: 0959-8278. doi: 10.1097/cej.0000000000000397.

Shephard, E. A. and W. T. Hamilton (2018). “Selection of men for investigationof possible testicular cancer in primary care: a large case-control study usingelectronic patient records”. In: Br J Gen Pract 68.673, e559–e565. issn:0960-1643. doi: 10.3399/bjgp18X697949.

Sheppard, J. P., S. Stevens, R. J. Stevens, et al. (2018). “Association of guidelineand policy changes with incidence of lifestyle advice and treatment for un-complicated mild hypertension in primary care: a longitudinal cohort studyin the Clinical Practice Research Datalink”. In: BMJ Open 8.9, e021827.issn: 2044-6055. doi: 10.1136/bmjopen-2018-021827.

Sheppard, J. P., S. Stevens, R. Stevens, et al. (2018). “Benefits and Harms ofAntihypertensive Treatment in Low-Risk Patients With Mild Hypertension”.In: JAMA Intern Med 178.12, pp. 1626–1634. issn: 2168-6106. doi: 10.

1001/jamainternmed.2018.4684.Silverwood, R. J. et al. (2018). “Severe and predominantly active atopic eczema

in adulthood and long term risk of cardiovascular disease: population basedcohort study”. In: Bmj 361, k1786. issn: 0959-8138. doi: 10.1136/bmj.k1786.

Simeonova, M. et al. (2018). “Increased risk of all-cause mortality associatedwith domperidone use in Parkinson’s patients: a population-based cohortstudy in the UK”. In: Br J Clin Pharmacol 84.11, pp. 2551–2561. issn:0306-5251. doi: 10.1111/bcp.13708.

Sinyavskaya, L. et al. (2018). “Comparative effect of statins on the risk ofincident Alzheimer disease”. In: Neurology 90.3, e179–e187. issn: 0028-3878.doi: 10.1212/wnl.0000000000004818.

Smith, M. et al. (2018). “Change in Albuminuria and Risk of Renal and Cardio-vascular Outcomes: Natural Variation Should Be Taken into Account”. In:Kidney Int Rep 3.4, pp. 939–949. issn: 2468-0249. doi: 10.1016/j.ekir.2018.04.004.

CPRD bibliography

98

Spanopoulos, D. et al. (2018a). “Prescription of DPP-4 Inhibitors to PatientsWith Adult Type 2 Diabetes Mellitus and Creatinine Clearance¿50 mL/min:The UK Primary Care Experience”. In: Clin Ther 40.8, 1424–1428.e4. issn:0149-2918. doi: 10.1016/j.clinthera.2018.06.002.

— (2018b). “Prescription of DPP-4 Inhibitors to Type 2 Diabetes MellitusPatients With Renal Impairment: A UK Primary Care Experience”. In: ClinTher 40.1, pp. 152–154. issn: 0149-2918. doi: 10.1016/j.clinthera.2017.11.009.

Spence, A. D. et al. (2018). “Statin use and survival in patients with gastric can-cer in two independent population-based cohorts”. In: PharmacoepidemiolDrug Saf. issn: 1053-8569. doi: 10.1002/pds.4688.

Stevens, S. L., R. J. McManus, and R. J. Stevens (2018). “The utility of long-term blood pressure variability for cardiovascular risk prediction in primarycare”. In: J Hypertens. issn: 0263-6352. doi: 10.1097/hjh.0000000000001923.

Strien, A. M. van et al. (2018). “Association Between Urinary Tract Infectionsand Antipsychotic Drug Use in Older Adults”. In: J Clin Psychopharmacol38.4, pp. 296–301. issn: 0271-0749. doi: 10.1097/jcp.0000000000000895.

Strongman, H., S. Christopher, et al. (2018). “Pioglitazone and cause-specificrisk of mortality in patients with type 2 diabetes: extended analysis froma European multidatabase cohort study”. In: BMJ Open Diabetes Res Care6.1, e000481. issn: 2052-4897 (Print) 2052-4897. doi: 10.1136/bmjdrc-

2017-000481.Strongman, H., I. Kausar, and T. M. Maher (2018). “Incidence, Prevalence, and

Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK”. In: AdvTher 35.5, pp. 724–736. issn: 0741-238x. doi: 10.1007/s12325-018-0693-1.

Suissa, S., S. Dell’Aniello, and P. Ernst (2018). “Comparative effectiveness ofLABA-ICS versus LAMA as initial treatment in COPD targeted by bloodeosinophils: a population-based cohort study”. In: Lancet Respir Med 6.11,pp. 855–862. issn: 2213-2600. doi: 10.1016/s2213-2600(18)30368-0.

Sultan, A. A. et al. (2018). “Risk of fragility fracture among patients with goutand the effect of urate-lowering therapy”. In: Cmaj 190.19, E581–e587. issn:0820-3946. doi: 10.1503/cmaj.170806.

Tamimi, I. et al. (2018). “Acetylcholinesterase inhibitors and the risk of os-teoporotic fractures: nested case-control study”. In: Osteoporos Int 29.4,pp. 849–857. issn: 0937-941x. doi: 10.1007/s00198-017-4346-z.

Tammes, P. et al. (2018). “Use of primary care data to predict those mostvulnerable to cold weather: a case-crossover analysis”. In: Br J Gen Pract68.668, e146–e156. issn: 0960-1643. doi: 10.3399/bjgp18X694829.

Thistle, J. E. et al. (2018). “Domperidone use and risk of primary liver cancer inthe Clinical Practice Research Datalink”. In: Cancer Epidemiol 55, pp. 170–175. issn: 1877-7821. doi: 10.1016/j.canep.2018.06.009.

Tran, J. et al. (2018). “Patterns and temporal trends of comorbidity amongadult patients with incident cardiovascular disease in the UK between 2000and 2014: A population-based cohort study”. In: PLoS Med 15.3, e1002513.issn: 1549-1277. doi: 10.1371/journal.pmed.1002513.

Tran-Duy, A. et al. (2018). “Use of proton pump inhibitors and risk of irondeficiency: a population-based case-control study”. In: J Intern Med. issn:0954-6820. doi: 10.1111/joim.12826.

CPRD bibliography

99

Turner, S. W. et al. (2018). “Applying UK real-world primary care data topredict asthma attacks in 3776 well-characterised children: a retrospectivecohort study”. In: NPJ Prim Care Respir Med 28.1, p. 28. issn: 2055-1010.doi: 10.1038/s41533-018-0095-5.

Tyrrell, E. G. et al. (2018). “Poisoning substances taken by young people: apopulation-based cohort study”. In: Br J Gen Pract 68.675, e703–e710. issn:0960-1643. doi: 10.3399/bjgp18X698897.

Vanni, S. et al. (2018). “Hemoglobin mRNA Changes in the Frontal Cortex ofPatients with Neurodegenerative Diseases”. In: Front Neurosci 12, p. 8. issn:1662-4548 (Print) 1662-453x. doi: 10.3389/fnins.2018.00008.

Vaz, L. R. et al. (2018). “Estimating the health-care costs of children born topregnant smokers in England: cohort study using primary and secondaryhealth-care data”. In: Addiction 113.7, pp. 1305–1316. issn: 0965-2140. doi:10.1111/add.14183.

Velde, R. Y. van der et al. (2018). “Incidence of subsequent fractures in the UKbetween 1990 and 2012 among individuals 50 years or older”. In: OsteoporosInt 29.11, pp. 2469–2475. issn: 0937-941x. doi: 10.1007/s00198- 018-

4636-0.Vinogradova, Y. et al. (2018). “Risks and benefits of direct oral anticoagulants

versus warfarin in a real world setting: cohort study in primary care”. In:Bmj 362, k2505. issn: 0959-8138. doi: 10.1136/bmj.k2505.

Voorham, J. et al. (2018). “Real-world effectiveness evaluation of budesonide/formoterolSpiromax for the management of asthma and chronic obstructive pulmonarydisease in the UK”. In: BMJ Open 8.10, e022051. issn: 2044-6055. doi:10.1136/bmjopen-2018-022051.

Walker, J. L. et al. (2018). “Effectiveness of herpes zoster vaccination in anolder United Kingdom population”. In: Vaccine 36.17, pp. 2371–2377. issn:0264-410x. doi: 10.1016/j.vaccine.2018.02.021.

Walker, V. M. et al. (2018). “What is the impact of regulatory guidance andexpiry of drug patents on dementia drug prescriptions in England? A trendanalysis in the Clinical Practice Research Datalink”. In: Alzheimers Res Ther10.1, p. 51. doi: 10.1186/s13195-018-0379-6.

Wang, Y. et al. (2018). “Risk of skin cancer among patients with myotonic dys-trophy type 1 based on primary care physician data from the U.K. ClinicalPractice Research Datalink”. In: Int J Cancer 142.6, pp. 1174–1181. issn:0020-7136. doi: 10.1002/ijc.31143.

Weir, S. et al. (2018). “Short- and long-term cost and utilization of health careresources in Parkinson’s disease in the UK”. In: Mov Disord 33.6, pp. 974–981. issn: 0885-3185. doi: 10.1002/mds.27302.

Wilding, J. et al. (2018). “Changes in HbA1c and weight, and treatment per-sistence, over the 18 months following initiation of second-line therapy inpatients with type 2 diabetes: results from the United Kingdom ClinicalPractice Research Datalink”. In: BMC Med 16.1, p. 116. issn: 1741-7015.doi: 10.1186/s12916-018-1085-8.

Wilkinson, S. et al. (2018). “Changing use of antidiabetic drugs in the UK:trends in prescribing 2000-2017”. In: BMJ Open 8.7, e022768. issn: 2044-6055. doi: 10.1136/bmjopen-2018-022768.

Williams, R. et al. (2018). “Cancer recording in patients with and without type2 diabetes in the Clinical Practice Research Datalink primary care data and

CPRD bibliography

100

linked hospital admission data: a cohort study”. In: BMJ Open 8.5, e020827.issn: 2044-6055. doi: 10.1136/bmjopen-2017-020827.

Wilson, J. C. et al. (2018). “Incidence and risk of glucocorticoid-associatedadverse effects in patients with rheumatoid arthritis”. In: Arthritis CareRes (Hoboken). issn: 2151-464x. doi: 10.1002/acr.23611.

Wing, K. et al. (2018). “Real-world effects of medications for chronic obstructivepulmonary disease: protocol for a UK population-based non-interventionalcohort study with validation against randomised trial results”. In: BMJ Open8.3, e019475. issn: 2044-6055. doi: 10.1136/bmjopen-2017-019475.

Wolfson, D. B. et al. (2018). “Benefits of combining prevalent and incidentcohorts: An application to myotonic dystrophy”. In: Stat Methods Med Res,p. 962280218804275. issn: 0962-2802. doi: 10.1177/0962280218804275.

Yanni, E. A. et al. (2018). “Burden of herpes zoster in 16 selected immunocom-promised populations in England: a cohort study in the Clinical PracticeResearch Datalink 2000-2012”. In: BMJ Open 8.6, e020528. issn: 2044-6055.doi: 10.1136/bmjopen-2017-020528.

Yu, D., K. P. Jordan, and G. Peat (2018). “Underrecording of osteoarthritisin United Kingdom primary care electronic health record data”. In: ClinEpidemiol 10, pp. 1195–1201. issn: 1179-1349 (Print) 1179-1349. doi: 10.2147/clep.s160059.

Yu, D., K. P. Jordan, K. I. E. Snell, et al. (2018). “Development and validation ofprediction models to estimate risk of primary total hip and knee replacementsusing data from the UK: two prospective open cohorts using the UK ClinicalPractice Research Datalink”. In: Ann Rheum Dis. issn: 0003-4967. doi:10.1136/annrheumdis-2018-213894.

Yu, O. et al. (2018). “Sulfonylureas as Initial Treatment for Type 2 Diabetes andthe Risk of Severe Hypoglycemia”. In: Am J Med 131.3, 317.e11–317.e22.issn: 0002-9343. doi: 10.1016/j.amjmed.2017.09.044.

Zghebi, S. S. et al. (2018). “Using electronic health records to quantify andstratify the severity of type 2 diabetes in primary care in England: rationaleand cohort study design”. In: BMJ Open 8.6, e020926. issn: 2044-6055. doi:10.1136/bmjopen-2017-020926.

Zhong, V. W., J. Juhaeri, S. R. Cole, et al. (2018). “HbA1C variability andhypoglycemia hospitalization in adults with type 1 and type 2 diabetes: Anested case-control study”. In: J Diabetes Complications 32.2, pp. 203–209.issn: 1056-8727. doi: 10.1016/j.jdiacomp.2017.10.008.

Zhong, V. W., J. Juhaeri, and E. J. Mayer-Davis (2018). “Trends in HospitalAdmission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Di-abetes in England, 1998-2013: A Retrospective Cohort Study”. In: DiabetesCare 41.9, pp. 1870–1877. issn: 0149-5992. doi: 10.2337/dc17-1583.

CPRD bibliography

101

2017

Abdul Sultan, A. et al. (2017). “Gout and subsequent erectile dysfunction: apopulation-based cohort study from England”. In: Arthritis Res Ther 19.1,p. 123. issn: 1478-6354. doi: 10.1186/s13075-017-1322-0.

Abhishek, A. et al. (2017). “Rheumatoid arthritis is getting less frequent-resultsof a nationwide population-based cohort study”. In: Rheumatology (Oxford)56.5, pp. 736–744. issn: 1462-0324. doi: 10.1093/rheumatology/kew468.

Alexakis, C. et al. (2017). “Do Thiopurines Reduce the Risk of Surgery in ElderlyOnset Inflammatory Bowel Disease? A 20-Year National Population-BasedCohort Study”. In: Inflamm Bowel Dis 23.4, pp. 672–680. issn: 1078-0998.doi: 10.1097/mib.0000000000001031.

Allen, C. and K. Donegan (2017). “The impact of regulatory action on theco-prescribing of renin-angiotensin system blockers in UK primary care”.In: Pharmacoepidemiol Drug Saf 26.7, pp. 858–862. issn: 1053-8569. doi:10.1002/pds.4219.

Ankarfeldt, M. Z. et al. (2017). “Assessment of channeling bias among initiatorsof glucose-lowering drugs: A UK cohort study”. In: Clin Epidemiol 9, pp. 19–30. issn: 1179-1349 (Print) 1179-1349. doi: 10.2147/clep.s124054.

Bailey, S. E. et al. (2017). “Clinical relevance of thrombocytosis in primarycare: a prospective cohort study of cancer incidence using English electronicmedical records and cancer registry data”. In: Br J Gen Pract 67.659, e405–e413. issn: 0960-1643. doi: 10.3399/bjgp17X691109.

Baker, R. et al. (2017). “Association between maternal depression and anxietyepisodes and rates of childhood injuries: a cohort study from England”. In:Inj Prev 23.6, pp. 396–402. issn: 1353-8047. doi: 10.1136/injuryprev-2016-042294.

Ban, L. et al. (2017). “Incidence of First Stroke in Pregnant and NonpregnantWomen of Childbearing Age: A Population-Based Cohort Study From Eng-land”. In: J Am Heart Assoc 6.4. issn: 2047-9980. doi: 10.1161/jaha.116.004601.

Barker, I., A. Steventon, and S. R. Deeny (2017). “Association between conti-nuity of care in general practice and hospital admissions for ambulatory caresensitive conditions: cross sectional study of routinely collected, person leveldata”. In: Bmj 356, j84. issn: 0959-8138. doi: 10.1136/bmj.j84.

Bayliss, L. E. et al. (2017). “The effect of patient age at intervention on riskof implant revision after total replacement of the hip or knee: a population-based cohort study”. In: Lancet 389.10077, pp. 1424–1430. issn: 0140-6736.doi: 10.1016/s0140-6736(17)30059-4.

Becker, C., S. S. Jick, and C. R. Meier (2017). “Selective Serotonin ReuptakeInhibitors and Cataract Risk: A Case-Control Analysis”. In: Ophthalmology124.11, pp. 1635–1639. issn: 0161-6420. doi: 10.1016/j.ophtha.2017.05.002.

Becker, C., S. S. Jick, C. R. Meier, and M. Bodmer (2017). “Metformin and therisk of renal cell carcinoma: a case-control analysis”. In: Eur J Cancer Prev26.3, pp. 257–262. issn: 0959-8278. doi: 10.1097/cej.0000000000000246.

Berni, E. et al. (2017). “Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics

CPRD bibliography

102

prescribed for respiratory tract infections: a retrospective cohort study”. In:BMJ Open 7.1, e013398. issn: 2044-6055. doi: 10.1136/bmjopen-2016-013398.

Bietry, F. A. et al. (2017). “Iron supplementation in Switzerland - A bi-national,descriptive and observational study”. In: Swiss Med Wkly 147, w14444. issn:0036-7672. doi: 10.4414/smw.2017.14444.

Birks, J. et al. (2017). “Evaluation of a prediction model for colorectal cancer:retrospective analysis of 2.5 million patient records”. In: Cancer Med 6.10,pp. 2453–2460. issn: 2045-7634. doi: 10.1002/cam4.1183.

Ble, A. et al. (2017). “Safety and Effectiveness of Statins for Prevention ofRecurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study”. In: J Gerontol A Biol Sci Med Sci 72.2, pp. 243–250.issn: 1079-5006. doi: 10.1093/gerona/glw082.

Borghs, S. et al. (2017). “Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-termretrospective matched cohort study”. In: BMC Neurol 17.1, p. 59. issn:1471-2377. doi: 10.1186/s12883-017-0837-y.

Bouras, G., E. M. Burns, et al. (2017). “Linked hospital and primary caredatabase analysis of the impact of short-term complications on recurrencein laparoscopic inguinal hernia repair”. In: Hernia 21.2, pp. 191–198. issn:1248-9204. doi: 10.1007/s10029-017-1575-1.

Bouras, G., S. R. Markar, et al. (2017). “The psychological impact of symptomsrelated to esophagogastric cancer resection presenting in primary care: Anational linked database study”. In: Eur J Surg Oncol 43.2, pp. 454–460.issn: 0748-7983. doi: 10.1016/j.ejso.2016.10.010.

Boven, J. van et al. (2017). “Real-world cost effectiveness comparison of symbi-cort turbuhaler and duoresp spiromax in UK patients with asthma or chronicobstructive pulmonary disease”. In: Value in Health 20.9, A645.

Bowman, K. et al. (2017). “Obesity in Older People With and Without Con-ditions Associated With Weight Loss: Follow-up of 955,000 Primary CarePatients”. In: J Gerontol A Biol Sci Med Sci 72.2, pp. 203–209. issn: 1079-5006. doi: 10.1093/gerona/glw147.

Braeken, D. C. et al. (2017). “Risk of community-acquired pneumonia in chronicobstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom”. In: Int J Chron Obstruct Pul-mon Dis 12, pp. 2425–2432. issn: 1176-9106. doi: 10.2147/copd.s138435.

Brassard, P. et al. (2017). “The effect of statins on influenza-like illness morbid-ity and mortality”. In: Pharmacoepidemiol Drug Saf 26.1, pp. 63–70. issn:1053-8569. doi: 10.1002/pds.4112.

Bronsveld, H. K. et al. (2017). “Trends in breast cancer incidence among womenwith type-2 diabetes in British general practice”. In: Prim Care Diabetes11.4, pp. 373–382. issn: 1878-0210. doi: 10.1016/j.pcd.2017.02.001.

Browne, J. et al. (2017). “Association of comorbidity and health service usageamong patients with dementia in the UK: a population-based study”. In:BMJ Open 7.3, e012546. issn: 2044-6055. doi: 10.1136/bmjopen-2016-012546.

Bruderer, S. G., D. Bodmer, et al. (2017). “Population-Based Study on theEpidemiology of Meniere’s Disease”. In: Audiol Neurootol 22.2, pp. 74–82.issn: 1420-3030. doi: 10.1159/000475875.

CPRD bibliography

103

Bruderer, S. G., C. R. Meier, et al. (2017). “The association between thyroiddisorders and incident gout: population-based case-control study”. In: ClinEpidemiol 9, pp. 205–215. issn: 1179-1349 (Print) 1179-1349. doi: 10.2147/clep.s128627.

But, A. et al. (2017). “Cancer risk among insulin users: comparing analogueswith human insulin in the CARING five-country cohort study”. In: Dia-betologia 60.9, pp. 1691–1703. issn: 0012-186x. doi: 10.1007/s00125-017-4312-5.

Carey, I. M. et al. (2017). “Do health checks for adults with intellectual disabilityreduce emergency hospital admissions? Evaluation of a natural experiment”.In: J Epidemiol Community Health 71.1, pp. 52–58. issn: 0143-005x. doi:10.1136/jech-2016-207557.

Carr, M. J. et al. (2017). “Premature Death Among Primary Care PatientsWith a History of Self-Harm”. In: Ann Fam Med 15.3, pp. 246–254. issn:1544-1709. doi: 10.1370/afm.2054.

Carreira, H. et al. (2017). “Adverse mental health outcomes in breast cancersurvivors compared to women who did not have cancer: systematic reviewprotocol”. In: Syst Rev 6.1, p. 162. issn: 2046-4053. doi: 10.1186/s13643-017-0551-2.

Caspard, H. et al. (2017). “Incidence of live-attenuated influenza vaccine ad-ministration beyond expiry date in children and adolescents aged 2-17 yearsin the UK: a population-based cohort study”. In: BMJ Open 7.7, e016520.issn: 2044-6055. doi: 10.1136/bmjopen-2017-016520.

Chalmers, J. D. et al. (2017). “Determinants of initial inhaled corticosteroid usein patients with GOLD A/B COPD: a retrospective study of UK generalpractice”. In: NPJ Prim Care Respir Med 27.1, p. 43. issn: 2055-1010. doi:10.1038/s41533-017-0040-z.

Chapple, C. R. et al. (2017). “Persistence and Adherence with Mirabegron ver-sus Antimuscarinic Agents in Patients with Overactive Bladder: A Retro-spective Observational Study in UK Clinical Practice”. In: Eur Urol 72.3,pp. 389–399. issn: 0302-2838. doi: 10.1016/j.eururo.2017.01.037.

Charlton, R. A. et al. (2017). “Sensitivity of the UK Clinical Practice ResearchDatalink to Detect Neurodevelopmental Effects of Medicine Exposure inUtero: Comparative Analysis of an Antiepileptic Drug-Exposed Cohort”. In:Drug Saf 40.5, pp. 387–397. issn: 0114-5916. doi: 10.1007/s40264-017-0506-5.

Chaudhry, Z. et al. (2017). “Outputs and Growth of Primary Care Databasesin the United Kingdom: Bibliometric Analysis”. In: J Innov Health Inform24.3, p. 942. issn: 2058-4555. doi: 10.14236/jhi.v24i3.942.

Chiquette, E. et al. (2017). “Estimating the prevalence of generalized and par-tial lipodystrophy: findings and challenges”. In: Diabetes Metab Syndr Obes10, pp. 375–383. issn: 1178-7007 (Print) 1178-7007. doi: 10.2147/dmso.s130810.

Chu, T. P. C., G. W. Moran, and T. R. Card (2017). “The Pattern of UnderlyingCause of Death in Patients with Inflammatory Bowel Disease in England: ARecord Linkage Study”. In: J Crohns Colitis 11.5, pp. 578–585. issn: 1873-9946. doi: 10.1093/ecco-jcc/jjw192.

Chu, T. P. et al. (2017). “Where are the opportunities for an earlier diagnosisof primary intracranial tumours in children and young adults?” In: Eur J

CPRD bibliography

104

Paediatr Neurol 21.2, pp. 388–395. issn: 1090-3798. doi: 10.1016/j.ejpn.2016.10.010.

Clarson, L. E. et al. (2017). “Factors Influencing Allopurinol Initiation in Pri-mary Care”. In: Ann Fam Med 15.6, pp. 557–560. issn: 1544-1709. doi:10.1370/afm.2137.

Cohen, A. T. et al. (2017). “Epidemiology of first and recurrent venous throm-boembolism in patients with active cancer. A population-based cohort study”.In: Thromb Haemost 117.1, pp. 57–65. issn: 0340-6245. doi: 10.1160/th15-08-0686.

Collin, S. M. et al. (2017a). “Health care resource use by patients before andafter a diagnosis of chronic fatigue syndrome (CFS/ME): a clinical practiceresearch datalink study”. In: BMC Fam Pract 18.1, p. 60. issn: 1471-2296.doi: 10.1186/s12875-017-0635-z.

— (2017b). “Trends in the incidence of chronic fatigue syndrome and fibromyal-gia in the UK, 2001-2013: a Clinical Practice Research Datalink study”. In: JR Soc Med 110.6, pp. 231–244. issn: 0141-0768. doi: 10.1177/0141076817702530.

Cooper, A. J. M. et al. (2017). “Prevalence and Incidence Trends for DiagnosedPrescription Opioid Use Disorders in the United Kingdom”. In: Pain Ther6.1, pp. 73–84. issn: 2193-8237 (Print). doi: 10.1007/s40122-017-0070-9.

Crane, M. M. et al. (2017). “Hand eczema and steroid-refractory chronic handeczema in general practice: prevalence and initial treatment”. In: Br J Der-matol 176.4, pp. 955–964. issn: 0007-0963. doi: 10.1111/bjd.14974.

Danese, M. D., M. Gleeson, R. I. Griffiths, et al. (2017). “Methods for estimatingcosts in patients with hyperlipidemia experiencing their first cardiovascularevent in the United Kingdom”. In: J Med Econ 20.9, pp. 931–937. issn:1369-6998. doi: 10.1080/13696998.2017.1345747.

Danese, M. D., M. Gleeson, L. Kutikova, et al. (2017). “Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retro-spective cohort study”. In: BMJ Open 7.5, e013851. issn: 2044-6055. doi:10.1136/bmjopen-2016-013851.

Datta-Nemdharry, P. et al. (2017). “Patterns of anti-diabetic medication use inpatients with type 2 diabetes mellitus in England and Wales”. In: Pharma-coepidemiol Drug Saf 26.2, pp. 127–135. issn: 1053-8569. doi: 10.1002/pds.4092.

Davies, N. M. et al. (2017). “How to compare instrumental variable and conven-tional regression analyses using negative controls and bias plots”. In: Int JEpidemiol 46.6, pp. 2067–2077. issn: 0300-5771. doi: 10.1093/ije/dyx014.

De Jong, H. J. I. et al. (2017). “Pattern of risks of systemic lupus erythematosusamong statin users: a population-based cohort study”. In: Ann Rheum Dis76.10, pp. 1723–1730. issn: 0003-4967. doi: 10.1136/annrheumdis-2016-210936.

Delgado, J. et al. (2017). “Outcomes of Treated Hypertension at Age 80 andOlder: Cohort Analysis of 79,376 Individuals”. In: J Am Geriatr Soc 65.5,pp. 995–1003. issn: 0002-8614. doi: 10.1111/jgs.14712.

Doble, B. et al. (2017). “Retrospective, multicohort analysis of the ClinicalPractice Research Datalink (CPRD) to determine differences in the costof medication wastage, dispensing fees and prescriber time of issuing eithershort (¡60 days) or long (¿/=60 days) prescription leng”. In: BMJ Open 7.12,e019382. issn: 2044-6055. doi: 10.1136/bmjopen-2017-019382.

CPRD bibliography

105

Dollerup, J. et al. (2017). “Cardiovascular risks in smokers treated with nico-tine replacement therapy: a historical cohort study”. In: Clin Epidemiol9, pp. 231–243. issn: 1179-1349 (Print) 1179-1349. doi: 10.2147/clep.

s127775.Donegan, K. et al. (2017). “Trends in diagnosis and treatment for people with

dementia in the UK from 2005 to 2015: a longitudinal retrospective cohortstudy”. In: Lancet Public Health 2.3, e149–e156. doi: 10 . 1016 / s2468 -

2667(17)30031-2.Douros, A. et al. (2017). “Pharmacologic Differences of Sulfonylureas and the

Risk of Adverse Cardiovascular and Hypoglycemic Events”. In: DiabetesCare 40.11, pp. 1506–1513. issn: 0149-5992. doi: 10.2337/dc17-0595.

Driessen, J. H. et al. (2017). “Long-term use of dipeptidyl peptidase-4 inhibitorsand risk of fracture: A retrospective population-based cohort study”. In:Diabetes Obes Metab 19.3, pp. 421–428. issn: 1462-8902. doi: 10.1111/

dom.12843.Durham, T. A. et al. (2017). “Utilization of Standard and Target-Specific Oral

Anticoagulants Among Adults in the United Kingdom With Incident AtrialFibrillation”. In: Am J Cardiol 120.10, pp. 1820–1829. issn: 0002-9149. doi:10.1016/j.amjcard.2017.07.091.

Eberg, M., R. W. Platt, and K. B. Filion (2017). “The Estimation of GestationalAge at Birth in Database Studies”. In: Epidemiology 28.6, pp. 854–862. issn:1044-3983. doi: 10.1097/ede.0000000000000713.

Farley, A. et al. (2017). “Physician Support of Smoking Cessation After Diag-nosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer”. In: Ann FamMed 15.5, pp. 443–450. issn: 1544-1709. doi: 10.1370/afm.2100.

Francis, N. A. et al. (2017). “The management of acne vulgaris in primarycare: a cohort study of consulting and prescribing patterns using the ClinicalPractice Research Datalink”. In: Br J Dermatol 176.1, pp. 107–115. issn:0007-0963. doi: 10.1111/bjd.15081.

Francois, C. et al. (2017). “Creating an index to measure health state of de-pressed patients in automated healthcare databases: the methodology”. In:J Mark Access Health Policy 5.1, p. 1372025. issn: 2001-6689 (Print) 2001-6689. doi: 10.1080/20016689.2017.1372025.

Franklin, M. et al. (2017). “Economic Evaluations Alongside Efficient StudyDesigns Using Large Observational Datasets: the PLEASANT Trial CaseStudy”. In: Pharmacoeconomics 35.5, pp. 561–573. issn: 1170-7690. doi:10.1007/s40273-016-0484-y.

Frey, N., A. Bircher, et al. (2017). “Validation of Stevens-Johnson syndromeor toxic epidermal necrolysis diagnoses in the Clinical Practice ResearchDatalink”. In: Pharmacoepidemiol Drug Saf 26.4, pp. 429–436. issn: 1053-8569. doi: 10.1002/pds.4124.

Frey, N., M. Bodmer, et al. (2017). “The risk of Stevens-Johnson syndrome andtoxic epidermal necrolysis in new users of antiepileptic drugs”. In: Epilepsia58.12, pp. 2178–2185. issn: 0013-9580. doi: 10.1111/epi.13925.

Frey, N., T. Hugle, et al. (2017). “Hyperlipidaemia and incident osteoarthritisof the hand: a population-based case-control study”. In: Osteoarthritis Car-tilage 25.7, pp. 1040–1045. issn: 1063-4584. doi: 10.1016/j.joca.2017.01.014.

CPRD bibliography

106

Frey, N., J. Jossi, et al. (2017). “The Epidemiology of Stevens-Johnson Syndromeand Toxic Epidermal Necrolysis in the UK”. In: J Invest Dermatol 137.6,pp. 1240–1247. issn: 0022-202x. doi: 10.1016/j.jid.2017.01.031.

Gamble, J. M. et al. (2017). “Association of insulin dosage with mortality or ma-jor adverse cardiovascular events: a retrospective cohort study”. In: LancetDiabetes Endocrinol 5.1, pp. 43–52. issn: 2213-8587. doi: 10.1016/s2213-8587(16)30316-3.

Gentil, M. L. et al. (2017). “Factors influencing the development of primarycare data collection projects from electronic health records: a systematicreview of the literature”. In: BMC Med Inform Decis Mak 17.1, p. 139. issn:1472-6947. doi: 10.1186/s12911-017-0538-x.

Gieling, E. M. et al. (2017). “Risk of major bleeding and stroke associated withthe use of vitamin K antagonists, nonvitamin K antagonist oral anticoagu-lants and aspirin in patients with atrial fibrillation: a cohort study”. In: BrJ Clin Pharmacol 83.8, pp. 1844–1859. issn: 0306-5251. doi: 10.1111/bcp.13265.

Glover, G. et al. (2017). “Mortality in people with intellectual disabilities inEngland”. In: J Intellect Disabil Res 61.1, pp. 62–74. issn: 0964-2633. doi:10.1111/jir.12314.

Gordon, J. et al. (2017). “Managing glycaemia in older people with type 2diabetes: A retrospective, primary care-based cohort study, with economicassessment of patient outcomes”. In: Diabetes Obes Metab 19.5, pp. 644–653.issn: 1462-8902. doi: 10.1111/dom.12867.

Gorricho, J. et al. (2017). “Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study”. In: Br J Clin Pharmacol83.9, pp. 2034–2044. issn: 0306-5251. doi: 10.1111/bcp.13288.

Grandi, S. M. et al. (2017). “Hypertensive Disorders in Pregnancy and the Riskof Subsequent Cardiovascular Disease”. In: Paediatr Perinat Epidemiol 31.5,pp. 412–421. issn: 0269-5022. doi: 10.1111/ppe.12388.

Granerod, J. et al. (2017). “Increased rates of sequelae post-encephalitis in indi-viduals attending primary care practices in the United Kingdom: a population-based retrospective cohort study”. In: J Neurol 264.2, pp. 407–415. issn:0340-5354. doi: 10.1007/s00415-016-8316-8.

Griffiths, R. I. et al. (2017). “Outcomes of preexisting diabetes mellitus in breast,colorectal, and prostate cancer”. In: J Cancer Surviv 11.5, pp. 604–613. issn:1932-2259. doi: 10.1007/s11764-017-0631-2.

Gulliford, M. C. et al. (2017). “Costs and Outcomes of Increasing Access toBariatric Surgery: Cohort Study and Cost-Effectiveness Analysis Using Elec-tronic Health Records”. In: Value Health 20.1, pp. 85–92. issn: 1098-3015.doi: 10.1016/j.jval.2016.08.734.

Gulliford, M. et al. (2017). “Inception and deprescribing of statins in peopleaged over 80 years: cohort study”. In: Age Ageing 46.6, pp. 1001–1005. issn:0002-0729. doi: 10.1093/ageing/afx100.

Hagberg, K. W., H. A. Divan, S. C. Fang, et al. (2017). “Risk of gynecomastiaand breast cancer associated with the use of 5-alpha reductase inhibitorsfor benign prostatic hyperplasia”. In: Clin Epidemiol 9, pp. 83–91. issn:1179-1349 (Print) 1179-1349. doi: 10.2147/clep.s124674.

Hagberg, K. W., H. A. Divan, J. C. Nickel, et al. (2017). “Risk of IncidentAntidepressant-Treated Depression Associated with Use of 5alpha-ReductaseInhibitors Compared with Use of alpha-Blockers in Men with Benign Pro-

CPRD bibliography

107

static Hyperplasia: A Population-Based Study Using the Clinical PracticeResearch Datalink”. In: Pharmacotherapy 37.5, pp. 517–527. issn: 0277-0008. doi: 10.1002/phar.1925.

Hagberg, K. W. and S. S. Jick (2017). “Validation of autism spectrum disorderdiagnoses recorded in the Clinical Practice Research Datalink, 1990-2014”.In: Clin Epidemiol 9, pp. 475–482. issn: 1179-1349 (Print) 1179-1349. doi:10.2147/clep.s139107.

Hansson, E. et al. (2017). “Herpes zoster risk after 21 specific cancers: population-based case-control study”. In: Br J Cancer 116.12, pp. 1643–1651. issn:0007-0920. doi: 10.1038/bjc.2017.124.

Herrington, W. G. et al. (2017). “Body-mass index and risk of advanced chronickidney disease: Prospective analyses from a primary care cohort of 1.4 millionadults in England”. In: PLoS One 12.3, e0173515. issn: 1932-6203. doi:10.1371/journal.pone.0173515.

Hicks, B. M., A. J. Klil-Drori, et al. (2017). “Androgen Deprivation Therapyand the Risk of Anemia in Men with Prostate Cancer”. In: Epidemiology28.5, pp. 712–718. issn: 1044-3983. doi: 10.1097/ede.0000000000000678.

Hicks, B. M., H. Yin, F. Bladou, et al. (2017). “Androgen deprivation therapyfor prostate cancer and the risk of hospitalisation for community-acquiredpneumonia”. In: Thorax 72.7, pp. 596–597. issn: 0040-6376. doi: 10.1136/thoraxjnl-2016-209512.

Hicks, B. M., H. Yin, L. Sinyavskaya, et al. (2017). “Metformin and the incidenceof viral associated cancers in patients with type 2 diabetes”. In: Int J Cancer141.1, pp. 121–128. issn: 0020-7136. doi: 10.1002/ijc.30733.

Holbrook, T. et al. (2017). “Direct medical costs of severe hypoglycaemic eventsin patients with type 2 diabetes in England: A retrospective database study”.In: Int J Clin Pract 71.6. issn: 1368-5031. doi: 10.1111/ijcp.12958.

Holden, S. E., S. Jenkins-Jones, et al. (2017). “Prevalence, glucose control andrelative survival of people with Type 2 diabetes in the UK from 1991 to2013”. In: Diabet Med 34.6, pp. 770–780. issn: 0742-3071. doi: 10.1111/dme.13332.

Holden, S. E., C. L. Morgan, et al. (2017). “Healthcare resource utilization andrelated financial costs associated with glucose lowering with either exenatideor basal insulin: A retrospective cohort study”. In: Diabetes Obes Metab 19.8,pp. 1097–1105. issn: 1462-8902. doi: 10.1111/dom.12916.

Humphreys, J. H. et al. (2017). “Quantifying the hepatotoxic risk of alcoholconsumption in patients with rheumatoid arthritis taking methotrexate”.In: Ann Rheum Dis 76.9, pp. 1509–1514. issn: 0003-4967. doi: 10.1136/annrheumdis-2016-210629.

Iwagami, M., L. A. Tomlinson, K. E. Mansfield, A. Casula, et al. (2017). “Valid-ity of estimated prevalence of decreased kidney function and renal replace-ment therapy from primary care electronic health records compared withnational survey and registry data in the United Kingdom”. In: Nephrol DialTransplant 32.suppl2, pp. ii142–ii150. issn: 0931-0509. doi: 10.1093/ndt/gfw318.

Iwagami, M., L. A. Tomlinson, K. E. Mansfield, H. I. McDonald, et al. (2017).“Prevalence, incidence, indication, and choice of antidepressants in patientswith and without chronic kidney disease: a matched cohort study in UKClinical Practice Research Datalink”. In: Pharmacoepidemiol Drug Saf 26.7,pp. 792–801. issn: 1053-8569. doi: 10.1002/pds.4212.

CPRD bibliography

108

Jain, A., A. J. van Hoek, et al. (2017). “Identifying social factors amongstolder individuals in linked electronic health records: An assessment in apopulation based study”. In: PLoS One 12.11, e0189038. issn: 1932-6203.doi: 10.1371/journal.pone.0189038.

Jain, A., H. I. McDonald, et al. (2017). “Risk factors for developing acute kidneyinjury in older people with diabetes and community-acquired pneumonia: apopulation-based UK cohort study”. In: BMC Nephrol 18.1, p. 142. issn:1471-2369. doi: 10.1186/s12882-017-0566-x.

Jick, S. et al. (2017). “Prevalence of hypercalcemia of malignancy among pedi-atric cancer patients in the UK Clinical Practice Research Datalink database”.In: Clin Epidemiol 9, pp. 339–343. issn: 1179-1349 (Print) 1179-1349. doi:10.2147/clep.s137616.

Joseph, R. M. et al. (2017). “Risks of smoking and benefits of smoking cessationon hospitalisations for cardiovascular events and respiratory infection inpatients with rheumatoid arthritis: a retrospective cohort study using theClinical Practice Research Datalink”. In: RMD Open 3.2, e000506. issn:2056-5933 (Print) 2056-5933. doi: 10.1136/rmdopen-2017-000506.

Judge, A. et al. (2017). “Protective effect of antirheumatic drugs on dementia inrheumatoid arthritis patients”. In: Alzheimers Dement (N Y) 3.4, pp. 612–621. issn: 2352-8737. doi: 10.1016/j.trci.2017.10.002.

Kaye, J. A. et al. (2017). “Cancer Incidence after Initiation of AntimuscarinicMedications for Overactive Bladder in the United Kingdom: Evidence forProtopathic Bias”. In: Pharmacotherapy 37.6, pp. 673–683. issn: 0277-0008.doi: 10.1002/phar.1932.

Khan, U. T. et al. (2017). “Venous thromboembolism and mortality in breastcancer: cohort study with systematic review and meta-analysis”. In: BMCCancer 17.1, p. 747. issn: 1471-2407. doi: 10.1186/s12885-017-3719-1.

Khosrow-Khavar, F. et al. (2017). “Androgen Deprivation Therapy and theRisk of Dementia in Patients With Prostate Cancer”. In: J Clin Oncol 35.2,pp. 201–207. issn: 0732-183x. doi: 10.1200/jco.2016.69.6203.

Kiconco, S., A. Abdul Sultan, and M. J. Grainge (2017). “Recurrence risk ofvenous thromboembolism and hormone use in women from England: a cohortstudy using clinical practice research datalink”. In: Br J Haematol 177.1,pp. 127–135. issn: 0007-1048. doi: 10.1111/bjh.14516.

Klil-Drori, A. J. et al. (2017). “Prolactin-Elevating Antipsychotics and the Riskof Endometrial Cancer”. In: J Clin Psychiatry 78.6, pp. 714–719. issn: 0160-6689. doi: 10.4088/JCP.15m10532.

Klop, C. et al. (2017). “The epidemiology of mortality after fracture in England:variation by age, sex, time, geographic location, and ethnicity”. In: Osteo-poros Int 28.1, pp. 161–168. issn: 0937-941x. doi: 10.1007/s00198-016-3787-0.

Knapen, L. M. et al. (2017). “Use of incretin agents and risk of acute andchronic pancreatitis: A population-based cohort study”. In: Diabetes ObesMetab 19.3, pp. 401–411. issn: 1462-8902. doi: 10.1111/dom.12833.

Kontopantelis, E. et al. (2017). “Longitudinal multiple imputation approachesfor body mass index or other variables with very low individual-level vari-ability: the mibmi command in Stata”. In: BMC Res Notes 10.1, p. 41. issn:1756-0500. doi: 10.1186/s13104-016-2365-z.

Kosiborod, M. et al. (2017). “Lower Risk of Heart Failure and Death in Pa-tients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other

CPRD bibliography

109

Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effective-ness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotranspo”.In: Circulation 136.3, pp. 249–259. issn: 0009-7322. doi: 10.1161/circulationaha.117.029190.

Kurdi, A. I., L. C. Chen, and R. A. Elliott (2017). “Exploring factors associatedwith patients’ adherence to antihypertensive drugs among people with pri-mary hypertension in the United Kingdom”. In: J Hypertens 35.9, pp. 1881–1890. issn: 0263-6352. doi: 10.1097/hjh.0000000000001382.

Lambrelli, D. et al. (2017). “Real-world treatment patterns among patientsinitiating on statins in England”. In: Value in Health 20.9, A630–631.

Lamy, F. X. et al. (2017). “The use of adjunctive antipsychotics to treat depres-sion in UK primary care”. In: Curr Med Res Opin 33.5, pp. 891–898. issn:0300-7995. doi: 10.1080/03007995.2017.1294055.

Landis, S. H., R. Suruki, et al. (2017). “Stability of Blood Eosinophil Count inPatients with COPD in the UK Clinical Practice Research Datalink”. In:Copd 14.4, pp. 382–388. issn: 1541-2563. doi: 10.1080/15412555.2017.1313827.

Landis, S. H., K. Wurst, et al. (2017). “Can Assessment of Disease Burden Priorto Changes in Initial COPD Maintenance Treatment Provide Insight intoRemaining Unmet Needs? A Retrospective Database Study in UK PrimaryCare”. In: Copd 14.1, pp. 80–85. issn: 1541-2563. doi: 10.1080/15412555.2016.1240159.

Lane, D. A. et al. (2017). “Temporal Trends in Incidence, Prevalence, andMortality of Atrial Fibrillation in Primary Care”. In: J Am Heart Assoc6.5. issn: 2047-9980. doi: 10.1161/jaha.116.005155.

Lane, S., E. Lynn, and S. Shakir (2017). “Measuring the impact of productwithdrawals and other major pharmacovigilance actions on public healthburden in the EU: Methodological considerations”. In: Drug Safety 40.10,pp. 953–4.

Langham, J. and S. Langham (2017). “European real world data sources tocharacterise flares in patients with systemic lupus erythematosus: A review”.In: Value in Health 20.9, A571.

Langham, S. et al. (2017). “Budget impact analysis of oral glycopyrroniumbromide (SialanarTM) for the symptomatic treatment of severe sialorrhoea(Drooling) in the UK setting”. In: Value in Health 20.9, A720.

Larivee, N., S. Suissa, J. Coulombe, et al. (2017). “Drospirenone-ContainingOral Contraceptive Pills and the Risk of Venous Thromboembolism: AnAssessment of Risk in First-Time Users and Restarters”. In: Drug Saf 40.7,pp. 583–596. issn: 0114-5916. doi: 10.1007/s40264-017-0525-2.

Larivee, N., S. Suissa, M. Eberg, et al. (2017). “Drospirenone-containing com-bined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study”. In: Bjog 124.11, pp. 1672–1679. issn: 1470-0328. doi: 10.1111/1471-0528.14358.

Leal, J. et al. (2017). “Cost-Effectiveness of Orthogeriatric and Fracture Liai-son Service Models of Care for Hip Fracture Patients: A Population-BasedStudy”. In: J Bone Miner Res 32.2, pp. 203–211. issn: 0884-0431. doi:10.1002/jbmr.2995.

Leite, A., N. J. Andrews, and S. L. Thomas (2017). “Assessing recording delaysin general practice records to inform near real-time vaccine safety surveil-lance using the Clinical Practice Research Datalink (CPRD)”. In: Pharma-

CPRD bibliography

110

coepidemiol Drug Saf 26.4, pp. 437–445. issn: 1053-8569. doi: 10.1002/pds.4173.

Leite, A., S. L. Thomas, and N. J. Andrews (2017). “Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink(CPRD)”. In: Vaccine 35.49 Pt B, pp. 6885–6892. issn: 0264-410x. doi:10.1016/j.vaccine.2017.09.022.

Li, L., T. Neogi, and S. Jick (2017). “Giant cell arteritis and vascular disease-riskfactors and outcomes: a cohort study using UK Clinical Practice ResearchDatalink”. In: Rheumatology (Oxford) 56.5, pp. 753–762. issn: 1462-0324.doi: 10.1093/rheumatology/kew482.

Liang, H. et al. (2017). “Incidence, prevalence, and natural history of primarysclerosing cholangitis in the United Kingdom”. In: Medicine (Baltimore)96.24, e7116. issn: 0025-7974. doi: 10.1097/md.0000000000007116.

Little, I. et al. (2017). “Venous thromboembolism in adults screened for sicklecell trait: a population-based cohort study with nested case-control analysis”.In: BMJ Open 7.3, e012665. issn: 2044-6055. doi: 10.1136/bmjopen-2016-012665.

Lo Re, V. et al. (2017). “Postauthorization safety study of the DPP-4 inhibitorsaxagliptin: a large-scale multinational family of cohort studies of five out-comes”. In: BMJ Open Diabetes Res Care 5.1, e000400. issn: 2052-4897(Print) 2052-4897. doi: 10.1136/bmjdrc-2017-000400.

Loo, S. Y. et al. (2017). “Trends in the prescription of novel oral anticoagulantsin UK primary care”. In: Br J Clin Pharmacol 83.9, pp. 2096–2106. issn:0306-5251. doi: 10.1111/bcp.13299.

Lum, K. J. et al. (2017). “Evaluation of methods to estimate missing days’supply within pharmacy data of the Clinical Practice Research Datalink(CPRD) and The Health Improvement Network (THIN)”. In: Eur J ClinPharmacol 73.1, pp. 115–123. issn: 0031-6970. doi: 10.1007/s00228-016-2148-4.

Mackenzie, I. S. et al. (2017). “Spironolactone use and risk of incident cancers: aretrospective, matched cohort study”. In: Br J Clin Pharmacol 83.3, pp. 653–663. issn: 0306-5251. doi: 10.1111/bcp.13152.

Maguire, A. et al. (2017). “Identifying rare diseases using electronic medicalrecords: the example of allergic bronchopulmonary aspergillosis”. In: Phar-macoepidemiol Drug Saf 26.7, pp. 785–791. issn: 1053-8569. doi: 10.1002/pds.4204.

Mandilaras, V. et al. (2017). “The use of drugs acting on the renin-angiotensinsystem and the incidence of pancreatic cancer”. In: Br J Cancer 116.1,pp. 103–108. issn: 0007-0920. doi: 10.1038/bjc.2016.375.

Mars, B., J. Heron, D. Gunnell, et al. (2017). “Prevalence and patterns ofantidepressant switching amongst primary care patients in the UK”. In:J Psychopharmacol 31.5, pp. 553–560. issn: 0269-8811. doi: 10 . 1177 /

0269881117693748.Mars, B., J. Heron, D. Kessler, et al. (2017). “Influences on antidepressant

prescribing trends in the UK: 1995-2011”. In: Soc Psychiatry Psychiatr Epi-demiol 52.2, pp. 193–200. issn: 0933-7954. doi: 10.1007/s00127- 016-

1306-4.Mathur, R. et al. (2017). “Population trends in the 10-year incidence and preva-

lence of diabetic retinopathy in the UK: a cohort study in the Clinical Prac-

CPRD bibliography

111

tice Research Datalink 2004-2014”. In: BMJ Open 7.2, e014444. issn: 2044-6055. doi: 10.1136/bmjopen-2016-014444.

McDonald, H. I. et al. (2017). “Do influenza and pneumococcal vaccines preventcommunity-acquired respiratory infections among older people with diabetesand does this vary by chronic kidney disease? A cohort study using electronichealth records”. In: BMJ Open Diabetes Res Care 5.1, e000332. issn: 2052-4897 (Print) 2052-4897. doi: 10.1136/bmjdrc-2016-000332.

McDonald, L. et al. (2017). “Identifying patients with lupus nephritis in theunited kingdom (UK) clinical practice research datalink (CPRD)”. In: Valuein Health 20.9, A743.

McGrogan, A., J. Snowball, and R. A. Charlton (2017). “Statins during preg-nancy: a cohort study using the General Practice Research Database toinvestigate pregnancy loss”. In: Pharmacoepidemiol Drug Saf 26.7, pp. 843–852. issn: 1053-8569. doi: 10.1002/pds.4176.

Mehta, H. B., V. Mehta, and J. S. Goodwin (2017). “Association of Hypo-glycemia With Subsequent Dementia in Older Patients With Type 2 Dia-betes Mellitus”. In: J Gerontol A Biol Sci Med Sci 72.8, pp. 1110–1116. issn:1079-5006. doi: 10.1093/gerona/glw217.

Miani, C. et al. (2017). “Clinical effectiveness and cost-effectiveness of issuinglonger versus shorter duration (3-month vs. 28-day) prescriptions in patientswith chronic conditions: systematic review and economic modelling”. In:Health Technol Assess 21.78, pp. 1–128. issn: 1366-5278. doi: 10.3310/

hta21780.Moore, E. et al. (2017). “Effects of Pulmonary Rehabilitation on Exacerbation

Number and Severity in People With COPD: An Historical Cohort StudyUsing Electronic Health Records”. In: Chest 152.6, pp. 1188–1202. issn:0012-3692. doi: 10.1016/j.chest.2017.05.006.

Morales, D. R. et al. (2017). “Respiratory effect of beta-blockers in people withasthma and cardiovascular disease: population-based nested case controlstudy”. In: BMC Med 15.1, p. 18. issn: 1741-7015. doi: 10.1186/s12916-017-0781-0.

Morgan, C. et al. (2017). “Incidence, clinical management, and mortality riskfollowing self harm among children and adolescents: cohort study in primarycare”. In: Bmj 359, j4351. issn: 0959-8138. doi: 10.1136/bmj.j4351.

Morris, M. et al. (2017). “Do pre-diagnosis primary care consultation patternsexplain deprivation-specific differences in net survival among women withbreast cancer? An examination of individually-linked data from the UK WestMidlands cancer registry, national screening programme”. In: BMC Cancer17.1, p. 155. issn: 1471-2407. doi: 10.1186/s12885-017-3129-4.

Mounce, L. T. A. et al. (2017). “Comorbid conditions delay diagnosis of col-orectal cancer: a cohort study using electronic primary care records”. In: BrJ Cancer 116.12, pp. 1536–1543. issn: 0007-0920. doi: 10.1038/bjc.2017.127.

Murray, C. S. et al. (2017). “Comparative Effectiveness of Step-up Therapiesin Children with Asthma Prescribed Inhaled Corticosteroids: A HistoricalCohort Study”. In: J Allergy Clin Immunol Pract 5.4, 1082–1090.e7. doi:10.1016/j.jaip.2016.12.028.

Navaratnam, V. et al. (2017). “Bronchiectasis and the risk of cardiovasculardisease: a population-based study”. In: Thorax 72.2, pp. 161–166. issn: 0040-6376. doi: 10.1136/thoraxjnl-2015-208188.

CPRD bibliography

112

Nightingale, A. L. et al. (2017). “Presentation of SLE in UK primary care usingthe Clinical Practice Research Datalink”. In: Lupus Sci Med 4.1, e000172.issn: 2053-8790 (Print) 2053-8790. doi: 10.1136/lupus-2016-000172.

Nissen, F. et al. (2017). “Validation of asthma recording in the Clinical PracticeResearch Datalink (CPRD)”. In: BMJ Open 7.8, e017474. issn: 2044-6055.doi: 10.1136/bmjopen-2017-017474.

Numbere, B. et al. (2017). “Adrenergic blockers and the risk for common solidcancers: a case-control study”. In: Eur J Cancer Prev 26.1, pp. 86–93. issn:0959-8278. doi: 10.1097/cej.0000000000000218.

Nwaru, B. I. et al. (2017). “External validation of a COPD prediction modelusing population-based primary care data: a nested case-control study”. In:Sci Rep 7, p. 44702. issn: 2045-2322. doi: 10.1038/srep44702.

Oshagbemi, O. A. et al. (2017). “Stability of Blood Eosinophils in Patients withChronic Obstructive Pulmonary Disease and in Control Subjects, and theImpact of Sex, Age, Smoking, and Baseline Counts”. In: Am J Respir CritCare Med 195.10, pp. 1402–1404. issn: 1073-449x. doi: 10.1164/rccm.

201701-0009LE.Palmer, K. T., S. D’Angelo, E. C. Harris, C. Linaker, C. R. Gale, et al. (2017).

“Frailty, prefrailty and employment outcomes in Health and EmploymentAfter Fifty (HEAF) Study”. In: Occup Environ Med 74.7, pp. 476–482. issn:1351-0711. doi: 10.1136/oemed-2016-104103.

Palmer, K. T., S. D’Angelo, E. C. Harris, C. Linaker, A. A. Sayer, et al. (2017).“Sleep disturbance and the older worker: findings from the Health and Em-ployment after Fifty study”. In: Scand J Work Environ Health 43.2, pp. 136–145. issn: 0355-3140. doi: 10.5271/sjweh.3618.

Parisi, R. et al. (2017). “Alcohol-Related Mortality in Patients With Psoriasis:A Population-Based Cohort Study”. In: JAMA Dermatol 153.12, pp. 1256–1262. issn: 2168-6068. doi: 10.1001/jamadermatol.2017.3225.

Pearce, F. A. et al. (2017). “The incidence, prevalence and mortality of granulo-matosis with polyangiitis in the UK Clinical Practice Research Datalink”. In:Rheumatology (Oxford) 56.4, pp. 589–596. issn: 1462-0324. doi: 10.1093/rheumatology/kew413.

Perry, D. C. et al. (2017). “A nationwide cohort study of slipped capital femoralepiphysis”. In: Arch Dis Child 102.12, pp. 1132–1136. issn: 0003-9888. doi:10.1136/archdischild-2016-312328.

Poppe, K. K. et al. (2017). “Developing and validating a cardiovascular riskscore for patients in the community with prior cardiovascular disease”. In:Heart 103.12, pp. 891–892. issn: 1355-6037. doi: 10.1136/heartjnl-2016-310668.

Pufulete, M. et al. (2017). “Effectiveness and cost-effectiveness of serum B-typenatriuretic peptide testing and monitoring in patients with heart failure inprimary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model”. In: Health Technol Assess 21.40, pp. 1–150. issn: 1366-5278. doi: 10.3310/hta21400.

Rahimi, K. et al. (2017). “Elevated blood pressure and risk of mitral regurgita-tion: A longitudinal cohort study of 5.5 million United Kingdom adults”. In:PLoS Med 14.10, e1002404. issn: 1549-1277. doi: 10.1371/journal.pmed.1002404.

Rajaram, S. et al. (2017). “Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian

CPRD bibliography

113

model-based approach”. In: PLoS One 12.12, e0186739. issn: 1932-6203.doi: 10.1371/journal.pone.0186739.

Ravindrarajah, R., A. Dregan, et al. (2017). “Declining blood pressure andintensification of blood pressure management among people over 80 years:cohort study using electronic health records”. In: J Hypertens 35.6, pp. 1276–1282. issn: 0263-6352. doi: 10.1097/hjh.0000000000001291.

Ravindrarajah, R., N. C. Hazra, et al. (2017). “Systolic Blood Pressure Tra-jectory, Frailty, and All-Cause Mortality ¿80 Years of Age: Cohort StudyUsing Electronic Health Records”. In: Circulation 135.24, pp. 2357–2368.issn: 0009-7322. doi: 10.1161/circulationaha.116.026687.

Rees, F. et al. (2017). “Early Clinical Features in Systemic Lupus Erythemato-sus: Can They Be Used to Achieve Earlier Diagnosis? A Risk PredictionModel”. In: Arthritis Care Res (Hoboken) 69.6, pp. 833–841. issn: 2151-464x. doi: 10.1002/acr.23021.

Renoux, C., S. Dell’Aniello, et al. (2017). “Bias from depletion of susceptibles:the example of hormone replacement therapy and the risk of venous throm-boembolism”. In: Pharmacoepidemiol Drug Saf 26.5, pp. 554–560. issn:1053-8569. doi: 10.1002/pds.4197.

Renoux, C., S. Vahey, et al. (2017). “Association of Selective Serotonin Reup-take Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage”. In:JAMA Neurol 74.2, pp. 173–180. issn: 2168-6149. doi: 10.1001/jamaneurol.2016.4529.

Riera-Montes, M., T. Cattaert, and T.V. Verstraeten (2017). “Rotavirus vacci-nation may reduce acute gastroenteritis rates across all age groups in Eng-land”. In: Value in Health 20.9, A780.

Roddy, E. et al. (2017). “Incident acute pseudogout and prior bisphospho-nate use: Matched case-control study in the UK-Clinical Practice ResearchDatalink”. In: Medicine (Baltimore) 96.12, e6177. issn: 0025-7974. doi: 10.1097/md.0000000000006177.

Rodgers, L. R. et al. (2017). “Cohort profile for the MASTERMIND study: usingthe Clinical Practice Research Datalink (CPRD) to investigate stratificationof response to treatment in patients with type 2 diabetes”. In: BMJ Open7.10, e017989. issn: 2044-6055. doi: 10.1136/bmjopen-2017-017989.

Ronaldson, S. J. et al. (2017). “Cost-effectiveness of antibiotics for COPD man-agement: observational analysis using CPRD data”. In: ERJ Open Res 3.2.issn: 2312-0541 (Print) 2312-0541. doi: 10.1183/23120541.00085-2016.

Rothnie, K. J. et al. (2017). “Validity and interpretation of spirometric record-ings to diagnose COPD in UK primary care”. In: Int J Chron Obstruct Pul-mon Dis 12, pp. 1663–1668. issn: 1176-9106. doi: 10.2147/copd.s133891.

Saine, M. E. et al. (2017). “Validity of diagnostic codes to identify hospitaliza-tions for infections among patients treated with oral anti-diabetic drugs”.In: Pharmacoepidemiol Drug Saf. issn: 1053-8569. doi: 10.1002/pds.4368.

Sanni, O. B. et al. (2017). “Commonly used medications and endometrial cancersurvival: a population-based cohort study”. In: Br J Cancer 117.3, pp. 432–438. issn: 0007-0920. doi: 10.1038/bjc.2017.207.

Sarginson, J. et al. (2017). “Temporal trends in antidepressant prescribing tochildren in UK primary care, 2000-2015”. In: J Affect Disord 210, pp. 312–318. issn: 0165-0327. doi: 10.1016/j.jad.2016.12.047.

Schmidt, M. et al. (2017a). “Adherence to guidelines for creatinine and potas-sium monitoring and discontinuation following renin-angiotensin system block-

CPRD bibliography

114

ade: a UK general practice-based cohort study”. In: BMJ Open 7.1, e012818.issn: 2044-6055. doi: 10.1136/bmjopen-2016-012818.

Schmidt, M. et al. (2017b). “Serum creatinine elevation after renin-angiotensinsystem blockade and long term cardiorenal risks: cohort study”. In: Bmj 356,j791. issn: 0959-8138. doi: 10.1136/bmj.j791.

Schmidt, S. A. et al. (2017). “Partner Bereavement and Risk of Herpes Zoster:Results from Two Population-Based Case-Control Studies in Denmark andthe United Kingdom”. In: Clin Infect Dis 64.5, pp. 572–579. issn: 1058-4838.doi: 10.1093/cid/ciw840.

Seliger, C. et al. (2017a). “Diabetes, use of metformin, and the risk of menin-gioma”. In: PLoS One 12.7, e0181089. issn: 1932-6203. doi: 10 . 1371 /

journal.pone.0181089.— (2017b). “Metabolic syndrome in relation to risk of meningioma”. In: On-

cotarget 8.2, pp. 2284–2292. issn: 1949-2553. doi: 10.18632/oncotarget.13667.

Shah, A. et al. (2017). “Geographic variation in secondary fracture preventionafter a hip fracture during 1999-2013: a UK study”. In: Osteoporos Int 28.1,pp. 169–178. issn: 0937-941x. doi: 10.1007/s00198-016-3811-4.

Sheppard, T. et al. (2017). “A comparison of methods for estimating the tempo-ral change in a continuous variable: Example of HbA1c in patients with di-abetes”. In: Pharmacoepidemiol Drug Saf 26.12, pp. 1474–1482. issn: 1053-8569. doi: 10.1002/pds.4273.

Shin, J. Y. et al. (2017). “Statin potency and the risk of hospitalization forcommunity-acquired pneumonia”. In: Br J Clin Pharmacol 83.6, pp. 1319–1327. issn: 0306-5251. doi: 10.1111/bcp.13208.

Sinnott, S. J., K. E. Mansfield, et al. (2017). “Biochemical monitoring afterinitiation of aldosterone antagonist therapy in users of renin-angiotensinsystem blockers: a UK primary care cohort study”. In: BMJ Open 7.11,e018153. issn: 2044-6055. doi: 10.1136/bmjopen-2017-018153.

Sinnott, S. J., L. Smeeth, et al. (2017). “Trends for prevalence and incidence ofresistant hypertension: population based cohort study in the UK 1995-2015”.In: Bmj 358, j3984. issn: 0959-8138. doi: 10.1136/bmj.j3984.

Skrtic, S. et al. (2017). “Contemporary risk estimates of three HbA1c variablesin relation to heart failure following diagnosis of type 2 diabetes”. In: Heart103.5, pp. 353–358. issn: 1355-6037. doi: 10.1136/heartjnl-2016-309806.

Spaetgens, B. et al. (2017). “Risk of infections in patients with gout: a population-based cohort study”. In: Sci Rep 7.1, p. 1429. issn: 2045-2322. doi: 10.1038/s41598-017-01588-5.

Springate, D. A., R. Parisi, E. Kontopantelis, et al. (2017). “Incidence, preva-lence and mortality of patients with psoriasis: a U.K. population-based co-hort study”. In: Br J Dermatol 176.3, pp. 650–658. issn: 0007-0963. doi:10.1111/bjd.15021.

Springate, D. A., R. Parisi, I. Olier, et al. (2017). “rEHR: An R package formanipulating and analysing Electronic Health Record data”. In: PLoS One12.2, e0171784. issn: 1932-6203. doi: 10.1371/journal.pone.0171784.

Stapley, S. A. et al. (2017). “Clinical features of bowel disease in patients aged¡50 years in primary care: a large case-control study”. In: Br J Gen Pract67.658, e336–e344. issn: 0960-1643. doi: 10.3399/bjgp17X690425.

Stevens, S. et al. (2017). “Patient-level and practice-level factors associatedwith consultation duration: a cross-sectional analysis of over one million

CPRD bibliography

115

consultations in English primary care”. In: BMJ Open 7.11, e018261. issn:2044-6055. doi: 10.1136/bmjopen-2017-018261.

Stewart, D. et al. (2017). “Alcohol consumption and all-cause mortality: ananalysis of general practice database records for patients with long-termconditions”. In: J Epidemiol Community Health 71.8, pp. 729–735. issn:0143-005x. doi: 10.1136/jech-2017-209241.

Stocks, S. J. et al. (2017). “Antipsychotic Prescribing to Patients Diagnosedwith Dementia Without a Diagnosis of Psychosis in the Context of NationalGuidance and Drug Safety Warnings: Longitudinal Study in UK GeneralPractice”. In: Drug Saf 40.8, pp. 679–692. issn: 0114-5916. doi: 10.1007/s40264-017-0538-x.

Stolk, L. M. et al. (2017). “Risk of myocardial infarction in patients with atrialfibrillation using vitamin K antagonists, aspirin or direct acting oral anti-coagulants”. In: Br J Clin Pharmacol 83.8, pp. 1835–1843. issn: 0306-5251.doi: 10.1111/bcp.13264.

Stolz, D. et al. (2017). “Gender differences in COPD exacerbations: Analysisfrom the CPRD database”. In: Thorax 72, A186.

Strongman, H. et al. (2017). “Pioglitazone and risk of mortality in patients withtype 2 diabetes: results from a European multidatabase cohort study”. In:BMJ Open Diabetes Res Care 5.1, e000364. issn: 2052-4897 (Print) 2052-4897. doi: 10.1136/bmjdrc-2016-000364.

Suissa, S., S. Dell’Aniello, and P. Ernst (2017a). “Concurrent use of long-actingbronchodilators in COPD and the risk of adverse cardiovascular events”. In:Eur Respir J 49.5. issn: 0903-1936. doi: 10.1183/13993003.02245-2016.

— (2017b). “Long-Acting Bronchodilator Initiation in COPD and the Risk ofAdverse Cardiopulmonary Events: A Population-Based Comparative SafetyStudy”. In: Chest 151.1, pp. 60–67. issn: 0012-3692. doi: 10.1016/j.chest.2016.08.001.

Suissa, S., E. E. Moodie, and S. Dell’Aniello (2017). “Prevalent new-user cohortdesigns for comparative drug effect studies by time-conditional propensityscores”. In: Pharmacoepidemiol Drug Saf 26.4, pp. 459–468. issn: 1053-8569.doi: 10.1002/pds.4107.

Suruki, R. Y. et al. (2017). “The frequency of asthma exacerbations and health-care utilization in patients with asthma from the UK and USA”. In: BMCPulm Med 17.1, p. 74. issn: 1471-2466. doi: 10.1186/s12890-017-0409-3.

Tammes, P. et al. (2017). “Continuity of Primary Care and Emergency HospitalAdmissions Among Older Patients in England”. In: Ann Fam Med 15.6,pp. 515–522. issn: 1544-1709. doi: 10.1370/afm.2136.

Taqi, A., H. Otete, and R.D. Knaggs (2017). “Trends in opioid prescribing inprimary care patients with knee osteoarthritis: A population based observa-tional study”. In: Value in Health 20.9, A540–A541.

Tate, A. R. et al. (2017). “Quality of recording of diabetes in the UK: how doesthe GP’s method of coding clinical data affect incidence estimates? Cross-sectional study using the CPRD database”. In: BMJ Open 7.1, e012905.issn: 2044-6055. doi: 10.1136/bmjopen-2016-012905.

Taylor, G. M. J. et al. (2017). “The effectiveness of varenicline versus nico-tine replacement therapy on long-term smoking cessation in primary care: aprospective cohort study of electronic medical records”. In: Int J Epidemiol46.6, pp. 1948–1957. issn: 0300-5771. doi: 10.1093/ije/dyx109.

CPRD bibliography

116

Thomas, S. L. et al. (2017). “Impact of the national rotavirus vaccination pro-gramme on acute gastroenteritis in England and associated costs averted”.In: Vaccine 35.4, pp. 680–686. issn: 0264-410x. doi: 10.1016/j.vaccine.2016.11.057.

Thompson, A., D. M. Ashcroft, et al. (2017). “Drug therapy for alcohol depen-dence in primary care in the UK: A Clinical Practice Research Datalinkstudy”. In: PLoS One 12.3, e0173272. issn: 1932-6203. doi: 10 . 1371 /

journal.pone.0173272.Thompson, A., A. K. Wright, et al. (2017). “Epidemiology of alcohol dependence

in UK primary care: Results from a large observational study using theClinical Practice Research Datalink”. In: PLoS One 12.3, e0174818. issn:1932-6203. doi: 10.1371/journal.pone.0174818.

Tillett, W. et al. (2017). “Interval between onset of psoriasis and psoriatic arthri-tis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort”. In: Rheumatology (Oxford) 56.12, pp. 2109–2113. issn: 1462-0324. doi: 10.1093/rheumatology/kex323.

Tomkins, S. et al. (2017). “Treating iron deficiency in patients with gastroin-testinal disease: Risk of re-attendance in secondary care”. In: PLoS One12.12, e0189952. issn: 1932-6203. doi: 10.1371/journal.pone.0189952.

Toth, P. P. et al. (2017). “Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention pop-ulation in the US payer context”. In: J Med Econ 20.6, pp. 555–564. issn:1369-6998. doi: 10.1080/13696998.2017.1284078.

Turner, S. et al. (2017). “Long-Acting beta-Agonist in Combination or Sepa-rate Inhaler as Step-Up Therapy for Children with Uncontrolled AsthmaReceiving Inhaled Corticosteroids”. In: J Allergy Clin Immunol Pract 5.1,99–106.e3. doi: 10.1016/j.jaip.2016.06.009.

Tyrrell, E. G. et al. (2017). “Differing patterns in intentional and unintentionalpoisonings among young people in England, 1998-2014: a population-basedcohort study”. In: J Public Health (Oxf) 39.2, e1–e9. issn: 1741-3842. doi:10.1093/pubmed/fdw075.

Velde, R. Y. van der et al. (2017). “Trends in oral anti-osteoporosis drug pre-scription in the United Kingdom between 1990 and 2012: Variation by age,sex, geographic location and ethnicity”. In: Bone 94, pp. 50–55. issn: 1873-2763. doi: 10.1016/j.bone.2016.10.013.

Venkatesan, S. et al. (2017). “Cohort study of preoperative blood pressure andrisk of 30-day mortality after elective non-cardiac surgery”. In: Br J Anaesth119.1, pp. 65–77. issn: 0007-0912. doi: 10.1093/bja/aex056.

Verstraeten, T., T. Cattaert, and G. Ferreira (2017). “Gender inequality in acutegastro-enteritis rates in England.” In: Value in Health 20.9, A781.

Verstraeten, T., T. Cattaert, J. Harris, et al. (2017). “Estimating the Burdenof Medically Attended Norovirus Gastroenteritis: Modeling Linked PrimaryCare and Hospitalization Datasets”. In: J Infect Dis 216.8, pp. 957–965.issn: 0022-1899. doi: 10.1093/infdis/jix410.

Viswanathan, A. et al. (2017). “Resource Utilization Among Glaucoma Patientsin the UK Treated with Beta-Blocker and Non-Beta-Blocker AdjunctiveTherapy: A Retrospective Cohort Analysis”. In: Adv Ther 34.7, pp. 1695–1706. issn: 0741-238x. doi: 10.1007/s12325-017-0541-8.

Vuik, S. I. et al. (2017). “Do hospitalisations for ambulatory care sensitiveconditions reflect low access to primary care? An observational cohort study

CPRD bibliography

117

of primary care usage prior to hospitalisation”. In: BMJ Open 7.8, e015704.issn: 2044-6055. doi: 10.1136/bmjopen-2016-015704.

Walker, J. L. et al. (2017). “Trends in the burden of varicella in UK generalpractice”. In: Epidemiol Infect 145.13, pp. 2678–2682. issn: 0950-2688. doi:10.1017/s0950268817001649.

Walker, S. and W. Hamilton (2017). “Risk of cervical cancer in symptomaticwomen aged ¿/=40 in primary care: A case-control study using electronicrecords”. In: Eur J Cancer Care (Engl) 26.3. issn: 0961-5423. doi: 10.1111/ecc.12706.

Watson, J. et al. (2017). “Identifying clinical features in primary care electronichealth record studies: methods for codelist development”. In: BMJ Open7.11, e019637. issn: 2044-6055. doi: 10.1136/bmjopen-2017-019637.

Weinstein, R. B. et al. (2017). “Channeling in the Use of Nonprescription Parac-etamol and Ibuprofen in an Electronic Medical Records Database: Evidenceand Implications”. In: Drug Saf 40.12, pp. 1279–1292. issn: 0114-5916. doi:10.1007/s40264-017-0581-7.

Weir, S., M. Samnaliev, T. C. Kuo, et al. (2017). “The incidence and healthcarecosts of persistent postoperative pain following lumbar spine surgery in theUK: a cohort study using the Clinical Practice Research Datalink (CPRD)and Hospital Episode Statistics (HES)”. In: BMJ Open 7.9, e017585. issn:2044-6055. doi: 10.1136/bmjopen-2017-017585.

Weir, S., M. Samnaliev, T-C. Kuo, et al. (2017a). “Does instrumented spinalsurgery have an increased rate of persistent post-operative pain (PPP)?” In:The Spine Journal 17.3, S11.

— (2017b). “The rate of persistent post-operative pain (FBSS) in revision lum-bar spinal surgery”. In: The Spine Journal 17.3, S10.

Weng, S. F. et al. (2017). “Can machine-learning improve cardiovascular riskprediction using routine clinical data?” In: PLoS One 12.4, e0174944. issn:1932-6203. doi: 10.1371/journal.pone.0174944.

West, J. et al. (2017). “Risk of hepatocellular carcinoma among individualswith different aetiologies of cirrhosis: a population-based cohort study”. In:Aliment Pharmacol Ther 45.7, pp. 983–990. issn: 0269-2813. doi: 10.1111/apt.13961.

Wilding, J.P.H. et al. (2017). “Changes in HbA1c and weight after initiation ofsecond-line therapy in patients with type 2 diabetes in clinical practice.” In:Diabetologia. 60.1, S301.

Wilding, J. et al. (2017). “Dapagliflozin therapy for type 2 diabetes in primarycare: Changes in HbA1c, weight and blood pressure over 2 years follow-up”.In: Prim Care Diabetes 11.5, pp. 437–444. issn: 1878-0210. doi: 10.1016/j.pcd.2017.04.004.

Williams, R. et al. (2017). “Cardiovascular safety of vildagliptin in patientswith type 2 diabetes: A European multi-database, non-interventional post-authorization safety study”. In: Diabetes Obes Metab 19.10, pp. 1473–1478.issn: 1462-8902. doi: 10.1111/dom.12951.

Wilson, C. L., K. M. Rhodes, and R. A. Payne (2017). “Financial incentivesimprove recognition but not treatment of cardiovascular risk factors in severemental illness”. In: PLoS One 12.6, e0179392. issn: 1932-6203. doi: 10.

1371/journal.pone.0179392.Wilson, J. C. et al. (2017a). “Incidence of outcomes potentially associated with

corticosteroid therapy in patients with giant cell arteritis”. In: Semin Arthri-

CPRD bibliography

118

tis Rheum 46.5, pp. 650–656. issn: 0049-0172. doi: 10.1016/j.semarthrit.2016.10.001.

Wilson, J. C. et al. (2017b). “Serious adverse effects associated with glucocorti-coid therapy in patients with giant cell arteritis (GCA): A nested case-controlanalysis”. In: Semin Arthritis Rheum 46.6, pp. 819–827. issn: 0049-0172.doi: 10.1016/j.semarthrit.2016.11.006.

Wing, K. et al. (2017). “Quantification of the risk of liver injury associatedwith flucloxacillin: a UK population-based cohort study”. In: J AntimicrobChemother 72.9, pp. 2636–2646. issn: 0305-7453. doi: 10.1093/jac/dkx183.

Wong, J. et al. (2017). “Evaluation of compliance to the timing of childhoodvaccinations following introduction of the meningococcal B vaccine in theUK”. In: Drug Safety 40.10, pp. 1000–1.

Wright, A. K. et al. (2017). “Life Expectancy and Cause-Specific Mortalityin Type 2 Diabetes: A Population-Based Cohort Study Quantifying Rela-tionships in Ethnic Subgroups”. In: Diabetes Care 40.3, pp. 338–345. issn:0149-5992. doi: 10.2337/dc16-1616.

Wu, J. W. et al. (2017). “Long-Term Use of Long-Acting Insulin Analogs andBreast Cancer Incidence in Women With Type 2 Diabetes”. In: J Clin Oncol35.32, pp. 3647–3653. issn: 0732-183x. doi: 10.1200/jco.2017.73.4491.

Xiao, X. et al. (2017). “SMAD3/Stat3 Signaling Mediates beta-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis-Related Diabetes”. In: Di-abetes 66.10, pp. 2646–2658. issn: 0012-1797. doi: 10.2337/db17-0537.

Yates, T. A. et al. (2017). “Lansoprazole use and tuberculosis incidence in theUnited Kingdom Clinical Practice Research Datalink: A population basedcohort”. In: PLoS Med 14.11, e1002457. issn: 1549-1277. doi: 10.1371/

journal.pmed.1002457.Young, G. J. et al. (2017). “Prostate-specific antigen (PSA) testing of men in

UK general practice: a 10-year longitudinal cohort study”. In: BMJ Open7.10, e017729. issn: 2044-6055. doi: 10.1136/bmjopen-2017-017729.

Yu, D. et al. (2017). “Population trends in the incidence and initial managementof osteoarthritis: age-period-cohort analysis of the Clinical Practice ResearchDatalink, 1992-2013”. In: Rheumatology (Oxford) 56.11, pp. 1902–1917. issn:1462-0324. doi: 10.1093/rheumatology/kex270.

Zghebi, S. S. et al. (2017). “Examining trends in type 2 diabetes incidence,prevalence and mortality in the UK between 2004 and 2014”. In: DiabetesObes Metab 19.11, pp. 1537–1545. issn: 1462-8902. doi: 10.1111/dom.

12964.Zhong, V. W. et al. (2017). “Incidence and Trends in Hypoglycemia Hospitaliza-

tion in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: ARetrospective Cohort Study”. In: Diabetes Care 40.12, pp. 1651–1660. issn:0149-5992. doi: 10.2337/dc16-2680.

CPRD bibliography

119

2016

Abdul Sultan, A. et al. (2016). “Adverse Pregnancy Outcomes Among Womenwith Inflammatory Bowel Disease: A Population-Based Study from Eng-land”. In: Inflamm Bowel Dis 22.7, pp. 1621–30. issn: 1078-0998. doi: 10.1097/mib.0000000000000802.

Afonso, A. et al. (2016). “A methodological comparison of two European pri-mary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction”. In: Eur JClin Pharmacol 72.9, pp. 1105–16. issn: 0031-6970. doi: 10.1007/s00228-016-2071-8.

Alexander, M., Y. Ding, et al. (2016). “Population prevalence of Down’s syn-drome in the United Kingdom”. In: J Intellect Disabil Res 60.9, pp. 874–8.issn: 0964-2633. doi: 10.1111/jir.12277.

Alexander, M., H. Petri, et al. (2016). “Morbidity and medication in a largepopulation of individuals with Down syndrome compared to the generalpopulation”. In: Dev Med Child Neurol 58.3, pp. 246–54. issn: 0012-1622.doi: 10.1111/dmcn.12868.

Alexandre, L. et al. (2016). “Association Between Statin Use After Diagnosisof Esophageal Cancer and Survival: A Population-Based Cohort Study”.In: Gastroenterology 150.4, 854–65.e1, 854–65.e1. issn: 0016-5085. doi: 10.1053/j.gastro.2015.12.039.

Amirthalingam, G. et al. (2016). “Sustained Effectiveness of the Maternal Per-tussis Immunization Program in England 3 Years Following Introduction”.In: Clin Infect Dis 63.suppl 4, S236–s243. issn: 1058-4838. doi: 10.1093/cid/ciw559.

Ang, C., E. Doyle, and A. Branch (2016). “Bisphosphonates as potential adju-vants for patients with cancers of the digestive system”. In: World J Gas-troenterol 22.3, pp. 906–16. issn: 1007-9327. doi: 10.3748/wjg.v22.i3.906.

Armstrong, D. et al. (2016). “The relationship between prior antimicrobial pre-scription and meningitis: a case-control study”. In: Br J Gen Pract 66.645,e228–33. issn: 0960-1643. doi: 10.3399/bjgp16X684313.

Asaria, M. et al. (2016). “Using electronic health records to predict costs andoutcomes in stable coronary artery disease”. In: Heart 102.10, pp. 755–62.issn: 1355-6037. doi: 10.1136/heartjnl-2015-308850.

Azoulay, L. et al. (2016). “Use of Calcium Channel Blockers and Risk of BreastCancer: A Population-based Cohort Study”. In: Epidemiology 27.4, pp. 594–601. issn: 1044-3983. doi: 10.1097/ede.0000000000000483.

Baker, R., E. Orton, et al. (2016). “Epidemiology of poisonings, fractures andburns among 0-24 year olds in England using linked health and mortalitydata”. In: Eur J Public Health 26.6, pp. 940–946. issn: 1101-1262. doi:10.1093/eurpub/ckw064.

Baker, R., L. J. Tata, D. Kendrick, T. Burch, et al. (2016). “Differing patternsin thermal injury incidence and hospitalisations among 0-4 year old childrenfrom England”. In: Burns 42.7, pp. 1609–1616. issn: 0305-4179. doi: 10.1016/j.burns.2016.05.007.

Baker, R., L. J. Tata, D. Kendrick, and E. Orton (2016). “Identification ofincident poisoning, fracture and burn events using linked primary care, sec-

CPRD bibliography

120

ondary care and mortality data from England: implications for research andsurveillance”. In: Inj Prev 22.1, pp. 59–67. issn: 1353-8047. doi: 10.1136/injuryprev-2015-041561.

Barker, I., T. Lloyd, and A. Steventon (2016). “Effect of a national requirementto introduce named accountable general practitioners for patients aged 75or older in England: regression discontinuity analysis of general practiceutilisation and continuity of care”. In: BMJ Open 6.9, e011422. issn: 2044-6055. doi: 10.1136/bmjopen-2016-011422.

Beau-Lejdstrom, R. et al. (2016). “Latest trends in ADHD drug prescribingpatterns in children in the UK: prevalence, incidence and persistence”. In:BMJ Open 6.6, e010508. issn: 2044-6055. doi: 10.1136/bmjopen-2015-010508.

Bedson, J. et al. (2016). “Trends in long-term opioid prescribing in primarycare patients with musculoskeletal conditions: an observational databasestudy”. In: Pain 157.7, pp. 1525–31. issn: 0304-3959. doi: 10.1097/j.

pain.0000000000000557.Berni, E., C. C. Butler, et al. (2016). “Comparative estimated effectiveness of

antibiotic classes as initial and secondary treatments of respiratory tractinfections: longitudinal analysis of routine data from UK primary care 1991-2012”. In: Curr Med Res Opin 32.6, pp. 1023–32. issn: 0300-7995. doi:10.1185/03007995.2016.1157459.

Berni, E., L. A. Scott, et al. (2016). “Non-Response to Antibiotic Treatment inAdolescents for Four Common Infections in UK Primary Care 1991-2012: ARetrospective, Longitudinal Study”. In: Antibiotics (Basel) 5.3. issn: 2079-6382 (Print) 2079-6382. doi: 10.3390/antibiotics5030025.

Blak, B. T. et al. (2016). “Weight change and healthcare resource use in Englishpatients with type 2 diabetes mellitus initiating a new diabetes medicationclass”. In: Int J Clin Pract 70.1, pp. 45–55. issn: 1368-5031. doi: 10.1111/ijcp.12746.

Bloechliger, M., A. Ceschi, S. Ruegg, S. S. Jick, et al. (2016). “Lifestyle fac-tors, psychiatric and neurologic comorbidities, and drug use associated withincident seizures among adult patients with depression: a population-basednested case-control study”. In: Eur J Epidemiol 31.11, pp. 1113–1122. issn:0393-2990. doi: 10.1007/s10654-016-0156-4.

Bloechliger, M., A. Ceschi, S. Ruegg, H. Kupferschmidt, et al. (2016). “Riskof Seizures Associated with Antidepressant Use in Patients with DepressiveDisorder: Follow-up Study with a Nested Case-Control Analysis Using theClinical Practice Research Datalink”. In: Drug Saf 39.4, pp. 307–21. issn:0114-5916. doi: 10.1007/s40264-015-0363-z.

Boef, A. G. et al. (2016). “Instrumental variable analysis as a complementaryanalysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives”. In: Pharmacoepi-demiol Drug Saf 25.3, pp. 317–24. issn: 1053-8569. doi: 10.1002/pds.3956.

Booth, H. P., O. Khan, et al. (2016). “Changing Epidemiology of BariatricSurgery in the UK: Cohort Study Using Primary Care Electronic HealthRecords”. In: Obes Surg 26.8, pp. 1900–5. issn: 0960-8923. doi: 10.1007/s11695-015-2032-9.

Booth, H. P., A. T. Prevost, and M. C. Gulliford (2016). “Severity of obesity andmanagement of hypertension, hypercholesterolaemia and smoking in primary

CPRD bibliography

121

care: population-based cohort study”. In: J Hum Hypertens 30.1, pp. 40–5.issn: 0950-9240. doi: 10.1038/jhh.2015.23.

Bornand, D. et al. (2016). “The risk of new onset depression in association withinfluenza–A population-based observational study”. In: Brain Behav Immun53, pp. 131–137. issn: 0889-1591. doi: 10.1016/j.bbi.2015.12.005.

Bours, S. et al. (2016). “Risk of vertebral and non-vertebral fractures in pa-tients with sarcoidosis: a population-based cohort”. In: Osteoporos Int 27.4,pp. 1603–1610. issn: 0937-941x. doi: 10.1007/s00198-015-3426-1.

Boxall, N. et al. (2016). “Evaluation of exposure to pioglitazone and risk ofprostate cancer: a nested case-control study”. In: BMJ Open Diabetes ResCare 4.1, e000303. issn: 2052-4897 (Print) 2052-4897. doi: 10.1136/bmjdrc-2016-000303.

Brauer, R., A. Ruigomez, G. Downey, et al. (2016). “Prevalence of antibioticuse: a comparison across various European health care data sources”. In:Pharmacoepidemiol Drug Saf 25 Suppl 1, pp. 11–20. issn: 1053-8569. doi:10.1002/pds.3831.

Brauer, R., A. Ruigomez, O. Klungel, et al. (2016). “The risk of acute liver injuryamong users of antibiotic medications: a comparison of case-only studies”.In: Pharmacoepidemiol Drug Saf 25 Suppl 1, pp. 39–46. issn: 1053-8569.doi: 10.1002/pds.3846.

Brodie, M. J. et al. (2016). “Clobazam and clonazepam use in epilepsy: Resultsfrom a UK database incident user cohort study”. In: Epilepsy Res 123,pp. 68–74. issn: 0920-1211. doi: 10.1016/j.eplepsyres.2016.04.003.

Brown, A. et al. (2016). “Comparison of dementia recorded in routinely collectedhospital admission data in England with dementia recorded in primary care”.In: Emerg Themes Epidemiol 13, p. 11. issn: 1742-7622 (Print) 1742-7622.doi: 10.1186/s12982-016-0053-z.

Brownrigg, J. R. et al. (2016). “Microvascular disease and risk of cardiovascularevents among individuals with type 2 diabetes: a population-level cohortstudy”. In: Lancet Diabetes Endocrinol 4.7, pp. 588–97. issn: 2213-8587.doi: 10.1016/s2213-8587(16)30057-2.

Brunt, K. van et al. (2016). “Basal-bolus Therapy in Patients with Type 2Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patternsand the Effect of Switching to Premixed Insulin”. In: Diabetes Ther 7.4,pp. 793–807. issn: 1869-6953 (Print). doi: 10.1007/s13300-016-0209-4.

Canavan, C., J. West, and T. Card (2016). “Calculating Total Health ServiceUtilisation and Costs from Routinely Collected Electronic Health RecordsUsing the Example of Patients with Irritable Bowel Syndrome Before andAfter Their First Gastroenterology Appointment”. In: Pharmacoeconomics34.2, pp. 181–94. issn: 1170-7690. doi: 10.1007/s40273-015-0339-y.

Carey, I. M., H. R. Anderson, et al. (2016). “Traffic pollution and the incidenceof cardiorespiratory outcomes in an adult cohort in London”. In: OccupEnviron Med 73.12, pp. 849–856. issn: 1351-0711. doi: 10.1136/oemed-2015-103531.

Carey, I. M., S. M. Shah, et al. (2016). “Health characteristics and consultationpatterns of people with intellectual disability: a cross-sectional databasestudy in English general practice”. In: Br J Gen Pract 66.645, e264–70.issn: 0960-1643. doi: 10.3399/bjgp16X684301.

Carr, M. J., D. M. Ashcroft, E. Kontopantelis, Y. Awenat, et al. (2016). “Theepidemiology of self-harm in a UK-wide primary care patient cohort, 2001-

CPRD bibliography

122

2013”. In: BMC Psychiatry 16, p. 53. issn: 1471-244x. doi: 10 . 1186 /

s12888-016-0753-5.Carr, M. J., D. M. Ashcroft, E. Kontopantelis, D. While, et al. (2016). “Clinical

management following self-harm in a UK-wide primary care cohort”. In: JAffect Disord 197, pp. 182–8. issn: 0165-0327. doi: 10.1016/j.jad.2016.03.013.

Chang, K. C. et al. (2016). “Impact of the National Health Service Health Checkon cardiovascular disease risk: a difference-in-differences matching analysis”.In: Cmaj 188.10, E228–38. issn: 0820-3946. doi: 10.1503/cmaj.151201.

Charlton, R. A. et al. (2016). “Asthma medication prescribing before, duringand after pregnancy: a study in seven European regions”. In: BMJ Open 6.1,e009237. issn: 2044-6055. doi: 10.1136/bmjopen-2015-009237.

Chhaya, V. et al. (2016a). “Emerging trends and risk factors for perianal surgeryin Crohn’s disease: a 20-year national population-based cohort study”. In:Eur J Gastroenterol Hepatol 28.8, pp. 890–5. issn: 0954-691x. doi: 10.1097/meg.0000000000000651.

— (2016b). “Steroid dependency and trends in prescribing for inflammatorybowel disease - a 20-year national population-based study”. In: AlimentPharmacol Ther 44.5, pp. 482–94. issn: 0269-2813. doi: 10.1111/apt.

13700.Chui, C. S. et al. (2016). “Association between oral fluoroquinolones and seizures:

A self-controlled case series study”. In: Neurology 86.18, pp. 1708–15. issn:0028-3878. doi: 10.1212/wnl.0000000000002633.

Clarke, A. T. et al. (2016). “High Dose Atorvastatin Associated with IncreasedRisk of Significant Hepatotoxicity in Comparison to Simvastatin in UKGPRD Cohort”. In: PLoS One 11.3, e0151587. issn: 1932-6203. doi: 10.1371/journal.pone.0151587.

Cohet, C. et al. (2016). “Effect of the adjuvanted (AS03) A/H1N1 2009 pan-demic influenza vaccine on the risk of rejection in solid organ transplant re-cipients in England: a self-controlled case series”. In: BMJ Open 6.1, e009264.issn: 2044-6055. doi: 10.1136/bmjopen-2015-009264.

Cope, A. L. et al. (2016). “Dental consultations in UK general practice andantibiotic prescribing rates: a retrospective cohort study”. In: Br J GenPract 66.646, e329–36. issn: 0960-1643. doi: 10.3399/bjgp16X684757.

Costello, R. et al. (2016). “Influenza and Pneumococcal Vaccination Uptakein Patients with Rheumatoid Arthritis Treated with ImmunosuppressiveTherapy in the UK: A Retrospective Cohort Study Using Data from theClinical Practice Research Datalink”. In: PLoS One 11.4, e0153848. issn:1932-6203. doi: 10.1371/journal.pone.0153848.

Crooks, C. J., T. R. Card, and J. West (2016). “The Use of a Bayesian Hierarchyto Develop and Validate a Co-Morbidity Score to Predict Mortality forLinked Primary and Secondary Care Data from the NHS in England”. In:PLoS One 11.10, e0165507. issn: 1932-6203. doi: 10.1371/journal.pone.0165507.

Curtis, E. M. et al. (2016). “Epidemiology of fractures in the United Kingdom1988-2012: Variation with age, sex, geography, ethnicity and socioeconomicstatus”. In: Bone 87, pp. 19–26. issn: 1873-2763. doi: 10.1016/j.bone.2016.03.006.

Dalem, J. van et al. (2016). “Risk of hypoglycaemia in users of sulphonylureascompared with metformin in relation to renal function and sulphonylurea

CPRD bibliography

123

metabolite group: population based cohort study”. In: Bmj 354, p. i3625.issn: 0959-8138. doi: 10.1136/bmj.i3625.

Danese, M. D. et al. (2016). “Estimating the economic burden of cardiovascularevents in patients receiving lipid-modifying therapy in the UK”. In: BMJOpen 6.8, e011805. issn: 2044-6055. doi: 10.1136/bmjopen-2016-011805.

Datta-Nemdharry, P., A. Thomson, and J. Beynon (2016). “Opportunities andChallenges in Developing a Cohort of Patients with Type 2 Diabetes MellitusUsing Electronic Primary Care Data”. In: PLoS One 11.11, e0162236. issn:1932-6203. doi: 10.1371/journal.pone.0162236.

DiBello, J. R. et al. (2016). “Prevalence of metabolic syndrome and its com-ponents among men with and without clinical benign prostatic hyperpla-sia: a large, cross-sectional, UK epidemiological study”. In: BJU Int 117.5,pp. 801–8. issn: 1464-4096. doi: 10.1111/bju.13334.

DiSantostefano, R. L. et al. (2016). “The frequency of, and adherence to, singlemaintenance and reliever therapy instructions in asthma: a descriptive anal-ysis”. In: NPJ Prim Care Respir Med 26, p. 16038. issn: 2055-1010. doi:10.1038/npjpcrm.2016.38.

Dos Santos, G. et al. (2016). “Risk of solid organ transplant rejection followingvaccination with seasonal trivalent inactivated influenza vaccines in England:A self-controlled case-series”. In: Vaccine 34.31, pp. 3598–606. issn: 0264-410x. doi: 10.1016/j.vaccine.2016.05.016.

Doyle, M. et al. (2016). “Suicide risk in primary care patients diagnosed with apersonality disorder: a nested case control study”. In: BMC Fam Pract 17,p. 106. issn: 1471-2296. doi: 10.1186/s12875-016-0479-y.

Drahos, J. et al. (2016). “Metabolic syndrome in relation to Barrett’s esophagusand esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink”. In: Cancer Epi-demiol 42, pp. 9–14. issn: 1877-7821. doi: 10.1016/j.canep.2016.02.008.

Eastwood, S. V. et al. (2016). “Algorithms for the Capture and Adjudicationof Prevalent and Incident Diabetes in UK Biobank”. In: PLoS One 11.9,e0162388. issn: 1932-6203. doi: 10.1371/journal.pone.0162388.

Emdin, C. A. et al. (2016). “Blood Pressure and Risk of Vascular Dementia:Evidence From a Primary Care Registry and a Cohort Study of TransientIschemic Attack and Stroke”. In: Stroke 47.6, pp. 1429–35. issn: 0039-2499.doi: 10.1161/strokeaha.116.012658.

Essers, I. et al. (2016). “Ankylosing spondylitis and risk of ischaemic heartdisease: a population-based cohort study”. In: Ann Rheum Dis 75.1, pp. 203–9. issn: 0003-4967. doi: 10.1136/annrheumdis-2014-206147.

Faillie, J. L. et al. (2016). “Association of Bile Duct and Gallbladder DiseasesWith the Use of Incretin-Based Drugs in Patients With Type 2 DiabetesMellitus”. In: JAMA Intern Med 176.10, pp. 1474–1481. issn: 2168-6106.doi: 10.1001/jamainternmed.2016.1531.

Fairhurst, C. et al. (2016). “Sodium channel-inhibiting drugs and cancer sur-vival: protocol for a cohort study using the CPRD primary care database”.In: BMJ Open 6.9, e011661. issn: 2044-6055. doi: 10.1136/bmjopen-2016-011661.

Farmer, A. J. et al. (2016). “Adherence to Oral Glucose-Lowering Therapiesand Associations With 1-Year HbA1c: A Retrospective Cohort Analysis ina Large Primary Care Database”. In: Diabetes Care 39.2, pp. 258–263. issn:0149-5992. doi: 10.2337/dc15-1194.

CPRD bibliography

124

Ferguson, S. et al. (2016). “The impact of persistence with bisphosphonates onhealth resource utilization and fracture risk in the UK: a study of patientrecords from the UK Clinical Practice Research Datalink”. In: J Eval ClinPract 22.1, pp. 31–39. issn: 1356-1294. doi: 10.1111/jep.12422.

Filion, K. B. et al. (2016). “A Multicenter Observational Study of Incretin-based Drugs and Heart Failure”. In: N Engl J Med 374.12, pp. 1145–54.issn: 0028-4793. doi: 10.1056/NEJMoa1506115.

Fleming, D. M. et al. (2016). “Influenza-attributable burden in United Kingdomprimary care”. In: Epidemiol Infect 144.3, pp. 537–47. issn: 0950-2688. doi:10.1017/s0950268815001119.

Forbes, H. J. et al. (2016). “Quantification of risk factors for postherpetic neu-ralgia in herpes zoster patients: A cohort study”. In: Neurology 87.1, pp. 94–102. issn: 0028-3878. doi: 10.1212/wnl.0000000000002808.

Forster, A. S. et al. (2016). “Do health checks improve risk factor detection inprimary care? Matched cohort study using electronic health records”. In:J Public Health (Oxf) 38.3, pp. 552–559. issn: 1741-3842. doi: 10.1093/pubmed/fdv119.

Francis, N. A. et al. (2016). “Understanding flucloxacillin prescribing trends andtreatment non-response in UK primary care: a Clinical Practice ResearchDatalink (CPRD) study”. In: J Antimicrob Chemother 71.7, pp. 2037–46.issn: 0305-7453. doi: 10.1093/jac/dkw084.

Freedman, B. et al. (2016). “Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation”. In: JAMA Cardiol 1.3, pp. 366–8. doi: 10.1001/jamacardio.2016.0393.

Frey, N. et al. (2016). “Type II diabetes mellitus and incident osteoarthritisof the hand: a population-based case-control analysis”. In: OsteoarthritisCartilage 24.9, pp. 1535–40. issn: 1063-4584. doi: 10.1016/j.joca.2016.04.005.

Fundament, T. et al. (2016). “Deep Brain Stimulation for Parkinson’s Diseasewith Early Motor Complications: A UK Cost-Effectiveness Analysis”. In:PLoS One 11.7, e0159340. issn: 1932-6203. doi: 10.1371/journal.pone.0159340.

Gallagher, A. M. et al. (2016). “The Impact of the Choice of Data Sourcein Record Linkage Studies Estimating Mortality in Venous Thromboem-bolism”. In: PLoS One 11.2, e0148349. issn: 1932-6203. doi: 10 . 1371 /

journal.pone.0148349.Gamble, J. M. et al. (2016). “Comparative effectiveness of incretin-based ther-

apies and the risk of death and cardiovascular events in 38,233 metforminmonotherapy users”. In: Medicine (Baltimore) 95.26, e3995. issn: 0025-7974.doi: 10.1097/md.0000000000003995.

Getz, K. D. et al. (2016). “Maternal Pre-pregnancy Body Mass Index andAutism Spectrum Disorder among Offspring: A Population-Based Case-ControlStudy”. In: Paediatr Perinat Epidemiol 30.5, pp. 479–87. issn: 0269-5022.doi: 10.1111/ppe.12306.

Grimaldi-Bensouda, L. et al. (2016). “Calcium channel blockers and cancer: arisk analysis using the UK Clinical Practice Research Datalink (CPRD)”.In: BMJ Open 6.1, e009147. issn: 2044-6055. doi: 10.1136/bmjopen-2015-009147.

Gulliford, M. C., H. P. Booth, et al. (2016). “Effect of Contemporary BariatricSurgical Procedures on Type 2 Diabetes Remission. A Population-Based

CPRD bibliography

125

Matched Cohort Study”. In: Obes Surg 26.10, pp. 2308–15. issn: 0960-8923.doi: 10.1007/s11695-016-2103-6.

Gulliford, M. C., M. V. Moore, et al. (2016). “Safety of reduced antibiotic pre-scribing for self limiting respiratory tract infections in primary care: cohortstudy using electronic health records”. In: Bmj 354, p. i3410. issn: 0959-8138. doi: 10.1136/bmj.i3410.

Hagberg, K. W., H. A. Divan, et al. (2016). “Risk of erectile dysfunction associ-ated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasiaor alopecia: population based studies using the Clinical Practice ResearchDatalink”. In: Bmj 354, p. i4823. issn: 0959-8138. doi: 10.1136/bmj.i4823.

Hagberg, K. W., L. Li, M. Peng, M. Paris, et al. (2016). “Rates of Cancersand Opportunistic Infections in Patients With Psoriatic Arthritis ComparedWith Patients Without Psoriatic Arthritis”. In: J Clin Rheumatol 22.5,pp. 241–7. issn: 1076-1608. doi: 10.1097/rhu.0000000000000364.

Hagberg, K. W., L. Li, M. Peng, K. Shah, et al. (2016). “Incidence rates of suici-dal behaviors and treated depression in patients with and without psoriaticarthritis using the Clinical Practice Research Datalink”. In: Mod Rheumatol26.5, pp. 774–9. issn: 1439-7595. doi: 10.3109/14397595.2015.1136726.

Hagberg, K. W., V. V. Sahasrabuddhe, et al. (2016). “Does Angiotensin-ConvertingEnzyme Inhibitor and beta-Blocker Use Reduce the Risk of Primary LiverCancer? A Case-Control Study Using the U.K. Clinical Practice ResearchDatalink”. In: Pharmacotherapy 36.2, pp. 187–95. issn: 0277-0008. doi: 10.1002/phar.1704.

Happich, M. et al. (2016). “Excess Costs Associated with Possible Misdiagnosisof Alzheimer’s Disease Among Patients with Vascular Dementia in a UKCPRD Population”. In: J Alzheimers Dis 53.1, pp. 171–83. issn: 1387-2877.doi: 10.3233/jad-150685.

Hassan, L. et al. (2016). “Prevalence and appropriateness of psychotropic med-ication prescribing in a nationally representative cross-sectional survey ofmale and female prisoners in England”. In: BMC Psychiatry 16.1, p. 346.issn: 1471-244x. doi: 10.1186/s12888-016-1055-7.

Hawley, S. et al. (2016). “Anti-Osteoporosis Medication Prescriptions and Inci-dence of Subsequent Fracture Among Primary Hip Fracture Patients in Eng-land and Wales: An Interrupted Time-Series Analysis”. In: J Bone MinerRes 31.11, pp. 2008–2015. issn: 0884-0431. doi: 10.1002/jbmr.2882.

Herrett, E. et al. (2016). “Text messaging reminders for influenza vaccine inprimary care: a cluster randomised controlled trial (TXT4FLUJAB)”. In:BMJ Open 6.2, e010069. issn: 2044-6055. doi: 10.1136/bmjopen-2015-010069.

Hesdorffer, D. C. et al. (2016). “Occurrence and Recurrence of Attempted Sui-cide Among People With Epilepsy”. In: JAMA Psychiatry 73.1, pp. 80–6.issn: 2168-622x. doi: 10.1001/jamapsychiatry.2015.2516.

Hicks, B. M. et al. (2016). “Glucagon-like peptide-1 analogues and risk of breastcancer in women with type 2 diabetes: population based cohort study usingthe UK Clinical Practice Research Datalink”. In: Bmj 355, p. i5340. issn:0959-8138. doi: 10.1136/bmj.i5340.

Hobbs, F. D. R. et al. (2016). “Clinical workload in UK primary care: a ret-rospective analysis of 100 million consultations in England, 2007-14”. In:Lancet 387.10035, pp. 2323–2330. issn: 0140-6736. doi: 10.1016/s0140-6736(16)00620-6.

CPRD bibliography

126

Holden, S. E., S. Jenkins-Jones, and C. J. Currie (2016). “Association be-tween Insulin Monotherapy versus Insulin plus Metformin and the Riskof All-Cause Mortality and Other Serious Outcomes: A Retrospective Co-hort Study”. In: PLoS One 11.5, e0153594. issn: 1932-6203. doi: 10.1371/journal.pone.0153594.

Hollingworth, W. et al. (2016). “The healthcare costs of heart failure during thelast five years of life: A retrospective cohort study”. In: Int J Cardiol 224,pp. 132–138. issn: 0167-5273. doi: 10.1016/j.ijcard.2016.09.021.

Hong, J. L. et al. (2016). “Identification of impaired fasting glucose, healthcareutilization and progression to diabetes in the UK using the Clinical Prac-tice Research Datalink (CPRD)”. In: Pharmacoepidemiol Drug Saf 25.12,pp. 1375–1386. issn: 1053-8569. doi: 10.1002/pds.4007.

Hosking, F. J. et al. (2016). “Mortality Among Adults With Intellectual Dis-ability in England: Comparisons With the General Population”. In: Am JPublic Health 106.8, pp. 1483–90. issn: 0090-0036. doi: 10.2105/ajph.

2016.303240.Huerta, C. et al. (2016). “Exposure to benzodiazepines (anxiolytics, hypnotics

and related drugs) in seven European electronic healthcare databases: across-national descriptive study from the PROTECT-EU Project”. In: Phar-macoepidemiol Drug Saf 25 Suppl 1, pp. 56–65. issn: 1053-8569. doi: 10.1002/pds.3825.

Humes, D. J. et al. (2016). “Risk of symptomatic venous thromboembolism fol-lowing emergency appendicectomy in adults”. In: Br J Surg 103.4, pp. 443–50. issn: 0007-1323. doi: 10.1002/bjs.10091.

Imfeld, P. et al. (2016). “Influenza infections and risk of Alzheimer’s disease”.In: Brain Behav Immun 57, pp. 187–192. issn: 0889-1591. doi: 10.1016/j.bbi.2016.03.014.

Iwagami, M. et al. (2016). “Diagnosis of acute kidney injury and its associa-tion with in-hospital mortality in patients with infective exacerbations ofbronchiectasis: cohort study from a UK nationwide database”. In: BMCPulm Med 16, p. 14. issn: 1471-2466. doi: 10.1186/s12890-016-0177-5.

Jameson, K. et al. (2016). “Adherence to NICE guidance on glucagon-likepeptide-1 receptor agonists among patients with type 2 diabetes mellitus:an evaluation using the Clinical Practice Research Datalink”. In: Curr MedRes Opin 32.1, pp. 49–60. issn: 0300-7995. doi: 10.1185/03007995.2015.1101372.

Johnson, M. E. et al. (2016). “Early real-world evidence of persistence on oral an-ticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohortstudy in UK primary care”. In: BMJ Open 6.9, e011471. issn: 2044-6055.doi: 10.1136/bmjopen-2016-011471.

Jong, R. G. de et al. (2016). “Comparability of the age and sex distribution ofthe UK Clinical Practice Research Datalink and the total Dutch population”.In: Pharmacoepidemiol Drug Saf 25.12, pp. 1460–1464. issn: 1053-8569. doi:10.1002/pds.4074.

Joseph, R. M. et al. (2016). “Smoking-Related Mortality in Patients WithEarly Rheumatoid Arthritis: A Retrospective Cohort Study Using the Clin-ical Practice Research Datalink”. In: Arthritis Care Res (Hoboken) 68.11,pp. 1598–1606. issn: 2151-464x. doi: 10.1002/acr.22882.

Joshi, R., S. Venkatesan, and P. R. Myles (2016). “A UK general practicepopulation cohort study investigating the association between lipid lowering

CPRD bibliography

127

drugs and 30-day mortality following medically attended acute respiratoryillness”. In: PeerJ 4, e1902. issn: 2167-8359 (Print) 2167-8359. doi: 10.

7717/peerj.1902.Judge, A. et al. (2016). “Models of care for the delivery of secondary fracture

prevention after hip fracture: a health service cost, clinical outcomes andcost-effectiveness study within a region of England”. In: Health Services andDelivery Research No. 4.28. doi: 10.3310/hsdr04280.

Julious, S. A. et al. (2016). “PLEASANT: Preventing and Lessening Exacer-bations of Asthma in School-age children Associated with a New Term -a cluster randomised controlled trial and economic evaluation”. In: HealthTechnol Assess 20.93, pp. 1–154. issn: 1366-5278. doi: 10.3310/hta20930.

Juszczyk, D. et al. (2016). “Electronically delivered, multicomponent interven-tion to reduce unnecessary antibiotic prescribing for respiratory infectionsin primary care: a cluster randomised trial using electronic health records-REDUCE Trial study original protocol”. In: BMJ Open 6.8, e010892. issn:2044-6055. doi: 10.1136/bmjopen-2015-010892.

Karasneh, R. A. et al. (2016). “Digoxin use after diagnosis of prostate cancerand survival: a population-based cohort study”. In: Pharmacoepidemiol DrugSaf 25.9, pp. 1099–103. issn: 1053-8569. doi: 10.1002/pds.4018.

Karystianis, G. et al. (2016). “Modelling and extraction of variability in free-text medication prescriptions from an anonymised primary care electronicmedical record research database”. In: BMC Med Inform Decis Mak 16,p. 18. issn: 1472-6947. doi: 10.1186/s12911-016-0255-x.

Khunti, K. et al. (2016). “Clinical inertia with regard to intensifying therapy inpeople with type 2 diabetes treated with basal insulin”. In: Diabetes ObesMetab 18.4, pp. 401–9. issn: 1462-8902. doi: 10.1111/dom.12626.

Kingswood, J. C., P. Crawford, et al. (2016). “The economic burden of tuberoussclerosis complex in the UK: A retrospective cohort study in the ClinicalPractice Research Datalink”. In: J Med Econ 19.11, pp. 1087–1098. issn:1369-6998. doi: 10.1080/13696998.2016.1199432.

Kingswood, J. C., P. Nasuti, et al. (2016). “The economic burden of tuberoussclerosis complex in UK patients with renal manifestations: a retrospectivecohort study in the clinical practice research datalink (CPRD)”. In: J MedEcon 19.12, pp. 1116–1126. issn: 1369-6998. doi: 10.1080/13696998.2016.1202254.

Klil-Drori, A. J., K. Tascilar, et al. (2016). “Androgen Deprivation Therapyand the Incidence of Inflammatory Bowel Disease in Patients With ProstateCancer”. In: Am J Epidemiol 184.1, pp. 15–22. issn: 0002-9262. doi: 10.1093/aje/kwv307.

Klil-Drori, A. J., H. Yin, et al. (2016). “Androgen Deprivation Therapy forProstate Cancer and the Risk of Venous Thromboembolism”. In: Eur Urol70.1, pp. 56–61. issn: 0302-2838. doi: 10.1016/j.eururo.2015.06.022.

Klop, C. et al. (2016). “Predicting the 10-year risk of hip and major osteoporoticfracture in rheumatoid arthritis and in the general population: an indepen-dent validation and update of UK FRAX without bone mineral density”.In: Ann Rheum Dis 75.12, pp. 2095–2100. issn: 0003-4967. doi: 10.1136/annrheumdis-2015-208958.

Knapen, L. M. et al. (2016). “Use of incretin agents and risk of pancreatic cancer:a population-based cohort study”. In: Diabetes Obes Metab 18.3, pp. 258–65.issn: 1462-8902. doi: 10.1111/dom.12605.

CPRD bibliography

128

Kontopantelis, E. et al. (2016). “Associations between exemption and survivaloutcomes in the UK’s primary care pay-for-performance programme: a retro-spective cohort study”. In: BMJ Qual Saf 25.9, pp. 657–70. issn: 2044-5415.doi: 10.1136/bmjqs-2015-004602.

Korhonen, P. et al. (2016). “Pioglitazone use and risk of bladder cancer inpatients with type 2 diabetes: retrospective cohort study using datasetsfrom four European countries”. In: Bmj 354, p. i3903. issn: 0959-8138. doi:10.1136/bmj.i3903.

Krishnamoorthi, R. et al. (2016). “Rates and predictors of progression to esophagealcarcinoma in a large population-based Barrett’s esophagus cohort”. In: Gas-trointest Endosc 84.1, 40–46.e7. issn: 0016-5107. doi: 10.1016/j.gie.

2015.12.036.Kuo, C. F. et al. (2016a). “Comorbidities in patients with gout prior to and

following diagnosis: case-control study”. In: Ann Rheum Dis 75.1, pp. 210–7. issn: 0003-4967. doi: 10.1136/annrheumdis-2014-206410.

— (2016b). “Impact of gout on the risk of atrial fibrillation”. In: Rheumatology(Oxford) 55.4, pp. 721–8. issn: 1462-0324. doi: 10.1093/rheumatology/kev418.

Lane, A. et al. (2016). “Patient-reported outcomes in the ProtecT randomizedtrial of clinically localized prostate cancer treatments: study design, andbaseline urinary, bowel and sexual function and quality of life”. In: BJU Int118.6, pp. 869–879. issn: 1464-4096. doi: 10.1111/bju.13582.

Lian, Y. et al. (2016). “Phosphodiesterase Type 5 Inhibitors and the Risk ofMelanoma Skin Cancer”. In: Eur Urol 70.5, pp. 808–815. issn: 0302-2838.doi: 10.1016/j.eururo.2016.04.035.

Lim, A. W., W. Hamilton, et al. (2016). “Performance characteristics of visu-alising the cervix in symptomatic young females: a review of primary carerecords in females with and without cervical cancer”. In: Br J Gen Pract66.644, e189–92. issn: 0960-1643. doi: 10.3399/bjgp16X683833.

Lim, A. W., R. Landy, et al. (2016). “Cytology in the diagnosis of cervicalcancer in symptomatic young women: a retrospective review”. In: Br J GenPract 66.653, e871–e879. issn: 0960-1643. doi: 10.3399/bjgp16X687937.

Lloyd, T. and A. Steventon (2016). “Effect of Named, Accountable GPs on Con-tinuity of Care: Protocol for a Regression Discontinuity Study of a NationalPolicy Change”. In: Int J Integr Care 16.1, p. 6. issn: 1568-4156 (Print).doi: 10.5334/ijic.2450.

MacIsaac, R. L. et al. (2016). “Allopurinol and Cardiovascular Outcomes inAdults With Hypertension”. In: Hypertension 67.3, pp. 535–40. issn: 0194-911x. doi: 10.1161/hypertensionaha.115.06344.

Mahmoudpour, S. H. et al. (2016). “Determinants of angiotensin-convertingenzyme inhibitor (ACEI) intolerance and angioedema in the UK ClinicalPractice Research Datalink”. In: Br J Clin Pharmacol 82.6, pp. 1647–1659.issn: 0306-5251. doi: 10.1111/bcp.13090.

Mansfield, K. E. et al. (2016). “Prescription of renin-angiotensin system blockersand risk of acute kidney injury: a population-based cohort study”. In: BMJOpen 6.12, e012690. issn: 2044-6055. doi: 10.1136/bmjopen-2016-012690.

Martinez, C., A. Katholing, K. Folkerts, et al. (2016). “Risk of recurrent venousthromboembolism after discontinuation of vitamin K antagonist treatment:a nested case-control study”. In: J Thromb Haemost 14.7, pp. 1374–83. issn:1538-7836. doi: 10.1111/jth.13337.

CPRD bibliography

129

Martinez, C., A. Katholing, C. Wallenhorst, et al. (2016). “Therapy persistencein newly diagnosed non-valvular atrial fibrillation treated with warfarin orNOAC. A cohort study”. In: Thromb Haemost 115.1, pp. 31–9. issn: 0340-6245. doi: 10.1160/th15-04-0350.

Martinez, C., S. Suissa, et al. (2016). “Testosterone treatment and risk of ve-nous thromboembolism: population based case-control study”. In: Bmj 355,p. i5968. issn: 0959-8138. doi: 10.1136/bmj.i5968.

Matthews, A., E. Herrett, et al. (2016). “Impact of statin related media coverageon use of statins: interrupted time series analysis with UK primary caredata”. In: Bmj 353, p. i3283. issn: 0959-8138. doi: 10.1136/bmj.i3283.

Matthews, A., S. M. Langan, et al. (2016). “Phosphodiesterase Type 5 Inhibitorsand Risk of Malignant Melanoma: Matched Cohort Study Using PrimaryCare Data from the UK Clinical Practice Research Datalink”. In: PLoS Med13.6, e1002037. issn: 1549-1277. doi: 10.1371/journal.pmed.1002037.

Mc Menamin, U. C. et al. (2016). “Metformin use and survival after colorectalcancer: A population-based cohort study”. In: Int J Cancer 138.2, pp. 369–79. issn: 0020-7136. doi: 10.1002/ijc.29720.

McGlynn, K. A. et al. (2016). “Menopausal hormone therapy use and risk ofprimary liver cancer in the clinical practice research datalink”. In: Int JCancer 138.9, pp. 2146–53. issn: 0020-7136. doi: 10.1002/ijc.29960.

Mehta, H. B., V. Mehta, C. J. Girman, et al. (2016). “Regression coefficient-based scoring system should be used to assign weights to the risk index”. In:J Clin Epidemiol 79, pp. 22–28. issn: 0895-4356. doi: 10.1016/j.jclinepi.2016.03.031.

Mehta, H. B., V. Mehta, C. L. Tsai, et al. (2016). “Development and Validationof the RxDx-Dementia Risk Index to Predict Dementia in Patients withType 2 Diabetes and Hypertension”. In: J Alzheimers Dis 49.2, pp. 423–32.issn: 1387-2877. doi: 10.3233/jad-150466.

Menamin, U. C. et al. (2016). “Metformin use and survival from lung cancer: Apopulation-based cohort study”. In: Lung Cancer 94, pp. 35–9. issn: 0169-5002. doi: 10.1016/j.lungcan.2016.01.012.

Merinopoulou, E. et al. (2016). “COPD exacerbations by disease severity inEngland”. In: Int J Chron Obstruct Pulmon Dis 11, pp. 697–709. issn: 1176-9106. doi: 10.2147/copd.s100250.

Merriel, S. W. et al. (2016). “Association between unexplained hypoalbuminaemiaand new cancer diagnoses in UK primary care patients”. In: Fam Pract 33.5,pp. 449–52. issn: 0263-2136. doi: 10.1093/fampra/cmw051.

Millett, E. R. et al. (2016). “Improved incidence estimates from linked vs. stand-alone electronic health records”. In: J Clin Epidemiol 75, pp. 66–9. issn:0895-4356. doi: 10.1016/j.jclinepi.2016.01.005.

Mohiuddin, S. et al. (2016). “Model-based cost-effectiveness analysis of B-typenatriuretic peptide-guided care in patients with heart failure”. In: BMJ Open6.12, e014010. issn: 2044-6055. doi: 10.1136/bmjopen-2016-014010.

Moon, R. J. et al. (2016). “Ethnic and geographic variations in the epidemiologyof childhood fractures in the United Kingdom”. In: Bone 85, pp. 9–14. issn:1873-2763. doi: 10.1016/j.bone.2016.01.015.

Moore, E. et al. (2016). “Linking e-health records, patient-reported symptomsand environmental exposure data to characterise and model COPD exacer-bations: protocol for the COPE study”. In: BMJ Open 6.7, e011330. issn:2044-6055. doi: 10.1136/bmjopen-2016-011330.

CPRD bibliography

130

Morales, D. R. et al. (2016). “Respiratory effect of beta-blocker eye drops inasthma: population-based study and meta-analysis of clinical trials”. In: Br JClin Pharmacol 82.3, pp. 814–22. issn: 0306-5251. doi: 10.1111/bcp.13006.

Morgan, A. D. et al. (2016). “COPD disease severity and the risk of venousthromboembolic events: a matched case-control study”. In: Int J ChronObstruct Pulmon Dis 11, pp. 899–908. issn: 1176-9106. doi: 10.2147/copd.s100533.

Moss, S. et al. (2016). “Prostate-specific antigen testing rates and referral pat-terns from general practice data in England”. In: Int J Clin Pract 70.4,pp. 312–8. issn: 1368-5031. doi: 10.1111/ijcp.12784.

Movahedi, M., M. E. Beauchamp, et al. (2016). “Risk of Incident DiabetesMellitus Associated With the Dosage and Duration of Oral GlucocorticoidTherapy in Patients With Rheumatoid Arthritis”. In: Arthritis Rheumatol68.5, pp. 1089–98. issn: 2326-5191. doi: 10.1002/art.39537.

Movahedi, M., R. Costello, et al. (2016). “Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: aretrospective cohort study”. In: Eur J Epidemiol 31.10, pp. 1045–1055. issn:0393-2990. doi: 10.1007/s10654-016-0167-1.

Nakafero, G. et al. (2016). “The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UKPrimary Care data”. In: Pharmacoepidemiol Drug Saf 25.11, pp. 1263–1273.issn: 1053-8569. doi: 10.1002/pds.4028.

Nielen, J. T., P. C. Dagnelie, et al. (2016). “Safety and efficacy of new oral anti-coagulants and low-molecular-weight heparins compared with aspirin in pa-tients undergoing total knee and hip replacements”. In: PharmacoepidemiolDrug Saf 25.11, pp. 1245–1252. issn: 1053-8569. doi: 10.1002/pds.4089.

Nielen, J. T., P. J. Emans, et al. (2016). “Severity of Diabetes Mellitus andTotal Hip or Knee Replacement: A Population-Based Case-Control Study”.In: Medicine (Baltimore) 95.20, e3739. issn: 0025-7974. doi: 10.1097/md.0000000000003739.

Nielen, J. T., F. de Vries, et al. (2016). “Use of thiazolidinediones and therisk of elective hip or knee replacement: a population based case-controlstudy”. In: Br J Clin Pharmacol 81.2, pp. 370–8. issn: 0306-5251. doi:10.1111/bcp.12786.

Nyberg, F. et al. (2016). “Comorbidity Burden in Trial-Aligned Patients withEstablished Gout in Germany, UK, US, and France: a Retrospective Analy-sis”. In: Adv Ther 33.7, pp. 1180–98. issn: 0741-238x. doi: 10.1007/s12325-016-0346-1.

Olier, I. et al. (2016). “Modelling Conditions and Health Care Processes inElectronic Health Records: An Application to Severe Mental Illness with theClinical Practice Research Datalink”. In: PLoS One 11.2, e0146715. issn:1932-6203. doi: 10.1371/journal.pone.0146715.

Olsen, J. R. et al. (2016). “Molluscum contagiosum and associations with atopiceczema in children: a retrospective longitudinal study in primary care”. In:Br J Gen Pract 66.642, e53–8. issn: 0960-1643. doi: 10.3399/bjgp15X688093.

Othman, F., T. R. Card, and C. J. Crooks (2016). “Proton pump inhibitorprescribing patterns in the UK: a primary care database study”. In: Phar-macoepidemiol Drug Saf 25.9, pp. 1079–87. issn: 1053-8569. doi: 10.1002/pds.4043.

CPRD bibliography

131

Othman, F., C. J. Crooks, and T. R. Card (2016). “Community acquired pneu-monia incidence before and after proton pump inhibitor prescription: popu-lation based study”. In: Bmj 355, p. i5813. issn: 0959-8138. doi: 10.1136/bmj.i5813.

Oyinlola, J. O., J. Campbell, and A. A. Kousoulis (2016). “Is real world evi-dence influencing practice? A systematic review of CPRD research in NICEguidances”. In: BMC Health Serv Res 16, p. 299. issn: 1472-6963. doi: 10.1186/s12913-016-1562-8.

Pang, M. et al. (2016). “Targeted Maximum Likelihood Estimation for Phar-macoepidemiologic Research”. In: Epidemiology 27.4, pp. 570–7. issn: 1044-3983. doi: 10.1097/ede.0000000000000487.

Parker, S. E., S. S. Jick, and M. M. Werler (2016). “Intrauterine device use andthe risk of pre-eclampsia: a case-control study”. In: Bjog 123.5, pp. 788–95.issn: 1470-0328. doi: 10.1111/1471-0528.13413.

Paul, S. K. et al. (2016). “Association of smoking and concomitant metforminuse with cardiovascular events and mortality in people newly diagnosed withtype 2 diabetes”. In: J Diabetes 8.3, pp. 354–62. issn: 1753-0407. doi: 10.1111/1753-0407.12302.

Peeters, P. J. et al. (2016). “Insulin glargine use and breast cancer risk: Asso-ciations with cumulative exposure”. In: Acta Oncol 55.7, pp. 851–8. issn:0284-186x. doi: 10.3109/0284186x.2016.1155736.

Price, D. et al. (2016). “Predicting frequent asthma exacerbations using bloodeosinophil count and other patient data routinely available in clinical prac-tice”. In: J Asthma Allergy 9, pp. 1–12. issn: 1178-6965 (Print) 1178-6965.doi: 10.2147/jaa.s97973.

Price, S. J. et al. (2016). “Is omission of free text records a possible source ofdata loss and bias in Clinical Practice Research Datalink studies? A case-control study”. In: BMJ Open 6.5, e011664. issn: 2044-6055. doi: 10.1136/bmjopen-2016-011664.

Pujades-Rodriguez, M., B. Duyx, S. L. Thomas, D. Stogiannis, A. Rahman, et al.(2016). “Rheumatoid Arthritis and Incidence of Twelve Initial Presentationsof Cardiovascular Disease: A Population Record-Linkage Cohort Study inEngland”. In: PLoS One 11.3, e0151245. issn: 1932-6203. doi: 10.1371/journal.pone.0151245.

Pujades-Rodriguez, M., B. Duyx, S. L. Thomas, D. Stogiannis, L. Smeeth, etal. (2016). “Associations between polymyalgia rheumatica and giant cellarteritis and 12 cardiovascular diseases”. In: Heart 102.5, pp. 383–9. issn:1355-6037. doi: 10.1136/heartjnl-2015-308514.

Quint, J. K. et al. (2016). “Changes in the incidence, prevalence and mortalityof bronchiectasis in the UK from 2004 to 2013: a population-based cohortstudy”. In: Eur Respir J 47.1, pp. 186–93. issn: 0903-1936. doi: 10.1183/13993003.01033-2015.

Rajaram, S. et al. (2016). “Uptake of childhood influenza vaccine from 2012-2013 to 2014-2015 in the UK and the implications for high-risk children: aretrospective observational cohort study”. In: BMJ Open 6.8, e010625. issn:2044-6055. doi: 10.1136/bmjopen-2015-010625.

Rees, D. A., S. Jenkins-Jones, and C. L. Morgan (2016). “Contemporary Repro-ductive Outcomes for Patients With Polycystic Ovary Syndrome: A Retro-spective Observational Study”. In: J Clin Endocrinol Metab 101.4, pp. 1664–72. issn: 0021-972x. doi: 10.1210/jc.2015-2682.

CPRD bibliography

132

Rees, F., M. Doherty, M. J. Grainge, et al. (2016). “Mortality in systemiclupus erythematosus in the United Kingdom 1999-2012”. In: Rheumatology(Oxford) 55.5, pp. 854–60. issn: 1462-0324. doi: 10.1093/rheumatology/kev424.

Rees, F., M. Doherty, M. Grainge, G. Davenport, et al. (2016). “The inci-dence and prevalence of systemic lupus erythematosus in the UK, 1999-2012”. In: Ann Rheum Dis 75.1, pp. 136–41. issn: 0003-4967. doi: 10.1136/annrheumdis-2014-206334.

Rees, F., M. Doherty, M. Grainge, P. Lanyon, et al. (2016). “Burden of Comor-bidity in Systemic Lupus Erythematosus in the UK, 1999-2012”. In: ArthritisCare Res (Hoboken) 68.6, pp. 819–27. issn: 2151-464x. doi: 10.1002/acr.22751.

Renoux, C., S. Dell’Aniello, et al. (2016). “Ventricular tachyarrhythmia andsudden cardiac death with domperidone use in Parkinson’s disease”. In: Br JClin Pharmacol 82.2, pp. 461–72. issn: 0306-5251. doi: 10.1111/bcp.12964.

Renoux, C., J. Y. Shin, et al. (2016). “Prescribing trends of attention-deficit hy-peractivity disorder (ADHD) medications in UK primary care, 1995-2015”.In: Br J Clin Pharmacol 82.3, pp. 858–68. issn: 0306-5251. doi: 10.1111/bcp.13000.

Renzi, C. et al. (2016). “Do colorectal cancer patients diagnosed as an emer-gency differ from non-emergency patients in their consultation patterns andsymptoms? A longitudinal data-linkage study in England”. In: Br J Cancer115.7, pp. 866–75. issn: 0007-0920. doi: 10.1038/bjc.2016.250.

Requena, G. et al. (2016). “Hip/femur fractures associated with the use ofbenzodiazepines (anxiolytics, hypnotics and related drugs): a methodologicalapproach to assess consistencies across databases from the PROTECT-EUproject”. In: Pharmacoepidemiol Drug Saf 25 Suppl 1, pp. 66–78. issn: 1053-8569. doi: 10.1002/pds.3816.

Robson, J. C. et al. (2016). “Which Patients with Giant Cell Arteritis WillDevelop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Re-search Datalink Study”. In: J Rheumatol 43.6, pp. 1085–92. issn: 0315-162X(Print) 0315-162x. doi: 10.3899/jrheum.151024.

Root, A. A. et al. (2016). “Evaluation of the risk of cardiovascular events withclarithromycin using both propensity score and self-controlled study de-signs”. In: Br J Clin Pharmacol 82.2, pp. 512–21. issn: 0306-5251. doi:10.1111/bcp.12983.

Rothnie, K. J., H. Mullerova, J. R. Hurst, et al. (2016). “Validation of theRecording of Acute Exacerbations of COPD in UK Primary Care ElectronicHealthcare Records”. In: PLoS One 11.3, e0151357. issn: 1932-6203. doi:10.1371/journal.pone.0151357.

Rothnie, K. J., H. Mullerova, S. L. Thomas, et al. (2016). “Recording of hos-pitalizations for acute exacerbations of COPD in UK electronic health carerecords”. In: Clin Epidemiol 8, pp. 771–782. issn: 1179-1349 (Print) 1179-1349. doi: 10.2147/clep.s117867.

Rudisill, C. et al. (2016). “Are healthcare costs from obesity associated withbody mass index, comorbidity or depression? Cohort study using electronichealth records”. In: Clin Obes 6.3, pp. 225–31. issn: 1758-8103. doi: 10.1111/cob.12144.

Schuerch, M. et al. (2016). “Impact of varying outcomes and definitions of suici-dality on the associations of antiepileptic drugs and suicidality: comparisons

CPRD bibliography

133

from UK Clinical Practice Research Datalink (CPRD) and Danish nationalregistries (DNR)”. In: Pharmacoepidemiol Drug Saf 25 Suppl 1, pp. 142–55.issn: 1053-8569. doi: 10.1002/pds.3928.

Seliger, C., C. R. Meier, et al. (2016a). “Statin use and risk of glioma: population-based case-control analysis”. In: Eur J Epidemiol 31.9, pp. 947–52. issn:0393-2990. doi: 10.1007/s10654-016-0145-7.

— (2016b). “Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics,and Risk of Glioma”. In: PLoS One 11.2, e0149293. issn: 1932-6203. doi:10.1371/journal.pone.0149293.

Seliger, C., C. Ricci, et al. (2016). “Diabetes, use of antidiabetic drugs, andthe risk of glioma”. In: Neuro Oncol 18.3, pp. 340–9. issn: 1522-8517. doi:10.1093/neuonc/nov100.

Shephard, E. A. et al. (2016). “Symptoms of adult chronic and acute leukaemiabefore diagnosis: large primary care case-control studies using electronicrecords”. In: Br J Gen Pract 66.644, e182–8. issn: 0960-1643. doi: 10 .

3399/bjgp16X683989.Spoendlin, J., G. Karatas, et al. (2016). “Rosacea in Patients with Ulcerative

Colitis and Crohn’s Disease: A Population-based Case-control Study”. In:Inflamm Bowel Dis 22.3, pp. 680–7. issn: 1078-0998. doi: 10.1097/mib.0000000000000644.

Spoendlin, J., J. B. Layton, et al. (2016). “The Risk of Achilles or Biceps Ten-don Rupture in New Statin Users: A Propensity Score-Matched SequentialCohort Study”. In: Drug Saf 39.12, pp. 1229–1237. issn: 0114-5916. doi:10.1007/s40264-016-0462-5.

Spoendlin, J., C. Meier, et al. (2016a). “Achilles or biceps tendon rupturein women and men with type 2 diabetes: A population-based case-controlstudy”. In: J Diabetes Complications 30.5, pp. 903–9. issn: 1056-8727. doi:10.1016/j.jdiacomp.2016.02.017.

— (2016b). “Bisphosphonate therapy start may transiently increase the risk oftendon rupture in patients with glucocorticoid co-medication: a population-based observational study”. In: Pharmacoepidemiol Drug Saf 25.10, pp. 1116–1123. issn: 1053-8569. doi: 10.1002/pds.4042.

Stevens, S. L. et al. (2016). “Chronic renal disease is not chronic kidney disease:implications for use of the QRISK and Joint British Societies risk scores”. In:Fam Pract 33.1, pp. 57–60. issn: 0263-2136. doi: 10.1093/fampra/cmv092.

Sultan, A. A. et al. (2016). “Development and validation of risk prediction modelfor venous thromboembolism in postpartum women: multinational cohortstudy”. In: Bmj 355, p. i6253. issn: 0959-8138. doi: 10.1136/bmj.i6253.

Tamblyn, R. et al. (2016). “Pharmacosurveillance without borders: electronichealth records in different countries can be used to address important method-ological issues in estimating the risk of adverse events”. In: J Clin Epidemiol77, pp. 101–111. issn: 0895-4356. doi: 10.1016/j.jclinepi.2016.03.033.

Tascilar, K., L. Azoulay, et al. (2016). “The Use of Telmisartan and the Incidenceof Cancer”. In: Am J Hypertens 29.12, pp. 1358–1365. issn: 0895-7061. doi:10.1093/ajh/hpw095.

Tascilar, K., S. Dell’Aniello, et al. (2016). “Statins and Risk of RheumatoidArthritis: A Nested Case-Control Study”. In: Arthritis Rheumatol 68.11,pp. 2603–2611. issn: 2326-5191. doi: 10.1002/art.39774.

CPRD bibliography

134

Taylor, S. et al. (2016). “Modelling estimates of the burden of respiratory syn-cytial virus infection in children in the UK”. In: BMJ Open 6.6, e009337.issn: 2044-6055. doi: 10.1136/bmjopen-2015-009337.

Tebboth, A. et al. (2016). “Demographic and Clinical Characteristics of PatientsWith Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors:A Retrospective Study of UK General Practice”. In: Clin Ther 38.8, 1825–1832.e15. issn: 0149-2918. doi: 10.1016/j.clinthera.2016.07.006.

Tuccori, M. et al. (2016). “Pioglitazone use and risk of bladder cancer: pop-ulation based cohort study”. In: Bmj 352, p. i1541. issn: 0959-8138. doi:10.1136/bmj.i1541.

Vamos, E. P. et al. (2016). “Effectiveness of the influenza vaccine in preventingadmission to hospital and death in people with type 2 diabetes”. In: Cmaj188.14, E342–e351. issn: 0820-3946. doi: 10.1503/cmaj.151059.

Varas-Lorenzo, C. et al. (2016). “Improving the Identification of Out-of-HospitalSudden Cardiac Deaths in a General Practice Research Database”. In: DrugsReal World Outcomes 3.3, pp. 353–358. issn: 2199-1154 (Print) 2198-9788.doi: 10.1007/s40801-016-0086-1.

Velde, R. Y. van der et al. (2016). “Secular trends in fracture incidence in theUK between 1990 and 2012”. In: Osteoporos Int 27.11, pp. 3197–3206. issn:0937-941x. doi: 10.1007/s00198-016-3650-3.

Venkatesan, S. et al. (2016). “Effects of five preoperative cardiovascular drugson mortality after coronary artery bypass surgery: A retrospective analysisof an observational study of 16, 192 patients”. In: Eur J Anaesthesiol 33.1,pp. 49–57. issn: 0265-0215. doi: 10.1097/eja.0000000000000340.

Verhaegh, B. P. et al. (2016). “High risk of drug-induced microscopic colitiswith concomitant use of NSAIDs and proton pump inhibitors”. In: AlimentPharmacol Ther 43.9, pp. 1004–13. issn: 0269-2813. doi: 10.1111/apt.13583.

Vezyridis, P. and S. Timmons (2016). “Evolution of primary care databasesin UK: a scientometric analysis of research output”. In: BMJ Open 6.10,e012785. issn: 2044-6055. doi: 10.1136/bmjopen-2016-012785.

Walker, A. J., D. R. Baldwin, et al. (2016). “Risk of venous thromboembolism inpeople with lung cancer: a cohort study using linked UK healthcare data”.In: Br J Cancer 115.1, pp. 115–21. issn: 0007-0920. doi: 10.1038/bjc.2016.143.

Walker, A. J., J. West, et al. (2016). “When are breast cancer patients at highestrisk of venous thromboembolism? A cohort study using English health caredata”. In: Blood 127.7, 849–57, quiz 953. issn: 0006-4971. doi: 10.1182/blood-2015-01-625582.

Walker, V. M. et al. (2016). “Can commonly prescribed drugs be repurposedfor the prevention or treatment of Alzheimer’s and other neurodegenerativediseases? Protocol for an observational cohort study in the UK ClinicalPractice Research Datalink”. In: BMJ Open 6.12, e012044. issn: 2044-6055.doi: 10.1136/bmjopen-2016-012044.

Watson, L. et al. (2016). “Consequences of delaying treatment intensificationin type 2 diabetes: evidence from a UK database”. In: Curr Med Res Opin32.9, pp. 1465–75. issn: 0300-7995. doi: 10.1185/03007995.2016.1157462.

Wei, L., T. MacDonald, and S. Shimi (2016). “Association between prior appen-dectomy and/or tonsillectomy in women and subsequent pregnancy rate: a

CPRD bibliography

135

cohort study”. In: Fertil Steril 106.5, pp. 1150–1156. issn: 0015-0282. doi:10.1016/j.fertnstert.2016.06.022.

Wexler, N. S. et al. (2016). “Incidence of adult Huntington’s disease in the UK:a UK-based primary care study and a systematic review”. In: BMJ Open6.2, e009070. issn: 2044-6055. doi: 10.1136/bmjopen-2015-009070.

Wilding, J. et al. (2016). “Glycated Hemoglobin, Body Weight and Blood Pres-sure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Pri-mary Care: A Retrospective Study”. In: Diabetes Ther 7.4, pp. 695–711.issn: 1869-6953 (Print). doi: 10.1007/s13300-016-0193-8.

Wilke, T. et al. (2016). “Non-Persistence and Non-Adherence of Patients withType 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: ARetrospective Analysis”. In: Diabetes Ther 7.1, pp. 105–24. issn: 1869-6953(Print). doi: 10.1007/s13300-015-0149-4.

Willame, C., L. Baril, et al. (2016). “Importance of feasibility assessments beforeimplementing non-interventional pharmacoepidemiologic studies of vaccines:lessons learned and recommendations for future studies”. In: Pharmacoepi-demiol Drug Saf 25.12, pp. 1397–1406. issn: 1053-8569. doi: 10.1002/pds.4081.

Willame, C., D. Rosillon, et al. (2016). “Risk of new onset autoimmune diseasein 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom”. In: Hum Vaccin Immunother12.11, pp. 2862–2871. issn: 2164-5515. doi: 10 . 1080 / 21645515 . 2016 .

1199308.Wilson, J. C. et al. (2016a). “A population-based study examining the risk of

malignancy in patients diagnosed with inflammatory bowel disease”. In: JGastroenterol 51.11, pp. 1050–1062. issn: 0944-1174. doi: 10.1007/s00535-016-1199-8.

— (2016b). “Inflammatory Bowel Disease and the Risk of Autoimmune Dis-eases”. In: J Crohns Colitis 10.2, pp. 186–93. issn: 1873-9946. doi: 10.

1093/ecco-jcc/jjv193.Windfuhr, K. et al. (2016). “Suicide risk linked with clinical consultation fre-

quency, psychiatric diagnoses and psychotropic medication prescribing in anational study of primary-care patients”. In: Psychol Med 46.16, pp. 3407–3417. issn: 0033-2917. doi: 10.1017/s0033291716001823.

Windsor, C. et al. (2016). “No association between exacerbation frequency andstroke in patients with COPD”. In: Int J Chron Obstruct Pulmon Dis 11,pp. 217–25. issn: 1176-9106. doi: 10.2147/copd.s95775.

Wing, K. et al. (2016). “Optimising case detection within UK electronic healthrecords: use of multiple linked databases for detecting liver injury”. In: BMJOpen 6.9, e012102. issn: 2044-6055. doi: 10.1136/bmjopen-2016-012102.

Yang, B., K. W. Hagberg, et al. (2016). “Associations of antibiotic use with riskof primary liver cancer in the Clinical Practice Research Datalink”. In: BrJ Cancer 115.1, pp. 85–9. issn: 0007-0920. doi: 10.1038/bjc.2016.148.

Yang, B., J. L. Petrick, et al. (2016). “Associations of NSAID and paraceta-mol use with risk of primary liver cancer in the Clinical Practice ResearchDatalink”. In: Cancer Epidemiol 43, pp. 105–11. issn: 1877-7821. doi: 10.1016/j.canep.2016.06.009.

Zghebi, S. S. et al. (2016). “Comparative risk of major cardiovascular eventsassociated with second-line antidiabetic treatments: a retrospective cohortstudy using UK primary care data linked to hospitalization and mortality

CPRD bibliography

136

records”. In: Diabetes Obes Metab 18.9, pp. 916–24. issn: 1462-8902. doi:10.1111/dom.12692.

Zingone, F. et al. (2016). “The risk of community-acquired pneumonia among9803 patients with coeliac disease compared to the general population: acohort study”. In: Aliment Pharmacol Ther 44.1, pp. 57–67. issn: 0269-2813.doi: 10.1111/apt.13652.

CPRD bibliography

137

2015

Abdul Sultan, A. et al. (2015). “Causes of death in people with coeliac disease inEngland compared with the general population: a competing risk analysis”.In: Gut 64.8, pp. 1220–6. issn: 0017-5749. doi: 10.1136/gutjnl-2014-308285.

Ali, A. K. et al. (2015). “Application of multicategory exposure marginal struc-tural models to investigate the association between long-acting beta-agonistsand prescribing of oral corticosteroids for asthma exacerbations in the Clin-ical Practice Research Datalink”. In: Value Health 18.2, pp. 260–70. issn:1098-3015. doi: 10.1016/j.jval.2014.11.007.

Arana, A. et al. (2015). “Risk of Out-of-Hospital Sudden Cardiac Death in Usersof Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study”. In: Drug Saf 38.12, pp. 1187–99. issn:0114-5916. doi: 10.1007/s40264-015-0338-0.

Asghar, Z., C. Coupland, and N. Siriwardena (2015). “Influenza vaccination andrisk of stroke: Self-controlled case-series study”. In: Vaccine 33.41, pp. 5458–5463. issn: 0264-410x. doi: 10.1016/j.vaccine.2015.08.013.

Assayag, J., M. N. Pollak, and L. Azoulay (2015). “The use of aspirin andthe risk of mortality in patients with prostate cancer”. In: J Urol 193.4,pp. 1220–5. issn: 0022-5347. doi: 10.1016/j.juro.2014.11.018.

Atkinson, R. W. et al. (2015). “Long-term exposure to outdoor air pollutionand the incidence of chronic obstructive pulmonary disease in a nationalEnglish cohort”. In: Occup Environ Med 72.1, pp. 42–8. issn: 1351-0711.doi: 10.1136/oemed-2014-102266.

Azoulay, L. et al. (2015). “5alpha-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer”. In: JAMA Oncol 1.3,pp. 314–20. issn: 2374-2437. doi: 10.1001/jamaoncol.2015.0387.

Baker, A. et al. (2015). “The impact of the ’Better Care Better Value’ prescribingpolicy on the utilisation of angiotensin-converting enzyme inhibitors andangiotensin receptor blockers for treating hypertension in the UK primarycare setting: longitudinal quasi-experimental desi”. In: BMC Health Serv Res15, p. 367. issn: 1472-6963. doi: 10.1186/s12913-015-1013-y.

Barakat, M. F. et al. (2015). “Acute kidney injury in stable COPD and atexacerbation”. In: Int J Chron Obstruct Pulmon Dis 10, pp. 2067–77. issn:1176-9106. doi: 10.2147/copd.s88759.

Baril, L. et al. (2015). “Risk of spontaneous abortion and other pregnancy out-comes in 15-25 year old women exposed to human papillomavirus-16/18AS04-adjuvanted vaccine in the United Kingdom”. In: Vaccine 33.48, pp. 6884–91. issn: 0264-410x. doi: 10.1016/j.vaccine.2015.07.024.

Baxter, G. et al. (2015). “Association of Adverse Events And Health ServiceUsage With Tapentadol Prolonged-Release Treatment Compared With Mor-phine Controlled-Release (Cr) And Oxycodone Cr: A Uk Primary CareObservational Study”. In: Value Health 18.7, A658. issn: 1098-3015. doi:10.1016/j.jval.2015.09.2385.

Becker, C., S. S. Jick, et al. (2015). “No evidence for a decreased risk of thyroidcancer in association with use of metformin or other antidiabetic drugs:

CPRD bibliography

138

a case-control study”. In: BMC Cancer 15, p. 719. issn: 1471-2407. doi:10.1186/s12885-015-1719-6.

Becker, C., J. C. Wilson, et al. (2015). “Non-steroidal anti-inflammatory drugsand the risk of head and neck cancer: A case-control analysis”. In: Int JCancer 137.10, pp. 2424–31. issn: 0020-7136. doi: 10.1002/ijc.29601.

Been, J. V. et al. (2015). “Smoke-free legislation and the incidence of paediatricrespiratory infections and wheezing/asthma: interrupted time series analysesin the four UK nations”. In: Sci Rep 5, p. 15246. issn: 2045-2322. doi:10.1038/srep15246.

Black, R. J. et al. (2015). “Half of U.K. patients with rheumatoid arthritis areprescribed oral glucocorticoid therapy in primary care: a retrospective drugutilisation study”. In: Arthritis Res Ther 17, p. 375. issn: 1478-6354. doi:10.1186/s13075-015-0895-8.

Ble, A. et al. (2015). “Any versus long-term prescribing of high risk medicationsin older people using 2012 Beers Criteria: results from three cross-sectionalsamples of primary care records for 2003/4, 2007/8 and 2011/12”. In: BMCGeriatr 15, p. 146. issn: 1471-2318. doi: 10.1186/s12877-015-0143-8.

Bloechliger, M. et al. (2015). “Antipsychotic drug use and the risk of seizures:follow-up study with a nested case-control analysis”. In: CNS Drugs 29.7,pp. 591–603. issn: 1172-7047. doi: 10.1007/s40263-015-0262-y.

Booth, H. P., A. T. Prevost, and M. C. Gulliford (2015). “Access to weightreduction interventions for overweight and obese patients in UK primarycare: population-based cohort study”. In: BMJ Open 5.1, e006642. issn:2044-6055. doi: 10.1136/bmjopen-2014-006642.

Bouras, G. et al. (2015). “Risk of Post-Discharge Venous Thromboembolism andAssociated Mortality in General Surgery: A Population-Based Cohort StudyUsing Linked Hospital and Primary Care Data in England”. In: PLoS One10.12, e0145759. issn: 1932-6203. doi: 10.1371/journal.pone.0145759.

Brauer, R., K. Bhaskaran, et al. (2015). “Glitazone Treatment and Incidence ofParkinson’s Disease among People with Diabetes: A Retrospective CohortStudy”. In: PLoS Med 12.7, e1001854. issn: 1549-1277. doi: 10 . 1371 /

journal.pmed.1001854.Brauer, R., L. Smeeth, et al. (2015). “Antipsychotic drugs and risks of myocar-

dial infarction: a self-controlled case series study”. In: Eur Heart J 36.16,pp. 984–92. issn: 0195-668x. doi: 10.1093/eurheartj/ehu263.

Bruderer, S. G. et al. (2015a). “Association of hormone therapy and incidentgout: population-based case-control study”. In: Menopause 22.12, pp. 1335–42. issn: 1072-3714. doi: 10.1097/gme.0000000000000474.

— (2015b). “Poorly controlled type 2 diabetes mellitus is associated with a de-creased risk of incident gout: a population-based case-control study”. In: AnnRheum Dis 74.9, pp. 1651–8. issn: 0003-4967. doi: 10.1136/annrheumdis-2014-205337.

Cao, X. et al. (2015). “Impact of Switching From High-Efficacy Lipid-LoweringTherapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attain-ment Among High-Risk Primary and Secondary Prevention Populations inthe United Kingdom”. In: Clin Ther 37.4, pp. 804–15. issn: 0149-2918. doi:10.1016/j.clinthera.2014.12.019.

Carbonari, D. M. et al. (2015). “Use of demographic and pharmacy data to iden-tify patients included within both the Clinical Practice Research Datalink(CPRD) and The Health Improvement Network (THIN)”. In: Pharmacoepi-

CPRD bibliography

139

demiol Drug Saf 24.9, pp. 999–1003. issn: 1053-8569. doi: 10.1002/pds.3844.

Cardwell, C. R., B. M. Hicks, et al. (2015). “Statin use after diagnosis of breastcancer and survival: a population-based cohort study”. In: Epidemiology26.1, pp. 68–78. issn: 1044-3983. doi: 10.1097/ede.0000000000000189.

Cardwell, C. R., U. Mc Menamin, et al. (2015). “Statin use and survival fromlung cancer: a population-based cohort study”. In: Cancer Epidemiol Biomark-ers Prev 24.5, pp. 833–41. issn: 1055-9965. doi: 10.1158/1055-9965.epi-15-0052.

Chang, K. C. et al. (2015). “Coverage of a national cardiovascular risk as-sessment and management programme (NHS Health Check): Retrospectivedatabase study”. In: Prev Med 78, pp. 1–8. issn: 0091-7435. doi: 10.1016/j.ypmed.2015.05.022.

Charlton, R. A. et al. (2015). “Safety of Fluticasone Propionate Prescribed forAsthma During Pregnancy: A UK Population-Based Cohort Study”. In: JAllergy Clin Immunol Pract 3.5, 772–9.e3. doi: 10.1016/j.jaip.2015.05.008.

Charlton, R. et al. (2015). “Antiepileptic drug prescribing before, during andafter pregnancy: a study in seven European regions”. In: PharmacoepidemiolDrug Saf 24.11, pp. 1144–54. issn: 1053-8569. doi: 10.1002/pds.3847.

Chhaya, V., R. C. Pollok, et al. (2015). “Impact of early thiopurines on surgeryin 2770 children and young people diagnosed with inflammatory bowel dis-ease: a national population-based study”. In: Aliment Pharmacol Ther 42.8,pp. 990–9. issn: 0269-2813. doi: 10.1111/apt.13361.

Chhaya, V., S. Saxena, E. Cecil, S. Chatu, et al. (2015). “The impact of timingand duration of thiopurine treatment on colectomy in ulcerative colitis: anational population-based study of incident cases between 1989-2009”. In:Aliment Pharmacol Ther 41.1, pp. 87–98. issn: 0269-2813. doi: 10.1111/apt.13017.

Chhaya, V., S. Saxena, E. Cecil, V. Subramanian, et al. (2015). “Impact of tim-ing and duration of thiopurine treatment on first perianal surgery in Crohn’sdisease: UK population-based study (1995-2009)”. In: Inflamm Bowel Dis21.2, pp. 385–91. issn: 1078-0998. doi: 10.1097/mib.0000000000000290.

Christiansen, C. F. et al. (2015). “Metformin initiation and renal impairment:a cohort study in Denmark and the UK”. In: BMJ Open 5.9, e008531. issn:2044-6055. doi: 10.1136/bmjopen-2015-008531.

Chu, T. P. et al. (2015). “Pattern of symptoms and signs of primary intracranialtumours in children and young adults: a record linkage study”. In: Arch DisChild 100.12, pp. 1115–22. issn: 0003-9888. doi: 10.1136/archdischild-2014-307578.

Cid Ruzafa, J. et al. (2015). “Estimated glomerular filtration rate progression inUK primary care patients with type 2 diabetes and diabetic kidney disease:a retrospective cohort study”. In: Int J Clin Pract 69.8, pp. 871–82. issn:1368-5031. doi: 10.1111/ijcp.12640.

Clarson, L. E. et al. (2015). “Increased risk of vascular disease associated withgout: a retrospective, matched cohort study in the UK clinical practice re-search datalink”. In: Ann Rheum Dis 74.4, pp. 642–7. issn: 0003-4967. doi:10.1136/annrheumdis-2014-205252.

Close, H. et al. (2015). “Risk of Ischaemic Heart Disease in Patients with Inflam-matory Bowel Disease: Cohort Study Using the General Practice Research

CPRD bibliography

140

Database”. In: PLoS One 10.10, e0139745. issn: 1932-6203. doi: 10.1371/journal.pone.0139745.

Crooks, C. J., J. West, and T. R. Card (2015). “A comparison of the recordingof comorbidity in primary and secondary care by using the Charlson Index topredict short-term and long-term survival in a routine linked data cohort”.In: BMJ Open 5.6, e007974. issn: 2044-6055. doi: 10.1136/bmjopen-2015-007974.

Culliford, D. et al. (2015). “Future projections of total hip and knee arthroplastyin the UK: results from the UK Clinical Practice Research Datalink”. In:Osteoarthritis Cartilage 23.4, pp. 594–600. issn: 1063-4584. doi: 10.1016/j.joca.2014.12.022.

Davies, N. M. et al. (2015). “What are the effects of varenicline compared withnicotine replacement therapy on long-term smoking cessation and clinicallyimportant outcomes? Protocol for a prospective cohort study”. In: BMJOpen 5.11, e009665. issn: 2044-6055. doi: 10.1136/bmjopen-2015-009665.

Douglas, I. J. et al. (2015a). “Bariatric Surgery in the United Kingdom: ACohort Study of Weight Loss and Clinical Outcomes in Routine ClinicalCare”. In: PLoS Med 12.12, e1001925. issn: 1549-1277. doi: 10 . 1371 /

journal.pmed.1001925.— (2015b). “The effectiveness of pharmaceutical interventions for obesity: weight

loss with orlistat and sibutramine in a United Kingdom population-basedcohort”. In: Br J Clin Pharmacol 79.6, pp. 1020–7. issn: 0306-5251. doi:10.1111/bcp.12578.

Driessen, J. H. et al. (2015). “Bone fracture risk is not associated with theuse of glucagon-like peptide-1 receptor agonists: a population-based cohortanalysis”. In: Calcif Tissue Int 97.2, pp. 104–12. issn: 0171-967x. doi: 10.1007/s00223-015-9993-5.

Edson-Heredia, E. et al. (2015). “Prevalence and incidence rates of cardiovas-cular, autoimmune, and other diseases in patients with psoriatic or psoriaticarthritis: a retrospective study using Clinical Practice Research Datalink”.In: J Eur Acad Dermatol Venereol 29.5, pp. 955–63. issn: 0926-9959. doi:10.1111/jdv.12742.

Faillie, J. L. et al. (2015). “Dipeptidyl peptidase-4 inhibitors and the risk ofcommunity-acquired pneumonia in patients with type 2 diabetes”. In: Di-abetes Obes Metab 17.4, pp. 379–85. issn: 1462-8902. doi: 10.1111/dom.12431.

Feudjo-Tepie, M. et al. (2015). “Comorbidities, bone-sparing agent prescriptionhistory and their determinants among postmenopausal women in UK pri-mary care settings: a retrospective database study”. In: Arch Osteoporos 10,p. 41. doi: 10.1007/s11657-015-0233-4.

Fildes, A. et al. (2015). “Probability of an Obese Person Attaining Normal BodyWeight: Cohort Study Using Electronic Health Records”. In: Am J PublicHealth 105.9, e54–9. issn: 0090-0036. doi: 10.2105/ajph.2015.302773.

Fleming, D. M. et al. (2015). “Modelling estimates of the burden of RespiratorySyncytial virus infection in adults and the elderly in the United Kingdom”.In: BMC Infect Dis 15, p. 443. issn: 1471-2334. doi: 10.1186/s12879-015-1218-z.

Forster, A. S. et al. (2015). “Estimating the yield of NHS Health Checks inEngland: a population-based cohort study”. In: J Public Health (Oxf) 37.2,pp. 234–40. issn: 1741-3842. doi: 10.1093/pubmed/fdu079.

CPRD bibliography

141

Fournier, J. P., L. Azoulay, et al. (2015). “Tramadol use and the risk of hospital-ization for hypoglycemia in patients with noncancer pain”. In: JAMA InternMed 175.2, pp. 186–93. issn: 2168-6106. doi: 10.1001/jamainternmed.

2014.6512.Fournier, J. P., H. Yin, et al. (2015). “Tramadol for noncancer pain and the risk

of hyponatremia”. In: Am J Med 128.4, 418–25.e5. issn: 0002-9343. doi:10.1016/j.amjmed.2014.10.046.

Gallagher, N. et al. (2015). “Increase in the pharmacological management ofType 2 diabetes with pay-for-performance in primary care in the UK”. In:Diabet Med 32.1, pp. 62–8. issn: 0742-3071. doi: 10.1111/dme.12575.

Goh, K. L. et al. (2015). “Angiotensin receptor blockers and risk of dementia:cohort study in UK Clinical Practice Research Datalink”. In: Br J ClinPharmacol 79.2, pp. 337–50. issn: 0306-5251. doi: 10.1111/bcp.12511.

Goossens, M. E., F. Buntinx, et al. (2015). “Influence of metformin intake on therisk of bladder cancer in type 2 diabetes patients”. In: Br J Clin Pharmacol80.6, pp. 1464–72. issn: 0306-5251. doi: 10.1111/bcp.12740.

Goossens, M. E., M. P. Zeegers, et al. (2015). “Risk of bladder cancer in patientswith diabetes: a retrospective cohort study”. In: BMJ Open 5.6, e007470.issn: 2044-6055. doi: 10.1136/bmjopen-2014-007470.

Gordon, J. P. et al. (2015). “Factors Predictive of Weight Gain and Implica-tions for Modeling in Type 2 Diabetes Patients Initiating Metformin andSulfonylurea Combination Therapy”. In: Diabetes Ther 6.4, pp. 495–507.issn: 1869-6953 (Print). doi: 10.1007/s13300-015-0134-y.

Ham, H. A. van den et al. (2015). “Comparative Performance of ATRIA, CHADS2,and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With AtrialFibrillation: Results From a National Primary Care Database”. In: J AmColl Cardiol 66.17, pp. 1851–9. issn: 0735-1097. doi: 10.1016/j.jacc.2015.08.033.

Hamada, S. and M. C. Gulliford (2015). “Antidiabetic and cardiovascular drugutilisation in patients diagnosed with type 2 diabetes mellitus over the age of80 years: a population-based cohort study”. In: Age Ageing 44.4, pp. 566–73.issn: 0002-0729. doi: 10.1093/ageing/afv065.

Hayes, J. F. et al. (2015). “The effect of sibutramine prescribing in routineclinical practice on cardiovascular outcomes: a cohort study in the UnitedKingdom”. In: Int J Obes (Lond) 39.9, pp. 1359–64. issn: 0307-0565. doi:10.1038/ijo.2015.86.

Hazra, N. C. et al. (2015). “Differences in Health at Age 100 According to Sex:Population-Based Cohort Study of Centenarians Using Electronic HealthRecords”. In: J Am Geriatr Soc 63.7, pp. 1331–7. issn: 0002-8614. doi:10.1111/jgs.13484.

Hazra, N. et al. (2015). “Incidence and mortality of relapsing polychondritis inthe UK: a population-based cohort study”. In: Rheumatology (Oxford) 54.12,pp. 2181–7. issn: 1462-0324. doi: 10.1093/rheumatology/kev240.

Herrett, E. et al. (2015). “Data Resource Profile: Clinical Practice ResearchDatalink (CPRD)”. In: Int J Epidemiol 44.3, pp. 827–36. issn: 0300-5771.doi: 10.1093/ije/dyv098.

Hicks, B. M. et al. (2015a). “Clopidogrel use and cancer-specific mortality:a population-based cohort study of colorectal, breast and prostate cancerpatients”. In: Pharmacoepidemiol Drug Saf 24.8, pp. 830–40. issn: 1053-8569. doi: 10.1002/pds.3807.

CPRD bibliography

142

Hicks, B. M. et al. (2015b). “Post-diagnostic oral bisphosphonate use and col-orectal cancer mortality: a population-based cohort study within the UKClinical Practice Research Datalink”. In: Br J Cancer 113.1, pp. 123–6.issn: 0007-0920. doi: 10.1038/bjc.2015.152.

Hippisley-Cox, J. and C. Coupland (2015a). “Development and validation ofrisk prediction equations to estimate future risk of blindness and lower limbamputation in patients with diabetes: cohort study”. In: Bmj 351, h5441.issn: 0959-8138. doi: 10.1136/bmj.h5441.

— (2015b). “Development and validation of risk prediction equations to esti-mate future risk of heart failure in patients with diabetes: a prospectivecohort study”. In: BMJ Open 5.9, e008503. issn: 2044-6055. doi: 10.1136/bmjopen-2015-008503.

Holden, S. E. et al. (2015). “Glucose-lowering with exogenous insulin monother-apy in type 2 diabetes: dose association with all-cause mortality, cardiovas-cular events and cancer”. In: Diabetes Obes Metab 17.4, pp. 350–62. issn:1462-8902. doi: 10.1111/dom.12412.

Hopkins, C., P. Andrews, and C. E. Holy (2015). “Does time to endoscopic sinussurgery impact outcomes in chronic rhinosinusitis? Retrospective analysisusing the UK clinical practice research data”. In: Rhinology 53.1, pp. 18–24.issn: 0300-0729 (Print) 0300-0729. doi: 10.4193/Rhin14.077.

Horspool, M. J. et al. (2015). “Preventing and Lessening Exacerbations ofAsthma in School-aged children Associated with a New Term (PLEASANT):Recruiting Primary Care Research Sites-the PLEASANT experience”. In:NPJ Prim Care Respir Med 25, p. 15066. issn: 2055-1010. doi: 10.1038/npjpcrm.2015.66.

Humes, D. J., A. Nordenskjold, et al. (2015). “Risk of venous thromboembolismin children after general surgery”. In: J Pediatr Surg 50.11, pp. 1870–3. issn:0022-3468. doi: 10.1016/j.jpedsurg.2015.05.010.

Humes, D. J., A. J. Walker, et al. (2015). “Variation in the risk of venousthromboembolism following colectomy”. In: Br J Surg 102.13, pp. 1629–38.issn: 0007-1323. doi: 10.1002/bjs.9923.

Ilo, D. et al. (2015). “Patient characteristics and treatment patterns for patientswith benign prostatic hyperplasia, erectile dysfunction or co-occurring be-nign prostatic hyperplasia and erectile dysfunction in general practices in theUK: a retrospective observational study”. In: Int J Clin Pract 69.8, pp. 853–62. issn: 1368-5031. doi: 10.1111/ijcp.12657.

Imfeld, P. et al. (2015). “Benzodiazepine Use and Risk of Developing Alzheimer’sDisease or Vascular Dementia: A Case-Control Analysis”. In: Drug Saf 38.10,pp. 909–19. issn: 0114-5916. doi: 10.1007/s40264-015-0319-3.

Mt-Isa, S. et al. (2015). “Prokinetics prescribing in paediatrics: evidence on cis-apride, domperidone, and metoclopramide”. In: J Pediatr Gastroenterol Nutr60.4, pp. 508–14. issn: 0277-2116. doi: 10.1097/mpg.0000000000000657.

Jaarsveld, C. H. van and M. C. Gulliford (2015). “Childhood obesity trendsfrom primary care electronic health records in England between 1994 and2013: population-based cohort study”. In: Arch Dis Child 100.3, pp. 214–9.issn: 0003-9888. doi: 10.1136/archdischild-2014-307151.

Jeffreys, M., M. T. Redaniel, and R. M. Martin (2015). “The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: a cohortstudy within the UK Clinical Practice Research Datalink”. In: BMC Cancer15, p. 670. issn: 1471-2407. doi: 10.1186/s12885-015-1684-0.

CPRD bibliography

143

Jick, S. S. et al. (2015). “Epidemiology of multiple sclerosis: results from a largeobservational study in the UK”. In: J Neurol 262.9, pp. 2033–41. issn: 0340-5354. doi: 10.1007/s00415-015-7796-2.

Jick, S. et al. (2015). “Prevalence of hypercalcemia of malignancy among can-cer patients in the UK: analysis of the Clinical Practice Research Datalinkdatabase”. In: Cancer Epidemiol 39.6, pp. 901–7. issn: 1877-7821. doi: 10.1016/j.canep.2015.10.012.

Judge, A. et al. (2015). “Can the publication of guidelines change the manage-ment of early rheumatoid arthritis? An interrupted time series analysis fromthe United Kingdom”. In: Rheumatology (Oxford) 54.12, pp. 2244–8. issn:1462-0324. doi: 10.1093/rheumatology/kev268.

Kang, E. M. et al. (2015). “Evaluating the validity of clinical codes to identifycataract and glaucoma in the UK Clinical Practice Research Datalink”. In:Pharmacoepidemiol Drug Saf 24.1, pp. 38–44. issn: 1053-8569. doi: 10.

1002/pds.3726.Karasneh, R. A., L. J. Murray, C. M. Hughes, et al. (2015). “Digoxin use after

diagnosis of colorectal cancer and survival: a population-based cohort study”.In: Cancer Epidemiol Biomarkers Prev 24.11, pp. 1804–7. issn: 1055-9965.doi: 10.1158/1055-9965.epi-15-0694.

Karasneh, R. A., L. J. Murray, U. C. Mc Menamin, et al. (2015). “Digoxinuse after diagnosis of breast cancer and survival: a population-based cohortstudy”. In: Breast Cancer Res Treat 151.3, pp. 661–9. issn: 0167-6806. doi:10.1007/s10549-015-3417-0.

Kendrick, T. et al. (2015a). “Changes in rates of recorded depression in Englishprimary care 2003-2013: Time trend analyses of effects of the economicrecession, and the GP contract quality outcomes framework (QOF)”. In:J Affect Disord 180, pp. 68–78. issn: 0165-0327. doi: 10.1016/j.jad.

2015.03.040.— (2015b). “Did NICE guidelines and the Quality Outcomes Framework change

GP antidepressant prescribing in England? Observational study with timetrend analyses 2003-2013”. In: J Affect Disord 186, pp. 171–7. issn: 0165-0327. doi: 10.1016/j.jad.2015.06.052.

Khunti, K. et al. (2015). “Hypoglycemia and risk of cardiovascular disease andall-cause mortality in insulin-treated people with type 1 and type 2 diabetes:a cohort study”. In: Diabetes Care 38.2, pp. 316–22. issn: 0149-5992. doi:10.2337/dc14-0920.

Klop, C. et al. (2015). “Anti-osteoporosis drug prescribing after hip fracture inthe UK: 2000-2010”. In: Osteoporos Int 26.7, pp. 1919–28. issn: 0937-941x.doi: 10.1007/s00198-015-3098-x.

Kontopantelis, E., I. Olier, et al. (2015). “Primary care consultation rates amongpeople with and without severe mental illness: a UK cohort study using theClinical Practice Research Datalink”. In: BMJ Open 5.12, e008650. issn:2044-6055. doi: 10.1136/bmjopen-2015-008650.

Kontopantelis, E., D. A. Springate, et al. (2015). “Glucose, blood pressure andcholesterol levels and their relationships to clinical outcomes in type 2 dia-betes: a retrospective cohort study”. In: Diabetologia 58.3, pp. 505–18. issn:0012-186x. doi: 10.1007/s00125-014-3473-8.

Koshy, E. et al. (2015). “Tonsillectomy among children with low baseline acutethroat infection consultation rates in UK general practices: a cohort study”.

CPRD bibliography

144

In: BMJ Open 5.2, e006686. issn: 2044-6055. doi: 10.1136/bmjopen-2014-006686.

Kuo, C. F. et al. (2015a). “Effect of allopurinol on all-cause mortality in adultswith incident gout: propensity score-matched landmark analysis”. In: Rheuma-tology (Oxford) 54.12, pp. 2145–50. issn: 1462-0324. doi: 10.1093/rheumatology/kev246.

— (2015b). “Rising burden of gout in the UK but continuing suboptimal man-agement: a nationwide population study”. In: Ann Rheum Dis 74.4, pp. 661–7. issn: 0003-4967. doi: 10.1136/annrheumdis-2013-204463.

Lamy, F. X. et al. (2015). “Pharmacotherapeutic strategies for patients treatedfor depression in UK primary care: a database analysis”. In: Curr Med ResOpin 31.4, pp. 795–807. issn: 0300-7995. doi: 10.1185/03007995.2015.1020362.

Lapi, F. et al. (2015). “The use of antidepressants and the risk of chronic atrialfibrillation”. In: J Clin Pharmacol 55.4, pp. 423–30. issn: 0091-2700. doi:10.1002/jcph.435.

Levin, D. et al. (2015). “Pioglitazone and bladder cancer risk: a multipopulationpooled, cumulative exposure analysis”. In: Diabetologia 58.3, pp. 493–504.issn: 0012-186x. doi: 10.1007/s00125-014-3456-9.

Li, L. et al. (2015). “Rates of Cardiovascular Disease and Major Adverse Cardio-vascular Events in Patients With Psoriatic Arthritis Compared to PatientsWithout Psoriatic Arthritis”. In: J Clin Rheumatol 21.8, pp. 405–10. issn:1076-1608. doi: 10.1097/rhu.0000000000000306.

Liang, H. et al. (2015). “Monitoring for proteinuria in patients with type 2diabetes mellitus”. In: BMJ Open Diabetes Res Care 3.1, e000071. issn:2052-4897 (Print) 2052-4897. doi: 10.1136/bmjdrc-2014-000071.

Liang, S. F. et al. (2015). “Semi automated transformation to OWL formattedfiles as an approach to data integration. A feasibility study using environ-mental, disease register and primary care clinical data”. In: Methods Inf Med54.1, pp. 32–40. issn: 0026-1270. doi: 10.3414/me13-02-0029.

Lusignan, S. de et al. (2015). “An algorithm to improve diagnostic accuracyin diabetes in computerised problem orientated medical records (POMR)compared with an established algorithm developed in episode orientatedrecords (EOMR)”. In: J Innov Health Inform 22.2, pp. 255–64. issn: 2058-4555. doi: 10.14236/jhi.v22i2.79.

Macedo, A. F. et al. (2015). “Determinants of oral anticoagulation control innew warfarin patients: analysis using data from Clinical Practice ResearchDatalink”. In: Thromb Res 136.2, pp. 250–60. issn: 0049-3848. doi: 10.

1016/j.thromres.2015.06.007.Martinez, C., A. Katholing, et al. (2015). “Increasing incidence of non-valvular

atrial fibrillation in the UK from 2001 to 2013”. In: Heart 101.21, pp. 1748–54. issn: 1355-6037. doi: 10.1136/heartjnl-2015-307808.

Martinez, C., C. Wallenhorst, et al. (2015). “Incidence rates of clinically signif-icant tinnitus: 10-year trend from a cohort study in England”. In: Ear Hear36.3, e69–75. issn: 0196-0202. doi: 10.1097/aud.0000000000000121.

Mc Menamin, U. C. et al. (2015). “Low-dose aspirin and survival from lungcancer: a population-based cohort study”. In: BMC Cancer 15, p. 911. issn:1471-2407. doi: 10.1186/s12885-015-1910-9.

McDonald, H. I. et al. (2015). “CKD and the risk of acute, community-acquiredinfections among older people with diabetes mellitus: a retrospective cohort

CPRD bibliography

145

study using electronic health records”. In: Am J Kidney Dis 66.1, pp. 60–8.issn: 0272-6386. doi: 10.1053/j.ajkd.2014.11.027.

McEwan, P. et al. (2015). “Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England”. In: BMJ Open Diabetes Res Care 3.1,e000057. issn: 2052-4897 (Print) 2052-4897. doi: 10.1136/bmjdrc-2014-000057.

McFadden, E. et al. (2015). “Implications of lower risk thresholds for statintreatment in primary prevention: analysis of CPRD and simulation mod-elling of annual cholesterol monitoring”. In: Prev Med 70, pp. 14–6. issn:0091-7435. doi: 10.1016/j.ypmed.2014.11.004.

McGlynn, K. A. et al. (2015). “Statin use and risk of primary liver cancer inthe Clinical Practice Research Datalink”. In: J Natl Cancer Inst 107.4. issn:0027-8874. doi: 10.1093/jnci/djv009.

Melzer, D. et al. (2015). “Much more medicine for the oldest old: trends in UKelectronic clinical records”. In: Age Ageing 44.1, pp. 46–53. issn: 0002-0729.doi: 10.1093/ageing/afu113.

Miller, A. et al. (2015). “Estimating the diagnostic accuracy of rheumatoidfactor in UK primary care: a study using the Clinical Practice ResearchDatalink”. In: Rheumatology (Oxford) 54.10, pp. 1882–9. issn: 1462-0324.doi: 10.1093/rheumatology/kev131.

Millett, E. R. et al. (2015). “Risk factors for hospital admission in the 28 days fol-lowing a community-acquired pneumonia diagnosis in older adults, and theircontribution to increasing hospitalisation rates over time: a cohort study”.In: BMJ Open 5.12, e008737. issn: 2044-6055. doi: 10.1136/bmjopen-

2015-008737.Mukherjee, S. et al. (2015). “What is the risk of having a total hip or knee

replacement for patients with lupus?” In: Lupus 24.2, pp. 198–202. issn:0961-2033. doi: 10.1177/0961203314547894.

Muller, S. et al. (2015). “An algorithm to identify rheumatoid arthritis in pri-mary care: a Clinical Practice Research Datalink study”. In: BMJ Open 5.12,e009309. issn: 2044-6055. doi: 10.1136/bmjopen-2015-009309.

Nakafero, G. et al. (2015). “Association between benzodiazepine use and ex-acerbations and mortality in patients with asthma: a matched case-controland survival analysis using the United Kingdom Clinical Practice ResearchDatalink”. In: Pharmacoepidemiol Drug Saf 24.8, pp. 793–802. issn: 1053-8569. doi: 10.1002/pds.3799.

Nielen, J. T. et al. (2015). “Identification of antithrombotic drugs related tototal joint replacement using anonymised free-text notes: a search strategyin the Clinical Practice Research Datalink”. In: BMJ Open 5.11, e009017.issn: 2044-6055. doi: 10.1136/bmjopen-2015-009017.

Nordstrom, B. L. et al. (2015). “Treatment patterns and lipid levels amongpatients with high-risk atherosclerotic CVD in the UK”. In: The BritishJournal of Cardiology. doi: 10.5837/bjc.2015.034.

Nyeland, M. E. et al. (2015). “Evaluation of the effectiveness of liraglutide andsitagliptin in type 2 diabetes: a retrospective study in UK primary care”.In: Int J Clin Pract 69.3, pp. 281–91. issn: 1368-5031. doi: 10.1111/ijcp.12575.

Olsson, M. et al. (2015). “Contemporary Risk Estimates of Three HbA1c Vari-ables for Myocardial Infarction in 101,799 Patients Following Diagnosis of

CPRD bibliography

146

Type 2 Diabetes”. In: Diabetes Care 38.8, pp. 1481–6. issn: 0149-5992. doi:10.2337/dc14-2351.

O’Rorke, M. A. et al. (2015). “The effect of warfarin therapy on breast, col-orectal, lung, and prostate cancer survival: a population-based cohort studyusing the Clinical Practice Research Datalink”. In: Cancer Causes Control26.3, pp. 355–66. issn: 0957-5243. doi: 10.1007/s10552-014-0511-2.

Palmaro, A., J. Dupouy, and M. Lapeyre-Mestre (2015). “Benzodiazepines andrisk of death: Results from two large cohort studies in France and UK”.In: Eur Neuropsychopharmacol 25.10, pp. 1566–77. issn: 0924-977x. doi:10.1016/j.euroneuro.2015.07.006.

Palmer, K. T., S. D’Angelo, et al. (2015). “Sensory impairments, problems ofbalance and accidental injury at work: a case-control study”. In: OccupEnviron Med 72.3, pp. 195–9. issn: 1351-0711. doi: 10.1136/oemed-2014-102422.

Palmer, K. T., K. Walker-Bone, et al. (2015). “Health and Employment afterFifty (HEAF): a new prospective cohort study”. In: BMC Public Health 15,p. 1071. issn: 1471-2458. doi: 10.1186/s12889-015-2396-8.

Parisi, R. et al. (2015). “Psoriasis and the Risk of Major Cardiovascular Events:Cohort Study Using the Clinical Practice Research Datalink”. In: J InvestDermatol 135.9, pp. 2189–2197. issn: 0022-202x. doi: 10.1038/jid.2015.87.

Paul, S. K. et al. (2015). “Delay in treatment intensification increases the risksof cardiovascular events in patients with type 2 diabetes”. In: CardiovascDiabetol 14, p. 100. issn: 1475-2840. doi: 10.1186/s12933-015-0260-x.

Peeters, P. J. et al. (2015). “The risk of colorectal cancer in patients with type 2diabetes: associations with treatment stage and obesity”. In: Diabetes Care38.3, pp. 495–502. issn: 0149-5992. doi: 10.2337/dc14-1175.

Perera, R. et al. (2015). “Optimal strategies for monitoring lipid levels in pa-tients at risk or with cardiovascular disease: a systematic review with sta-tistical and cost-effectiveness modelling”. In: Health Technol Assess 19.100,pp. 1–401, vii–viii. issn: 1366-5278. doi: 10.3310/hta191000.

Petherick, E. S., K. E. Pickett, and N. A. Cullum (2015). “Can different primarycare databases produce comparable estimates of burden of disease: resultsof a study exploring venous leg ulceration”. In: Fam Pract 32.4, pp. 374–80.issn: 0263-2136. doi: 10.1093/fampra/cmv013.

Petri, H. et al. (2015). “Incidence of giant cell arteritis and characteristics of pa-tients: data-driven analysis of comorbidities”. In: Arthritis Care Res (Hobo-ken) 67.3, pp. 390–5. issn: 2151-464x. doi: 10.1002/acr.22429.

Pfeil, A. M. et al. (2015). “Trends in incidence and medical resource utilisation inpatients with chronic lymphocytic leukaemia: insights from the UK ClinicalPractice Research Datalink (CPRD)”. In: Ann Hematol 94.3, pp. 421–9.issn: 0939-5555. doi: 10.1007/s00277-014-2217-7.

Pockett, R. D. et al. (2015). “Burden of Illness in UK Subjects with ReportedRespiratory Infections Vaccinated or Unvaccinated against Influenza: A Ret-rospective Observational Study”. In: PLoS One 10.8, e0134928. issn: 1932-6203. doi: 10.1371/journal.pone.0134928.

Prieto-Alhambra, D. et al. (2015). “Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: apopulation-based cohort study”. In: Ann Rheum Dis 74.3, pp. 557–63. issn:0003-4967. doi: 10.1136/annrheumdis-2013-204043.

CPRD bibliography

147

Punekar, Y. S., S. H. Landis, et al. (2015). “Characteristics, disease burdenand costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care”. In: Respir Res 16, p. 141. issn:1465-9921. doi: 10.1186/s12931-015-0295-2.

Punekar, Y. S., K. Wurst, and A. Shukla (2015). “Resource Use and Costs up toTwo Years Post Diagnosis Among Newly Diagnosed COPD Patients in theUK Primary Care Setting: A Retrospective Cohort Study”. In: Copd 12.3,pp. 267–75. issn: 1541-2563. doi: 10.3109/15412555.2014.933953.

Qizilbash, N. et al. (2015). “BMI and risk of dementia in two million people overtwo decades: a retrospective cohort study”. In: Lancet Diabetes Endocrinol3.6, pp. 431–436. issn: 2213-8587. doi: 10.1016/s2213-8587(15)00033-9.

Redaniel, M. T. et al. (2015). “Diagnostic intervals and its association withbreast, prostate, lung and colorectal cancer survival in England: historicalcohort study using the Clinical Practice Research Datalink”. In: PLoS One10.5, e0126608. issn: 1932-6203. doi: 10.1371/journal.pone.0126608.

Reilly, S. et al. (2015). “Inequalities in physical comorbidity: a longitudinalcomparative cohort study of people with severe mental illness in the UK”.In: BMJ Open 5.12, e009010. issn: 2044-6055. doi: 10.1136/bmjopen-

2015-009010.Reinau, D. et al. (2015). “Nonsteroidal anti-inflammatory drugs and the risk

of nonmelanoma skin cancer”. In: Int J Cancer 137.1, pp. 144–53. issn:0020-7136. doi: 10.1002/ijc.29357.

Renoux, C., S. Dell’Aniello, et al. (2015). “Antiepileptic drugs and the risk of is-chaemic stroke and myocardial infarction: a population-based cohort study”.In: BMJ Open 5.8, e008365. issn: 2044-6055. doi: 10.1136/bmjopen-2015-008365.

Renoux, C., L. M. Lix, et al. (2015). “Serotonin-Norepinephrine Reuptake In-hibitors and the Risk of AKI: A Cohort Study of Eight AdministrativeDatabases and Meta-Analysis”. In: Clin J Am Soc Nephrol 10.10, pp. 1716–22. issn: 1555-9041. doi: 10.2215/cjn.11271114.

Ridd, M. J. et al. (2015). “Patient-doctor continuity and diagnosis of cancer:electronic medical records study in general practice”. In: Br J Gen Pract65.634, e305–11. issn: 0960-1643. doi: 10.3399/bjgp15X684829.

Robson, J. C. et al. (2015). “The relative risk of aortic aneurysm in patients withgiant cell arteritis compared with the general population of the UK”. In: AnnRheum Dis 74.1, pp. 129–35. issn: 0003-4967. doi: 10.1136/annrheumdis-2013-204113.

Rothnie, K. J. et al. (2015). “Closing the mortality gap after a myocardial in-farction in people with and without chronic obstructive pulmonary disease”.In: Heart 101.14, pp. 1103–10. issn: 1355-6037. doi: 10.1136/heartjnl-2014-307251.

Saine, M. E. et al. (2015). “Determinants of saxagliptin use among patients withtype 2 diabetes mellitus treated with oral anti-diabetic drugs”. In: BMCPharmacol Toxicol 16, p. 8. issn: 2050-6511. doi: 10.1186/s40360-015-0007-z.

Sammon, C. J., R. A. Charlton, et al. (2015). “The incidence of childhood andadolescent seizures in the UK from 1999 to 2011: A retrospective cohortstudy using the Clinical Practice Research Datalink”. In: Vaccine 33.51,pp. 7364–7369. issn: 0264-410x. doi: 10.1016/j.vaccine.2015.07.093.

CPRD bibliography

148

Sammon, C. J., A. Miller, et al. (2015). “Missing laboratory test data in elec-tronic general practice records: analysis of rheumatoid factor recording in theclinical practice research datalink”. In: Pharmacoepidemiol Drug Saf 24.5,pp. 504–9. issn: 1053-8569. doi: 10.1002/pds.3750.

Shephard, E. A., R. D. Neal, P. W. Rose, et al. (2015a). “Quantifying the risk ofHodgkin lymphoma in symptomatic primary care patients aged ¿/=40 years:a case-control study using electronic records”. In: Br J Gen Pract 65.634,e289–94. issn: 0960-1643. doi: 10.3399/bjgp15X684805.

— (2015b). “Quantifying the risk of non-Hodgkin lymphoma in symptomaticprimary care patients aged ¿/=40 years: a large case-control study usingelectronic records”. In: Br J Gen Pract 65.634, e281–8. issn: 0960-1643.doi: 10.3399/bjgp15X684793.

Shephard, E. A., R. D. Neal, P. Rose, et al. (2015). “Quantifying the risk ofmultiple myeloma from symptoms reported in primary care patients: a largecase-control study using electronic records”. In: Br J Gen Pract 65.631,e106–13. issn: 0960-1643. doi: 10.3399/bjgp15X683545.

Spoendlin, J. et al. (2015). “Oral and inhaled glucocorticoid use and risk ofAchilles or biceps tendon rupture: a population-based case-control study”.In: Ann Med 47.6, pp. 492–8. issn: 0785-3890. doi: 10.3109/07853890.2015.1074272.

Springate, D. A. et al. (2015). “Can analyses of electronic patient records be in-dependently and externally validated? Study 2–the effect of beta-adrenoceptorblocker therapy on cancer survival: a retrospective cohort study”. In: BMJOpen 5.4, e007299. issn: 2044-6055. doi: 10.1136/bmjopen-2014-007299.

Stocks, S. J. et al. (2015). “Examining variations in prescribing safety in UKgeneral practice: cross sectional study using the Clinical Practice ResearchDatalink”. In: Bmj 351, h5501. issn: 0959-8138. doi: 10.1136/bmj.h5501.

Stolwijk, C. et al. (2015). “The epidemiology of extra-articular manifestations inankylosing spondylitis: a population-based matched cohort study”. In: AnnRheum Dis 74.7, pp. 1373–8. issn: 0003-4967. doi: 10.1136/annrheumdis-2014-205253.

Strongman, H. et al. (2015). “Comparison of diabetes-associated secondaryhealthcare utilization between alternative oral antihyperglycaemic dual ther-apy combinations with metformin in patients with type 2 diabetes: an ob-servational cohort study”. In: Diabetes Obes Metab 17.6, pp. 573–80. issn:1462-8902. doi: 10.1111/dom.12458.

Thomson, A. et al. (2015). “Monitoring and Evaluating the Effect of RegulatoryAction: Some Recent Case Studies”. In: Ther Innov Regul Sci 49.4, pp. 473–482. issn: 2168-4790. doi: 10.1177/2168479015570333.

Tuccori, M. et al. (2015). “The Use of Glyburide Compared With Other Sul-fonylureas and the Risk of Cancer in Patients With Type 2 Diabetes”. In:Diabetes Care 38.11, pp. 2083–9. issn: 0149-5992. doi: 10.2337/dc15-1358.

Turner, S. W. et al. (2015). “Initial step-up treatment changes in asthmatic chil-dren already prescribed inhaled corticosteroids: a historical cohort study”.In: NPJ Prim Care Respir Med 25, p. 15041. issn: 2055-1010. doi: 10.1038/npjpcrm.2015.41.

Venkatesan, S. et al. (2015). “Development of processes allowing near real-timerefinement and validation of triage tools during the early stage of an outbreakin readiness for surge: the FLU-CATs Study”. In: Health Technol Assess19.89, pp. 1–132. issn: 1366-5278. doi: 10.3310/hta19890.

CPRD bibliography

149

Vinogradova, Y., C. Coupland, P. Brindle, et al. (2015). “Patients who discontin-ued statin treatment: a protocol for cohort study using primary care data”.In: BMJ Open 5.10, e008701. issn: 2044-6055. doi: 10.1136/bmjopen-

2015-008701.Vinogradova, Y., C. Coupland, and J. Hippisley-Cox (2015). “Use of combined

oral contraceptives and risk of venous thromboembolism: nested case-controlstudies using the QResearch and CPRD databases”. In: Bmj 350, h2135.issn: 0959-8138. doi: 10.1136/bmj.h2135.

Vissers, P. A. et al. (2015). “The association between glucose-lowering drug useand mortality among breast cancer patients with type 2 diabetes”. In: BreastCancer Res Treat 150.2, pp. 427–37. issn: 0167-6806. doi: 10.1007/s10549-015-3331-5.

Warnier, M. J. et al. (2015). “Are ECG monitoring recommendations beforeprescription of QT-prolonging drugs applied in daily practice? The exampleof haloperidol”. In: Pharmacoepidemiol Drug Saf 24.7, pp. 701–8. issn: 1053-8569. doi: 10.1002/pds.3792.

Weng, S. F., J. Kai, H. Andrew Neil, et al. (2015). “Improving identificationof familial hypercholesterolaemia in primary care: derivation and validationof the familial hypercholesterolaemia case ascertainment tool (FAMCAT)”.In: Atherosclerosis 238.2, pp. 336–43. issn: 0021-9150. doi: 10.1016/j.

atherosclerosis.2014.12.034.Weng, S. F., J. Kai, I. N. Guha, et al. (2015). “The value of aspartate amino-

transferase and alanine aminotransferase in cardiovascular disease risk as-sessment”. In: Open Heart 2.1, e000272. issn: 2053-3624 (Print) 2053-3624.doi: 10.1136/openhrt-2015-000272.

Wetten, S. et al. (2015). “Diagnosis and treatment of chlamydia and gonorrhoeain general practice in England 2000-2011: a population-based study usingdata from the UK Clinical Practice Research Datalink”. In: BMJ Open 5.5,e007776. issn: 2044-6055. doi: 10.1136/bmjopen-2015-007776.

Wijnands, J. M. et al. (2015). “Individuals With Type 2 Diabetes MellitusAre at an Increased Risk of Gout But This Is Not Due to Diabetes: APopulation-Based Cohort Study”. In: Medicine (Baltimore) 94.32, e1358.issn: 0025-7974. doi: 10.1097/md.0000000000001358.

Wilson, J. C. et al. (2015). “Previously diagnosed influenza infections and therisk of developing epilepsy”. In: Epidemiol Infect 143.11, pp. 2408–15. issn:0950-2688. doi: 10.1017/s0950268814003380.

Wvan der Zanden, R. et al. (2015). “Use of Dipeptidyl-Peptidase-4 Inhibitorsand the Risk of Pneumonia: A Population-Based Cohort Study”. In: PLoSOne 10.10, e0139367. issn: 1932-6203. doi: 10.1371/journal.pone.0139367.

Yska, J. P. et al. (2015). “Remission of Type 2 Diabetes Mellitus in Patients Af-ter Different Types of Bariatric Surgery: A Population-Based Cohort Studyin the United Kingdom”. In: JAMA Surg 150.12, pp. 1126–33. issn: 2168-6254. doi: 10.1001/jamasurg.2015.2398.

Yu, J. et al. (2015). “History of cardiovascular events and cardiovascular riskfactors among patients initiating strontium ranelate for treatment of osteo-porosis”. In: Int J Womens Health 7, pp. 913–8. issn: 1179-1411 (Print)1179-1411. doi: 10.2147/ijwh.s88627.

Yu, O. H., K. B. Filion, et al. (2015). “Incretin-based drugs and the risk ofcongestive heart failure”. In: Diabetes Care 38.2, pp. 277–84. issn: 0149-5992. doi: 10.2337/dc14-1459.

CPRD bibliography

150

Yu, O. H., H. Yin, and L. Azoulay (2015). “The combination of DPP-4 inhibitorsversus sulfonylureas with metformin after failure of first-line treatment in therisk for major cardiovascular events and death”. In: Can J Diabetes 39.5,pp. 383–9. issn: 1499-2671. doi: 10.1016/j.jcjd.2015.02.002.

Zingone, F. et al. (2015). “Risk of acute appendicitis in and around pregnancy: apopulation-based cohort study from England”. In: Ann Surg 261.2, pp. 332–7. issn: 0003-4932. doi: 10.1097/sla.0000000000000780.

CPRD bibliography

151

2014

Abbing-Karahagopian, V., C. Huerta, et al. (2014). “Antidepressant prescribingin five European countries: application of common definitions to assess theprevalence, clinical observations, and methodological implications”. In: EurJ Clin Pharmacol 70.7, pp. 849–57. issn: 0031-6970. doi: 10.1007/s00228-014-1676-z.

Abbing-Karahagopian, V., X. Kurz, et al. (2014). “Bridging differences in out-comes of pharmacoepidemiological studies: design and first results of thePROTECT project”. In: Curr Clin Pharmacol 9.2, pp. 130–8. issn: 1574-8847.

Abdul Sultan, A. et al. (2014). “Pregnancy complications and adverse birthoutcomes among women with celiac disease: a population-based study fromEngland”. In: Am J Gastroenterol 109.10, pp. 1653–61. issn: 0002-9270. doi:10.1038/ajg.2014.196.

Alexandre, L. et al. (2014). “Statin use is associated with reduced risk of histo-logic subtypes of esophageal cancer: a nested case-control analysis”. In: Gas-troenterology 146.3, pp. 661–8. issn: 0016-5085. doi: 10.1053/j.gastro.2013.11.046.

Amirthalingam, G. et al. (2014). “Effectiveness of maternal pertussis vaccinationin England: an observational study”. In: Lancet 384.9953, pp. 1521–8. issn:0140-6736. doi: 10.1016/s0140-6736(14)60686-3.

Azoulay, L. et al. (2014). “Initiation of warfarin in patients with atrial fibrilla-tion: early effects on ischaemic strokes”. In: Eur Heart J 35.28, pp. 1881–7.issn: 0195-668x. doi: 10.1093/eurheartj/eht499.

Bannister, C. A., S. E. Holden, et al. (2014). “Can people with type 2 diabeteslive longer than those without? A comparison of mortality in people initiatedwith metformin or sulphonylurea monotherapy and matched, non-diabeticcontrols”. In: Diabetes Obes Metab 16.11, pp. 1165–73. issn: 1462-8902. doi:10.1111/dom.12354.

Bannister, C. A., C. D. Poole, et al. (2014). “External validation of the UKPDSrisk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations”. In: Diabetes Care 37.2, pp. 537–45. issn: 0149-5992.doi: 10.2337/dc13-1159.

Beattie, C. J. et al. (2014). “Allopurinol initiation and change in blood pressurein older adults with hypertension”. In: Hypertension 64.5, pp. 1102–7. issn:0194-911x. doi: 10.1161/hypertensionaha.114.03953.

Becker, C. et al. (2014). “Metformin and the risk of head and neck cancer: acase-control analysis”. In: Diabetes Obes Metab 16.11, pp. 1148–54. issn:1462-8902. doi: 10.1111/dom.12351.

Bensimon, L. et al. (2014). “Type 2 diabetes and the risk of mortality amongpatients with prostate cancer”. In: Cancer Causes Control 25.3, pp. 329–38.issn: 0957-5243. doi: 10.1007/s10552-013-0334-6.

Bhaskaran, K. et al. (2014). “Body-mass index and risk of 22 specific cancers:a population-based cohort study of 5.24 million UK adults”. In: Lancet384.9945, pp. 755–65. issn: 0140-6736. doi: 10 . 1016 / s0140 - 6736(14 )

60892-8.

CPRD bibliography

152

Bloechliger, M. et al. (2014). “Malaria chemoprophylaxis regimens: a descriptivedrug utilization study”. In: Travel Med Infect Dis 12.6 Pt B, pp. 718–25. issn:1477-8939. doi: 10.1016/j.tmaid.2014.05.006.

Boggon, R. et al. (2014). “Smoking cessation interventions following acute coro-nary syndrome: a missed opportunity?” In: Eur J Prev Cardiol 21.6, pp. 767–73. issn: 2047-4873. doi: 10.1177/2047487312460517.

Booth, H. P., A. T. Prevost, and M. C. Gulliford (2014). “Impact of body massindex on prevalence of multimorbidity in primary care: cohort study”. In:Fam Pract 31.1, pp. 38–43. issn: 0263-2136. doi: 10.1093/fampra/cmt061.

Booth, H. et al. (2014). “Incidence of type 2 diabetes after bariatric surgery:population-based matched cohort study”. In: Lancet Diabetes Endocrinol2.12, pp. 963–8. issn: 2213-8587. doi: 10.1016/s2213-8587(14)70214-1.

Bradley, M. C. et al. (2014). “Potentially inappropriate prescribing among olderpeople in the United Kingdom”. In: BMC Geriatr 14, p. 72. issn: 1471-2318.doi: 10.1186/1471-2318-14-72.

Bruderer, S. G. et al. (2014). “Incidence of and risk factors for severe hypo-glycaemia in treated type 2 diabetes mellitus patients in the UK–a nestedcase-control analysis”. In: Diabetes Obes Metab 16.9, pp. 801–11. issn: 1462-8902. doi: 10.1111/dom.12282.

Bruderer, S. et al. (2014). “Use of diuretics and risk of incident gout: a population-based case-control study”. In: Arthritis Rheumatol 66.1, pp. 185–96. issn:2326-5191. doi: 10.1002/art.38203.

Bultink, I. E. et al. (2014). “Elevated risk of clinical fractures and associatedrisk factors in patients with systemic lupus erythematosus versus matchedcontrols: a population-based study in the United Kingdom”. In: OsteoporosInt 25.4, pp. 1275–83. issn: 0937-941x. doi: 10.1007/s00198-013-2587-z.

Card, T. R., J. Siffledeen, and K. M. Fleming (2014). “Are IBD patients morelikely to have a prior diagnosis of irritable bowel syndrome? Report of acase-control study in the General Practice Research Database”. In: UnitedEuropean Gastroenterol J 2.6, pp. 505–12. issn: 2050-6406 (Print) 2050-6406.doi: 10.1177/2050640614554217.

Cardwell, C. R., E. M. Flahavan, et al. (2014). “Low-dose aspirin and survival inmen with prostate cancer: a study using the UK Clinical Practice ResearchDatalink”. In: Cancer Causes Control 25.1, pp. 33–43. issn: 0957-5243. doi:10.1007/s10552-013-0306-x.

Cardwell, C. R., B. M. Hicks, et al. (2014). “Statin use after colorectal cancerdiagnosis and survival: a population-based cohort study”. In: J Clin Oncol32.28, pp. 3177–83. issn: 0732-183x. doi: 10.1200/jco.2013.54.4569.

Cardwell, C. R., A. T. Kunzmann, et al. (2014). “Low-dose aspirin use afterdiagnosis of colorectal cancer does not increase survival: a case-control anal-ysis of a population-based cohort”. In: Gastroenterology 146.3, 700–708.e2.issn: 0016-5085. doi: 10.1053/j.gastro.2013.11.005.

Cardwell, C. R., U. C. Mc Menamin, et al. (2014). “Drugs affecting the renin-angiotensin system and survival from cancer: a population based study ofbreast, colorectal and prostate cancer patient cohorts”. In: BMC Med 12,p. 28. issn: 1741-7015. doi: 10.1186/1741-7015-12-28.

Charlton, R. et al. (2014). “The Clinical Practice Research Datalink for drugsafety in pregnancy research: an overview”. In: Therapie 69.1, pp. 83–9. issn:0040-5957 (Print) 0040-5957. doi: 10.2515/therapie/2014007.

CPRD bibliography

153

Chen, L. et al. (2014). “Health care resource utilisation in primary care prior toand after a diagnosis of Alzheimer’s disease: a retrospective, matched case-control study in the United Kingdom”. In: BMC Geriatr 14, p. 76. issn:1471-2318. doi: 10.1186/1471-2318-14-76.

Close, H. et al. (2014). “Renal failure in lithium-treated bipolar disorder: aretrospective cohort study”. In: PLoS One 9.3, e90169. issn: 1932-6203. doi:10.1371/journal.pone.0090169.

Cooper, C., K. M. Fox, and J. S. Borer (2014). “Ischaemic cardiac events and useof strontium ranelate in postmenopausal osteoporosis: a nested case-controlstudy in the CPRD”. In: Osteoporos Int 25.2, pp. 737–45. issn: 0937-941x.doi: 10.1007/s00198-013-2582-4.

Cornish, R. P. et al. (2014). “Validating childhood asthma in an epidemiologicalstudy using linked electronic patient records”. In: BMJ Open 4.4, e005345.issn: 2044-6055 (Print) 2044-6055. doi: 10.1136/bmjopen-2014-005345.

Couraud, S., L. Azoulay, et al. (2014). “Cardiac glycosides use and the risk oflung cancer: a nested case-control study”. In: BMC Cancer 14, p. 573. issn:1471-2407. doi: 10.1186/1471-2407-14-573.

Couraud, S., S. Dell’Aniello, et al. (2014). “Cardiac glycosides and the riskof breast cancer in women with chronic heart failure and supraventriculararrhythmia”. In: Breast Cancer Res Treat 146.3, pp. 619–26. issn: 0167-6806.doi: 10.1007/s10549-014-3058-8.

Currie, C. J. et al. (2014). “Antibiotic treatment failure in four common infec-tions in UK primary care 1991-2012: longitudinal analysis”. In: Bmj 349,g5493. issn: 0959-8138. doi: 10.1136/bmj.g5493.

Das, R. et al. (2014). “An Observational Cohort Study of Diabetes-AssociatedSecondary Health Care Utilisation in Patients With Type 2 Diabetes Pre-scribed Dual Combination Therapy With Oral Anti-Hyperglycaemic Agentsin the UK”. In: Value Health 17.7, A360. issn: 1098-3015. doi: 10.1016/j.jval.2014.08.782.

Dial, S. et al. (2014). “Antihypertensive agents acting on the renin-angiotensinsystem and the risk of sepsis”. In: Br J Clin Pharmacol 78.5, pp. 1151–8.issn: 0306-5251. doi: 10.1111/bcp.12419.

Donegan, K., B. King, and P. Bryan (2014). “Safety of pertussis vaccinationin pregnant women in UK: observational study”. In: Bmj 349, g4219. issn:0959-8138. doi: 10.1136/bmj.g4219.

Dregan, A., J. Charlton, et al. (2014). “Chronic inflammatory disorders and riskof type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study”. In: Circulation 130.10, pp. 837–44. issn: 0009-7322.doi: 10.1161/circulationaha.114.009990.

Dregan, A., T. P. van Staa, et al. (2014). “Point-of-care cluster randomized trialin stroke secondary prevention using electronic health records”. In: Stroke45.7, pp. 2066–71. issn: 0039-2499. doi: 10.1161/strokeaha.114.005713.

Driessen, J. H. et al. (2014). “Use of dipeptidyl peptidase-4 inhibitors for type2 diabetes mellitus and risk of fracture”. In: Bone 68, pp. 124–30. issn:1873-2763. doi: 10.1016/j.bone.2014.07.030.

Duijnhoven, R. G. et al. (2014). “Long-term use of 5alpha-reductase inhibitorsand the risk of male breast cancer”. In: Cancer Causes Control 25.11, pp. 1577–82. issn: 0957-5243. doi: 10.1007/s10552-014-0455-6.

Eppenga, W. L. et al. (2014). “Risk of lactic acidosis or elevated lactate con-centrations in metformin users with renal impairment: a population-based

CPRD bibliography

154

cohort study”. In: Diabetes Care 37.8, pp. 2218–24. issn: 0149-5992. doi:10.2337/dc13-3023.

Faillie, J. L. et al. (2014). “Incretin based drugs and risk of acute pancreatitisin patients with type 2 diabetes: cohort study”. In: Bmj 348, g2780. issn:0959-8138. doi: 10.1136/bmj.g2780.

Filion, K. B. et al. (2014). “Proton pump inhibitors and the risk of hospital-isation for community-acquired pneumonia: replicated cohort studies withmeta-analysis”. In: Gut 63.4, pp. 552–8. issn: 0017-5749. doi: 10.1136/

gutjnl-2013-304738.Forbes, H. J. et al. (2014). “Quantification of risk factors for herpes zoster:

population based case-control study”. In: Bmj 348, g2911. issn: 0959-8138.doi: 10.1136/bmj.g2911.

Fournier, J. P., R. G. Duijnhoven, et al. (2014). “Concurrent use of statins andhormone therapy and risk of venous thromboembolism in postmenopausalwomen: a population-based case-control study”. In: Menopause 21.9, pp. 1023–6. issn: 1072-3714. doi: 10.1097/gme.0000000000000279.

Fournier, J. P., H. Yin, et al. (2014). “Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus”. In: Cmaj186.15, pp. 1138–45. issn: 0820-3946. doi: 10.1503/cmaj.140688.

Fox, B. D. et al. (2014). “The use of antidepressants and the risk of idiopathicpulmonary arterial hypertension”. In: Can J Cardiol 30.12, pp. 1633–9. issn:0828-282x. doi: 10.1016/j.cjca.2014.09.031.

Furlano, R. I. et al. (2014). “Bone fractures in children with autistic spectrumdisorder”. In: J Dev Behav Pediatr 35.6, pp. 353–9. issn: 0196-206x. doi:10.1097/dbp.0000000000000070.

Gadoud, A. et al. (2014). “Palliative care among heart failure patients in primarycare: a comparison to cancer patients using English family practice data”.In: PLoS One 9.11, e113188. issn: 1932-6203. doi: 10.1371/journal.pone.0113188.

Gallagher, A. M. et al. (2014). “Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleed-ing outcomes”. In: BMJ Open 4.1, e003839. issn: 2044-6055 (Print) 2044-6055. doi: 10.1136/bmjopen-2013-003839.

Gao, W. et al. (2014). “Managing cancer pain at the end of life with multiplestrong opioids: a population-based retrospective cohort study in primarycare”. In: PLoS One 9.1, e79266. issn: 1932-6203. doi: 10.1371/journal.pone.0079266.

Gibson-Smith, D. et al. (2014). “The risk of major and any (non-hip) fragilityfracture after hip fracture in the United Kingdom: 2000-2010”. In: OsteoporosInt 25.11, pp. 2555–63. issn: 0937-941x. doi: 10.1007/s00198-014-2799-x.

Gulliford, M. C., N. Bhattarai, et al. (2014). “Cost-effectiveness of a universalstrategy of brief dietary intervention for primary prevention in primary care:population-based cohort study and Markov model”. In: Cost Eff ResourAlloc 12.1, p. 4. issn: 1478-7547 (Print) 1478-7547. doi: 10.1186/1478-7547-12-4.

Gulliford, M. C., J. Charlton, et al. (2014). “Impact and cost-effectiveness of auniversal strategy to promote physical activity in primary care: population-based cohort study and Markov model”. In: Eur J Health Econ 15.4, pp. 341–51. issn: 1618-7598. doi: 10.1007/s10198-013-0477-0.

CPRD bibliography

155

Gulliford, M. C., A. Dregan, et al. (2014). “Continued high rates of antibioticprescribing to adults with respiratory tract infection: survey of 568 UKgeneral practices”. In: BMJ Open 4.10, e006245. issn: 2044-6055. doi: 10.1136/bmjopen-2014-006245.

Gulliford, M. C., T. P. van Staa, et al. (2014). “Cluster randomized trialsutilizing primary care electronic health records: methodological issues indesign, conduct, and analysis (eCRT Study)”. In: Trials 15, p. 220. issn:1745-6215. doi: 10.1186/1745-6215-15-220.

Gulliford, M. C., T. Van Staa, et al. (2014). “Electronic health records for inter-vention research: a cluster randomized trial to reduce antibiotic prescribingin primary care (eCRT study)”. In: Ann Fam Med 12.4, pp. 344–51. issn:1544-1709. doi: 10.1370/afm.1659.

Gulliford, M. et al. (2014). “Social and material deprivation and the cost-effectiveness of an intervention to promote physical activity: cohort studyand Markov model”. In: J Public Health (Oxf) 36.4, pp. 674–83. issn: 1741-3842. doi: 10.1093/pubmed/fdt132.

Hagberg, K. W. et al. (2014). “Anti-diabetic medications and risk of primaryliver cancer in persons with type II diabetes”. In: Br J Cancer 111.9, pp. 1710–7. issn: 0007-0920. doi: 10.1038/bjc.2014.447.

Hamilton, F. et al. (2014). “The risk of cancer in primary care patients withhypercalcaemia: a cohort study using electronic records”. In: Br J Cancer111.7, pp. 1410–2. issn: 0007-0920. doi: 10.1038/bjc.2014.433.

Hancock, A. T. et al. (2014). “Risk of vascular events in patients with polymyal-gia rheumatica”. In: Cmaj 186.13, E495–501. issn: 0820-3946. doi: 10.1503/cmaj.140266.

Hassan, L. et al. (2014). “A comparison of psychotropic medication prescribingpatterns in East of England prisons and the general population”. In: J Psy-chopharmacol 28.4, pp. 357–62. issn: 0269-8811. doi: 10.1177/0269881114523863.

Hazra, N. and M. Gulliford (2014). “Evaluating pancreatitis in primary care: apopulation-based cohort study”. In: Br J Gen Pract 64.622, e295–301. issn:0960-1643. doi: 10.3399/bjgp14X679732.

Hippisley-Cox, J., C. Coupland, and P. Brindle (2014). “The performance ofseven QPrediction risk scores in an independent external sample of patientsfrom general practice: a validation study”. In: BMJ Open 4.8, e005809. issn:2044-6055. doi: 10.1136/bmjopen-2014-005809.

Holden, S. E. et al. (2014). “How many people inject insulin? UK estimates from1991 to 2010”. In: Diabetes Obes Metab 16.6, pp. 553–9. issn: 1462-8902. doi:10.1111/dom.12260.

Huiart, L. et al. (2014). “Measuring persistence to hormonal therapy in patientswith breast cancer: accounting for temporary treatment discontinuation”.In: Pharmacoepidemiol Drug Saf 23.8, pp. 882–9. issn: 1053-8569. doi: 10.1002/pds.3631.

Ishiguro, C. et al. (2014). “Antipsychotic drugs and risk of idiopathic venousthromboembolism: a nested case-control study using the CPRD”. In: Phar-macoepidemiol Drug Saf 23.11, pp. 1168–75. issn: 1053-8569. doi: 10.1002/pds.3699.

Jameson, K., K. D’Oca, et al. (2014). “Adherence to Nice Guidance For Ini-tiating Glp-1 Mimetics Among Patients With Type 2 Diabetes In PrimaryCare In England And Wales - An Evaluation Using The Clinical Practice

CPRD bibliography

156

Research Datalink (Cprd)”. In: Value Health 17.7, A362. issn: 1098-3015.doi: 10.1016/j.jval.2014.08.794.

Jameson, K., S. Jick, et al. (2014). “Prevalence and management of chronickidney disease in primary care patients in the UK”. In: Int J Clin Pract68.9, pp. 1110–21. issn: 1368-5031. doi: 10.1111/ijcp.12454.

Jick, S. S. et al. (2014). “Mortality of patients with multiple sclerosis: a cohortstudy in UK primary care”. In: J Neurol 261.8, pp. 1508–17. issn: 0340-5354.doi: 10.1007/s00415-014-7370-3.

Jones, R. C. et al. (2014). “Opportunities to diagnose chronic obstructive pul-monary disease in routine care in the UK: a retrospective study of a clin-ical cohort”. In: Lancet Respir Med 2.4, pp. 267–76. issn: 2213-2600. doi:10.1016/s2213-2600(14)70008-6.

Khalid, J. M. et al. (2014). “Rates and risk of hospitalisation among patientswith type 2 diabetes: retrospective cohort study using the UK General Prac-tice Research Database linked to English Hospital Episode Statistics”. In:Int J Clin Pract 68.1, pp. 40–8. issn: 1368-5031. doi: 10.1111/ijcp.12265.

Klop, C. et al. (2014). “Mortality in British hip fracture patients, 2000-2010: apopulation-based retrospective cohort study”. In: Bone 66, pp. 171–7. issn:1873-2763. doi: 10.1016/j.bone.2014.06.011.

Kontopantelis, E. et al. (2014). “Withdrawing performance indicators: retro-spective analysis of general practice performance under UK Quality andOutcomes Framework”. In: Bmj 348, g330. issn: 0959-8138. doi: 10.1136/bmj.g330.

Lambrelli, D. et al. (2014). “Retrospective database study to assess the economicimpact of hip fracture in the United Kingdom”. In: J Med Econ 17.11,pp. 817–25. issn: 1369-6998. doi: 10.3111/13696998.2014.959588.

Langan, S. M. et al. (2014). “Risk of stroke following herpes zoster: a self-controlled case-series study”. In: Clin Infect Dis 58.11, pp. 1497–503. issn:1058-4838. doi: 10.1093/cid/ciu098.

Li, L., B. M. Ambegaonkar, et al. (2014). “Association of a reduction in low-density lipoprotein cholesterol with incident cardiovascular and cerebrovas-cular events among people with type 2 diabetes mellitus”. In: Eur J PrevCardiol 21.7, pp. 855–65. issn: 2047-4873. doi: 10.1177/2047487313481752.

Li, L., A. Roddam, et al. (2014). “Switch patterns of osteoporosis medicationand its impact on persistence among postmenopausal women in the U.K.General Practice Research Database”. In: Menopause 21.10, pp. 1106–13.issn: 1072-3714. doi: 10.1097/gme.0000000000000214.

Li, L., S. Setoguchi, and S. Jick (2014). “Validity of non-fatal idiopathic seriousventricular arrhythmia in UK-based Clinical Practice Research Datalink”.In: Pharmacoepidemiol Drug Saf 23.9, pp. 999–1001. issn: 1053-8569. doi:10.1002/pds.3664.

Liang, H. et al. (2014). “Increased risk of subsequent myocardial infarction inpatients with type 2 diabetes: a retrospective cohort study using the U.K.General Practice Research Database”. In: Diabetes Care 37.5, pp. 1329–37.issn: 0149-5992. doi: 10.2337/dc13-1953.

Lipscombe, L. L. et al. (2014). “Atypical antipsychotics and hyperglycemicemergencies: multicentre, retrospective cohort study of administrative data”.In: Schizophr Res 154.1-3, pp. 54–60. issn: 0920-9964. doi: 10.1016/j.schres.2014.01.043.

CPRD bibliography

157

Macedo, A. F. et al. (2014). “Statins and the risk of type 2 diabetes mellitus:cohort study using the UK clinical practice pesearch datalink”. In: BMCCardiovasc Disord 14, p. 85. issn: 1471-2261. doi: 10.1186/1471-2261-14-85.

Mackenzie, I. S. et al. (2014). “Incidence and prevalence of multiple sclerosisin the UK 1990-2010: a descriptive study in the General Practice ResearchDatabase”. In: J Neurol Neurosurg Psychiatry 85.1, pp. 76–84. issn: 0022-3050. doi: 10.1136/jnnp-2013-305450.

Maguire, A., B. D. Mitchell, and J. C. Ruzafa (2014). “Antihyperglycaemictreatment patterns, observed glycaemic control and determinants of treat-ment change among patients with type 2 diabetes in the United Kingdomprimary care: a retrospective cohort study”. In: BMC Endocr Disord 14,p. 73. issn: 1472-6823 (Print) 1472-6823. doi: 10.1186/1472-6823-14-73.

Makar, G. A., J. H. Holmes, and Y. X. Yang (2014). “Angiotensin-convertingenzyme inhibitor therapy and colorectal cancer risk”. In: J Natl Cancer Inst106.2, djt374. issn: 0027-8874. doi: 10.1093/jnci/djt374.

Margulis, A. V., E. M. Kang, and T. A. Hammad (2014). “Patterns of prescrip-tion of antidepressants and antipsychotics across and within pregnancies in apopulation-based UK cohort”. In: Matern Child Health J 18.7, pp. 1742–52.issn: 1092-7875. doi: 10.1007/s10995-013-1419-2.

Martinez, C., A. T. Cohen, et al. (2014). “Epidemiology of first and recurrentvenous thromboembolism: a population-based cohort study in patients with-out active cancer”. In: Thromb Haemost 112.2, pp. 255–63. issn: 0340-6245.doi: 10.1160/th13-09-0793.

Martinez, C., A. Katholing, and S. B. Freedman (2014). “Adverse prognosisof incidentally detected ambulatory atrial fibrillation. A cohort study”. In:Thromb Haemost 112.2, pp. 276–86. issn: 0340-6245. doi: 10.1160/th4-04-0383.

Matcho, A. et al. (2014). “Fidelity assessment of a clinical practice researchdatalink conversion to the OMOP common data model”. In: Drug Saf 37.11,pp. 945–59. issn: 0114-5916. doi: 10.1007/s40264-014-0214-3.

Mathur, R. et al. (2014). “Completeness and usability of ethnicity data in UK-based primary care and hospital databases”. In: J Public Health (Oxf) 36.4,pp. 684–92. issn: 1741-3842. doi: 10.1093/pubmed/fdt116.

Matok, I. et al. (2014). “Immortal time bias in observational studies of drug ef-fects in pregnancy”. In: Birth Defects Res A Clin Mol Teratol 100.9, pp. 658–62. issn: 1542-0752. doi: 10.1002/bdra.23271.

McCourt, C. et al. (2014). “Beta-blocker usage after malignant melanoma diag-nosis and survival: a population-based nested case-control study”. In: Br JDermatol 170.4, pp. 930–8. issn: 0007-0963. doi: 10.1111/bjd.12894.

McDonald, H. I. et al. (2014). “New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospec-tive cohort study using linked electronic health records”. In: Diabet Med31.5, pp. 606–14. issn: 0742-3071. doi: 10.1111/dme.12384.

McGrogan, A., J. Snowball, and C. S. de Vries (2014). “Pregnancy losses inwomen with Type 1 or Type 2 diabetes in the UK: an investigation usingprimary care records”. In: Diabet Med 31.3, pp. 357–65. issn: 0742-3071.doi: 10.1111/dme.12332.

Menon, S., P. Nightingale, and N. Trudgill (2014). “Is hormone replacementtherapy in post-menopausal women associated with a reduced risk of oe-

CPRD bibliography

158

sophageal cancer?” In: United European Gastroenterol J 2.5, pp. 374–82.issn: 2050-6406 (Print) 2050-6406. doi: 10.1177/2050640614543736.

Moore, A., A. Harnden, and R. Mayon-White (2014). “Recognising Kawasakidisease in UK primary care: a descriptive study using the Clinical PracticeResearch Datalink”. In: Br J Gen Pract 64.625, e477–83. issn: 0960-1643.doi: 10.3399/bjgp14X680953.

Morgan, C. L., J. Mukherjee, et al. (2014a). “Association between first-linemonotherapy with sulphonylurea versus metformin and risk of all-cause mor-tality and cardiovascular events: a retrospective, observational study”. In:Diabetes Obes Metab 16.10, pp. 957–62. issn: 1462-8902. doi: 10.1111/

dom.12302.— (2014b). “Combination therapy with metformin plus sulphonylureas versus

metformin plus DPP-4 inhibitors: association with major adverse cardio-vascular events and all-cause mortality”. In: Diabetes Obes Metab 16.10,pp. 977–83. issn: 1462-8902. doi: 10.1111/dom.12306.

Morgan, C. L., J. Puelles, et al. (2014). “The effect of withdrawal of rosigli-tazone on treatment pathways, diabetes control and patient outcomes: aretrospective cohort study”. In: J Diabetes Complications 28.3, pp. 360–4.issn: 1056-8727. doi: 10.1016/j.jdiacomp.2014.01.007.

Morgan, E., C. C. Patterson, and C. R. Cardwell (2014). “General practice-recorded depression and antidepressant use in young people with newly di-agnosed Type 1 diabetes: a cohort study using the Clinical Practice Re-search Datalink”. In: Diabet Med 31.2, pp. 241–5. issn: 0742-3071. doi:10.1111/dme.12330.

Muller, S. et al. (2014). “Is cancer associated with polymyalgia rheumatica? Acohort study in the General Practice Research Database”. In: Ann RheumDis 73.10, pp. 1769–73. issn: 0003-4967. doi: 10.1136/annrheumdis-2013-203465.

Mullerova, H., C. Lu, et al. (2014). “Prevalence and burden of breathlessnessin patients with chronic obstructive pulmonary disease managed in primarycare”. In: PLoS One 9.1, e85540. issn: 1932-6203. doi: 10.1371/journal.pone.0085540.

Mullerova, H., A. Shukla, et al. (2014). “Risk factors for acute exacerbationsof COPD in a primary care population: a retrospective observational co-hort study”. In: BMJ Open 4.12, e006171. issn: 2044-6055. doi: 10.1136/bmjopen-2014-006171.

Mundy, L. M., T. Sampson, and J. W. Logie (2014). “Retapamulin prescriptionsand monitored off-label use”. In: Paediatr Drugs 16.4, pp. 331–6. issn: 1174-5878. doi: 10.1007/s40272-014-0077-1.

Murray, L. J. et al. (2014). “Post-diagnostic prescriptions for low-dose aspirinand breast cancer-specific survival: a nested case-control study in a breastcancer cohort from the UK Clinical Practice Research Datalink”. In: BreastCancer Res 16.2, R34. issn: 1465-5411. doi: 10.1186/bcr3638.

Neal, R. D. et al. (2014). “Comparison of cancer diagnostic intervals beforeand after implementation of NICE guidelines: analysis of data from the UKGeneral Practice Research Database”. In: Br J Cancer 110.3, pp. 584–92.issn: 0007-0920. doi: 10.1038/bjc.2013.791.

O’Meara, H. et al. (2014). “Electronic health records for biological sample collec-tion: feasibility study of statin-induced myopathy using the Clinical Practice

CPRD bibliography

159

Research Datalink”. In: Br J Clin Pharmacol 77.5, pp. 831–8. issn: 0306-5251. doi: 10.1111/bcp.12269.

Palmer, K. T. et al. (2014a). “Epilepsy, diabetes mellitus and accidental injuryat work”. In: Occup Med (Lond) 64.6, pp. 448–53. issn: 0962-7480. doi:10.1093/occmed/kqu079.

— (2014b). “The role of mental health problems and common psychotropic drugtreatments in accidental injury at work: a case-control study”. In: OccupEnviron Med 71.5, pp. 308–12. issn: 1351-0711. doi: 10.1136/oemed-2013-101948.

Pauriah, M. et al. (2014). “High-potency statin and ezetimibe use and mortalityin survivors of an acute myocardial infarction: a population-based study”.In: Heart 100.11, pp. 867–72. issn: 1355-6037. doi: 10.1136/heartjnl-2013-304678.

Peeters, P. J. et al. (2014). “The risk of venous thromboembolism in patientswith multiple sclerosis: the Clinical Practice Research Datalink”. In: J ThrombHaemost 12.4, pp. 444–51. issn: 1538-7836. doi: 10.1111/jth.12523.

Pouwels, S., A. de Boer, H. G. Leufkens, W. E. Weber, C. Cooper, H. A.van Onzenoort, et al. (2014). “Risk of fracture in patients with musculardystrophies”. In: Osteoporos Int 25.2, pp. 509–18. issn: 0937-941x. doi:10.1007/s00198-013-2442-2.

Pouwels, S., A. de Boer, H. G. Leufkens, W. E. Weber, C. Cooper, T. P. van Staa,et al. (2014). “Risk of fracture in patients with Guillain-Barre syndrome”. In:Osteoporos Int 25.7, pp. 1845–51. issn: 0937-941x. doi: 10.1007/s00198-014-2705-6.

Pouwels, S., A. de Boer, H. G. Leufkens, W. E. Weber, C. Cooper, and F.de Vries (2014). “Risk of fracture in patients with Charcot-Marie-Toothdisease”. In: Muscle Nerve 50.6, pp. 919–24. issn: 0148-639x. doi: 10.1002/mus.24240.

Prasad, V. et al. (2014). “Injury among children and young adults with epilepsy”.In: Pediatrics 133.5, pp. 827–35. issn: 0031-4005. doi: 10.1542/peds.2013-2554.

Price, D. et al. (2014). “Switching patients from other inhaled corticosteroiddevices to the Easyhaler((R)): historical, matched-cohort study of real-lifeasthma patients”. In: J Asthma Allergy 7, pp. 31–51. issn: 1178-6965 (Print)1178-6965. doi: 10.2147/jaa.s59386.

Price, S. J. et al. (2014). “Non-visible versus visible haematuria and bladdercancer risk: a study of electronic records in primary care”. In: Br J GenPract 64.626, e584–9. issn: 0960-1643. doi: 10.3399/bjgp14X681409.

Punekar, Y. S., A. Shukla, and H. Mullerova (2014). “COPD management costsaccording to the frequency of COPD exacerbations in UK primary care”.In: Int J Chron Obstruct Pulmon Dis 9, pp. 65–73. issn: 1176-9106. doi:10.2147/copd.s54417.

Quint, J. K. et al. (2014). “Validation of chronic obstructive pulmonary diseaserecording in the Clinical Practice Research Datalink (CPRD-GOLD)”. In:BMJ Open 4.7, e005540. issn: 2044-6055 (Print) 2044-6055. doi: 10.1136/bmjopen-2014-005540.

Ratib, S., K. M. Fleming, et al. (2014). “1 and 5 year survival estimates forpeople with cirrhosis of the liver in England, 1998-2009: a large populationstudy”. In: J Hepatol 60.2, pp. 282–9. issn: 0168-8278. doi: 10.1016/j.jhep.2013.09.027.

CPRD bibliography

160

Ratib, S., J. West, et al. (2014). “Diagnosis of liver cirrhosis in England, a cohortstudy, 1998-2009: a comparison with cancer”. In: Am J Gastroenterol 109.2,pp. 190–8. issn: 0002-9270. doi: 10.1038/ajg.2013.405.

Redaniel, M. T. et al. (2014). “The association of vitamin D supplementationwith the risk of cancer in postmenopausal women”. In: Cancer Causes Con-trol 25.2, pp. 267–71. issn: 0957-5243. doi: 10.1007/s10552-013-0328-4.

Reeves, D. et al. (2014). “Can analyses of electronic patient records be indepen-dently and externally validated? The effect of statins on the mortality of pa-tients with ischaemic heart disease: a cohort study with nested case-controlanalysis”. In: BMJ Open 4.4, e004952. issn: 2044-6055 (Print) 2044-6055.doi: 10.1136/bmjopen-2014-004952.

Reinau, D. et al. (2014). “Epidemiology of basal cell carcinoma in the UnitedKingdom: incidence, lifestyle factors, and comorbidities”. In: Br J Cancer111.1, pp. 203–6. issn: 0007-0920. doi: 10.1038/bjc.2014.265.

Richy, F. F. et al. (2014). “Incidence of lactic acidosis in patients with type2 diabetes with and without renal impairment treated with metformin: aretrospective cohort study”. In: Diabetes Care 37.8, pp. 2291–5. issn: 0149-5992. doi: 10.2337/dc14-0464.

Ruigomez, A. et al. (2014). “Ascertainment of acute liver injury in two Europeanprimary care databases”. In: Eur J Clin Pharmacol 70.10, pp. 1227–35. issn:0031-6970. doi: 10.1007/s00228-014-1721-y.

Schneider, C. et al. (2014). “Use of anti-malarial drugs and the risk of developingeye disorders”. In: Travel Med Infect Dis 12.1, pp. 40–7. issn: 1477-8939. doi:10.1016/j.tmaid.2013.07.007.

Scowcroft, A. C. and M. R. Cowie (2014). “Atrial fibrillation: improvement inidentification and stroke preventive therapy - data from the UK ClinicalPractice Research Datalink, 2000-2012”. In: Int J Cardiol 171.2, pp. 169–73.issn: 0167-5273. doi: 10.1016/j.ijcard.2013.11.086.

Siriwardena, A. N., Z. Asghar, and C. C. Coupland (2014). “Influenza andpneumococcal vaccination and risk of stroke or transient ischaemic attack-matched case control study”. In: Vaccine 32.12, pp. 1354–61. issn: 0264-410x. doi: 10.1016/j.vaccine.2014.01.029.

Sondergaard, J. and A. Halling (2014). “The PROTECCT-M study: a cohortstudy investigating associations between novel specific biomarkers, patient-related, healthcare system markers and the trajectory of COPD patientstreated in primary care”. In: BMC Pulm Med 14, p. 88. issn: 1471-2466.doi: 10.1186/1471-2466-14-88.

Spoendlin, J., F. Bichsel, et al. (2014). “The association between psychiatricdiseases, psychotropic drugs and the risk of incident rosacea”. In: Br JDermatol 170.4, pp. 878–83. issn: 0007-0963. doi: 10.1111/bjd.12734.

Spoendlin, J., J. J. Voegel, et al. (2014). “Antihypertensive drugs and the riskof incident rosacea”. In: Br J Dermatol 171.1, pp. 130–6. issn: 0007-0963.doi: 10.1111/bjd.12838.

Springate, D. A. et al. (2014). “ClinicalCodes: an online clinical codes reposi-tory to improve the validity and reproducibility of research using electronicmedical records”. In: PLoS One 9.6, e99825. issn: 1932-6203. doi: 10.1371/journal.pone.0099825.

Staa, T. P. van, D. F. Carr, et al. (2014). “Predictors and outcomes of in-creases in creatine phosphokinase concentrations or rhabdomyolysis risk dur-

CPRD bibliography

161

ing statin treatment”. In: Br J Clin Pharmacol 78.3, pp. 649–59. issn: 0306-5251. doi: 10.1111/bcp.12367.

Staa, T. P. van, L. Dyson, et al. (2014). “The opportunities and challenges ofpragmatic point-of-care randomised trials using routinely collected electronicrecords: evaluations of two exemplar trials”. In: Health Technol Assess 18.43,pp. 1–146. issn: 1366-5278. doi: 10.3310/hta18430.

Staa, T. P. van, M. Gulliford, et al. (2014). “Prediction of cardiovascular risk us-ing Framingham, ASSIGN and QRISK2: how well do they predict individualrather than population risk?” In: PLoS One 9.10, e106455. issn: 1932-6203.doi: 10.1371/journal.pone.0106455.

Tate, A. R. et al. (2014). “Exploiting the potential of large databases of elec-tronic health records for research using rapid search algorithms and an in-tuitive query interface”. In: J Am Med Inform Assoc 21.2, pp. 292–8. issn:1067-5027. doi: 10.1136/amiajnl-2013-001847.

Taylor, P. N., A. Iqbal, et al. (2014). “Falling threshold for treatment of border-line elevated thyrotropin levels-balancing benefits and risks: evidence from alarge community-based study”. In: JAMA Intern Med 174.1, pp. 32–9. issn:2168-6106. doi: 10.1001/jamainternmed.2013.11312.

Taylor, P. N., C. Minassian, et al. (2014). “TSH levels and risk of miscarriagein women on long-term levothyroxine: a community-based study”. In: J ClinEndocrinol Metab 99.10, pp. 3895–902. issn: 0021-972x. doi: 10.1210/jc.2014-1954.

Thomas, G. et al. (2014). “Obesity paradox in people newly diagnosed withtype 2 diabetes with and without prior cardiovascular disease”. In: DiabetesObes Metab 16.4, pp. 317–25. issn: 1462-8902. doi: 10.1111/dom.12217.

Thomas, S. L. et al. (2014). “Chickenpox and risk of stroke: a self-controlledcase series analysis”. In: Clin Infect Dis 58.1, pp. 61–8. issn: 1058-4838.doi: 10.1093/cid/cit659.

Toovey, S. et al. (2014). “Comparative benefit of malaria chemoprophylaxismodelled in United Kingdom travellers”. In: Travel Med Infect Dis 12.6 PtB, pp. 726–32. issn: 1477-8939. doi: 10.1016/j.tmaid.2014.08.005.

Tsilidis, K. K. et al. (2014). “Metformin does not affect cancer risk: a co-hort study in the U.K. Clinical Practice Research Datalink analyzed likean intention-to-treat trial”. In: Diabetes Care 37.9, pp. 2522–32. issn: 0149-5992. doi: 10.2337/dc14-0584.

Vinogradova, Y., C. Coupland, and J. Hippisley-Cox (2014). “Exposure to com-bined oral contraceptives and risk of venous thromboembolism: a protocol fornested case-control studies using the QResearch and the CPRD databases”.In: BMJ Open 4.4, e004499. issn: 2044-6055 (Print) 2044-6055. doi: 10.1136/bmjopen-2013-004499.

Walker, A (2014). “Esophageal Cancer and Bisphosphonates”. In: J Pharm DrugDevel 2.1, p. 101. doi: 10.15744/2348-9782.1.301.

Walker, A. J. et al. (2014). “Variation in the risk of venous thromboembolismin people with colorectal cancer: a population-based cohort study from Eng-land”. In: J Thromb Haemost 12.5, pp. 641–9. issn: 1538-7836.

Walker, S., C. Hyde, and W. Hamilton (2014). “Risk of breast cancer in symp-tomatic women in primary care: a case-control study using electronic records”.In: Br J Gen Pract 64.629, e788–93. issn: 0960-1643. doi: 10.3399/bjgp14X682873.

Wallace, G. et al. (2014). “The effect of body mass index on the risk of post-operative complications during the 6 months following total hip replace-

CPRD bibliography

162

ment or total knee replacement surgery”. In: Osteoarthritis Cartilage 22.7,pp. 918–27. issn: 1063-4584. doi: 10.1016/j.joca.2014.04.013.

Wei, L. et al. (2014). “Cardiovascular risk associated with sodium-containingmedicines”. In: Expert Opin Drug Saf 13.11, pp. 1515–23. issn: 1474-0338.doi: 10.1517/14740338.2014.970163.

Weich, S. et al. (2014). “Effect of anxiolytic and hypnotic drug prescriptionson mortality hazards: retrospective cohort study”. In: Bmj 348, g1996. issn:0959-8138. doi: 10.1136/bmj.g1996.

West, J. et al. (2014). “Incidence and prevalence of celiac disease and dermatitisherpetiformis in the UK over two decades: population-based study”. In: AmJ Gastroenterol 109.5, pp. 757–68. issn: 0002-9270. doi: 10.1038/ajg.

2014.55.Wilson, A. B. et al. (2014). “Relative risk of myelodysplastic syndromes in pa-

tients with autoimmune disorders in the General Practice Research Database”.In: Cancer Epidemiol 38.5, pp. 544–9. issn: 1877-7821. doi: 10.1016/j.canep.2014.08.003.

Wing, K. et al. (2014). “Development of predictive genetic tests for improvingthe safety of new medicines: the utilization of routinely collected electronichealth records”. In: Drug Discov Today 19.4, pp. 361–6. issn: 1359-6446.doi: 10.1016/j.drudis.2013.11.003.

Wurst, K. E., Y. S. Punekar, and A. Shukla (2014). “Treatment evolution af-ter COPD diagnosis in the UK primary care setting”. In: PLoS One 9.9,e105296. issn: 1932-6203. doi: 10.1371/journal.pone.0105296.

Wurst, K. E., A. Shukla, et al. (2014). “Respiratory pharmacotherapy use inpatients newly diagnosed with chronic obstructive pulmonary disease in aprimary care setting in the UK: a retrospective cohort study”. In: Copd 11.5,pp. 521–30. issn: 1541-2563. doi: 10.3109/15412555.2014.922064.

Zhou, E. H. et al. (2014). “Risk of acute myocardial infarction, stroke, or deathin patients initiating olmesartan or other angiotensin receptor blockers - a co-hort study using the Clinical Practice Research Datalink”. In: Pharmacoepi-demiol Drug Saf 23.4, pp. 340–7. issn: 1053-8569. doi: 10.1002/pds.3549.

Zin, C. S., L. C. Chen, and R. D. Knaggs (2014). “Changes in trends and patternof strong opioid prescribing in primary care”. In: Eur J Pain 18.9, pp. 1343–51. issn: 1090-3801. doi: 10.1002/j.1532-2149.2014.496.x.

CPRD bibliography

163

2013

Abdul Sultan, A., L. J. Tata, et al. (2013). “The incidence of first venous throm-boembolism in and around pregnancy using linked primary and secondarycare data: a population based cohort study from England and comparativemeta-analysis”. In: PLoS One 8.7, e70310. issn: 1932-6203. doi: 10.1371/journal.pone.0070310.

Abdul Sultan, A., J. West, et al. (2013). “Risk of first venous thromboembolismin pregnant women in hospital: population based cohort study from Eng-land”. In: Bmj 347, f6099. issn: 0959-8138. doi: 10.1136/bmj.f6099.

Alexandropoulou, K. et al. (2013). “Temporal trends of Barrett’s oesophagusand gastro-oesophageal reflux and related oesophageal cancer over a 10-yearperiod in England and Wales and associated proton pump inhibitor andH2RA prescriptions: a GPRD study”. In: Eur J Gastroenterol Hepatol 25.1,pp. 15–21. issn: 0954-691x. doi: 10.1097/MEG.0b013e3283595086.

Assayag, J. et al. (2013). “Androgen deprivation therapy and the risk of col-orectal cancer in patients with prostate cancer”. In: Cancer Causes Control24.5, pp. 839–45. issn: 0957-5243. doi: 10.1007/s10552-012-0132-6.

Atkinson, R. W. et al. (2013). “Long-term exposure to outdoor air pollutionand incidence of cardiovascular diseases”. In: Epidemiology 24.1, pp. 44–53.issn: 1044-3983. doi: 10.1097/EDE.0b013e318276ccb8.

Azoulay, L. et al. (2013). “The concurrent use of antithrombotic therapies andthe risk of bleeding in patients with atrial fibrillation”. In: Thromb Haemost109.3, pp. 431–9. issn: 0340-6245. doi: 10.1160/th12-08-0542.

Bannon, F. J. et al. (2013). “Non-steroidal anti-inflammatory drug use andbrain tumour risk: a case-control study within the Clinical Practice ResearchDatalink”. In: Cancer Causes Control 24.11, pp. 2027–34. issn: 0957-5243.doi: 10.1007/s10552-013-0279-9.

Bazelier, M. T. et al. (2013). “Risk of fracture with thiazolidinediones: an in-dividual patient data meta-analysis”. In: Front Endocrinol (Lausanne) 4,p. 11. issn: 1664-2392 (Print) 1664-2392. doi: 10.3389/fendo.2013.00011.

Becker, C., S. S. Jick, et al. (2013). “Metformin and the risk of endometrialcancer: a case-control analysis”. In: Gynecol Oncol 129.3, pp. 565–9. issn:0090-8258. doi: 10.1016/j.ygyno.2013.03.009.

Becker, C., C. R. Meier, et al. (2013). “Case-control analysis on metformin andcancer of the esophagus”. In: Cancer Causes Control 24.10, pp. 1763–70.issn: 0957-5243. doi: 10.1007/s10552-013-0253-6.

Bhaskaran, K. et al. (2013). “Representativeness and optimal use of body massindex (BMI) in the UK Clinical Practice Research Datalink (CPRD)”. In:BMJ Open 3.9, e003389. issn: 2044-6055. doi: 10.1136/bmjopen-2013-003389.

Boggon, R., R. Hubbard, et al. (2013). “Variability of antibiotic prescribing inpatients with chronic obstructive pulmonary disease exacerbations: a cohortstudy”. In: BMC Pulm Med 13, p. 32. issn: 1471-2466. doi: 10.1186/1471-2466-13-32.

Boggon, R., T. P. van Staa, et al. (2013). “Cancer recording and mortalityin the General Practice Research Database and linked cancer registries”.

CPRD bibliography

164

In: Pharmacoepidemiol Drug Saf 22.2, pp. 168–75. issn: 1053-8569. doi:10.1002/pds.3374.

Booth, H. P., A. T. Prevost, and M. C. Gulliford (2013a). “Epidemiology ofclinical body mass index recording in an obese population in primary care:a cohort study”. In: J Public Health (Oxf) 35.1, pp. 67–74. issn: 1741-3842.doi: 10.1093/pubmed/fds063.

— (2013b). “Validity of smoking prevalence estimates from primary care elec-tronic health records compared with national population survey data forEngland, 2007 to 2011”. In: Pharmacoepidemiol Drug Saf 22.12, pp. 1357–61. issn: 1053-8569. doi: 10.1002/pds.3537.

Briggs, P. E. et al. (2013). “Impact of UK Medical Eligibility Criteria imple-mentation on prescribing of combined hormonal contraceptives”. In: J FamPlann Reprod Health Care 39.3, pp. 190–6. issn: 1471-1893 (Print) 1471-1893. doi: 10.1136/jfprhc-2012-100376.

Brilleman, S. L., S. Purdy, et al. (2013). “Implications of comorbidity for pri-mary care costs in the UK: a retrospective observational study”. In: Br JGen Pract 63.609, e274–82. issn: 0960-1643. doi: 10.3399/bjgp13X665242.

Brilleman, S. L. and C. Salisbury (2013). “Comparing measures of multimor-bidity to predict outcomes in primary care: a cross sectional study”. In: FamPract 30.2, pp. 172–8. issn: 0263-2136. doi: 10.1093/fampra/cms060.

Busby, J. et al. (2013). “Temporal growth and geographic variation in the useof laboratory tests by NHS general practices: using routine data to identifyresearch priorities”. In: Br J Gen Pract 63.609, e256–66. issn: 0960-1643.doi: 10.3399/bjgp13X665224.

Camejo, R. R. et al. (2013). “Assessing the determinants of the potential forcost-effectiveness over time: the empirical case of COPD”. In: Value Health16.2, pp. 426–33. issn: 1098-3015. doi: 10.1016/j.jval.2012.11.006.

Card, T. R. et al. (2013). “An excess of prior irritable bowel syndrome diagnosesor treatments in Celiac disease: evidence of diagnostic delay”. In: Scand JGastroenterol 48.7, pp. 801–7. issn: 0036-5521. doi: 10.3109/00365521.2013.786130.

Cardwell, C. R. et al. (2013). “Beta-blocker usage and breast cancer survival:a nested case-control study within a UK clinical practice research datalinkcohort”. In: Int J Epidemiol 42.6, pp. 1852–61. issn: 0300-5771. doi: 10.1093/ije/dyt196.

Carey, I. M. et al. (2013). “Mortality associations with long-term exposureto outdoor air pollution in a national English cohort”. In: Am J RespirCrit Care Med 187.11, pp. 1226–33. issn: 1073-449x. doi: 10.1164/rccm.201210-1758OC.

Carr, D. F. et al. (2013). “SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice re-search datalink”. In: Clin Pharmacol Ther 94.6, pp. 695–701. issn: 0009-9236. doi: 10.1038/clpt.2013.161.

Chapman, C. R. and D. H. Bradshaw (2013). “Only modest long-term opioiddose escalation occurs over time in chronic nonmalignant pain management”.In: J Pain Palliat Care Pharmacother 27.4, pp. 370–7. issn: 1536-0288. doi:10.3109/15360288.2013.846957.

Charlton, J. et al. (2013). “Impact of deprivation on occurrence, outcomes andhealth care costs of people with multiple morbidity”. In: J Health Serv ResPolicy 18.4, pp. 215–23. issn: 1355-8196. doi: 10.1177/1355819613493772.

CPRD bibliography

165

Charlton, R. A., A. Hutchison, et al. (2013). “Asthma management in preg-nancy”. In: PLoS One 8.4, e60247. issn: 1932-6203. doi: 10.1371/journal.pone.0060247.

Charlton, R. A., J. M. Snowball, et al. (2013). “Colorectal cancer risk reductionfollowing macrogol exposure: a cohort and nested case control study in theUK”. In: PLoS One 8.12, e83203. issn: 1932-6203. doi: 10.1371/journal.pone.0083203.

Chollet, J. et al. (2013). “A clinical research practice datalink analysis of an-tidepressant treatment patterns and health care costs in generalized anxietydisorder”. In: Value Health 16.8, pp. 1133–9. issn: 1098-3015. doi: 10.1016/j.jval.2013.09.001.

Cornish, R. P. et al. (2013). “Socio-economic position and childhood multi-morbidity: a study using linkage between the Avon Longitudinal Study ofParents and Children and the General Practice Research Database”. In: IntJ Equity Health 12, p. 66. issn: 1475-9276. doi: 10.1186/1475-9276-12-66.

Cotton, S. J. et al. (2013). “The risk of a subsequent cancer diagnosis afterherpes zoster infection: primary care database study”. In: Br J Cancer 108.3,pp. 721–6. issn: 0007-0920. doi: 10.1038/bjc.2013.13.

Crooks, C. J., T. R. Card, and J. West (2013). “Excess long-term mortalityfollowing non-variceal upper gastrointestinal bleeding: a population-basedcohort study”. In: PLoS Med 10.4, e1001437. issn: 1549-1277. doi: 10 .

1371/journal.pmed.1001437.Crooks, C. J., J. West, and T. R. Card (2013). “Comorbidities affect risk of non-

variceal upper gastrointestinal bleeding”. In: Gastroenterology 144.7, 1384–93, 1393.e1–2, 1393.e1–2. issn: 0016-5085. doi: 10.1053/j.gastro.2013.02.040.

Crowther, M. J., P. C. Lambert, and K. R. Abrams (2013). “Adjusting formeasurement error in baseline prognostic biomarkers included in a time-to-event analysis: a joint modelling approach”. In: BMC Med Res Methodol 13,p. 146. issn: 1471-2288. doi: 10.1186/1471-2288-13-146.

Culliford, D. et al. (2013). “A population-based survival analysis describing theassociation of body mass index on time to revision for total hip and kneereplacements: results from the UK general practice research database”. In:BMJ Open 3.11, e003614. issn: 2044-6055. doi: 10.1136/bmjopen-2013-003614.

Currie, C. J. et al. (2013). “Mortality and other important diabetes-relatedoutcomes with insulin vs other antihyperglycemic therapies in type 2 dia-betes”. In: J Clin Endocrinol Metab 98.2, pp. 668–77. issn: 0021-972x. doi:10.1210/jc.2012-3042.

Davies, N. M., D. Gunnell, et al. (2013). “Physicians’ prescribing preferenceswere a potential instrument for patients’ actual prescriptions of antidepres-sants”. In: J Clin Epidemiol 66.12, pp. 1386–96. issn: 0895-4356. doi: 10.1016/j.jclinepi.2013.06.008.

Davies, N. M., G. D. Smith, et al. (2013). “COX-2 selective nonsteroidal anti-inflammatory drugs and risk of gastrointestinal tract complications andmyocardial infarction: an instrumental variable analysis”. In: Epidemiology24.3, pp. 352–62. issn: 1044-3983. doi: 10.1097/EDE.0b013e318289e024.

Dawson, J. et al. (2013). “Acetaminophen use and change in blood pressure ina hypertensive population”. In: J Hypertens 31.7, 1485–90, discussion 1490.issn: 0263-6352. doi: 10.1097/HJH.0b013e328360f6f8.

CPRD bibliography

166

Dodd, C. N. et al. (2013). “International collaboration to assess the risk ofGuillain Barre Syndrome following Influenza A (H1N1) 2009 monovalentvaccines”. In: Vaccine 31.40, pp. 4448–58. issn: 0264-410x. doi: 10.1016/j.vaccine.2013.06.032.

Dommett, R. M., M. T. Redaniel, et al. (2013). “Features of cancer in teenagersand young adults in primary care: a population-based nested case-controlstudy”. In: Br J Cancer 108.11, pp. 2329–33. issn: 0007-0920. doi: 10.

1038/bjc.2013.191.Dommett, R. M., T. Redaniel, et al. (2013). “Risk of childhood cancer with

symptoms in primary care: a population-based case-control study”. In: Br JGen Pract 63.606, e22–9. issn: 0960-1643. doi: 10.3399/bjgp13X660742.

Donegan, K. et al. (2013). “Bivalent human papillomavirus vaccine and the riskof fatigue syndromes in girls in the UK”. In: Vaccine 31.43, pp. 4961–7. issn:0264-410x. doi: 10.1016/j.vaccine.2013.08.024.

Dormuth, C. R. et al. (2013). “Use of high potency statins and rates of admissionfor acute kidney injury: multicenter, retrospective observational analysis ofadministrative databases”. In: Bmj 346, f880. issn: 0959-8138. doi: 10.

1136/bmj.f880.Douglas, I. J. et al. (2013). “Orlistat and the risk of acute liver injury: self

controlled case series study in UK Clinical Practice Research Datalink”. In:Bmj 346, f1936. issn: 0959-8138. doi: 10.1136/bmj.f1936.

Douglas, I. et al. (2013). “Juvenile Huntington’s disease: a population-basedstudy using the General Practice Research Database”. In: BMJ Open 3.4.issn: 2044-6055 (Print) 2044-6055. doi: 10.1136/bmjopen-2012-002085.

Ehrenstein, V. et al. (2013). “Rosiglitazone use and post-discontinuation gly-caemic control in two European countries, 2000-2010”. In: BMJ Open 3.9,e003424. issn: 2044-6055. doi: 10.1136/bmjopen-2013-003424.

Erviti, J., A. Alonso, J. Gorricho, et al. (2013). “Oral bisphosphonates maynot decrease hip fracture risk in elderly Spanish women: a nested case-control study”. In: BMJ Open 3.2. issn: 2044-6055 (Print) 2044-6055. doi:10.1136/bmjopen-2012-002084.

Erviti, J., A. Alonso, B. Oliva, et al. (2013). “Oral bisphosphonates are associ-ated with increased risk of subtrochanteric and diaphyseal fractures in elderlywomen: a nested case-control study”. In: BMJ Open 3.1. issn: 2044-6055.doi: 10.1136/bmjopen-2012-002091.

Evans, S. J. et al. (2013). “Prevalence of adult Huntington’s disease in theUK based on diagnoses recorded in general practice records”. In: J NeurolNeurosurg Psychiatry 84.10, pp. 1156–60. issn: 0022-3050. doi: 10.1136/jnnp-2012-304636.

Frisher, M. et al. (2013). “Incidence of psychoses among drug dependent patientsin primary care with no psychiatric history: a retrospective observationalmatched-cohort study”. In: The European Journal of Psychiatry 27, pp. 240–7.

Garcia Rodriguez, L. A., S. Johansson, and L. Cea Soriano (2013). “Use ofclopidogrel and proton pump inhibitors after a serious acute coronary event:risk of coronary events and peptic ulcer bleeding”. In: Thromb Haemost110.5, pp. 1014–24. issn: 0340-6245. doi: 10.1160/th13-03-0225.

George, J. et al. (2013). “Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-controlstudy”. In: Bmj 347, f6954. issn: 0959-8138. doi: 10.1136/bmj.f6954.

CPRD bibliography

167

Hagberg, K. W. et al. (2013). “Incidence of bone metastases in breast cancerpatients in the United Kingdom: results of a multi-database linkage studyusing the general practice research database”. In: Cancer Epidemiol 37.3,pp. 240–6. issn: 1877-7821. doi: 10.1016/j.canep.2013.01.006.

Hak, E., B. Mulder, et al. (2013). “Use of acid-suppressive drugs in pregnancyand the risk of childhood asthma: bidirectional crossover study using thegeneral practice research database”. In: Drug Saf 36.11, pp. 1097–104. issn:0114-5916. doi: 10.1007/s40264-013-0093-z.

Hak, E., K. M. Shea, and S. S. Jick (2013). “Association of infant pneumococcalvaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRD”. In: Vaccine 31.12, pp. 1590–6. issn: 0264-410x. doi: 10.1016/j.vaccine.2013.01.018.

Hak, E., T. W. de Vries, et al. (2013). “Association of childhood attention-deficit/hyperactivity disorder with atopic diseases and skin infections? Amatched case-control study using the General Practice Research Database”.In: Ann Allergy Asthma Immunol 111.2, 102–106.e2. issn: 1081-1206. doi:10.1016/j.anai.2013.05.023.

Hall, G. C. et al. (2013). “An observational descriptive study of the epidemiologyand treatment of neuropathic pain in a UK general population”. In: BMCFam Pract 14, p. 28. issn: 1471-2296. doi: 10.1186/1471-2296-14-28.

Ham, H. A. van den et al. (2013). “The patterns of anticoagulation control andthe risk of stroke, bleeding and mortality in patients with non-valvular atrialfibrillation”. In: J Thromb Haemost 11.1, pp. 107–15. issn: 1538-7836. doi:10.1111/jth.12041.

Hammad, T. A. et al. (2013). “Determining the predictive value of Read codesto identify congenital cardiac malformations in the UK Clinical PracticeResearch Datalink”. In: Pharmacoepidemiol Drug Saf 22.11, pp. 1233–8.issn: 1053-8569. doi: 10.1002/pds.3511.

Hawkins, N. M. et al. (2013). “The UK National Health Service: deliveringequitable treatment across the spectrum of coronary disease”. In: Circ Car-diovasc Qual Outcomes 6.2, pp. 208–16. issn: 1941-7713. doi: 10.1161/

circoutcomes.111.000058.Herrett, E., J. George, et al. (2013). “Type and timing of heralding in ST-

elevation and non-ST-elevation myocardial infarction: an analysis of prospec-tively collected electronic healthcare records linked to the national registryof acute coronary syndromes”. In: Eur Heart J Acute Cardiovasc Care 2.3,pp. 235–45. issn: 2048-8726. doi: 10.1177/2048872613487495.

Herrett, E., A. D. Shah, et al. (2013). “Completeness and diagnostic validity ofrecording acute myocardial infarction events in primary care, hospital care,disease registry, and national mortality records: cohort study”. In: Bmj 346,f2350. issn: 0959-8138. doi: 10.1136/bmj.f2350.

Hicks, B. M. et al. (2013). “beta-Blocker usage and colorectal cancer mortality:a nested case-control study in the UK Clinical Practice Research Datalinkcohort”. In: Ann Oncol 24.12, pp. 3100–6. issn: 0923-7534. doi: 10.1093/annonc/mdt381.

Hippisley-Cox, J. and C. Coupland (2013). “Predicting risk of emergency ad-mission to hospital using primary care data: derivation and validation ofQAdmissions score”. In: BMJ Open 3.8, e003482. issn: 2044-6055. doi: 10.1136/bmjopen-2013-003482.

CPRD bibliography

168

Holden, S. E. et al. (2013). “The prevalence and incidence, resource use andfinancial costs of treating people with attention deficit/hyperactivity dis-order (ADHD) in the United Kingdom (1998 to 2010)”. In: Child AdolescPsychiatry Ment Health 7.1, p. 34. issn: 1753-2000 (Print) 1753-2000. doi:10.1186/1753-2000-7-34.

Holden, S. H. et al. (2013). “The incidence of type 2 diabetes in the UnitedKingdom from 1991 to 2010”. In: Diabetes Obes Metab 15.9, pp. 844–52.issn: 1462-8902. doi: 10.1111/dom.12123.

Hong, J. L. et al. (2013). “Risk of colorectal cancer after initiation of orlistat:matched cohort study”. In: Bmj 347, f5039. issn: 0959-8138. doi: 10.1136/bmj.f5039.

Hong, J. et al. (2013). “Costs associated with treatment of chronic low backpain: an analysis of the UK General Practice Research Database”. In: Spine(Phila Pa 1976) 38.1, pp. 75–82. issn: 0362-2436. doi: 10 . 1097 / BRS .

0b013e318276450f.Howell-Jones, R. et al. (2013). “Declining genital Warts in young women in

england associated with HPV 16/18 vaccination: an ecological study”. In:J Infect Dis 208.9, pp. 1397–403. issn: 0022-1899. doi: 10.1093/infdis/jit361.

Humes, D. J. et al. (2013). “Population-based study of presentation and adverseoutcomes after femoral hernia surgery”. In: Br J Surg 100.13, pp. 1827–32.issn: 0007-1323. doi: 10.1002/bjs.9336.

Imfeld, P., M. Bodmer, et al. (2013a). “Risk of incident stroke in patients withAlzheimer disease or vascular dementia”. In: Neurology 81.10, pp. 910–9.issn: 0028-3878. doi: 10.1212/WNL.0b013e3182a35151.

— (2013b). “Seizures in patients with Alzheimer’s disease or vascular dementia:a population-based nested case-control analysis”. In: Epilepsia 54.4, pp. 700–7. issn: 0013-9580. doi: 10.1111/epi.12045.

Imfeld, P., Y. B. Brauchli Pernus, et al. (2013). “Epidemiology, co-morbidities,and medication use of patients with Alzheimer’s disease or vascular dementiain the UK”. In: J Alzheimers Dis 35.3, pp. 565–73. issn: 1387-2877. doi:10.3233/jad-121819.

Iyer, P. G. et al. (2013). “Association of Barrett’s esophagus with type II Dia-betes Mellitus: results from a large population-based case-control study”.In: Clin Gastroenterol Hepatol 11.9, 1108–1114.e5. issn: 1542-3565. doi:10.1016/j.cgh.2013.03.024.

Jameson, K. et al. (2013). “Impact of lipid-lowering therapy on the prevalence ofdyslipidaemia in patients at high-risk of cardiovascular events in UK primarycare - a retrospective database study”. In: Int J Clin Pract 67.12, pp. 1228–37. issn: 1368-5031. doi: 10.1111/ijcp.12238.

Jick, S. S. and K. W. Hagberg (2013). “The risk of adverse outcomes in associ-ation with use of testosterone products: a cohort study using the UK-basedgeneral practice research database”. In: Br J Clin Pharmacol 75.1, pp. 260–70. issn: 0306-5251. doi: 10.1111/j.1365-2125.2012.04326.x.

Jones, M. E. et al. (2013). “Risk of Mortality (including Sudden Cardiac Death)and Major Cardiovascular Events in Users of Olanzapine and Other Antipsy-chotics: A Study with the General Practice Research Database”. In: Cardio-vasc Psychiatry Neurol 2013, p. 647476. issn: 2090-0163 (Print) 2090-0171.doi: 10.1155/2013/647476.

CPRD bibliography

169

Jordan, K. P. et al. (2013). “Incidence of prostate, breast, lung and colorectalcancer following new consultation for musculoskeletal pain: a cohort studyamong UK primary care patients”. In: Int J Cancer 133.3, pp. 713–20. issn:0020-7136. doi: 10.1002/ijc.28055.

Kadam, U. T., M. Blagojevic, and J. Belcher (2013). “Statin use and clinicalosteoarthritis in the general population: a longitudinal study”. In: J GenIntern Med 28.7, pp. 943–9. issn: 0884-8734. doi: 10.1007/s11606-013-2382-8.

Kalra, P. R. et al. (2013). “Discontinuation of beta-blockers in cardiovasculardisease: UK primary care cohort study”. In: Int J Cardiol 167.6, pp. 2695–9.issn: 0167-5273. doi: 10.1016/j.ijcard.2012.06.116.

Kehoe, P. G. et al. (2013). “Associations of angiotensin targeting antihyperten-sive drugs with mortality and hospitalization in primary care patients withdementia”. In: J Alzheimers Dis 33.4, pp. 999–1008. issn: 1387-2877. doi:10.3233/jad-2012-121090.

Khunti, K. et al. (2013). “Clinical inertia in people with type 2 diabetes: aretrospective cohort study of more than 80,000 people”. In: Diabetes Care36.11, pp. 3411–7. issn: 0149-5992. doi: 10.2337/dc13-0331.

Kontopantelis, E. et al. (2013). “Recorded quality of primary care for patientswith diabetes in England before and after the introduction of a financialincentive scheme: a longitudinal observational study”. In: BMJ Qual Saf22.1, pp. 53–64. issn: 2044-5415. doi: 10.1136/bmjqs-2012-001033.

Lalmohamed, A. et al. (2013). “Patterns of risk of cancer in patients with metal-on-metal hip replacements versus other bearing surface types: a record link-age study between a prospective joint registry and general practice electronichealth records in England”. In: PLoS One 8.7, e65891. issn: 1932-6203. doi:10.1371/journal.pone.0065891.

Lanza, L. L. et al. (2013). “Use of depot medroxyprogesterone acetate contra-ception and incidence of bone fracture”. In: Obstet Gynecol 121.3, pp. 593–600. issn: 0029-7844. doi: 10.1097/AOG.0b013e318283d1a1.

Lapi, F., L. Azoulay, M. T. Niazi, et al. (2013). “Androgen deprivation therapyand risk of acute kidney injury in patients with prostate cancer”. In: Jama310.3, pp. 289–96. issn: 0098-7484. doi: 10.1001/jama.2013.8638.

Lapi, F., L. Azoulay, H. Yin, et al. (2013). “Concurrent use of diuretics, an-giotensin converting enzyme inhibitors, and angiotensin receptor blockerswith non-steroidal anti-inflammatory drugs and risk of acute kidney in-jury: nested case-control study”. In: Bmj 346, e8525. issn: 0959-8138. doi:10.1136/bmj.e8525.

Li, L. et al. (2013a). “Opioid use for noncancer pain and risk of fracture in adults:a nested case-control study using the general practice research database”.In: Am J Epidemiol 178.4, pp. 559–69. issn: 0002-9262. doi: 10.1093/aje/kwt013.

— (2013b). “Opioid use for noncancer pain and risk of myocardial infarctionamongst adults”. In: J Intern Med 273.5, pp. 511–26. issn: 0954-6820. doi:10.1111/joim.12035.

— (2013c). “Opioids and risk of type 2 diabetes in adults with non-cancer pain”.In: Pain Physician 16.1, pp. 77–88. issn: 1533-3159.

Lopez Bernal, J. A. et al. (2013). “Lower respiratory tract infection in the firstyear of life is associated with worse lung function in adult life: prospective

CPRD bibliography

170

results from the Barry Caerphilly Growth study”. In: Ann Epidemiol 23.7,pp. 422–7. issn: 1047-2797. doi: 10.1016/j.annepidem.2013.05.006.

Margulis, A. V. et al. (2013). “Use of selective serotonin reuptake inhibitors inpregnancy and cardiac malformations: a propensity-score matched cohort inCPRD”. In: Pharmacoepidemiol Drug Saf 22.9, pp. 942–51. issn: 1053-8569.doi: 10.1002/pds.3462.

Martinez, C., R. W. Jones, and S. Rietbrock (2013). “Trends in the prevalenceof antipsychotic drug use among patients with Alzheimer’s disease and otherdementias including those treated with antidementia drugs in the communityin the UK: a cohort study”. In: BMJ Open 3.1. issn: 2044-6055. doi: 10.1136/bmjopen-2012-002080.

Micali, N. et al. (2013). “The incidence of eating disorders in the UK in 2000-2009: findings from the General Practice Research Database”. In: BMJ Open3.5. issn: 2044-6055. doi: 10.1136/bmjopen-2013-002646.

Millett, E. R. et al. (2013). “Incidence of community-acquired lower respiratorytract infections and pneumonia among older adults in the United Kingdom:a population-based study”. In: PLoS One 8.9, e75131. issn: 1932-6203. doi:10.1371/journal.pone.0075131.

Minassian, C. et al. (2013). “Acute maternal infection and risk of pre-eclampsia:a population-based case-control study”. In: PLoS One 8.9, e73047. issn:1932-6203. doi: 10.1371/journal.pone.0073047.

Morales, D. R. et al. (2013). “Impact of clinical trial findings on Bell’s palsymanagement in general practice in the UK 2001-2012: interrupted time seriesregression analysis”. In: BMJ Open 3.7. issn: 2044-6055. doi: 10.1136/

bmjopen-2013-003121.Morgan, C. L. et al. (2013). “Primary prevention of diabetic retinopathy with fi-

brates: a retrospective, matched cohort study”. In: BMJ Open 3.12, e004025.issn: 2044-6055 (Print) 2044-6055. doi: 10.1136/bmjopen-2013-004025.

Murray, M. L. et al. (2013). “An inventory of European data sources for the long-term safety evaluation of methylphenidate”. In: Eur Child Adolesc Psychia-try 22.10, pp. 605–18. issn: 1018-8827. doi: 10.1007/s00787-013-0386-x.

Nicholas, J. M. et al. (2013). “Fracture risk with use of liver enzyme inducingantiepileptic drugs in people with active epilepsy: cohort study using thegeneral practice research database”. In: Seizure 22.1, pp. 37–42. issn: 1059-1311. doi: 10.1016/j.seizure.2012.10.002.

Nicholson, A. et al. (2013). “Optimising use of electronic health records todescribe the presentation of rheumatoid arthritis in primary care: a strategyfor developing code lists”. In: PLoS One 8.2, e54878. issn: 1932-6203. doi:10.1371/journal.pone.0054878.

Norton, S. et al. (2013). “A study of baseline prevalence and cumulative in-cidence of comorbidity and extra-articular manifestations in RA and theirimpact on outcome”. In: Rheumatology (Oxford) 52.1, pp. 99–110. issn: 1462-0324. doi: 10.1093/rheumatology/kes262.

Padwal, R. S. et al. (2013). “A simple prediction rule for all-cause mortality ina cohort eligible for bariatric surgery”. In: JAMA Surg 148.12, pp. 1109–15.issn: 2168-6254. doi: 10.1001/jamasurg.2013.3953.

Pitman, R. J., L. D. Nagy, and M. J. Sculpher (2013). “Cost-effectiveness ofchildhood influenza vaccination in England and Wales: Results from a dy-namic transmission model”. In: Vaccine 31.6, pp. 927–42. issn: 0264-410x.doi: 10.1016/j.vaccine.2012.12.010.

CPRD bibliography

171

Poole, C. D. et al. (2013). “Omega-3 Fatty acids and mortality outcome inpatients with and without type 2 diabetes after myocardial infarction: aretrospective, matched-cohort study”. In: Clin Ther 35.1, pp. 40–51. issn:0149-2918. doi: 10.1016/j.clinthera.2012.11.008.

Pouwels, S., M. T. Bazelier, A. de Boer, W. E. Weber, C. K. Neef, et al. (2013).“Five-year fracture risk estimation in patients with Parkinson’s disease”. In:Bone 56.2, pp. 266–70. issn: 1873-2763. doi: 10.1016/j.bone.2013.06.018.

Pouwels, S., M. T. Bazelier, A. de Boer, W. E. Weber, C. Neef, et al. (2013).“Risk of fracture in patients with Parkinson’s disease”. In: Osteoporos Int24.8, pp. 2283–90. issn: 0937-941x. doi: 10.1007/s00198-013-2300-2.

Pouwels, S., A. de Boer, et al. (2013). “Fracture rate in patients with myasthe-nia gravis: the general practice research database”. In: Osteoporos Int 24.2,pp. 467–76. issn: 0937-941x. doi: 10.1007/s00198-012-1970-5.

Qiu, H. et al. (2013). “Initial metformin or sulphonylurea exposure and canceroccurrence among patients with type 2 diabetes mellitus”. In: Diabetes ObesMetab 15.4, pp. 349–57. issn: 1462-8902. doi: 10.1111/dom.12036.

Quint, J. K. et al. (2013). “Effect of beta blockers on mortality after myocar-dial infarction in adults with COPD: population based cohort study of UKelectronic healthcare records”. In: Bmj 347, f6650. issn: 0959-8138. doi:10.1136/bmj.f6650.

Reed, C. et al. (2013). “Health care costs before and after diagnosis of depres-sion in patients with unexplained pain: a retrospective cohort study usingthe United Kingdom General Practice Research Database”. In: ClinicoeconOutcomes Res 5, pp. 37–47. issn: 1178-6981 (Print) 1178-6981.

Refoios Camejo, R. et al. (2013). “The determinants of cost-effectiveness po-tential: an historical perspective on lipid-lowering therapies”. In: Pharma-coeconomics 31.5, pp. 445–54. issn: 1170-7690. doi: 10.1007/s40273-013-0041-x.

Sammon, C. J. et al. (2013). “Pandemic influenza vaccination during pregnancy:an investigation of vaccine uptake during the 2009/10 pandemic vaccinationcampaign in Great Britain”. In: Hum Vaccin Immunother 9.4, pp. 917–23.issn: 2164-5515. doi: 10.4161/hv.23277.

Schneider, C. et al. (2013). “Antimalarial chemoprophylaxis and the risk ofneuropsychiatric disorders”. In: Travel Med Infect Dis 11.2, pp. 71–80. issn:1477-8939. doi: 10.1016/j.tmaid.2013.02.008.

Scowcroft, A. C., S. Lee, and J. Mant (2013). “Thromboprophylaxis of elderlypatients with AF in the UK: an analysis using the General Practice ResearchDatabase (GPRD) 2000-2009”. In: Heart 99.2, pp. 127–32. issn: 1355-6037.doi: 10.1136/heartjnl-2012-302843.

Shephard, E. et al. (2013). “Clinical features of kidney cancer in primary care: acase-control study using primary care records”. In: Br J Gen Pract 63.609,e250–5. issn: 0960-1643. doi: 10.3399/bjgp13X665215.

Skow, A., I. Douglas, and L. Smeeth (2013). “The association between Parkin-son’s disease and anti-epilepsy drug carbamazepine: a case-control study us-ing the UK General Practice Research Database”. In: Br J Clin Pharmacol76.5, pp. 816–22. issn: 0306-5251. doi: 10.1111/bcp.12100.

Smiechowski, B. B. et al. (2013). “The use of metformin and the incidence of lungcancer in patients with type 2 diabetes”. In: Diabetes Care 36.1, pp. 124–9.issn: 0149-5992. doi: 10.2337/dc12-0740.

CPRD bibliography

172

Smiechowski, B. et al. (2013). “The use of metformin and colorectal cancerincidence in patients with type II diabetes mellitus”. In: Cancer EpidemiolBiomarkers Prev 22.10, pp. 1877–83. issn: 1055-9965. doi: 10.1158/1055-9965.epi-13-0196.

Solaymani-Dodaran, M., T. R. Card, and J. West (2013). “Cause-specific mor-tality of people with Barrett’s esophagus compared with the general popula-tion: a population-based cohort study”. In: Gastroenterology 144.7, 1375–83,1383.e1. issn: 0016-5085. doi: 10.1053/j.gastro.2013.02.050.

Spoendlin, J. et al. (2013). “Migraine, triptans, and the risk of developingrosacea: a population-based study within the United Kingdom”. In: J AmAcad Dermatol 69.3, pp. 399–406. issn: 0190-9622. doi: 10.1016/j.jaad.2013.03.027.

Staa, T. P. van et al. (2013). “The efficiency of cardiovascular risk assessment:do the right patients get statin treatment?” In: Heart 99.21, pp. 1597–602.issn: 1355-6037. doi: 10.1136/heartjnl-2013-303698.

Taylor, B., H. Jick, and D. Maclaughlin (2013). “Prevalence and incidence ratesof autism in the UK: time trend from 2004-2010 in children aged 8 years”. In:BMJ Open 3.10, e003219. issn: 2044-6055. doi: 10.1136/bmjopen-2013-003219.

Taylor, K. S. et al. (2013). “All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes ina large U.K. primary care database”. In: Diabetes Care 36.8, pp. 2366–71.issn: 0149-5992. doi: 10.2337/dc12-1513.

Thomas, K. H., N. Davies, et al. (2013). “Validation of suicide and self-harmrecords in the Clinical Practice Research Datalink”. In: Br J Clin Pharmacol76.1, pp. 145–57. issn: 0306-5251. doi: 10.1111/bcp.12059.

Thomas, K. H., R. M. Martin, et al. (2013). “Smoking cessation treatment andrisk of depression, suicide, and self harm in the Clinical Practice ResearchDatalink: prospective cohort study”. In: Bmj 347, f5704. issn: 0959-8138.doi: 10.1136/bmj.f5704.

Tsang, C. et al. (2013a). “Adverse events recorded in English primary care:observational study using the General Practice Research Database”. In: Br JGen Pract 63.613, e534–42. issn: 0960-1643. doi: 10.3399/bjgp13X670660.

— (2013b). “Cancer diagnosed by emergency admission in England: an observa-tional study using the general practice research database”. In: BMC HealthServ Res 13, p. 308. issn: 1472-6963. doi: 10.1186/1472-6963-13-308.

Varyani, F. K., J. West, and T. R. Card (2013). “Primary biliary cirrhosisdoes not increase the risk of UTIs following diagnosis compared to otherchronic liver diseases?” In: Liver Int 33.3, pp. 384–8. issn: 1478-3223. doi:10.1111/liv.12107.

Vasilakis-Scaramozza, C., A. Aschengrau, H. J. Cabral, et al. (2013a). “Antihy-pertensive drugs and the risk of congenital anomalies”. In: Pharmacotherapy33.5, pp. 476–82. issn: 0277-0008. doi: 10.1002/phar.1212.

— (2013b). “Asthma drugs and the risk of congenital anomalies”. In: Pharma-cotherapy 33.4, pp. 363–8. issn: 0277-0008. doi: 10.1002/phar.1213.

Vasilakis-Scaramozza, C., A. Aschengrau, H. Cabral, et al. (2013). “Antidepres-sant use during early pregnancy and the risk of congenital anomalies”. In:Pharmacotherapy 33.7, pp. 693–700. issn: 0277-0008. doi: 10.1002/phar.1211.

CPRD bibliography

173

Vinogradova, Y., C. Coupland, and J. Hippisley-Cox (2013a). “Exposure tobisphosphonates and risk of common non-gastrointestinal cancers: series ofnested case-control studies using two primary-care databases”. In: Br J Can-cer 109.3, pp. 795–806. issn: 0007-0920. doi: 10.1038/bjc.2013.383.

— (2013b). “Exposure to bisphosphonates and risk of gastrointestinal cancers:series of nested case-control studies with QResearch and CPRD data”. In:Bmj 346, f114. issn: 0959-8138. doi: 10.1136/bmj.f114.

Walker, A. J. et al. (2013). “Incidence of venous thromboembolism in patientswith cancer - a cohort study using linked United Kingdom databases”. In:Eur J Cancer 49.6, pp. 1404–13. issn: 0959-8049. doi: 10.1016/j.ejca.2012.10.021.

Walker, S., C. Hyde, and W. Hamilton (2013). “Risk of uterine cancer insymptomatic women in primary care: case-control study using electronicrecords”. In: Br J Gen Pract 63.614, e643–8. issn: 0960-1643. doi: 10 .

3399/bjgp13X671632.Wei, L., T. M. MacDonald, and I. S. Mackenzie (2013). “Pioglitazone and blad-

der cancer: a propensity score matched cohort study”. In: Br J Clin Phar-macol 75.1, pp. 254–9. issn: 0306-5251. doi: 10.1111/j.1365-2125.2012.04325.x.

Wilson, J. C. et al. (2013). “Non-steroidal anti-inflammatory drug use andcervical cancer risk: a case-control study using the Clinical Practice ResearchDatalink”. In: Cancer Epidemiol 37.6, pp. 897–904. issn: 1877-7821. doi:10.1016/j.canep.2013.08.010.

CPRD bibliography

174

2012

Amar, R. K. et al. (2012a). “Drug-/radiation-induced interstitial lung disease inthe United Kingdom general population: incidence, all-cause mortality andcharacteristics at diagnosis”. In: Respirology 17.5, pp. 861–8. issn: 1323-7799.doi: 10.1111/j.1440-1843.2012.02187.x.

— (2012b). “Incidence of the pneumoconioses in the United Kingdom generalpopulation between 1997 and 2008”. In: Respiration 84.3, pp. 200–6. issn:0025-7931. doi: 10.1159/000338116.

Azoulay, L., T. L. Assimes, et al. (2012). “Long-term use of angiotensin receptorblockers and the risk of cancer”. In: PLoS One 7.12, e50893. issn: 1932-6203.doi: 10.1371/journal.pone.0050893.

Azoulay, L., S. Dell’Aniello, et al. (2012). “A net clinical benefit analysis ofwarfarin and aspirin on stroke in patients with atrial fibrillation: a nestedcase-control study”. In: BMC Cardiovasc Disord 12, p. 49. issn: 1471-2261.doi: 10.1186/1471-2261-12-49.

Azoulay, L., H. Yin, et al. (2012). “The use of pioglitazone and the risk ofbladder cancer in people with type 2 diabetes: nested case-control study”.In: Bmj 344, e3645. issn: 0959-8138. doi: 10.1136/bmj.e3645.

Bakhai, A. et al. (2012). “Co-administration of statins with cytochrome P4503A4 inhibitors in a UK primary care population”. In: PharmacoepidemiolDrug Saf 21.5, pp. 485–93. issn: 1053-8569. doi: 10.1002/pds.2308.

Bartholomeeusen, S. et al. (2012). “Higher incidence of common diagnoses inpatients with low back pain in primary care”. In: Pain Pract 12.1, pp. 1–6.issn: 1530-7085. doi: 10.1111/j.1533-2500.2011.00466.x.

Bazelier, M. T., S. Mueller-Schotte, et al. (2012). “Risk of cataract and glaucomain patients with multiple sclerosis”. In: Mult Scler 18.5, pp. 628–38. issn:1352-4585. doi: 10.1177/1352458511426737.

Bazelier, M. T., T. P. van Staa, et al. (2012). “A simple score for estimating thelong-term risk of fracture in patients with multiple sclerosis”. In: Neurology79.9, pp. 922–8. issn: 0028-3878. doi: 10.1212/WNL.0b013e318266faae.

Berger, A. et al. (2012). “Clinical characteristics and patterns of healthcareutilization in patients with painful neuropathic disorders in UK generalpractice: a retrospective cohort study”. In: BMC Neurol 12, p. 8. issn: 1471-2377. doi: 10.1186/1471-2377-12-8.

Bhaskaran, K. et al. (2012). “Angiotensin receptor blockers and risk of cancer:cohort study among people receiving antihypertensive drugs in UK GeneralPractice Research Database”. In: Bmj 344, e2697. issn: 0959-8138. doi:10.1136/bmj.e2697.

Bhattarai, N. et al. (2012). “Coding, recording and incidence of different formsof coronary heart disease in primary care”. In: PLoS One 7.1, e29776. issn:1932-6203. doi: 10.1371/journal.pone.0029776.

Blumentals, W. A. et al. (2012). “Body mass index and the incidence of influenza-associated pneumonia in a UK primary care cohort”. In: Influenza OtherRespir Viruses 6.1, pp. 28–36. issn: 1750-2640. doi: 10.1111/j.1750-

2659.2011.00262.x.

CPRD bibliography

175

Bodmer, M., C. Becker, S. S. Jick, et al. (2012). “Metformin does not alter therisk of lung cancer: a case-control analysis”. In: Lung Cancer 78.2, pp. 133–7. issn: 0169-5002. doi: 10.1016/j.lungcan.2012.08.010.

Bodmer, M., C. Becker, C. Meier, et al. (2012a). “Use of antidiabetic agents andthe risk of pancreatic cancer: a case-control analysis”. In: Am J Gastroenterol107.4, pp. 620–6. issn: 0002-9270. doi: 10.1038/ajg.2011.483.

— (2012b). “Use of metformin is not associated with a decreased risk of colorec-tal cancer: a case-control analysis”. In: Cancer Epidemiol Biomarkers Prev21.2, pp. 280–6. issn: 1055-9965. doi: 10.1158/1055-9965.epi-11-0992-t.

Boggon, R., S. Eaton, et al. (2012). “Current prescribing of statins and persis-tence to statins following ACS in the UK: a MINAP/GPRD study”. In: BrJ Cardiol 19, p. 24.

Boggon, R., G. Y. Lip, et al. (2012). “Resource utilization and outcomes inpatients with atrial fibrillation: a case control study”. In: Appl Health EconHealth Policy 10.4, pp. 249–59. issn: 1175-5652. doi: 10.2165/11599940-000000000-00000.

Bradley, M. C. et al. (2012). “Proton pump inhibitors and histamine-2-receptorantagonists and pancreatic cancer risk: a nested case-control study”. In: BrJ Cancer 106.1, pp. 233–9. issn: 0007-0920. doi: 10.1038/bjc.2011.511.

Brodovicz, K. G. et al. (2012). “Impact of diabetes duration and chronic pan-creatitis on the association between type 2 diabetes and pancreatic can-cer risk”. In: Diabetes Obes Metab 14.12, pp. 1123–8. issn: 1462-8902. doi:10.1111/j.1463-1326.2012.01667.x.

Cai, B. et al. (2012). “An algorithm to identify medical practices common toboth the General Practice Research Database and The Health ImprovementNetwork database”. In: Pharmacoepidemiol Drug Saf 21.7, pp. 770–774.issn: 1053-8569. doi: 10.1002/pds.3277.

Cardwell, C. R. et al. (2012). “Exposure to oral bisphosphonates and risk ofcancer”. In: Int J Cancer 131.5, E717–25. issn: 0020-7136. doi: 10.1002/ijc.27389.

Charlton, R. et al. (2012). “Colorectal cancer incidence on the General PracticeResearch Database”. In: Pharmacoepidemiol Drug Saf 21.7, pp. 775–783.issn: 1053-8569. doi: 10.1002/pds.3236.

Close, H. et al. (2012). “Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study”. In: BMC Gastroen-terol 12, p. 56. issn: 1471-230x. doi: 10.1186/1471-230x-12-56.

Crooks, C. J., T. R. Card, and J. West (2012). “Defining upper gastrointestinalbleeding from linked primary and secondary care data and the effect onoccurrence and 28 day mortality”. In: BMC Health Serv Res 12, p. 392.issn: 1472-6963. doi: 10.1186/1472-6963-12-392.

Culliford, D. J. et al. (2012). “The lifetime risk of total hip and knee arthro-plasty: results from the UK general practice research database”. In: Os-teoarthritis Cartilage 20.6, pp. 519–24. issn: 1063-4584. doi: 10.1016/j.joca.2012.02.636.

Denaxas, S. C. et al. (2012). “Data resource profile: cardiovascular disease re-search using linked bespoke studies and electronic health records (CAL-IBER)”. In: Int J Epidemiol 41.6, pp. 1625–38. issn: 0300-5771. doi: 10.1093/ije/dys188.

CPRD bibliography

176

Dommett, R. M. et al. (2012). “Features of childhood cancer in primary care: apopulation-based nested case-control study”. In: Br J Cancer 106.5, pp. 982–7. issn: 0007-0920. doi: 10.1038/bjc.2011.600.

Douglas, I. J. et al. (2012). “Clopidogrel and interaction with proton pumpinhibitors: comparison between cohort and within person study designs”. In:Bmj 345, e4388. issn: 0959-8138. doi: 10.1136/bmj.e4388.

Dregan, A., H. Moller, et al. (2012). “Validity of cancer diagnosis in a pri-mary care database compared with linked cancer registrations in England.Population-based cohort study”. In: Cancer Epidemiol 36.5, pp. 425–9. issn:1877-7821. doi: 10.1016/j.canep.2012.05.013.

Dregan, A., T. Van Staa, et al. (2012). “Cluster randomized trial in the generalpractice research database: 2. Secondary prevention after first stroke (eCRTstudy): study protocol for a randomized controlled trial”. In: Trials 13,p. 181. issn: 1745-6215. doi: 10.1186/1745-6215-13-181.

Edwards, C. J. et al. (2012). “Regional and temporal variation in the treatmentof rheumatoid arthritis across the UK: a descriptive register-based cohortstudy”. In: BMJ Open 2.6. issn: 2044-6055. doi: 10.1136/bmjopen-2012-001603.

Ernst, P. et al. (2012). “Pramipexole use and the risk of pneumonia”. In: BMCNeurol 12, p. 113. issn: 1471-2377. doi: 10.1186/1471-2377-12-113.

Fleming, K. M. et al. (2012). “All-cause mortality in people with cirrhosiscompared with the general population: a population-based cohort study”.In: Liver Int 32.1, pp. 79–84. issn: 1478-3223. doi: 10.1111/j.1478-

3231.2011.02517.x.Forbes, H. J. et al. (2012). “Prescription of antiviral therapy after herpes zoster

in general practice: who receives therapy?” In: Br J Gen Pract 62.605, e808–14. issn: 0960-1643. doi: 10.3399/bjgp12X659277.

Gallagher, A. M. et al. (2012). “Quality of INR control and outcomes followingvenous thromboembolism”. In: Clin Appl Thromb Hemost 18.4, pp. 370–8.issn: 1076-0296. doi: 10.1177/1076029611426139.

Girman, C. J. et al. (2012). “Risk of acute renal failure in patients with Type2 diabetes mellitus”. In: Diabet Med 29.5, pp. 614–21. issn: 0742-3071. doi:10.1111/j.1464-5491.2011.03498.x.

Green, J. et al. (2012). “Menopausal hormone therapy and risk of gastroin-testinal cancer: nested case-control study within a prospective cohort, andmeta-analysis”. In: Int J Cancer 130.10, pp. 2387–96. issn: 0020-7136. doi:10.1002/ijc.26236.

Hawkins, N. M. et al. (2012). “Community care in England: reducing socioeco-nomic inequalities in heart failure”. In: Circulation 126.9, pp. 1050–7. issn:0009-7322. doi: 10.1161/circulationaha.111.088047.

Hernandez, R. K. et al. (2012). “Patient-related risk factors for fracture-healingcomplications in the United Kingdom General Practice Research Database”.In: Acta Orthop 83.6, pp. 653–60. issn: 1745-3674. doi: 10.3109/17453674.2012.747054.

Hesdorffer, D. C. et al. (2012). “Epilepsy, suicidality, and psychiatric disorders: abidirectional association”. In: Ann Neurol 72.2, pp. 184–91. issn: 0364-5134.doi: 10.1002/ana.23601.

Higginson, I. J. and W. Gao (2012). “Opioid prescribing for cancer pain duringthe last 3 months of life: associated factors and 9-year trends in a nationwide

CPRD bibliography

177

United Kingdom cohort study”. In: J Clin Oncol 30.35, pp. 4373–9. issn:0732-183x. doi: 10.1200/jco.2012.42.0919.

Hirji, I., S. W. Andersson, et al. (2012). “Incidence of genital infection among pa-tients with type 2 diabetes in the UK General Practice Research Database”.In: J Diabetes Complications 26.6, pp. 501–5. issn: 1056-8727. doi: 10.1016/j.jdiacomp.2012.06.012.

Hirji, I., Z. Guo, et al. (2012). “Incidence of urinary tract infection amongpatients with type 2 diabetes in the UK General Practice Research Database(GPRD)”. In: J Diabetes Complications 26.6, pp. 513–6. issn: 1056-8727.doi: 10.1016/j.jdiacomp.2012.06.008.

Hirst, C. J., C. Cabrera, and M. Kirby (2012). “Epidemiology of castrationresistant prostate cancer: a longitudinal analysis using a UK primary caredatabase”. In: Cancer Epidemiol 36.6, e349–53. issn: 1877-7821. doi: 10.1016/j.canep.2012.07.012.

Hodgkinson, J. A., C. J. Taylor, and F. D. Hobbs (2012). “Treatment pathwaysfor patients with atrial fibrillation”. In: Int J Clin Pract 66.1, pp. 44–52.issn: 1368-5031. doi: 10.1111/j.1742-1241.2011.02818.x.

Humes, D. J. and J. West (2012). “Role of acute diverticulitis in the develop-ment of complicated colonic diverticular disease and 1-year mortality afterdiagnosis in the UK: population-based cohort study”. In: Gut 61.1, pp. 95–100. issn: 0017-5749. doi: 10.1136/gut.2011.238808.

Imfeld, P. et al. (2012). “Metformin, other antidiabetic drugs, and risk of Alzheimer’sdisease: a population-based case-control study”. In: J Am Geriatr Soc 60.5,pp. 916–21. issn: 0002-8614. doi: 10.1111/j.1532-5415.2012.03916.x.

Irizarry, M. C. et al. (2012). “Risk of cancer in patients exposed to gabapentinin two electronic medical record systems”. In: Pharmacoepidemiol Drug Saf21.2, pp. 214–25. issn: 1053-8569. doi: 10.1002/pds.2266.

Jick, H. et al. (2012). “Comparison of prescription drug costs in the UnitedStates and the United Kingdom, part 2: proton pump inhibitors”. In: Phar-macotherapy 32.6, pp. 489–92. issn: 0277-0008. doi: 10.1002/j.1875-

9114.2012.01111.x.Jick, S. and D. Pennap (2012). “Drospirenone- and levonorgestrel-containing

oral contraceptives and the risk of gallbladder disease”. In: Contraception86.3, pp. 220–3. issn: 0010-7824. doi: 10.1016/j.contraception.2012.01.006.

Jong, H. J. de et al. (2012). “Use of statins is associated with an increased risk ofrheumatoid arthritis”. In: Ann Rheum Dis 71.5, pp. 648–54. issn: 0003-4967.doi: 10.1136/ard.2011.155622.

Khashan, A. S. et al. (2012). “Increased risk of miscarriage and ectopic preg-nancy among women with irritable bowel syndrome”. In: Clin GastroenterolHepatol 10.8, pp. 902–9. issn: 1542-3565. doi: 10.1016/j.cgh.2012.02.014.

Kulik, M. C. et al. (2012). “Comparison of tobacco control scenarios: quantifyingestimates of long-term health impact using the DYNAMO-HIA modelingtool”. In: PLoS One 7.2, e32363. issn: 1932-6203. doi: 10.1371/journal.pone.0032363.

Lalmohamed, A., M. T. Bazelier, et al. (2012). “Causes of death in patientswith multiple sclerosis and matched referent subjects: a population-basedcohort study”. In: Eur J Neurol 19.7, pp. 1007–14. issn: 1351-5101. doi:10.1111/j.1468-1331.2012.03668.x.

CPRD bibliography

178

Lalmohamed, A., F. de Vries, et al. (2012). “Risk of fracture after bariatricsurgery in the United Kingdom: population based, retrospective cohort study”.In: Bmj 345, e5085. issn: 0959-8138. doi: 10.1136/bmj.e5085.

Langan, S. M. et al. (2012). “Incidence, mortality, and disease associationsof pyoderma gangrenosum in the United Kingdom: a retrospective cohortstudy”. In: J Invest Dermatol 132.9, pp. 2166–70. issn: 0022-202x. doi:10.1038/jid.2012.130.

Le Ray, I. et al. (2012). “Local estrogen therapy and risk of breast cancerrecurrence among hormone-treated patients: a nested case-control study”.In: Breast Cancer Res Treat 135.2, pp. 603–9. issn: 0167-6806. doi: 10.

1007/s10549-012-2198-y.Lee, S. et al. (2012). “Representativeness of the dabigatran, apixaban and ri-

varoxaban clinical trial populations to real-world atrial fibrillation patientsin the United Kingdom: a cross-sectional analysis using the General Prac-tice Research Database”. In: BMJ Open 2.6. issn: 2044-6055. doi: 10.1136/bmjopen-2012-001768.

Leonard, C. E. et al. (2012). “Proton pump inhibitors and traditional nons-teroidal anti-inflammatory drugs and the risk of acute interstitial nephritisand acute kidney injury”. In: Pharmacoepidemiol Drug Saf 21.11, pp. 1155–72. issn: 1053-8569. doi: 10.1002/pds.3329.

Lhachimi, S. K., K. J. Cole, et al. (2012). “Health impacts of increasing alcoholprices in the European Union: a dynamic projection”. In: Prev Med 55.3,pp. 237–43. issn: 0091-7435. doi: 10.1016/j.ypmed.2012.06.006.

Lhachimi, S. K., W. J. Nusselder, et al. (2012). “DYNAMO-HIA–a DynamicModeling tool for generic Health Impact Assessments”. In: PLoS One 7.5,e33317. issn: 1932-6203. doi: 10.1371/journal.pone.0033317.

Li, H. et al. (2012). “Comorbidities and Concomitant Medication Use in Menwith Prostate Cancer or High Levels of PSA Compared to Matched Controls:A GPRD Analysis”. In: J Cancer Epidemiol 2012, p. 291704. issn: 1687-8558. doi: 10.1155/2012/291704.

Li, L. et al. (2012). “Persistence with osteoporosis medications among post-menopausal women in the UK General Practice Research Database”. In:Menopause 19.1, pp. 33–40. issn: 1072-3714. doi: 10.1097/gme.0b013e318221bacd.

Lo Re, V 3rd. et al. (2012). “Safety of saxagliptin: rationale for and design of aseries of postmarketing observational studies”. In: Pharmacoepidemiol DrugSaf 21.11, pp. 1202–15. issn: 1053-8569. doi: 10.1002/pds.3318.

Mackenzie, I. S. et al. (2012). “Spironolactone and risk of incident breast cancerin women older than 55 years: retrospective, matched cohort study”. In: Bmj345, e4447. issn: 0959-8138. doi: 10.1136/bmj.e4447.

Moor, C. de et al. (2012). “A retrospective comparison of acute rhinosinusitisoutcomes in patients prescribed antibiotics, mometasone furoate nasal spray,or both”. In: Am J Rhinol Allergy 26.4, pp. 308–14. issn: 1945-8932. doi:10.2500/ajra.2012.26.3781.

Morgan, C. L., S. Jenkins-Jones, C. J. Currie, et al. (2012). “Evaluation ofadverse outcome in young women with polycystic ovary syndrome versusmatched, reference controls: a retrospective, observational study”. In: J ClinEndocrinol Metab 97.9, pp. 3251–60. issn: 0021-972x. doi: 10.1210/jc.2012-1690.

Morgan, C. L., S. Jenkins-Jones, M. Evans, et al. (2012). “Weight change inpeople with type 2 diabetes: secular trends and the impact of alternative

CPRD bibliography

179

antihyperglycaemic drugs”. In: Diabetes Obes Metab 14.5, pp. 424–32. issn:1462-8902. doi: 10.1111/j.1463-1326.2011.01552.x.

Morgan, C. L., C. D. Poole, et al. (2012). “What next after metformin? A retro-spective evaluation of the outcome of second-line, glucose-lowering therapiesin people with type 2 diabetes”. In: J Clin Endocrinol Metab 97.12, pp. 4605–12. issn: 0021-972x. doi: 10.1210/jc.2012-3034.

Mullerova, H. et al. (2012). “The natural history of community-acquired pneu-monia in COPD patients: a population database analysis”. In: Respir Med106.8, pp. 1124–33. issn: 0954-6111. doi: 10.1016/j.rmed.2012.04.008.

Nicholas, J. M. et al. (2012). “Trends in antiepileptic drug utilisation in UKprimary care 1993-2008: cohort study using the General Practice ResearchDatabase”. In: Seizure 21.6, pp. 466–70. issn: 1059-1311. doi: 10.1016/j.seizure.2012.04.014.

Page, L. A. et al. (2012). “Temperature-related deaths in people with psychosis,dementia and substance misuse”. In: Br J Psychiatry 200.6, pp. 485–90.issn: 0007-1250. doi: 10.1192/bjp.bp.111.100404.

Perry, D. C. et al. (2012a). “Comorbidities in Perthes’ disease: a case controlstudy using the General Practice Research database”. In: J Bone Joint SurgBr 94.12, pp. 1684–9. issn: 0301-620x. doi: 10.1302/0301-620x.94b12.29974.

— (2012b). “Legg-Calve-Perthes disease in the UK: geographic and temporaltrends in incidence reflecting differences in degree of deprivation in child-hood”. In: Arthritis Rheum 64.5, pp. 1673–9. issn: 0004-3591. doi: 10 .

1002/art.34316.Pitman, R. J., L. J. White, and M. Sculpher (2012). “Estimating the clinical im-

pact of introducing paediatric influenza vaccination in England and Wales”.In: Vaccine 30.6, pp. 1208–24. issn: 0264-410x. doi: 10.1016/j.vaccine.2011.11.106.

Platt, R. W., J. A. Delaney, and S. Suissa (2012). “The positivity assumptionand marginal structural models: the example of warfarin use and risk ofbleeding”. In: Eur J Epidemiol 27.2, pp. 77–83. issn: 0393-2990. doi: 10.1007/s10654-011-9637-7.

Redaniel, M. T. et al. (2012). “Associations of type 2 diabetes and diabetestreatment with breast cancer risk and mortality: a population-based cohortstudy among British women”. In: Cancer Causes Control 23.11, pp. 1785–95. issn: 0957-5243. doi: 10.1007/s10552-012-0057-0.

Renoux, C. et al. (2012). “Dopamine agonist use and the risk of heart failure”.In: Pharmacoepidemiol Drug Saf 21.1, pp. 34–41. issn: 1053-8569. doi: 10.1002/pds.2267.

Sammon, C. J. et al. (2012). “Factors associated with uptake of seasonal andpandemic influenza vaccine among clinical risk groups in the UK: an analysisusing the General Practice Research Database”. In: Vaccine 30.14, pp. 2483–9. issn: 0264-410x. doi: 10.1016/j.vaccine.2011.11.077.

Saragoussi, D. et al. (2012). “Antidepressant switching patterns in the treatmentof major depressive disorder: a General Practice Research Database (GPRD)Study”. In: Int J Clin Pract 66.11, pp. 1079–87. issn: 1368-5031. doi: 10.1111/j.1742-1241.2012.03015.x.

Shah, A. D., C. Martinez, and H. Hemingway (2012). “The freetext matchingalgorithm: a computer program to extract diagnoses and causes of death

CPRD bibliography

180

from unstructured text in electronic health records”. In: BMC Med InformDecis Mak 12, p. 88. issn: 1472-6947. doi: 10.1186/1472-6947-12-88.

Shephard, E. A. et al. (2012). “Clinical features of bladder cancer in primarycare”. In: Br J Gen Pract 62.602, e598–604. issn: 0960-1643. doi: 10.3399/bjgp12X654560.

Shi, N., Z. Cao, et al. (2012). “Healthcare utilization among patients withdepression before and after initiating duloxetine in the United Kingdom”.In: J Med Econ 15.4, pp. 672–80. issn: 1369-6998. doi: 10.3111/13696998.2012.672941.

Shi, N., E. Durden, et al. (2012). “Predictors of Treatment with Duloxetineor Venlafaxine XR among Adult Patients Treated for Depression in Pri-mary Care Practices in the United Kingdom”. In: Depress Res Treat 2012,p. 815363. issn: 2090-1321. doi: 10.1155/2012/815363.

Simkiss, D. E. et al. (2012). “Health service use in families where childrenenter public care: a nested case control study using the General PracticeResearch Database”. In: BMC Health Serv Res 12, p. 65. issn: 1472-6963.doi: 10.1186/1472-6963-12-65.

Singh, G. et al. (2012). “Cancer risk in people with epilepsy using valproate-sodium”. In: Acta Neurol Scand 125.4, pp. 234–40. issn: 0001-6314. doi:10.1111/j.1600-0404.2011.01607.x.

Spoendlin, J. et al. (2012). “A study on the epidemiology of rosacea in the U.K”.In: Br J Dermatol 167.3, pp. 598–605. issn: 0007-0963. doi: 10.1111/j.1365-2133.2012.11037.x.

Staa, T. P. van, D. Patel, et al. (2012). “Glucose-lowering agents and the pat-terns of risk for cancer: a study with the General Practice Research Databaseand secondary care data”. In: Diabetologia 55.3, pp. 654–65. issn: 0012-186x.doi: 10.1007/s00125-011-2390-3.

Staa, T. P., B. Goldacre, et al. (2012). “Pragmatic randomised trials usingroutine electronic health records: putting them to the test”. In: Bmj 344,e55. issn: 0959-8138. doi: 10.1136/bmj.e55.

Stapley, S. et al. (2012). “The risk of pancreatic cancer in symptomatic patientsin primary care: a large case-control study using electronic records”. In: BrJ Cancer 106.12, pp. 1940–4. issn: 0007-0920. doi: 10.1038/bjc.2012.190.

Suissa, D. et al. (2012). “Non-steroidal anti-inflammatory drugs and the riskof Clostridium difficile-associated disease”. In: Br J Clin Pharmacol 74.2,pp. 370–5. issn: 0306-5251. doi: 10.1111/j.1365-2125.2012.04191.x.

Taylor, A., S. Stapley, and W. Hamilton (2012). “Jaundice in primary care: acohort study of adults aged ¿45 years using electronic medical records”. In:Fam Pract 29.4, pp. 416–20. issn: 0263-2136. doi: 10.1093/fampra/cmr118.

Toovey, S. et al. (2012). “Post-marketing assessment of neuropsychiatric adverseevents in influenza patients treated with oseltamivir: an updated review”.In: Adv Ther 29.10, pp. 826–48. issn: 0741-238x. doi: 10.1007/s12325-012-0050-8.

Vamos, E. P. et al. (2012). “Association of systolic and diastolic blood pressureand all cause mortality in people with newly diagnosed type 2 diabetes:retrospective cohort study”. In: Bmj 345, e5567. issn: 0959-8138. doi: 10.1136/bmj.e5567.

Violato, M. et al. (2012). “Resource use and costs associated with coeliac diseasebefore and after diagnosis in 3,646 cases: results of a UK primary care

CPRD bibliography

181

database analysis”. In: PLoS One 7.7, e41308. issn: 1932-6203. doi: 10.

1371/journal.pone.0041308.Walker, A. J., M. J. Grainge, and T. R. Card (2012). “Aspirin and other non-

steroidal anti-inflammatory drug use and colorectal cancer survival: a cohortstudy”. In: Br J Cancer 107.9, pp. 1602–7. issn: 0007-0920. doi: 10.1038/bjc.2012.427.

Walker, A. J., M. Grainge, et al. (2012). “Survival of glioma and colorectalcancer patients using tricyclic antidepressants post-diagnosis”. In: CancerCauses Control 23.12, pp. 1959–64. issn: 0957-5243. doi: 10.1007/s10552-012-0073-0.

Wang, Z. et al. (2012). “Extracting diagnoses and investigation results fromunstructured text in electronic health records by semi-supervised machinelearning”. In: PLoS One 7.1, e30412. issn: 1932-6203. doi: 10.1371/journal.pone.0030412.

Warren-Gash, C. et al. (2012). “Influenza infection and risk of acute myocardialinfarction in England and Wales: a CALIBER self-controlled case seriesstudy”. In: J Infect Dis 206.11, pp. 1652–9. issn: 0022-1899. doi: 10.1093/infdis/jis597.

Webb, R. T. et al. (2012a). “Risk of self-harm in physically ill patients in UKprimary care”. In: J Psychosom Res 73.2, pp. 92–7. issn: 0022-3999. doi:10.1016/j.jpsychores.2012.05.010.

— (2012b). “Suicide risk in primary care patients with major physical diseases:a case-control study”. In: Arch Gen Psychiatry 69.3, pp. 256–64. issn: 0003-990x. doi: 10.1001/archgenpsychiatry.2011.1561.

Wright, E. et al. (2012). “Bisphosphonates and risk of upper gastrointestinalcancer–a case control study using the General Practice Research Database(GPRD)”. In: PLoS One 7.10, e47616. issn: 1932-6203. doi: 10 . 1371 /

journal.pone.0047616.Zenner, D. et al. (2012). “Risk of tuberculosis in pregnancy: a national, primary

care-based cohort and self-controlled case series study”. In: Am J Respir CritCare Med 185.7, pp. 779–84. issn: 1073-449x. doi: 10.1164/rccm.201106-1083OC.

CPRD bibliography

182

2011

Ackers, R. et al. (2011). “Mortality rates and causes of death in children withepilepsy prescribed antiepileptic drugs: a retrospective cohort study usingthe UK General Practice Research Database”. In: Drug Saf 34.5, pp. 403–13. issn: 0114-5916. doi: 10.2165/11588480-000000000-00000.

Azoulay, L., S. Dell’Aniello, B. Gagnon, et al. (2011). “Metformin and theincidence of prostate cancer in patients with type 2 diabetes”. In: CancerEpidemiol Biomarkers Prev 20.2, pp. 337–44. issn: 1055-9965. doi: 10 .

1158/1055-9965.epi-10-0940.Azoulay, L., S. Dell’Aniello, L. Huiart, et al. (2011). “Concurrent use of tamox-

ifen with CYP2D6 inhibitors and the risk of breast cancer recurrence”. In:Breast Cancer Res Treat 126.3, pp. 695–703. issn: 0167-6806. doi: 10.1007/s10549-010-1162-y.

Azoulay, L., H. Yin, S. Benayoun, et al. (2011). “Androgen-deprivation therapyand the risk of stroke in patients with prostate cancer”. In: Eur Urol 60.6,pp. 1244–50. issn: 0302-2838. doi: 10.1016/j.eururo.2011.08.041.

Azoulay, L., H. Yin, C. Renoux, et al. (2011). “The use of atypical antipsychoticsand the risk of breast cancer”. In: Breast Cancer Res Treat 129.2, pp. 541–8.issn: 0167-6806. doi: 10.1007/s10549-011-1506-2.

Bazelier, M. T. et al. (2011). “The risk of fracture in patients with multiplesclerosis: the UK general practice research database”. In: J Bone Miner Res26.9, pp. 2271–9. issn: 0884-0431. doi: 10.1002/jbmr.418.

Becker, C., G. P. Brobert, et al. (2011). “Risk of incident depression in patientswith Parkinson disease in the UK”. In: Eur J Neurol 18.3, pp. 448–53. issn:1351-5101. doi: 10.1111/j.1468-1331.2010.03176.x.

Becker, C., S. S. Jick, and C. R. Meier (2011). “NSAID use and risk of Parkinsondisease: a population-based case-control study”. In: Eur J Neurol 18.11,pp. 1336–42. issn: 1351-5101. doi: 10.1111/j.1468-1331.2011.03399.x.

Bennett, D. et al. (2011). “Prevalence of diagnosed adult immune thrombocy-topenia in the United Kingdom”. In: Adv Ther 28.12, pp. 1096–104. issn:0741-238x. doi: 10.1007/s12325-011-0084-3.

Bodmer, M., C. Becker, et al. (2011). “Use of metformin and the risk of ovariancancer: a case-control analysis”. In: Gynecol Oncol 123.2, pp. 200–4. issn:0090-8258. doi: 10.1016/j.ygyno.2011.06.038.

Bodmer, M., Y. B. Brauchli, et al. (2011). “Diabetes mellitus and the risk ofcholecystectomy”. In: Dig Liver Dis 43.9, pp. 742–7. issn: 1590-8658. doi:10.1016/j.dld.2011.04.014.

Boggon, R. et al. (2011). “Clopidogrel discontinuation after acute coronary syn-dromes: frequency, predictors and associations with death and myocardialinfarction–a hospital registry-primary care linked cohort (MINAP-GPRD)”.In: Eur Heart J 32.19, pp. 2376–86. issn: 0195-668x. doi: 10.1093/eurheartj/ehr340.

Bolland, B. J. et al. (2011). “The effect of hip and knee arthroplasty on oral anti-inflammatory use and the relationship to body mass index: results from theUK general practice research database”. In: Osteoarthritis Cartilage 19.1,pp. 29–36. issn: 1063-4584. doi: 10.1016/j.joca.2010.10.012.

CPRD bibliography

183

Brauchli, Y. B., S. S. Jick, and C. R. Meier (2011). “Statin use and risk of first-time psoriasis diagnosis”. In: J Am Acad Dermatol 65.1, pp. 77–83. issn:0190-9622. doi: 10.1016/j.jaad.2010.05.039.

Byford, S. et al. (2011). “Impact of treatment success on health service use andcost in depression: longitudinal database analysis”. In: Pharmacoeconomics29.2, pp. 157–70. issn: 1170-7690. doi: 10.2165/11537360- 000000000-00000.

Charlton, R. A. et al. (2011). “Comparing the General Practice Research Databaseand the UK Epilepsy and Pregnancy Register as tools for postmarketing ter-atogen surveillance: anticonvulsants and the risk of major congenital mal-formations”. In: Drug Saf 34.2, pp. 157–71. issn: 0114-5916. doi: 10.2165/11584970-000000000-00000.

Chen, Y. C. et al. (2011). “Academic impact of a public electronic healthdatabase: bibliometric analysis of studies using the general practice researchdatabase”. In: PLoS One 6.6, e21404. issn: 1932-6203. doi: 10 . 1371 /

journal.pone.0021404.Chi, C. C., G. Kirtschig, et al. (2011). “Evidence-based (S3) guideline on topical

corticosteroids in pregnancy”. In: Br J Dermatol 165.5, pp. 943–52. issn:0007-0963. doi: 10.1111/j.1365-2133.2011.10513.x.

Chi, C. C., R. T. Mayon-White, and F. T. Wojnarowska (2011). “Safety oftopical corticosteroids in pregnancy: a population-based cohort study”. In:J Invest Dermatol 131.4, pp. 884–91. issn: 0022-202x. doi: 10.1038/jid.2010.392.

Davies, N. M. et al. (2011). “Associations of anti-hypertensive treatments withAlzheimer’s disease, vascular dementia, and other dementias”. In: J AlzheimersDis 26.4, pp. 699–708. issn: 1387-2877. doi: 10.3233/jad-2011-110347.

De Natale, R., C. Le Pen, and G. Berdeaux (2011). “Efficiency of glaucoma drugregulation in 5 European countries: a 1995-2006 longitudinal prescriptionanalysis”. In: J Glaucoma 20.4, pp. 234–9. issn: 1057-0829.

Desai, S. et al. (2011). “Genital warts and cost of care in England”. In: SexTransm Infect 87.6, pp. 464–8. issn: 1368-4973. doi: 10.1136/sti.2010.048421.

DiSantostefano, R. L. and K. J. Davis (2011). “Prescription patterns in asthmapatients initiating salmeterol in UK general practice: a retrospective cohortstudy using the General Practice Research Database (GPRD)”. In: Drug Saf34.6, pp. 511–20. issn: 0114-5916. doi: 10.2165/11587370- 000000000-00000.

Dixon, W. G. and D. H. Solomon (2011). “Bisphosphonates and esophagealcancer–a pathway through the confusion”. In: Nat Rev Rheumatol 7.6, pp. 369–72. issn: 1759-4790. doi: 10.1038/nrrheum.2011.60.

Douglas, I., L. Smeeth, and D. Irvine (2011). “The use of antidepressants andthe risk of haemorrhagic stroke: a nested case control study”. In: Br J ClinPharmacol 71.1, pp. 116–20. issn: 0306-5251. doi: 10.1111/j.1365-2125.2010.03797.x.

Dregan, A., A. Grieve, et al. (2011). “Potential application of item-responsetheory to interpretation of medical codes in electronic patient records”. In:BMC Med Res Methodol 11, p. 168. issn: 1471-2288. doi: 10.1186/1471-2288-11-168.

CPRD bibliography

184

Dregan, A., M. A. Toschke, et al. (2011). “Utility of electronic patient records inprimary care for stroke secondary prevention trials”. In: BMC Public Health11, p. 86. issn: 1471-2458. doi: 10.1186/1471-2458-11-86.

Ernst, P. et al. (2011). “Risk of herpes zoster in patients prescribed inhaledcorticosteroids: a cohort study”. In: BMC Pulm Med 11, p. 59. issn: 1471-2466. doi: 10.1186/1471-2466-11-59.

Filion, K. B. et al. (2011). “Thiazolidinediones and the risk of incident congestiveheart failure among patients with type 2 diabetes mellitus”. In: Pharmacoepi-demiol Drug Saf 20.8, pp. 785–96. issn: 1053-8569. doi: 10.1002/pds.2165.

French, C. E. et al. (2011). “Estimation of the rate of pelvic inflammatorydisease diagnoses: trends in England, 2000-2008”. In: Sex Transm Dis 38.3,pp. 158–62. issn: 0148-5717. doi: 10.1097/OLQ.0b013e3181f22f3e.

Gallagher, A. M., E. Setakis, et al. (2011). “Risks of stroke and mortalityassociated with suboptimal anticoagulation in atrial fibrillation patients”. In:Thromb Haemost 106.5, pp. 968–77. issn: 0340-6245. doi: 10.1160/th11-05-0353.

Gallagher, A. M., L. Smeeth, et al. (2011). “Risk of death and cardiovascularoutcomes with thiazolidinediones: a study with the general practice researchdatabase and secondary care data”. In: PLoS One 6.12, e28157. issn: 1932-6203. doi: 10.1371/journal.pone.0028157.

Gao, W., M. Gulliford, and I. J. Higginson (2011). “Prescription patterns ofanalgesics in the last 3 months of life: a retrospective analysis of 10202 lungcancer patients”. In: Br J Cancer 104.11, pp. 1704–10. issn: 0007-0920. doi:10.1038/bjc.2011.150.

Gulliford, M. C. et al. (2011). “Cluster randomised trial in the General Prac-tice Research Database: 1. Electronic decision support to reduce antibioticprescribing in primary care (eCRT study)”. In: Trials 12, p. 115. issn: 1745-6215. doi: 10.1186/1745-6215-12-115.

Hammersley, V. et al. (2011). “Developing and testing search strategies to iden-tify patients with active seasonal allergic rhinitis in general practice”. In:Prim Care Respir J 20.1, pp. 71–4. issn: 1471-4418. doi: 10.4104/pcrj.2010.00086.

Herrett, E. L., S. L. Thomas, and L. Smeeth (2011). “Validity of diagnoses in thegeneral practice research database”. In: Br J Gen Pract 61.588, pp. 438–9.issn: 0960-1643. doi: 10.3399/bjgp11X583092.

Hodgkinson, J. A., C. J. Taylor, and F. D. Hobbs (2011). “Predictors of incidentatrial fibrillation and influence of medications: a retrospective case-controlstudy”. In: Br J Gen Pract 61.587, e353–61. issn: 0960-1643. doi: 10.3399/bjgp11X578034.

Huerta, C. et al. (2011). “Risk factors for intestinal ischaemia among patientsregistered in a UK primary care database: a nested case-control study”. In:Aliment Pharmacol Ther 33.8, pp. 969–78. issn: 0269-2813. doi: 10.1111/j.1365-2036.2011.04614.x.

Huiart, L., S. Dell’Aniello, and S. Suissa (2011). “Use of tamoxifen and aro-matase inhibitors in a large population-based cohort of women with breastcancer”. In: Br J Cancer 104.10, pp. 1558–63. issn: 0007-0920. doi: 10.1038/bjc.2011.140.

Humes, D. J. et al. (2011). “Concurrent drug use and the risk of perforatedcolonic diverticular disease: a population-based case-control study”. In: Gut60.2, pp. 219–24. issn: 0017-5749. doi: 10.1136/gut.2010.217281.

CPRD bibliography

185

Imkampe, A. K. and M. C. Gulliford (2011). “Trends in Type 1 diabetes inci-dence in the UK in 0- to 14-year-olds and in 15- to 34-year-olds, 1991-2008”.In: Diabet Med 28.7, pp. 811–4. issn: 0742-3071. doi: 10.1111/j.1464-5491.2011.03288.x.

Jordan, R. E., R. J. Lancashire, and P. Adab (2011). “An evaluation of Birming-ham Own Health telephone care management service among patients withpoorly controlled diabetes. A retrospective comparison with the GeneralPractice Research Database”. In: BMC Public Health 11, p. 707. issn: 1471-2458. doi: 10.1186/1471-2458-11-707.

Julious, S. A. et al. (2011). “Seasonality of medical contacts in school-agedchildren with asthma: association with school holidays”. In: Public Health125.11, pp. 769–76. issn: 0033-3506. doi: 10.1016/j.puhe.2011.08.005.

Kelly, F. et al. (2011). “The London low emission zone baseline study”. In: ResRep Health Eff Inst 163, pp. 3–79. issn: 1041-5505 (Print) 1041-5505.

Khan, N. F., D. Mant, et al. (2011). “Long-term health outcomes in a Britishcohort of breast, colorectal and prostate cancer survivors: a database study”.In: Br J Cancer 105 Suppl 1, S29–37. issn: 0007-0920. doi: 10.1038/bjc.2011.420.

Khan, N. F., E. Watson, and P. W. Rose (2011). “Primary care consultationbehaviours of long-term, adult survivors of cancer in the UK”. In: Br J GenPract 61.584, pp. 197–9. issn: 0960-1643. doi: 10.3399/bjgp11X561195.

Lafuma, A. et al. (2011). “Treatment persistence and cost-effectiveness of latanoprost/latanoprost-timolol, bimatoprost/bimatoprost-timolol, and travoprost/travoprost-timololin glaucoma: an analysis based on the United Kingdom general practitionerresearch database”. In: Clin Ophthalmol 5, pp. 361–7. issn: 1177-5467. doi:10.2147/opth.s16888.

Langan, S. M., R. W. Groves, and J. West (2011). “The relationship betweenneurological disease and bullous pemphigoid: a population-based case-controlstudy”. In: J Invest Dermatol 131.3, pp. 631–6. issn: 0022-202x. doi: 10.1038/jid.2010.357.

Laredo, L. et al. (2011). “Risk of cerebrovascular accident associated with useof antipsychotics: population-based case-control study”. In: J Am GeriatrSoc 59.7, pp. 1182–7. issn: 0002-8614. doi: 10.1111/j.1532-5415.2011.03479.x.

Lee, S., A. C. Shafe, and M. R. Cowie (2011). “UK stroke incidence, mortalityand cardiovascular risk management 1999-2008: time-trend analysis fromthe General Practice Research Database”. In: BMJ Open 1.2, e000269. issn:2044-6055. doi: 10.1136/bmjopen-2011-000269.

Luqmani, R. et al. (2011). “Mortality in Wegener’s granulomatosis: a bimodalpattern”. In: Rheumatology (Oxford) 50.4, pp. 697–702. issn: 1462-0324. doi:10.1093/rheumatology/keq351.

Martin-Merino, E. et al. (2011). “Androgen deprivation therapy and the risk ofcoronary heart disease and heart failure in patients with prostate cancer: anested case-control study in UK primary care”. In: Drug Saf 34.11, pp. 1061–77. issn: 0114-5916. doi: 10.2165/11594540-000000000-00000.

Mehta, N. N. et al. (2011). “Attributable risk estimate of severe psoriasis onmajor cardiovascular events”. In: Am J Med 124.8, 775.e1–6. issn: 0002-9343. doi: 10.1016/j.amjmed.2011.03.028.

Miller, D. P. et al. (2011). “Long-term use of fluticasone propionate/salmeterolfixed-dose combination and incidence of cataracts and glaucoma among

CPRD bibliography

186

chronic obstructive pulmonary disease patients in the UK General PracticeResearch Database”. In: Int J Chron Obstruct Pulmon Dis 6, pp. 467–76.issn: 1176-9106. doi: 10.2147/copd.s14247.

Osterman, M. T. et al. (2011). “No increased risk of myocardial infarction amongpatients with ulcerative colitis or Crohn’s disease”. In: Clin GastroenterolHepatol 9.10, pp. 875–80. issn: 1542-3565. doi: 10.1016/j.cgh.2011.06.032.

Parkin, L., K. W. Hagberg, and H. Jick (2011). “Comprehensive comparison ofdrug prescribing in the United States and United Kingdom”. In: Pharma-cotherapy 31.7, pp. 623–9. issn: 0277-0008. doi: 10.1592/phco.31.7.623.

Parkin, L., K. Sharples, et al. (2011). “Risk of venous thromboembolism in usersof oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database”. In: Bmj342, p. d2139. issn: 0959-8138. doi: 10.1136/bmj.d2139.

Patch, C. et al. (2011). “Use of antihypertensive medications and mortality ofpatients with autosomal dominant polycystic kidney disease: a population-based study”. In: Am J Kidney Dis 57.6, pp. 856–62. issn: 0272-6386. doi:10.1053/j.ajkd.2011.01.023.

Price, D. et al. (2011). “Effectiveness of inhaler types for real-world asthma man-agement: retrospective observational study using the GPRD”. In: J AsthmaAllergy 4, pp. 37–47. issn: 1178-6965. doi: 10.2147/jaa.s17709.

Prieto-Alhambra, D., M. K. Javaid, A. Judge, J. Maskell, et al. (2011). “Fracturerisk before and after total hip replacement in patients with osteoarthritis:potential benefits of bisphosphonate use”. In: Arthritis Rheum 63.4, pp. 992–1001. issn: 0004-3591. doi: 10.1002/art.30214.

Prieto-Alhambra, D., M. K. Javaid, A. Judge, D. Murray, et al. (2011). “As-sociation between bisphosphonate use and implant survival after primarytotal arthroplasty of the knee or hip: population based retrospective cohortstudy”. In: Bmj 343, p. d7222. issn: 0959-8138. doi: 10.1136/bmj.d7222.

Prieto-Alhambra, D., M. K. Javaid, J. Maskell, et al. (2011). “Changes in hipfracture rate before and after total knee replacement due to osteoarthritis: apopulation-based cohort study”. In: Ann Rheum Dis 70.1, pp. 134–8. issn:0003-4967. doi: 10.1136/ard.2010.131110.

Punekar, Y. S., A. Ahmad, and H. A. Saleh (2011). “Estimating the effectof nasal steroid treatment on repeat polypectomies: survival time analysisusing the General Practice Research Database”. In: Rhinology 49.2, pp. 190–4. issn: 0300-0729 (Print) 0300-0729. doi: 10.4193/Rhino10.004.

Rani, F. A. et al. (2011). “Mortality in children and adolescents prescribedantipsychotic medication: a retrospective cohort study using the UK generalpractice research database”. In: Drug Saf 34.9, pp. 773–81. issn: 0114-5916.doi: 10.2165/11591120-000000000-00000.

Ridsdale, L. et al. (2011). “Epilepsy mortality and risk factors for death inepilepsy: a population-based study”. In: Br J Gen Pract 61.586, e271–8.issn: 0960-1643. doi: 10.3399/bjgp11X572463.

Rothenbacher, D. et al. (2011). “Frequency and risk factors of gout flares in alarge population-based cohort of incident gout”. In: Rheumatology (Oxford)50.5, pp. 973–81. issn: 1462-0324. doi: 10.1093/rheumatology/keq363.

Salisbury, C. et al. (2011). “Epidemiology and impact of multimorbidity inprimary care: a retrospective cohort study”. In: Br J Gen Pract 61.582,e12–21. issn: 0960-1643. doi: 10.3399/bjgp11X548929.

CPRD bibliography

187

Schneider-Lindner, V. et al. (2011a). “Antibacterial drugs and the risk of community-associated methicillin-resistant Staphylococcus aureus in children”. In: ArchPediatr Adolesc Med 165.12, pp. 1107–14. issn: 1072-4710. doi: 10.1001/archpediatrics.2011.143.

— (2011b). “Secular trends of antibacterial prescribing in UK paediatric pri-mary care”. In: J Antimicrob Chemother 66.2, pp. 424–33. issn: 0305-7453.doi: 10.1093/jac/dkq452.

Shafe, A. C. et al. (2011). “The LUCK study: Laxative Usage in patients withGP-diagnosed Constipation in the UK, within the general population andin pregnancy. An epidemiological study using the General Practice ResearchDatabase (GPRD)”. In: Therap Adv Gastroenterol 4.6, pp. 343–63. issn:1756-283x. doi: 10.1177/1756283x11417483.

Shah, A. D. et al. (2011). “Threshold haemoglobin levels and the prognosis ofstable coronary disease: two new cohorts and a systematic review and meta-analysis”. In: PLoS Med 8.5, e1000439. issn: 1549-1277. doi: 10.1371/

journal.pmed.1000439.Soest, E. M. van et al. (2011). “Suboptimal gastroprotective coverage of NSAID

use and the risk of upper gastrointestinal bleeding and ulcers: an observa-tional study using three European databases”. In: Gut 60.12, pp. 1650–9.issn: 0017-5749. doi: 10.1136/gut.2011.239848.

Staa, T. P. van et al. (2011). “A comparison of risk stratification schemes forstroke in 79,884 atrial fibrillation patients in general practice”. In: J ThrombHaemost 9.1, pp. 39–48. issn: 1538-7836. doi: 10.1111/j.1538- 7836.

2010.04085.x.Stapley, S. and W. Hamilton (2011). “Gynaecological symptoms reported by

young women: examining the potential for earlier diagnosis of cervical can-cer”. In: Fam Pract 28.6, pp. 592–8. issn: 0263-2136. doi: 10.1093/fampra/cmr033.

Stowe, J. et al. (2011). “Risk of convulsions in children after monovalent H1N1(2009) and trivalent influenza vaccines: a database study”. In: Vaccine 29.51,pp. 9467–72. issn: 0264-410x. doi: 10.1016/j.vaccine.2011.10.029.

Suh, D. C. et al. (2011). “Impact of rosiglitazone therapy on the lipid profile,glycemic control, and medication costs among type 2 diabetes patients”.In: Curr Med Res Opin 27.8, pp. 1623–33. issn: 0300-7995. doi: 10.1185/03007995.2011.595001.

Suissa, S. et al. (2011). “Long-term effects of insulin glargine on the risk ofbreast cancer”. In: Diabetologia 54.9, pp. 2254–62. issn: 0012-186x. doi:10.1007/s00125-011-2190-9.

Toovey, S., S. S. Jick, and C. R. Meier (2011). “Parkinson’s disease or Parkinsonsymptoms following seasonal influenza”. In: Influenza Other Respir Viruses5.5, pp. 328–33. issn: 1750-2640. doi: 10.1111/j.1750-2659.2011.00232.x.

Toschke, A. M. et al. (2011). “Antihypertensive treatment after first stroke inprimary care: results from the General Practitioner Research Database”.In: J Hypertens 29.1, pp. 154–60. issn: 0263-6352. doi: 10 . 1097 / HJH .

0b013e32833f3897.Vamos, E. P. et al. (2011). “Association of practice size and pay-for-performance

incentives with the quality of diabetes management in primary care”. In:Cmaj 183.12, E809–16. issn: 0820-3946. doi: 10.1503/cmaj.101187.

CPRD bibliography

188

Varyani, F. K., J. West, and T. R. Card (2011). “An increased risk of urinarytract infection precedes development of primary biliary cirrhosis”. In: BMCGastroenterol 11, p. 95. issn: 1471-230x. doi: 10.1186/1471-230x-11-95.

Walker, A. J., T. Card, et al. (2011). “Tricyclic antidepressants and the incidenceof certain cancers: a study using the GPRD”. In: Br J Cancer 104.1, pp. 193–7. issn: 0007-0920. doi: 10.1038/sj.bjc.6605996.

Walker, A. J., J. West, et al. (2011). “Angiotensin converting enzyme inhibitorsand hepatocellular carcinoma incidence in the General Practice ResearchDatabase”. In: Cancer Causes Control 22.12, pp. 1743–7. issn: 0957-5243.doi: 10.1007/s10552-011-9837-1.

Walker, A. M. (2011). “Identification of esophageal cancer in the General Prac-tice Research Database”. In: Pharmacoepidemiol Drug Saf 20.11, pp. 1159–67. issn: 1053-8569. doi: 10.1002/pds.2249.

Walters, P. et al. (2011). “The relationship between asthma and depression inprimary care patients: a historical cohort and nested case control study”.In: PLoS One 6.6, e20750. issn: 1932-6203. doi: 10.1371/journal.pone.0020750.

Watson, L. et al. (2011). “Weight and glycaemic control in type 2 diabetes:what is the outcome of insulin initiation?” In: Diabetes Obes Metab 13.9,pp. 823–31. issn: 1462-8902. doi: 10.1111/j.1463-1326.2011.01413.x.

CPRD bibliography

189

2010

Abuabara, K. et al. (2010). “Cause-specific mortality in patients with severepsoriasis: a population-based cohort study in the U.K”. In: Br J Dermatol163.3, pp. 586–92. issn: 0007-0963. doi: 10.1111/j.1365- 2133.2010.

09941.x.Alonso, A. et al. (2010). “Association of smoking with amyotrophic lateral

sclerosis risk and survival in men and women: a prospective study”. In: BMCNeurol 10, p. 6. issn: 1471-2377. doi: 10.1186/1471-2377-10-6.

Andersohn, F., R. Schade, et al. (2010). “Use of antiepileptic drugs in epilepsyand the risk of self-harm or suicidal behavior”. In: Neurology 75.4, pp. 335–40. issn: 0028-3878. doi: 10.1212/WNL.0b013e3181ea157e.

Andersohn, F., M. Waring, and E. Garbe (2010). “Risk of ischemic stroke inpatients with Crohn’s disease: a population-based nested case-control study”.In: Inflamm Bowel Dis 16.8, pp. 1387–92. issn: 1078-0998. doi: 10.1002/ibd.21187.

Armstrong, R. G., J. West, and T. R. Card (2010). “Risk of cancer in inflamma-tory bowel disease treated with azathioprine: a UK population-based case-control study”. In: Am J Gastroenterol 105.7, pp. 1604–9. issn: 0002-9270.doi: 10.1038/ajg.2009.745.

Azoulay, L., V. Schneider-Lindner, S. Dell’Aniello, K. B. Filion, et al. (2010).“Thiazolidinediones and the risk of incident strokes in patients with type2 diabetes: a nested case-control study”. In: Pharmacoepidemiol Drug Saf19.4, pp. 343–50. issn: 1053-8569. doi: 10.1002/pds.1883.

Azoulay, L., V. Schneider-Lindner, S. Dell’Aniello, A. Schiffrin, et al. (2010).“Combination therapy with sulfonylureas and metformin and the preventionof death in type 2 diabetes: a nested case-control study”. In: Pharmacoepi-demiol Drug Saf 19.4, pp. 335–42. issn: 1053-8569. doi: 10.1002/pds.1834.

Becker, C., G. P. Brobert, et al. (2010). “Cancer risk in association with Parkin-son disease: a population-based study”. In: Parkinsonism Relat Disord 16.3,pp. 186–90. issn: 1353-8020. doi: 10.1016/j.parkreldis.2009.11.005.

Becker, C., S. S. Jick, and C. R. Meier (2010). “Risk of stroke in patients withidiopathic Parkinson disease”. In: Parkinsonism Relat Disord 16.1, pp. 31–5.issn: 1353-8020. doi: 10.1016/j.parkreldis.2009.06.005.

Bodmer, M. et al. (2010). “Long-term metformin use is associated with de-creased risk of breast cancer”. In: Diabetes Care 33.6, pp. 1304–8. issn:0149-5992. doi: 10.2337/dc09-1791.

Bradley, M. C., C. M. Hughes, M. M. Cantwell, and L. J. Murray (2010).“Statins and pancreatic cancer risk: a nested case-control study”. In: CancerCauses Control 21.12, pp. 2093–100. issn: 0957-5243. doi: 10.1007/s10552-010-9628-0.

Bradley, M. C., C. M. Hughes, M. M. Cantwell, G. Napolitano, et al. (2010).“Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nestedcase-control study”. In: Br J Cancer 102.9, pp. 1415–21. issn: 0007-0920.doi: 10.1038/sj.bjc.6605636.

Breart, G. et al. (2010). “Osteoporosis and venous thromboembolism: a retro-spective cohort study in the UK General Practice Research Database”. In:

1

CPRD bibliography

190

Osteoporos Int 21.7, pp. 1181–7. issn: 0937-941x. doi: 10.1007/s00198-009-1050-7.

Cardwell, C. R. et al. (2010). “Exposure to oral bisphosphonates and risk ofesophageal cancer”. In: Jama 304.6, pp. 657–63. issn: 0098-7484. doi: 10.1001/jama.2010.1098.

Charlton, R. A. et al. (2010). “Identifying major congenital malformations inthe UK General Practice Research Database (GPRD): a study reportingon the sensitivity and added value of photocopied medical records and freetext in the GPRD”. In: Drug Saf 33.9, pp. 741–50. issn: 0114-5916. doi:10.2165/11536820-000000000-00000.

Coleman, J. J. et al. (2010). “Oversight: a retrospective study of biochemicalmonitoring in patients beginning antihypertensive drug treatment in primarycare”. In: Br J Clin Pharmacol 70.1, pp. 109–17. issn: 0306-5251. doi: 10.1111/j.1365-2125.2010.03654.x.

Cooper, C. et al. (2010). “The epidemiology of osteonecrosis: findings from theGPRD and THIN databases in the UK”. In: Osteoporos Int 21.4, pp. 569–77.issn: 0937-941x. doi: 10.1007/s00198-009-1003-1.

Cornish, R. et al. (2010). “Risk of death during and after opiate substitutiontreatment in primary care: prospective observational study in UK GeneralPractice Research Database”. In: Bmj 341, p. c5475. issn: 0959-8138. doi:10.1136/bmj.c5475.

Culliford, D. J. et al. (2010). “Temporal trends in hip and knee replacement inthe United Kingdom: 1991 to 2006”. In: J Bone Joint Surg Br 92.1, pp. 130–5. issn: 0301-620x. doi: 10.1302/0301-620x.92b1.22654.

Currie, C. J. et al. (2010). “Survival as a function of HbA(1c) in people withtype 2 diabetes: a retrospective cohort study”. In: Lancet 375.9713, pp. 481–9. issn: 0140-6736. doi: 10.1016/s0140-6736(09)61969-3.

Devine, S. et al. (2010). “The identification of pregnancies within the generalpractice research database”. In: Pharmacoepidemiol Drug Saf 19.1, pp. 45–50. issn: 1053-8569. doi: 10.1002/pds.1862.

Egbring, M., G. A. Kullak-Ublick, and S. Russmann (2010). “Phynx: an opensource software solution supporting data management and web-based patient-level data review for drug safety studies in the general practice researchdatabase and other health care databases”. In: Pharmacoepidemiol DrugSaf 19.1, pp. 38–44. issn: 1053-8569. doi: 10.1002/pds.1860.

Fleming, K. M. et al. (2010). “The rate of decompensation and clinical progres-sion of disease in people with cirrhosis: a cohort study”. In: Aliment Phar-macol Ther 32.11-12, pp. 1343–50. issn: 0269-2813. doi: 10.1111/j.1365-2036.2010.04473.x.

Frisher, M., D. Short, and J. Bashford (2010). “Determining patient charac-teristics for decision analysis support systems using anonymized electronicpatient records”. In: Health Informatics J 16.1, pp. 49–57. issn: 1460-4582.doi: 10.1177/1460458209353559.

Girman, C. J. et al. (2010). “Patients with type 2 diabetes mellitus have higherrisk for acute pancreatitis compared with those without diabetes”. In: Dia-betes Obes Metab 12.9, pp. 766–71. issn: 1462-8902. doi: 10.1111/j.1463-1326.2010.01231.x.

Green, J. et al. (2010). “Oral bisphosphonates and risk of cancer of oesophagus,stomach, and colorectum: case-control analysis within a UK primary carecohort”. In: Bmj 341, p. c4444. issn: 0959-8138. doi: 10.1136/bmj.c4444.

2

CPRD bibliography

191

Gulliford, M. C. et al. (2010). “Declining 1-year case-fatality of stroke andincreasing coverage of vascular risk management: population-based cohortstudy”. In: J Neurol Neurosurg Psychiatry 81.4, pp. 416–22. issn: 0022-3050.doi: 10.1136/jnnp.2009.193136.

Herrett, E. et al. (2010). “Validation and validity of diagnoses in the GeneralPractice Research Database: a systematic review”. In: Br J Clin Pharmacol69.1, pp. 4–14. issn: 0306-5251. doi: 10.1111/j.1365-2125.2009.03537.x.

Ishihara, L. et al. (2010). “Exploring differential prescribing between anti-epilepticdrugs in epilepsy patients with a history of mood disorders”. In: Pharma-coepidemiol Drug Saf 19.3, pp. 289–95. issn: 1053-8569. doi: 10.1002/pds.1905.

Iversen, L. et al. (2010). “Menopause-related workload in general practice 1996-2005: a retrospective study in the UK”. In: Fam Pract 27.5, pp. 499–506.issn: 0263-2136. doi: 10.1093/fampra/cmq038.

Jick, H. and K. W. Hagberg (2010a). “Effectiveness of influenza vaccination inthe United kingdom, 1996-2007”. In: Pharmacotherapy 30.12, pp. 1199–206.issn: 0277-0008. doi: 10.1592/phco.30.12.1199.

— (2010b). “Measles in the United Kingdom 1990-2008 and the effectivenessof measles vaccines”. In: Vaccine 28.29, pp. 4588–92. issn: 0264-410x. doi:10.1016/j.vaccine.2010.04.084.

Johansson, S. et al. (2010). “Prospective drug safety monitoring using the UKprimary-care General Practice Research Database: theoretical framework,feasibility analysis and extrapolation to future scenarios”. In: Drug Saf 33.3,pp. 223–32. issn: 0114-5916. doi: 10.2165/11319010-000000000-00000.

Jordan, K. P. and P. Croft (2010). “Mortality and cancer in patients with newmusculoskeletal episodes: a cohort study”. In: Br J Gen Pract 60.572, e105–11. issn: 0960-1643. doi: 10.3399/bjgp10X483526.

Khan, N. F., S. E. Harrison, and P. W. Rose (2010). “Validity of diagnos-tic coding within the General Practice Research Database: a systematic re-view”. In: Br J Gen Pract 60.572, e128–36. issn: 0960-1643. doi: 10.3399/bjgp10X483562.

Khan, N. F., D. Mant, and P. W. Rose (2010). “Quality of care for chronicdiseases in a British cohort of long-term cancer survivors”. In: Ann FamMed 8.5, pp. 418–24. issn: 1544-1709. doi: 10.1370/afm.1162.

Khan, N. F., R. Perera, et al. (2010). “Adaptation and validation of the CharlsonIndex for Read/OXMIS coded databases”. In: BMC Fam Pract 11, p. 1. issn:1471-2296. doi: 10.1186/1471-2296-11-1.

Khan, N. F., A. M. Ward, et al. (2010). “Consulting and prescribing behaviourfor anxiety and depression in long-term survivors of cancer in the UK”. In:Eur J Cancer 46.18, pp. 3339–44. issn: 0959-8049. doi: 10.1016/j.ejca.2010.07.035.

Kiri, V. A. et al. (2010). “Recent trends in lung cancer and its association withCOPD: an analysis using the UK GP Research Database”. In: Prim CareRespir J 19.1, pp. 57–61. issn: 1471-4418. doi: 10.4104/pcrj.2009.00048.

Kurd, S. K. et al. (2010). “The risk of depression, anxiety, and suicidality inpatients with psoriasis: a population-based cohort study”. In: Arch Dermatol146.8, pp. 891–5. issn: 0003-987x. doi: 10.1001/archdermatol.2010.186.

MacDonald, M. R. et al. (2010). “Treatment of type 2 diabetes and outcomesin patients with heart failure: a nested case-control study from the U.K.

3

CPRD bibliography

192

hortinr

Highlight

General Practice Research Database”. In: Diabetes Care 33.6, pp. 1213–8.issn: 0149-5992. doi: 10.2337/dc09-2227.

Martinez, C. et al. (2010). “Use of venlafaxine compared with other antidepres-sants and the risk of sudden cardiac death or near death: a nested case-control study”. In: Bmj 340, p. c249. issn: 0959-8138. doi: 10.1136/bmj.c249.

McDowell, S. E. et al. (2010). “Laboratory monitoring and adverse patient out-comes with antihypertensive therapy in primary care”. In: Pharmacoepi-demiol Drug Saf 19.5, pp. 482–9. issn: 1053-8569. doi: 10.1002/pds.1935.

Mehta, N. N. et al. (2010). “Patients with severe psoriasis are at increasedrisk of cardiovascular mortality: cohort study using the General PracticeResearch Database”. In: Eur Heart J 31.8, pp. 1000–6. issn: 0195-668x.doi: 10.1093/eurheartj/ehp567.

Meier, C. et al. (2010). “Use of depot medroxyprogesterone acetate and fracturerisk”. In: J Clin Endocrinol Metab 95.11, pp. 4909–16. issn: 0021-972x. doi:10.1210/jc.2010-0032.

Merriman, N. A. et al. (2010). “Hip fracture risk in patients with a diagnosis ofpernicious anemia”. In: Gastroenterology 138.4, pp. 1330–7. issn: 0016-5085.doi: 10.1053/j.gastro.2009.12.007.

Miller, D. P. et al. (2010). “Long-term use of fluticasone propionate/salmeterolfixed-dose combination and incidence of nonvertebral fractures among pa-tients with COPD in the UK General Practice Research Database”. In:Phys Sportsmed 38.4, pp. 19–27. issn: 0091-3847 (Print) 0091-3847. doi:10.3810/psm.2010.12.1821.

Ng, E., K. M. McGrail, and J. A. Johnson (2010). “Hospitalization risk in a type2 diabetes cohort”. In: Health Rep 21.3, pp. 29–35. issn: 0840-6529 (Print)0840-6529.

Nicholson, A. et al. (2010a). “Management of epididymo-orchitis in primarycare: results from a large UK primary care database”. In: Br J Gen Pract60.579, e407–22. issn: 0960-1643. doi: 10.3399/bjgp10X532413.

— (2010b). “Management of first-episode pelvic inflammatory disease in pri-mary care: results from a large UK primary care database”. In: Br J GenPract 60.579, e395–406. issn: 0960-1643. doi: 10.3399/bjgp10X532404.

Renoux, C., S. Dell’Aniello, E. Garbe, et al. (2010). “Transdermal and oralhormone replacement therapy and the risk of stroke: a nested case-controlstudy”. In: Bmj 340, p. c2519. issn: 0959-8138. doi: 10.1136/bmj.c2519.

Renoux, C., S. Dell’Aniello, and S. Suissa (2010). “Hormone replacement ther-apy and the risk of venous thromboembolism: a population-based study”. In:J Thromb Haemost 8.5, pp. 979–86. issn: 1538-7836. doi: 10.1111/j.1538-7836.2010.03839.x.

Rodriguez, L. A. et al. (2010). “Heart failure, myocardial infarction, lung cancerand death in COPD patients: a UK primary care study”. In: Respir Med104.11, pp. 1691–9. issn: 0954-6111. doi: 10.1016/j.rmed.2010.04.018.

Sarpatwari, A. et al. (2010). “Thromboembolic events among adult patientswith primary immune thrombocytopenia in the United Kingdom GeneralPractice Research Database”. In: Haematologica 95.7, pp. 1167–75. issn:0390-6078. doi: 10.3324/haematol.2009.018390.

Sazonov, V. et al. (2010). “Association between dyslipidemia and vascular eventsin patients treated with statins: report from the UK General Practice Re-

4

CPRD bibliography

193

hortinr

Highlight

search Database”. In: Atherosclerosis 208.1, pp. 210–6. issn: 0021-9150. doi:10.1016/j.atherosclerosis.2009.07.021.

Schaer, B. A. et al. (2010). “Risk for incident atrial fibrillation in patients whoreceive antihypertensive drugs: a nested case-control study”. In: Ann InternMed 152.2, pp. 78–84. issn: 0003-4819. doi: 10.7326/0003-4819-152-2-201001190-00005.

Schneider, C., U. Bothner, et al. (2010). “Chronic obstructive pulmonary diseaseand the risk of cardiovascular diseases”. In: Eur J Epidemiol 25.4, pp. 253–60. issn: 0393-2990. doi: 10.1007/s10654-010-9435-7.

Schneider, C., S. S. Jick, et al. (2010a). “COPD and the risk of depression”. In:Chest 137.2, pp. 341–7. issn: 0012-3692. doi: 10.1378/chest.09-0614.

— (2010b). “Reflux disease, gastrointestinal ulcer or weight loss in patients withCOPD”. In: Copd 7.3, pp. 172–8. issn: 1541-2563. doi: 10.3109/15412555.2010.481698.

Siriwardena, A. N., S. M. Gwini, and C. A. Coupland (2010). “Influenza vac-cination, pneumococcal vaccination and risk of acute myocardial infarction:matched case-control study”. In: Cmaj 182.15, pp. 1617–23. issn: 0820-3946.doi: 10.1503/cmaj.091891.

Tate, A. R., A. Nicholson, and J. A. Cassell (2010). “Are GPs under-investigatingolder patients presenting with symptoms of ovarian cancer? Observationalstudy using General Practice Research Database”. In: Br J Cancer 102.6,pp. 947–51. issn: 0007-0920. doi: 10.1038/sj.bjc.6605593.

Taylor, C. J., J. Hodgkinson, and F. D. Hobbs (2010). “Rhythm control agentsand adverse events in patients with atrial fibrillation”. In: Int J Clin Pract64.8, pp. 1069–75. issn: 1368-5031. doi: 10.1111/j.1742- 1241.2010.

02426.x.Thomas, M. et al. (2010). “Prescribing patterns of asthma controller therapy for

children in UK primary care: a cross-sectional observational study”. In: BMCPulm Med 10, p. 29. issn: 1471-2466. doi: 10.1186/1471-2466-10-29.

Vries, F. de, E. Setakis, and T. P. van Staa (2010). “Concomitant use of ibupro-fen and paracetamol and the risk of major clinical safety outcomes”. In: BrJ Clin Pharmacol 70.3, pp. 429–38. issn: 0306-5251. doi: 10.1111/j.1365-2125.2010.03705.x.

Vries, F. de, E. Setakis, B. Zhang, et al. (2010). “Long-acting beta2-agonists inadult asthma and the pattern of risk of death and severe asthma outcomes: astudy using the GPRD”. In: Eur Respir J 36.3, pp. 494–502. issn: 0903-1936.doi: 10.1183/09031936.00124209.

Wade, A. G. et al. (2010). “Healthcare expenditure in severely depressed patientstreated with escitalopram, generic SSRIs or venlafaxine in the UK”. In:Curr Med Res Opin 26.5, pp. 1161–70. issn: 0300-7995. doi: 10.1185/

03007991003738519.Yong, M. et al. (2010). “Epidemiology of paediatric immune thrombocytope-

nia in the General Practice Research Database”. In: Br J Haematol 149.6,pp. 855–64. issn: 0007-1048. doi: 10.1111/j.1365-2141.2010.08176.x.

5

CPRD bibliography

194

hortinr

Highlight

2009

Ackers, R. et al. (2009). “Changing trends in antiepileptic drug prescribing ingirls of child-bearing potential”. In: Arch Dis Child 94.6, pp. 443–7. issn:0003-9888. doi: 10.1136/adc.2008.144386.

Alonso, A., G. Logroscino, et al. (2009). “Incidence and lifetime risk of motorneuron disease in the United Kingdom: a population-based study”. In: EurJ Neurol 16.6, pp. 745–51. issn: 1351-5101.

Alonso, A., L. A. Rodriguez, et al. (2009). “Use of antidepressants and the risk ofParkinson’s disease: a prospective study”. In: J Neurol Neurosurg Psychiatry80.6, pp. 671–4. issn: 0022-3050. doi: 10.1136/jnnp.2008.152983.

Andersohn, F. et al. (2009). “Long-term use of antidepressants for depressivedisorders and the risk of diabetes mellitus”. In: Am J Psychiatry 166.5,pp. 591–8. issn: 0002-953x. doi: 10.1176/appi.ajp.2008.08071065.

Bernier, M. O. et al. (2009). “Combined oral contraceptive use and the risk ofsystemic lupus erythematosus”. In: Arthritis Rheum 61.4, pp. 476–81. issn:0004-3591 (Print) 0004-3591. doi: 10.1002/art.24398.

Bodmer, M. et al. (2009). “Statin use and risk of gallstone disease followedby cholecystectomy”. In: Jama 302.18, pp. 2001–7. issn: 0098-7484. doi:10.1001/jama.2009.1601.

Brauchli, Y. B., S. S. Jick, F. Curtin, et al. (2009). “Lithium, antipsychotics,and risk of psoriasis”. In: J Clin Psychopharmacol 29.2, pp. 134–40. issn:0271-0749. doi: 10.1097/JCP.0b013e31819a4b7c.

Brauchli, Y. B., S. S. Jick, M. Miret, et al. (2009a). “Psoriasis and risk of incidentcancer: an inception cohort study with a nested case-control analysis”. In: JInvest Dermatol 129.11, pp. 2604–12. issn: 0022-202x. doi: 10.1038/jid.2009.113.

— (2009b). “Psoriasis and risk of incident myocardial infarction, stroke or tran-sient ischaemic attack: an inception cohort study with a nested case-controlanalysis”. In: Br J Dermatol 160.5, pp. 1048–56. issn: 0007-0963. doi: 10.1111/j.1365-2133.2008.09020.x.

Crooks, C. J. et al. (2009). “The epidemiology of haemochromatosis: a population-based study”. In: Aliment Pharmacol Ther 29.2, pp. 183–92. issn: 0269-2813.doi: 10.1111/j.1365-2036.2008.03874.x.

De Natale, R., A. Lafuma, and G. Berdeaux (2009). “Cost effectiveness of travo-prost versus a fixed combination of latanoprost/timolol in patients with ocu-lar hypertension or glaucoma: analysis based on the UK general practitionerresearch database”. In: Clin Drug Investig 29.2, pp. 111–20. issn: 1173-2563(Print) 1173-2563. doi: 10.2165/0044011-200929020-00005.

Delaney, J. A., S. S. Daskalopoulou, and S. Suissa (2009). “Traditional versusmarginal structural models to estimate the effectiveness of beta-blocker useon mortality after myocardial infarction”. In: Pharmacoepidemiol Drug Saf18.1, pp. 1–6. issn: 1053-8569. doi: 10.1002/pds.1676.

Douglas, I. J. et al. (2009). “The risk of fractures associated with thiazolidine-diones: a self-controlled case-series study”. In: PLoS Med 6.9, e1000154. issn:1549-1277. doi: 10.1371/journal.pmed.1000154.

Evans, H. E., C. H. Mercer, et al. (2009). “Trends in HIV testing and recordingof HIV status in the UK primary care setting: a retrospective cohort study

1

CPRD bibliography

195

hortinr

Highlight

1995-2005”. In: Sex Transm Infect 85.7, pp. 520–6. issn: 1368-4973. doi:10.1136/sti.2008.034801.

Evans, H. E., A. Tsourapas, et al. (2009). “Primary care consultations and costsamong HIV-positive individuals in UK primary care 1995-2005: a cohortstudy”. In: Sex Transm Infect 85.7, pp. 543–9. issn: 1368-4973. doi: 10.1136/sti.2009.035865.

Feudjo-Tepie, M. A., S. A. Hall, et al. (2009). “Risk of cataract among idio-pathic thrombocytopenic purpura patients in the UK general practice re-search database”. In: Pharmacoepidemiol Drug Saf 18.5, pp. 380–5. issn:1053-8569. doi: 10.1002/pds.1723.

Feudjo-Tepie, M. A., G. Le Roux, et al. (2009). “Comorbidities of idiopathicthrombocytopenic purpura: a population-based study”. In: Adv Hematol2009, p. 963506. doi: 10.1155/2009/963506.

Filion, K. B. et al. (2009). “Trends in the prescription of anti-diabetic medica-tions in the United Kingdom: a population-based analysis”. In: Pharmacoepi-demiol Drug Saf 18.10, pp. 973–6. issn: 1053-8569. doi: 10.1002/pds.1802.

Flory, J. H. et al. (2009). “Antidiabetic action of bezafibrate in a large observa-tional database”. In: Diabetes Care 32.4, pp. 547–51. issn: 0149-5992. doi:10.2337/dc08-1809.

Frisher, M., I. Crome, et al. (2009). “Assessing the impact of cannabis useon trends in diagnosed schizophrenia in the United Kingdom from 1996 to2005”. In: Schizophr Res 113.2-3, pp. 123–8. issn: 0920-9964. doi: 10.1016/j.schres.2009.05.031.

Frisher, M., O. Martino, et al. (2009). “Trends in drug misuse recorded inprimary care in the UK from 1998 to 2005”. In: J Public Health (Oxf) 31.1,pp. 69–73. issn: 1741-3842. doi: 10.1093/pubmed/fdn081.

Gallagher, A. M., J. Leighton-Scott, and T. P. van Staa (2009). “Utilizationcharacteristics and treatment persistence in patients prescribed low-dosebuprenorphine patches in primary care in the United Kingdom: a retro-spective cohort study”. In: Clin Ther 31.8, pp. 1707–15. issn: 0149-2918.doi: 10.1016/j.clinthera.2009.08.022.

Garcia Rodriguez, L. A. et al. (2009). “Chronic obstructive pulmonary diseasein UK primary care: incidence and risk factors”. In: Copd 6.5, pp. 369–79.issn: 1541-2563.

Gauthier, A. et al. (2009). “Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom”. In: Epidemiol Infect 137.1,pp. 38–47. issn: 0950-2688 (Print) 0950-2688. doi: 10.1017/s0950268808000678.

Gelfand, J. M. et al. (2009). “The risk of stroke in patients with psoriasis”. In:J Invest Dermatol 129.10, pp. 2411–8. issn: 0022-202x. doi: 10.1038/jid.2009.112.

Gribbin, J. et al. (2009). “Incidence and mortality of falls amongst older peoplein primary care in the United Kingdom”. In: Qjm 102.7, pp. 477–83. issn:1460-2393. doi: 10.1093/qjmed/hcp064.

Grosso, A., I. Douglas, A. D. Hingorani, et al. (2009). “Inhaled tiotropiumbromide and risk of stroke”. In: Br J Clin Pharmacol 68.5, pp. 731–6. issn:0306-5251. doi: 10.1111/j.1365-2125.2009.03517.x.

Grosso, A., I. Douglas, A. Hingorani, et al. (2009). “Oral bisphosphonates andrisk of atrial fibrillation and flutter in women: a self-controlled case-seriessafety analysis”. In: PLoS One 4.3, e4720. issn: 1932-6203. doi: 10.1371/journal.pone.0004720.

2

CPRD bibliography

196

Gulliford, M. C. and J. Charlton (2009). “Is relative mortality of type 2 diabetesmellitus decreasing?” In: Am J Epidemiol 169.4, pp. 455–61. issn: 0002-9262.doi: 10.1093/aje/kwn342.

Gulliford, M. C., J. Charlton, et al. (2009). “Selection of medical diagnosticcodes for analysis of electronic patient records. Application to stroke in aprimary care database”. In: PLoS One 4.9, e7168. issn: 1932-6203. doi:10.1371/journal.pone.0007168.

Gulliford, M. et al. (2009). “Selective decrease in consultations and antibioticprescribing for acute respiratory tract infections in UK primary care up to2006”. In: J Public Health (Oxf) 31.4, pp. 512–20. issn: 1741-3842. doi:10.1093/pubmed/fdp081.

Gunnell, D. et al. (2009). “Varenicline and suicidal behaviour: a cohort studybased on data from the General Practice Research Database”. In: Bmj 339,b3805. issn: 0959-8138. doi: 10.1136/bmj.b3805.

Hamilton, W. T. et al. (2009). “Risk markers for both chronic fatigue and irri-table bowel syndromes: a prospective case-control study in primary care”. In:Psychol Med 39.11, pp. 1913–21. issn: 0033-2917. doi: 10.1017/s0033291709005601.

Heckbert, S. R. et al. (2009). “Antihypertensive treatment with ACE inhibitorsor beta-blockers and risk of incident atrial fibrillation in a general hyper-tensive population”. In: Am J Hypertens 22.5, pp. 538–44. issn: 0895-7061.doi: 10.1038/ajh.2009.33.

Hsia, Y. and K. Maclennan (2009). “Rise in psychotropic drug prescribing inchildren and adolescents during 1992-2001: a population-based study in theUK”. In: Eur J Epidemiol 24.4, pp. 211–6. issn: 0393-2990. doi: 10.1007/s10654-009-9321-3.

Hsia, Y., A. C. Neubert, et al. (2009). “An increase in the prevalence of type1 and 2 diabetes in children and adolescents: results from prescription datafrom a UK general practice database”. In: Br J Clin Pharmacol 67.2, pp. 242–9. issn: 0306-5251. doi: 10.1111/j.1365-2125.2008.03347.x.

Humes, D. J. et al. (2009). “A population-based study of perforated diverticu-lar disease incidence and associated mortality”. In: Gastroenterology 136.4,pp. 1198–205. issn: 0016-5085. doi: 10.1053/j.gastro.2008.12.054.

Jick, H., D. P. Chamberlin, and K. W. Hagberg (2009). “The origin and spreadof a mumps epidemic: United kingdom, 2003-2006”. In: Epidemiology 20.5,pp. 656–61. issn: 1044-3983. doi: 10.1097/EDE.0b013e3181b056f5.

Jick, H., K. W. Hagberg, and P. Egger (2009). “Rate of suicide in patients takingmontelukast”. In: Pharmacotherapy 29.2, pp. 165–6. issn: 0277-0008 (Print)0277-0008. doi: 10.1592/phco.29.2.165.

Jick, S. S. et al. (2009). “The risk of unintended pregnancies in users of thecontraceptive patch compared to users of oral contraceptives in the UKGeneral Practice Research Database”. In: Contraception 80.2, pp. 142–51.issn: 0010-7824. doi: 10.1016/j.contraception.2009.02.013.

Jones, R. et al. (2009). “Alarm symptoms and identification of non-cancer diag-noses in primary care: cohort study”. In: Bmj 339, b3094. issn: 0959-8138.doi: 10.1136/bmj.b3094.

Kernick, D. et al. (2009). “What happens to new-onset headache in childrenthat present to primary care? A case-cohort study using electronic primarycare records”. In: Cephalalgia 29.12, pp. 1311–6. issn: 0333-1024. doi: 10.1111/j.1468-2982.2009.01872.x.

3

CPRD bibliography

197

Martinez, C., T. Sullivan, and W. A. Hauser (2009). “Prevalence of acuterepetitive seizures (ARS) in the United Kingdom”. In: Epilepsy Res 87.2-3,pp. 137–43. issn: 0920-1211. doi: 10.1016/j.eplepsyres.2009.08.006.

McCarthy, S., P. Asherson, et al. (2009). “Attention-deficit hyperactivity dis-order: treatment discontinuation in adolescents and young adults”. In: Br JPsychiatry 194.3, pp. 273–7. issn: 0007-1250. doi: 10.1192/bjp.bp.107.045245.

McCarthy, S., N. Cranswick, et al. (2009). “Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective co-hort study of children, adolescents and young adults using the general prac-tice research database”. In: Drug Saf 32.11, pp. 1089–96. issn: 0114-5916.doi: 10.2165/11317630-000000000-00000.

Millett, C. et al. (2009). “Pay for perfomance and the quality of diabetes man-agement in individuals with and without co-morbid medical conditions”. In:J R Soc Med 102.9, pp. 369–77. issn: 0141-0768. doi: 10.1258/jrsm.2009.090171.

Moore, M. et al. (2009). “Explaining the rise in antidepressant prescribing: adescriptive study using the general practice research database”. In: Bmj 339,b3999. issn: 0959-8138. doi: 10.1136/bmj.b3999.

Phatak, H. et al. (2009). “Prevalence and predictors of lipid abnormalities inpatients treated with statins in the UK general practice”. In: Atherosclerosis202.1, pp. 225–33. issn: 0021-9150. doi: 10.1016/j.atherosclerosis.

2008.03.016.Punekar, Y. S. and A. Sheikh (2009a). “Establishing the incidence and preva-

lence of clinician-diagnosed allergic conditions in children and adolescentsusing routinely collected data from general practices”. In: Clin Exp Allergy39.8, pp. 1209–16. issn: 0954-7894. doi: 10.1111/j.1365- 2222.2009.

03248.x.— (2009b). “Establishing the sequential progression of multiple allergic diag-

noses in a UK birth cohort using the General Practice Research Database”.In: Clin Exp Allergy 39.12, pp. 1889–95. issn: 0954-7894. doi: 10.1111/j.1365-2222.2009.03366.x.

Rietbrock, S., M. Olson, and T. P. van Staa (2009). “The potential effectson fracture outcomes of improvements in persistence and compliance withbisphosphonates”. In: Qjm 102.1, pp. 35–42. issn: 1460-2393. doi: 10.1093/qjmed/hcn130.

Rietbrock, S., J. M. Plumb, et al. (2009). “How effective are dose-adjusted war-farin and aspirin for the prevention of stroke in patients with chronic atrialfibrillation? An analysis of the UK General Practice Research Database”.In: Thromb Haemost 101.3, pp. 527–34. issn: 0340-6245 (Print) 0340-6245.

Rodriguez, L. A. et al. (2009). “Rheumatoid arthritis in UK primary care:incidence and prior morbidity”. In: Scand J Rheumatol 38.3, pp. 173–7.issn: 0300-9742. doi: 10.1080/03009740802448825.

Ruigomez, A., E. L. Masso-Gonzalez, et al. (2009). “Chest pain without estab-lished ischaemic heart disease in primary care patients: associated comor-bidities and mortality”. In: Br J Gen Pract 59.560, e78–86. issn: 0960-1643.doi: 10.3399/bjgp09X407054.

Ruigomez, A., M. A. Wallander, et al. (2009). “Irritable bowel syndrome andgastroesophageal reflux disease in primary care: is there a link?” In: Dig DisSci 54.5, pp. 1079–86. issn: 0163-2116. doi: 10.1007/s10620-008-0462-0.

4

CPRD bibliography

198

hortinr

Highlight

Schneider, C., S. S. Jick, and C. R. Meier (2009a). “Risk of cardiovascular out-comes in users of estradiol/dydrogesterone or other HRT preparations”. In:Climacteric 12.5, pp. 445–53. issn: 1369-7137. doi: 10.1080/13697130902780853.

— (2009b). “Risk of gynecological cancers in users of estradiol/dydrogesteroneor other HRT preparations”. In: Climacteric 12.6, pp. 514–24. issn: 1369-7137. doi: 10.3109/13697130903075352.

Schoonen, W. M. et al. (2009). “Epidemiology of immune thrombocytopenicpurpura in the General Practice Research Database”. In: Br J Haematol145.2, pp. 235–44. issn: 0007-1048. doi: 10.1111/j.1365- 2141.2009.

07615.x.El-Serag, H., C. Hill, and R. Jones (2009). “Systematic review: the epidemiology

of gastro-oesophageal reflux disease in primary care, using the UK GeneralPractice Research Database”. In: Aliment Pharmacol Ther 29.5, pp. 470–80.issn: 0269-2813. doi: 10.1111/j.1365-2036.2008.03901.x.

Simon, T. A. et al. (2009). “Malignancies in the rheumatoid arthritis abataceptclinical development programme: an epidemiological assessment”. In: AnnRheum Dis 68.12, pp. 1819–26. issn: 0003-4967. doi: 10.1136/ard.2008.097527.

Somers, E. C. et al. (2009). “Are individuals with an autoimmune disease athigher risk of a second autoimmune disorder?” In: Am J Epidemiol 169.6,pp. 749–55. issn: 0002-9262. doi: 10.1093/aje/kwn408.

Staa, T. P. van, H. G. Leufkens, et al. (2009). “A comparison of cost effectivenessusing data from randomized trials or actual clinical practice: selective cox-2inhibitors as an example”. In: PLoS Med 6.12, e1000194. issn: 1549-1277.doi: 10.1371/journal.pmed.1000194.

Staa, T. P. van and J. M. Sprafka (2009). “Study of adverse outcomes in womenusing testosterone therapy”. In: Maturitas 62.1, pp. 76–80. issn: 0378-5122(Print) 0378-5122. doi: 10.1016/j.maturitas.2008.11.001.

Stowe, J. et al. (2009). “Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using theUnited Kingdom General Practice Research Database”. In: Am J Epidemiol169.3, pp. 382–8. issn: 0002-9262. doi: 10.1093/aje/kwn310.

Sundstrom, A. et al. (2009). “The risk of venous thromboembolism associatedwith the use of tranexamic acid and other drugs used to treat menorrhagia: acase-control study using the General Practice Research Database”. In: Bjog116.1, pp. 91–7. issn: 1470-0328. doi: 10.1111/j.1471-0528.2008.01926.x.

Tannen, R. L., M. G. Weiner, and D. Xie (2009). “Use of primary care elec-tronic medical record database in drug efficacy research on cardiovascularoutcomes: comparison of database and randomised controlled trial findings”.In: Bmj 338, b81. issn: 0959-8138. doi: 10.1136/bmj.b81.

Tate, A. R. et al. (2009). “Determining the date of diagnosis–is it a simplematter? The impact of different approaches to dating diagnosis on estimatesof delayed care for ovarian cancer in UK primary care”. In: BMC Med ResMethodol 9, p. 42. issn: 1471-2288. doi: 10.1186/1471-2288-9-42.

Thomas, M., D. Price, et al. (2009). “Inhaled corticosteroids for asthma: impactof practice level device switching on asthma control”. In: BMC Pulm Med9, p. 1. issn: 1471-2466. doi: 10.1186/1471-2466-9-1.

Thomas, M., J. von Ziegenweidt, et al. (2009). “High-dose inhaled corticosteroidsversus add-on long-acting beta-agonists in asthma: an observational study”.

5

CPRD bibliography

199

hortinr

Highlight

In: J Allergy Clin Immunol 123.1, 116–121.e10. issn: 0091-6749. doi: 10.1016/j.jaci.2008.09.035.

Thompson, P. L. et al. (2009). “Effect of antibiotics for otitis media on mas-toiditis in children: a retrospective cohort study using the United kingdomgeneral practice research database”. In: Pediatrics 123.2, pp. 424–30. issn:0031-4005. doi: 10.1542/peds.2007-3349.

Toschke, A. M. et al. (2009). “Antihypertensive treatment after stroke and all-cause mortality–an analysis of the General Practitioner Research Database(GPRD)”. In: Cerebrovasc Dis 28.2, pp. 105–11. issn: 1015-9770. doi: 10.1159/000223434.

Turner, S. et al. (2009). “Prescribing trends in asthma: a longitudinal obser-vational study”. In: Arch Dis Child 94.1, pp. 16–22. issn: 0003-9888. doi:10.1136/adc.2008.140681.

Tzoulaki, I. et al. (2009). “Risk of cardiovascular disease and all cause mortalityamong patients with type 2 diabetes prescribed oral antidiabetes drugs:retrospective cohort study using UK general practice research database”.In: Bmj 339, b4731. issn: 0959-8138. doi: 10.1136/bmj.b4731.

Vries, F. de et al. (2009). “Fracture risk in patients receiving acid-suppressantmedication alone and in combination with bisphosphonates”. In: OsteoporosInt 20.12, pp. 1989–98. issn: 0937-941x. doi: 10.1007/s00198-009-0891-4.

Watson, L. et al. (2009). “The effect of concurrent pain on the management ofpatients with depression: an analysis of NHS healthcare resource utilisationusing the GPRD database”. In: Int J Clin Pract 63.5, pp. 698–706. issn:1368-5031. doi: 10.1111/j.1742-1241.2009.02017.x.

Watts, R. A. et al. (2009). “Prevalence and incidence of Wegener’s granulomato-sis in the UK general practice research database”. In: Arthritis Rheum 61.10,pp. 1412–6. issn: 0004-3591 (Print) 0004-3591. doi: 10.1002/art.24544.

Watts, R. et al. (2009). “The epidemiology of Takayasu arteritis in the UK”. In:Rheumatology (Oxford) 48.8, pp. 1008–11. issn: 1462-0324. doi: 10.1093/rheumatology/kep153.

Winchester, C. C. et al. (2009). “Antibiotic prescribing and outcomes of lowerrespiratory tract infection in UK primary care”. In: Chest 135.5, pp. 1163–1172. issn: 0012-3692. doi: 10.1378/chest.07-2940.

Wong, I. C. et al. (2009). “Cessation of attention deficit hyperactivity disorderdrugs in the young (CADDY)–a pharmacoepidemiological and qualitativestudy”. In: Health Technol Assess 13.50, pp. iii–iv, ix–xi, 1–120. issn: 1366-5278. doi: 10.3310/hta13490.

Zhang, B. et al. (2009). “The pattern of risk of myocardial infarction in pa-tients taking asthma medication: a study with the General Practice Re-search Database”. In: J Hypertens 27.7, pp. 1485–92. issn: 0263-6352. doi:10.1097/HJH.0b013e32832af68d.

6

CPRD bibliography

200

2008

Abajo, F. J. de and L. A. Garcia-Rodriguez (2008). “Risk of upper gastroin-testinal tract bleeding associated with selective serotonin reuptake inhibitorsand venlafaxine therapy: interaction with nonsteroidal anti-inflammatorydrugs and effect of acid-suppressing agents”. In: Arch Gen Psychiatry 65.7,pp. 795–803. issn: 0003-990x. doi: 10.1001/archpsyc.65.7.795.

Abel, K. M. et al. (2008). “Sex- and age-specific incidence of fractures in mentalillness: a historical, population-based cohort study”. In: J Clin Psychiatry69.9, pp. 1398–403. issn: 0160-6689.

Becker, C., G. P. Brobert, P. M. Almqvist, et al. (2008a). “Migraine incidence,comorbidity and health resource utilization in the UK”. In: Cephalalgia 28.1,pp. 57–64. issn: 0333-1024. doi: 10.1111/j.1468-2982.2007.01469.x.

— (2008b). “The risk of newly diagnosed asthma in migraineurs with or withoutprevious triptan prescriptions”. In: Headache 48.4, pp. 606–10. issn: 0017-8748 (Print) 0017-8748. doi: 10.1111/j.1526-4610.2007.01030.x.

Becker, C., G. P. Brobert, S. Johansson, et al. (2008). “Diabetes in patientswith idiopathic Parkinson’s disease”. In: Diabetes Care 31.9, pp. 1808–12.issn: 0149-5992. doi: 10.2337/dc08-0479.

Becker, C., S. S. Jick, and C. R. Meier (2008). “Use of statins and the risk ofParkinson’s disease: a retrospective case-control study in the UK”. In: DrugSaf 31.5, pp. 399–407. issn: 0114-5916 (Print) 0114-5916.

Brauchli, Y. B., S. S. Jick, F. Curtin, et al. (2008a). “Association betweenbeta-blockers, other antihypertensive drugs and psoriasis: population-basedcase-control study”. In: Br J Dermatol 158.6, pp. 1299–307. issn: 0007-0963.doi: 10.1111/j.1365-2133.2008.08563.x.

— (2008b). “Association between use of thiazolidinediones or other oral an-tidiabetics and psoriasis: A population based case-control study”. In: J AmAcad Dermatol 58.3, pp. 421–9. issn: 0190-9622. doi: 10.1016/j.jaad.2007.11.023.

Brauchli, Y. B., S. S. Jick, and C. R. Meier (2008). “Psoriasis and the risk ofincident diabetes mellitus: a population-based study”. In: Br J Dermatol159.6, pp. 1331–7. issn: 0007-0963. doi: 10.1111/j.1365- 2133.2008.

08814.x.Bremner, S. A. et al. (2008). “Infections presenting for clinical care in early

life and later risk of hay fever in two UK birth cohorts”. In: Allergy 63.3,pp. 274–83. issn: 0105-4538. doi: 10.1111/j.1398-9995.2007.01599.x.

Card, T. R., M. Solaymani-Dodaran, and J. West (2008). “Incidence and mor-tality of primary sclerosing cholangitis in the UK: a population-based cohortstudy”. In: J Hepatol 48.6, pp. 939–44. issn: 0168-8278 (Print) 0168-8278.doi: 10.1016/j.jhep.2008.02.017.

Cardwell, C. R., D. J. Carson, and C. C. Patterson (2008). “No associationbetween routinely recorded infections in early life and subsequent risk ofchildhood-onset Type 1 diabetes: a matched case-control study using theUK General Practice Research Database”. In: Diabet Med 25.3, pp. 261–7.issn: 0742-3071. doi: 10.1111/j.1464-5491.2007.02351.x.

Cardwell, C. R., P. A. McKinney, et al. (2008). “Infections in early life andchildhood leukaemia risk: a UK case-control study of general practitioner

1

CPRD bibliography

201

hortinr

Highlight

hortinr

Highlight

records”. In: Br J Cancer 99.9, pp. 1529–33. issn: 0007-0920. doi: 10.1038/sj.bjc.6604696.

Charlton, J., R. Latinovic, and M. C. Gulliford (2008). “Explaining the declinein early mortality in men and women with type 2 diabetes: a population-based cohort study”. In: Diabetes Care 31.9, pp. 1761–6. issn: 0149-5992.doi: 10.2337/dc08-0137.

Charlton, R. A. et al. (2008). “Data resources for investigating drug exposureduring pregnancy and associated outcomes: the General Practice ResearchDatabase (GPRD) as an alternative to pregnancy registries”. In: Drug Saf31.1, pp. 39–51. issn: 0114-5916 (Print) 0114-5916.

Cheeta, S. et al. (2008). “Low identification of alcohol use disorders in gen-eral practice in England”. In: Addiction 103.5, pp. 766–73. issn: 0965-2140(Print) 0965-2140. doi: 10.1111/j.1360-0443.2008.02198.x.

Choi, C. W. et al. (2008). “Is obesity associated with gastropharyngeal refluxdisease?” In: World J Gastroenterol 14.2, pp. 265–71. issn: 1007-9327 (Print)1007-9327.

Daskalopoulou, S. S. et al. (2008). “Discontinuation of statin therapy followingan acute myocardial infarction: a population-based study”. In: Eur Heart J29.17, pp. 2083–91. issn: 0195-668x. doi: 10.1093/eurheartj/ehn346.

Delaney, J. A., E. E. Moodie, and S. Suissa (2008). “Validating the effects of drugtreatment on blood pressure in the General Practice Research Database”.In: Pharmacoepidemiol Drug Saf 17.6, pp. 535–45. issn: 1053-8569. doi:10.1002/pds.1553.

Delaney, J. A., V. Schneider-Lindner, et al. (2008). “Mortality after infectionwith methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in thecommunity”. In: BMC Med 6, p. 2. issn: 1741-7015. doi: 10.1186/1741-7015-6-2.

Denis, P., A. Lafuma, and G. Berdeaux (2008). “Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associatedwith prostaglandin analogues, for glaucoma as recorded by The United King-dom General Practitioner Research Database”. In: Clin Ophthalmol 2.2,pp. 321–9. issn: 1177-5467 (Print) 1177-5467.

Devine, S. et al. (2008). “Validation of neural tube defects in the full featured–general practice research database”. In: Pharmacoepidemiol Drug Saf 17.5,pp. 434–44. issn: 1053-8569. doi: 10.1002/pds.1573.

Douglas, I. J. and L. Smeeth (2008). “Exposure to antipsychotics and risk ofstroke: self controlled case series study”. In: Bmj 337, a1227. issn: 0959-8138.doi: 10.1136/bmj.a1227.

Gallagher, A. M., S. Rietbrock, M. Olson, et al. (2008). “Fracture outcomesrelated to persistence and compliance with oral bisphosphonates”. In: J BoneMiner Res 23.10, pp. 1569–75. issn: 0884-0431. doi: 10.1359/jbmr.080510.

Gallagher, A. M., S. Rietbrock, J. Plumb, et al. (2008). “Initiation and per-sistence of warfarin or aspirin in patients with chronic atrial fibrillation ingeneral practice: do the appropriate patients receive stroke prophylaxis?” In:J Thromb Haemost 6.9, pp. 1500–6. issn: 1538-7836. doi: 10.1111/j.1538-7836.2008.03059.x.

Garcia Rodriguez, L. A. et al. (2008). “Relationship between gastroesophagealreflux disease and COPD in UK primary care”. In: Chest 134.6, pp. 1223–1230. issn: 0012-3692. doi: 10.1378/chest.08-0902.

2

CPRD bibliography

202

Garcia-Rodriguez, L. A. et al. (2008). “The safety of rosuvastatin in comparisonwith other statins in over 100,000 statin users in UK primary care”. In:Pharmacoepidemiol Drug Saf 17.10, pp. 943–52. issn: 1053-8569. doi: 10.1002/pds.1603.

Griffin, J. et al. (2008). “Comparison of tiotropium bromide and combinedipratropium/salbutamol for the treatment of COPD: a UK General PracticeResearch Database 12-month follow-up study”. In: Prim Care Respir J 17.2,pp. 104–10. issn: 1471-4418 (Print) 1471-4418. doi: 10.3132/pcrj.2008.00024.

Hammad, T. A., D. J. Graham, et al. (2008). “Onset of acute myocardial infarc-tion after use of non-steroidal anti-inflammatory drugs”. In: Pharmacoepi-demiol Drug Saf 17.4, pp. 315–21. issn: 1053-8569. doi: 10.1002/pds.1560.

Hammad, T. A., M. A. McAdams, et al. (2008). “Determining the predictivevalue of Read/OXMIS codes to identify incident acute myocardial infarctionin the General Practice Research Database”. In: Pharmacoepidemiol DrugSaf 17.12, pp. 1197–201. issn: 1053-8569. doi: 10.1002/pds.1672.

Huerta, C. et al. (2008). “Risk of myocardial infarction and overall mortality insurvivors of venous thromboembolism”. In: Thromb J 6, p. 10. issn: 1477-9560. doi: 10.1186/1477-9560-6-10.

Jick, S. S. and L. Li (2008). “Antidepressant drug use and risk of venous throm-boembolism”. In: Pharmacotherapy 28.2, pp. 144–50. issn: 0277-0008 (Print)0277-0008. doi: 10.1592/phco.28.2.144.

Kaye, J. A. and H. Jick (2008). “Proton pump inhibitor use and risk of hipfractures in patients without major risk factors”. In: Pharmacotherapy 28.8,pp. 951–9. issn: 0277-0008 (Print) 0277-0008. doi: 10.1592/phco.28.8.951.

Lafuma, A. and G. Berdeaux (2008). “Costs and persistence of carbonic an-hydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, inglaucoma and ocular hypertension: an analysis of the UK-GPRD database”.In: Curr Med Res Opin 24.5, pp. 1519–27. issn: 0300-7995. doi: 10.1185/030079908x292038.

Lafuma, A., C. Laurendeau, and G. Berdeaux (2008). “Costs and persistenceof brimonidine versus brinzolamide in everyday glaucoma care: an analysisconducted on the UK General Practitioner Research Database”. In: J MedEcon 11.3, pp. 485–97. issn: 1369-6998 (Print) 1369-6998. doi: 10.3111/13696990802211107.

Lewis, J. D. et al. (2008). “Immunosuppressant medications and mortality ininflammatory bowel disease”. In: Am J Gastroenterol 103.6, 1428–35, quiz1436. issn: 0002-9270. doi: 10.1111/j.1572-0241.2008.01836.x.

Meier, C. et al. (2008). “Use of thiazolidinediones and fracture risk”. In: ArchIntern Med 168.8, pp. 820–5. issn: 0003-9926. doi: 10.1001/archinte.168.8.820.

Meropol, S. B. et al. (2008). “Adverse events associated with prolonged antibi-otic use”. In: Pharmacoepidemiol Drug Saf 17.5, pp. 523–32. issn: 1053-8569.doi: 10.1002/pds.1547.

Mikaeloff, Y., A. Kezouh, and S. Suissa (2008). “Nonsteroidal anti-inflammatorydrug use and the risk of severe skin and soft tissue complications in patientswith varicella or zoster disease”. In: Br J Clin Pharmacol 65.2, pp. 203–9.issn: 0306-5251. doi: 10.1111/j.1365-2125.2007.02997.x.

Molokhia, M. et al. (2008). “Statin induced myopathy and myalgia: time trendanalysis and comparison of risk associated with statin class from 1991-2006”.

3

CPRD bibliography

203

In: PLoS One 3.6, e2522. issn: 1932-6203. doi: 10.1371/journal.pone.0002522.

Mulnier, H. E. et al. (2008). “Risk of myocardial infarction in men and womenwith type 2 diabetes in the UK: a cohort study using the General PracticeResearch Database”. In: Diabetologia 51.9, pp. 1639–45. issn: 0012-186X(Print) 0012-186x. doi: 10.1007/s00125-008-1076-y.

Nitsch, D. et al. (2008). “Age-related macular degeneration and complementactivation-related diseases: a population-based case-control study”. In: Oph-thalmology 115.11, pp. 1904–10. issn: 0161-6420. doi: 10.1016/j.ophtha.2008.06.035.

Opatrny, L., J. A. Delaney, and S. Suissa (2008). “Gastro-intestinal haemorrhagerisks of selective serotonin receptor antagonist therapy: a new look”. In: BrJ Clin Pharmacol 66.1, pp. 76–81. issn: 0306-5251. doi: 10.1111/j.1365-2125.2008.03154.x.

Osborn, D. et al. (2008). “Suicide and severe mental illnesses. Cohort studywithin the UK general practice research database”. In: Schizophr Res 99.1-3, pp. 134–8. issn: 0920-9964 (Print) 0920-9964. doi: 10.1016/j.schres.2007.11.025.

Phatak, H., C. Wentworth, and T. A. Burke (2008). “Lipid testing among pa-tients beginning statin therapy in general practice in the United Kingdom”.In: Value Health 11.5, pp. 933–8. issn: 1098-3015. doi: 10.1111/j.1524-4733.2008.00345.x.

Rani, F. et al. (2008). “Epidemiologic features of antipsychotic prescribing tochildren and adolescents in primary care in the United Kingdom”. In: Pedi-atrics 121.5, pp. 1002–9. issn: 0031-4005. doi: 10.1542/peds.2007-2008.

Renoux, C. et al. (2008). “Hormone replacement therapy use and the risk ofstroke”. In: Maturitas 61.4, pp. 305–9. issn: 0378-5122 (Print) 0378-5122.doi: 10.1016/j.maturitas.2008.09.020.

Rietbrock, S. et al. (2008). “Chronic atrial fibrillation: Incidence, prevalence,and prediction of stroke using the Congestive heart failure, Hypertension,Age ¿75, Diabetes mellitus, and prior Stroke or transient ischemic attack(CHADS2) risk stratification scheme”. In: Am Heart J 156.1, pp. 57–64.issn: 0002-8703. doi: 10.1016/j.ahj.2008.03.010.

Seaman, H. E. et al. (2008). “Endometriosis and its coexistence with irritablebowel syndrome and pelvic inflammatory disease: findings from a nationalcase-control study–Part 2”. In: Bjog 115.11, pp. 1392–6. issn: 1470-0328.doi: 10.1111/j.1471-0528.2008.01879.x.

Setakis, E., H. G. Leufkens, and T. P. van Staa (2008). “Changes in the char-acteristics of patients prescribed selective cyclooxygenase 2 inhibitors afterthe 2004 withdrawal of rofecoxib”. In: Arthritis Rheum 59.8, pp. 1105–11.issn: 0004-3591 (Print) 0004-3591. doi: 10.1002/art.23925.

Shawe, J. et al. (2008). “Use of hormonal contraceptive methods by womenwith diabetes”. In: Prim Care Diabetes 2.4, pp. 195–9. issn: 1878-0210. doi:10.1016/j.pcd.2008.10.003.

Solaymani-Dodaran, M. et al. (2008). “Risk of cardiovascular and cerebrovas-cular events in primary biliary cirrhosis: a population-based cohort study”.In: Am J Gastroenterol 103.11, pp. 2784–8. issn: 0002-9270. doi: 10.1111/j.1572-0241.2008.02092.x.

4

CPRD bibliography

204

Staa, T. P. van, C. Cooper, et al. (2008). “Individualizing the risks and benefitsof postmenopausal hormone therapy”. In: Menopause 15.2, pp. 374–81. issn:1072-3714 (Print) 1072-3714. doi: 10.1097/gme.0b013e31812e558f.

Staa, T. P. van, S. Rietbrock, et al. (2008). “Does the varied use of NSAIDsexplain the differences in the risk of myocardial infarction?” In: J InternMed 264.5, pp. 481–92. issn: 0954-6820. doi: 10.1111/j.1365-2796.2008.01991.x.

Staa, T. P. van, L. Smeeth, et al. (2008a). “Evaluating drug toxicity signals: isa hierarchical classification of evidence useful or a hindrance?” In: Pharma-coepidemiol Drug Saf 17.5, pp. 475–84. issn: 1053-8569. doi: 10.1002/pds.1568.

— (2008b). “What is the harm-benefit ratio of Cox-2 inhibitors?” In: Int JEpidemiol 37.2, pp. 405–13. issn: 0300-5771. doi: 10.1093/ije/dym296.

Tannen, R. L., M. G. Weiner, and D. Xie (2008). “Replicated studies of two ran-domized trials of angiotensin-converting enzyme inhibitors: further empiricvalidation of the ’prior event rate ratio’ to adjust for unmeasured confound-ing by indication”. In: Pharmacoepidemiol Drug Saf 17.7, pp. 671–85. issn:1053-8569. doi: 10.1002/pds.1584.

Thomas, S. L. et al. (2008). “How accurate are diagnoses for rheumatoid arthritisand juvenile idiopathic arthritis in the general practice research database?”In: Arthritis Rheum 59.9, pp. 1314–21. issn: 0004-3591 (Print) 0004-3591.doi: 10.1002/art.24015.

Thompson, P. L. et al. (2008). “Has UK guidance affected general practitionerantibiotic prescribing for otitis media in children?” In: J Public Health (Oxf)30.4, pp. 479–86. issn: 1741-3842. doi: 10.1093/pubmed/fdn072.

Walters, K. et al. (2008). “Panic disorder and risk of new onset coronary heartdisease, acute myocardial infarction, and cardiac mortality: cohort study us-ing the general practice research database”. In: Eur Heart J 29.24, pp. 2981–8. issn: 0195-668x. doi: 10.1093/eurheartj/ehn477.

Weiner, M. G., K. Barnhart, et al. (2008). “Hormone therapy and coronary heartdisease in young women”. In: Menopause 15.1, pp. 86–93. issn: 1072-3714(Print) 1072-3714. doi: 10.1097/gme.0b013e3180413e45.

Weiner, M. G., D. Xie, and R. L. Tannen (2008). “Replication of the Scan-dinavian Simvastatin Survival Study using a primary care medical recorddatabase prompted exploration of a new method to address unmeasuredconfounding”. In: Pharmacoepidemiol Drug Saf 17.7, pp. 661–70. issn: 1053-8569. doi: 10.1002/pds.1585.

Willemen, M. J. et al. (2008). “Psychiatric and cardiovascular comorbiditiesin patients with diabetes mellitus starting antiobesity drugs”. In: Obesity(Silver Spring) 16.10, pp. 2331–5. issn: 1930-7381 (Print) 1930-7381. doi:10.1038/oby.2008.362.

Yang, Y. X. et al. (2008). “Chronic statin therapy and the risk of colorectalcancer”. In: Pharmacoepidemiol Drug Saf 17.9, pp. 869–76. issn: 1053-8569.doi: 10.1002/pds.1599.

Yurgin, N., K. Secnik, and M. J. Lage (2008). “Obesity and the use of insulin: astudy of patients with type 2 diabetes in the UK”. In: J Diabetes Complica-tions 22.4, pp. 235–40. issn: 1056-8727. doi: 10.1016/j.jdiacomp.2006.12.001.

5

CPRD bibliography

205

hortinr

Highlight

2007

Aberra, F. N. et al. (2007). “Risk for active tuberculosis in inflammatory boweldisease patients”. In: Clin Gastroenterol Hepatol 5.9, pp. 1070–5. issn: 1542-3565. doi: 10.1016/j.cgh.2007.04.007.

Ackers, R. et al. (2007). “Prioritizing children’s medicines for research: a pharmaco-epidemiological study of antiepileptic drugs”. In: Br J Clin Pharmacol 63.6,pp. 689–97. issn: 0306-5251 (Print) 0306-5251. doi: 10.1111/j.1365-

2125.2006.02842.x.Alonso, A., S. S. Jick, et al. (2007). “Incidence of multiple sclerosis in the United

Kingdom : findings from a population-based cohort”. In: J Neurol 254.12,pp. 1736–41. issn: 0340-5354 (Print) 0340-5354. doi: 10.1007/s00415-007-0602-z.

Alonso, A., L. A. Rodriguez, et al. (2007). “Gout and risk of Parkinson disease:a prospective study”. In: Neurology 69.17, pp. 1696–700. issn: 0028-3878.doi: 10.1212/01.wnl.0000279518.10072.df.

Becker, C. et al. (2007). “Migraine and the risk of stroke, TIA, or death inthe UK (CME)”. In: Headache 47.10, pp. 1374–84. issn: 0017-8748 (Print)0017-8748. doi: 10.1111/j.1526-4610.2007.00937.x.

Bowe, W. P., O. Hoffstad, and D. J. Margolis (2007). “Upper respiratory tractinfection in household contacts of acne patients”. In: Dermatology 215.3,pp. 213–8. issn: 1018-8665. doi: 10.1159/000106579.

Bremner, S. A. et al. (2007). “Vaccinations, infections and antibacterials in thefirst grass pollen season of life and risk of later hayfever”. In: Clin Exp Allergy37.4, pp. 512–7. issn: 0954-7894 (Print) 0954-7894. doi: 10.1111/j.1365-2222.2007.02697.x.

Burke, T. A. et al. (2007). “The effect of antihypertensive drugs and drugcombinations on the incidence of new-onset type-2 diabetes mellitus”. In:Pharmacoepidemiol Drug Saf 16.9, pp. 979–87. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.1444.

Cook, M. N. et al. (2007). “Initial monotherapy with either metformin or sulpho-nylureas often fails to achieve or maintain current glycaemic goals in patientswith Type 2 diabetes in UK primary care”. In: Diabet Med 24.4, pp. 350–8. issn: 0742-3071 (Print) 0742-3071. doi: 10.1111/j.1464-5491.2007.02078.x.

Delaney, J. A., S. S. Daskalopoulou, et al. (2007). “Lifestyle variables and therisk of myocardial infarction in the general practice research database”. In:BMC Cardiovasc Disord 7, p. 38. issn: 1471-2261. doi: 10.1186/1471-2261-7-38.

Delaney, J. A., L. Opatrny, et al. (2007). “Drug drug interactions betweenantithrombotic medications and the risk of gastrointestinal bleeding”. In:Cmaj 177.4, pp. 347–51. issn: 0820-3946. doi: 10.1503/cmaj.070186.

Douglas, I. J. et al. (2007). “A case-control study of drug risk factors for age-related macular degeneration”. In: Ophthalmology 114.6, pp. 1164–9. issn:0161-6420. doi: 10.1016/j.ophtha.2006.09.018.

Dunn, N. et al. (2007). “Use of antibiotics for sore throat and incidence ofquinsy”. In: Br J Gen Pract 57.534, pp. 45–9. issn: 0960-1643 (Print) 0960-1643.

1

CPRD bibliography

206

Edwards, C. J. et al. (2007). “The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthri-tis in patients with rheumatoid arthritis”. In: Arthritis Rheum 57.7, pp. 1151–7. issn: 0004-3591 (Print) 0004-3591. doi: 10.1002/art.23003.

Filion, K. B. et al. (2007). “The impact of over-the-counter simvastatin onthe number of statin prescriptions in the United Kingdom: a view fromthe General Practice Research Database”. In: Pharmacoepidemiol Drug Saf16.1, pp. 1–4. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.1314.

Garde, E. M. van de et al. (2007). “Angiotensin-converting enzyme inhibitor useand protection against pneumonia in patients with diabetes”. In: J Hypertens25.1, pp. 235–9. issn: 0263-6352 (Print) 0263-6352. doi: 10.1097/HJH.

0b013e328010520a.Gelfand, J. M. et al. (2007). “The risk of mortality in patients with psoriasis:

results from a population-based study”. In: Arch Dermatol 143.12, pp. 1493–9. issn: 0003-987x. doi: 10.1001/archderm.143.12.1493.

Hamilton, W. and D. Kernick (2007). “Clinical features of primary brain tu-mours: a case-control study using electronic primary care records”. In: Br JGen Pract 57.542, pp. 695–9. issn: 0960-1643 (Print) 0960-1643.

Hennessy, S. et al. (2007). “Observed association between antidepressant useand pneumonia risk was confounded by comorbidity measures”. In: J ClinEpidemiol 60.9, pp. 911–8. issn: 0895-4356 (Print) 0895-4356. doi: 10.1016/j.jclinepi.2006.11.022.

Hogler, W. et al. (2007). “Incidence of skeletal complications during treatmentof childhood acute lymphoblastic leukemia: comparison of fracture risk withthe General Practice Research Database”. In: Pediatr Blood Cancer 48.1,pp. 21–7. issn: 1545-5009 (Print) 1545-5009. doi: 10.1002/pbc.20701.

Howard, L., G. Kirkwood, and M. Leese (2007). “Risk of hip fracture in patientswith a history of schizophrenia”. In: Br J Psychiatry 190, pp. 129–34. issn:0007-1250 (Print) 0007-1250. doi: 10.1192/bjp.bp.106.023671.

Huerta, C., S. Johansson, et al. (2007). “Risk factors and short-term mortalityof venous thromboembolism diagnosed in the primary care setting in theUnited Kingdom”. In: Arch Intern Med 167.9, pp. 935–43. issn: 0003-9926(Print) 0003-9926. doi: 10.1001/archinte.167.9.935.

Huerta, C., E. Rivero, and L. A. Rodriguez (2007). “Incidence and risk factorsfor psoriasis in the general population”. In: Arch Dermatol 143.12, pp. 1559–65. issn: 0003-987x. doi: 10.1001/archderm.143.12.1559.

Hughes, G. et al. (2007). “Use of a primary care database to determine trendsin genital chlamydia testing, diagnostic episodes and management in UKgeneral practice, 1990-2004”. In: Sex Transm Infect 83.4, pp. 310–3. issn:1368-4973 (Print) 1368-4973. doi: 10.1136/sti.2006.022673.

Jackson, H. et al. (2007). “Influence of ursodeoxycholic acid on the mortalityand malignancy associated with primary biliary cirrhosis: a population-basedcohort study”. In: Hepatology 46.4, pp. 1131–7. issn: 0270-9139 (Print) 0270-9139. doi: 10.1002/hep.21795.

Jick, S. S., J. A. Kaye, and H. Jick (2007). “Diclofenac and acute myocardialinfarction in patients with no major risk factors”. In: Br J Clin Pharmacol64.5, pp. 662–7. issn: 0306-5251 (Print) 0306-5251. doi: 10.1111/j.1365-2125.2007.02942.x.

2

CPRD bibliography

207

Jones, R. et al. (2007). “Alarm symptoms in early diagnosis of cancer in pri-mary care: cohort study using General Practice Research Database”. In: Bmj334.7602, p. 1040. issn: 0959-8138. doi: 10.1136/bmj.39171.637106.AE.

Jordan, K. et al. (2007). “Measuring disease prevalence: a comparison of mus-culoskeletal disease using four general practice consultation databases”. In:Br J Gen Pract 57.534, pp. 7–14. issn: 0960-1643 (Print) 0960-1643.

Lafuma, A. and G. Berdeaux (2007). “Costs and effectiveness of travoprostversus a dorzolamide + timolol fixed combination in first-line treatment ofglaucoma: analysis conducted on the United Kingdom General PractitionerResearch Database”. In: Curr Med Res Opin 23.12, pp. 3009–16. issn: 0300-7995. doi: 10.1185/030079907x242836.

MacDonald, T. M., S. V. Morant, and E. Mozaffari (2007). “Drug treatmentdiscontinuation and achievement of target blood pressure and cholesterol inUnited Kingdom primary care”. In: Curr Med Res Opin 23.11, pp. 2765–74.issn: 0300-7995. doi: 10.1185/030079907x233124.

Margolis, D. J., O. Hoffstad, and R. R. Isseroff (2007). “Association betweenthe use of beta-adrenergic receptor agents and the development of venousleg ulcers”. In: Arch Dermatol 143.10, pp. 1275–80. issn: 0003-987X (Print)0003-987x. doi: 10.1001/archderm.143.10.1275.

Nightingale, A. L., R. D. Farmer, and C. S. de Vries (2007). “Systemic lu-pus erythematosus prevalence in the UK: methodological issues when usingthe General Practice Research Database to estimate frequency of chronicrelapsing-remitting disease”. In: Pharmacoepidemiol Drug Saf 16.2, pp. 144–51. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.1253.

Osborn, D. P. et al. (2007). “Relative risk of cardiovascular and cancer mortalityin people with severe mental illness from the United Kingdom’s GeneralPractice Rsearch Database”. In: Arch Gen Psychiatry 64.2, pp. 242–9. issn:0003-990X (Print) 0003-990x. doi: 10.1001/archpsyc.64.2.242.

Petersen, I. and A. C. Hayward (2007). “Antibacterial prescribing in primarycare”. In: J Antimicrob Chemother 60 Suppl 1, pp. i43–47. issn: 0305-7453(Print) 0305-7453. doi: 10.1093/jac/dkm156.

Petersen, I., A. M. Johnson, et al. (2007). “Protective effect of antibiotics againstserious complications of common respiratory tract infections: retrospectivecohort study with the UK General Practice Research Database”. In: Bmj335.7627, p. 982. issn: 0959-8138. doi: 10.1136/bmj.39345.405243.BE.

Pitman, R. J. et al. (2007). “Assessing the burden of influenza and other respi-ratory infections in England and Wales”. In: J Infect 54.6, pp. 530–8. issn:0163-4453. doi: 10.1016/j.jinf.2006.09.017.

Rubino, A. et al. (2007). “Risk of suicide during treatment with venlafaxine,citalopram, fluoxetine, and dothiepin: retrospective cohort study”. In: Bmj334.7587, p. 242. issn: 0959-8138. doi: 10.1136/bmj.39041.445104.BE.

Ruigomez, A., L. A. Garcia Rodriguez, et al. (2007). “Risk of cerebrovascularaccident after a first diagnosis of atrial fibrillation”. In: Clin Cardiol 30.12,pp. 624–8. issn: 0160-9289 (Print) 0160-9289. doi: 10.1002/clc.20178.

Ruigomez, A., L. A. Rodriguez, et al. (2007). “Endoscopic findings in a cohort ofnewly diagnosed gastroesophageal reflux disease patients registered in a UKprimary care database”. In: Dis Esophagus 20.6, pp. 504–9. issn: 1120-8694(Print) 1120-8694. doi: 10.1111/j.1442-2050.2007.00745.x.

3

CPRD bibliography

208

Schade, R. et al. (2007). “Dopamine agonists and the risk of cardiac-valveregurgitation”. In: N Engl J Med 356.1, pp. 29–38. issn: 0028-4793. doi:10.1056/NEJMoa062222.

Schlienger, R. G. et al. (2007). “Statins and the risk of pneumonia: a population-based, nested case-control study”. In: Pharmacotherapy 27.3, pp. 325–32.issn: 0277-0008 (Print) 0277-0008. doi: 10.1592/phco.27.3.325.

Seaman, H. E. et al. (2007). “Venous thromboembolism and cyproterone acetatein men with prostate cancer: a study using the General Practice ResearchDatabase”. In: BJU Int 99.6, pp. 1398–403. issn: 1464-4096 (Print) 1464-4096. doi: 10.1111/j.1464-410X.2007.06859.x.

Sharland, M. (2007). “The use of antibacterials in children: a report of theSpecialist Advisory Committee on Antimicrobial Resistance (SACAR) Pae-diatric Subgroup”. In: J Antimicrob Chemother 60 Suppl 1, pp. i15–26. issn:0305-7453 (Print) 0305-7453. doi: 10.1093/jac/dkm153.

Smitten, A. L. et al. (2007). “The risk of herpes zoster in patients with rheuma-toid arthritis in the United States and the United Kingdom”. In: ArthritisRheum 57.8, pp. 1431–8. issn: 0004-3591 (Print) 0004-3591. doi: 10.1002/art.23112.

Somers, E. C. et al. (2007). “Incidence of systemic lupus erythematosus in theUnited Kingdom, 1990-1999”. In: Arthritis Rheum 57.4, pp. 612–8. issn:0004-3591 (Print) 0004-3591. doi: 10.1002/art.22683.

Srinivasan, R. et al. (2007). “Risk of colorectal cancer in women with a priordiagnosis of gynecologic malignancy”. In: J Clin Gastroenterol 41.3, pp. 291–6. issn: 0192-0790 (Print) 0192-0790. doi: 10.1097/01.mcg.0000225587.85953.06.

Staa, T. P. van et al. (2007). “Individual fracture risk and the cost-effectivenessof bisphosphonates in patients using oral glucocorticoids”. In: Rheumatology(Oxford) 46.3, pp. 460–6. issn: 1462-0324 (Print) 1462-0324. doi: 10.1093/rheumatology/kel249.

Tannen, R. L. et al. (2007a). “A simulation using data from a primary carepractice database closely replicated the women’s health initiative trial”. In:J Clin Epidemiol 60.7, pp. 686–95. issn: 0895-4356 (Print) 0895-4356. doi:10.1016/j.jclinepi.2006.10.012.

— (2007b). “Estrogen affects post-menopausal women differently than estrogenplus progestin replacement therapy”. In: Hum Reprod 22.6, pp. 1769–77.issn: 0268-1161 (Print) 0268-1161. doi: 10.1093/humrep/dem031.

Velthuis-Te Wierik, E. J., P. T. Hendricks, and C. Martinez (2007). “Preferentialprescribing of tibolone and combined estrogen plus progestogen therapy inpostmenopausal women”. In: Menopause 14.3 Pt 1, pp. 518–27. issn: 1072-3714 (Print) 1072-3714. doi: 10.1097/01.gme.0000247012.54468.75.

Vries, F. de, M. Bracke, et al. (2007). “Fracture risk with intermittent high-doseoral glucocorticoid therapy”. In: Arthritis Rheum 56.1, pp. 208–14. issn:0004-3591 (Print) 0004-3591. doi: 10.1002/art.22294.

Vries, F. de, P. C. Souverein, et al. (2007). “Use of beta-blockers and the riskof hip/femur fracture in the United Kingdom and The Netherlands”. In:Calcif Tissue Int 80.2, pp. 69–75. issn: 0171-967X (Print) 0171-967x. doi:10.1007/s00223-006-0213-1.

Wallander, M. A., S. Johansson, A. Ruigomez, and L. A. Garcia Rodriguez(2007). “Unspecified abdominal pain in primary care: the role of gastroin-

4

CPRD bibliography

209

hortinr

Highlight

testinal morbidity”. In: Int J Clin Pract 61.10, pp. 1663–70. issn: 1368-5031(Print) 1368-5031. doi: 10.1111/j.1742-1241.2007.01529.x.

Wallander, M. A., S. Johansson, A. Ruigomez, L. A. Garcia Rodriguez, and R.Jones (2007). “Morbidity associated with sleep disorders in primary care:a longitudinal cohort study”. In: Prim Care Companion J Clin Psychiatry9.5, pp. 338–45. issn: 1523-5998 (Print) 1523-5998.

Wilting, I. et al. (2007). “Lithium use and the risk of fractures”. In: Bone 40.5,pp. 1252–8. issn: 8756-3282 (Print) 1873-2763. doi: 10.1016/j.bone.2006.12.055.

Wurst, K. E. et al. (2007a). “Evaluation of the General Practice ResearchDatabase congenital heart defects prevalence: comparison to United King-dom national systems”. In: Birth Defects Res A Clin Mol Teratol 79.4,pp. 309–16. issn: 1542-0752 (Print) 1542-0752. doi: 10.1002/bdra.20356.

— (2007b). “The utility of the general practice research database to examineselected congenital heart defects: a validation study”. In: PharmacoepidemiolDrug Saf 16.8, pp. 867–77. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.1431.

Yang, Y. X. et al. (2007). “Chronic proton pump inhibitor therapy and the riskof colorectal cancer”. In: Gastroenterology 133.3, pp. 748–54. issn: 0016-5085(Print) 0016-5085. doi: 10.1053/j.gastro.2007.06.022.

5

CPRD bibliography

210

hortinr

Highlight

2006

Aina, F. O. et al. (2006). “Hormone replacement therapy and cataract: a population-based case-control study”. In: Eye (Lond) 20.4, pp. 417–22. issn: 0950-222X(Print) 0950-222x. doi: 10.1038/sj.eye.6701877.

Alonso, A., S. S. Jick, and M. A. Hernan (2006). “Allergy, histamine 1 receptorblockers, and the risk of multiple sclerosis”. In: Neurology 66.4, pp. 572–5.issn: 0028-3878. doi: 10.1212/01.wnl.0000198507.13597.45.

Alonso, A., S. S. Jick, H. Jick, et al. (2006). “Antibiotic use and risk of multiplesclerosis”. In: Am J Epidemiol 163.11, pp. 997–1002. issn: 0002-9262 (Print)0002-9262. doi: 10.1093/aje/kwj123.

Andersohn, F., R. Schade, et al. (2006). “Cyclooxygenase-2 selective nons-teroidal anti-inflammatory drugs and the risk of ischemic stroke: a nestedcase-control study”. In: Stroke 37.7, pp. 1725–30. issn: 0039-2499. doi: 10.1161/01.str.0000226642.55207.94.

Andersohn, F., S. Suissa, and E. Garbe (2006). “Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugsand risk of acute myocardial infarction”. In: Circulation 113.16, pp. 1950–7.issn: 0009-7322. doi: 10.1161/circulationaha.105.602425.

Apter, A. J. et al. (2006). “Is there cross-reactivity between penicillins andcephalosporins?” In: Am J Med 119.4, 354.e11–9. issn: 0002-9343. doi: 10.1016/j.amjmed.2005.10.052.

Arana, A. et al. (2006). “Hormone therapy and cerebrovascular events: a population-based nested case-control study”. In: Menopause 13.5, pp. 730–6. issn: 1072-3714 (Print) 1072-3714. doi: 10.1097/01.gme.0000233494.28335.71.

Ashworth, M. et al. (2006). “Age-related changes in consultations and antibioticprescribing for acute respiratory infections, 1995-2000. Data from the UKGeneral Practice Research Database”. In: J Clin Pharm Ther 31.5, pp. 461–7. issn: 0269-4727 (Print) 0269-4727. doi: 10.1111/j.1365-2710.2006.00765.x.

Brankin, E. et al. (2006). “The impact of dosing frequency on compliance andpersistence with bisphosphonates among postmenopausal women in the UK:evidence from three databases”. In: Curr Med Res Opin 22.7, pp. 1249–56.issn: 0300-7995 (Print) 0300-7995. doi: 10.1185/030079906x112688.

Burke, T. A. et al. (2006). “Discontinuation of antihypertensive drugs amongnewly diagnosed hypertensive patients in UK general practice”. In: J Hyper-tens 24.6, pp. 1193–200. issn: 0263-6352 (Print) 0263-6352. doi: 10.1097/01.hjh.0000226211.95936.f5.

Burnham, J. M. et al. (2006). “Childhood onset arthritis is associated withan increased risk of fracture: a population based study using the GeneralPractice Research Database”. In: Ann Rheum Dis 65.8, pp. 1074–9. issn:0003-4967 (Print) 0003-4967. doi: 10.1136/ard.2005.048835.

Card, T. R. et al. (2006). “Is an internal comparison better than using nationaldata when estimating mortality in longitudinal studies?” In: J EpidemiolCommunity Health 60.9, pp. 819–21. issn: 0143-005X (Print) 0143-005x.doi: 10.1136/jech.2005.041202.

1

CPRD bibliography

211

Carlson, C. et al. (2006). “Diabetes mellitus and antipsychotic treatment in theUnited Kingdom”. In: Eur Neuropsychopharmacol 16.5, pp. 366–75. issn:0924-977X (Print) 0924-977x. doi: 10.1016/j.euroneuro.2005.11.002.

Cassell, J. A. et al. (2006). “Trends in sexually transmitted infections in generalpractice 1990-2000: population based study using data from the UK generalpractice research database”. In: Bmj 332.7537, pp. 332–4. issn: 0959-8138.doi: 10.1136/bmj.38726.404120.7C.

Fox, K. M. et al. (2006). “Prevalence of inadequate glycemic control amongpatients with type 2 diabetes in the United Kingdom general practice re-search database: A series of retrospective analyses of data from 1998 through2002”. In: Clin Ther 28.3, pp. 388–95. issn: 0149-2918 (Print) 0149-2918.doi: 10.1016/j.clinthera.2006.03.005.

Garcia Rodriguez, L. A., A. Ruigomez, and J. Panes (2006). “Acute gastroen-teritis is followed by an increased risk of inflammatory bowel disease”. In:Gastroenterology 130.6, pp. 1588–94. issn: 0016-5085 (Print) 0016-5085. doi:10.1053/j.gastro.2006.02.004.

Garde, E. M. van de et al. (2006). “Statin treatment and reduced risk of pneumo-nia in patients with diabetes”. In: Thorax 61.11, pp. 957–61. issn: 0040-6376(Print) 0040-6376. doi: 10.1136/thx.2006.062885.

Gelfand, J. M., A. L. Neimann, et al. (2006). “Risk of myocardial infarction inpatients with psoriasis”. In: Jama 296.14, pp. 1735–41. issn: 0098-7484. doi:10.1001/jama.296.14.1735.

Gelfand, J. M., D. B. Shin, et al. (2006). “The risk of lymphoma in patientswith psoriasis”. In: J Invest Dermatol 126.10, pp. 2194–201. issn: 0022-202X(Print) 0022-202x. doi: 10.1038/sj.jid.5700410.

Gonzalez-Perez, A. and L. A. Rodriguez (2006). “Upper gastrointestinal com-plications among users of paracetamol”. In: Basic Clin Pharmacol Toxicol98.3, pp. 297–303. issn: 1742-7835 (Print) 1742-7835. doi: 10.1111/j.1742-7843.2006.pto_248.x.

Gore, M. et al. (2006). “Prevalence of contraindicated medical conditions anduse of precluded medications in patients with painful neuropathic disordersprescribed amitriptyline”. In: Pain Pract 6.4, pp. 265–72. issn: 1530-7085.doi: 10.1111/j.1533-2500.2006.00101.x.

Gupta, G., E. Lautenbach, and J. D. Lewis (2006). “Incidence and risk factorsfor herpes zoster among patients with inflammatory bowel disease”. In: ClinGastroenterol Hepatol 4.12, pp. 1483–90. issn: 1542-3565 (Print) 1542-3565.doi: 10.1016/j.cgh.2006.09.019.

Hall, G. C. et al. (2006). “Epidemiology and treatment of neuropathic pain: theUK primary care perspective”. In: Pain 122.1-2, pp. 156–62. issn: 0304-3959.doi: 10.1016/j.pain.2006.01.030.

Handoko, K. B. et al. (2006). “Risk of aplastic anemia in patients using antiepilep-tic drugs”. In: Epilepsia 47.7, pp. 1232–6. issn: 0013-9580 (Print) 0013-9580.doi: 10.1111/j.1528-1167.2006.00596.x.

Hardy, J. R. et al. (2006). “Safety of medications prescribed before and duringearly pregnancy in a cohort of 81,975 mothers from the UK General PracticeResearch Database”. In: Pharmacoepidemiol Drug Saf 15.8, pp. 555–64.issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.1269.

Hernan, M. A., G. Logroscino, and L. A. Garcia Rodriguez (2006). “Nonsteroidalanti-inflammatory drugs and the incidence of Parkinson disease”. In: Neurol-

2

CPRD bibliography

212

ogy 66.7, pp. 1097–9. issn: 0028-3878. doi: 10.1212/01.wnl.0000204446.82823.28.

Hernandez-Diaz, S. and L. A. Garcia Rodriguez (2006). “Cardioprotective as-pirin users and their excess risk of upper gastrointestinal complications”. In:BMC Med 4, p. 22. issn: 1741-7015. doi: 10.1186/1741-7015-4-22.

Huerta, C. et al. (2006). “Non-steroidal anti-inflammatory drugs and risk offirst hospital admission for heart failure in the general population”. In: Heart92.11, pp. 1610–5. issn: 1355-6037. doi: 10.1136/hrt.2005.082388.

Hughes, R. A. et al. (2006). “No association between immunization and Guillain-Barre syndrome in the United Kingdom, 1992 to 2000”. In: Arch InternMed 166.12, pp. 1301–4. issn: 0003-9926 (Print) 0003-9926. doi: 10.1001/archinte.166.12.1301.

Jick, H. et al. (2006). “Nonsteroidal antiinflammatory drugs and acute myocar-dial infarction in patients with no major risk factors”. In: Pharmacotherapy26.10, pp. 1379–87. issn: 0277-0008 (Print) 0277-0008. doi: 10.1592/phco.26.10.1379.

Jick, S. S. et al. (2006). “Glucocorticoid use, other associated factors, and therisk of tuberculosis”. In: Arthritis Rheum 55.1, pp. 19–26. issn: 0004-3591(Print) 0004-3591. doi: 10.1002/art.21705.

Jones, R. et al. (2006). “Physical and psychological co-morbidity in irritablebowel syndrome: a matched cohort study using the General Practice Re-search Database”. In: Aliment Pharmacol Ther 24.5, pp. 879–86. issn: 0269-2813 (Print) 0269-2813. doi: 10.1111/j.1365-2036.2006.03044.x.

Kim, J. et al. (2006). “Hormone replacement therapy and acute myocardialinfarction: a large observational study exploring the influence of age”. In:Int J Epidemiol 35.3, pp. 731–8. issn: 0300-5771 (Print) 0300-5771. doi:10.1093/ije/dyi285.

Latinovic, R., M. C. Gulliford, and R. A. Hughes (2006). “Incidence of commoncompressive neuropathies in primary care”. In: J Neurol Neurosurg Psychia-try 77.2, pp. 263–5. issn: 0022-3050 (Print) 0022-3050. doi: 10.1136/jnnp.2005.066696.

Latinovic, R., M. Gulliford, and L. Ridsdale (2006). “Headache and migrainein primary care: consultation, prescription, and referral rates in a largepopulation”. In: J Neurol Neurosurg Psychiatry 77.3, pp. 385–7. issn: 0022-3050 (Print) 0022-3050. doi: 10.1136/jnnp.2005.073221.

Mulnier, H. E. et al. (2006). “Mortality in people with type 2 diabetes in theUK”. In: Diabet Med 23.5, pp. 516–21. issn: 0742-3071 (Print) 0742-3071.doi: 10.1111/j.1464-5491.2006.01838.x.

Nightingale, A. L., R. D. Farmer, and C. S. de Vries (2006). “Incidence of clini-cally diagnosed systemic lupus erythematosus 1992-1998 using the UK Gen-eral Practice Research Database”. In: Pharmacoepidemiol Drug Saf 15.9,pp. 656–61. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.1199.

Noakes, K. et al. (2006). “Pneumococcal polysaccharide vaccine uptake in Eng-land, 1989-2003, prior to the introduction of a vaccination programme forolder adults”. In: J Public Health (Oxf) 28.3, pp. 242–7. issn: 1741-3842(Print) 1741-3842. doi: 10.1093/pubmed/fdl017.

Odeyemi, I. A. et al. (2006). “Epidemiology, prescribing patterns and resourceuse associated with overactive bladder in UK primary care”. In: Int J ClinPract 60.8, pp. 949–58. issn: 1368-5031 (Print) 1368-5031. doi: 10.1111/j.1742-1241.2006.01057.x.

3

CPRD bibliography

213

Ruigomez, A., L. A. Garcia Rodriguez, M. A. Wallander, S. Johansson, andJ. Dent (2006). “Comparison of gastro-oesophageal reflux disease and heart-burn diagnoses in UK primary care”. In: Curr Med Res Opin 22.9, pp. 1661–8. issn: 0300-7995 (Print) 0300-7995. doi: 10.1185/030079906x120986.

Ruigomez, A., L. A. Garcia Rodriguez, M. A. Wallander, S. Johansson, andS. Eklund (2006). “Esophageal stricture: incidence, treatment patterns, andrecurrence rate”. In: Am J Gastroenterol 101.12, pp. 2685–92. issn: 0002-9270 (Print) 0002-9270. doi: 10.1111/j.1572-0241.2006.00828.x.

Ruigomez, A., L. A. Rodriguez, et al. (2006). “Chest pain in general practice:incidence, comorbidity and mortality”. In: Fam Pract 23.2, pp. 167–74. issn:0263-2136 (Print) 0263-2136. doi: 10.1093/fampra/cmi124.

Shah, A. D. and C. Martinez (2006). “An algorithm to derive a numerical dailydose from unstructured text dosage instructions”. In: PharmacoepidemiolDrug Saf 15.3, pp. 161–6. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.1151.

Smeeth, L., C. Cook, and A. J. Hall (2006). “Incidence of diagnosed polymyalgiarheumatica and temporal arteritis in the United Kingdom, 1990-2001”. In:Ann Rheum Dis 65.8, pp. 1093–8. issn: 0003-4967 (Print) 0003-4967. doi:10.1136/ard.2005.046912.

Smith, S. et al. (2006). “Reducing variation in antibacterial prescribing rates for’cough/cold’ and sore throat between 1993 and 2001: regional analyses usingthe general practice research database”. In: Public Health 120.8, pp. 752–9.issn: 0033-3506 (Print) 0033-3506. doi: 10.1016/j.puhe.2006.02.007.

Soedamah-Muthu, S. S. et al. (2006a). “All-cause mortality rates in patientswith type 1 diabetes mellitus compared with a non-diabetic population fromthe UK general practice research database, 1992-1999”. In: Diabetologia 49.4,pp. 660–6. issn: 0012-186X (Print) 0012-186x. doi: 10.1007/s00125-005-0120-4.

— (2006b). “High risk of cardiovascular disease in patients with type 1 diabetesin the U.K.: a cohort study using the general practice research database”.In: Diabetes Care 29.4, pp. 798–804. issn: 0149-5992 (Print) 0149-5992.

Solaymani-Dodaran, M. et al. (2006). “Fracture risk in people with primary bil-iary cirrhosis: a population-based cohort study”. In: Gastroenterology 131.6,pp. 1752–7. issn: 0016-5085 (Print) 0016-5085. doi: 10.1053/j.gastro.2006.09.012.

Souverein, P. C. et al. (2006). “Use of antiepileptic drugs and risk of frac-tures: case-control study among patients with epilepsy”. In: Neurology 66.9,pp. 1318–24. issn: 0028-3878. doi: 10.1212/01.wnl.0000210503.89488.88.

Staa, T. P. van et al. (2006). “Clinical assessment of the long-term risk of fracturein patients with rheumatoid arthritis”. In: Arthritis Rheum 54.10, pp. 3104–12. issn: 0004-3591 (Print) 0004-3591. doi: 10.1002/art.22117.

Stowe, J. et al. (2006). “Bell’s palsy and parenteral inactivated influenza vac-cine”. In: Hum Vaccin 2.3, pp. 110–2. issn: 1554-8600 (Print) 1554-8600.

Tam, C. C. et al. (2006). “Incidence of Guillain-Barre syndrome among patientswith Campylobacter infection: a general practice research database study”.In: J Infect Dis 194.1, pp. 95–7. issn: 0022-1899 (Print) 0022-1899. doi:10.1086/504294.

Tannen, R. L., M. G. Weiner, and S. M. Marcus (2006). “Simulation of theSyst-Eur randomized control trial using a primary care electronic medical

4

CPRD bibliography

214

hortinr

Highlight

record was feasible”. In: J Clin Epidemiol 59.3, pp. 254–64. issn: 0895-4356(Print) 0895-4356. doi: 10.1016/j.jclinepi.2005.08.008.

Verdel, B. M. et al. (2006). “Difference in risks of allergic reaction to sulfonamidedrugs based on chemical structure”. In: Ann Pharmacother 40.6, pp. 1040–6.issn: 1060-0280 (Print) 1060-0280. doi: 10.1345/aph.1G642.

Vries, C. S. de, S. E. Bromley, and R. D. Farmer (2006). “Myocardial infarctionrisk and hormone replacement: differences between products”. In: Maturitas53.3, pp. 343–50. issn: 0378-5122 (Print) 0378-5122. doi: 10 . 1016 / j .

maturitas.2005.06.004.Vries, F. de et al. (2006). “Reanalysis of two studies with contrasting results on

the association between statin use and fracture risk: the General PracticeResearch Database”. In: Int J Epidemiol 35.5, pp. 1301–8. issn: 0300-5771(Print) 0300-5771. doi: 10.1093/ije/dyl147.

West, J. et al. (2006). “Risk of schizophrenia in people with coeliac disease,ulcerative colitis and Crohn’s disease: a general population-based study”.In: Aliment Pharmacol Ther 23.1, pp. 71–4. issn: 0269-2813 (Print) 0269-2813. doi: 10.1111/j.1365-2036.2006.02720.x.

Williamson, I. et al. (2006). “Consultations for middle ear disease, antibioticprescribing and risk factors for reattendance: a case-linked cohort study”.In: Br J Gen Pract 56.524, pp. 170–5. issn: 0960-1643 (Print) 0960-1643.

5

CPRD bibliography

215

2005

Aberra, F. N. et al. (2005). “Antibiotic use and the risk of flare of inflammatorybowel disease”. In: Clin Gastroenterol Hepatol 3.5, pp. 459–65. issn: 1542-3565 (Print) 1542-3565.

Alonso, A. et al. (2005). “Recent use of oral contraceptives and the risk ofmultiple sclerosis”. In: Arch Neurol 62.9, pp. 1362–5. issn: 0003-9942 (Print)0003-9942. doi: 10.1001/archneur.62.9.1362.

Ashworth, M. et al. (2005). “Variations in antibiotic prescribing and consulta-tion rates for acute respiratory infection in UK general practices 1995-2000”.In: Br J Gen Pract 55.517, pp. 603–8. issn: 0960-1643 (Print) 0960-1643.

Black, C., J. A. Kaye, and H. Jick (2005). “Cesarean delivery in the UnitedKingdom: time trends in the general practice research database”. In: ObstetGynecol 106.1, pp. 151–5. issn: 0029-7844 (Print) 0029-7844. doi: 10.1097/01.AOG.0000160429.22836.c0.

Bradbury, B. D., T. L. Lash, et al. (2005). “Tamoxifen-treated breast carcinomapatients and the risk of acute myocardial infarction and newly-diagnosedangina”. In: Cancer 103.6, pp. 1114–21. issn: 0008-543X (Print) 0008-543x.doi: 10.1002/cncr.20900.

Bradbury, B. D., J. B. Wilk, and J. A. Kaye (2005). “Obesity and the risk ofprostate cancer (United States)”. In: Cancer Causes Control 16.6, pp. 637–41. issn: 0957-5243 (Print) 0957-5243. doi: 10.1007/s10552-005-0383-6.

Clifford, G. M., J. Logie, and R. D. Farmer (2005). “No risk of drug-associatedliver injury with alpha1-adrenoreceptor blocking agents in men with BPH:results from an observational study using the GPRD”. In: Pharmacoepi-demiol Drug Saf 14.2, pp. 75–80. issn: 1053-8569 (Print) 1053-8569. doi:10.1002/pds.973.

Cook, M. N. et al. (2005). “Glycemic control continues to deteriorate aftersulfonylureas are added to metformin among patients with type 2 diabetes”.In: Diabetes Care 28.5, pp. 995–1000. issn: 0149-5992 (Print) 0149-5992.

Currin, L. et al. (2005). “Time trends in eating disorder incidence”. In: Br JPsychiatry 186, pp. 132–5. issn: 0007-1250 (Print) 0007-1250. doi: 10.1192/bjp.186.2.132.

Dial, S. et al. (2005). “Use of gastric acid-suppressive agents and the riskof community-acquired Clostridium difficile-associated disease”. In: Jama294.23, pp. 2989–95. issn: 0098-7484. doi: 10.1001/jama.294.23.2989.

Dunn, N., C. Holmes, and M. Mullee (2005). “Does lithium therapy protectagainst the onset of dementia?” In: Alzheimer Dis Assoc Disord 19.1, pp. 20–2. issn: 0893-0341 (Print) 0893-0341.

Dunn, N., M. Mullee, et al. (2005). “Association between dementia and infec-tious disease: evidence from a case-control study”. In: Alzheimer Dis AssocDisord 19.2, pp. 91–4. issn: 0893-0341 (Print) 0893-0341.

Edwards, C. J. et al. (2005). “The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the UnitedKingdom General Practice Research Database”. In: Rheumatology (Oxford)44.11, pp. 1394–8. issn: 1462-0324 (Print) 1462-0324. doi: 10.1093/rheumatology/kei024.

1

CPRD bibliography

216

Fischer, L. M. et al. (2005). “Current use of nonsteroidal antiinflammatorydrugs and the risk of acute myocardial infarction”. In: Pharmacotherapy25.4, pp. 503–10. issn: 0277-0008 (Print) 0277-0008.

Fleming, D. M. et al. (2005). “Concerning: ’Why has antibiotic prescribingfor respiratory illness declined in primary care? A longitudinal study usingthe General Practice Research Database’”. In: J Public Health (Oxf) 27.2,pp. 228–9, 228–9. issn: 1741-3842 (Print) 1741-3842. doi: 10.1093/pubmed/fdi007.

Frisher, M. et al. (2005). “Substance misuse and psychiatric illness: prospectiveobservational study using the general practice research database”. In: JEpidemiol Community Health 59.10, pp. 847–50. issn: 0143-005X (Print)0143-005x. doi: 10.1136/jech.2004.030833.

Garcia Rodriguez, L. A. and A. Gonzalez-Perez (2005). “Use of antibiotics andrisk of breast cancer”. In: Am J Epidemiol 161.7, pp. 616–9. issn: 0002-9262(Print) 0002-9262. doi: 10.1093/aje/kwi087.

Gasse, C. et al. (2005). “Drug interactions and risk of acute bleeding lead-ing to hospitalisation or death in patients with chronic atrial fibrillationtreated with warfarin”. In: Thromb Haemost 94.3, pp. 537–43. issn: 0340-6245 (Print) 0340-6245. doi: 10.1160/th05-03-0166.

Gelfand, J. M. et al. (2005). “Prevalence and treatment of psoriasis in the UnitedKingdom: a population-based study”. In: Arch Dermatol 141.12, pp. 1537–41. issn: 0003-987X (Print) 0003-987x. doi: 10.1001/archderm.141.12.1537.

Giuli, F. de et al. (2005). “Incidence and outcome of persons with a clinicaldiagnosis of heart failure in a general practice population of 696,884 in theUnited Kingdom”. In: Eur J Heart Fail 7.3, pp. 295–302. issn: 1388-9842(Print) 1388-9842. doi: 10.1016/j.ejheart.2004.10.017.

Gonzalez-Perez, A. and L. A. Garcia Rodriguez (2005a). “Breast cancer riskamong users of antidepressant medications”. In: Epidemiology 16.1, pp. 101–5. issn: 1044-3983 (Print) 1044-3983.

— (2005b). “Prostate cancer risk among men with diabetes mellitus (Spain)”.In: Cancer Causes Control 16.9, pp. 1055–8. issn: 0957-5243 (Print) 0957-5243. doi: 10.1007/s10552-005-4705-5.

Gulliford, M. C., G. Adams, et al. (2005). “Intraclass correlation coefficientand outcome prevalence are associated in clustered binary data”. In: J ClinEpidemiol 58.3, pp. 246–51. issn: 0895-4356 (Print) 0895-4356. doi: 10.

1016/j.jclinepi.2004.08.012.Gulliford, M. C., J. Charlton, and R. Latinovic (2005a). “Increased utilization

of primary care 5 years before diagnosis of type 2 diabetes: a matched cohortstudy”. In: Diabetes Care 28.1, pp. 47–52. issn: 0149-5992 (Print) 0149-5992.

— (2005b). “Trends in antihypertensive and lipid-lowering therapy in subjectswith type II diabetes: clinical effectiveness or clinical discretion?” In: J HumHypertens 19.2, pp. 111–7. issn: 0950-9240 (Print) 0950-9240. doi: 10.1038/sj.jhh.1001787.

Gupta, G., J. M. Gelfand, and J. D. Lewis (2005). “Increased risk for demyeli-nating diseases in patients with inflammatory bowel disease”. In: Gastroen-terology 129.3, pp. 819–26. issn: 0016-5085 (Print) 0016-5085. doi: 10.1053/j.gastro.2005.06.022.

2

CPRD bibliography

217

hortinr

Highlight

hortinr

Highlight

Hamilton, W. T. et al. (2005). “The prognosis of different fatigue diagnosticlabels: a longitudinal survey”. In: Fam Pract 22.4, pp. 383–8. issn: 0263-2136 (Print) 0263-2136. doi: 10.1093/fampra/cmi021.

Helms, P. J. et al. (2005). “Utility of routinely acquired primary care datafor paediatric disease epidemiology and pharmacoepidemiology”. In: Br JClin Pharmacol 59.6, pp. 684–90. issn: 0306-5251 (Print) 0306-5251. doi:10.1111/j.1365-2125.2005.02404.x.

Hernan, M. A. et al. (2005). “Cigarette smoking and the progression of multiplesclerosis”. In: Brain 128.Pt 6, pp. 1461–5. issn: 0006-8950. doi: 10.1093/brain/awh471.

Huerta, C., J. Castellsague, et al. (2005). “Nonsteroidal anti-inflammatory drugsand risk of ARF in the general population”. In: Am J Kidney Dis 45.3,pp. 531–9. issn: 0272-6386. doi: 10.1053/j.ajkd.2004.12.005.

Huerta, C., S. F. Lanes, and L. A. Garcia Rodriguez (2005). “Respiratory medi-cations and the risk of cardiac arrhythmias”. In: Epidemiology 16.3, pp. 360–6. issn: 1044-3983 (Print) 1044-3983.

Hugenholtz, G. W. et al. (2005). “Risk of hip/femur fractures in patients usingantipsychotics”. In: Bone 37.6, pp. 864–70. issn: 8756-3282 (Print) 1873-2763. doi: 10.1016/j.bone.2005.07.005.

Joseph, C., N. Goddard, and D. Gelb (2005). “Influenza vaccine uptake anddistribution in England and Wales using data from the General Practice Re-search Database, 1989/90-2003/04”. In: J Public Health (Oxf) 27.4, pp. 371–7. issn: 1741-3842 (Print) 1741-3842. doi: 10.1093/pubmed/fdi054.

Kaye, J. A. and H. Jick (2005). “Antibiotics and the risk of breast cancer”. In:Epidemiology 16.5, pp. 688–90. issn: 1044-3983 (Print) 1044-3983.

Kiri, V. A., G. Bettoncelli, et al. (2005). “Inhaled corticosteroids are moreeffective in COPD patients when used with LABA than with SABA”. In:Respir Med 99.9, pp. 1115–24. issn: 0954-6111 (Print) 0954-6111. doi: 10.1016/j.rmed.2005.02.018.

Kiri, V. A., N. B. Pride, et al. (2005). “Inhaled corticosteroids in chronic ob-structive pulmonary disease: results from two observational designs free ofimmortal time bias”. In: Am J Respir Crit Care Med 172.4, pp. 460–4. issn:1073-449X (Print) 1073-449x. doi: 10.1164/rccm.200502-210OC.

Koro, C. E., S. J. Bowlin, and S. R. Weiss (2005). “Antidiabetic therapy andthe risk of heart failure in type 2 diabetic patients: an independent effect orconfounding by indication”. In: Pharmacoepidemiol Drug Saf 14.10, pp. 697–703. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.1069.

Lawson, A. et al. (2005). “Autoimmune cholestatic liver disease in people withcoeliac disease: a population-based study of their association”. In: AlimentPharmacol Ther 21.4, pp. 401–5. issn: 0269-2813 (Print) 0269-2813. doi:10.1111/j.1365-2036.2005.02328.x.

Lewis, J. D. et al. (2005). “The relationship between time since registrationand measured incidence rates in the General Practice Research Database”.In: Pharmacoepidemiol Drug Saf 14.7, pp. 443–51. issn: 1053-8569 (Print)1053-8569. doi: 10.1002/pds.1115.

Logie, J., G. M. Clifford, and R. D. Farmer (2005). “Incidence, prevalence andmanagement of lower urinary tract symptoms in men in the UK”. In: BJU Int95.4, pp. 557–62. issn: 1464-4096 (Print) 1464-4096. doi: 10.1111/j.1464-410X.2005.05339.x.

3

CPRD bibliography

218

Margolis, D. J. et al. (2005). “Antibiotic treatment of acne may be associatedwith upper respiratory tract infections”. In: Arch Dermatol 141.9, pp. 1132–6. issn: 0003-987X (Print) 0003-987x. doi: 10.1001/archderm.141.9.1132.

Martinez, C. et al. (2005). “Antidepressant treatment and the risk of fatal andnon-fatal self harm in first episode depression: nested case-control study”. In:Bmj 330.7488, p. 389. issn: 0959-8138. doi: 10.1136/bmj.330.7488.389.

Maru, S. et al. (2005). “Antidiabetic drugs and heart failure risk in patientswith type 2 diabetes in the U.K. primary care setting”. In: Diabetes Care28.1, pp. 20–6. issn: 0149-5992 (Print) 0149-5992.

Mikuls, T. R., J. T. Farrar, W. B. Bilker, S. Fernandes, and K. G. Saag (2005).“Suboptimal physician adherence to quality indicators for the managementof gout and asymptomatic hyperuricaemia: results from the UK GeneralPractice Research Database (GPRD)”. In: Rheumatology (Oxford) 44.8, pp. 1038–42. issn: 1462-0324 (Print) 1462-0324. doi: 10.1093/rheumatology/keh679.

Mikuls, T. R., J. T. Farrar, W. B. Bilker, S. Fernandes, Jr. Schumacher H. R.,et al. (2005). “Gout epidemiology: results from the UK General PracticeResearch Database, 1990-1999”. In: Ann Rheum Dis 64.2, pp. 267–72. issn:0003-4967 (Print) 0003-4967. doi: 10.1136/ard.2004.024091.

Mines, D. et al. (2005). “Prevalence of risk factors for suicide in patients pre-scribed venlafaxine, fluoxetine, and citalopram”. In: Pharmacoepidemiol DrugSaf 14.6, pp. 367–72. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.1095.

Ruigomez, A., S. Johansson, et al. (2005). “Predictors and prognosis of parox-ysmal atrial fibrillation in general practice in the UK”. In: BMC CardiovascDisord 5, p. 20. issn: 1471-2261. doi: 10.1186/1471-2261-5-20.

Ruigomez, A., L. A. Rodriguez, et al. (2005). “Gastroesophageal reflux diseaseand asthma: a longitudinal study in UK general practice”. In: Chest 128.1,pp. 85–93. issn: 0012-3692 (Print) 0012-3692. doi: 10.1378/chest.128.1.85.

Russmann, S. et al. (2005). “Risk of cholestatic liver disease associated withflucloxacillin and flucloxacillin prescribing habits in the UK: cohort studyusing data from the UK General Practice Research Database”. In: Br JClin Pharmacol 60.1, pp. 76–82. issn: 0306-5251 (Print) 0306-5251. doi:10.1111/j.1365-2125.2005.02370.x.

Ryan, R. et al. (2005). “New cases of diabetes mellitus in England and Wales,1994-1998: database study”. In: Public Health 119.10, pp. 892–9. issn: 0033-3506 (Print) 0033-3506. doi: 10.1016/j.puhe.2005.03.011.

Shao, T. and Y. X. Yang (2005). “Cholecystectomy and the risk of colorectalcancer”. In: Am J Gastroenterol 100.8, pp. 1813–20. issn: 0002-9270 (Print)0002-9270. doi: 10.1111/j.1572-0241.2005.41610.x.

Smeeth, L. et al. (2005). “A case control study of age related macular degen-eration and use of statins”. In: Br J Ophthalmol 89.9, pp. 1171–5. issn:0007-1161 (Print) 0007-1161. doi: 10.1136/bjo.2004.064477.

Solaymani-Dodaran, M. et al. (2005). “Mortality associated with Barrett’s esoph-agus and gastroesophageal reflux disease diagnoses-a population-based co-hort study”. In: Am J Gastroenterol 100.12, pp. 2616–21. issn: 0002-9270(Print) 0002-9270. doi: 10.1111/j.1572-0241.2005.00340.x.

Soriano, J. B. et al. (2005). “Patterns of comorbidities in newly diagnosed COPDand asthma in primary care”. In: Chest 128.4, pp. 2099–107. issn: 0012-3692(Print) 0012-3692. doi: 10.1378/chest.128.4.2099.

4

CPRD bibliography

219

Souverein, P. C. et al. (2005). “Incidence of fractures among epilepsy patients:a population-based retrospective cohort study in the General Practice Re-search Database”. In: Epilepsia 46.2, pp. 304–10. issn: 0013-9580 (Print)0013-9580. doi: 10.1111/j.0013-9580.2005.23804.x.

Staa, T. P. van, T. Card, et al. (2005). “5-Aminosalicylate use and colorectalcancer risk in inflammatory bowel disease: a large epidemiological study”.In: Gut 54.11, pp. 1573–8. issn: 0017-5749 (Print) 0017-5749. doi: 10.1136/gut.2005.070896.

Staa, T. P. van, P. Geusens, et al. (2005). “A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids”. In: Qjm 98.3,pp. 191–8. issn: 1460-2725 (Print) 1460-2393. doi: 10.1093/qjmed/hci029.

Sullivan, C. O. et al. (2005). “Case-mix and variation in specialist referrals ingeneral practice”. In: Br J Gen Pract 55.516, pp. 529–33. issn: 0960-1643(Print) 0960-1643.

Tata, L. J. et al. (2005). “General population based study of the impact oftricyclic and selective serotonin reuptake inhibitor antidepressants on therisk of acute myocardial infarction”. In: Heart 91.4, pp. 465–71. issn: 1355-6037. doi: 10.1136/hrt.2004.037457.

Vries, C. S. de et al. (2005). “Tibolone and endometrial cancer: a cohort andnested case-control study in the UK”. In: Drug Saf 28.3, pp. 241–9. issn:0114-5916 (Print) 0114-5916.

Vries, F. de et al. (2005). “Severity of obstructive airway disease and risk ofosteoporotic fracture”. In: Eur Respir J 25.5, pp. 879–84. issn: 0903-1936(Print) 0903-1936. doi: 10.1183/09031936.05.00058204.

Wade, A. G., I. Toumi, and M. E. Hemels (2005). “A probabilistic cost-effectivenessanalysis of escitalopram, generic citalopram and venlafaxine as a first-linetreatment of major depressive disorder in the UK”. In: Curr Med Res Opin21.4, pp. 631–42. issn: 0300-7995 (Print) 0300-7995. doi: 10.1185/030079905x41462.

Watson, L. et al. (2005). “Obtaining optimal control in mild asthma: theory andpractice”. In: Fam Pract 22.3, pp. 305–10. issn: 0263-2136 (Print) 0263-2136.doi: 10.1093/fampra/cmi013.

Yang, Y. X., S. Hennessy, and J. D. Lewis (2005). “Type 2 diabetes mellitus andthe risk of colorectal cancer”. In: Clin Gastroenterol Hepatol 3.6, pp. 587–94.issn: 1542-3565 (Print) 1542-3565.

5

CPRD bibliography

220

2004

Abajo, F. J. de et al. (2004). “Acute and clinically relevant drug-induced liverinjury: a population based case-control study”. In: Br J Clin Pharmacol58.1, pp. 71–80. issn: 0306-5251 (Print) 0306-5251. doi: 10.1111/j.1365-2125.2004.02133.x.

Andrews, N. et al. (2004). “Thimerosal exposure in infants and developmentaldisorders: a retrospective cohort study in the United kingdom does notsupport a causal association”. In: Pediatrics 114.3, pp. 584–91. issn: 0031-4005. doi: 10.1542/peds.2003-1177-L.

Apter, A. J. et al. (2004). “Represcription of penicillin after allergic-like events”.In: J Allergy Clin Immunol 113.4, pp. 764–70. issn: 0091-6749 (Print) 0091-6749. doi: 10.1016/j.jaci.2003.11.032.

Ashworth, M. et al. (2004). “Why has antibiotic prescribing for respiratoryillness declined in primary care? A longitudinal study using the GeneralPractice Research Database”. In: J Public Health (Oxf) 26.3, pp. 268–74.issn: 1741-3842 (Print) 1741-3842. doi: 10.1093/pubmed/fdh160.

Boyle, P. et al. (2004). “5-Alpha reductase inhibition provides superior benefitsto alpha blockade by preventing AUR and BPH-related surgery”. In: EurUrol 45.5, pp. 620–6, 620–6. issn: 0302-2838 (Print) 0302-2838. doi: 10.1016/j.eururo.2003.09.012.

Bradbury, B. D. and H. Jick (2004). “In vitro fertilization and childhood retinoblas-toma”. In: Br J Clin Pharmacol 58.2, pp. 209–11. issn: 0306-5251 (Print)0306-5251. doi: 10.1111/j.1365-2125.2004.02109.x.

Bradbury, B. D., T. L. Lash, et al. (2004). “Tamoxifen and cataracts: a nullassociation”. In: Breast Cancer Res Treat 87.2, pp. 189–96. issn: 0167-6806(Print) 0167-6806. doi: 10.1023/b:brea.0000041626.76694.85.

Bromley, S. E., C. S. de Vries, and R. D. Farmer (2004). “Utilisation of hormonereplacement therapy in the United Kingdom. A descriptive study using thegeneral practice research database”. In: Bjog 111.4, pp. 369–76. issn: 1470-0328 (Print) 1470-0328.

Card, T., R. F. Logan, et al. (2004). “Antibiotic use and the development ofCrohn’s disease”. In: Gut 53.2, pp. 246–50. issn: 0017-5749 (Print) 0017-5749.

Card, T., J. West, et al. (2004). “Hip fractures in patients with inflammatorybowel disease and their relationship to corticosteroid use: a population basedcohort study”. In: Gut 53.2, pp. 251–5. issn: 0017-5749 (Print) 0017-5749.

Carey, I. M. et al. (2004). “Developing a large electronic primary care database(Doctors’ Independent Network) for research”. In: Int J Med Inform 73.5,pp. 443–53. issn: 1386-5056 (Print) 1386-5056. doi: 10.1016/j.ijmedinf.2004.02.002.

Cleary, P., S. Shorvon, and R. Tallis (2004). “Late-onset seizures as a predictorof subsequent stroke”. In: Lancet 363.9416, pp. 1184–6. issn: 0140-6736. doi:10.1016/s0140-6736(04)15946-1.

Cooper, C. et al. (2004). “Epidemiology of childhood fractures in Britain: a studyusing the general practice research database”. In: J Bone Miner Res 19.12,pp. 1976–81. issn: 0884-0431 (Print) 0884-0431. doi: 10.1359/jbmr.040902.

1

CPRD bibliography

221

De Wilde, S. et al. (2004). “A comparison of the recording of 30 common child-hood conditions in the Doctor’s Independent Network and General Prac-tice Research Databases”. In: Health Stat Q 22, pp. 21–31. issn: 1465-1645(Print) 1465-1645.

Fischer, L. M., R. G. Schlienger, C. M. Matter, et al. (2004). “Discontinuationof nonsteroidal anti-inflammatory drug therapy and risk of acute myocardialinfarction”. In: Arch Intern Med 164.22, pp. 2472–6. issn: 0003-9926 (Print)0003-9926. doi: 10.1001/archinte.164.22.2472.

Fischer, L. M., R. G. Schlienger, C. Matter, et al. (2004). “Effect of rheumatoidarthritis or systemic lupus erythematosus on the risk of first-time acutemyocardial infarction”. In: Am J Cardiol 93.2, pp. 198–200. issn: 0002-9149(Print) 0002-9149.

Fombonne, E. et al. (2004). “Validation of the diagnosis of autism in generalpractitioner records”. In: BMC Public Health 4, p. 5. issn: 1471-2458. doi:10.1186/1471-2458-4-5.

Frisher, M. et al. (2004). “Prevalence of comorbid psychiatric illness and sub-stance misuse in primary care in England and Wales”. In: J Epidemiol Com-munity Health 58.12, pp. 1036–41. issn: 0143-005X (Print) 0143-005x. doi:10.1136/jech.2003.017384.

Gaitatzis, A. et al. (2004). “The epidemiology of the comorbidity of epilepsy inthe general population”. In: Epilepsia 45.12, pp. 1613–22. issn: 0013-9580(Print) 0013-9580. doi: 10.1111/j.0013-9580.2004.17504.x.

Gallagher, A. M. et al. (2004). “Incidence of fatigue symptoms and diagnosespresenting in UK primary care from 1990 to 2001”. In: J R Soc Med 97.12,pp. 571–5. issn: 0141-0768 (Print) 0141-0768. doi: 10.1258/jrsm.97.12.571.

Garcia Rodriguez, L. A. and A. Gonzalez-Perez (2004a). “Inverse association be-tween nonsteroidal anti-inflammatory drugs and prostate cancer”. In: Can-cer Epidemiol Biomarkers Prev 13.4, pp. 649–53. issn: 1055-9965 (Print)1055-9965.

— (2004b). “Risk of breast cancer among users of aspirin and other anti-inflammatory drugs”. In: Br J Cancer 91.3, pp. 525–9. issn: 0007-0920(Print) 0007-0920. doi: 10.1038/sj.bjc.6602003.

Geoghegan, J. M. et al. (2004). “Risk factors in carpal tunnel syndrome”. In:J Hand Surg Br 29.4, pp. 315–20. issn: 0266-7681 (Print) 0266-7681. doi:10.1016/j.jhsb.2004.02.009.

Gonzalez-Perez, A., G. Ronquist, and L. A. Garcia Rodriguez (2004). “Breastcancer incidence and use of antihypertensive medication in women”. In:Pharmacoepidemiol Drug Saf 13.8, pp. 581–5. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.910.

Hall, G. C. et al. (2004). “Triptans in migraine: the risks of stroke, cardiovasculardisease, and death in practice”. In: Neurology 62.4, pp. 563–8. issn: 0028-3878.

Hansell, A. L. et al. (2004). “Medical event profiling of COPD patients”. In:Pharmacoepidemiol Drug Saf 13.8, pp. 547–55. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.931.

Hardy, J. R. et al. (2004). “Strategies for identifying pregnancies in the au-tomated medical records of the General Practice Research Database”. In:Pharmacoepidemiol Drug Saf 13.11, pp. 749–59. issn: 1053-8569 (Print)1053-8569. doi: 10.1002/pds.935.

2

CPRD bibliography

222

hortinr

Highlight

Hennessy, S. et al. (2004). “Comparative cardiac safety of low-dose thioridazineand low-dose haloperidol”. In: Br J Clin Pharmacol 58.1, pp. 81–7. issn:0306-5251 (Print) 0306-5251. doi: 10.1111/j.1365-2125.2004.02098.x.

Hernan, M. A., S. S. Jick, et al. (2004). “Recombinant hepatitis B vaccineand the risk of multiple sclerosis: a prospective study”. In: Neurology 63.5,pp. 838–42. issn: 0028-3878.

Hernan, M. A., G. Logroscino, and L. A. Rodriguez (2004). “A prospective studyof alcoholism and the risk of Parkinson’s disease”. In: J Neurol 251 Suppl 7,pp. vII14–7. issn: 0340-5354 (Print) 0340-5354. doi: 10.1007/s00415-004-1705-4.

Howard, L. M. et al. (2004). “The psychosocial outcome of pregnancy in womenwith psychotic disorders”. In: Schizophr Res 71.1, pp. 49–60. issn: 0920-9964(Print) 0920-9964. doi: 10.1016/j.schres.2004.01.003.

Jick, H. and J. A. Kaye (2004). “Autism and DPT vaccination in the UnitedKingdom”. In: N Engl J Med 350.26, pp. 2722–3. issn: 0028-4793. doi:10.1056/nejm200406243502623.

Jick, H., J. A. Kaye, and C. Black (2004). “Incidence and prevalence of drug-treated attention deficit disorder among boys in the UK”. In: Br J Gen Pract54.502, pp. 345–7. issn: 0960-1643 (Print) 0960-1643.

Jick, H., J. A. Kaye, and S. S. Jick (2004). “Antidepressants and the riskof suicidal behaviors”. In: Jama 292.3, pp. 338–43. issn: 0098-7484. doi:10.1001/jama.292.3.338.

Jick, S. S. and B. D. Bradbury (2004). “Statins and newly diagnosed diabetes”.In: Br J Clin Pharmacol 58.3, pp. 303–9. issn: 0306-5251 (Print) 0306-5251.doi: 10.1111/j.1365-2125.2004.02142.x.

Kaye, J. A. and H. Jick (2004a). “Epidemiology of lower limb fractures in generalpractice in the United Kingdom”. In: Inj Prev 10.6, pp. 368–74. issn: 1353-8047 (Print) 1353-8047. doi: 10.1136/ip.2004.005843.

— (2004b). “Statin use and cancer risk in the General Practice Research Database”.In: Br J Cancer 90.3, pp. 635–7. issn: 0007-0920 (Print) 0007-0920. doi:10.1038/sj.bjc.6601566.

Lewis, J. D., F. N. Aberra, et al. (2004). “Seasonal variation in flares of in-flammatory bowel disease”. In: Gastroenterology 126.3, pp. 665–73. issn:0016-5085 (Print) 0016-5085.

Lewis, J. D. and C. Brensinger (2004). “Agreement between GPRD smokingdata: a survey of general practitioners and a population-based survey”. In:Pharmacoepidemiol Drug Saf 13.7, pp. 437–41. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.902.

Mangtani, P. et al. (2004). “A cohort study of the effectiveness of influenza vac-cine in older people, performed using the United Kingdom general practiceresearch database”. In: J Infect Dis 190.1, pp. 1–10. issn: 0022-1899 (Print)0022-1899. doi: 10.1086/421274.

Margolis, D. J., J. Knauss, and W. Bilker (2004). “Medical conditions associatedwith venous leg ulcers”. In: Br J Dermatol 150.2, pp. 267–73. issn: 0007-0963(Print) 0007-0963.

McKeever, T. M. et al. (2004). “Vaccination and allergic disease: a birth cohortstudy”. In: Am J Public Health 94.6, pp. 985–9. issn: 0090-0036 (Print)0090-0036.

3

CPRD bibliography

223

hortinr

Highlight

Meier, C. R., K. Wilcock, and S. S. Jick (2004). “The risk of severe depression,psychosis or panic attacks with prophylactic antimalarials”. In: Drug Saf27.3, pp. 203–13. issn: 0114-5916 (Print) 0114-5916.

Morant, S. V. et al. (2004). “Application of a propensity score to adjust for chan-nelling bias with NSAIDs”. In: Pharmacoepidemiol Drug Saf 13.6, pp. 345–53. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.946.

Murray, M. L., C. S. de Vries, and I. C. Wong (2004). “A drug utilisation studyof antidepressants in children and adolescents using the General PracticeResearch Database”. In: Arch Dis Child 89.12, pp. 1098–102. issn: 0003-9888. doi: 10.1136/adc.2004.064956.

Nightingale, A. L. and R. D. Farmer (2004). “Ischemic stroke in young women: anested case-control study using the UK General Practice Research Database”.In: Stroke 35.7, pp. 1574–8. issn: 0039-2499. doi: 10.1161/01.STR.0000129789.58837.e4.

Peng, M. M. and H. Jick (2004). “A population-based study of the incidence,cause, and severity of anaphylaxis in the United Kingdom”. In: Arch InternMed 164.3, pp. 317–9. issn: 0003-9926 (Print) 0003-9926. doi: 10.1001/archinte.164.3.317.

Ronquist, G. et al. (2004). “Association between captopril, other antihyperten-sive drugs and risk of prostate cancer”. In: Prostate 58.1, pp. 50–6. issn:0270-4137 (Print) 0270-4137. doi: 10.1002/pros.10294.

Ruigomez, A. et al. (2004). “Natural history of gastro-oesophageal reflux diseasediagnosed in general practice”. In: Aliment Pharmacol Ther 20.7, pp. 751–60. issn: 0269-2813 (Print) 0269-2813. doi: 10.1111/j.1365-2036.2004.02169.x.

Schlienger, R. G., L. M. Fischer, et al. (2004). “Current use of selective serotoninreuptake inhibitors and risk of acute myocardial infarction”. In: Drug Saf27.14, pp. 1157–65. issn: 0114-5916 (Print) 0114-5916.

Schlienger, R. G., S. S. Jick, and C. R. Meier (2004). “Inhaled corticosteroidsand the risk of fractures in children and adolescents”. In: Pediatrics 114.2,pp. 469–73. issn: 0031-4005.

Schlienger, R. G., M. E. Kraenzlin, et al. (2004). “Use of beta-blockers and riskof fractures”. In: Jama 292.11, pp. 1326–32. issn: 0098-7484. doi: 10.1001/jama.292.11.1326.

Seaman, H. E., C. S. de Vries, and R. D. Farmer (2004). “Venous thromboem-bolism associated with cyproterone acetate in combination with ethiny-loestradiol (Dianette): observational studies using the UK General Prac-tice Research Database”. In: Pharmacoepidemiol Drug Saf 13.7, pp. 427–36.issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.896.

Smeeth, L., C. Cook, E. Fombonne, et al. (2004). “MMR vaccination and per-vasive developmental disorders: a case-control study”. In: Lancet 364.9438,pp. 963–9. issn: 0140-6736. doi: 10.1016/s0140-6736(04)17020-7.

Smeeth, L., C. Cook, P. E. Fombonne, et al. (2004). “Rate of first recordeddiagnosis of autism and other pervasive developmental disorders in UnitedKingdom general practice, 1988 to 2001”. In: BMC Med 2, p. 39. issn: 1741-7015. doi: 10.1186/1741-7015-2-39.

Smeeth, L., S. L. Thomas, et al. (2004). “Risk of myocardial infarction and strokeafter acute infection or vaccination”. In: N Engl J Med 351.25, pp. 2611–8.issn: 0028-4793. doi: 10.1056/NEJMoa041747.

4

CPRD bibliography

224

Smith, G. E. et al. (2004). “What has happened to antimicrobial usage inprimary care in the United Kingdom since the SMAC report? - descrip-tion of trends in antimicrobial usage using the General Practice ResearchDatabase”. In: J Public Health (Oxf) 26.4, pp. 359–64. issn: 1741-3842(Print) 1741-3842. doi: 10.1093/pubmed/fdh179.

Solaymani-Dodaran, M. et al. (2004). “Risk of extra-oesophageal malignanciesand colorectal cancer in Barrett’s oesophagus and gastro-oesophageal re-flux”. In: Scand J Gastroenterol 39.7, pp. 680–5. issn: 0036-5521 (Print)0036-5521. doi: 10.1080/00365520410004802.

Souverein, P. C. et al. (2004). “Use of oral glucocorticoids and risk of cardiovas-cular and cerebrovascular disease in a population based case-control study”.In: Heart 90.8, pp. 859–65. issn: 1355-6037. doi: 10 . 1136 / hrt . 2003 .

020180.Staa, T. P. van, N. Bishop, et al. (2004). “Are inhaled corticosteroids associated

with an increased risk of fracture in children?” In: Osteoporos Int 15.10,pp. 785–91. issn: 0937-941X (Print) 0937-941x. doi: 10.1007/s00198-004-1606-5.

Staa, T. P. van, S. Travis, et al. (2004). “5-aminosalicylic acids and the riskof renal disease: a large British epidemiologic study”. In: Gastroenterology126.7, pp. 1733–9. issn: 0016-5085 (Print) 0016-5085.

Torgerson, D. J. et al. (2004). “Pharmaceutical treatment of symptomatic ver-tebral fractures in primary care”. In: Ann Rheum Dis 63.7, pp. 853–6. issn:0003-4967 (Print) 0003-4967. doi: 10.1136/ard.2003.013508.

Van De Vijver, D. A., T. Walley, and H. Petri (2004). “Epidemiology of restlesslegs syndrome as diagnosed in UK primary care”. In: Sleep Med 5.5, pp. 435–40. issn: 1389-9457 (Print) 1389-9457. doi: 10.1016/j.sleep.2004.07.003.

Varney, S. J. and J. F. Guest (2004). “Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contracep-tion in the UK”. In: Pharmacoeconomics 22.17, pp. 1141–51. issn: 1170-7690(Print) 1170-7690.

West, J., R. F. Logan, T. R. Card, et al. (2004). “Risk of vascular disease inadults with diagnosed coeliac disease: a population-based study”. In: AlimentPharmacol Ther 20.1, pp. 73–9. issn: 0269-2813 (Print) 0269-2813. doi:10.1111/j.1365-2036.2004.02008.x.

West, J., R. F. Logan, C. J. Smith, et al. (2004). “Malignancy and mortalityin people with coeliac disease: population based cohort study”. In: Bmj329.7468, pp. 716–9. issn: 0959-8138. doi: 10.1136/bmj.38169.486701.7C.

Yang, Y. X., S. Hennessy, and J. D. Lewis (2004). “Insulin therapy and colorectalcancer risk among type 2 diabetes mellitus patients”. In: Gastroenterology127.4, pp. 1044–50. issn: 0016-5085 (Print) 0016-5085.

Zhou, Z. et al. (2004). “Persistency and treatment failure in newly diagnosedopen angle glaucoma patients in the United Kingdom”. In: Br J Ophthalmol88.11, pp. 1391–4. issn: 0007-1161 (Print) 0007-1161. doi: 10.1136/bjo.2003.037713.

5

CPRD bibliography

225

2003

Black, C., J. A. Kaye, and H. Jick (2003). “MMR vaccine and idiopathic throm-bocytopaenic purpura”. In: Br J Clin Pharmacol 55.1, pp. 107–11. issn:0306-5251 (Print) 0306-5251.

Blumentals, W. A., R. R. Brown, and A. Gomez-Caminero (2003). “Antihyper-tensive treatment and erectile dysfunction in a cohort of type II diabetespatients”. In: Int J Impot Res 15.5, pp. 314–7. issn: 0955-9930 (Print) 0955-9930. doi: 10.1038/sj.ijir.3901041.

Bremner, S. A. et al. (2003). “Early-life exposure to antibacterials and the sub-sequent development of hayfever in childhood in the UK: case-control studiesusing the General Practice Research Database and the Doctors’ IndependentNetwork”. In: Clin Exp Allergy 33.11, pp. 1518–25. issn: 0954-7894 (Print)0954-7894.

Card, T., R. Hubbard, and R. F. Logan (2003). “Mortality in inflammatorybowel disease: a population-based cohort study”. In: Gastroenterology 125.6,pp. 1583–90. issn: 0016-5085 (Print) 0016-5085.

Carey, I. M. et al. (2003). “Implications of the problem orientated medical record(POMR) for research using electronic GP databases: a comparison of theDoctors Independent Network Database (DIN) and the General PracticeResearch Database (GPRD)”. In: BMC Fam Pract 4, p. 14. issn: 1471-2296.doi: 10.1186/1471-2296-4-14.

Deschaseaux-Voinet, C., A. Lafuma, and G. Berdeaux (2003). “Cost and effec-tiveness of brinzolamide versus dorzolamide in current practice: an analysisbased on the UK-GPRD database”. In: J Med Econ 6.1-4, pp. 69–78.

Forrest, C. B. et al. (2003). “Referral of children to specialists in the UnitedStates and the United kingdom”. In: Arch Pediatr Adolesc Med 157.3, pp. 279–85. issn: 1072-4710 (Print) 1072-4710.

Garcia Rodriguez, L. A. and S. Hernandez-Diaz (2003). “Nonsteroidal antiin-flammatory drugs as a trigger of clinical heart failure”. In: Epidemiology14.2, pp. 240–6. issn: 1044-3983 (Print) 1044-3983. doi: 10.1097/01.ede.0000034633.74133.c3.

Gelfand, J. M. et al. (2003). “Lymphoma rates are low but increased in patientswith psoriasis: results from a population-based cohort study in the UnitedKingdom”. In: Arch Dermatol 139.11, pp. 1425–9. issn: 0003-987X (Print)0003-987x. doi: 10.1001/archderm.139.11.1425.

Hoare, J (2003). “Comparison of area-based inequality measures and diseasemorbidity in England, 1994–1998.” In: Health Stat Q 18, pp. 18–24.

Hoare, J., M. Bruce, and A. Majeed (2003). “Prevalence of treated asthma andits management in general practice in England and Wales, 1994–1998”. In:Health Stat Q 17, pp. 15–22.

Hollowell, J. et al. (2003). “The incidence of bleeding complications associatedwith warfarin treatment in general practice in the United Kingdom”. In: BrJ Gen Pract 53.489, pp. 312–4. issn: 0960-1643 (Print) 0960-1643.

Howard, L. M. et al. (2003). “Medical outcome of pregnancy in women withpsychotic disorders and their infants in the first year after birth”. In: Br JPsychiatry 182, pp. 63–7. issn: 0007-1250 (Print) 0007-1250.

1

CPRD bibliography

226

Hubbard, R. et al. (2003). “Exposure to tricyclic and selective serotonin re-uptake inhibitor antidepressants and the risk of hip fracture”. In: Am JEpidemiol 158.1, pp. 77–84. issn: 0002-9262 (Print) 0002-9262.

Huerta, C. et al. (2003). “Users of oral steroids are at a reduced risk of developingirritable bowel syndrome”. In: Pharmacoepidemiol Drug Saf 12.7, pp. 583–8.issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.836.

Jick, H. and J. A. Kaye (2003). “Epidemiology and possible causes of autism”.In: Pharmacotherapy 23.12, pp. 1524–30. issn: 0277-0008 (Print) 0277-0008.

Jick, S. S. et al. (2003). “Validity of the general practice research database”. In:Pharmacotherapy 23.5, pp. 686–9. issn: 0277-0008 (Print) 0277-0008.

Kaye, J. A., B. D. Bradbury, and H. Jick (2003). “Changes in antipsychoticdrug prescribing by general practitioners in the United Kingdom from 1991to 2000: a population-based observational study”. In: Br J Clin Pharmacol56.5, pp. 569–75. issn: 0306-5251 (Print) 0306-5251.

Kaye, J. A. and H. Jick (2003). “Incidence of erectile dysfunction and char-acteristics of patients before and after the introduction of sildenafil in theUnited Kingdom: cross sectional study with comparison patients”. In: Bmj326.7386, pp. 424–5. issn: 0959-8138. doi: 10.1136/bmj.326.7386.424.

Linden, P. D. van der et al. (2003). “Increased risk of achilles tendon rupturewith quinolone antibacterial use, especially in elderly patients taking oralcorticosteroids”. In: Arch Intern Med 163.15, pp. 1801–7. issn: 0003-9926(Print) 0003-9926. doi: 10.1001/archinte.163.15.1801.

MacDonald, T. M. et al. (2003). “Channelling bias and the incidence of gastroin-testinal haemorrhage in users of meloxicam, coxibs, and older, non-specificnon-steroidal anti-inflammatory drugs”. In: Gut 52.9, pp. 1265–70. issn:0017-5749 (Print) 0017-5749.

Margolis, D. J. et al. (2003). “Medical conditions as risk factors for pressureulcers in an outpatient setting”. In: Age Ageing 32.3, pp. 259–64. issn: 0002-0729 (Print) 0002-0729.

McInnes, G. T. (2003). “The differences between ACE inhibitor-treated andcalcium channel blocker-treated hypertensive patients”. In: J Clin Hypertens(Greenwich) 5.5, pp. 337–44. issn: 1524-6175 (Print) 1524-6175.

Rowlands, S. and P. Hannaford (2003). “The incidence of sterilisation in theUK”. In: Bjog 110.9, pp. 819–24. issn: 1470-0328 (Print) 1470-0328.

Ruigomez, A. et al. (2003). “Is hormone replacement therapy associated with anincreased risk of irritable bowel syndrome?” In: Maturitas 44.2, pp. 133–40.issn: 0378-5122 (Print) 0378-5122.

Seaman, H. E., C. S. de Vries, and R. D. Farmer (2003a). “Differences in the useof combined oral contraceptives amongst women with and without acne”. In:Hum Reprod 18.3, pp. 515–21. issn: 0268-1161 (Print) 0268-1161.

— (2003b). “The risk of liver disorders in women prescribed cyproterone acetatein combination with ethinyloestradiol (Dianette): a nested case-control studyusing the GPRD”. In: Pharmacoepidemiol Drug Saf 12.7, pp. 541–50. issn:1053-8569 (Print) 1053-8569. doi: 10.1002/pds.857.

— (2003c). “The risk of venous thromboembolism in women prescribed cypro-terone acetate in combination with ethinyl estradiol: a nested cohort analysisand case-control study”. In: Hum Reprod 18.3, pp. 522–6. issn: 0268-1161(Print) 0268-1161.

2

CPRD bibliography

227

hortinr

Highlight

Smeeth, L., M. Boulis, et al. (2003). “A population based case-control study ofcataract and inhaled corticosteroids”. In: Br J Ophthalmol 87.10, pp. 1247–51. issn: 0007-1161 (Print) 0007-1161.

Smeeth, L., R. Hubbard, and A. E. Fletcher (2003). “Cataract and the use ofstatins: a case-control study”. In: Qjm 96.5, pp. 337–43. issn: 1460-2725(Print) 1460-2393.

Smith, S. et al. (2003). “Head lice diagnosed in general practice in the West Mid-lands between 1993 and 2000: a survey using the General Practice ResearchDatabase”. In: Commun Dis Public Health 6.2, pp. 139–43. issn: 1462-1843(Print) 1462-1843.

Soriano, J. B., K. J. Davis, et al. (2003). “The proportional Venn diagram ofobstructive lung disease: two approximations from the United States andthe United Kingdom”. In: Chest 124.2, pp. 474–81. issn: 0012-3692 (Print)0012-3692.

Soriano, J. B., V. A. Kiri, et al. (2003). “Increasing prevalence of asthma in UKprimary care during the 1990s”. In: Int J Tuberc Lung Dis 7.5, pp. 415–21.issn: 1027-3719 (Print) 1027-3719.

Souverein, P. C. et al. (2003). “Use of alpha-blockers and the risk of hip/femurfractures”. In: J Intern Med 254.6, pp. 548–54. issn: 0954-6820 (Print) 0954-6820.

Staa, T. P. van, F. Boulton, et al. (2003). “Neutropenia and agranulocytosisin England and Wales: incidence and risk factors”. In: Am J Hematol 72.4,pp. 248–54. issn: 0361-8609 (Print) 0361-8609. doi: 10.1002/ajh.10295.

Staa, T. P. van, C. Cooper, H. G. Leufkens, and N. Bishop (2003). “Childrenand the risk of fractures caused by oral corticosteroids”. In: J Bone MinerRes 18.5, pp. 913–8. issn: 0884-0431 (Print) 0884-0431. doi: 10.1359/jbmr.2003.18.5.913.

Staa, T. P. van, C. Cooper, H. G. Leufkens, J. W. Lammers, et al. (2003). “Theuse of inhaled corticosteroids in the United Kingdom and the Netherlands”.In: Respir Med 97.5, pp. 578–85. issn: 0954-6111 (Print) 0954-6111.

Strom, B. L. et al. (2003). “Absence of cross-reactivity between sulfonamide an-tibiotics and sulfonamide nonantibiotics”. In: N Engl J Med 349.17, pp. 1628–35. issn: 0028-4793. doi: 10.1056/NEJMoa022963.

Tata, L. J. et al. (2003). “Does influenza vaccination increase consultations,corticosteroid prescriptions, or exacerbations in subjects with asthma orchronic obstructive pulmonary disease?” In: Thorax 58.10, pp. 835–9. issn:0040-6376 (Print) 0040-6376.

Toledano, M. B. et al. (2003). “Temporal trends in orchidopexy, Great Britain,1992-1998”. In: Environ Health Perspect 111.1, pp. 129–32. issn: 0091-6765(Print) 0091-6765. doi: 10.1289/ehp.5446.

Watson, D. J., T. Rhodes, and H. A. Guess (2003). “All-cause mortality andvascular events among patients with rheumatoid arthritis, osteoarthritis, orno arthritis in the UK General Practice Research Database”. In: J Rheumatol30.6, pp. 1196–202. issn: 0315-162X (Print) 0315-162x.

West, J. et al. (2003). “Fracture risk in people with celiac disease: a population-based cohort study”. In: Gastroenterology 125.2, pp. 429–36. issn: 0016-5085(Print) 0016-5085.

Wood, S. L., H. Jick, and R. Sauve (2003). “The risk of stillbirth in pregnanciesbefore and after the onset of diabetes”. In: Diabet Med 20.9, pp. 703–7. issn:0742-3071 (Print) 0742-3071.

3

CPRD bibliography

228

Yang, C. C., S. S. Jick, and H. Jick (2003). “Lipid-lowering drugs and the risk ofdepression and suicidal behavior”. In: Arch Intern Med 163.16, pp. 1926–32.issn: 0003-9926 (Print) 0003-9926. doi: 10.1001/archinte.163.16.1926.

Yang, C. C., S. S. Jick, and M. A. Testa (2003a). “Discontinuation and switchingof therapy after initiation of lipid-lowering drugs: the effects of comorbiditiesand patient characteristics”. In: Br J Clin Pharmacol 56.1, pp. 84–91. issn:0306-5251 (Print) 0306-5251.

— (2003b). “Who receives lipid-lowering drugs: the effects of comorbidities andpatient characteristics on treatment initiation”. In: Br J Clin Pharmacol55.3, pp. 288–98. issn: 0306-5251 (Print) 0306-5251.

4

CPRD bibliography

229

hortinr

Highlight

2002

Bailey, K, C Ellis, and A Majeed (2002). “Trends in the treatment of osteoporo-sis and types of drug treatments prescribed in general practice in Englandand Wales, 1994 to 1998”. In: Health Stat Q 16, pp. 5–13.

Black, C. and H. Jick (2002). “Etiology and frequency of rhabdomyolysis”. In:Pharmacotherapy 22.12, pp. 1524–6. issn: 0277-0008 (Print) 0277-0008.

Black, C., J. A. Kaye, and H. Jick (2002a). “Clinical risk factors for venousthromboembolus in users of the combined oral contraceptive pill”. In: Br JClin Pharmacol 53.6, pp. 637–40. issn: 0306-5251 (Print) 0306-5251.

— (2002b). “Relation of childhood gastrointestinal disorders to autism: nestedcase-control study using data from the UK General Practice Research Database”.In: Bmj 325.7361, pp. 419–21. issn: 0959-8138.

Bradbury, B. D. and S. S. Jick (2002). “Itraconazole and fluconazole and certainrare, serious adverse events”. In: Pharmacotherapy 22.6, pp. 697–700. issn:0277-0008 (Print) 0277-0008.

Castellsague, J. et al. (2002). “Risk of serious skin disorders among users of oralantifungals: a population-based study”. In: BMC Dermatol 2, p. 14. issn:1471-5945.

Clifford, G. M. and R. D. Farmer (2002). “Drug or symptom-induced depressionin men treated with alpha 1-blockers for benign prostatic hyperplasia? Anested case-control study”. In: Pharmacoepidemiol Drug Saf 11.1, pp. 55–61. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.671.

Davey, G. et al. (2002). “Association between migraine and asthma: matchedcase-control study”. In: Br J Gen Pract 52.482, pp. 723–7. issn: 0960-1643(Print) 0960-1643.

Forrest, C. B. et al. (2002). “Comparison of specialty referral rates in the UnitedKingdom and the United States: retrospective cohort analysis”. In: Bmj325.7360, pp. 370–1. issn: 0959-8138.

Gaitatzis, A. et al. (2002). “Differences in the use of health services amongpeople with and without epilepsy in the United Kingdom: socio-economicand disease-specific determinants”. In: Epilepsy Res 50.3, pp. 233–41. issn:0920-1211 (Print) 0920-1211.

Hajat, S., H. R. Anderson, et al. (2002). “Effects of air pollution on generalpractitioner consultations for upper respiratory diseases in London”. In:Occup Environ Med 59.5, pp. 294–9. issn: 1351-0711 (Print) 1351-0711.

Hajat, S. and A. Haines (2002). “Associations of cold temperatures with GPconsultations for respiratory and cardiovascular disease amongst the elderlyin London”. In: Int J Epidemiol 31.4, pp. 825–30. issn: 0300-5771 (Print)0300-5771.

Howard, L. M. et al. (2002). “The general fertility rate in women with psychoticdisorders”. In: Am J Psychiatry 159.6, pp. 991–7. issn: 0002-953X (Print)0002-953x. doi: 10.1176/appi.ajp.159.6.991.

Hubbard, R. B. et al. (2002). “Inhaled corticosteroids and hip fracture: a population-based case-control study”. In: Am J Respir Crit Care Med 166.12 Pt 1,pp. 1563–6. issn: 1073-449X (Print) 1073-449x. doi: 10.1164/rccm.200206-606OC.

1

CPRD bibliography

230

hortinr

Highlight

Hubbard, R. and A. Venn (2002). “The impact of coexisting connective tissuedisease on survival in patients with fibrosing alveolitis”. In: Rheumatology(Oxford) 41.6, pp. 676–9. issn: 1462-0324 (Print) 1462-0324.

Huerta, C. and L. A. Garcia Rodriguez (2002). “Risk of clinical blood dyscrasiain a cohort of antibiotic users”. In: Pharmacotherapy 22.5, pp. 630–6. issn:0277-0008 (Print) 0277-0008.

Huerta, C., L. A. Garcia Rodriguez, et al. (2002). “Risk of irritable bowelsyndrome among asthma patients”. In: Pharmacoepidemiol Drug Saf 11.1,pp. 31–5. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.666.

Huerta, C., S. Z. Zhao, and L. A. Garcia Rodriguez (2002). “Risk of acute liverinjury in patients with diabetes”. In: Pharmacotherapy 22.9, pp. 1091–6.issn: 0277-0008 (Print) 0277-0008.

Johansson, S. et al. (2002). “Treatment patterns among newly diagnosed heartfailure patients in general practice”. In: Eur J Clin Pharmacol 57.11, pp. 813–7. issn: 0031-6970 (Print) 0031-6970.

Kang, J. Y. et al. (2002). “Peptic ulceration in general practice in Englandand Wales 1994-98: period prevalence and drug management”. In: AlimentPharmacol Ther 16.6, pp. 1067–74. issn: 0269-2813 (Print) 0269-2813.

Kaye, J. A. et al. (2002). “Statin use, hyperlipidaemia, and the risk of breastcancer”. In: Br J Cancer 86.9, pp. 1436–9. issn: 0007-0920 (Print) 0007-0920.doi: 10.1038/sj.bjc.6600267.

Kennerfalk, A. et al. (2002). “Geriatric drug therapy and healthcare utilizationin the United kingdom”. In: Ann Pharmacother 36.5, pp. 797–803. issn:1060-0280 (Print) 1060-0280. doi: 10.1345/aph.1A226.

Kornegay, C. J., C. Vasilakis-Scaramozza, and H. Jick (2002). “Incident diabetesassociated with antipsychotic use in the United Kingdom general practiceresearch database”. In: J Clin Psychiatry 63.9, pp. 758–62. issn: 0160-6689(Print) 0160-6689.

Koro, C. E., D. O. Fedder, G. J. L’Italien, S. S. Weiss, et al. (2002). “Assessmentof independent effect of olanzapine and risperidone on risk of diabetes amongpatients with schizophrenia: population based nested case-control study”. In:Bmj 325.7358, p. 243. issn: 0959-8138.

Koro, C. E., D. O. Fedder, G. J. L’Italien, S. Weiss, et al. (2002). “An assessmentof the independent effects of olanzapine and risperidone exposure on the riskof hyperlipidemia in schizophrenic patients”. In: Arch Gen Psychiatry 59.11,pp. 1021–6. issn: 0003-990X (Print) 0003-990x.

Lanes, S. F., L. A. Garcia Rodriguez, and C. Huerta (2002). “Respiratory med-ications and risk of asthma death”. In: Thorax 57.8, pp. 683–6. issn: 0040-6376 (Print) 0040-6376.

Lewis, J. D. et al. (2002). “Validity and completeness of the General PracticeResearch Database for studies of inflammatory bowel disease”. In: Pharma-coepidemiol Drug Saf 11.3, pp. 211–8. issn: 1053-8569 (Print) 1053-8569.doi: 10.1002/pds.698.

Macfarlane, A et al. (2002). “Can the General Practice Research Database beused to monitor the health of babies and their mothers?” In: Health Stat Q13, pp. 5–15.

Margolis, D. J., W. Bilker, J. Knauss, et al. (2002). “The incidence and preva-lence of pressure ulcers among elderly patients in general medical practice”.In: Ann Epidemiol 12.5, pp. 321–5. issn: 1047-2797 (Print) 1047-2797.

2

CPRD bibliography

231

Margolis, D. J., W. Bilker, J. Santanna, et al. (2002). “Venous leg ulcer: inci-dence and prevalence in the elderly”. In: J Am Acad Dermatol 46.3, pp. 381–6. issn: 0190-9622 (Print) 0190-9622.

Margolis, D. J., J. Knauss, and W. Bilker (2002). “Hormone replacement ther-apy and prevention of pressure ulcers and venous leg ulcers”. In: Lancet359.9307, pp. 675–7. issn: 0140-6736 (Print) 0140-6736. doi: 10 . 1016 /

s0140-6736(02)07806-6.Martin, R. M. et al. (2002). “Population need for coronary revascularisation:

are national targets for England credible?” In: Heart 88.6, pp. 627–33. issn:1355-6037.

McCarney, R., P. Fisher, and R. van Haselen (2002). “Accruing large numbersof patients in primary care trials by retrospective recruitment methods”. In:Complement Ther Med 10.2, pp. 63–8. issn: 0965-2299 (Print) 0965-2299.

McKeever, T. M., S. A. Lewis, C. Smith, J. Collins, et al. (2002). “Early exposureto infections and antibiotics and the incidence of allergic disease: a birthcohort study with the West Midlands General Practice Research Database”.In: J Allergy Clin Immunol 109.1, pp. 43–50. issn: 0091-6749 (Print) 0091-6749.

McKeever, T. M., S. A. Lewis, C. Smith, and R. Hubbard (2002a). “Mode ofdelivery and risk of developing allergic disease”. In: J Allergy Clin Immunol109.5, pp. 800–2. issn: 0091-6749 (Print) 0091-6749.

— (2002b). “The importance of prenatal exposures on the development of aller-gic disease: a birth cohort study using the West Midlands General PracticeDatabase”. In: Am J Respir Crit Care Med 166.6, pp. 827–32. issn: 1073-449X (Print) 1073-449x. doi: 10.1164/rccm.200202-158OC.

Meier, C. R., S. Krahenbuhl, et al. (2002). “Association between body massindex and liver disorders: an epidemiological study”. In: J Hepatol 37.6,pp. 741–7. issn: 0168-8278 (Print) 0168-8278.

Meier, C. R., S. Schmitz, and H. Jick (2002). “Association between acetaminophenor nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast,or colon cancer”. In: Pharmacotherapy 22.3, pp. 303–9. issn: 0277-0008(Print) 0277-0008.

Newnham, A. et al. (2002). “Prevalence of diagnosed diabetes mellitus in generalpractice in England and Wales, 1994 to 1998”. In: Health Stat Q 14, pp. 5–13.

Purcell, B. et al. (2002). “Epilepsy prevalence and prescribing patterns in Eng-land and Wales.” In: Health Stat Q 15.Autumn, pp. 23–30.

Rowlands, S., R. Hooper, et al. (2002). “The epidemiology and treatment ofBell’s palsy in the UK”. In: Eur J Neurol 9.1, pp. 63–7. issn: 1351-5101(Print) 1351-5101.

Rowlands, S. and K. Moser (2002). “Consultation rates from the general practiceresearch database”. In: Br J Gen Pract 52.481, pp. 658–60. issn: 0960-1643(Print) 0960-1643.

Ruigomez, A., S. Johansson, M. A. Wallander, and L. A. Garcia Rodriguez(2002). “Risk of mortality in a cohort of patients newly diagnosed withchronic atrial fibrillation”. In: BMC Cardiovasc Disord 2, p. 5. issn: 1471-2261.

Ruigomez, A., S. Johansson, M. A. Wallander, and L. A. Rodriguez (2002).“Incidence of chronic atrial fibrillation in general practice and its treatment

3

CPRD bibliography

232

hortinr

Highlight

pattern”. In: J Clin Epidemiol 55.4, pp. 358–63. issn: 0895-4356 (Print)0895-4356.

Ryan, R. and A. Majeed (2002). “Prevalence of treated hypertension in generalpractice in England and Wales, 1994 to 1998.” In: Health Stat Q 16, pp. 14–8.

Schlienger, R. G., H. Jick, and C. R. Meier (2002). “Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction”.In: Br J Clin Pharmacol 54.3, pp. 327–32. issn: 0306-5251 (Print) 0306-5251.

Sheppard, M. C., R. Holder, and J. A. Franklyn (2002). “Levothyroxine treat-ment and occurrence of fracture of the hip”. In: Arch Intern Med 162.3,pp. 338–43. issn: 0003-9926 (Print) 0003-9926.

Shorvon, S. D., R. C. Tallis, and H. K. Wallace (2002). “Antiepileptic drugs:coprescription of proconvulsant drugs and oral contraceptives: a nationalstudy of antiepileptic drug prescribing practice”. In: J Neurol NeurosurgPsychiatry 72.1, pp. 114–5. issn: 0022-3050 (Print) 0022-3050.

Soriano, J. B. et al. (2002). “Survival in COPD patients after regular use offluticasone propionate and salmeterol in general practice”. In: Eur Respir J20.4, pp. 819–25. issn: 0903-1936 (Print) 0903-1936.

Staa, T. P. van, H. G. Leufkens, and C. Cooper (2002a). “Does a fracture atone site predict later fractures at other sites? A British cohort study”. In:Osteoporos Int 13.8, pp. 624–9. issn: 0937-941X (Print) 0937-941x. doi:10.1007/s001980200084.

— (2002b). “Utility of medical and drug history in fracture risk predictionamong men and women”. In: Bone 31.4, pp. 508–14. issn: 8756-3282 (Print)1873-2763.

Staa, T. P. van, P. Selby, et al. (2002). “Incidence and natural history of Paget’sdisease of bone in England and Wales”. In: J Bone Miner Res 17.3, pp. 465–71. issn: 0884-0431 (Print) 0884-0431. doi: 10.1359/jbmr.2002.17.3.465.

Watson, D. J. et al. (2002). “Lower risk of thromboembolic cardiovascular eventswith naproxen among patients with rheumatoid arthritis”. In: Arch InternMed 162.10, pp. 1105–10. issn: 0003-9926 (Print) 0003-9926.

Wrigley, T., A. Tinto, and A. Majeed (2002). “Age and sex specific antibioticprescribing patterns in general practice in England and Wales, 1994 to 1998.”In: Health Stat Q 14, pp. 14–20.

Wyatt, K. M. et al. (2002). “Prescribing patterns in premenstrual syndrome”.In: BMC Womens Health 2.1, p. 4. issn: 1472-6874.

Yang, C. C., S. S. Jick, and H. Jick (2002). “Statins and the risk of idiopathicvenous thromboembolism”. In: Br J Clin Pharmacol 53.1, pp. 101–5. issn:0306-5251 (Print) 0306-5251.

4

CPRD bibliography

233

hortinr

Highlight

2001

Abajo, F. J. de and L. A. Garcia Rodriguez (2001). “Risk of upper gastroin-testinal bleeding and perforation associated with low-dose aspirin as plainand enteric-coated formulations”. In: BMC Clin Pharmacol 1, p. 1. issn:1472-6904.

Andrews, N. et al. (2001). “Does oral polio vaccine cause intussusception ininfants? Evidence from a sequence of three self-controlled cases series studiesin the United Kingdom”. In: Eur J Epidemiol 17.8, pp. 701–6. issn: 0393-2990 (Print) 0393-2990.

Bommel, M. J. van et al. (2001). “Consultations and referrals for dyspepsia ingeneral practice–a one year database survey”. In: Postgrad Med J 77.910,pp. 514–8. issn: 0032-5473 (Print) 0032-5473.

Chapple, C. R. (2001). “Lower urinary tract symptoms suggestive of benignprostatic obstruction–Triumph: design and implementation”. In: Eur Urol39 Suppl 3, pp. 31–6. issn: 0302-2838 (Print) 0302-2838. doi: 10.1159/

000052565.Ellis, C, S Gnani, and A Majeed (2001). “Prevalence and management of heart

failure in general practice in England and Wales, 1994-98”. In: Health StatQ. 11, pp. 17–24.

Frischer, M. et al. (2001). “Trends in antibiotic prescribing and associated in-dications in primary care from 1993 to 1997”. In: J Public Health Med 23.1,pp. 69–73. issn: 0957-4832 (Print) 0957-4832.

Gaist, D. et al. (2001). “Lipid-lowering drugs and risk of myopathy: a population-based follow-up study”. In: Epidemiology 12.5, pp. 565–9. issn: 1044-3983(Print) 1044-3983.

Gale, C. R. et al. (2001). “Patterns of prescribing of nutritional supplements inthe United Kingdom”. In: Clin Nutr 20.4, pp. 333–7. issn: 0261-5614 (Print)0261-5614. doi: 10.1054/clnu.2001.0396.

Garcia Rodriguez, L. A. and S. Hernandez-Diaz (2001a). “Relative risk of up-per gastrointestinal complications among users of acetaminophen and non-steroidal anti-inflammatory drugs”. In: Epidemiology 12.5, pp. 570–6. issn:1044-3983 (Print) 1044-3983.

— (2001b). “The risk of upper gastrointestinal complications associated withnonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, andcombinations of these agents”. In: Arthritis Res 3.2, pp. 98–101. issn: 1465-9905 (Print) 1465-9905. doi: 10.1186/ar146.

Garcia-Rodriguez, L. A. and C. Huerta-Alvarez (2001). “Reduced risk of col-orectal cancer among long-term users of aspirin and nonaspirin nonsteroidalantiinflammatory drugs”. In: Epidemiology 12.1, pp. 88–93. issn: 1044-3983(Print) 1044-3983.

Gibbs, R. G. et al. (2001). “Diagnosis and initial management of stroke andtransient ischemic attack across UK health regions from 1992 to 1996: ex-perience of a national primary care database”. In: Stroke 32.5, pp. 1085–90.issn: 0039-2499.

Hajat, S. et al. (2001). “Association between air pollution and daily consulta-tions with general practitioners for allergic rhinitis in London, United King-

1

CPRD bibliography

234

hortinr

Highlight

dom”. In: Am J Epidemiol 153.7, pp. 704–14. issn: 0002-9262 (Print) 0002-9262.

Hernandez-Diaz, S. and L. A. Garcia-Rodriguez (2001). “Epidemiologic assess-ment of the safety of conventional nonsteroidal anti-inflammatory drugs”.In: Am J Med 110 Suppl 3A, 20s–7s. issn: 0002-9343 (Print) 0002-9343.

Hernandez-Diaz, S. and L. A. Rodriguez (2001). “Steroids and risk of uppergastrointestinal complications”. In: Am J Epidemiol 153.11, pp. 1089–93.issn: 0002-9262 (Print) 0002-9262.

Higuchi, L. M. et al. (2001). “Inflammatory bowel disease associated with im-mune thrombocytopenic purpura in children”. In: J Pediatr GastroenterolNutr 33.5, pp. 582–7. issn: 0277-2116 (Print) 0277-2116.

Hodgson, C. and C. Ellis (2001). “Time trends in GP outpatient referrals.” In:Health Statistics Quartely 10, pp. 14–9.

Huerta, C., L. A. Garcia Rodriguez, et al. (2001). “The risk of obstructiveairways disease in a glaucoma population”. In: Pharmacoepidemiol Drug Saf10.2, pp. 157–63. issn: 1053-8569 (Print) 1053-8569. doi: 10.1002/pds.567.

Huerta, C. and L. A. Rodriguez (2001). “Incidence of ocular melanoma in thegeneral population and in glaucoma patients”. In: J Epidemiol CommunityHealth 55.5, pp. 338–9. issn: 0143-005X (Print) 0143-005x.

Jick, H., C. Vasilakis-Scaramozza, and S. S. Jick (2001). “Live attenuated poliovaccine and the risk of intussusception”. In: Br J Clin Pharmacol 52.4,pp. 451–3. issn: 0306-5251 (Print) 0306-5251.

Jick, S. S., C. Vasilakis-Scaramozza, and W. C. Maier (2001). “The risk ofcataract among users of inhaled steroids”. In: Epidemiology 12.2, pp. 229–34. issn: 1044-3983 (Print) 1044-3983.

Johansson, S. et al. (2001). “Incidence of newly diagnosed heart failure in UKgeneral practice”. In: Eur J Heart Fail 3.2, pp. 225–31. issn: 1388-9842(Print) 1388-9842.

Kaye, J. A., M. del Mar Melero-Montes, and H. Jick (2001). “Mumps, measles,and rubella vaccine and the incidence of autism recorded by general practi-tioners: a time trend analysis”. In: Bmj 322.7284, pp. 460–3. issn: 0959-8138(Print) 0959-8138.

Kaye, J. A., M. W. Myers, and H. Jick (2001). “Acetaminophen and the riskof renal and bladder cancer in the general practice research database”. In:Epidemiology 12.6, pp. 690–4. issn: 1044-3983 (Print) 1044-3983.

Lawrenson, R. A. and J. W. Logie (2001). “Antibiotic failure in the treatmentof urinary tract infections in young women”. In: J Antimicrob Chemother48.6, pp. 895–901. issn: 0305-7453 (Print) 0305-7453.

Lawrenson, R. et al. (2001). “Renal failure in patients with neurogenic lowerurinary tract dysfunction”. In: Neuroepidemiology 20.2, pp. 138–43. issn:0251-5350 (Print) 0251-5350. doi: 10.1159/000054774.

Lewis, J. D. et al. (2001). “Inflammatory bowel disease is not associated with anincreased risk of lymphoma”. In: Gastroenterology 121.5, pp. 1080–7. issn:0016-5085 (Print) 0016-5085.

Logie, J. W. et al. (2001). “Lower urinary tract symptoms suggestive of benignprostatic obstruction–Triumph: the role of general practice databases”. In:Eur Urol 39 Suppl 3, pp. 42–7. issn: 0302-2838 (Print) 0302-2838. doi:10.1159/000052567.

Majeed, A., K. Moser, and K. Carroll (2001). “Trends in the prevalence andmanagement of atrial fibrillation in general practice in England and Wales,

2

CPRD bibliography

235

1994-1998: analysis of data from the general practice research database”. In:Heart 86.3, pp. 284–8. issn: 1355-6037.

McGuire, A. et al. (2001). “The excess cost of acute exacerbations of chronicbronchitis in patients aged 45 and older in England and Wales”. In: ValueHealth 4.5, pp. 370–5. issn: 1098-3015 (Print) 1098-3015. doi: 10.1046/j.1524-4733.2001.45049.x.

McKeever, T. M. et al. (2001). “Siblings, multiple births, and the incidenceof allergic disease: a birth cohort study using the West Midlands generalpractice research database”. In: Thorax 56.10, pp. 758–62. issn: 0040-6376(Print) 0040-6376.

Meier, C. R., R. G. Schlienger, and H. Jick (2001). “Use of selective serotoninreuptake inhibitors and risk of developing first-time acute myocardial in-farction”. In: Br J Clin Pharmacol 52.2, pp. 179–84. issn: 0306-5251 (Print)0306-5251.

MFG, Akram (2001). “Prevalence of comorbid mental illness and drug userecorded in general practice: preliminary findings from the general practiceresearch database”. In: Drugs: education, prevention and policy 8.3, pp. 275–80.

Moser, K. (2001). “Inequalities in treated heart disease and mental illness inEngland and Wales, 1994-1998”. In: Br J Gen Pract 51.467, pp. 438–44.issn: 0960-1643 (Print) 0960-1643.

Rowlands, S., H. Devalia, and R. Lawrenson (2001a). “Preferential prescribing oftype of combined oral contraceptive pill by general practitioners to teenagerswith acne”. In: Eur J Contracept Reprod Health Care 6.1, pp. 9–13. issn:1362-5187 (Print) 1362-5187.

— (2001b). “Use of the combined oral contraceptive pill by under 16s”. In:J Fam Plann Reprod Health Care 27.1, pp. 17–9. issn: 1471-1893 (Print)1471-1893.

Rowlands, S., H. Devalia, C. Smith, et al. (2001). “Otitis externa in UK generalpractice: a survey using the UK General Practi

cprd bibliography

Documents